0000917520-20-000020.txt : 20200507 0000917520-20-000020.hdr.sgml : 20200507 20200507163510 ACCESSION NUMBER: 0000917520-20-000020 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 93 CONFORMED PERIOD OF REPORT: 20200331 FILED AS OF DATE: 20200507 DATE AS OF CHANGE: 20200507 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRA LIFESCIENCES HOLDINGS CORP CENTRAL INDEX KEY: 0000917520 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 510317849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-26224 FILM NUMBER: 20857042 BUSINESS ADDRESS: STREET 1: 1100 CAMPUS ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6092750500 MAIL ADDRESS: STREET 1: 1100 CAMPUS ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRA LIFESCIENCES CORP DATE OF NAME CHANGE: 19950614 10-Q 1 iart-2020033110xq.htm 10-Q Document
false--12-31Q120200000917520P3Y5.004.504.00P1M430300066520004000002000000.010.0124000000024000000088735000891040008000008775000001000001000000150000001500000000P9MP6Y28650004294000 0000917520 2020-01-01 2020-03-31 0000917520 2020-05-05 0000917520 2019-01-01 2019-03-31 0000917520 2019-12-31 0000917520 2020-03-31 0000917520 2018-12-31 0000917520 2019-03-31 0000917520 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000917520 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000917520 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000917520 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0000917520 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0000917520 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000917520 us-gaap:TreasuryStockMember 2020-01-01 2020-03-31 0000917520 us-gaap:CommonStockMember 2019-12-31 0000917520 us-gaap:CommonStockMember 2020-03-31 0000917520 us-gaap:TreasuryStockMember 2020-03-31 0000917520 us-gaap:TreasuryStockMember 2019-12-31 0000917520 iart:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2020-01-01 0000917520 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000917520 us-gaap:RetainedEarningsMember 2019-12-31 0000917520 us-gaap:RetainedEarningsMember 2020-03-31 0000917520 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000917520 iart:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-01-01 0000917520 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0000917520 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000917520 us-gaap:TreasuryStockMember 2018-12-31 0000917520 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000917520 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0000917520 us-gaap:CommonStockMember 2019-03-31 0000917520 us-gaap:RetainedEarningsMember 2019-03-31 0000917520 us-gaap:TreasuryStockMember 2019-01-01 2019-03-31 0000917520 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0000917520 us-gaap:CommonStockMember 2018-12-31 0000917520 us-gaap:TreasuryStockMember 2019-03-31 0000917520 us-gaap:RetainedEarningsMember 2018-12-31 0000917520 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000917520 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000917520 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000917520 iart:ArkisBioSciencesInc.Member 2019-07-29 2019-07-29 0000917520 iart:ReboundTherapeuticsCorporationMember 2019-09-09 2019-09-09 0000917520 iart:IntegratedShoulderCollaborationInc.Member us-gaap:LicensingAgreementsMember 2019-01-04 2019-01-04 0000917520 iart:ArkisBioSciencesInc.Member iart:MilestonePaymentTwoMember 2019-07-29 0000917520 iart:ArkisBioSciencesInc.Member 2019-07-29 0000917520 iart:ReboundTherapeuticsCorporationMember iart:DeferredTaxAssetMember 2019-09-09 2019-09-09 0000917520 iart:ReboundTherapeuticsCorporationMember 2019-12-31 0000917520 iart:ArkisBioSciencesInc.Member iart:MilestonePaymentOneMember 2019-07-29 0000917520 iart:ReboundTherapeuticsCorporationMember 2019-01-01 2019-12-31 0000917520 iart:ReboundTherapeuticsCorporationMember 2019-09-09 0000917520 iart:ReboundTherapeuticsCorporationMember 2019-01-01 2019-03-31 0000917520 iart:ReboundTherapeuticsCorporationMember us-gaap:CashAndCashEquivalentsMember 2019-09-09 2019-09-09 0000917520 iart:ArkisBioSciencesInc.Member 2019-12-31 0000917520 iart:ReboundTherapeuticsCorporationMember us-gaap:InProcessResearchAndDevelopmentMember 2019-09-09 2019-09-09 0000917520 iart:ArkisBioSciencesInc.Member us-gaap:DevelopedTechnologyRightsMember 2019-07-29 0000917520 iart:ArkisBioSciencesInc.Member us-gaap:DevelopedTechnologyRightsMember 2019-07-29 2019-07-29 0000917520 iart:ArkisBioSciencesInc.Member us-gaap:LicensingAgreementsMember 2019-07-29 0000917520 iart:ArkisBioSciencesInc.Member us-gaap:LicensingAgreementsMember 2019-07-29 2019-07-29 0000917520 iart:PrivateLabelMember iart:OrthopedicsandTissueTechnologiesMember 2020-01-01 2020-03-31 0000917520 iart:InstrumentsMember iart:CodmanSpecialtySurgicalMember 2019-01-01 2019-03-31 0000917520 iart:RegenerativeSkinAndWoundMember iart:OrthopedicsandTissueTechnologiesMember 2020-01-01 2020-03-31 0000917520 iart:NeurosurgeryMember iart:CodmanSpecialtySurgicalMember 2019-01-01 2019-03-31 0000917520 iart:ExtremityOrthopedicsMember iart:OrthopedicsandTissueTechnologiesMember 2020-01-01 2020-03-31 0000917520 iart:OrthopedicsandTissueTechnologiesMember 2020-01-01 2020-03-31 0000917520 iart:OrthopedicsandTissueTechnologiesMember 2019-01-01 2019-03-31 0000917520 iart:InstrumentsMember iart:CodmanSpecialtySurgicalMember 2020-01-01 2020-03-31 0000917520 iart:RegenerativeSkinAndWoundMember iart:OrthopedicsandTissueTechnologiesMember 2019-01-01 2019-03-31 0000917520 iart:ExtremityOrthopedicsMember iart:OrthopedicsandTissueTechnologiesMember 2019-01-01 2019-03-31 0000917520 iart:CodmanSpecialtySurgicalMember 2019-01-01 2019-03-31 0000917520 iart:NeurosurgeryMember iart:CodmanSpecialtySurgicalMember 2020-01-01 2020-03-31 0000917520 iart:CodmanSpecialtySurgicalMember 2020-01-01 2020-03-31 0000917520 iart:PrivateLabelMember iart:OrthopedicsandTissueTechnologiesMember 2019-01-01 2019-03-31 0000917520 srt:MaximumMember 2020-01-01 2020-03-31 0000917520 2020-04-01 2020-03-31 0000917520 srt:MinimumMember 2020-01-01 2020-03-31 0000917520 us-gaap:InProcessResearchAndDevelopmentMember 2020-03-31 0000917520 iart:AllOtherMember 2019-01-01 2019-12-31 0000917520 iart:TrademarksBrandNamesMember 2019-12-31 0000917520 us-gaap:CustomerRelationshipsMember 2019-12-31 0000917520 iart:TrademarksBrandNamesMember 2019-01-01 2019-12-31 0000917520 iart:AllOtherMember 2019-12-31 0000917520 iart:CompletedTechnologyMember 2019-12-31 0000917520 us-gaap:TradeNamesMember 2019-12-31 0000917520 iart:SupplierRelationShipsMember 2019-01-01 2019-12-31 0000917520 iart:SupplierRelationShipsMember 2019-12-31 0000917520 iart:CompletedTechnologyMember 2019-01-01 2019-12-31 0000917520 us-gaap:CustomerRelationshipsMember 2019-01-01 2019-12-31 0000917520 iart:OrthopedicsandTissueTechnologiesMember 2019-12-31 0000917520 iart:CodmanSpecialtySurgicalMember 2020-03-31 0000917520 iart:OrthopedicsandTissueTechnologiesMember 2020-03-31 0000917520 iart:CodmanSpecialtySurgicalMember 2019-12-31 0000917520 us-gaap:CustomerRelationshipsMember 2020-03-31 0000917520 iart:CompletedTechnologyMember 2020-03-31 0000917520 iart:SupplierRelationShipsMember 2020-03-31 0000917520 us-gaap:TradeNamesMember 2020-03-31 0000917520 iart:CompletedTechnologyMember 2020-01-01 2020-03-31 0000917520 iart:AllOtherMember 2020-03-31 0000917520 iart:TrademarksBrandNamesMember 2020-03-31 0000917520 us-gaap:CustomerRelationshipsMember 2020-01-01 2020-03-31 0000917520 iart:AllOtherMember 2020-01-01 2020-03-31 0000917520 iart:SupplierRelationShipsMember 2020-01-01 2020-03-31 0000917520 iart:TrademarksBrandNamesMember 2020-01-01 2020-03-31 0000917520 us-gaap:InProcessResearchAndDevelopmentMember 2019-12-31 0000917520 iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember us-gaap:ConvertibleDebtMember 2020-02-04 0000917520 us-gaap:StandbyLettersOfCreditMember 2020-02-03 0000917520 us-gaap:SecuredDebtMember iart:TermLoanFacilityMember us-gaap:FairValueInputsLevel2Member 2020-03-31 0000917520 iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember us-gaap:ConvertibleDebtMember 2020-02-04 2020-02-04 0000917520 us-gaap:RevolvingCreditFacilityMember us-gaap:FairValueInputsLevel2Member 2020-03-31 0000917520 iart:SwinglineLoanMember 2020-02-03 0000917520 iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember us-gaap:ConvertibleDebtMember 2020-01-01 2020-03-31 0000917520 srt:MaximumMember iart:SeniorCreditFacilityMember 2020-01-01 2020-03-31 0000917520 srt:MaximumMember iart:SeniorCreditFacilityMember us-gaap:EurodollarMember 2020-01-01 2020-03-31 0000917520 us-gaap:RevolvingCreditFacilityMember 2020-03-31 0000917520 us-gaap:StandbyLettersOfCreditMember iart:SeniorCreditFacilityMember 2020-03-31 0000917520 iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember us-gaap:ConvertibleDebtMember 2020-03-31 0000917520 us-gaap:RevolvingCreditFacilityMember 2019-12-31 0000917520 iart:SeniorCreditFacilityMember 2020-02-03 0000917520 iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:CallOptionMember 2020-01-01 2020-03-31 0000917520 us-gaap:SecuredDebtMember iart:TermLoanAFacilityMember 2020-03-31 0000917520 iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:CallOptionMember 2020-02-04 2020-02-04 0000917520 us-gaap:RevolvingCreditFacilityMember 2020-02-03 0000917520 iart:SecuredDebtCurrentMember us-gaap:SecuredDebtMember iart:TermLoanAFacilityMember 2020-03-31 0000917520 iart:SeniorCreditFacilityMember iart:OneMonthEurodollarRateMember 2020-01-01 2020-03-31 0000917520 srt:MinimumMember iart:SeniorCreditFacilityMember 2020-01-01 2020-03-31 0000917520 iart:SeniorCreditFacilityMember us-gaap:FederalFundsEffectiveSwapRateMember 2020-01-01 2020-03-31 0000917520 us-gaap:SecuredDebtMember iart:TermLoanFacilityMember 2020-02-03 0000917520 us-gaap:SecuredDebtMember iart:TermLoanAFacilityMember 2019-12-31 0000917520 srt:MinimumMember iart:SeniorCreditFacilityMember us-gaap:EurodollarMember 2020-01-01 2020-03-31 0000917520 iart:SeniorCreditFacilityMember 2020-01-01 2020-03-31 0000917520 us-gaap:FairValueInputsLevel2Member 2020-03-31 0000917520 2018-10-01 2018-12-31 0000917520 us-gaap:StandbyLettersOfCreditMember iart:SeniorCreditFacilityMember 2019-12-31 0000917520 iart:DebtCovenantPeriod2Member iart:SeniorCreditFacilityMember 2020-02-03 0000917520 iart:DebtCovenantPeriod1Member iart:SeniorCreditFacilityMember 2020-02-03 0000917520 iart:DebtCovenantPeriod3Member iart:SeniorCreditFacilityMember 2020-02-03 0000917520 iart:SwapOneMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-12-31 0000917520 iart:SwapOneMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 iart:SwapThreeMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 iart:SwapTwoMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-12-31 0000917520 iart:SwapThreeMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-12-31 0000917520 iart:SwapOneMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-12-31 0000917520 iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 iart:SwapTwoMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-12-31 0000917520 iart:SwapThreeMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-12-31 0000917520 iart:SwapTwoMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2020-01-01 2020-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2018-12-31 0000917520 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2020-01-01 2020-03-31 0000917520 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2019-01-01 2019-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2020-01-01 2020-03-31 0000917520 us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-03-31 0000917520 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-12-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-03-31 0000917520 us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2019-01-01 2019-03-31 0000917520 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2020-03-31 0000917520 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000917520 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2020-03-31 0000917520 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2018-12-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-12-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2020-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2019-12-31 0000917520 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2019-03-31 0000917520 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2019-12-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2019-03-31 0000917520 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedFebruary62017Tranche1Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:ThreeMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedOctober102018Tranche2Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedDecember182018Tranche1Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedDecember182018Tranche2Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedFebruary62017Tranche2Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedDecember132017Tranche5Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedOctober102018Tranche1Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedDecember132017Tranche3Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedOctober102018Tranche3Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedMarch272017Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedDecember132017Tranche1Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedDecember132017Tranche4Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedDecember132017Tranche2Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedOctober102018Tranche1Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2019-12-31 0000917520 iart:InterestRateSwapDesignatedDecember182018Tranche1Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2019-12-31 0000917520 iart:InterestRateSwapDesignatedDecember132017Tranche3Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2019-12-31 0000917520 iart:InterestRateSwapDesignatedOctober102018Tranche2Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2019-12-31 0000917520 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 iart:InterestRateSwapDesignatedFebruary62017Tranche1Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:ThreeMonthUSDLIBORMember 2019-12-31 0000917520 iart:InterestRateSwapDesignatedDecember132017Tranche2Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2019-12-31 0000917520 iart:InterestRateSwapDesignatedDecember132017Tranche5Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2019-12-31 0000917520 iart:InterestRateSwapDesignatedOctober102018Tranche3Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2019-12-31 0000917520 iart:InterestRateSwapDesignatedMarch272017Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2019-12-31 0000917520 iart:InterestRateSwapDesignatedDecember182018Tranche2Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2019-12-31 0000917520 iart:InterestRateSwapDesignatedDecember132017Tranche1Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2019-12-31 0000917520 iart:InterestRateSwapDesignatedFebruary62017Tranche2Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2019-12-31 0000917520 iart:InterestRateSwapDesignatedDecember132017Tranche4Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractTwoMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractFiveMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractThreeMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractOneMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractThreeMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractFourMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractFourMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractThreeMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractOneMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractTwoMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractFourMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractFiveMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2020-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractOneMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractFiveMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractTwoMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:SwapTwoMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2020-03-31 0000917520 iart:SwapTwoMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:SwapThreeMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-03-31 0000917520 iart:SwapTwoMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-03-31 0000917520 iart:SwapOneMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-03-31 0000917520 iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:SwapOneMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:SwapThreeMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2020-03-31 0000917520 iart:SwapOneMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2020-03-31 0000917520 iart:SwapThreeMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 us-gaap:OtherLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 iart:AccruedExpensesAndOtherCurrentLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 us-gaap:OtherLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:AccruedExpensesAndOtherCurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 us-gaap:OtherAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 us-gaap:OtherAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 us-gaap:OtherAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:AccruedExpensesAndOtherCurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 us-gaap:OtherLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 us-gaap:OtherAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 iart:AccruedExpensesAndOtherCurrentLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 us-gaap:OtherAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 us-gaap:OtherAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 us-gaap:OtherLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractTwoMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractOneMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractFiveMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractThreeMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractFourMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractTwoMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractFourMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractFiveMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractFourMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractThreeMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractOneMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractTwoMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractFiveMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractThreeMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractOneMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-12-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-03-31 0000917520 us-gaap:InterestRateSwapMember 2020-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-03-31 0000917520 us-gaap:InterestRateSwapMember 2019-12-31 0000917520 iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-03-31 0000917520 iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:ShortMember 2017-10-02 0000917520 iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:LongMember 2017-10-02 0000917520 iart:RestrictedStockAwardsAndUnitsMember 2020-01-01 2020-03-31 0000917520 srt:DirectorMember us-gaap:EmployeeStockOptionMember 2020-01-01 2020-03-31 0000917520 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-03-31 0000917520 iart:EmployeeMember us-gaap:EmployeeStockOptionMember 2020-01-01 2020-03-31 0000917520 srt:MaximumMember iart:DirectorsandCertainExecutiveOfficersMember us-gaap:EmployeeStockOptionMember 2020-01-01 2020-03-31 0000917520 iart:RestrictedStockAwardsAndUnitsMember 2020-03-31 0000917520 us-gaap:EmployeeStockOptionMember 2020-03-31 0000917520 iart:PerformanceStockAndRestrictedStockAwardsMember 2020-01-01 2020-03-31 0000917520 us-gaap:PerformanceSharesMember 2020-01-01 2020-03-31 0000917520 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2020-01-01 2020-03-31 0000917520 srt:MinimumMember iart:DirectorsandCertainExecutiveOfficersMember us-gaap:EmployeeStockOptionMember 2020-01-01 2020-03-31 0000917520 2019-05-01 2019-05-31 0000917520 us-gaap:BuildingMember 2020-03-31 0000917520 us-gaap:VehiclesMember 2020-03-31 0000917520 srt:AffiliatedEntityMember 2020-01-01 2020-03-31 0000917520 iart:FiveYearOptionLeaseFromNovember12032ThroughOctober312037Member srt:AffiliatedEntityMember 2020-01-01 2020-03-31 0000917520 iart:FiveYearOptionLeaseFromNovember12037ThroughOctober312042Member srt:AffiliatedEntityMember 2020-01-01 2020-03-31 0000917520 iart:RelatedPartiesMember 2019-12-31 0000917520 iart:ThirdPartiesMember 2019-12-31 0000917520 iart:ThirdPartiesMember 2020-03-31 0000917520 iart:RelatedPartiesMember 2020-03-31 0000917520 srt:AffiliatedEntityMember 2019-01-01 2019-03-31 0000917520 iart:CertainPurchasersMember us-gaap:ConvertibleDebtMember 2020-01-01 2020-03-31 0000917520 2020-02-05 2020-02-05 0000917520 2018-12-11 0000917520 srt:ScenarioForecastMember us-gaap:SubsequentEventMember 2020-04-01 2020-06-30 0000917520 2019-01-01 2019-12-31 0000917520 us-gaap:ConvertibleDebtMember 2020-01-01 2020-03-31 0000917520 2020-02-05 0000917520 us-gaap:ForeignCountryMember us-gaap:SwissFederalTaxAdministrationFTAMember 2019-01-01 2019-03-31 0000917520 us-gaap:ForeignCountryMember us-gaap:SwissFederalTaxAdministrationFTAMember 2019-01-01 2019-12-31 0000917520 iart:PerformanceSharesandRestrictedUnitsMember 2019-12-31 0000917520 us-gaap:OtherExpenseMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-03-31 0000917520 us-gaap:InterestIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-03-31 0000917520 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-03-31 0000917520 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0000917520 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-31 0000917520 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-03-31 0000917520 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-31 0000917520 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-03-31 0000917520 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000917520 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-03-31 0000917520 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-31 0000917520 us-gaap:OperatingSegmentsMember 2019-01-01 2019-03-31 0000917520 us-gaap:OperatingSegmentsMember iart:OrthopedicsandTissueTechnologiesMember 2020-01-01 2020-03-31 0000917520 us-gaap:OperatingSegmentsMember iart:CodmanSpecialtySurgicalMember 2020-01-01 2020-03-31 0000917520 us-gaap:OperatingSegmentsMember 2020-01-01 2020-03-31 0000917520 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-03-31 0000917520 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-03-31 0000917520 us-gaap:OperatingSegmentsMember iart:CodmanSpecialtySurgicalMember 2019-01-01 2019-03-31 0000917520 us-gaap:OperatingSegmentsMember iart:OrthopedicsandTissueTechnologiesMember 2019-01-01 2019-03-31 0000917520 country:US 2020-01-01 2020-03-31 0000917520 srt:AsiaPacificMember 2020-01-01 2020-03-31 0000917520 srt:EuropeMember 2020-01-01 2020-03-31 0000917520 srt:AsiaPacificMember 2019-01-01 2019-03-31 0000917520 srt:EuropeMember 2019-01-01 2019-03-31 0000917520 country:US 2019-01-01 2019-03-31 0000917520 iart:RestOfWorldMember 2019-01-01 2019-03-31 0000917520 iart:RestOfWorldMember 2020-01-01 2020-03-31 0000917520 iart:DermaSciencesMember iart:BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember 2020-01-01 2020-03-31 0000917520 iart:DermaSciencesMember 2020-03-31 0000917520 iart:DermaSciencesMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2019-01-01 2019-03-31 0000917520 iart:DermaSciencesMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2018-12-31 0000917520 iart:DermaSciencesMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2019-03-31 0000917520 iart:DermaSciencesMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2019-12-31 0000917520 iart:ArkisBioSciencesInc.Member us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2019-12-31 0000917520 iart:ArkisBioSciencesInc.Member us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2020-01-01 2020-03-31 0000917520 iart:DermaSciencesMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2020-01-01 2020-03-31 0000917520 iart:DermaSciencesMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2020-03-31 0000917520 iart:ArkisBioSciencesInc.Member us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2020-03-31 0000917520 iart:DermaSciencesMember 2019-03-31 iart:plan iso4217:GBP xbrli:pure iart:asset iso4217:CHF iso4217:EUR iso4217:USD xbrli:shares iso4217:USD xbrli:shares iart:liability iart:renewal_option iart:Segment iart:product
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
FORM 10-Q
 
(Mark One)
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2020
or
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             
COMMISSION FILE NO. 0-26224
 
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
 
Delaware
 
51-0317849
(STATE OR OTHER JURISDICTION OF
INCORPORATION OR ORGANIZATION)
 
(I.R.S. EMPLOYER
IDENTIFICATION NO.)
 
 
1100 Campus Road
 
08540
Princeton
,
New Jersey
 
(ZIP CODE)
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)
 
Registrant's Telephone Number, Including Area Code: (609) 275-0500
Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report:
Securities registered pursuant to Section 12(b) of the Act:
TITLE OF EACH CLASS
TRADING SYMBOL
NAME OF EACH EXCHANGE ON WHICH REGISTERED
Common Stock, Par Value $.01 Per Share
IART
Nasdaq Global Select Market
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and "emerging growth company" in Rule 12b-2 of the Exchange Act.




Large accelerated filer
☒
Accelerated filer
☐
 
 
 
 
Non-accelerated filer
☐  
Smaller reporting company
☐
 
 
 
 
Emerging growth company
☐
 
 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes  ☐    No  ☒
Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.  Yes  ☐    No  ☒
The number of shares of the registrant’s Common Stock, $0.01 par value, outstanding as of May 5, 2020 was 84,843,053.
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
INDEX
 



 
Page
Number
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EX-101 INSTANCE DOCUMENT
 
EX-101 SCHEMA DOCUMENT
 
EX-101 CALCULATION LINKBASE DOCUMENT
 
EX-101 DEFINITION LINKBASE DOCUMENT
 
EX-101 LABELS LINKBASE DOCUMENT
 
EX-101 PRESENTATION LINKBASE DOCUMENT
 



PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE INCOME / (LOSS)
(UNAUDITED)
(In thousands, except per share amounts)
 
 
Three Months Ended March 31,
 
2020
 
2019
Total revenue, net
$
354,324

 
$
359,690

Costs and expenses:
 
 
 
Cost of goods sold
133,476

 
128,912

Research and development
20,816

 
18,321

Selling, general and administrative
165,952

 
174,870

Intangible asset amortization
6,977

 
5,279

Total costs and expenses
327,221

 
327,382

Operating income
27,103

 
32,308

Interest income
2,570

 
2,428

Interest expense
(17,752
)
 
(13,149
)
Other income(expense), net
(479
)
 
3,236

Income before income taxes
11,442

 
24,823

Provision (benefit) for income taxes
2,262

 
(7,933
)
Net income
$
9,180

 
$
32,756

 
 
 
 
Net income per share
 
 
 
Basic
$
0.11

 
$
0.38

Diluted
$
0.11

 
$
0.38

 
 
 
 
Weighted average common shares outstanding (See Note 13):
 
 
 
Basic
85,188

 
85,343

Diluted
85,892

 
86,258

Comprehensive income (loss) (See Note 14)
$
(19,007
)
 
$
21,520



The accompanying unaudited notes are an integral part of these condensed consolidated financial statements.

4

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
(In thousands, except per share amounts)
 
 
March 31, 2020
 
December 31, 2019
ASSETS
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
357,712

 
$
198,911

Trade accounts receivable, net of allowances of $6,652 and $4,303
245,546

 
275,296

Inventories, net
338,082

 
316,054

Prepaid expenses and other current assets
67,332

 
67,907

  Total current assets
1,008,672

 
858,168

Property, plant and equipment, net
335,903

 
337,404

Right of use asset - operating leases
95,890

 
94,530

Intangible assets, net
1,014,227

 
1,031,591

Goodwill
951,554

 
954,280

Deferred tax assets, net
2,330

 
12,623

Other assets
38,989

 
14,644

Total assets
$
3,447,565

 
$
3,303,240

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
Current liabilities:
 
 
 
Current portion of borrowings under senior credit facility
$
—

 
$
45,000

Current portion of lease liability - operating leases
12,964

 
12,253

Accounts payable, trade
97,061

 
113,090

Contract liabilities
4,860

 
4,772

Accrued compensation
55,630

 
79,385

Accrued expenses and other current liabilities
75,970

 
76,809

  Total current liabilities
246,485

 
331,309

Long-term borrowings under senior credit facility
1,018,032

 
1,198,561

Long-term borrowings under securitization facility
98,500

 
104,500

Long-term convertible securities
460,159

 
—

Lease liability - operating leases
100,328

 
97,504

Deferred tax liabilities
24,221

 
36,553

Other liabilities
158,037

 
118,077

Total liabilities
2,105,762

 
1,886,504

Commitments and contingencies (Refer to Note 16)

 

Stockholders’ equity:
 
 
 
Preferred stock; no par value; 15,000 authorized shares; none outstanding
—

 
—

Common stock; $0.01 par value; 240,000 authorized shares; 89,104 and 88,735 issued at March 31, 2020 and December 31, 2019, respectively
889

 
887

Additional paid-in capital
1,240,455

 
1,213,620

Treasury stock, at cost; 4,294 shares and 2,865 shares at March 31, 2020 and December 31, 2019, respectively
(202,506
)
 
(119,943
)
Accumulated other comprehensive loss
(104,588
)
 
(76,402
)
Retained earnings
407,553

 
398,574

Total stockholders’ equity
1,341,803

 
1,416,736

Total liabilities and stockholders’ equity
$
3,447,565

 
$
3,303,240



The accompanying unaudited notes are an integral part of these condensed consolidated financial statements.

5


INTEGRA LIFESCIENCES HOLDINGS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(In thousands)
 
Three Months Ended March 31,
 
2020
 
2019
OPERATING ACTIVITIES:
 
 
 
Net income
$
9,180

 
$
32,756

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Depreciation and amortization
29,151

 
27,093

Deferred income tax benefit/provision
5,068

 
(6,843
)
Share-based compensation
3,750

 
4,083

Amortization of debt issuance costs and expenses associated with debt refinancing
4,246

 
1,357

Accretion of bond issuance discount
2,529

 
—

Loss on disposal of property and equipment
374

 
367

Change in fair value of contingent consideration and others
(1,051
)
 
194

Changes in assets and liabilities:
 
 
 
Accounts receivable
28,301

 
(13,705
)
Inventories
(26,236
)
 
(12,048
)
Prepaid expenses and other current assets
4,683

 
(12,949
)
Other non-current assets
3,000

 
(628
)
Accounts payable, accrued expenses and other current liabilities
(40,235
)
 
5,387

Contract liabilities
338

 
(188
)
Other non-current liabilities
(2,284
)
 
4,608

Net cash provided by operating activities
20,814

 
29,484

INVESTING ACTIVITIES:
 
 
 
Purchases of property and equipment
(16,519
)
 
(16,086
)
Acquired in-process research and development

(5,000
)
 
—

Proceeds from note receivable
—

 
245

Proceeds from sale of property and equipment
34

 
35

Net cash used in investing activities
(21,485
)
 
(15,806
)
FINANCING ACTIVITIES:
 
 
 
Proceeds from borrowings of long-term indebtedness
113,200

 
67,200

Payments on debt
(344,200
)
 
(57,400
)
Purchase of option hedge on convertible notes
(104,248
)
 
—

Proceeds from convertible notes issuance
575,000

 
—

Proceeds from sale of stock purchase warrants
44,562

 
—

Payment of debt issuance costs
(20,264
)
 
—

Purchases of treasury stock
(100,000
)
 
—

Proceeds from exercised stock options
2,303

 
1,750

Cash taxes paid in net equity settlement
(4,348
)
 
(6,157
)
Net cash provided by financing activities
162,005

 
5,393

Effect of exchange rate changes on cash and cash equivalents
(2,533
)
 
(884
)
Net increase in cash and cash equivalents
158,801

 
18,187

Cash and cash equivalents at beginning of period
198,911

 
138,838

Cash and cash equivalents at end of period
$
357,712

 
$
157,025

The accompanying unaudited notes are an integral part of these condensed consolidated financial statements.

6

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDER'S EQUITY
(UNAUDITED)
(In thousands)

 
Three Months Ended March 31, 2020
 
Common Stock
 
Treasury Stock
 
Additional Paid-In Capital
 
Accumulated Other Comprehensive Loss
 
Retained Earnings
 
Total Equity
Shares
 
Amount
Shares
 
Amount
 
(In thousands)
Balance, January 1, 2020
88,735

 
$
887

 
(2,865
)
 
$
(119,943
)
 
$
1,213,620

 
$
(76,401
)
 
$
398,573

 
$
1,416,736

Net income
—

 
—

 
—

 
—

 
—

 
—

 
9,180

 
9,180

Other comprehensive loss, net of tax
—

 
—

 
—

 
—

 
—

 
(28,187
)
 
—

 
(28,187
)
Issuance of common stock through employee stock purchase plan
13

 
—

 
—

 
—

 
694

 
—

 
—

 
694

Issuance of common stock for vesting of share based awards, net of shares withheld for taxes
357

 
2

 
10

 
476

 
(3,217
)
 
—

 
—

 
(2,739
)
Share-based compensation
 
 
—

 
—

 
—

 
3,781

 
—

 
—

 
3,781

Share repurchase and equity component of the convertible note issuance, net

—

 
—

 
(135
)
 
(7,632
)
 
42,538

 
—

 
—

 
34,906

Accelerated shares repurchased
—

 
—

 
(1,304
)
 
(75,407
)
 
(16,961
)
 
—

 
—

 
(92,368
)
Adoption of Update No. 2016-13
—

 
—

 
—

 
—

 
—

 
—

 
(200
)
 
(200
)
Balance, March 31, 2020
89,105

 
$
889

 
(4,294
)
 
$
(202,506
)
 
$
1,240,455

 
$
(104,588
)
 
$
407,553

 
$
1,341,803


 
Three Months Ended March 31, 2019
 
Common Stock
 
Treasury Stock
 
Additional Paid-In Capital
 
Accumulated Other Comprehensive Loss
 
Retained Earnings
 
Total Equity
Shares
 
Amount
Shares
 
Amount
 
(In thousands)
Balance, January 1, 2019
88,044

 
$
880

 
(2,881
)
 
$
(120,615
)
 
$
1,192,601

 
$
(45,443
)
 
$
348,373

 
$
1,375,796

Net income
—

 
$
—

 
—

 
—

 
—

 
—

 
32,756

 
32,756

Other comprehensive loss, net of tax
—

 
$
—

 
—

 
—

 
—

 
(11,236
)
 
—

 
(11,236
)
Issuance of common stock through employee stock purchase plan
17

 
$
—

 
—

 
$
—

 
716

 
$
—

 
$
—

 
$
716

Issuance of common stock for vesting of share based awards, net of shares withheld for taxes
243

 
$
2

 
12

 
506

 
(5,629
)
 
—

 
—

 
(5,121
)
Share-based compensation
—

 
$
—

 
—

 
—

 
4,119

 
—

 
—

 
4,119

Balance, March 31, 2019
88,304

 
$
882

 
(2,869
)
 
$
(120,109
)
 
$
1,191,807

 
$
(56,679
)
 
$
381,129

 
$
1,397,030


The accompanying unaudited notes are an integral part of these condensed consolidated financial statements.





7

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

1. BASIS OF PRESENTATION
General
The terms “we,” “our,” “us,” “Company” and “Integra” refer to Integra LifeSciences Holdings Corporation, a Delaware corporation, and its subsidiaries unless the context suggests otherwise.
In the opinion of management, the March 31, 2020 unaudited condensed consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the financial position, statement of changes in shareholder's equity, results of operations and cash flows of the Company. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements for the year ended December 31, 2019 included in the Company’s Annual Report on Form 10-K. The December 31, 2019 consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States. Operating results for the three month period ended March 31, 2020 are not necessarily indicative of the results to be expected for the entire year.
The preparation of consolidated financial statements is in conformity with generally accepted accounting principles in the United States ("GAAP") which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of the equity component of convertible debt instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates. The novel coronavirus (“COVID-19”) pandemic and the resulting adverse impacts to global economic conditions, as well as our operations, may impact future estimates including, but not limited to, inventory valuations, fair value measurements, goodwill and long-lived asset impairments, the effectiveness of the Company’s hedging instruments, deferred tax valuation allowances, and allowances for doubtful accounts receivable.
Risks and Uncertainties
The Company is subject to risks and uncertainties as a result of the COVID-19 pandemic. The extent of the impact of the COVID-19 pandemic on the Company's business is highly uncertain and difficult to predict, as the response to the pandemic is in its incipient stages and information is rapidly evolving. The Company's customers are diverting resources to treat COVID-19 patients and deferring elective surgical procedures, both of which are likely to impact hospitals' abilities to meet their obligations, including to the Company. Furthermore, capital markets and economies worldwide have also been negatively impacted by the COVID-19 pandemic, and it is likely that it could cause a local and/or global economic recession. Such economic disruption has had an adverse effect on our business as hospitals curtail and reduce capital and overall spending. Policymakers around the globe have responded with fiscal policy actions to support the healthcare industry and economy as a whole. The magnitude and overall effectiveness of these actions remains uncertain.The severity of the impact of the COVID-19 pandemic on the Company's business will depend on a number of factors, including, but not limited to, the duration and severity of the pandemic and the extent and severity of the impact on the Company's customers, all of which are uncertain and cannot be predicted with certainty. The Company's future results of operations and liquidity could be adversely impacted by delays in payments of outstanding receivable amounts beyond normal payment terms, supply chain disruptions and uncertain demand, and the impact of any initiatives or programs that the Company may undertake to address financial and operations challenges faced by its customers. The Company has implemented contingency plans to address the operational impact of COVID-19 and ensure ongoing operations.
Recently Issued Accounting Standards
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The ASU is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The ASU requires the measurement of all expected credit losses for financial assets including trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other

8
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)

organizations will now use forward-looking information to better inform their credit loss estimates. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a modified retrospective transition method which requires a cumulative-effect adjustment to the opening balance of retained earnings to be recognized on the date of adoption with no change to financial results reported in prior periods. The cumulative-effect adjustment recorded on January 1, 2020, is not material. The adoption of this ASU did not have a significant impact on the Company's consolidated financial statements and related disclosures.
The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the current COVID-19 pandemic, or other customer-specific factors. Although the Company has historically not experienced significant credit losses, it is possible that there could be a adverse impact from potential as hospital's cash flows are impacted by their response to the COVID-19 pandemic and deferral of elective surgical procedures.
In August 2018, the FASB issued ASU 2018-14, Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans. The new guidance modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans, including removing certain previous disclosure requirements, adding certain new disclosure requirements, and clarifying certain other disclosure requirements. The ASU will be effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption is permitted. The adoption is not expected to have a material impact on the Condensed and Consolidated Financial Statements.
In August 2018, the FASB issued ASU No. 2018-15, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40), relating to a customer's accounting for implementation, set-up, and other upfront costs incurred in a cloud computing arrangement that is hosted by a vendor (e.g., a service contract). Under the new guidance, a customer will apply the same criteria for capitalizing implementation costs as it would for an arrangement that has a software license. The new guidance also prescribes the balance sheet, income statement, and cash flow classification of the capitalized implementation costs and related amortization expense, and requires additional quantitative and qualitative disclosures. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a prospective transition method. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.
In December 2019, the FASB issued ASU No. 2019-12, Income Taxes: Simplifying the Accounting for Income Taxes intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The new guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively. The Company is currently assessing the impact of this standard on the financial condition and results of operations.
In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform, which provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. This amendment applies to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This ASU is effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. The Company is currently assessing the impact that this ASU will have on its consolidated financial statements.
There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.
2. BUSINESS DEVELOPMENT
Arkis BioSciences Inc.
On July 29, 2019, the Company acquired Arkis BioSciences Inc. ("Arkis") for an acquisition purchase price of $30.9 million (the "Arkis Acquisition") plus contingent consideration of up to $25.5 million, that may be payable based on the successful completion of certain development and commercial milestones. The contingent consideration had an acquisition date fair value of $13.1 million. Arkis was a privately-held company that marketed the CerebroFlo® external ventricular drainage (EVD) catheter with Endexo® technology, a permanent additive designed to reduce the potential for catheter obstruction due to thrombus formation.
Assets Acquired and Liabilities Assumed at Fair Value

9
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)

The Arkis Acquisition has been accounted for using the acquisition method of accounting. This method requires that assets acquired and liabilities assumed in a business combination to be recognized at their fair values as of the acquisition date. As of March 31, 2020 certain amounts relating to tax related matters have not been finalized. The finalization of these matters could result in changes to goodwill.
The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date:
 
Preliminary Valuation as of March 31, 2020
 
Weighted Average Life
 
(Dollars in thousands)
 
 
Cash
$
90

 
 
Other current assets
751

 
 
Property, plant and equipment
159

 
 
Deferred tax assets
1,535

 
 
Intangible assets:
 
 
 
CerebroFlo developed technology
20,100

 
15 years
Enabling technology license
1,980

 
14 years
Goodwill
27,600

 
 
Total assets acquired
52,215

 
 
 
 
 
 
Accounts payable, accrued expenses and other liabilities
2,926

 
 
Contingent consideration
13,100

 
 
Deferred tax liabilities
5,305

 
 
     Net assets acquired
$
30,884

 
 

Intangible Assets
The estimated fair value of the intangible assets was determined using the income approach, which is a valuation technique that provides an estimate of the fair value of an asset based on market participant expectations of the cash flows an asset would generate over its remaining useful life. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each asset (including net revenues, cost of sales, R&D costs, selling and marketing costs, and working capital/contributory asset charges), the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of each asset’s life cycle, and competitive trends impacting the asset and each cash flow stream.
The Company used a discount rate of 14.5% to arrive at the present value for the acquired intangible assets to reflect the rate of return a market participant would expect to earn and incremental commercial uncertainty in the cash flow projections. No assurances can be given that the underlying assumptions used to prepare the discounted cash flow analysis will not change. For these and other reasons, actual results may vary significantly from estimated results.  
Goodwill
The Company allocated goodwill related to the Arkis Acquisition to the Codman Specialty Surgical segment. Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected revenue and cost synergies of the combined company and assembled workforce. One of the key factors that contributes to the recognition of goodwill, and a driver for the Company's acquisition of Arkis, is the planned expansion of the Endexo technology with the existing products within the Codman Specialty Surgical segment. Goodwill recognized as a result of this acquisition is non-deductible for income tax purposes.
Contingent Consideration
The Company determines the acquisition date fair value of contingent consideration obligations based on a probability-weighted income approach derived from revenue estimates and a probability assessment with respect to the likelihood of achieving contingent obligations. The fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined using the fair value concepts in ASC 820. The resultant probability-weighted cash flows are discounted using an appropriate effective annual interest rate. At each reporting date, the contingent consideration obligation will be revalued to estimated fair value and changes in fair value will be reflected as income or expense in the Company's consolidated statement of operations. Changes in the fair value of the contingent consideration obligations may result from changes in discount periods and rates, changes in the timing and amount of revenue estimates and changes in probability assumptions with respect to the likelihood of achieving the various contingent payment obligations.

10
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)

Adverse changes in assumptions utilized in the contingent consideration fair value estimates could result in an increase in the contingent consideration obligation and a corresponding charge to operating results.
As part of the acquisition, the Company is required to pay the former shareholders of Arkis up to $25.5 million based on the timing of certain development milestones of $10.0 million and commercial sales milestones of $15.5 million, respectively. The Company used a probability weighted income approach to calculate the fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specified milestone. The Company estimated the fair value of the contingent consideration to be $13.1 million at the acquisition date. The estimated fair value as of March 31, 2020 was $13.2 million. This amount is included in other liabilities at March 31, 2020 in the consolidated balance sheets of the Company.
Deferred Tax Liabilities
Deferred tax liabilities result from identifiable intangible assets’ fair value adjustments. These adjustments create excess book basis over tax basis which is tax-effected by the statutory tax rates of applicable jurisdictions.
The pro forma results are not presented for this acquisition as they are not material.
Rebound Therapeutics Corporation
On September 9, 2019, the Company acquired Rebound Therapeutics Corporation (“Rebound”), developers of a single-use medical device known as the AURORA Surgiscope® System ("Aurora") which enables minimally invasive access, using optics and illumination, for visualization, diagnostic and therapeutic use in neurosurgery (the “Rebound transaction”). Under the terms of the Rebound transaction, the Company made an upfront payment of $67.1 million and are committed to pay up to $35.0 million of contingent development milestones upon achievement of certain regulatory milestones. The acquisition of Rebound was primarily concentrated in one single identifiable asset and thus, for accounting purposes, the Company has concluded that the acquired assets do not meet the accounting definition of a business. The initial payment was allocated primarily to Aurora, resulting in a $59.9 million in-process research and development expense. The balance of approximately $7.2 million, which included $2.1 million of cash and cash equivalents and a net deferred tax asset of $4.2 million, was allocated to the remaining net assets acquired. The deferred tax asset primarily resulted from a federal net operating loss carry forward.
During the fourth quarter of 2019, the Company achieved the first developmental milestone which triggered a $5.0 million obligation to be paid to former shareholders of Rebound. The Company recorded $5.0 million as in-process research and development expense in the consolidated statements of operations during the year ended December 31, 2019. The obligation was included in accrued expenses and other current liabilities at December 31, 2019 in the consolidated balance sheets. The milestone was paid during the first quarter of 2020.
Integrated Shoulder Collaboration, Inc.
On January 4, 2019, the Company entered into a licensing agreement with Integrated Shoulder Collaboration, Inc ("ISC"). Under the terms of the agreement, the Company paid ISC $1.7 million for the exclusive, worldwide license to commercialize its short stem and stemless shoulder system. A patent related to short stem and stemless shoulder systems was issued to ISC during the first quarter of 2019. ISC is eligible to receive royalties on sales of the short stem and stemless shoulder system. The Company has the option to acquire ISC at a date four years subsequent to the first commercial sale, which becomes mandatory upon the achievement of a certain sales thresholds of the short stem and stemless shoulder system, for an amount not to exceed $80.0 million. The transaction was accounted for as an asset acquisition as the Company concluded that it acquired primarily one asset. During the quarter ended March 31, 2019, The total upfront payment of $1.7 million was expensed as a component of research and development expense and the future milestone and option payments will be recorded if the corresponding events become probable.

3. REVENUES FROM CONTRACTS WITH CUSTOMERS
Summary of Accounting Policies on Revenue Recognition
Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services.
Total revenue, net, includes product sales, product royalties and other revenues, such as fees received for services.
For products shipped with FOB shipping point terms, the control of the product passes to the customer at the time of shipment. For shipments in which the control of the product is transferred when the customer receives the product, the Company recognizes revenue upon receipt by the customer. Certain products that the Company produces for private label customers have no alternative use and the Company has a right of payment for performance to date. Revenues from those products are recognized over the period that the Company manufactures these products, which is typically one to three months. The Company uses the input method to

11
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)

measure the manufacturing activities completed to date, which depicts the progress of the Company's performance obligation of transferring control of goods being manufactured for private label customers.
A portion of the Company's product revenue is generated from consigned inventory maintained at hospitals and distributors, and also from inventory physically held by field sales representatives. For these types of product sales, the Company retains control until the product has been used or implanted, at which time revenue is recognized.   
Revenues from sale of products and services are evidenced by either a contract with the customer or a valid purchase order and an invoice which includes all relevant terms of sale. For product sales, invoices are generally issued upon the transfer of control (or upon the completion of the manufacturing in the case of the private label transactions recognized over time) and are typically payable thirty days after the invoice date. The Company performs a review of each specific customer's creditworthiness and ability to pay prior to acceptance as a customer. Further, the Company performs periodic reviews of its customers' creditworthiness prospectively.
Performance Obligations
The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.
Significant Judgments
Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant.
The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract.
The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally ninety days.
The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.
Contract Asset and Liability
Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheet.
Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.
The following table summarizes the changes in the contract asset and liability balances for the three months ended March 31, 2020:

12
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)

Contract Asset
 
Contract asset, January 1, 2020
$
8,680

Transferred to trade receivable of contract asset included
     in beginning of the year contract asset
(8,680
)
Contract asset, net of transferred to trade receivables on contracts during the period
7,944

Contract asset, March 31, 2020
$
7,944

 
 
Contract Liability
 
Contract liability, January 1, 2020
$
11,946

Recognition of revenue included in beginning of year contract liability
(1,291
)
Contract liability, net of revenue recognized on contracts during the period
1,691

Foreign currency translation
(147
)
Contract liability, March 31, 2020
$
12,199


At March 31, 2020, the short-term portion of the contract liability of $4.9 million and the long-term portion of $7.3 million were included in accrued expenses and other current liabilities and other liabilities in the consolidated balance sheet.
As of March 31, 2020, the Company is expected to recognize approximately 40% of unsatisfied (or partially unsatisfied) performance obligations as revenue through 2020, with the remaining balance to be recognized in 2021 and thereafter.
Shipping and Handling Fees
The Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.
Product Warranties
Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.
Taxes Collected from Customers
The Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer.
Disaggregated Revenue
The following table presents revenues disaggregated by the major sources of revenues for the three months ended March 31, 2020 and 2019 (amounts in thousands):
 
Three Months Ended March 31, 2020
Three Months Ended March 31, 2019
 
(amounts in thousands)
Neurosurgery
$
184,943

$
179,520

Instruments
46,497

55,048

Total Codman Specialty Surgical
231,440

234,568

 
 
 
Wound Reconstruction and Care
72,267

74,963

Extremity Orthopedics
21,472

22,685

Private Label
29,145

27,474

Total Orthopedics and Tissue Technologies
122,884

125,122

Total revenue
$
354,324

$
359,690



13
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)

Prior period amounts were reclassified between categories within the Codman Specialty Surgical segment to conform to the current period presentation.
See Note 15, Segment and Geographical Information, for details of revenues based on the location of the customer.
4. INVENTORIES
Inventories, net consisted of the following:
 
March 31, 2020
 
December 31, 2019
 
(In thousands)
Finished goods
$
217,078

 
$
201,870

Work in process
53,624

 
48,333

Raw materials
67,380

 
65,851

Total inventories
$
338,082

 
$
316,054





5. GOODWILL AND OTHER INTANGIBLE ASSETS
Goodwill
Changes in the carrying amount of goodwill for the three-month period ended March 31, 2020 were as follows:
 
Codman Specialty
Surgical
 
Orthopedics and
Tissue Technologies
 
Total
 
(In thousands)
Goodwill at December 31, 2019
$
653,500

 
$
300,780

 
$
954,280

Foreign currency translation
(1,867
)
 
(859
)
 
(2,726
)
Goodwill at March 31, 2020
$
651,633

 
$
299,921

 
$
951,554


The components of the Company’s identifiable intangible assets were as follows:
 
March 31, 2020
 
Weighted
Average
Life
 
Cost
 
Accumulated
Amortization
 
Net
 
(Dollars in thousands)
Completed technology
19 years
 
$
881,856

 
$
(225,350
)
 
$
656,506

Customer relationships
12 years
 
221,193

 
(123,896
)
 
97,297

Trademarks/brand names
28 years
 
103,472

 
(29,190
)
 
74,282

Codman tradename
Indefinite
 
163,680

 
—

 
163,680

Supplier relationships
27 years
 
34,721

 
(18,304
)
 
16,417

All other(1)
4 years
 
10,787

 
(4,742
)
 
6,045

 
 
 
$
1,415,709

 
$
(401,482
)
 
$
1,014,227



14
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)

 
December 31, 2019
 
Weighted
Average
Life
 
Cost
 
Accumulated
Amortization
 
Net
 
(Dollars in thousands)
Completed technology
19 years
 
$
880,623

 
$
(213,702
)
 
$
666,921

Customer relationships
12 years
 
222,575

 
(119,393
)
 
103,182

Trademarks/brand names
28 years
 
103,873

 
(28,514
)
 
75,359

Codman tradename
Indefinite
 
163,126

 
—

 
163,126

Supplier relationships
27 years
 
34,721

 
(17,947
)
 
16,774

All other (1)
4 years
 
10,869

 
(4,640
)
 
6,229

 
 
 
$
1,415,787

 
$
(384,196
)
 
$
1,031,591



(1)
At March 31, 2020 and December 31, 2019, all other included IPR&D of $1.0 million, which was indefinite-lived.
Based on quarter-end exchange rates, amortization expense (including amounts reported in cost of product revenues) is expected to be approximately $56.1 million for the remainder of 2020, $64.4 million in 2021, $60.8 million in 2022, $60.0 million in 2023, $59.2 million in 2024, $59.1 million in 2025 and $491.9 million thereafter.
6. DEBT
Sixth Amended and Restated Senior Credit Agreement
On February 3, 2020, the Company entered into the sixth amendment and restatement (the "February 2020 Amendment") of its Senior Credit Facility (the "Senior Credit Facility") with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. The February 2020 Amendment extended the maturity date to February 3, 2025. The Company continues to have the aggregate principal amount of up to approximately $2.2 billion available to it through the following facilities: (i) a $877.5 million Term Loan facility, and (ii) a $1.3 billion revolving credit facility, which includes a $60 million sublimit for the issuance of standby letters of credit and a $60 million sublimit for swingline loans. The first mandatory repayment under the Term Loan portion of the February 2020 Amendment is due June 30, 2021.
In connection with the February 2020 Amendment, the Company’s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:
Fiscal Quarter
 
Maximum Consolidated Total Leverage Ratio
 
 
 
First fiscal quarter ending after the Closing Date through June 30, 2022
 
5.00 to 1.00
September 30, 2022 through June 30, 2023
 
4.50 to 1.00
September 30, 2023 and the last day of each fiscal quarter thereafter
 
4.00 to 1.00

Borrowings under the Senior Credit Facility bear interest, at the Company’s option, at a rate equal to the following:
i.
the Eurodollar Rate (as defined in the amendment and restatement) in effect from time to time plus the applicable rate (ranging from 1.00% to 1.75%), or
ii.
the highest of:
1.
the weighted average overnight Federal funds rate, as published by the Federal Reserve Bank of New York, plus 0.50%
2.
the prime lending rate of Bank of America, N.A. or
3.
the one-month Eurodollar Rate plus 1.00%

The applicable rates are based on the Company’s consolidated total leverage ratio (defined as the ratio of (a) consolidated funded indebtedness as of such date less cash that is not subject to any restriction on the use or investment thereof (b) consolidated EBITDA as defined by the February 2020 amendment, for the period of four consecutive fiscal quarters ending on such date).
The Company will pay an annual commitment fee (ranging from 0.15% to 0.30%), based on the Company's consolidated total leverage ratio, on the amount available for borrowing under the revolving credit facility.

15
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)

The Senior Credit Facility is collateralized by substantially all of the assets of the Company’s U.S. subsidiaries, excluding intangible assets. The Senior Credit Facility is subject to various financial and negative covenants and at March 31, 2020, the Company was in compliance with all such covenants. The Company capitalized $4.6 million of financing costs in connection with modification of the Senior Credit Facility and wrote off $1.2 million of previously capitalized financing costs during the first quarter of 2020.
At March 31, 2020 and December 31, 2019, there was $150.0 million and $375.0 million outstanding, respectively, under the revolving credit component of the Senior Credit Facility at weighted average interest rates of 2.5% and 3.2%, respectively. At March 31, 2020 and December 31, 2019, there was $877.5 million outstanding, respectively, under the Term Loan component of the Senior Credit Facility at a weighted average interest rate of 2.4% and 3.2%, respectively. At March 31, 2020, there is no current portion of the Term Loan component of the Senior Credit Facility as the first mandatory repayment is due June 30, 2021.
Convertible Senior Notes
On February 4, 2020, the Company issued $575.0 million aggregate principal amount of its of 0.5% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes will mature on August 15, 2025 and bear interest at a rate of 0.5% per annum payable semi-annually in arrears, unless earlier converted, repurchased or redeemed in accordance with the terms of the Notes. The portion of debt proceeds that was classified as equity at the time of the offering was $104.5 million, and that amount is being amortized to interest expense using the effective interest method through August 2025. The effective interest rate implicit in the liability component is 4.2%. In connection with this offering, the Company capitalized $13.2 million of financing fees. At March 31, 2020, the carrying amount of the liability component was $473.0 million, the remaining unamortized discount was $102.0 million, and the principal amount outstanding was $575.0 million. The fair value of the 2025 Notes at March 31, 2020 was $507.7 million.
The 2025 Notes are senior, unsecured obligations of the Company, and are convertible into cash and shares of its common stock based on initial conversion rate, subject to adjustment of 13.5739 shares per $1,000 principal amounts of the 2025 Notes (which represents an initial conversion price of $73.67 per share). The 2025 Notes convert only in the following circumstances: (1) if the closing price of the Company's common stock has been at least 130% of the conversion price during the period; (2) if the average trading price per $1000 principal amount of the 2025 Notes is less than or equal to 98% of the average conversion value of the 2025 Notes during a period as defined in the indenture; (3) at any time on or after February 20, 2023; or (4) if specified corporate transactions occur. As of March 31, 2020, none of these conditions existed with respect to the 2025 Notes and as a result the 2025 Notes are classified as long term.
Holders of the Notes will have the right to require the Company to repurchase for cash all or a portion of their Notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the Notes). The Company will also be required to increase the conversion rate for holders who convert their Notes in connection with certain fundamental changes occurring prior to the maturity date or following delivery by the Company of a notice of redemption.

In connection with the issuance of the 2025 Notes, the Company entered into call transactions and warrant transactions, primarily with affiliates of the initial purchasers of the 2025 Notes (the “hedge participants”). The cost of the call transactions was $104.2 million for the 2025 Notes. The Company received $44.5 million of proceeds from the warrant transactions for the 2025 Notes. The call transactions involved purchasing call options from the hedge participants, and the warrant transactions involved selling call options to the hedge participants with a higher strike price than the purchased call options. The initial strike price of the call transactions was $73.67, subject to anti-dilution adjustments substantially similar to those in the 2025 Notes. The initial strike price of the warrant transactions was $113.34 for the 2025 Notes, subject to customary anti-dilution adjustments.
During the three months ended March 31, 2020, the Company recognized cash interest of $0.4 million and amortization of the discount on the liability component of $2.5 million for a total interest charge of $2.9 million on the 2020 Notes.
Securitization Facility
During the fourth quarter of 2018, the Company entered into an accounts receivable securitization facility (the "Securitization Facility") under which accounts receivable of certain domestic subsidiaries are sold on a non-recourse basis to a special purpose entity (“SPE”), which is a bankruptcy-remote, consolidated subsidiary of the Company. Accordingly, the assets of the SPE are not available to satisfy the obligations of the Company or any of its subsidiaries. From time to time, the SPE may finance such accounts receivable with a revolving loan facility secured by a pledge of such accounts receivable. The amount of outstanding borrowings on the Securitization Facility at any one time is limited to $150.0 million. The Securitization Facility Agreement ("Securitization Agreement") is for an initial three-year term and may be extended. The Securitization Agreement governing the Securitization Facility contains certain covenants and termination events. An occurrence of an event of default or a termination event under this Securitization Agreement may give rise to the right of its counterparty to terminate this facility. As of March 31, 2020, the Company was in compliance with the covenants and none of the termination events had occurred. At

16
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)

March 31, 2020 and December 31, 2019, the Company had $98.5 million and $104.5 million, respectively, of outstanding borrowings under its Securitization Facility at a weighted average interest rate of 2.6% and 2.8%, respectively.
The fair value of outstanding borrowings of the Senior Credit Facility's revolving credit and Term Loan components at March 31, 2020 were $130.4 million and, $771.3 million, respectively. The fair value of the outstanding borrowing of the Securitization Facility at March 31, 2020 was $94.5 million. These fair values were determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable inputs that reflect unadjusted quoted prices for identical assets or liabilities.
Letters of credit outstanding as of March 31, 2020 and December 31, 2019 totaled $0.8 million. There were no amounts drawn as of March 31, 2020.
Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:
Quarter Ended March 31, 2020
 
Principal Repayment
 
 
(In thousands)
Remainder of 2020
 
$
—

2021
 
33,750

2022
 
45,000

2023
 
61,875

2024
 
67,500

2025
 
669,375

 
 
$
877,500


The outstanding balance of the revolving credit component of the Senior Credit Facility is due on February 3, 2025.
7. DERIVATIVE INSTRUMENTS
Interest Rate Hedging
The Company’s interest rate risk relates to U.S. dollar denominated variable interest rate borrowings. The Company uses interest rate swap derivative instruments to manage earnings and cash flow exposure resulting from changes in interest rates. These interest rate swaps apply a fixed interest rate on a portion of the Company's expected LIBOR-indexed floating-rate borrowings.
The Company held the following interest rate swaps as of March 31, 2020 (dollar amounts in thousands):
Hedged Item
 
Current Notional Amount
 
Designation Date
 
Effective Date
 
Termination Date
 
Fixed Interest Rate
 
Estimated Fair Value
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
3-month USD LIBOR Loan
 
50,000

 
February 6, 2017
 
June 30, 2017
 
June 30, 2020
 
1.834
%
 
$
(48
)
1-month USD LIBOR Loan
 
100,000

 
February 6, 2017
 
June 30, 2017
 
June 30, 2020
 
1.652
%
 
(233
)
1-month USD LIBOR Loan
 
100,000

 
March 27, 2017
 
December 31, 2017
 
June 30, 2021
 
1.971
%
 
(2,024
)
1-month USD LIBOR Loan
 
150,000

 
December 13, 2017
 
January 1, 2018
 
December 31, 2022
 
2.201
%
 
(7,467
)
1-month USD LIBOR Loan
 
150,000

 
December 13, 2017
 
January 1, 2018
 
December 31, 2022
 
2.201
%
 
(7,388
)
1-month USD LIBOR Loan
 
100,000

 
December 13, 2017
 
July 1, 2019
 
June 30, 2024
 
2.423
%
 
(8,475
)
1-month USD LIBOR Loan
 
50,000

 
December 13, 2017
 
July 1, 2019
 
June 30, 2024
 
2.423
%
 
(3,994
)
1-month USD LIBOR Loan
 
200,000

 
December 13, 2017
 
January 1, 2018
 
December 31, 2024
 
2.313
%
 
(16,279
)
1-month USD LIBOR Loan
 
75,000

 
October 10, 2018
 
July 1, 2020
 
June 30, 2025
 
3.220
%
 
(10,186
)
1-month USD LIBOR Loan
 
75,000

 
October 10, 2018
 
July 1, 2020
 
June 30, 2025
 
3.199
%
 
(10,165
)
1-month USD LIBOR Loan
 
75,000

 
October 10, 2018
 
July 1, 2020
 
June 30, 2025
 
3.209
%
 
(10,185
)
1-month USD LIBOR Loan
 
100,000

 
December 18, 2018
 
December 30, 2022
 
December 31, 2027
 
2.885
%
 
(9,453
)
1-month USD LIBOR Loan
 
100,000

 
December 18, 2018
 
December 30, 2022
 
December 31, 2027
 
2.867
%
 
(9,855
)
Total interest rate derivatives designated as cash flow hedge
 
$
1,325,000

 
 
 
 
 
 
 
 
 
$
(95,752
)

The Company held the following interest rate swaps as of December 31, 2019 (dollar amounts in thousands):

17
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)

Hedged Item
 
Current Notional Amount
 
Designation Date
 
Effective Date
 
Termination Date
 
Fixed Interest Rate
 
Estimated Fair Value
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
3-month USD LIBOR
 
50,000

 
February 6, 2017
 
June 30, 2017
 
June 30, 2020
 
1.834
%
 
(2
)
1-month USD LIBOR
 
100,000

 
February 6, 2017
 
June 30, 2017
 
June 30, 2020
 
1.652
%
 
12

1-month USD LIBOR
 
100,000

 
March 27, 2017
 
December 31, 2017
 
June 30, 2021
 
1.971
%
 
(581
)
1-month USD LIBOR
 
150,000

 
December 13, 2017
 
January 1, 2018
 
December 31, 2022
 
2.201
%
 
(2,880
)
1-month USD LIBOR
 
150,000

 
December 13, 2017
 
January 1, 2018
 
December 31, 2022
 
2.201
%
 
(2,880
)
1-month USD LIBOR
 
100,000

 
December 13, 2017
 
July 1, 2019
 
June 30, 2024
 
2.423
%
 
(3,517
)
1-month USD LIBOR
 
50,000

 
December 13, 2017
 
July 1, 2019
 
June 30, 2024
 
2.423
%
 
(1,778
)
1-month USD LIBOR
 
200,000

 
December 13, 2017
 
January 1, 2018
 
December 31, 2024
 
2.313
%
 
(6,595
)
1-month USD LIBOR
 
75,000

 
October 10, 2018
 
July 1, 2020
 
June 30, 2025
 
3.220
%
 
(5,750
)
1-month USD LIBOR
 
75,000

 
October 10, 2018
 
July 1, 2020
 
June 30, 2025
 
3.199
%
 
(5,747
)
1-month USD LIBOR
 
75,000

 
October 10, 2018
 
July 1, 2020
 
June 30, 2025
 
3.209
%
 
(5,807
)
1-month USD LIBOR
 
100,000

 
December 18, 2018
 
December 30, 2022
 
December 31, 2027
 
2.885
%
 
(4,930
)
1-month USD LIBOR
 
100,000

 
December 18, 2018
 
December 30, 2022
 
December 31, 2027
 
2.867
%
 
(4,691
)
Total interest rate derivatives designated as cash flow hedge
 
$
1,325,000

 
 
 
 
 
 
 
 
 
(45,145
)

The Company has designated these derivative instruments as cash flow hedges. The Company assesses the effectiveness of these derivative instruments and has recorded the changes in the fair value of the derivative instrument designated as a cash flow hedge as unrealized gains or losses in accumulated other comprehensive loss (“AOCL”), net of tax, until the hedged item affected earnings, at which point any gain or loss was reclassified to earnings. If the hedged cash flow does not occur, or if it becomes probable that it will not occur, the Company will reclassify the remaining amount of any gain or loss on the related cash flow hedge recorded in AOCL to interest expense at that time.


Foreign Currency Hedging
From time to time the Company enters into foreign currency hedge contracts intended to protect the U.S. dollar value of certain forecasted foreign currency denominated transactions. The Company assesses the effectiveness of the contracts that are designated as hedging instruments. The changes in fair value of foreign currency cash flow hedges are recorded in AOCL, net of tax, until the hedged item affects earnings. Once the related hedged item affects earnings, the Company reclassifies amounts recorded in AOCL to earnings. If the hedged forecasted transaction does not occur, or if it becomes probable that it will not occur, the Company will reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. For contracts not designated as hedging instruments, the changes in fair value of the contracts are recognized in other income (expense), net in the consolidated statements of operation, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.
The success of the Company’s hedging program depends, in part, on forecasts of certain activity denominated in foreign currency. The Company may experience unanticipated currency exchange gains or losses to the extent that there are differences between forecasted and actual activities during periods of currency volatility. In addition, changes in currency exchange rates related to any unhedged transactions may affect earnings and cash flows.
Cross-Currency Rate Swaps
On October 2, 2017, the Company entered into cross-currency swap agreements to convert a notional amount of $300.0 million equivalent to 291.2 million of CHF denominated intercompany loans into U.S. dollars. The CHF-denominated intercompany loans were the result of the purchase of intellectual property by a subsidiary in Switzerland as part of an acquisition. The objective of these cross-currency swaps is to reduce volatility of earnings and cash flows associated with changes in the foreign currency exchange rate. Under the terms of these contracts, which have been designated as cash flow hedges, the Company will make interest payments in Swiss Francs and receive interest in U.S. dollars. Upon the maturity of these contracts, the Company will pay the principal amount of the loans in Swiss Francs and receive U.S. dollars from the counterparties.
The Company held the following cross-currency rate swaps as of March 31, 2020 (dollar amounts in thousands):

18
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)

 
 
 
 
 
 
 
 
 
 
 
March 31, 2020
 
 
Effective Date
 
Termination Date
 
Fixed Rate
 
Aggregate Notional Amount
 
Fair Value
Asset (Liability)
 
 
 
 
 
 
 
 
 
 
 
Pay CHF
 
October 2, 2017
 
October 2, 2020
 
1.75%
 
CHF
32,355

 
$
(74
)
Receive U.S.$
 
 
4.38%
 
$
33,333

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay CHF
 
October 2, 2017
 
October 2, 2021
 
1.85%
 
CHF
48,533

 
531

Receive U.S.$
 
 
4.46%
 
$
50,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay CHF
 
October 2, 2017
 
October 2, 2022
 
1.95%
 
CHF
145,597

 
3,416

Receive U.S.$
 
 
4.52%
 
$
150,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Total
 
 
 
 
 
 
 
 
 
 
$
3,874


The Company held the following cross-currency rate swaps as of December 31, 2019 (dollar amounts in thousands):
 
 
 
 
 
 
 
 
 
 
 
December 31, 2019
 
 
Effective Date
 
Termination Date
 
Fixed Rate
 
Aggregate Notional Amount
 
Fair Value
Asset (Liability)
 
 
 
 
 
 
 
 
 
 
 
Pay CHF
 
October 2, 2017
 
October 2, 2020
 
1.75%
 
CHF
32,355

 
$
(101
)
Receive U.S.$
 
 
4.38%
 
$
33,333

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay CHF
 
October 2, 2017
 
October 2, 2021
 
1.85%
 
CHF
48,533

 
(119
)
Receive U.S.$
 
 
4.46%
 
$
50,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay CHF
 
October 2, 2017
 
October 2, 2022
 
1.95%
 
CHF
145,598

 
(289
)
Receive U.S.$
 
 
4.52%
 
$
150,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Total
 
 
 
 
 
 
 
 
 
 
$
(509
)


The cross- currency swaps are carried on the consolidated balance sheet at fair value, and changes in the fair values are recorded as unrealized gains or losses in AOCL. For the three months ended March 31, 2020 and 2019, the Company recorded a loss of $1.7 million and a gain of $3.3 million, respectively, in other income(expense), net related to change in fair value related to the foreign currency rate translation to offset the gains or losses recognized on the intercompany loan.
For the three months ended March 31, 2020 and 2019, the Company recorded gains of $5.9 million and $5.5 million, respectively, in AOCL related to change in fair value of the cross-currency swaps.
For the three months ended March 31, 2020 and 2019, the Company recorded gains of $1.5 million and $1.9 million, respectively, in other income (expense), net included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps.
The estimated gain that is expected to be reclassified to other income (expense), net from AOCL as of March 31, 2020 within the next twelve months is $5.1 million. As of March 31, 2020, the Company does not expect any gains or losses will be reclassified into earnings as a result of the discontinuance of these cash flow hedges because the original forecasted transaction will not occur.
Net Investment Hedges
The Company manages certain foreign exchange risks through a variety of strategies, including hedging. The Company is exposed to foreign exchange risk from its international operations through foreign currency purchases, net investments in foreign subsidiaries, and foreign currency assets and liabilities created in the normal course of business. On October 1, 2018, the Company entered into cross-currency swap agreements designated as net investment hedges to partially offset the effects of foreign currency on foreign subsidiaries.
The Company held the following cross-currency rate swaps designated as net investment hedges as of March 31, 2020 and December 31, 2019, respectively (dollar amounts in thousands):

19
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)

 
 
 
 
 
 
 
 
 
 
 
March 31, 2020
 
 
Effective Date
 
Termination Date
 
Fixed Rate
 
Aggregate Notional Amount
 
Fair Value
Asset (Liability)
 
 
 
 
 
 
 
 
 
 
 
Pay EUR
 
October 3, 2018
 
September 30, 2021
 
—%
 
EUR
44,859

 
$
4,082

Receive U.S.$
 
 
 
3.01%
 
$
52,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay EUR
 
October 3, 2018
 
September 30, 2023
 
—%
 
EUR
51,760

 
6,298

Receive U.S.$
 
 
 
2.57%
 
$
60,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay EUR
 
October 3, 2018
 
September 30, 2025
 
—%
 
EUR
38,820

 
5,174

Receive U.S.$
 
 
 
2.19%
 
$
45,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay GBP
 
October 3, 2018
 
September 30, 2025
 
1.67%
 
GBP
128,284

 
16,773

Receive U.S.$
 
 
 
2.71%
 
$
167,500

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay CHF
 
October 3, 2018
 
September 30, 2025
 
—%
 
CHF
165,172

 
(6,965
)
Receive GBP
 
 
 
1.67%
 
GBP
128,284

 
 
 
 
 
 
 
 
 
 
 
 
 
Total
 
 
 
 
 
 
 
 
 
 
$
25,362



 
 
 
 
 
 
 
 
 
 
 
December 31, 2019
 
 
Effective Date
 
Termination Date
 
Fixed Rate
 
Aggregate Notional Amount
 
Fair Value
Asset (Liability)
 
 
 
 
 
 
 
 
 
 
 
Pay EUR
 
October 3, 2018
 
September 30, 2021
 
—%
 
EUR
44,859

 
$
2,459

Receive U.S.$
 
 
 
3.01%
 
$
52,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay EUR
 
October 3, 2018
 
September 30, 2023
 
—%
 
EUR
51,760

 
3,087

Receive U.S.$
 
 
 
2.57%
 
$
60,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay EUR
 
October 3, 2018
 
September 30, 2025
 
—%
 
EUR
38,820

 
2,032

Receive U.S.$
 
 
 
2.19%
 
$
45,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay GBP
 
October 3, 2018
 
September 30, 2025
 
1.67%
 
GBP
128,284

 
(154
)
Receive U.S.$
 
 
 
2.71%
 
$
167,500

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay CHF
 
October 3, 2018
 
September 30, 2025
 
—%
 
CHF
165,172

 
1,221

Receive GBP
 
 
 
1.67%
 
GBP
128,284

 
 
 
 
 
 
 
 
 
 
 
 
 
Total
 
 
 
 
 
 
 
 
 
 
$
8,645



The cross-currency swaps were carried on the consolidated balance sheet at fair value and changes in the fair values were recorded as unrealized gains or losses in AOCL. For the three months ended March 31, 2020 and 2019, the Company recorded gains of $16.7 million and $7.9 million in AOCL related to the change in fair value of the cross-currency swaps.
For the three months ended March 31, 2020 and 2019, the Company recorded gains of $2.2 million and $2.3 million in interest income included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps.
The estimated gain that is expected to be reclassified to interest income from AOCL as of March 31, 2020 within the next twelve months is $8.2 million.
Counterparty Credit Risk
The Company manages its concentration of counterparty credit risk on its derivative instruments by limiting acceptable counterparties to a group of major financial institutions with investment grade credit ratings, and by actively monitoring their credit ratings and outstanding positions on an ongoing basis. Therefore, the Company considers the credit risk of the counterparties

20
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)

to be low. Furthermore, none of the Company’s derivative transactions are subject to collateral or other security arrangements, and none contain provisions that depend upon the Company’s credit ratings from any credit rating agency.
Fair Value of Derivative Instruments
The Company has classified all of its derivative instruments within Level 2 of the fair value hierarchy because observable inputs are available for substantially the full term of the derivative instruments. The fair values of the interest rate swaps and cross-currency swaps were developed using a market approach based on publicly available market yield curves and the terms of the swap. The Company performs ongoing assessments of counterparty credit risk.

The following table summarizes the fair value for derivatives designated as hedging instruments in the condensed consolidated balance sheets as of March 31, 2020 and December 31, 2019:
 
 
Fair Value as of
Location on Balance Sheet (1):
 
March 31, 2020
 
December 31, 2019
 
 
(In thousands)
Derivatives designated as hedges — Assets:
 
 
 
 
Prepaid expenses and other current assets
 
 
 
 
Cash Flow Hedges
 
 
 
 
Interest rate swap(2)
 
$
—

 
$
12

Cross-currency swap
 
5,065

 
5,032

Net Investment Hedges
 
 
 
 
Cross-currency swap
 
8,164

 
7,952

Other assets
 
 
 
 
Cash Flow Hedges
 
 
 
 
Interest rate swap(2)
 
—

 
—

Cross-currency swap
 
—

 
—

Net Investment Hedges
 
 
 
 
Cross-currency swap
 
26,307

 
3,465

Total derivatives designated as hedges — Assets
 
$
39,536

 
$
16,461

 
 
 
 
 
Derivatives designated as hedges — Liabilities:
 
 
 
 
Accrued expenses and other current liabilities
 
 
 
 
Cash Flow Hedges
 
 
 
 
Interest rate swap(2)
 
$
19,793

 
$
6,635

Cross-currency swap
 
74

 
101

Other liabilities
 
 
 
 
Cash Flow Hedges
 
 
 
 
Interest rate swap(2)
 
75,959

 
38,522

Cross-currency swap
 
1,117

 
5,440

Net Investment Hedges
 
 
 
 
Cross-currency swap
 
9,109

 
2,772

Total derivatives designated as hedges — Liabilities
 
$
106,052

 
$
53,470

 
(1) 
The Company classifies derivative assets and liabilities as non-current based on the cash flows expected to be incurred within the following 12 months.
(2) 
At March 31, 2020 and December 31, 2019, the notional amount related to the Company’s interest rate swaps were $1.3 billion and $1.3 billion, respectively.

21
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)

The following presents the effect of derivative instruments designated as cash flow hedges on the accompanying condensed consolidated statement of operations during the three months ended March 31, 2020 and 2019:
 
Balance in AOCL
Beginning of
Quarter
 
Amount of
Gain (Loss)
Recognized in
AOCL
 
Amount of Gain (Loss)
Reclassified from
AOCL into
Earnings
 
Balance in AOCL
End of Quarter
 
Location in
Statements of
Operations
 
(In thousands)
Three Months Ended March 31, 2020
 
 
 
 
 
 
 
 
 
Cash Flow Hedges
 
 
 
 
 
 
 
 
 
Interest rate swap
$
(45,145
)
 
$
(51,651
)
 
$
(1,043
)
 
$
(95,753
)
 
Interest expense
Cross-currency swap
177

 
5,907

 
(182
)
 
6,266

 
Other income (expense), net
Net Investment Hedges
 
 
 
 
 
 
 
 
 
Cross-currency swap
10,229

 
18,897

 
2,180

 
26,946

 
Interest income
 
$
(34,739
)
 
$
(26,847
)
 
$
955

 
$
(62,541
)
 
 
Three Months Ended March 31, 2019
 
 
 
 
 
 
 
 
 
Cash Flow Hedges
 
 
 
 
 
 
 
 
 
Interest rate swap
$
619

 
$
(15,891
)
 
$
1,406

 
$
(16,678
)
 
Interest expense
Cross-currency swap
(6,190
)
 
7,473

 
5,178

 
(3,895
)
 
Other income (expense), net
Net Investment Hedges
 
 
 
 
 
 
 
 
 
Cross-currency swap
(632
)
 
10,221

 
2,327

 
7,262

 
Interest income
 
$
(6,203
)
 
$
1,803

 
$
8,911

 
$
(13,311
)
 
 


 
8. STOCK-BASED COMPENSATION
As of March 31, 2020, the Company had stock options, restricted stock awards, performance stock units, contract stock awards and restricted stock unit awards outstanding under two plans, the 2001 Equity Incentive Plan (the “2001 Plan”) and the 2003 Equity Incentive Plan (the “2003 Plan,” and collectively, the “Plans”).
Stock options issued under the Plans become exercisable over specified periods, generally within four years from the date of grant for officers and employees, and within one year from date of grant for directors and generally expire eight years from the grant date for employees, and from six to ten years for directors and certain executive officers. The Company values stock option grants using the binomial distribution model. Restricted stock issued under the Plans vests over specified periods, generally three years after the date of grant. The vesting of performance stock issued under the Plans is subject to service and performance conditions.
Stock Options
As of March 31, 2020, there were approximately $8.2 million of total unrecognized compensation costs related to unvested stock options. These costs are expected to be recognized over a weighted-average period of approximately three years. There were 348,587 stock options granted during the three months ended March 31, 2020. For the three months ended March 31, 2020, the weighted average grant date fair value for stock options was $13.03 per option.
Awards of Restricted Stock and Performance Stock
Performance stock and restricted stock awards generally have requisite service periods of three years. Performance stock units are subject to graded vesting conditions based on revenue goals of the Company. The Company expenses the fair value of restricted stock awards on a straight-line basis over the requisite service period. As of March 31, 2020, there was approximately $37.3 million of total unrecognized compensation costs related to these unvested awards. The Company expects to recognize these costs over a weighted-average period of approximately two years. The Company granted 262,623 restricted stock awards and 180,875 performance stock awards during the three months ended March 31, 2020. For the three months ended March 31, 2020, the weighted average grant date fair value for restricted stock awards and performance stock units was $43.89 and $43.39 per award, respectively.
The Company has no formal policy related to the repurchase of stock for the purpose of satisfying stock-based compensation obligations.

22
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)

The Company also maintains an Employee Stock Purchase Plan (the “ESPP”), which provides eligible employees with the opportunity to acquire shares of common stock at periodic intervals by means of accumulated payroll deductions. The ESPP is a non-compensatory plan based on its terms.
9. RETIREMENT PLANS
The Company maintains defined benefit pension plans that cover certain employees in Austria, France, Japan, Germany and Switzerland.
Net periodic benefit costs for the Company’s defined benefit pension plans for the three months ended March 31, 2020 were $1.0 million. The components of the net periodic benefit costs other than the service cost component of $0.9 million for the three months ended March 31, 2020, are included in other income (expense), net in the consolidated statements of operations.
Net periodic benefit costs for the Company’s defined benefit pension plans for the three months ended March 31, 2019 was $0.5 million. The components of the net periodic benefit costs other than the service cost component of $0.7 million for the three months ended March 31, 2019, respectively, are included in other income (expense), net in the consolidated statements of operations.
The estimated fair values of plan assets were $31.3 million and $30.8 million as of March 31, 2020 and December 31, 2019, respectively. The net plan assets of the pension plans are invested in common trusts as of March 31, 2020 and December 31, 2019. Common trusts are classified as Level 2 in the fair value hierarchy. The fair value of common trusts is valued at the net asset value based on the fair values of the underlying investments of the trusts as determined by the sponsor of the trusts. The investment strategy of the Company's defined benefit plans is both to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within an appropriate risk profile.
Deferred Compensation Plan
In May 2019, the Company adopted the Integra LifeSciences Deferred Compensation Plan (the “Plan”). Under the Plan, certain employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation.
During the first quarter of 2020, employees participating in the Plan began to defer their compensation. This deferred compensation is invested in funds offered under the Plan and is valued based on Level 1 measurements in the fair value hierarchy. The purpose of the Plan is to retain key employees by providing them with an opportunity to defer a portion of their compensation as elected by the participant in accordance with the Plan. Any amounts set aside to defray the liabilities assumed by the Company will remain the general assets of the Company until such amounts are distributed to the participants. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices. The fair value of these assets at March 31, 2020 was $1.2 million. Offsetting liabilities relating to the deferred compensation plan are included in Other liabilities.
10. LEASES AND RELATED PARTY LEASES
The Company leases administrative, manufacturing, research and distribution facilities and vehicles through operating lease agreements. The Company has no finance leases as of March 31, 2020. Many of the Company's leases include both lease (e.g., fixed payments including rent) and non-lease components (e.g., common-area or other maintenance costs). For vehicles, the Company has elected the practical expedient to group lease and non-lease components. 
Most facility leases include one or more options to renew. The exercise of lease renewal options is typically at the Company's sole discretion, therefore, the majority of renewals to extend the lease terms are not included in the ROU assets and lease liabilities as they are not reasonably certain of exercise. The Company regularly evaluates renewal options and when they are reasonably certain of exercise, the renewal period is included in the lease term.
As most of the Company's leases do not provide an implicit rate, the Company uses a collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of the lease payments.
Total operating lease expense for the three months ended March 31, 2020 and March 31, 2019, was $4.8 million and $4.4 million respectively, which includes $0.1 million, in related party operating lease expense.
Supplemental balance sheet information related to operating leases at March 31, 2020 were as follows:

23
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)

 
March 31, 2020
 
(In thousands, except lease term and discount rate)
ROU assets
$
95,890

 
 
Current lease liabilities
$
12,964

Non-current lease liabilities
100,328

Total lease liabilities
$
113,292

 
 
Weighted average remaining lease term (in years):
 
Leased facilities
12.5

Leased vehicles
1.7

 
 
Weighted average discount rate:
 
Leased facilities
5.2
%
Leased vehicles
2.4
%

Supplemental cash flow information related to leases was as follows for the three months ended March 31, 2020 (in thousands):
 
March 31, 2020
 
(In thousands)
Cash paid for amounts included in the measurement of lease liabilities:
 
Operating cash flows from operating leases
$
3,229

 
 
ROU assets obtained in exchange for lease liabilities:
 
Operating leases
$
5,808


Future minimum lease payments under operating leases at March 31, 2020 were as follows:
 
Related Parties
 
Third Parties
 
Total
 
(In thousands)
2020
$
222

 
$
10,334

 
$
10,556

2021
296

 
13,018

 
13,314

2022
296

 
14,198

 
14,494

2023
296

 
11,658

 
11,954

2024
296

 
11,022

 
11,318

Thereafter
1,429

 
91,026

 
92,455

Total minimum lease payments
$
2,835

 
$
151,256

 
$
154,091

Less: Imputed interest
 
 
 
 
40,799

Total lease liabilities
 
 
 
 
113,292

Less: Current lease liabilities
 
 
 
 
12,964

Long-term lease liabilities
 
 
 
 
100,328









24
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)

Future minimum lease payments under operating leases at December 31, 2019 were as follows:
 
Related Parties
 
Third Parties
 
Total
 
(In thousands)
2020
$
296

 
$
12,100

 
$
12,396

2021
296

 
12,951

 
13,247

2022
296

 
13,753

 
14,049

2023
296

 
11,386

 
11,682

2024
296

 
11,060

 
11,356

Thereafter
1,428

 
91,235

 
92,663

Total minimum lease payments
$
2,908

 
$
152,485

 
$
155,393

Less: Imputed interest
 
 
 
 
45,636

Total lease liabilities
 
 
 
 
109,757

Less: Current lease liabilities
 
 
 
 
12,253

Long-term lease liabilities
 
 
 
 
97,504


There were no future minimum lease payments under capital leases at December 31, 2019.
Related Party Leases
The Company leases its manufacturing facility in Plainsboro, New Jersey, from a general partnership that is 50% owned by a corporation whose shareholders are trusts, whose beneficiaries include family members of the Company’s principal stockholder and former director. The term of the current lease agreement is through October 31, 2032 at an annual rate of approximately $0.3 million per year. The current lease agreement also provides (i) a 5-year renewal option for the Company to extend the lease from November 1, 2032 through October 31, 2037 at the fair market rental rate of the premises, and (ii) another 5-year renewal option to extend the lease from November 1, 2037 through October 31, 2042 at the fair market rental rate of the premises.
11. TREASURY STOCK
As of March 31, 2020 and December 31, 2019, there were 4.3 million and 2.9 million shares of treasury stock outstanding with a cost of $202.5 million and $119.9 million, at a weighted average cost per share of $47.17 and $41.87, respectively.
On December 11, 2018, the Board of Directors authorized the Company to repurchase up to $225.0 million of the Company’s common stock. The program allows the Company to repurchase its shares opportunistically from time to time. The repurchase authorization expires in December 2020.

During the three months ended March 31, 2020, the Company repurchased 1.4 million shares of Integra’s common stock as part of our existing share repurchase authorization. The Company utilized $100.0 million of net proceeds from the offering of the Convertible Senior Notes to execute the share repurchase transactions. This included $7.6 million from certain purchasers of the convertible notes in conjunction with the closing of the offering. On February 5, 2020, the Company entered into a
$92.4 million accelerated share repurchase ("ASR") to complete the remaining $100.0 million of share repurchase. The Company received 1.3 million shares at inception of the ASR, which represented approximately 80% of the expected total shares. The remaining 20% of the expected total shares is expected to settle during the second quarter of 2020, upon which additional shares of common stock may be delivered to the Company or, under certain circumstances, the Company may be required to make a cash payment or may elect to deliver shares of our common stock to the ASR counterparty. The total number of shares to be delivered or the amount of such payment, as well as the final average price per share, will be based on the volume-weighted average price, less a discount, of the Company's common stock during the term of the transaction.

The Company has $125.0 million remaining under the share repurchase of its Common Stock. The price and timing of any future purchases under the share repurchase program will depend on factors such as levels of cash generation from operations, the volume of stock option exercises by employees, cash requirements for acquisitions, dividends, economic and market conditions and stock price.


25
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)

12. INCOME TAXES
The following table provides a summary of the Company's effective tax rate:
 
Three Months Ended March 31,
 
2020
 
2019
Reported tax rate
19.8
%
 
(32.0
)%


The Company’s effective income tax rates for the three months ended March 31, 2020 and 2019 were 19.8% and (32.0)%, respectively. For the three months ended March 31, 2020, the primary drivers of the higher tax rate were lower book income in lower-taxed jurisdictions and a $3.3 million valuation allowance on certain foreign deferred tax assets as the Company determined that it is no longer more likely than not that these foreign deferred tax assets would be realized due to the adverse impact of the COVID-19 pandemic in certain jurisdictions. For the three months ended March 31, 2019, the primary drivers of the lower rate were a $0.7 million higher tax benefit related to equity compensation and a tax benefit of $10.8 million ($0.13 per share) related to a federal tax holiday in Switzerland, which was finalized during the quarter ended March 31, 2019. The Company received a Switzerland federal tax credit of $12.0 million CHF, which can be used over a seven-year period, ending in 2024.
As of March 31, 2020, the Company has not provided deferred income taxes on unrepatriated earnings from foreign subsidiaries as they are deemed indefinitely reinvested. Such taxes would primarily be attributable to foreign withholding taxes and local income taxes when such earnings are distributed. As such, the Company has determined the tax impact of repatriating these earnings would not be material as of March 31, 2020. The company does not anticipate the need to repatriate earnings from foreign subsidiaries as a result of the impact of the COVID-19 pandemic.
On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was signed into law. The CARES Act includes certain income tax provisions for corporations and individuals, among other provisions. The Company does not expect the CARES Act to have a significant impact on the tax provision for income.

13. NET INCOME PER SHARE
Basic and diluted net income per share was as follows:
 
Three Months Ended March 31,
 
2020
 
2019
 
(In thousands, except per share amounts)
Basic net income per share:
 
 
 
Net income
$
9,180

 
$
32,756

Weighted average common shares outstanding
85,188

 
85,343

Basic net income per common share
$
0.11

 
$
0.38

 
 
 
 
Diluted net income per share:
 
 
 
Net income
$
9,180

 
$
32,756

 
 
 
 
Weighted average common shares outstanding — Basic
85,188

 
85,343

Effect of dilutive securities:
 
 
 
Stock options and restricted stock
704

 
915

Weighted average common shares for diluted earnings per share
85,892

 
86,258

 
 
 
 
Diluted net income per common share
$
0.11

 
$
0.38



Common stock of approximately 0.4 million shares at March 31, 2020, and 2019 that are issuable through exercise of dilutive securities were not included in the computation of diluted net income per share because their effect would have been anti-dilutive.

26
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)

Performance Shares and Restricted Units that entitle the holders to approximately 0.5 million shares of common stock are included in the basic and diluted weighted average shares outstanding calculation from their date of issuance because no further consideration is due related to the issuance of the underlying common shares.

14. COMPREHENSIVE INCOME (LOSS)

Comprehensive income (loss) was as follows:
 
Three Months Ended March 31,
 
2020
 
2019
 
(In thousands)
Net income
$
9,180

 
$
32,756

Foreign currency translation adjustment
(6,813
)
 
(7,009
)
Change in unrealized loss on derivatives, net of tax
(21,306
)
 
(4,236
)
Pension liability adjustment, net of tax
(68
)
 
9

Comprehensive income (loss), net
$
(19,007
)
 
$
21,520


Changes in accumulated other comprehensive loss by component between December 31, 2019 and March 31, 2020 are presented in the table below, net of tax:
 
 
Gains and Losses on Derivatives
 
Defined Benefit Pension Items
 
Foreign Currency Items
 
Total
 
 
(In thousands)
Balance at January 1, 2020
 
$
(26,625
)
 
$
(9,709
)
 
$
(40,067
)
 
$
(76,401
)
Other comprehensive loss
 
(20,577
)
 
(68
)
 
(6,813
)
 
(27,458
)
Less: Amounts reclassified from accumulated other comprehensive loss
 
729

 
—

 
—

 
729

Net current-period other comprehensive loss
 
(21,306
)
 
(68
)
 
(6,813
)
 
(28,187
)
Balance at March 31, 2020
 
$
(47,931
)
 
$
(9,777
)
 
$
(46,880
)
 
$
(104,588
)

For the three months ended March 31, 2020, the Company reclassified a loss of $0.1 million from accumulated other comprehensive loss to other income (expense), net and $0.9 million from interest income.
15. SEGMENT AND GEOGRAPHIC INFORMATION
The Company internally manages two global reportable segments and reports the results of its businesses to its chief operating decision maker. The two reportable segments and their activities are described below.
•
The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the instruments business, which sells more than 40,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.
•
The Orthopedics and Tissue Technologies segment includes such offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair products.
The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs.
The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by each reportable segment for the three months ended March 31, 2020 and 2019 are as follows:

27
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)

 
Three Months Ended March 31,
 
2020
 
2019
 
(In thousands)
Segment Net Sales
 
 
 
Codman Specialty Surgical
$
231,440

 
$
234,568

Orthopedics and Tissue Technologies
122,884

 
125,122

Total revenues
$
354,324

 
$
359,690

Segment Profit
 
 
 
Codman Specialty Surgical
$
87,235

 
$
91,380

Orthopedics and Tissue Technologies
31,271

 
40,495

Segment profit
118,506

 
131,875

Amortization
(6,977
)
 
(5,279)

Corporate and other
(84,426
)
 
(94,288
)
Operating income
$
27,103

 
$
32,308


The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment.
The Company attributes revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following:
 
Three Months Ended March 31,
 
2020
 
2019
 
(In thousands)
United States
$
246,852

 
$
256,726

Europe
45,896

 
48,640

Asia Pacific
39,960

 
35,700

Rest of World
21,616

 
18,624

Total Revenues
$
354,324

 
$
359,690



16. COMMITMENTS AND CONTINGENCIES
In consideration for certain technology, manufacturing, distribution, and selling rights and licenses granted to the Company, the Company has agreed to pay royalties on sales of certain products that it sells. The royalty payments that the Company made under these agreements were not significant for any of the periods presented.
The Company is subject to various claims, lawsuits and proceedings in the ordinary course of the Company's business, including claims by current or former employees, distributors and competitors and with respect to its products and product liability claims, lawsuits and proceedings, some of which have been settled by the Company. In the opinion of management, such claims are either adequately covered by insurance or otherwise indemnified, or are not expected, individually or in the aggregate, to result in a material, adverse effect on the Company's financial condition. However, it is possible that the Company's results of operations, financial position and cash flows in a particular period could be materially affected by these contingencies.
The Company accrues for loss contingencies when it is deemed probable that a loss has been incurred and that loss is estimable. The amounts accrued are based on the full amount of the estimated loss before considering insurance proceeds and do not include an estimate for legal fees expected to be incurred in connection with the loss contingency. The Company consistently accrues legal fees expected to be incurred in connection with loss contingencies as those fees are incurred by outside counsel as a period cost.
Contingent Consideration
The Company determined the fair value of contingent consideration during the three-month period ended March 31, 2020 and March 31, 2019 to reflect the change in estimates, additions, payments, transfers and the time value of money during the period.
A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the three months ended March 31, 2020 and March 31, 2019 is as follows (in thousands):

28
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)

Three Months Ended March 31, 2020
Contingent Consideration Liability Related to Acquisition of Arkis (See Note 2)
 
Contingent Consideration
 Liability Related to Acquisition of Derma Sciences
Location in Financial Statements
 
Long-term
 
Long-term
 
Balance as of January 1, 2020
$
14,210

 
$
230

 
Payments
—

 
—

 
Loss from change in fair value of contingent consideration liabilities
(1,051
)
 
—

Research and development
Balance as of March 31, 2020
$
13,159

 
$
230

 

Three Months Ended March 31, 2019
 
Contingent Consideration
 Liability Related to Acquisition of Derma Sciences
Location in Financial Statements
 
 
Long-term
 
Balance as of January 1, 2019
 
$
230

 
Payments
 
—

 
Loss from change in fair value of contingent consideration liabilities
 
—

Research and development
Balance as of March 31, 2019
 
$
230

 

Derma Sciences
The Company assumed contingent consideration incurred by Derma Sciences, Inc. ("Derma Sciences") related to its acquisitions of BioD and the intellectual property related to Medihoney products. The Company accounted for the contingent liabilities by recording their fair value on the date of the acquisition based on a probability weighted income approach. The Company has already paid $33.3 million related to the aforementioned contingent liabilities. One contingent liability remains which relates to net sales of Medihoney products exceeding certain amounts defined in the agreement between the Company and Derma Sciences. The potential maximum undiscounted payment amounts to $3.0 million. The estimated fair value as of March 31, 2020 and March 31, 2019 was $0.2 million.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis of the Company's financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and the related notes thereto appearing elsewhere in this report and our consolidated financial statements for the year ended December 31, 2019 included in our Annual Report on Form 10-K.
We have made statements in this report which constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”). These forward-looking statements are subject to a number of risks, uncertainties and assumptions about the Company and other matters. These forward-looking statements include, but are not limited to, statements related to the Company's expectations regarding the potential impacts of the COVID-19 pandemic on our business, financial condition, and results of operations. These statements should, therefore, be considered in light of various important factors, including, but not limited to, the following: The Company's ability to obtain accurate procedure volume in the midst of the COVID-19 pandemic; the risk that the COVID-19 pandemic could lead to further material delays and cancellations of, or reduced demand for, procedures; curtailed or delayed capital spending by hospitals; disruption to the Company's supply chain; closures of our facilities; delays in gathering clinical evidence; diversion of management and other resources to respond to the COVID-19 outbreak; the impact of global and regional economic and credit market conditions on healthcare spending; the risk that the COVID-19 virus disrupts local economies and causes economies in our key markets to enter prolonged recessions. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of many factors, including but not limited to those set forth under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2019, and under the heading "Risk Factors" in this report. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
You can identify these forward-looking statements by forward-looking words such as “believe,” “may,” “might,” “could,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “seek,” “plan,” “expect,” “should,” “would” and similar expressions in this report.


29


GENERAL
Integra, headquartered in Princeton, New Jersey, is a world leader in medical technology. The Company was founded in 1989 with the acquisition of an engineered collagen technology platform used to repair and regenerate tissue. Since then, Integra has developed numerous product lines from this technology for applications ranging from burn and deep tissue wounds, to the repair of dura mater in the brain, and repair of nerves and tendons. The Company has expanded its base regenerative technology business to include surgical instruments, neurosurgical products, advanced wound care, collagen matrix products for hernia and plastic & reconstructive surgery, and orthopedic hardware, through a combination of several global acquisitions and development of products internally to further meet the needs of its customers and impact patient care.
We manufacture and sell our products in two reportable business segments: Codman Specialty Surgical and Orthopedics and Tissue Technologies. Our Codman Specialty Surgical products comprise of specialty surgical implants and instrumentation for a broad range of specialties. This segment includes products and solutions for dural access and repair, instruments, advanced energy, cerebral spinal fluid ("CSF") management and neuro monitoring including market-leading product portfolios used in neurosurgery operation suites and critical care units. Our Orthopedics and Tissue Technologies product portfolios consist of differentiated regenerative technology products for soft tissue repair and tissue regeneration products, surgical reconstruction, and small bone fixation and joint replacement hardware products for both upper extremities and lower extremities. This business also includes private label sales of a broad set of our regenerative and wound care medical technologies.
We have key manufacturing and research facilities located in California, New Jersey, Ohio, Massachusetts, Tennessee, Texas, Canada, France, Germany, Ireland, Switzerland and Puerto Rico. We also source most of our handheld surgical instruments, specialty metal and pyrocarbon implants, and dural sealant products through specialized third-party vendors.
Codman Specialty Surgical products are sold through a combination of directly employed sales representatives, distributors and wholesalers, depending on the customer call point.
Orthopedics and Tissue Technologies products are sold through directly employed sales representatives, distributors focused on their respective surgical specialties, and strategic partners.
Integra is committed to delivering high quality products that positively impact the lives of millions of patients and their families. We focus on four key pillars of our strategy: 1) building an execution-focused culture, 2) achieving relevant scale, 3) improving agility and innovation, and 4) leading in customer experience. We believe that by sharpening our focus on these areas through improved planning and communication, optimization of our infrastructure, and strategically aligned tuck-in acquisitions, we can build scale, increase competitiveness and achieve our long-term goals.
To this end, the executive leadership team has established the following key priorities aligned to the following areas of focus:
Strategic Acquisitions. An important part of the Company's strategy is pursuing strategic transactions and licensing agreements that increase relevant scale in the clinical areas in which Integra competes. In 2019, we closed out of 45 transition service agreements, covering 90 countries, marking the successful completion of the integration of the Codman Neurosurgery acquisition, the most significant acquisition in the Company’s history. This acquisition expanded the Company's portfolio of neurosurgery products and established us as the world leader in neurosurgery. It has also enabled us to bring our entire product portfolio to a global market. In 2019, we acquired Arkis Biosciences, Inc. and Rebound Therapeutics Corporation, both of which align with Company’s strategy to acquire and develop innovative technologies that address unmet needs.
Portfolio Optimization and New Product Introductions. We are investing in innovative product development to drive a multi-generational pipeline for our key product franchises. Our product development efforts span across our key global franchises focused on potential for significant returns on investment. In 2019, we launched ten new products across our key product franchises. In addition to new product development, we are funding studies to gather clinical evidence to support launches, ensure market access and improve reimbursement for existing products. In 2019, we discontinued certain low-growth, low margin products. We continue to identify ways of optimizing our portfolio including identifying low-growth, low-margin products and product franchises for discontinuation.
Commercial Channel Investments. With acquisitions, new product introductions and a broader portfolio of products, investing in our sales channels is a core part of our strategy to create specialization and greater focus on reaching new and existing customers and addressing their needs. Internationally, we have increased our commercial resources significantly in many markets and are making investments to support our sales organization and maximize our commercial opportunities. We now have a strong international sales channel that will deliver our current portfolio as well as position us for expansion. In addition, we continue to build upon our leadership brands across our product franchises to enable us to engage hospital systems through enterprise-wide contracts.

30

Customer Experience. We aspire to be ranked as a best-in-class provider and are committed to strengthen our relationships with all customers. We strive to consistently deliver outstanding customer service and continue to invest in technologies, systems and processes to improve the way our customers do business with us. Additionally, we expect to build on the success of our professional education programs to drive continued customer familiarity with our growing portfolio of medical technologies globally.
Clinical and Product Development Activities
We continue to invest in collecting clinical evidence to support the Company's existing products and new product launches, and to ensure that we obtain market access for broader and more cost-effective solutions.
During 2019, within the Codman Specialty Surgical segment, we launched our new electrosurgery generator and irrigator system, an innovative customer-centric toolkit for our Certas™ Plus Programmable Valve along with additional shunt configurations. We launched DuraGen® in Japan. DuraGen is the first and only non-autologous collagen xenograft approved for use as a dural substitute in Japan. We are focused on the development of core clinical applications in our electromechanical technologies portfolio. Also, we updated our CUSA Clarity platform to incorporate new ultrasonic handpiece, surgical tips and integrated electrosurgical capabilities. We continue to work with several instrument partners to bring new surgical instrument platforms to the market. This enables us to add new instruments with minimal expense and invest in ongoing development, such as our next generation of LED technology with our DUO LED Surgical Headlight System.
During 2019, within our Orthopedic and Tissue Technologies segment, we launched the Panta® II TTC Arthrodesis Nail System in the U.S. The Panta II system is our new fusion nail used in ankle fixation. We also launched a Small Post Baseplate in our Reverse Shoulder System that accommodates smaller patients. We initiated the limited market release of enhancements to our Salto Talaris® Total Ankle System. We continue to work on advanced shoulder products and are developing a pyrocarbon shoulder hemiarthroplasty product to add to our orthopedic reconstruction portfolio.
COVID-19 Pandemic
The Company's focus during this global crisis remains on supporting patients, providing customers with life-saving products, and protecting the well-being of its employees. Earlier in the first quarter of 2020, the Company implemented contingency plans to address the operational impact of COVID-19 and ensure ongoing operations. The rapid and evolving spread of the virus resulted in an unprecedented challenge to the global healthcare industry. In response to the challenge as the pandemic evolved in March 2020, the Company has expanded its contingency plans to enable its manufacturing and distribution sites around the world to continue operating at levels required to meet demand and to provide for the safety of its employees. In addition, the Company has initiated significant cost-savings measures in April, which include the following:

•
Reduced executive management and director compensation
•
Reduced cash compensation for all other employees through reduced commissions, reduction in hours, and/or furloughs
•
Hiring freeze, elimination of overtime, cessation of third-party services and temporary contractor relationships
•
Significant reduction in capital expenditures and discretionary spending including travel, events and marketing programs

The Company remains confident that the markets in which it competes remain attractive over the long term. These comprehensive spending cuts were necessary to protect our financial strength in the face of near-term challenges. Yet, despite those challenges, the Company remains focused on managing the business for the long-term, including preserving full time jobs needed to support the expected rebound in surgical procedure volumes. The Company's adaptability and resiliency in the face of this unprecedented crisis is made possible in part by prior investments in technology infrastructure and operations as well as our talented and committed global workforce. And despite the current cost-reduction measures, we continue to prioritize and invest in our critical R&D and clinical programs. Based on the ongoing impact from restrictions on surgical procedures and shelter-in-place policies, the Company expects revenue to decline in the second quarter of 2020. The Company cannot predict with certainty the extent to which the COVID-19 pandemic will impact procedures in the second quarter and beyond.

Information pertaining to additional risk factors as it relates to COVID-19 can be found in Item 1A. Risk Factors.
FDA Matters
On June 22, 2015, the FDA (the “FDA”) issued an Untitled Letter (the "Untitled Letter") alleging that BioD LLC's ("BioD") morselized amniotic membrane tissue based products do not meet the criteria for regulation as HCT/Ps solely under Section 361 of the Public Health Services Act ("Section 361") and that, as a result, BioD would need a biologics license to lawfully market those morselized products. Since the issuance of the Untitled Letter, BioD and more recently the Company have been in discussions with the FDA to communicate their disagreement with the FDA’s assertion that certain products are more than

31

minimally manipulated. The FDA has not changed its position that certain of the BioD acquired products are not eligible for marketing solely under Section 361.
In November 2017, the FDA issued the final guidance document related to human tissue titled, “Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use” (the “HCT/P Final Guidance”). The HCT/P Final Guidance maintains the FDA’s position that products such as the Company’s morselized amniotic membrane tissue-based products do not meet the criteria for regulation solely as HCT/Ps. In addition, the FDA articulated a risk-based approach to enforcement and, while some uses for amniotic membrane tissue-based products would have as much as thirty-six months of enforcement discretion, other high risk uses could be subject to immediate enforcement action. The Company does not believe the uses for its amniotic membrane tissue-based products fall into the high-risk category. As of March 31, 2020 the Company has not received any further notice of enforcement action from the FDA regarding its morselized amniotic tissue-based products. Nonetheless, we can make no assurances that the FDA will continue to exercise its enforcement discretion with respect to the Company’s morselized amniotic membrane tissue-based products, and any potential action of the FDA could have a financial impact regarding the sales of such products. The Company has been considering and continues to consider regulatory approval pathways for its morselized amniotic membrane tissue-based products.
Revenues from BioD morselized amniotic membrane based products for the three months ended March 31, 2020 were less than 1.0% of consolidated revenues.
On March 7, 2019, TEI Biosciences, Inc. a subsidiary of the Company received a Warning Letter (the “Warning Letter”), dated March 6, 2019, from the United States Food and Drug Administration. The warning letter relates to quality systems issues at our manufacturing facility located in Boston, Massachusetts. The letter resulted from an inspection held at that facility in October and November 2018 and did not identify any new observations that were not already provided in the Form 483 that followed the inspection. The Company has provided detailed responses to the FDA as to its corrective actions on a monthly basis and, since the conclusion of the inspection, has undertaken significant efforts to remediate the observations and continues to do so. The warning letter does not restrict the Company’s ability to manufacture or ship products or require the recall of any products. Nor does it restrict our ability to seek FDA 510(k) clearance of products. The letter states that requests for Certificates to Foreign Governments will not be granted until the violations have been corrected. Additionally, premarket approval applications for Class III devices to which the Quality System regulation violations are reasonably related will not be approved until the violations have been corrected. The TEI Boston facility manufactures extracellular bovine matrix (EBM) products. The Company does not expect to incur material incremental expense for remediation activities. The Company submitted its initial response to the FDA Warning Letter on March 28, 2019 and provides regular progress reports to the FDA. We cannot, however, give any assurances that the FDA will be satisfied with our response to the letter or as to the expected date of the resolution of the matters included in the letter. Until the issues cited in the letter are resolved to the FDA’s satisfaction, the FDA may initiate additional regulatory action without further notice. Any adverse regulatory action, depending on its magnitude, may restrict us from effectively manufacturing, marketing and selling our products and could have a material adverse effect on our business, financial condition and results of operations.
Revenues of products manufactured in the TEI Boston facility for the three months ended March 31, 2020 were approximately 4.9% of consolidated revenues.


RESULTS OF OPERATIONS
Executive Summary
Net income for the three months ended March 31, 2020 was $9.2 million, or $0.11 per diluted share, as compared to $32.8 million or $0.38 per diluted share for the three months ended March 31, 2019.
The net income for the three months ended March 31, 2020 was impacted by the COVID-19 pandemic which resulted in a decrease to revenue and additional expenses due to COVID-19 related charges. Further, the Company also had an increase in interest expense due to the issuance of the Convertible Senior Notes and valuation allowance on certain deferred tax assets as a result of the impact of the COVID-19 pandemic and lower book income in lower-taxed jurisdictions.
Prior to the spread of COVID-19, the Company experienced procedure growth trends consistent with those experienced in the fourth quarter of 2019, including strength in general surgery, growth across both divisions in the U.S., and strong performance in international markets. For the first two and a half months of the first quarter of 2020, revenue was trending at the higher end of the Company’s expectations. However, in March as a result of the speed and severity of the spread of COVID-19, Federal, state and several medical and professional associations began to recommend patients defer treatment of all non-urgent medical conditions. These recommendations included unprecedented shelter-in-place policies across the country, which in addition to limiting elective procedures, resulted in a much lower incidence of traumatic injuries, which are a meaningful part of our procedure

32

base. As a result, in mid-March the Company began to experience a significant decline in surgical and medical intervention procedures as healthcare providers reallocated resources to address the increasing demands caused by COVID-19.
The Company's first quarter performance reflects the early impact of the COVID-19 global pandemic and our initial response. By reacting swiftly in February and working with customers and distributors, we were largely able to mitigate the initial revenue impact of the social and economic shutdowns that took place in large parts of China. First quarter total revenues as of March 31, 2020, were $354 million, representing a decline of 1.5% from prior year revenues. The Company has estimated the revenue impact from the decline in surgical procedures to be approximately $20 to $25 million in the first quarter of 2020 compared to its original first quarter revenue expectations. Based on April trends and the ongoing impact from restrictions on surgical procedures and shelter-in-place policies, the Company expects a more substantial negative impact on second quarter performance. The Company believes it is important to remember that our underlying end-markets, especially neurosurgery and regenerative medicine, are not experiencing fundamental changes to the disease conditions. In many cases these conditions can only be deferred for a short period of time, after which an adverse clinical outcome can occur.
In the Codman Specialty Surgical segment, the Company saw growth across all Neurosurgery products, led by notable outperformance in CSF management and advanced energy. The Instruments business declined double-digits in the first quarter of 2020 driven by COVID-19 related deferrals on small capital equipment and general surgical instruments. The Company had a solid start to the quarter with strong performance in its Neurosurgery products, including dural access and repair due to continued growth in Japan, and advanced purchases in several international indirect markets due to increased concerns over the spread of COVID-19. In the second half of March the segment was heavily impacted by COVID-19, as the Company saw steep declines in sales across all products, particularly in the U.S. markets. Overall global revenues declined by low single digits in the first quarter of 2020 mainly driven by declines in sales due to COVID-19. The impact of COVID-19 on this segment is approximately $10 to $13 million compared to its original first quarter revenue expectations.
In the Orthopedics and Tissue Technologies segment, the Company also saw early strength in our regenerative products, driven mostly by amniotics and Surgimend, as supply was increased following capacity expansion investments made last year. The Company's broader wound reconstruction portfolio saw strong customer demand in the first couple months of Q1 2020 however, during March the Company saw a decline in these products largely due to the impact of COVID-19 in areas such as non-emergent chronic wounds and plastic and reconstructive surgical procedures. Additionally, the Company’s private label business reported mid-single digit sales growth, with limited COVID-19 impact as first quarter orders were largely pre-scheduled and in line with expectations. Beginning in late March, the Company saw a significant slowing of its Orthopedics business as non-emergent surgeries began to get deferred resulting in a decrease of mid-single digits in these products for the first quarter of 2020. Overall global revenues declined by low single digits in the first quarter of 2020 resulting from the impact of COVID-19 on this segment of approximately $10 to 12 million compared to its original first quarter revenue expectations.
The depth and extent to which the COVID-19 pandemic will impact individual markets will vary based on the availability of testing capabilities, personal protective equipment, intensive care units and operating rooms, and medical staff as well as government interventions. As COVID-19 continues to spread, it is likely that surgical procedures will decline from those rates experienced in the first quarter of 2020. While some markets, e.g., China, appear to be recovering, it is possible that a recurrence of COVID-19 will negatively impact non-emergent surgical procedures. For both the Codman Specialty Surgical and Orthopedics and Tissue Technologies segments, the Company has assigned each of its core product families into one of three categories based on procedure severity, meaning whether a procedure is more urgent, moderately urgent or more deferrable. For example, where the Company has visibility, as in traumatic brain injuries which require cerebral spinal fluid management or neuro monitoring, or burns and acute wounds, it has classified these products as more urgent. The Company has classified products such as orthopedics and small capital equipment as more deferrable, as the Company has seen hospitals defer these related procedures and purchases in light of COVID-19 resource and near-term budget prioritization. A large percentage of the Company's products fall into the moderately urgent category including dural access & repair and chronic wounds. The majority of these moderately urgent products involve procedures that cannot be deferred beyond 30 to 90 days without an adverse clinical outcome. The Company notes that there is some level of variability in these category assessments, as physicians will need to evaluate patients’ underlying medical conditions to determine procedure urgency. Moreover, the Company does not expect all markets to recover at the same pace. While we cannot reliably estimate the extent or length of the impact with certainty, we expect procedure volume to significantly decline or be delayed in the second quarter of 2020 and beyond as COVID-19 infections spread, causing additional strain on hospital resources, coupled with the recommended deferrals of less urgent procedures by governments and other authorities. The Company's revenue profile amidst COVID-19 is as follows:

33

chart.jpg
Capital markets and worldwide economies have also been significantly impacted by the COVID-19 pandemic, and it is possible that it could cause a local and/or global economic recession. Such economic recession could have a material adverse effect on the Company's long-term business as hospitals curtail and reduce capital and overall spending. The COVID-19 pandemic and local actions, such as “shelter-in-place” orders and restrictions on our ability to travel and access our customers or temporary closures of our facilities or the facilities of our suppliers and their contract manufacturers, could further significantly impact our sales and our ability to ship our products and supply our customers. Any of these events could negatively impact the number of surgical and medical intervention procedures performed and have a material adverse effect on our business, financial condition, results of operations, or cash flows.
Income before taxes includes the following special charges:
 
Three Months Ended March 31,
 
2020
 
2019
 
(In thousands)
Acquisition and integration-related charges
$
6,166

 
$
19,463

Structural optimization charges
2,896

 
4,797

EU medical device regulation
2,187

 
1,109

Litigation charges
346

 
1,249

Discontinued product lines charges
3,185

 
1,400

COVID-19 pandemic related charges (1)
4,706

 
—

Expenses related to debt refinancing
2,740

 
—

Convertible debt non-cash interest expense
2,529

 
—

  Total
$
24,755

 
$
28,018


34

(1) Charges relates to business interruptions and cost associated from COVID-19 pandemic which impacted the Company's operations globally.
The items reported above are reflected in the condensed consolidated statements of operations as follows: 
 
Three Months Ended March 31,
 
2020
 
2019
 
(In thousands)
Cost of goods sold
$
9,307

 
$
3,883

Research and development
(1,051
)
 
1,675

Selling, general and administrative
11,230

 
22,460

Interest expense
5,269

 
—

  Total
$
24,755

 
$
28,018

We typically define special charges as items for which the amounts and/or timing of such expenses may vary significantly from period to period, depending upon our acquisition, integration and restructuring activities, and for which the amounts are non-cash in nature, or for which the amounts are not expected to recur at the same magnitude. We believe that given our ongoing strategy of seeking acquisitions, our continuing focus on rationalizing our existing manufacturing and distribution infrastructure and our continuing review of various product lines in relation to our current business strategy, some of the special charges discussed above could recur with similar materiality in the future.
We believe that the separate identification of these special charges provides important supplemental information to investors regarding financial and business trends relating to our financial condition and results of operations. Investors may find this information useful in assessing comparability of our operating performance from period to period, assessing the objectives that management has established, and against other companies in our industry. We provide this information to investors so that they can analyze our operating results in the same way that management does and to use this information in their assessment of our core business and valuation of Integra.
Revenues and Gross Margin
The Company's revenues and gross margin on product revenues were as follows:
 
Three Months Ended March 31,
 
2020
 
2019
Segment Net Sales
(Dollars in thousands)
Codman Specialty Surgical
$
231,440

 
$
234,568

Orthopedics & Tissue Technologies
122,884

 
125,122

Total revenue
354,324

 
359,690

Cost of goods sold
133,476

 
128,912

Gross margin on total revenues
$
220,848

 
$
230,778

Gross margin as a percentage of total revenues
62.3
%
 
64.2
%
Three Months Ended March 31, 2020 as Compared to Three Months Ended March 31, 2019
Revenues and Gross Margin
For the three months ended March 31, 2020, total revenues decreased by $5.4 million to $354.3 million from $359.7 million for the same period in 2019. Domestic revenues decreased by $9.9 million, or (3.8)%, to $246.9 million and were 69.7% of total revenues for the three months ended March 31, 2020. International revenues increased by $4.5 million to $107.5 million for the three months ended March 31, 2020 compared to $103.0 million during the same period in the prior year. The net decrease of $5.4 million was a result of decline in both segments due to disruption from COVID-19 as well as an unfavorable impact of foreign exchange of $1.7 million and $3.5 million due to discontinued and divested products.
Codman Specialty Surgical revenues were $231.4 million, a decrease of $3.1 million, or (1.3)% from the prior-year period. The decrease primarily resulted from Instruments which decreased double-digits offset by single-digit growth in Dural Access and Repair and CUSA Clarity offset with an unfavorable impact of foreign exchange.
Orthopedics and Tissue Technologies revenues were $122.9 million, a decrease of $2.2 million, or (1.8)% from the prior-year period. Upper and Lower extremities sales decreased mid-single digits compared to the same period last year.

35

Gross margin decreased to $220.8 million for the three-month period ended March 31, 2020, a decrease of $10 million from $230.8 million for the same period last year. Gross margin as a percentage of total revenue decreased to 62.3% for the first quarter of 2020 from 64.2% in the same period last year. This decrease primarily related to increase in inventory reserves for discontinued product lines and charges occurred because of COVID-19 pandemic.
Operating Expenses
The following is a summary of operating expenses as a percent of total revenues: 
 
Three Months Ended March 31,
 
2020

2019
Research and development
5.9
%

5.1
%
Selling, general and administrative
46.8
%

48.6
%
Intangible asset amortization
2.0
%

1.5
%
  Total operating expenses
54.7
%

55.2
%
Total operating expenses, which consist of selling, general and administrative expenses, research and development expenses, in-process research and development expense and amortization expenses, decreased by $4.7 million, or (2.4)% to $193.7 million in the three months ended March 31, 2020, compared to $198.5 million in the same period in 2019.
Research and development expenses for the three months ended March 31, 2020 increased by $2.5 million as compared to the prior year primarily resulting from costs related to product development, including product development for the new acquisition completed in 2019. General and administrative costs decreased by $9.8 million as compared to the prior year primarily resulting from less acquisition and integration related charges compared to three month period ended March 31, 2019.
The Company's spending in the first quarter of 2020 reflected normal business activities into March as well as incurring certain costs associated with the impact of the COVID-19 pandemic, including doubtful account reserves, expedited freight, contract cancellation fees, personal protection equipment for our employees, and extra cleaning of our facilities. While certain spending will decrease in the second quarter of 2020 as a result of a reduction in revenue and activities limited by the COVID-19 pandemic, much of our spending will continue. We will continue to support our customers and invest in manufacturing and our supply chain to ensure supply for our customers. Certain costs will decline as the underlying activities are restricted by the COVID-19 pandemic, including travel and related expenses. The Company has eliminated spending that is ineffective due to the COVID-19 pandemic, such as surgeon and hospital events, and we are pausing hiring and outside professional services.
Non-Operating Income and Expenses
The following is a summary of non-operating income and expenses:
 
Three Months Ended March 31,
 
2020
 
2019
 
(In thousands)
Interest income
$
2,570

 
$
2,428

Interest expense
(17,752
)
 
(13,149
)
Other income(expense), net
(479
)
 
3,236


36

Interest Income and Interest Expense
Interest expense for the three months ended March 31, 2020 increased by $4.6 million as compared to the same period last year primarily due to increased interest expense, including non-cash interest expense, due to the issuance of the Convertible Senior Notes and expenses associated with Amended and Restated Senior Credit Agreement.
Other Income (Expense), net
Other income (expense), net for the three months ended March 31, 2020, decreased by $3.7 million as compared to the same period last year primarily due to unfavorable impact of foreign exchange.
Income Taxes
 
Three Months Ended March 31,
 
2020
 
2019
 
(In thousands)
Income before income taxes
$
11,442

 
$
24,823

Income tax (benefit) expense
2,262

 
(7,933
)
Effective tax rate
19.8
%
 
(32.0
)%
The Company’s effective income tax rates for the three months ended March 31, 2020 and 2019 were 19.8% and (32.0)%, respectively.
For the three months ended March 31, 2020, the primary drivers of the higher tax rate were lower book income in lower-taxed jurisdictions and a $3.3 million valuation allowance on certain foreign deferred tax assets as the Company determined that it is no longer more likely than not that these foreign deferred tax assets would be realized due to the adverse impact of the COVID-19 pandemic in certain jurisdictions.
For the three months ended March 31, 2019, the primary drivers of the lower rate were a tax benefit of $10.8 million related to federal tax holiday in Switzerland and $0.7 million higher tax benefit related to equity compensation. The Company received a Switzerland federal tax credit of 12 million CHF, which can be used over a seven-year period, ending in 2024.
On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was signed into law. The CARES Act includes certain income tax provisions for corporations and individuals, among other provisions. The Company does not expect the CARES Act to have a significant impact on the tax provision for income.
The Company expects its effective income tax rate for the full year to be approximately (14.6)% driven primarily by the projection of a full year pretax loss from the impact of the COVID-19 on the Company's U.S. GAAP financial results. This estimate could be revised in the future as additional information is presented to the Company.

The effective tax rate may vary from period to period depending on, among other factors, the geographic and business mix of taxable earnings and losses, tax planning and settlements with various taxing authorities. We consider these factors and others, including the Company's history of generating taxable earnings, in assessing our ability to realize tax assets on a quarterly basis.

While it is often difficult to predict the final outcome or the timing of resolution of any particular matter with the various Federal, state, and foreign tax authorities, we believe that our reserves reflect the most probable outcome of known tax contingencies. Settlement of any particular issue would usually require the use of cash. Favorable resolution would be recognized as a reduction to our annual effective tax rate in the year of resolution. The tax reserves are presented in the balance sheet within other liabilities, except for amounts relating to items that we expect to pay in the coming year, which would be classified as current income taxes payable.


37

GEOGRAPHIC PRODUCT REVENUES AND OPERATIONS
The Company attributes revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following:
 
Three Months Ended March 31,
 
2020
 
2019
 
(In thousands)
United States
$
246,852

 
$
256,726

Europe
45,896

 
48,640

Asia Pacific
39,960

 
35,700

Rest of World
21,616

 
18,624

Total Revenues
$
354,324

 
$
359,690

The Company generates significant revenues outside the U.S., a portion of which are U.S. dollar-denominated transactions conducted with customers who generate revenue in currencies other than the U.S. dollar. As a result, currency fluctuations between the U.S. dollar and the currencies in which those customers do business could have an impact on the demand for the Company's products in foreign countries. Local economic conditions, regulatory compliance or political considerations, the effectiveness of our sales representatives and distributors, local competition and changes in local medical practice all may combine to affect our sales into markets outside the U.S.
Domestic revenues decreased to $246.9 million for the three months ended March 31, 2020 compared to the same period last year. European sales decreased by $2.7 million for the three months ended March 31, 2020 compared to the same period last year. Decrease in Domestic and European revenues was primarily due to adverse effects of the COVID-19 pandemic. Sales to customers in Asia Pacific and the Rest of the World for the three months ended March 31, 2020 increased by $7.3 million compared to the same period last year primarily driven by increases including Dural Access and Repair due to continued growth in Japan, and growth in international sales due partially to advanced purchases in several indirect markets due to increased concerns over the spread of COVID-19 in overseas countries.
LIQUIDITY AND CAPITAL RESOURCES
Cash and Marketable Securities
The Company had cash and cash equivalents totaling approximately $357.7 million and $198.9 million at March 31, 2020 and December 31, 2019 respectively, which are valued based on Level 1 measurements in the fair value hierarchy. At March 31, 2020, our non-U.S. subsidiaries held approximately $152.2 million of cash and cash equivalents that are available for use outside the U.S. The Company asserts that it has the ability and intends to indefinitely reinvest the undistributed earnings from its foreign operations unless there is no material tax cost to remit the earnings into the U.S. The Company does not anticipate the need to repatriate earnings from foreign subsidiaries as a result of the impact of the COVID-19 pandemic.


38

Cash Flows
 
Three Months Ended March 31,
 
2020
 
2019
 
(In thousands)
Net cash provided by operating activities
$
20,814

 
$
29,484

Net cash used in investing activities
(21,485
)
 
(15,806
)
Net cash provided by financing activities
162,005

 
5,393

Effect of exchange rate fluctuations on cash
(2,533
)
 
(884
)
Cash Flows Provided by Operating Activities
Operating cash flows for the three months ended March 31, 2020 decreased compared to the same period in 2019. Net income after non-cash adjustments decreased for the three months ended March 31, 2020 by approximately $5.8 million compared to the same period in 2019 primarily due to adverse effects of the COVID-19 pandemic. The changes in assets and liabilities, net of business acquisitions, decreased cash flows from operating activities by $32.4 million for the three months ended March 31, 2020 compared to an increase of $29.5 million for the same period in 2019. The decrease in 2020 is primarily driven by increased investment in inventories related to new product launches and legal entity manufacturing changes associated with the Codman Neurosurgery acquisition integration. In addition, decreases were also driven by reduced payables offset by decreases in accounts receivable due to progress in collection efforts.
Cash Flows Used in Investing Activities
During the three months ended March 31, 2020, we paid $16.5 million for capital expenditures, most of which were directed to our Mansfield, Massachusetts facility, our new Princeton, New Jersey facility and commercial expansion and $5.0 million payment related to the first developmental milestone for Rebound.
During the three months ended March 31, 2019, the Company paid $16.1 million for capital expenditures, most of which were directed to our Mansfield, Massachusetts facility, and commercial expansion.
Cash Flows Used in Financing Activities
Our principal sources of cash from financing activities in the three months ended March 31, 2020 were $515.3 million proceeds from the issuance of Convertible Senior Notes including the call and warrant transactions, $113.2 million borrowing under our Senior Credit Facility and Securitization Facility and $2.3 million in proceeds from the exercise of stock options. These were offset by repayments of $344.2 million on the revolving portion of our Senior Credit Facility and Securitization Facility, $20.3 million debt issuance costs related to the Amended and Restated Credit Agreement, $100 million purchases of treasury stock and $4.3 million cash taxes paid in net equity settlement.
Our principal sources of cash from financing activities in the three months ended March 31, 2019 were $67.2 million from borrowings under our Senior Credit Facility and Securitization Facility. These were offset by repayments of $57.4 million on the revolving portion of our Senior Credit Facility and Securitization Facility and $6.2 million cash taxes paid in net equity settlement.
Amended and Restated Senior Credit Agreement, Convertible Senior Notes, Securitization and Related Hedging Activities
See Note 6 - Debt to the current period’s condensed consolidated financial statements for a discussion of our Amended and Restated Senior Credit Agreement, Convertible Senior Notes and Securitization Facility and Note 7 - Derivative Instruments for discussion of our hedging activities.
As a result of the COVID-19 pandemic, we expect to continue to experience materially lower sales for as long as the deferral of surgeries continues. We are forecasting that for the next twelve months, sales and earnings will be sufficient to remain in compliance with our financial covenants under the terms of the February 2020 Amendment to the Senior Credit Facility. We have undertaken steps to reduce our spending and expenses in light of our expectation that our revenues will be depressed over the next several months. While we expect that we will be well positioned when surgeries begin to return to their pre-pandemic levels, we are unable to predict with certainty how long the COVID-19 pandemic will last, or how severe its economic impact will be. Even after the COVID-19 pandemic and government responses thereto have subsided, residual economic and other effects may have an impact on the demand for post-pandemic surgery levels that are difficult to predict. If the downturn is more severe and prolonged than we currently expect, we may need to take further steps to reduce our costs.



39

Share Repurchase Plan
On December 11, 2018, the Board of Directors authorized the Company to repurchase up to $225.0 million of the Company’s common stock. The program allows the Company to repurchase its shares opportunistically from time to time. The repurchase authorization expires in December 2020.

During the three months ended March 31, 2020, the Company repurchased 1.4 million shares of Integra’s common stock as a part of our existing share repurchase authorization. The Company utilized $100.0 million of net proceeds from the offering of the Convertible Senior Notes to execute the share repurchase transactions. This included $7.6 million from certain purchasers of the convertible notes in conjunction with the closing of the offering. On February 5, 2020, the Company entered into a
$92.4 million accelerated share repurchase ("ASR") to complete the remaining $100.0 million of share repurchase. The Company received 1.3 million shares through an accelerated share repurchase ("ASR"), which represented approximately 80% of the expected total shares. The remaining 20% of the expected total shares is expected to settle during the second quarter of 2020, upon which additional shares of common stock may be delivered to the Company or, under certain circumstances, the Company may be required to make a cash payment or may elect to deliver shares of our common stock to the ASR counterparty. The total number of shares to be delivered or the amount of such payment, as well as the final average price per share, will be based on the volume-weighted average price, less a discount, of our common stock during the term of the transaction.

The Company has $125.0 million remaining under the share repurchase of its Common Stock. The price and timing of any future purchases under the share repurchase program will depend on factors such as levels of cash generation from operations, the volume of stock option exercises by employees, cash requirements for acquisitions, dividends, economic and market conditions and stock price.
Dividend Policy
The Company has not paid any cash dividends on our common stock since our formation. Our Senior Credit Facility limits the amount of dividends that we may pay. Any future determinations to pay cash dividends on our common stock will be at the discretion of our Board of Directors and will depend upon our financial condition, results of operations, cash flows and other factors deemed relevant by the Board of Directors.
Capital Resources
We believe that our cash and available borrowings under the Senior Credit Facility are sufficient to finance our operations and capital expenditures for the foreseeable future. Our future capital requirements will depend on many factors, including the growth of our business, the timing and introduction of new products and investments, strategic plans and acquisitions, among others. Additional sources of liquidity available to us include short term borrowings and the issuance of long term debt and equity securities. Further, as part of our actions to manage the impacts of COVID-19 on our business, we will significantly reduce our capital expenditures for 2020.
As a result of the COVID-19 pandemic, the Company expects to experience reduced cash flow from operations as a result of decreased revenues and earnings. Moreover, we are focused on ensuring that we have adequate inventory on hand given the potential disruption of the COVID-19 pandemic to our suppliers and their supply chain and, accordingly, may continue to maintain these higher levels of inventory during the second quarter of 2020 and beyond.
Off-Balance Sheet Arrangements
The Company has no off–balance sheet financing arrangements during the three months ended March 31, 2020 that have or are reasonably likely to have, a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our interests.
Contractual Obligations and Commitments
As of March 31, 2020, the Company is obligated to pay the following amounts under various agreements:

40

 
 
 
Payments Due by Calendar Year

Total
 
Remaining 2020
 
2021-2022
 
2023-2024
 
Thereafter
 
(In millions)
Revolving Credit Facility (1)
$
150.0

 
$
—


$
—

 
$
—

 
$
150.0

Term Loan
877.5

 
—


78.8

 
129.3

 
669.4

Securitization Facility (1)
98.5


—


98.5


—


—

Convertible Debt (4)
575.0

 
—

 
—

 
—

 
575.0

Interest (2)
91.1

 
15.6


39.6

 
34.4

 
1.5

Employment Agreements (3)
0.7

 
0.7


—

 
—

 
—

Operating Leases
154.2

 
10.6


27.8

 
23.3

 
92.5

Purchase Obligations
1.0

 
0.6


0.4

 
—

 
—

Other
4.4

 
1.0


0.7

 
1.6

 
1.1

Total
$
1,952.4

 
$
28.5


$
245.8

 
$
188.6

 
$
1,489.5

(1
)
The Company may borrow and make payments against the revolving credit portion of its Senior Credit Facility and Securitization Facility from time to time and considers all of the outstanding amounts to be long term based on its current intent and ability to repay the borrowing outside of the next twelve-month period.
(2
)
Interest is calculated on the term loan portion of the Senior Credit Facility based on current interest rates paid by the Company. [As the revolving credit facility and Securitization Facility can be repaid at any time, no interest has been included in the calculation.]
(3
)
Amounts shown under Employment Agreements do not include compensation resulting from a change in control.
(4
)
On February 4, 2020, the Company issued $575.0 million aggregate principal amount of its of 0.5% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes will mature on August 15, 2025 and bear interest at a rate of 0.5% per annum payable semi-annually in arrears, unless earlier converted, repurchased or redeemed in accordance with the terms of the Notes. See Note 6, Debt, for the details on the 2025 Notes.
 
The Company has excluded its contingent consideration obligation related to a prior and current year acquisitions from the contractual obligations table above; this liability had a total estimated fair value of $13.4 million at March 31, 2020. This liability has been excluded because the amount to be paid and the potential payment date is not fixed.
The Company has excluded its option to acquire Integrated Shoulder Collaboration Inc., which becomes mandatory upon achievement of a certain sales threshold, for an amount not to exceed $80.0 million. This liability has been excluded because the amount to be paid and the potential payment date is not fixed.
The Company has excluded its future pension contribution obligations and deferred compensation obligations from the table above. This has been excluded because the future amounts to be paid and the potential payment dates are not fixed.
The Company has excluded the liability for uncertain tax benefits from the contractual obligations table above, including interest and penalties, totaling $0.8 million at March 31, 2020. This liability for uncertain tax benefits has been excluded because we cannot make a reliable estimate of the period in which the uncertain tax benefits may be realized.
OTHER MATTERS
Critical Accounting Estimates
The critical accounting estimates included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2019 have not materially changed.
Recently Issued Accounting Standards
Information regarding new accounting pronouncements is included in Note 1 - Basis of Presentation to the current period’s condensed consolidated financial statements.

41

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are exposed to various market risks, including changes in foreign currency exchange rates and interest rates that could adversely affect our results of operations and financial condition. To manage the volatility relating to these typical business exposures, we may enter into various derivative transactions when appropriate. We do not hold or issue derivative instruments for trading or other speculative purposes.
Foreign Currency Exchange and Other Rate Risks

We operate on a global basis and are exposed to the risk that changes in foreign currency exchange rates could adversely affect our financial condition, results of operations and cash flows. We are primarily exposed to foreign currency exchange rate risk with respect to transactions and net assets denominated in Euros ("EUR"), British pounds ("GBP"), Swiss francs ("CHF"), Canadian dollars, Japanese yen, Mexican pesos, Brazilian reais, Australian dollars and Chinese yuan. We manage the foreign currency exposure centrally, on a combined basis, which allows us to net exposures and to take advantage of any natural offsets. To mitigate the impact of currency fluctuations on transactions denominated in nonfunctional currencies, we periodically enter into derivative financial instruments in the form of foreign currency exchange forward contracts with major financial institutions. We temporarily record realized and unrealized gains and losses on these contracts that qualify as cash flow hedges in other comprehensive income, and then recognize them in other income or expense when the hedged item affects net earnings.
From time to time, we enter into foreign currency forward exchange contracts to manage currency exposures for transactions denominated in a currency other than an entity’s functional currency. As a result, the impact of foreign currency gains/losses recognized in earnings are partially offset by gains/losses on the related foreign currency forward exchange contracts in the same reporting period. Refer to Note 7, Derivative Instruments for further information.
We maintain written policies and procedures governing our risk management activities. With respect to derivatives, changes in hedged items are generally expected to be completely offset by changes in the fair value of hedge instruments. Consequently, foreign currency exchange contracts would not subject us to material risk due to exchange rate movements, because gains and losses on these contracts offset gains and losses on the assets, liabilities or transactions being hedged.
The results of operations discussed herein have not been materially affected by inflation.
Interest Rate Risk
Cash and Cash Equivalents - We are exposed to the risk of interest rate fluctuations on the interest income earned on our cash and cash equivalents. A hypothetical 100 basis point movement in interest rates applicable to our cash and cash equivalents outstanding at March 31, 2020 would increase interest income by approximately $3.6 million on an annual basis. No significant decrease in interest income would be expected as our cash balances are earning interest at rates of approximately one basis point. We are subject to foreign currency exchange risk with respect to cash balances maintained in foreign currencies.
Debt - Our interest rate risk relates primarily to U.S. dollar LIBOR-indexed borrowings. We use interest rate derivative instruments to manage our earnings and cash flow exposure to changes in interest rates. These interest rate swaps fix the interest rate on a portion of our expected LIBOR-indexed floating-rate borrowings. See Note 7, Derivative Instruments, for the details of interest rate swaps.
The total notional amount of interest rate swaps in effect as of March 31, 2020 was $900 million. Based on our outstanding borrowings at March 31, 2020, a 100 basis points change in interest rates would have impacted interest expense on the unhedged portion of the debt by $2.3 million on an annualized basis.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
The Company maintains disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in our Exchange Act report is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. Disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Management has designed our disclosure controls and procedures to provide reasonable assurance of achieving the desired control objectives.
As required by Exchange Act Rule 13a-15(b), the Company has carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2020. Based upon this evaluation, our principal

42

executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of March 31, 2020 to provide such reasonable assurance.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that occurred during the quarter ended March 31, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
In response to business integration activities, the Company has and will continue to further align and streamline the design and operation of the financial control environment to be responsive to the changing business model.
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
Information pertaining to legal proceedings can be found in Note 16. Commitment and Contingencies.

ITEM 1A. RISK FACTORS
The following risk factors are in addition to the risks described in the Company’s Form 10-K under Item 1A, “Risk Factors” for its fiscal year ended December 31, 2019 and in its subsequent periodic reports filed with the Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended. The risk factors described below may have the effect of heightening many of the risks contained in the Company’s Form 10-K and other periodic reports.
The effects of the COVID-19 pandemic have significantly impacted global economic conditions and have affected our operations, supply chain, distribution, sales force, as well as the financial stability of hospitals and other customers, and could cause a reduction in all operative procedures, which could materially adversely affect our business, results of operations, financial condition, and stock price.
On March 11, 2020, the World Health Organization (“WHO”) characterized the Novel Coronavirus Disease 2019 (“COVID-19”) as a pandemic. On March 13, 2020, the President of the United States declared a national emergency in response to the COVID-19 pandemic. In an effort to control the spread of COVID-19, governments around the world, including in the U.S., have implemented measures including quarantines, “shelter in place” orders, “stay at home” orders, travel restrictions, business operation restrictions, school closures, and other similar types of measures. The impact of the pandemic, while still evolving, has caused significant economic and financial uncertainty in the U.S. and around the world, generating concerns the effects will lead to a global recession or depression. Governments around the world are attempting to mitigate the economic impact by passing fiscal stimulus measures to assist monetarily with the impacts of COVID-19. Furthermore, variance in actions by governments around the world, economic or otherwise, could result in disparate impact on businesses, including our business, and lead to impactful geopolitical instability.
We are unable to assess with certainty the extent to which COVID-19 impacts our future results. Those impacts will depend on future developments that are highly unpredictable and uncertain, such as the severity of the pandemic and global actions in response thereto. Our existing insurance coverage will not provide protection for all of the COVID-19-related disruption that has or may arise during this time. Our management team is focused on mitigating adverse effects of the pandemic, thereby shifting their focus from other priorities. Should these conditions worsen, or endure for an extended period of time, the Company may face operational and other risks that the Company faced prior to the pandemic but are elevated due to the disruption of the pandemic. We continue to assess our business operations and the impact COVID-19 may have on our financial results, but there are no assurances that such analysis will enable us to avoid or precisely forecast the impact or consequences of COVID-19, including business downturns and/or a recession. A recession or depression could materially affect our business, including but not limited to our future access to capital, and negatively impact the value of our stock.
Our ability to manufacture products may be materially adversely impacted by the coronavirus.
Similar to many other employers in the U.S., the Company is requiring many employees to work remotely. We have continued to operate certain manufacturing facilities to date in compliance with federal, state and local orders regarding COVID-19. The health of the Company’s workforce is our top concern. Accordingly, the Company’s management team may have to enact further precautionary measures to minimize any impact to our employees. Should our ability to manufacture as a result of COVID-19 be impacted it may not be possible for us to manufacture relevant products at required levels or at all. We may not be able to obtain necessary products or components from our suppliers and vendors due to the additional constraints. A reduction or interruption in any of our manufacturing processes could have a material adverse effect on our business, results of operations, financial condition and cash flows which include, without limitation, the Company’s liquidity or access to, or cost of, credit. The Company is unable to quantify the full extent of the impact nor is it able to predict the ultimate consequences. Moreover, continuation of manufacturing operations may be dependent upon adequate access to personal protective equipment (“PPE”). In the event that access to PPE is constrained, manufacturing operations maybe impacted.

43

Our sales may be materially adversely impacted by the coronavirus.
In March 2020, the Centers for Medicare and Medicaid Services (“CMS”) recommended the postponement of elective procedures until further notice to preserve PPE. The American College of Surgeons (the “ACS”), following CMS, called for hospitals to “minimize, postpone or cancel” elective procedures until the COVID-19 outbreak slows down. On April 16, 2020, the President of the United States announced a plan that would allow elective surgeries to resume. On April 17, 2020, the ACS released a guide for health care facilities preparing to resume elective surgery once the COVID-19 disease was under control in their respective areas. The postponement from March of elective surgeries may negatively impact the demand for and sales of our products. A major component of our sales force function is the ability to meet with health care providers in person to discuss our products. Moreover, continuation of sales maybe dependent upon adequate access to PPE in order to gain access to health care providers. In the event that access to PPE is constrained, sales may be impacted. The current “shelter in place” and social distancing mandates may negatively affect demand by limiting the ability of our sales force to maintain their contacts with health care personnel for an unknown period of time. Additionally, variance on a state-by-state basis of the resumption of elective surgeries may further impact our business. There is also a risk that our international distributors may not remain financially viable due to COVID-19 and that our customers will not be able to purchase our products or pay for such products on a timely basis, or at all. As a result, we are uncertain as to whether our sales force, distributors, and customers will be able to increase or maintain current levels of sales or pricing, which could materially adversely impact our business.
We are subject to stringent domestic and foreign medical device regulations and any adverse regulatory action may adversely affect our financial condition and business operations.
Our products, development activities and manufacturing processes are subject to extensive and rigorous regulation by numerous government agencies, including the FDA and comparable foreign agencies. To varying degrees, each of these agencies monitors and enforces our compliance with laws and regulations governing the development, testing, manufacturing, labeling, marketing and distribution of our medical devices. We are also subject to regulations that may apply to certain of our products that are Drug/Device Combination products or are considered to be subject to pharmaceutical regulations outside the U.S. The process of obtaining marketing approval or clearance from the FDA and comparable foreign regulatory agencies for new products, or for enhancements or modifications to existing products, could
•take a significant amount of time;
•require the expenditure of substantial financial and other resources;
•involve rigorous and expensive pre-clinical and clinical testing, as well as increased post-market surveillance;
•lead to failed clinical trials or weakened clinical evidence
•involve modifications, repairs or replacements of our products; and
•result in limitations on the indicated uses of our products.
We cannot be certain that we will receive required approval or clearance from the FDA and foreign regulatory agencies for new products or modifications to existing products on a timely basis. The failure to receive approval or clearance for significant new products or modifications to existing products on a timely basis could have a material, adverse effect on our financial condition and results of operations.
Both before and after a product is commercially released, we have ongoing responsibilities under FDA and foreign regulations. For example, we are required to comply with the FDA's Quality System Regulation, which mandates that manufacturers of medical devices adhere to certain quality assurance requirements pertaining to, among other things, validation of manufacturing processes, controls for purchasing product components, and documentation practices. As another example, the Federal Medical Device Reporting regulation requires us to provide information to the FDA whenever there is evidence that reasonably suggests that a device may have caused or contributed to a death or serious injury or, that a malfunction occurred which would be likely to cause or contribute to a death or serious injury upon recurrence. Compliance with applicable regulatory requirements is subject to continual review and is monitored rigorously through periodic inspections by the FDA, which may result in observations on Form 483, and in some cases warning letters, that require corrective action. If the FDA or equivalent foreign agency were to conclude that we are not in compliance with applicable laws or regulations, or that any of our medical devices are ineffective or pose an unreasonable health risk, the FDA or equivalent foreign agency could ban such medical devices, detain or seize such medical devices, order a recall, repair, replacement, or refund of such devices, or require us to notify health professionals and others that the devices present unreasonable risks of substantial harm to the public health.
Governments are expected to continue to scrutinize the industry closely with inspections, and possibly enforcement actions, by the FDA or equivalent foreign agencies. Additionally, the FDA may restrict manufacturing and impose other operating restrictions, enjoin and restrain certain violations of applicable law pertaining to medical devices, and assess civil or criminal penalties against our officers, employees, or us. The FDA may also recommend prosecution to the Department of Justice. Any adverse regulatory action, depending on its magnitude, may restrict us from effectively manufacturing, marketing and selling our products and could have a material, adverse effect on our financial condition and results of operations. In addition, negative publicity and product

44

liability claims resulting from any adverse regulatory action could have a material, adverse effect on our financial condition and results of operations.
While we have taken measures to enhance our Quality System, we cannot assure that future inspections by the FDA and the standards they apply will not result in warning letters for any facility in the future. We are also subject to inspections of our Quality System by regulatory agencies outside the U.S. which could result in the issuance of nonconformance or significant requirements to our Quality System.
The FDA Reauthorization Act of 2017 (“FDARA”), which includes the reauthorization of the Medical Device User Fee Amendments of 2012, as well as other medical device provisions, went into effect October 1, 2017. This includes performance goals and user fees paid to the FDA by medical device companies when they register and list with the FDA and when they submit an application to market a device in the U.S. Under FDARA, this user fee program has been reauthorized through fiscal year 2022. Under the Medical Device User Fee Amendments, or MDUFA III, there are additional requirements regarding the FDA Establishment Registration and Listing of Medical Devices. All U.S. and foreign manufacturers must register and list medical devices for sale in the U.S. All of our facilities comply with these requirements. That said, we also source products from foreign contract manufacturers and we continue to monitor their compliance with these regulations. In such an event, we will need to determine if there are alternative foreign contract manufacturers who comply with the FDA Establishment Registration requirements. If such a foreign contract manufacturer is a sole supplier of one of our products, there is a risk that we may not be able to source another supplier and our business could be adversely affected.
We are subject to extensive complex regulatory requirements by domestic and foreign government agencies and any failure to comply with our ongoing responsibilities under their applicable laws and regulations could result in a material adverse impact on our business.
In addition, the United States Federal Food, Drug, and Cosmetic Act (“FDCA”) permits device manufacturers to promote products solely for the uses and indications set forth in the approved product labeling. A number of enforcement actions have been taken against manufacturers that promote products for “off-label” uses, including actions alleging that federal health care program reimbursement of products promoted for "off-label" uses are false and fraudulent claims to the government. The failure to comply with “off-label” promotion restrictions can result in significant financial penalties and a required corporate integrity agreement with the federal government imposing significant administrative obligations and costs, and potential evaluation from federal health care programs.
Foreign governmental regulations have become more stringent and we may become subject to even more rigorous regulation by foreign governmental authorities in the future, which could have a material, adverse effect on our business, financial condition and results of operations. Penalties for a company's noncompliance with foreign governmental regulation could be severe, including revocation or suspension of a company's business license and criminal sanctions. For example, we are subject to Good Manufacturing Practice regulations for Pharmaceuticals in the EU for certain of our products. These regulations also mandate that manufacturers of medical devices (or those that are considered pharmaceuticals) adhere to certain quality assurance requirements pertaining to, among other things, validation of manufacturing processes, controls for purchasing product components, and documentation practices. There may be additional regulations if such products are considered pharmaceuticals outside the U.S.
In addition, the European Medical Device Regulation (“EU MDR”) passed in the European Parliament on April 5, 2017 and went into effect on May 25, 2017, replacing the Medical Device Directive. The EU MDR is an extensive reform of the rules that govern the medical device industry in Europe. Under this regulation, manufacturers will have three (3) years to comply with a broad set of new rules for almost every kind of medical device. The EU MDR will require changes in the clinical evidence required for medical devices, post-market clinical follow-up evidence, annual reporting of safety information for Class III products, and bi-annual reporting for Class II products, Unique Device Identification (“UDI”) for all products, submission of core data elements to a European UDI database prior to placement of a device on the market, reclassification of medical devices, and multiple other labeling changes. The European Parliament has recently announced changes to the timing of implementation for Class I Reusable from May 26, 2020 to May 26, 2024 and the EUDAMED Database from May 26, 2020 to May 26, 2022.
Under the EU MDR rules, medical device companies will have to, among other things, do the following:
•
provide significantly more clinical evidence to bring new products to market and even to keep existing products on the market;
•
make changes to product labeling, register every CE Marked product and make certain product data available tin the EUDAMED database which will be available to the public; and
•
conduct product portfolio assessments to determine the impact of the EU MDR on the Company's margins.
Overall, medical device companies can expect longer lead times to obtain product registrations (CE Mark Certification) in the EU and a substantially costlier pathway to compliance in the EU. We are not yet able to determine the costs of complying with these regulations, how the EU will interpret and enforce them, what the timeliness for approvals of products will be and the overall

45

effect of the EU MDR on the marketplace. Given the significant additional pre-market and post-market requirements imposed by the EU MDR, the overall impact of these new rules could have a material, adverse effect on the Company’s revenues and expenses.
On April 23, 2020, the European Parliament delayed the implementation date of the EU MDR from May 26, 2020 to May 26, 2021 due to COVID-19. We are unable to determine at this time the ultimate impact of the COVID-19 pandemic on the Company’s product registrations or development, including whether the FDA and/or comparable foreign agencies will be impacted by the pandemic in ways that will cause delays in clinical trials, quality inspections and/or regulatory approvals. Such delays could result in a material adverse impact on the Company’s business operations.
Economic and political instability around the world could adversely affect the ability of hospitals, other customers, suppliers and distributors to access funds or otherwise have available liquidity, which could reduce orders for our products or interrupt our production or distribution or result in a reduction in elective and non-reimbursed operative procedures.
Economic and political instability around the world could adversely affect the ability of hospitals and other customers to access funds to enable them to fund their operating and capital budgets. As a result, hospitals and other customers could reduce budgets or put all or part of their budgets on hold or close their operations, which could have a negative effect on our sales, particularly the sales of capital equipment such as our ultrasonic surgical aspirators, neuromonitors and stereotactic products, or result in a reduction in elective and non-reimbursed procedures. The occurrence of those economic conditions could make it more difficult for us to accurately forecast and plan our future business activities and depending on their severity, could have a material, adverse effect on our business, financial condition and results of operations.
The COVID-19 pandemic has led to disruption and volatility in global financial markets, decreasing economic activity. Many companies have reported experiencing reduced liquidity and uncertainty in their ability to raise capital. If these conditions result in a prolonged economic downturn, the impact to our customers could have a material adverse effect on our results of operations.
Our leverage and debt service obligations could adversely affect our business.
As of December 31, 2019, our total consolidated external debt was approximately $1.3 billion. We may also incur additional indebtedness in the future. Our substantial indebtedness could have material, adverse consequences, including:
•
making it more difficult for us to satisfy our financial obligations;
•
increasing our vulnerability to adverse economic, regulatory and industry conditions, and placing us at a disadvantage compared to our competitors that are less leveraged;
•
limiting our ability to compete and our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate; and
•
limiting our ability to borrow additional funds for working capital, capital expenditures, acquisitions and general corporate or other purposes.
Our debt service obligations will require us to use a portion of our operating cash flow to pay interest and principal on indebtedness instead of for other corporate purposes, including funding future expansion of our business, acquisitions, and ongoing capital expenditures, which could impede our growth. In addition, our ability to comply with, renegotiate or extend the Company’s debt obligations will depend on our operating and financial performance, which in turn is subject to prevailing economic conditions and financial, business and other factors beyond our control.  Any disruptions in our operations, the financial markets, or the overall economy, including as a result of COVID-19, may adversely affect the availability and cost of credit to us and/or our ability to comply with our existing obligations.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Information pertaining to our common stock under the repurchase program can be found in Note 11. Treasury Stock.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
None.
ITEM 6. EXHIBITS
Reference is hereby made to the Exhibit Index on page 48.



46

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
 
 
 
 
 
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
 
 
 
Date:
May 7, 2020
 
/s/ Peter J. Arduini
 
 
 
Peter J. Arduini
 
 
 
President and Chief Executive Officer
 
 
 
(Principal Executive Officer)
 
 
 
Date:
May 7, 2020
 
/s/ Carrie L. Anderson
 
 
 
Carrie L. Anderson
 
 
 
Corporate Vice President and Chief Financial Officer
 
 
 
(Principal Financial Officer)
 
 
 
 
Date:
May 7, 2020
 
/s/ Jeffrey A. Mosebrook
 
 
 
Jeffrey A. Mosebrook
 
 
 
Senior Vice President, Corporate Controller
 
 
 
(Principal Accounting Officer)


47


Exhibits
 
 
 
 
 
*31.1
 
 
 
*31.2
 
 
 
*32.1
 
 
 
*32.2
 
 
 
 
*†101.INS
 
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
 
 
*†101.SCH
 
XBRL Taxonomy Extension Schema Document
 
 
*†101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
*†101.DEF
 
XBRL Definition Linkbase Document
 
 
*†101.LAB
 
XBRL Taxonomy Extension Labels Linkbase Document
 
 
*†101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document
 
*
Filed herewith

† The financial information of Integra LifeSciences Holdings Corporation Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 filed on May 7, 2020 formatted in XBRL (Extensible Business Reporting Language): (i) the Condensed Consolidated Statements of Operations and Comprehensive Income, (ii) the Condensed Consolidated Balance Sheets, (iii) Parenthetical Data to the Condensed Consolidated Balance Sheets, (iv) the Condensed Consolidated Statements of Cash Flows, and (v) Notes to Condensed Consolidated Financial Statements, is furnished electronically herewith.

 




48
 EX-31.1 2 iart-20200331xexx311.htm EXHIBIT 31.1 Exhibit
Exhibit 31.1
Certification of Principal Executive Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Peter J. Arduini, certify that:
1.
I have reviewed this quarterly report on Form 10-Q of Integra LifeSciences Holdings Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:
(a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
Date:
May 7, 2020
/s/ Peter J. Arduini
 
 
Peter J. Arduini
 
 
President and Chief Executive Officer


 EX-31.2 3 iart-20200331xexx312.htm EXHIBIT 31.2 Exhibit
Exhibit 31.2
Certification of Principal Financial Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Carrie L. Anderson, certify that:
1.
I have reviewed this quarterly report on Form 10-Q of Integra LifeSciences Holdings Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:
(a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:
May 7, 2020
/s/ Carrie L. Anderson
 
 
Carrie L. Anderson
 
 
Corporate Vice President and Chief Financial Officer


 EX-32.1 4 iart-20200331xexx321.htm EXHIBIT 32.1 Exhibit
Exhibit 32.1
Certification of Principal Executive Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
I, Peter J. Arduini, President and Chief Executive Officer of Integra LifeSciences Holdings Corporation (the “Company”), hereby certify that, to my knowledge:
1.
The Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2020 (the “Report”) fully complies with the requirement of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Date:
May 7, 2020
/s/ Peter J. Arduini
 
 
Peter J. Arduini
 
 
President and Chief Executive Officer


 EX-32.2 5 iart-20200331xexx322.htm EXHIBIT 32.2 Exhibit
Exhibit 32.2
Certification of Principal Financial Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
I, Carrie L. Anderson, Corporate Vice President and Chief Financial Officer of Integra LifeSciences Holdings Corporation (the “Company”), hereby certify that, to my knowledge:
1.
The Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2020 (the “Report”) fully complies with the requirement of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Date:
May 7, 2020
/s/ Carrie L. Anderson
 
 
Carrie L. Anderson
 
 
Corporate Vice President and Chief Financial Officer


 EX-101.SCH 6 iart-20200331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2101100 - Disclosure - BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - BASIS OF PRESENTATION (Policies) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - BUSINESS DEVELOPMENT link:presentationLink link:calculationLink link:definitionLink 2405404 - Disclosure - BUSINESS DEVELOPMENT - Asset Acquisition, Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - BUSINESS DEVELOPMENT - Business Combination, Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - BUSINESS DEVELOPMENT - Business Combination, Schedule of Purchase Price Allocation (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - BUSINESS DEVELOPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 2131100 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 2431402 - Disclosure - COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details) link:presentationLink link:calculationLink link:definitionLink 2431403 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2331301 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 2129100 - Disclosure - COMPREHENSIVE INCOME (LOSS) link:presentationLink link:calculationLink link:definitionLink 2429404 - Disclosure - COMPREHENSIVE INCOME (LOSS) - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2429403 - Disclosure - COMPREHENSIVE INCOME (LOSS) - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details) link:presentationLink link:calculationLink link:definitionLink 2429402 - Disclosure - COMPREHENSIVE INCOME (LOSS) - Schedule of Comprehensive Income (Details) link:presentationLink link:calculationLink link:definitionLink 2329301 - Disclosure - COMPREHENSIVE INCOME (LOSS) (Tables) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 1002501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDER'S EQUITY link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME / (LOSS) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - DEBT link:presentationLink link:calculationLink link:definitionLink 2418404 - Disclosure - DEBT - Contractual Maturity Table (Details) link:presentationLink link:calculationLink link:definitionLink 2418403 - Disclosure - DEBT - Maximum Total Leverage Ratio Table (Details) link:presentationLink link:calculationLink link:definitionLink 2418402 - Disclosure - DEBT - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2318301 - Disclosure - DEBT (Tables) link:presentationLink link:calculationLink link:definitionLink 2121100 - Disclosure - DERIVATIVE INSTRUMENTS link:presentationLink link:calculationLink link:definitionLink 2421407 - Disclosure - DERIVATIVE INSTRUMENTS - Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations (Details) link:presentationLink link:calculationLink link:definitionLink 2421406 - Disclosure - DERIVATIVE INSTRUMENTS - Fair Value of Derivative Instruments By Balance Sheet Location (Details) link:presentationLink link:calculationLink link:definitionLink 2421403 - Disclosure - DERIVATIVE INSTRUMENTS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2421404 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Cross Currency Swap Derivatives (Details) link:presentationLink link:calculationLink link:definitionLink 2421402 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Derivatives (Details) link:presentationLink link:calculationLink link:definitionLink 2421405 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Net Investment Hedges Derivatives (Details) link:presentationLink link:calculationLink link:definitionLink 2321301 - Disclosure - DERIVATIVE INSTRUMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - DOCUMENT AND ENTITY INFORMATION link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 2414403 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Components of Company's Identifiable Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2414404 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in Carrying Amount of Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 2127100 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 2427403 - Disclosure - INCOME TAXES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2427402 - Disclosure - INCOME TAXES - Summary of Effective Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 2327301 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - INVENTORIES link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - INVENTORIES - Schedule of Net Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - INVENTORIES (Tables) link:presentationLink link:calculationLink link:definitionLink 2125100 - Disclosure - LEASES AND RELATED PARTY LEASES link:presentationLink link:calculationLink link:definitionLink 2425405 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases, After Adoption of 842 (Details) link:presentationLink link:calculationLink link:definitionLink 2425405 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases, After Adoption of 842 (Details) link:presentationLink link:calculationLink link:definitionLink 2425402 - Disclosure - LEASES AND RELATED PARTY LEASES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2425403 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details) link:presentationLink link:calculationLink link:definitionLink 2425404 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 2325301 - Disclosure - LEASES AND RELATED PARTY LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 2128100 - Disclosure - NET INCOME PER SHARE link:presentationLink link:calculationLink link:definitionLink 2428402 - Disclosure - NET INCOME PER SHARE - Basic and Diluted Net Income Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2428403 - Disclosure - NET INCOME PER SHARE - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2328301 - Disclosure - NET INCOME PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 2124100 - Disclosure - RETIREMENT PLANS link:presentationLink link:calculationLink link:definitionLink 2424401 - Disclosure - RETIREMENT PLANS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2411403 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative, Revenue Remaining Performance Obligation (Details) link:presentationLink link:calculationLink link:definitionLink 2411404 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Changes in Contract Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2411405 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Revenues Disaggregated by Major Source (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables) link:presentationLink link:calculationLink link:definitionLink 2130100 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION link:presentationLink link:calculationLink link:definitionLink 2430402 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2430403 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Net Sales and Profit by Reportable Segment (Details) link:presentationLink link:calculationLink link:definitionLink 2330301 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 2430404 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Total Revenue by Major Geographic Area (Details) link:presentationLink link:calculationLink link:definitionLink 2123100 - Disclosure - STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 2423401 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2126100 - Disclosure - TREASURY STOCK link:presentationLink link:calculationLink link:definitionLink 2426401 - Disclosure - TREASURY STOCK - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 iart-20200331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 iart-20200331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 iart-20200331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Segment Reporting [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] United States UNITED STATES Europe Europe [Member] Asia Pacific Asia Pacific [Member] Rest of World Rest Of World [Member] Revenues from rest of the world. Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Total Revenues Revenue from Contract with Customer, Excluding Assessed Tax Revenue from Contract with Customer [Abstract] Revenue, Initial Application Period Cumulative Effect Transition [Table] Revenue, Initial Application Period Cumulative Effect Transition [Table] Statistical Measurement [Axis] Statistical Measurement [Axis] Statistical Measurement [Domain] Statistical Measurement [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Manufacturing period for products shipped with no alternative use and right of payment for performance Revenue From Contract With Customer, Products Shipped With No Alternative Use And Right Of Payment For Performance, Manufacturing Period Revenue From Contract With Customer, Products Shipped With No Alternative Use And Right Of Payment For Performance, Manufacturing Period Number of days from shipment to issue a credit Return Policy, Issue Of Credit, Number Of Days From Shipment Return Policy, Issue of Credit, Number of Days from Shipment Short-term portion of contract liability Contract with Customer, Liability, Current Long-term portion of contract liability Contract with Customer, Liability, Noncurrent Product warranty period (up to) Revenue, Product Warranty Period Revenue, Product Warranty Period Derivative Instruments and Hedging Activities Disclosure [Abstract] Schedule of Derivative Instruments Schedule of Derivative Instruments [Table Text Block] Schedule of Fair Value and Presentation of Derivatives Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Effect of Derivative Instruments Designated as Cash Flow Hedges on Statements of Operations Derivative Instruments, Gain (Loss) [Table Text Block] Derivative [Table] Derivative [Table] Hedging Designation [Axis] Hedging Designation [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Designated as Hedging Instrument Designated as Hedging Instrument [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Hedging Relationship [Domain] Hedging Relationship [Domain] Net Investment Hedges Net Investment Hedging [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Cross Currency Interest Rate Swap One Cross Currency Interest Rate Contract One [Member] Cross Currency Interest Rate Contract One [Member] Cross Currency Interest Rate Swap Two Cross Currency Interest Rate Contract Two [Member] Cross Currency Interest Rate Contract Two [Member] Cross Currency Interest Rate Swap Three Cross Currency Interest Rate Contract Three [Member] Cross Currency Interest Rate Contract Three [Member] Cross Currency Interest Rate Swap Four Cross Currency Interest Rate Contract Four [Member] Cross Currency Interest Rate Contract Four [Member] Cross Currency Interest Rate Swap Five Cross Currency Interest Rate Contract Five [Member] Cross Currency Interest Rate Contract Five [Member] Cross Currency Interest Rate Swap Cross Currency Interest Rate Contract [Member] Position [Axis] Position [Axis] Position [Domain] Position [Domain] Long Long [Member] Short Short [Member] Derivative [Line Items] Derivative [Line Items] Fixed Rate Derivative, Fixed Interest Rate Aggregate Notional Amount Derivative, Notional Amount Fair Value Asset (Liability) Derivative, Fair Value, Net Income Statement [Abstract] Total revenue, net Costs and expenses: Costs and Expenses [Abstract] Cost of goods sold Cost of Goods and Services Sold Research and development Research and Development Expense Selling, general and administrative Selling, General and Administrative Expense Intangible asset amortization Amortization of Intangible Assets Total costs and expenses Costs and Expenses Operating income Operating Income (Loss) Interest income Investment Income, Interest Interest expense Interest Expense Other income(expense), net Other Nonoperating Income (Expense) Income before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Provision (benefit) for income taxes Income Tax Expense (Benefit) Net income Net Income (Loss) Attributable to Parent Net income per share Earnings Per Share [Abstract] Basic (in dollars per share) Earnings Per Share, Basic Diluted (in dollars per share) Earnings Per Share, Diluted Weighted average common shares outstanding (See Note 13): Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic (in shares) Weighted Average Number of Shares Outstanding, Basic Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Comprehensive income (loss) (See Note 14) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Equity [Abstract] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Gains and Losses on Derivatives Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Defined Benefit Pension Items Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Foreign Currency Items Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Total AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Balance, Beginning of Period Stockholders' Equity Attributable to Parent Other comprehensive loss OCI, before Reclassifications, Net of Tax, Attributable to Parent Less: Amounts reclassified from accumulated other comprehensive loss Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent Net current-period other comprehensive loss Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Balance, End of Period Organization, Consolidation and Presentation of Financial Statements [Abstract] Basis Of Presentation Basis of Accounting, Policy [Policy Text Block] Recently Issued Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Summary of Accounting Policies on Revenue Recognition and Shipping and Handling Fees Revenue from Contract with Customer [Policy Text Block] Product Warranties Extended Product Warranty, Policy [Policy Text Block] Taxes Collected from Customers Revenue, Transaction Price Measurement, Tax Exclusion [Policy Text Block] Basic and Diluted Net Income Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Leases [Abstract] Supplemental Balance Sheet Information Assets And Liabilities, Lessee [Table Text Block] Assets And Liabilities, Lessee [Table Text Block] Supplemental Cash Flow Information Cash Flow, Lessee [Table Text Block] Cash Flow, Lessee [Table Text Block] Schedule of Operating Lease Maturities Lessee, Operating Lease, Liability, Maturity [Table Text Block] Statement of Stockholders' Equity [Abstract] Statement [Table] Statement [Table] Common Stock Common Stock [Member] Treasury Stock Treasury Stock [Member] Additional Paid-In Capital Additional Paid-in Capital [Member] Accumulated Other Comprehensive Loss Retained Earnings Retained Earnings [Member] Cumulative Effect, Period Of Adoption [Axis] Cumulative Effect, Period Of Adoption [Axis] Cumulative Effect, Period Of Adoption [Axis] Cumulative Effect, Period Of Adoption [Domain] Cumulative Effect, Period Of Adoption [Domain] [Domain] for Cumulative Effect, Period Of Adoption [Axis] Cumulative Effect, Period Of Adoption, Adjustment Cumulative Effect, Period Of Adoption, Adjustment [Member] Cumulative Effect, Period Of Adoption, Adjustment [Member] Statement [Line Items] Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Balance Beginning of Period, Shares (in shares) Shares, Issued Balance, Beginning of Period, Treasury Stock, Shares (in shares) Treasury Stock, Shares Net income Other comprehensive loss, net of tax Issuance of common stock through employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Issuance of common stock through employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Issuance of common stock for vesting of share based awards, net of shares withheld for taxes (in shares) Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture Issuance of common stock for vesting of share based awards, net of shares withheld for taxes Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Share-based compensation APIC, Share-based Payment Arrangement, Increase for Cost Recognition Share repurchase and equity component of the convertible note issuance, net (in shares) Stock Issued During Period, Shares, Treasury Stock Reissued Share repurchase and equity component of the convertible note issuance, net Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt Accelerated shares repurchased (in shares) Stock Repurchased During Period, Shares Accelerated shares repurchased Stock Repurchased During Period, Value Balance End of Period, Shares (in shares) Balance, End of Period, Treasury Stock, Shares (in shares) Cash Flow Hedges Cash Flow Hedging [Member] Investment, Name [Axis] Investment, Name [Axis] Investment, Name [Domain] Investment, Name [Domain] Swap One Swap One [Member] Swap One [Member] Swap Two Swap Two [Member] Swap Two [Member] Swap Three Swap Three [Member] Swap Three [Member] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Codman Codman [Member] Codman [Member] Cross-currency swap Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Arkis Arkis BioSciences Inc. [Member] Arkis BioSciences Inc. [Member] Derma Sciences Derma Sciences [Member] Derma Sciences [Member] Liability Class [Axis] Liability Class [Axis] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Contingent Consideration Liability Contingent Consideration Liability [Member] Contingent Consideration Liability [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 3 Fair Value, Inputs, Level 3 [Member] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Balance, Beginning of Period Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Payments Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Loss from change in fair value of contingent consideration liabilities Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Balance, End of Period Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Codman Specialty Surgical Codman Specialty Surgical [Member] Codman Specialty Surgical [Member] Number of reportable segments Number of Reportable Segments Number of products offered (more than) Segment Reporting Information, Number Of Products Offered Number of products sold by a segment Treasury Stock Transactions, Excluding Value of Shares Reissued [Abstract] Class of Treasury Stock [Table] Class of Treasury Stock [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Convertible Debt Convertible Debt [Member] Counterparty Name [Axis] Counterparty Name [Axis] Counterparty Name [Domain] Counterparty Name [Domain] Certain Purchasers Certain Purchasers [Member] Certain Purchasers [Member] Scenario [Axis] Scenario [Axis] Scenario [Domain] Scenario [Domain] Forecast Forecast [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event Subsequent Event [Member] Equity, Class of Treasury Stock [Line Items] Equity, Class of Treasury Stock [Line Items] Treasury stock (in shares) Treasury Stock, Common, Shares Treasury stock Treasury Stock, Common, Value Treasury stock, average cost per share (in dollars per share) Treasury Stock Acquired, Average Cost Per Share Stock repurchase program, authorized amount (up to) Stock Repurchase Program, Authorized Amount Stock repurchased during period (in shares) Net proceeds from offering of convertible senior notes Proceeds from Convertible Debt Accelerated share repurchase program, payment Accelerated Share Repurchases, Settlement (Payment) or Receipt Accelerated shares repurchased, amount Accelerated share repurchases, percentage of expected total repurchased Accelerated Share Repurchases, Percentage Of Expected Total Repurchased Accelerated Share Repurchases, Percentage Of Expected Total Repurchased Remaining amount under share repurchase Stock Repurchase Program, Remaining Authorized Repurchase Amount Inventory, Net [Abstract] Finished goods Inventory, Finished Goods, Net of Reserves Work in process Inventory, Work in Process, Net of Reserves Raw materials Inventory, Raw Materials and Purchased Parts, Net of Reserves Inventories, net Inventory, Net Goodwill and Intangible Assets Disclosure [Abstract] Expected annual amortization expense, remainder of 2020 Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year Expected annual amortization expense, in 2021 Finite-Lived Intangible Assets, Amortization Expense, Year Two Expected annual amortization expense, in 2022 Finite-Lived Intangible Assets, Amortization Expense, Year Three Expected annual amortization expense, in 2023 Finite-Lived Intangible Assets, Amortization Expense, Year Four Expected annual amortization expense, in 2024 Finite-Lived Intangible Assets, Amortization Expense, Year Five Expected annual amortization expense, in 2025 Finite-Lived Intangible Assets, Amortization Expense, Year Six Finite-Lived Intangible Assets, Amortization Expense, Year Six Expected annual amortization expense, thereafter Finite-Lived Intangible Assets, Amortization Expense, After Year Six Finite-Lived Intangible Assets, Amortization Expense, After Year Six Schedule of Comprehensive Income (Loss) Comprehensive Income (Loss) [Table Text Block] Schedule of Changes in Accumulated Other Comprehensive Loss by Component Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Debt Disclosure [Abstract] Schedule of Long-term Debt Maximum Leverage Ratios Schedule of Long-term Debt Instruments [Table Text Block] Schedule of Maturities of Long-term Debt Schedule of Maturities of Long-term Debt [Table Text Block] Income Tax Disclosure [Abstract] Schedule of Effective Income Tax Rate Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table] Derivative Instruments, Gain (Loss) [Table] Derivative, by Nature [Axis] Derivative, Name [Domain] Interest rate swap Interest Rate Swap [Member] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Interest expense Interest Expense [Member] Other income (expense), net Other Nonoperating Income (Expense) [Member] Interest income Interest Income [Member] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Roll Forward] Amount of Gain (Loss) Recognized in AOCL Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Amount of Gain (Loss) Reclassified from AOCL into Earnings Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax SEGMENT AND GEOGRAPHIC INFORMATION Segment Reporting Disclosure [Text Block] Business Combinations [Abstract] Schedule of Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Completed technology Completed Technology [Member] Completed technology. Customer relationships Customer Relationships [Member] Trademarks/brand names Trademarks Brand Names [Member] Trademarks Brand Names. Supplier relationships Supplier Relation Ships [Member] Supplier Relation Ships [Member] All other All Other [Member] All Other [Member] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Codman tradename Trade Names [Member] IPR&D In Process Research and Development [Member] Acquired Finite-Lived Intangible Assets [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] Weighted Average Life Finite-Lived Intangible Asset, Useful Life Cost Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill. Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Net Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill. Other Indefinite-lived Intangible Assets Other Indefinite-lived Intangible Assets Retirement Benefits [Abstract] Net periodic benefit costs Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Service cost component Defined Benefit Plan, Service Cost Estimated fair value of plan assets Defined Benefit Plan, Plan Assets, Amount Defer payment and taxation, base salary, percentage (up to) Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage Defer payment and taxation, bonus and other eligible cash compensation, percentage (up to) Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage Deferred compensation plan, fair value of assets Deferred Compensation Plan Assets RETIREMENT PLANS Pension and Other Postretirement Benefits Disclosure [Text Block] Total Revenue By Major Geographic Area Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Contingent Consideration by Type [Axis] Contingent Consideration by Type [Axis] Contingent Consideration Type [Domain] Contingent Consideration Type [Domain] Development Milestones Milestone Payment One [Member] Milestone Payment One [Member] Commercial Sales Milestones Milestone Payment Two [Member] Milestone Payment Two [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Purchase price of business combination Business Combination, Consideration Transferred Contingent consideration, liability (up to) Business Combination, Contingent Consideration, Liability Contingent consideration, fair value Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability Acquired intangible assets, discount rate Acquired Finite-lived Intangible Assets, Discount Rate Acquired Finite-lived Intangible Assets, Discount Rate TREASURY STOCK Treasury Stock [Text Block] Statement of Financial Position [Abstract] ASSETS Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Trade accounts receivable, net of allowances of $6,652 and $4,303 Accounts Receivable, after Allowance for Credit Loss, Current Inventories, net Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Total current assets Assets, Current Property, plant and equipment, net Property, Plant and Equipment, Net Right of use asset - operating leases Operating Lease, Right-of-Use Asset Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Goodwill Goodwill Deferred tax assets, net Deferred Income Tax Assets, Net Other assets Other Assets, Noncurrent Total assets Assets LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Current portion of borrowings under senior credit facility Secured Debt, Current Current portion of lease liability - operating leases Operating Lease, Liability, Current Accounts payable, trade Accounts Payable, Trade, Current Contract liabilities Accrued compensation Employee-related Liabilities, Current Accrued expenses and other current liabilities Accrued Liabilities, Current Total current liabilities Liabilities, Current Long-term borrowings under senior credit facility Secured Long-term Debt, Noncurrent Long-term borrowings under securitization facility Secured Long-Term Debt, Securitization Program, Noncurrent Secured Long-Term Debt, Securitization Program, Noncurrent Long-term convertible securities Convertible Debt, Noncurrent Lease liability - operating leases Operating Lease, Liability, Noncurrent Deferred tax liabilities Deferred Income Tax Liabilities, Net Other liabilities Other Liabilities, Noncurrent Total liabilities Liabilities Commitments and contingencies (Refer to Note 16) Commitments and Contingencies Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Preferred stock; no par value; 15,000 authorized shares; none outstanding Preferred Stock, Value, Issued Common stock; $0.01 par value; 240,000 authorized shares; 89,104 and 88,735 issued at March 31, 2020 and December 31, 2019, respectively Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital, Common Stock Treasury stock, at cost; 4,294 shares and 2,865 shares at March 31, 2020 and December 31, 2019, respectively Treasury Stock, Value Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Retained earnings Retained Earnings (Accumulated Deficit) Total stockholders’ equity Total liabilities and stockholders’ equity Liabilities and Equity Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Debt Covenant Period [Axis] Debt Covenant Period [Axis] Debt Covenant Period [Axis] Debt Covenant Period [Domain] Debt Covenant Period [Domain] [Domain] for Debt Covenant Period [Axis] First fiscal quarter ending after the Closing Date through June 30, 2022 Debt Covenant Period 1 [Member] Debt Covenant Period 1 [Member] September 30, 2022 through June 30, 2023 Debt Covenant Period 2 [Member] Debt Covenant Period 2 [Member] September 30, 2023 and the last day of each fiscal quarter thereafter Debt Covenant Period 3 [Member] Debt Covenant Period 3 [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Senior Credit Facility Senior Credit Facility [Member] Senior Credit Facility. Debt Instrument [Line Items] Debt Instrument [Line Items] Maximum Consolidated Total Leverage Ratio Debt Instrument, Covenant, Maximum Leverage Ratio Debt Instrument, Covenant, Maximum Leverage Ratio Share-based Payment Arrangement [Abstract] STOCK-BASED COMPENSATION Share-based Payment Arrangement [Text Block] DERIVATIVE INSTRUMENTS Derivative Instruments and Hedging Activities Disclosure [Text Block] Reported tax rate Effective Income Tax Rate Reconciliation, Percent NET INCOME PER SHARE Earnings Per Share [Text Block] Schedule of Operating Leased Assets [Table] Schedule of Operating Leased Assets [Table] Related Parties Related Parties [Member] Related Parties [Member] Third Parties Third Parties [Member] Third Parties [Member] Operating Leased Assets [Line Items] Operating Leased Assets [Line Items] 2020 Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months 2020 Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year 2021 Lessee, Operating Lease, Liability, Payments, Due Year Two 2022 Lessee, Operating Lease, Liability, Payments, Due Year Three 2023 Lessee, Operating Lease, Liability, Payments, Due Year Four 2024 Lessee, Operating Lease, Liability, Payments, Due Year Five Thereafter Lessee, Operating Lease, Liability, Payments, Due after Year Five Total minimum lease payments Lessee, Operating Lease, Liability, Payments, Due Less: Imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Total lease liabilities Operating Lease, Liability Less: Current lease liabilities Long-term lease liabilities Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Award Type [Axis] Award Type [Axis] Award Type [Domain] Award Type [Domain] Performance Shares and Restricted Units Performance Shares and Restricted Units [Member] Performance Shares and Restricted Units Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Shares excluded from computation as their effect would be antidilutive (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Additional EPS shares (in shares) Additional EPS Shares Additional shares included in the basic and diluted calculation from their date of issuance because no further consideration is due related to the issuance of the underlying common shares CerebroFlo developed technology Developed Technology Rights [Member] Enabling technology license Licensing Agreements [Member] Cash Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other Property, plant and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Deferred tax assets Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets Intangible assets: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill [Abstract] Intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill Accounts payable, accrued expenses and other liabilities Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accounts Payable, Accrued Expenses And Other Liabilities Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accounts Payable, Accrued Expenses And Other Liabilities Contingent consideration Deferred tax liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Net assets acquired Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Weighted Average Life Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Expected performance obligation through 2020, percentage Revenue, Remaining Performance Obligation, Percentage Performance obligations expected to be satisfied, expected timing Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] 3-Month USD LIBOR Three Month USD LIBOR [Member] Three Month USD LIBOR [Member] 1-Month USD LIBOR One Month USD LIBOR [Member] One Month USD LIBOR [Member] Interest Rate Swap Designated February 6, 2017 Tranche 1 Interest Rate Swap Designated February 6, 2017 Tranche 1 [Member] Interest Rate Swap Designated February 6, 2017 Tranche 1 [Member] Interest Rate Swap Designated February 6, 2017 Tranche 2 Interest Rate Swap Designated February 6, 2017 Tranche 2 [Member] Interest Rate Swap Designated February 6, 2017 Tranche 2 [Member] Interest Rate Swap Designated March 27, 2017 Interest Rate Swap Designated March 27, 2017 [Member] Interest Rate Swap Designated March 27, 2017 [Member] Interest Rate Swap Designated December 13, 2017 Tranche 1 Interest Rate Swap Designated December 13, 2017 Tranche 1 [Member] Interest Rate Swap Designated December 13, 2017 Tranche 1 [Member] Interest Rate Swap Designated December 13, 2017 Tranche 2 Interest Rate Swap Designated December 13, 2017 Tranche 2 [Member] Interest Rate Swap Designated December 13, 2017 Tranche 2 [Member] Interest Rate Swap Designated December 13, 2017 Tranche 3 Interest Rate Swap Designated December 13, 2017 Tranche 3 [Member] Interest Rate Swap Designated December 13, 2017 Tranche 3 [Member] Interest Rate Swap Designated December 13, 2017 Tranche 4 Interest Rate Swap Designated December 13, 2017 Tranche 4 [Member] Interest Rate Swap Designated December 13, 2017 Tranche 4 [Member] Interest Rate Swap Designated December 13, 2017 Tranche 5 Interest Rate Swap Designated December 13, 2017 Tranche 5 [Member] Interest Rate Swap Designated December 13, 2017 Tranche 5 [Member] Interest Rate Swap Designated October 10, 2018 Tranche 1 Interest Rate Swap Designated October 10, 2018 Tranche 1 [Member] Interest Rate Swap Designated October 10, 2018 Tranche 1 [Member] Interest Rate Swap Designated October 10, 2018 Tranche 2 Interest Rate Swap Designated October 10, 2018 Tranche 2 [Member] Interest Rate Swap Designated October 10, 2018 Tranche 2 [Member] Interest Rate Swap Designated October 10, 2018 Tranche 3 Interest Rate Swap Designated October 10, 2018 Tranche 3 [Member] Interest Rate Swap Designated October 10, 2018 Tranche 3 [Member] Interest Rate Swap Designated December 18, 2018 Tranche 1 Interest Rate Swap Designated December 18, 2018 Tranche 1 [Member] Interest Rate Swap Designated December 18, 2018 Tranche 1 [Member] Interest Rate Swap Designated December 18, 2018 Tranche 2 Interest Rate Swap Designated December 18, 2018 Tranche 2 [Member] Interest Rate Swap Designated December 18, 2018 Tranche 2 [Member] Current Notional Amount Fixed Interest Rate Estimated Fair Value, Assets (Liabilities) GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill and Intangible Assets Disclosure [Text Block] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Stock options Share-based Payment Arrangement, Option [Member] Restricted stock awards/stock units Restricted Stock Awards And Units [Member] Restricted Stock Awards And Units [Member] Performance stock and Restricted stock awards Performance Stock And Restricted Stock Awards [Member] Performance Stock And Restricted Stock Awards [Member] Performance shares Performance Shares [Member] Title of Individual [Axis] Title of Individual [Axis] Title of Individual [Domain] Title of Individual [Domain] Directors Director [Member] Employees Employee [Member] Employee [Member] Directors and Certain Executive Officers Directors and Certain Executive Officers [Member] Directors and Certain Executive Officers [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based compensation arrangement by share-based payment award, number of plans Share-based Compensation Arrangement by Share-based Payment Award, Number of Plans Share-based Compensation Arrangement by Share-based Payment Award, Number of Plans Stock options exercisable, vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Expiration period Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Total unrecognized compensation costs Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Weighted-average period for cost recognition Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Grants in period, net of forfeitures (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Options, weighted average grant date fair value (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Requisite service periods of awards Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period Awards granted during the period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Other than options, weighted average grant date fair value (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Cover [Abstract] Document Type Document Type Document Quarterly Report Document Quarterly Report Document Period End Date Document Period End Date Document Transition Report Document Transition Report Entity File Number Entity File Number Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address Entity Address, Address Line One Entity City Entity Address, City or Town Entity State Entity Address, State or Province Entity Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Current Reporting Status Entity Current Reporting Status Entity Interactive Data Current Entity Interactive Data Current Entity Filer Category Entity Filer Category Smaller Reporting Company Entity Small Business Emerging Growth Company Entity Emerging Growth Company Entity Shell Company Entity Shell Company Entity Bankruptcy Proceedings, Reporting Current Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Amendment Flag Amendment Flag Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Statement of Cash Flows [Abstract] OPERATING ACTIVITIES: Net Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Deferred income tax benefit/provision Deferred Income Tax Expense (Benefit) Share-based compensation Share-based Payment Arrangement, Noncash Expense Amortization of debt issuance costs and expenses associated with debt refinancing Amortization Of Debt Issuance Costs And Debt Refinanced Fees Amortization Of Debt Issuance Costs And Debt Refinanced Fees Accretion of bond issuance discount Accretion Expense Loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Change in fair value of contingent consideration and others Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Changes in assets and liabilities: Changes In Assets And Liabilities [Abstract] Changes In Assets And Liabilities [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Inventories Increase (Decrease) in Inventories Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Other non-current assets Increase (Decrease) in Other Operating Assets Accounts payable, accrued expenses and other current liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Contract liabilities Increase (Decrease) in Contract with Customer, Liability Other non-current liabilities Increase (Decrease) in Other Noncurrent Liabilities Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities INVESTING ACTIVITIES: Net Cash Provided by (Used in) Investing Activities [Abstract] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Acquired in-process research and development Payments to Acquire in Process Research and Development Proceeds from note receivable Proceeds from Collection of Notes Receivable Proceeds from sale of property and equipment Proceeds from Sale of Property, Plant, and Equipment Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities FINANCING ACTIVITIES: Net Cash Provided by (Used in) Financing Activities [Abstract] Proceeds from borrowings of long-term indebtedness Proceeds from Issuance of Secured Debt Payments on debt Repayments of Secured Debt Purchase of option hedge on convertible notes Payments For Option Index To Issuers Equity Payments For Options Indexed to Issuer's Equity Proceeds from convertible notes issuance Proceeds from sale of stock purchase warrants Proceeds from Issuance of Warrants Payment of debt issuance costs Payments of Debt Issuance Costs Purchases of treasury stock Payments for Repurchase of Common Stock Proceeds from exercised stock options Proceeds from Stock Options Exercised Cash taxes paid in net equity settlement Payment, Tax Withholding, Share-based Payment Arrangement Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Net increase in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash and cash equivalents at beginning of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash and cash equivalents at end of period Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Leased facilities Building [Member] Leased vehicles Vehicles [Member] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] ROU assets Current lease liabilities Non-current lease liabilities Weighted average remaining lease term (in years) Operating Lease, Weighted Average Remaining Lease Term Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent INVENTORIES Inventory Disclosure [Text Block] BUSINESS DEVELOPMENT Business Combination And Asset Acquisition Disclosure [Text Block] Business Combination And Asset Acquisition Disclosure [Text Block] Cash paid for amounts included in the measurement of lease liabilities: Cash Flow, Lessee [Abstract] Cash Flow, Lessee [Abstract] Operating cash flows from operating leases Operating Lease, Payments ROU assets obtained in exchange for lease liabilities: Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract] Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract] Operating leases Right-of-Use Asset Obtained in Exchange for Operating Lease Liability INCOME TAXES Income Tax Disclosure [Text Block] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Orthopedics and Tissue Technologies Orthopedics and Tissue Technologies [Member] Orthopedics and Tissue Technologies [Member] Goodwill [Line Items] Goodwill [Line Items] Goodwill [Roll Forward] Goodwill [Roll Forward] Beginning of Period Foreign currency translation Goodwill, Foreign Currency Translation Gain (Loss) End of Period Income Tax Contingency [Table] Income Tax Contingency [Table] Income Tax Authority [Axis] Income Tax Authority [Axis] Income Tax Authority [Domain] Income Tax Authority [Domain] Foreign Tax Authority Foreign Tax Authority [Member] Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Swiss Federal Tax Administration (FTA) Swiss Federal Tax Administration (FTA) [Member] Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] Effective income tax rate Valuation Allowance, foreign deferred tax assets Deferred Tax Assets, Valuation Allowance Tax benefit related to equity compensation Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount Effective income tax rate reconciliation, tax benefit, federal tax holiday Effective Income Tax Rate Reconciliation, Tax Holiday, Amount Effective income tax rate reconciliation, tax benefit, federal tax holiday (in dollars per share) Effective Income Tax Rate Reconciliation, Tax Holiday, Per Share Effective Income Tax Rate Reconciliation, Tax Holiday, Per Share Federal tax credit Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount Schedule of Inventories, Net Schedule of Inventory, Current [Table Text Block] Contract Asset Change In Contract With Customer, Asset [Roll Forward] Change In Contract With Customer, Asset [Roll Forward] Contract asset, Beginning of period Contract with Customer, Asset, after Allowance for Credit Loss Transferred to trade receivable of contract asset included in beginning of the year contract asset Contract with Customer, Asset, Reclassified to Receivable Contract asset, net of transferred to trade receivables on contracts during the period Contract With Customer, Asset, Net Of Reclassified To Receivable Contract With Customer, Asset, Net Of Reclassified To Receivable Contract asset, End of Period Contract Liability Change In Contract With Customer, Liability [Roll Forward] Change In Contract With Customer, Liability [Roll Forward] Contract liability, Beginning of Period Contract with Customer, Liability Recognition of revenue included in beginning of year contract liability Contract with Customer, Liability, Revenue Recognized Contract liability, net of revenue recognized on contracts during the period Contract With Customer, Liability, Net Of Revenue Recognized And Foreign Currency Translation Contract With Customer, Liability, Net Of Revenue Recognized And Foreign Currency Translation Foreign currency translation Contract With Customer, Liability, Increase From Foreign Currency Translation Contract With Customer, Liability, Increase From Foreign Currency Translation Contract liability, End of Period Codman Specialty Surgical Consolidation Items [Axis] Consolidation Items [Axis] Operating Activities [Domain] Consolidation Items [Domain] Operating Segments Operating Segments [Member] Corporate and other Corporate, Non-Segment [Member] Segment Net Sales Segment Reporting Information, Operating Income (Loss) [Abstract] Segment Profit Segment Reporting Information, Profit (Loss) [Abstract] Operating income Amortization Related Party [Axis] Related Party [Axis] Related Party [Domain] Related Party [Domain] Affiliated Entity Affiliated Entity [Member] Property Subject to or Available for Operating Lease [Axis] Property Subject to or Available for Operating Lease [Axis] Property Subject to or Available for Operating Lease [Domain] Property Subject to or Available for Operating Lease [Domain] Five Year Option Lease From November 1, 2032 Through October 31, 2037 Five Year Option Lease From November12032 Through October312037 [Member] Five-Year Option Lease From November 1, 2032 Through October 31, 2037 member Five Year Option Lease From November 1, 2037 Through October 31, 2042 Five Year Option Lease From November12037 Through October312042 [Member] Five-Year Option Lease From November 1, 2037 Through October 31, 2042 [Member] Number of renewal options (or more) Lessee, Operating Lease, Number Of Renewal Options Lessee, Operating Lease, Number Of Renewal Options Operating lease expense Operating Lease, Expense Future minimum lease payments capital leases Finance Lease, Liability, Payment, Due Percent of manufacturing facility owned by corporation whose shareholders are trusts whose beneficiaries include family members of company's former director Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director Annual rate of lease agreement Annual Rate Of Lease Agreement Annual rate of lease agreement. Option to extend lease, years Option To Extend Lease, Years Option to extend lease, years. Period for extended lease Lessee, Operating Lease, Option to Extend Schedule Of Asset Acquisition [Table] Schedule Of Asset Acquisition [Table] Schedule Of Asset Acquisition [Table] Asset Acquisition [Axis] Asset Acquisition [Axis] Asset Acquisition [Axis] Asset Acquisition [Domain] Asset Acquisition [Domain] [Domain] for Asset Acquisition [Axis] Rebound Rebound Therapeutics Corporation [Member] Rebound Therapeutics Corporation [Member] ISC Integrated Shoulder Collaboration, Inc. [Member] Integrated Shoulder Collaboration, Inc. [Member] In-Process Research and Development Expense Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Cash and Cash Equivalents Cash and Cash Equivalents [Member] Deferred Tax Asset Deferred Tax Asset [Member] Deferred Tax Asset [Member] Schedule Of Asset Acquisition [Line Items] Schedule Of Asset Acquisition [Line Items] [Line Items] for Schedule Of Asset Acquisition [Table] Upfront payment Asset Acquisition, Consideration Transferred Asset Acquisition, Consideration Transferred Contingent development milestone payments commitment (up to) Asset Acquisition, Maximum Contingent Development Milestone Payments, If Circumstances Met Asset Acquisition, Maximum Contingent Development Milestone Payments Number of assets acquired Asset Acquisition, Number Of Assets Acquired Asset Acquisition, Number Of Assets Acquired Remaining net assets acquired Asset Acquisition, Assets Acquired And Liabilities Assumed, Net Asset Acquisition, Assets Acquired And Liabilities Assumed, Net Development milestone Asset Acquisition, Development Milestone Payment To Be Paid Asset Acquisition, Development Milestone Payment In-process research and development Research and Development in Process Upfront payment, intangible assets Payments to Acquire Intangible Assets Option to acquire, period subsequent to first commercial sale Asset Acquisition, Option To Acquire, Period Subsequent To Commercial Sale, If Circumstances Met Asset Acquisition, Option To Acquire, Period Subsequent To Commercial Sale, If Circumstances Met Maximum future purchase price, if circumstances met (not to exceed) Asset Acquisition, Maximum Future Consideration Transferred, If Circumstances Met Asset Acquisition, Maximum Future Consideration Transferred, If Circumstances Met Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Product and Service [Axis] Product and Service [Axis] Product and Service [Domain] Product and Service [Domain] Neurosurgery Neurosurgery [Member] Neurosurgery [Member] Instruments Instruments [Member] Instruments [Member] Wound Reconstruction and Care Regenerative Skin And Wound [Member] Regenerative Skin And Wound [Member] Extremity Orthopedics Extremity Orthopedics [Member] Extremity Orthopedics [Member] Private Label Private Label [Member] Private Label [Member] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] LEASES AND RELATED PARTY LEASES Lessee, Operating Leases [Text Block] Basic net income per share: Earnings Per Share, Basic [Abstract] Net income Weighted average common shares outstanding - Basic (in shares) Basic net income per common share (in dollars per share) Diluted net income per share: Earnings Per Share, Diluted [Abstract] Effect of dilutive securities: Dilutive Securities, Effect on Basic Earnings Per Share [Abstract] Stock options and restricted stock (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Weighted average common shares for diluted earnings per share (in shares) Diluted net income per common share (in dollars per share) Current notional amount Gain (loss) recorded in other income, net Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Gain recorded in AOCI, change in fair value Gain reclassified into other income Gain (Loss) on Derivative Instruments, Net, Pretax Gain expected to be reclassified to earnings in the next twelve months Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net Gain recorded in AOCL, net investment hedge, change in fair value Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Remainder of 2020 Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year 2021 Long-term Debt, Maturities, Repayments of Principal in Year Two 2022 Long-term Debt, Maturities, Repayments of Principal in Year Three 2023 Long-term Debt, Maturities, Repayments of Principal in Year Four 2024 Long-term Debt, Maturities, Repayments of Principal in Year Five 2025 Long-term Debt, Maturities, Repayments of Principal after Year Five Principal Repayment Long-term Debt Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Secured Debt Secured Debt [Member] Revolving Credit Facility Revolving Credit Facility [Member] Standby Letters of Credit Standby Letters of Credit [Member] Swingline Loans Swingline Loan [Member] Swingline Loan [Member] Eurodollar Eurodollar [Member] Overnight Federal Funds Fed Funds Effective Rate Overnight Index Swap Rate [Member] One Month Eurodollar Rate One Month Eurodollar Rate [Member] One Month Eurodollar Rate [Member] Term Loan A Term Loan A Facility [Member] Term Loan A Facility [Member] 2025 Notes Two Thousand Twenty Five Senior Convertible Notes [Member] Two Thousand Twenty Five Senior Convertible Notes [Member] Term Loan Facility Term Loan Facility [Member] Term Loan Facility [Member] Secured Debt, Current Secured Debt, Current [Member] Secured Debt, Current [Member] Option Indexed to Issuer's Equity [Axis] Option Indexed to Issuer's Equity [Axis] Option Indexed to Issuer's Equity, Type [Domain] Option Indexed to Issuer's Equity, Type [Domain] Call Option Call Option [Member] Fair Value, Inputs, Level 2 Fair Value, Inputs, Level 2 [Member] Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Interest rates available Debt Instrument, Basis Spread on Variable Rate Line of credit, commitment fee percentage Line of Credit Facility, Commitment Fee Percentage Incremental financing costs capitalized Debt Issuance Costs, Gross Previously capitalized financing costs, written-off Write off of Deferred Debt Issuance Cost Line of credit facility outstanding Long-term Line of Credit Weighted average interest rate on debt Debt, Weighted Average Interest Rate Convertible notes, maximum borrowing capacity Debt Instrument, Face Amount Convertible notes, interest rate Debt Instrument, Interest Rate, Stated Percentage Debt proceeds, classified as equity at time of offering Debt Instrument, Convertible, Carrying Amount of Equity Component Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Carrying amount, liability component Unamortized discount Debt Instrument, Unamortized Discount Fair value Debt Instrument, Fair Value Disclosure Initial conversion rate Debt Instrument, Convertible, Conversion Ratio Initial conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price Maximum selling price of the company's common stock of the conversion price Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period Maximum average conversion value of notes Debt Instrument, Maximum Average Conversion Value Of Notes Debt Instrument, Maximum Average Conversion Value Of Notes Redemption price, percentage Debt Instrument, Redemption Price, Percentage Cost of call transactions Proceeds from warrant transactions Initial strike price (in dollars per share) Option Indexed to Issuer's Equity, Strike Price Warrant strike price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Cash interest Interest Expense, Debt, Excluding Amortization Amortization of discount Amortization of Debt Discount (Premium) Interest expense Interest Expense, Debt Securitization program outstanding borrowings, maximum limit Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit Securitization program, term Debt, Accounts Receivable Securitization, Term Debt, Accounts Receivable Securitization, Term Weighted average interest rate, accounts receivable securitization revolving loan facility Debt, Weighted Average Interest Rate, From Securitization Debt, Weighted Average Interest Rate, From Securitization Line of credit facility, fair value of amount outstanding Line of Credit Facility, Fair Value of Amount Outstanding Securitization facility, outstanding borrowings, fair value Securitization Facility, Fair Value Of Amount Outstanding Securitization Facility, Fair Value Of Amount Outstanding Letters of credit outstanding Letters of Credit Outstanding, Amount REVENUES FROM CONTRACTS WITH CUSTOMERS Revenue from Contract with Customer [Text Block] Schedule of Changes in Contract Assets and Contract Liabilities Contract with Customer, Asset and Liability [Table Text Block] Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Loss Contingencies [Table] Loss Contingencies [Table] BioD Earnout Payments and Medihoney Earnout Payments BioD Earnout Payments and Medihoney Earnout Payments [Member] BioD Earnout Payments and Medihoney Earnout Payments [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Payment for contingent consideration Payment for Contingent Consideration Liability, Financing Activities Number of contingent liabilities remaining Business Combination, Contingent Consideration, Number Of Liabilities Business Combination, Contingent Consideration, Number Of Liabilities Maximum contingent consideration Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Contingent consideration, liability Schedule of Changes in Carrying Amount of Goodwill Schedule of Goodwill [Table Text Block] Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Schedule of Indefinite-Lived Intangible Assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] DEBT Debt Disclosure [Text Block] Other Income (Expense), net Other Expense [Member] Interest income Amounts gain (loss) reclassified from accumulated other comprehensive loss Trade accounts receivable, allowance Accounts Receivable, Allowance for Credit Loss, Current Preferred stock, authorized shares (in shares) Preferred Stock, Shares Authorized Preferred stock, outstanding shares (in shares) Preferred Stock, Shares Outstanding Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, authorized shares (in shares) Common Stock, Shares Authorized Common stock, issued shares (in shares) Common Stock, Shares, Issued Treasury stock, shares (in shares) Schedule of Contingent Consideration Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Change in unrealized loss on derivatives, net of tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent Pension liability adjustment, net of tax Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent Comprehensive income (loss), net Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Interest Rate Swap Prepaid expenses and other current assets Prepaid Expenses and Other Current Assets [Member] Other assets Other Assets [Member] Accrued expenses and other current liabilities Accrued Expenses And Other Current Liabilities [Member] Accrued expenses and other current liabilities. Other liabilities Other Liabilities [Member] Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Total derivatives designated as hedges — Assets Derivative Asset, Fair Value, Gross Asset Total derivatives designated as hedges — Liabilities Derivative Liability, Fair Value, Gross Liability COMPREHENSIVE INCOME (LOSS) Comprehensive Income (Loss) Note [Text Block] BASIS OF PRESENTATION Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] EX-101.PRE 10 iart-20200331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 11 chart.jpg GRAPHIC begin 644 chart.jpg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htm IDEA: XBRL DOCUMENT v3.20.1
COMMITMENTS AND CONTINGENCIES - Narrative (Details) - Derma Sciences
 3 Months Ended
Mar. 31, 2020
USD ($)
liability
Mar. 31, 2019
USD ($)
Loss Contingencies [Line Items]    
Number of contingent liabilities remaining | liability 1  
Maximum contingent consideration $ 3,000,000.0  
Contingent consideration, liability 200,000 $ 200,000
BioD Earnout Payments and Medihoney Earnout Payments    
Loss Contingencies [Line Items]    
Payment for contingent consideration $ 33,300,000  
XML 13 R70.htm IDEA: XBRL DOCUMENT v3.20.1
SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details)
 3 Months Ended
Mar. 31, 2020
Segment
product
Segment Reporting Information [Line Items]  
Number of reportable segments | Segment 2
Codman Specialty Surgical  
Segment Reporting Information [Line Items]  
Number of products offered (more than) | product 40,000
XML 14 R53.htm IDEA: XBRL DOCUMENT v3.20.1
DERIVATIVE INSTRUMENTS - Schedule of Net Investment Hedges Derivatives (Details) - Designated as Hedging Instrument - Net Investment Hedges
€ in Thousands, £ in Thousands, SFr in Thousands, $ in Thousands
Mar. 31, 2020
GBP (£)
Mar. 31, 2020
CHF (SFr)
Mar. 31, 2020
EUR (€)
Mar. 31, 2020
USD ($)
Dec. 31, 2019
GBP (£)
Dec. 31, 2019
CHF (SFr)
Dec. 31, 2019
EUR (€)
Dec. 31, 2019
USD ($)
Cross Currency Interest Rate Swap One                
Derivative [Line Items]                
Fair Value Asset (Liability)       $ 4,082       $ 2,459
Cross Currency Interest Rate Swap One | Long                
Derivative [Line Items]                
Fixed Rate 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Aggregate Notional Amount | €     € 44,859       € 44,859  
Cross Currency Interest Rate Swap One | Short                
Derivative [Line Items]                
Fixed Rate 3.01% 3.01% 3.01% 3.01% 3.01% 3.01% 3.01% 3.01%
Aggregate Notional Amount       $ 52,000       $ 52,000
Cross Currency Interest Rate Swap Two                
Derivative [Line Items]                
Fair Value Asset (Liability)       $ 6,298       $ 3,087
Cross Currency Interest Rate Swap Two | Long                
Derivative [Line Items]                
Fixed Rate 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Aggregate Notional Amount | €     € 51,760       € 51,760  
Cross Currency Interest Rate Swap Two | Short                
Derivative [Line Items]                
Fixed Rate 2.57% 2.57% 2.57% 2.57% 2.57% 2.57% 2.57% 2.57%
Aggregate Notional Amount       $ 60,000       $ 60,000
Cross Currency Interest Rate Swap Three                
Derivative [Line Items]                
Fair Value Asset (Liability)       $ 5,174       $ 2,032
Cross Currency Interest Rate Swap Three | Long                
Derivative [Line Items]                
Fixed Rate 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Aggregate Notional Amount | €     € 38,820       € 38,820  
Cross Currency Interest Rate Swap Three | Short                
Derivative [Line Items]                
Fixed Rate 2.19% 2.19% 2.19% 2.19% 2.19% 2.19% 2.19% 2.19%
Aggregate Notional Amount       $ 45,000       $ 45,000
Cross Currency Interest Rate Swap Four                
Derivative [Line Items]                
Fair Value Asset (Liability)       $ 16,773       $ (154)
Cross Currency Interest Rate Swap Four | Long                
Derivative [Line Items]                
Fixed Rate 1.67% 1.67% 1.67% 1.67% 1.67% 1.67% 1.67% 1.67%
Aggregate Notional Amount | £ £ 128,284       £ 128,284      
Cross Currency Interest Rate Swap Four | Short                
Derivative [Line Items]                
Fixed Rate 2.71% 2.71% 2.71% 2.71% 2.71% 2.71% 2.71% 2.71%
Aggregate Notional Amount       $ 167,500       $ 167,500
Cross Currency Interest Rate Swap Five                
Derivative [Line Items]                
Fair Value Asset (Liability)       $ (6,965)       $ 1,221
Cross Currency Interest Rate Swap Five | Long                
Derivative [Line Items]                
Fixed Rate 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Aggregate Notional Amount | SFr   SFr 165,172       SFr 165,172    
Cross Currency Interest Rate Swap Five | Short                
Derivative [Line Items]                
Fixed Rate 1.67% 1.67% 1.67% 1.67% 1.67% 1.67% 1.67% 1.67%
Aggregate Notional Amount | £ £ 128,284       £ 128,284      
Cross Currency Interest Rate Swap                
Derivative [Line Items]                
Fair Value Asset (Liability)       $ 25,362       $ 8,645
XML 15 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 16 R57.htm IDEA: XBRL DOCUMENT v3.20.1
RETIREMENT PLANS - Narrative (Details) - USD ($)
$ in Millions
 1 Months Ended 3 Months Ended
May 31, 2019
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Retirement Benefits [Abstract]        
Net periodic benefit costs   $ 1.0 $ 0.5  
Service cost component   0.9 $ 0.7  
Estimated fair value of plan assets   31.3   $ 30.8
Defer payment and taxation, base salary, percentage (up to) 75.00%      
Defer payment and taxation, bonus and other eligible cash compensation, percentage (up to) 100.00%      
Deferred compensation plan, fair value of assets   $ 1.2    
XML 17 R36.htm IDEA: XBRL DOCUMENT v3.20.1
BUSINESS DEVELOPMENT - Business Combination, Narrative (Details) - Arkis - USD ($)
Jul. 29, 2019
Dec. 31, 2019
Business Acquisition [Line Items]    
Purchase price of business combination $ 30,900,000  
Contingent consideration, liability (up to) 25,500,000  
Contingent consideration, fair value $ 13,100,000 $ 13,200,000
Acquired intangible assets, discount rate 14.50%  
Development Milestones    
Business Acquisition [Line Items]    
Contingent consideration, liability (up to) $ 10,000,000.0  
Commercial Sales Milestones    
Business Acquisition [Line Items]    
Contingent consideration, liability (up to) $ 15,500,000  
XML 18 R32.htm IDEA: XBRL DOCUMENT v3.20.1
NET INCOME PER SHARE (Tables)
 3 Months Ended
Mar. 31, 2020
Earnings Per Share [Abstract]  
Basic and Diluted Net Income Per Share
Basic and diluted net income per share was as follows:
 
Three Months Ended March 31,
 
2020
 
2019
 
(In thousands, except per share amounts)
Basic net income per share:
 
 
 
Net income
$
9,180

 
$
32,756

Weighted average common shares outstanding
85,188

 
85,343

Basic net income per common share
$
0.11

 
$
0.38

 
 
 
 
Diluted net income per share:
 
 
 
Net income
$
9,180

 
$
32,756

 
 
 
 
Weighted average common shares outstanding — Basic
85,188

 
85,343

Effect of dilutive securities:
 
 
 
Stock options and restricted stock
704

 
915

Weighted average common shares for diluted earnings per share
85,892

 
86,258

 
 
 
 
Diluted net income per common share
$
0.11

 
$
0.38
XML 19 R9999.htm IDEA: XBRL DOCUMENT v3.20.1
Label Element Value
Cumulative Effect, Period Of Adoption, Adjustment [Member]  
Stockholders' Equity Attributable to Parent us-gaap_StockholdersEquity $ (200,000)
Cumulative Effect, Period Of Adoption, Adjustment [Member] | Retained Earnings [Member]  
Stockholders' Equity Attributable to Parent us-gaap_StockholdersEquity $ (200,000)
XML 20 R11.htm IDEA: XBRL DOCUMENT v3.20.1
GOODWILL AND OTHER INTANGIBLE ASSETS
 3 Months Ended
Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL AND OTHER INTANGIBLE ASSETS
Goodwill
Changes in the carrying amount of goodwill for the three-month period ended March 31, 2020 were as follows:
 
Codman Specialty
Surgical
 
Orthopedics and
Tissue Technologies
 
Total
 
(In thousands)
Goodwill at December 31, 2019
$
653,500

 
$
300,780

 
$
954,280

Foreign currency translation
(1,867
)
 
(859
)
 
(2,726
)
Goodwill at March 31, 2020
$
651,633

 
$
299,921

 
$
951,554


The components of the Company’s identifiable intangible assets were as follows:
 
March 31, 2020
 
Weighted
Average
Life
 
Cost
 
Accumulated
Amortization
 
Net
 
(Dollars in thousands)
Completed technology
19 years
 
$
881,856

 
$
(225,350
)
 
$
656,506

Customer relationships
12 years
 
221,193

 
(123,896
)
 
97,297

Trademarks/brand names
28 years
 
103,472

 
(29,190
)
 
74,282

Codman tradename
Indefinite
 
163,680

 
—

 
163,680

Supplier relationships
27 years
 
34,721

 
(18,304
)
 
16,417

All other(1)
4 years
 
10,787

 
(4,742
)
 
6,045

 
 
 
$
1,415,709

 
$
(401,482
)
 
$
1,014,227


 
December 31, 2019
 
Weighted
Average
Life
 
Cost
 
Accumulated
Amortization
 
Net
 
(Dollars in thousands)
Completed technology
19 years
 
$
880,623

 
$
(213,702
)
 
$
666,921

Customer relationships
12 years
 
222,575

 
(119,393
)
 
103,182

Trademarks/brand names
28 years
 
103,873

 
(28,514
)
 
75,359

Codman tradename
Indefinite
 
163,126

 
—

 
163,126

Supplier relationships
27 years
 
34,721

 
(17,947
)
 
16,774

All other (1)
4 years
 
10,869

 
(4,640
)
 
6,229

 
 
 
$
1,415,787

 
$
(384,196
)
 
$
1,031,591



(1)
At March 31, 2020 and December 31, 2019, all other included IPR&D of $1.0 million, which was indefinite-lived.
Based on quarter-end exchange rates, amortization expense (including amounts reported in cost of product revenues) is expected to be approximately $56.1 million for the remainder of 2020, $64.4 million in 2021, $60.8 million in 2022, $60.0 million in 2023, $59.2 million in 2024, $59.1 million in 2025 and $491.9 million thereafter.
XML 21 R15.htm IDEA: XBRL DOCUMENT v3.20.1
RETIREMENT PLANS
 3 Months Ended
Mar. 31, 2020
Retirement Benefits [Abstract]  
RETIREMENT PLANS RETIREMENT PLANS
The Company maintains defined benefit pension plans that cover certain employees in Austria, France, Japan, Germany and Switzerland.
Net periodic benefit costs for the Company’s defined benefit pension plans for the three months ended March 31, 2020 were $1.0 million. The components of the net periodic benefit costs other than the service cost component of $0.9 million for the three months ended March 31, 2020, are included in other income (expense), net in the consolidated statements of operations.
Net periodic benefit costs for the Company’s defined benefit pension plans for the three months ended March 31, 2019 was $0.5 million. The components of the net periodic benefit costs other than the service cost component of $0.7 million for the three months ended March 31, 2019, respectively, are included in other income (expense), net in the consolidated statements of operations.
The estimated fair values of plan assets were $31.3 million and $30.8 million as of March 31, 2020 and December 31, 2019, respectively. The net plan assets of the pension plans are invested in common trusts as of March 31, 2020 and December 31, 2019. Common trusts are classified as Level 2 in the fair value hierarchy. The fair value of common trusts is valued at the net asset value based on the fair values of the underlying investments of the trusts as determined by the sponsor of the trusts. The investment strategy of the Company's defined benefit plans is both to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within an appropriate risk profile.
Deferred Compensation Plan
In May 2019, the Company adopted the Integra LifeSciences Deferred Compensation Plan (the “Plan”). Under the Plan, certain employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation.
During the first quarter of 2020, employees participating in the Plan began to defer their compensation. This deferred compensation is invested in funds offered under the Plan and is valued based on Level 1 measurements in the fair value hierarchy. The purpose of the Plan is to retain key employees by providing them with an opportunity to defer a portion of their compensation as elected by the participant in accordance with the Plan. Any amounts set aside to defray the liabilities assumed by the Company will remain the general assets of the Company until such amounts are distributed to the participants. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices. The fair value of these assets at March 31, 2020 was $1.2 million. Offsetting liabilities relating to the deferred compensation plan are included in Other liabilities.
XML 22 R19.htm IDEA: XBRL DOCUMENT v3.20.1
NET INCOME PER SHARE
 3 Months Ended
Mar. 31, 2020
Earnings Per Share [Abstract]  
NET INCOME PER SHARE NET INCOME PER SHARE
Basic and diluted net income per share was as follows:
 
Three Months Ended March 31,
 
2020
 
2019
 
(In thousands, except per share amounts)
Basic net income per share:
 
 
 
Net income
$
9,180

 
$
32,756

Weighted average common shares outstanding
85,188

 
85,343

Basic net income per common share
$
0.11

 
$
0.38

 
 
 
 
Diluted net income per share:
 
 
 
Net income
$
9,180

 
$
32,756

 
 
 
 
Weighted average common shares outstanding — Basic
85,188

 
85,343

Effect of dilutive securities:
 
 
 
Stock options and restricted stock
704

 
915

Weighted average common shares for diluted earnings per share
85,892

 
86,258

 
 
 
 
Diluted net income per common share
$
0.11

 
$
0.38



Common stock of approximately 0.4 million shares at March 31, 2020, and 2019 that are issuable through exercise of dilutive securities were not included in the computation of diluted net income per share because their effect would have been anti-dilutive.
Performance Shares and Restricted Units that entitle the holders to approximately 0.5 million shares of common stock are included in the basic and diluted weighted average shares outstanding calculation from their date of issuance because no further consideration is due related to the issuance of the underlying common shares.
XML 23 R23.htm IDEA: XBRL DOCUMENT v3.20.1
BASIS OF PRESENTATION (Policies)
 3 Months Ended
Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis Of Presentation BASIS OF PRESENTATION
General
The terms “we,” “our,” “us,” “Company” and “Integra” refer to Integra LifeSciences Holdings Corporation, a Delaware corporation, and its subsidiaries unless the context suggests otherwise.
In the opinion of management, the March 31, 2020 unaudited condensed consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the financial position, statement of changes in shareholder's equity, results of operations and cash flows of the Company. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements for the year ended December 31, 2019 included in the Company’s Annual Report on Form 10-K. The December 31, 2019 consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States. Operating results for the three month period ended March 31, 2020 are not necessarily indicative of the results to be expected for the entire year.
The preparation of consolidated financial statements is in conformity with generally accepted accounting principles in the United States ("GAAP") which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of the equity component of convertible debt instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates. The novel coronavirus (“COVID-19”) pandemic and the resulting adverse impacts to global economic conditions, as well as our operations, may impact future estimates including, but not limited to, inventory valuations, fair value measurements, goodwill and long-lived asset impairments, the effectiveness of the Company’s hedging instruments, deferred tax valuation allowances, and allowances for doubtful accounts receivable.
Recently Issued Accounting Standards
Recently Issued Accounting Standards
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The ASU is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The ASU requires the measurement of all expected credit losses for financial assets including trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other
organizations will now use forward-looking information to better inform their credit loss estimates. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a modified retrospective transition method which requires a cumulative-effect adjustment to the opening balance of retained earnings to be recognized on the date of adoption with no change to financial results reported in prior periods. The cumulative-effect adjustment recorded on January 1, 2020, is not material. The adoption of this ASU did not have a significant impact on the Company's consolidated financial statements and related disclosures.
The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the current COVID-19 pandemic, or other customer-specific factors. Although the Company has historically not experienced significant credit losses, it is possible that there could be a adverse impact from potential as hospital's cash flows are impacted by their response to the COVID-19 pandemic and deferral of elective surgical procedures.
In August 2018, the FASB issued ASU 2018-14, Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans. The new guidance modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans, including removing certain previous disclosure requirements, adding certain new disclosure requirements, and clarifying certain other disclosure requirements. The ASU will be effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption is permitted. The adoption is not expected to have a material impact on the Condensed and Consolidated Financial Statements.
In August 2018, the FASB issued ASU No. 2018-15, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40), relating to a customer's accounting for implementation, set-up, and other upfront costs incurred in a cloud computing arrangement that is hosted by a vendor (e.g., a service contract). Under the new guidance, a customer will apply the same criteria for capitalizing implementation costs as it would for an arrangement that has a software license. The new guidance also prescribes the balance sheet, income statement, and cash flow classification of the capitalized implementation costs and related amortization expense, and requires additional quantitative and qualitative disclosures. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a prospective transition method. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.
In December 2019, the FASB issued ASU No. 2019-12, Income Taxes: Simplifying the Accounting for Income Taxes intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The new guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively. The Company is currently assessing the impact of this standard on the financial condition and results of operations.
In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform, which provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. This amendment applies to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This ASU is effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. The Company is currently assessing the impact that this ASU will have on its consolidated financial statements.
There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.
Summary of Accounting Policies on Revenue Recognition and Shipping and Handling Fees
Shipping and Handling Fees
The Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.
Summary of Accounting Policies on Revenue Recognition
Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services.
Total revenue, net, includes product sales, product royalties and other revenues, such as fees received for services.
For products shipped with FOB shipping point terms, the control of the product passes to the customer at the time of shipment. For shipments in which the control of the product is transferred when the customer receives the product, the Company recognizes revenue upon receipt by the customer. Certain products that the Company produces for private label customers have no alternative use and the Company has a right of payment for performance to date. Revenues from those products are recognized over the period that the Company manufactures these products, which is typically one to three months. The Company uses the input method to
measure the manufacturing activities completed to date, which depicts the progress of the Company's performance obligation of transferring control of goods being manufactured for private label customers.
A portion of the Company's product revenue is generated from consigned inventory maintained at hospitals and distributors, and also from inventory physically held by field sales representatives. For these types of product sales, the Company retains control until the product has been used or implanted, at which time revenue is recognized.   
Revenues from sale of products and services are evidenced by either a contract with the customer or a valid purchase order and an invoice which includes all relevant terms of sale. For product sales, invoices are generally issued upon the transfer of control (or upon the completion of the manufacturing in the case of the private label transactions recognized over time) and are typically payable thirty days after the invoice date. The Company performs a review of each specific customer's creditworthiness and ability to pay prior to acceptance as a customer. Further, the Company performs periodic reviews of its customers' creditworthiness prospectively.
Performance Obligations
The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.
Significant Judgments
Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant.
The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract.
The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally ninety days.
The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.
Contract Asset and Liability
Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheet.
Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.
Product Warranties
Product Warranties
Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.
Taxes Collected from Customers
Taxes Collected from Customers
The Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer.
XML 24 R27.htm IDEA: XBRL DOCUMENT v3.20.1
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)
 3 Months Ended
Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Changes in Carrying Amount of Goodwill
Changes in the carrying amount of goodwill for the three-month period ended March 31, 2020 were as follows:
 
Codman Specialty
Surgical
 
Orthopedics and
Tissue Technologies
 
Total
 
(In thousands)
Goodwill at December 31, 2019
$
653,500

 
$
300,780

 
$
954,280

Foreign currency translation
(1,867
)
 
(859
)
 
(2,726
)
Goodwill at March 31, 2020
$
651,633

 
$
299,921

 
$
951,554
Schedule of Finite-Lived Intangible Assets
The components of the Company’s identifiable intangible assets were as follows:
 
March 31, 2020
 
Weighted
Average
Life
 
Cost
 
Accumulated
Amortization
 
Net
 
(Dollars in thousands)
Completed technology
19 years
 
$
881,856

 
$
(225,350
)
 
$
656,506

Customer relationships
12 years
 
221,193

 
(123,896
)
 
97,297

Trademarks/brand names
28 years
 
103,472

 
(29,190
)
 
74,282

Codman tradename
Indefinite
 
163,680

 
—

 
163,680

Supplier relationships
27 years
 
34,721

 
(18,304
)
 
16,417

All other(1)
4 years
 
10,787

 
(4,742
)
 
6,045

 
 
 
$
1,415,709

 
$
(401,482
)
 
$
1,014,227


 
December 31, 2019
 
Weighted
Average
Life
 
Cost
 
Accumulated
Amortization
 
Net
 
(Dollars in thousands)
Completed technology
19 years
 
$
880,623

 
$
(213,702
)
 
$
666,921

Customer relationships
12 years
 
222,575

 
(119,393
)
 
103,182

Trademarks/brand names
28 years
 
103,873

 
(28,514
)
 
75,359

Codman tradename
Indefinite
 
163,126

 
—

 
163,126

Supplier relationships
27 years
 
34,721

 
(17,947
)
 
16,774

All other (1)
4 years
 
10,869

 
(4,640
)
 
6,229

 
 
 
$
1,415,787

 
$
(384,196
)
 
$
1,031,591



(1)
At March 31, 2020 and December 31, 2019, all other included IPR&D of $1.0 million, which was indefinite-lived.
Schedule of Indefinite-Lived Intangible Assets
The components of the Company’s identifiable intangible assets were as follows:
 
March 31, 2020
 
Weighted
Average
Life
 
Cost
 
Accumulated
Amortization
 
Net
 
(Dollars in thousands)
Completed technology
19 years
 
$
881,856

 
$
(225,350
)
 
$
656,506

Customer relationships
12 years
 
221,193

 
(123,896
)
 
97,297

Trademarks/brand names
28 years
 
103,472

 
(29,190
)
 
74,282

Codman tradename
Indefinite
 
163,680

 
—

 
163,680

Supplier relationships
27 years
 
34,721

 
(18,304
)
 
16,417

All other(1)
4 years
 
10,787

 
(4,742
)
 
6,045

 
 
 
$
1,415,709

 
$
(401,482
)
 
$
1,014,227


 
December 31, 2019
 
Weighted
Average
Life
 
Cost
 
Accumulated
Amortization
 
Net
 
(Dollars in thousands)
Completed technology
19 years
 
$
880,623

 
$
(213,702
)
 
$
666,921

Customer relationships
12 years
 
222,575

 
(119,393
)
 
103,182

Trademarks/brand names
28 years
 
103,873

 
(28,514
)
 
75,359

Codman tradename
Indefinite
 
163,126

 
—

 
163,126

Supplier relationships
27 years
 
34,721

 
(17,947
)
 
16,774

All other (1)
4 years
 
10,869

 
(4,640
)
 
6,229

 
 
 
$
1,415,787

 
$
(384,196
)
 
$
1,031,591



(1)
At March 31, 2020 and December 31, 2019, all other included IPR&D of $1.0 million, which was indefinite-lived.
XML 25 R61.htm IDEA: XBRL DOCUMENT v3.20.1
LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases, After Adoption of 842 (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Operating Leased Assets [Line Items]    
2020   $ 12,396
2020 $ 10,556  
2021 13,314 13,247
2022 14,494 14,049
2023 11,954 11,682
2024 11,318 11,356
Thereafter 92,455 92,663
Total minimum lease payments 154,091 155,393
Less: Imputed interest 40,799 45,636
Total lease liabilities 113,292 109,757
Less: Current lease liabilities 12,964 12,253
Long-term lease liabilities 100,328 97,504
Related Parties    
Operating Leased Assets [Line Items]    
2020   296
2020 222  
2021 296 296
2022 296 296
2023 296 296
2024 296 296
Thereafter 1,429 1,428
Total minimum lease payments 2,835 2,908
Third Parties    
Operating Leased Assets [Line Items]    
2020   12,100
2020 10,334  
2021 13,018 12,951
2022 14,198 13,753
2023 11,658 11,386
2024 11,022 11,060
Thereafter 91,026 91,235
Total minimum lease payments $ 151,256 $ 152,485
XML 26 R65.htm IDEA: XBRL DOCUMENT v3.20.1
NET INCOME PER SHARE - Basic and Diluted Net Income Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Basic net income per share:    
Net income $ 9,180 $ 32,756
Weighted average common shares outstanding - Basic (in shares) 85,188 85,343
Basic net income per common share (in dollars per share) $ 0.11 $ 0.38
Diluted net income per share:    
Net income $ 9,180 $ 32,756
Weighted average common shares outstanding - Basic (in shares) 85,188 85,343
Effect of dilutive securities:    
Stock options and restricted stock (in shares) 704 915
Weighted average common shares for diluted earnings per share (in shares) 85,892 86,258
Diluted net income per common share (in dollars per share) $ 0.11 $ 0.38
XML 27 R69.htm IDEA: XBRL DOCUMENT v3.20.1
COMPREHENSIVE INCOME (LOSS) - Narrative (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2020
USD ($)
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Amounts gain (loss) reclassified from accumulated other comprehensive loss $ 729
Gains and Losses on Derivatives  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Amounts gain (loss) reclassified from accumulated other comprehensive loss 729
Other Income (Expense), net | Gains and Losses on Derivatives  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Amounts gain (loss) reclassified from accumulated other comprehensive loss (100)
Interest income | Gains and Losses on Derivatives  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Amounts gain (loss) reclassified from accumulated other comprehensive loss $ 900
XML 28 R46.htm IDEA: XBRL DOCUMENT v3.20.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)
$ in Millions
Mar. 31, 2020
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
Expected annual amortization expense, remainder of 2020 $ 56.1
Expected annual amortization expense, in 2021 64.4
Expected annual amortization expense, in 2022 60.8
Expected annual amortization expense, in 2023 60.0
Expected annual amortization expense, in 2024 59.2
Expected annual amortization expense, in 2025 59.1
Expected annual amortization expense, thereafter $ 491.9
XML 29 R4.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Statement of Financial Position [Abstract]    
Trade accounts receivable, allowance $ 6,652 $ 4,303
Preferred stock, authorized shares (in shares) 15,000,000 15,000,000
Preferred stock, outstanding shares (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, authorized shares (in shares) 240,000,000 240,000,000
Common stock, issued shares (in shares) 89,104,000 88,735,000
Treasury stock, shares (in shares) 4,294,000 2,865,000
XML 30 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 31 R42.htm IDEA: XBRL DOCUMENT v3.20.1
REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Revenues Disaggregated by Major Source (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Disaggregation of Revenue [Line Items]    
Total Revenues $ 354,324 $ 359,690
Codman Specialty Surgical    
Disaggregation of Revenue [Line Items]    
Total Revenues 231,440 234,568
Codman Specialty Surgical | Neurosurgery    
Disaggregation of Revenue [Line Items]    
Total Revenues 184,943 179,520
Codman Specialty Surgical | Instruments    
Disaggregation of Revenue [Line Items]    
Total Revenues 46,497 55,048
Orthopedics and Tissue Technologies    
Disaggregation of Revenue [Line Items]    
Total Revenues 122,884 125,122
Orthopedics and Tissue Technologies | Wound Reconstruction and Care    
Disaggregation of Revenue [Line Items]    
Total Revenues 72,267 74,963
Orthopedics and Tissue Technologies | Extremity Orthopedics    
Disaggregation of Revenue [Line Items]    
Total Revenues 21,472 22,685
Orthopedics and Tissue Technologies | Private Label    
Disaggregation of Revenue [Line Items]    
Total Revenues $ 29,145 $ 27,474
XML 32 R8.htm IDEA: XBRL DOCUMENT v3.20.1
BUSINESS DEVELOPMENT
 3 Months Ended
Mar. 31, 2020
Business Combinations [Abstract]  
BUSINESS DEVELOPMENT BUSINESS DEVELOPMENT
Arkis BioSciences Inc.
On July 29, 2019, the Company acquired Arkis BioSciences Inc. ("Arkis") for an acquisition purchase price of $30.9 million (the "Arkis Acquisition") plus contingent consideration of up to $25.5 million, that may be payable based on the successful completion of certain development and commercial milestones. The contingent consideration had an acquisition date fair value of $13.1 million. Arkis was a privately-held company that marketed the CerebroFlo® external ventricular drainage (EVD) catheter with Endexo® technology, a permanent additive designed to reduce the potential for catheter obstruction due to thrombus formation.
Assets Acquired and Liabilities Assumed at Fair Value
The Arkis Acquisition has been accounted for using the acquisition method of accounting. This method requires that assets acquired and liabilities assumed in a business combination to be recognized at their fair values as of the acquisition date. As of March 31, 2020 certain amounts relating to tax related matters have not been finalized. The finalization of these matters could result in changes to goodwill.
The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date:
 
Preliminary Valuation as of March 31, 2020
 
Weighted Average Life
 
(Dollars in thousands)
 
 
Cash
$
90

 
 
Other current assets
751

 
 
Property, plant and equipment
159

 
 
Deferred tax assets
1,535

 
 
Intangible assets:
 
 
 
CerebroFlo developed technology
20,100

 
15 years
Enabling technology license
1,980

 
14 years
Goodwill
27,600

 
 
Total assets acquired
52,215

 
 
 
 
 
 
Accounts payable, accrued expenses and other liabilities
2,926

 
 
Contingent consideration
13,100

 
 
Deferred tax liabilities
5,305

 
 
     Net assets acquired
$
30,884

 
 

Intangible Assets
The estimated fair value of the intangible assets was determined using the income approach, which is a valuation technique that provides an estimate of the fair value of an asset based on market participant expectations of the cash flows an asset would generate over its remaining useful life. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each asset (including net revenues, cost of sales, R&D costs, selling and marketing costs, and working capital/contributory asset charges), the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of each asset’s life cycle, and competitive trends impacting the asset and each cash flow stream.
The Company used a discount rate of 14.5% to arrive at the present value for the acquired intangible assets to reflect the rate of return a market participant would expect to earn and incremental commercial uncertainty in the cash flow projections. No assurances can be given that the underlying assumptions used to prepare the discounted cash flow analysis will not change. For these and other reasons, actual results may vary significantly from estimated results.  
Goodwill
The Company allocated goodwill related to the Arkis Acquisition to the Codman Specialty Surgical segment. Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected revenue and cost synergies of the combined company and assembled workforce. One of the key factors that contributes to the recognition of goodwill, and a driver for the Company's acquisition of Arkis, is the planned expansion of the Endexo technology with the existing products within the Codman Specialty Surgical segment. Goodwill recognized as a result of this acquisition is non-deductible for income tax purposes.
Contingent Consideration
The Company determines the acquisition date fair value of contingent consideration obligations based on a probability-weighted income approach derived from revenue estimates and a probability assessment with respect to the likelihood of achieving contingent obligations. The fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined using the fair value concepts in ASC 820. The resultant probability-weighted cash flows are discounted using an appropriate effective annual interest rate. At each reporting date, the contingent consideration obligation will be revalued to estimated fair value and changes in fair value will be reflected as income or expense in the Company's consolidated statement of operations. Changes in the fair value of the contingent consideration obligations may result from changes in discount periods and rates, changes in the timing and amount of revenue estimates and changes in probability assumptions with respect to the likelihood of achieving the various contingent payment obligations.
Adverse changes in assumptions utilized in the contingent consideration fair value estimates could result in an increase in the contingent consideration obligation and a corresponding charge to operating results.
As part of the acquisition, the Company is required to pay the former shareholders of Arkis up to $25.5 million based on the timing of certain development milestones of $10.0 million and commercial sales milestones of $15.5 million, respectively. The Company used a probability weighted income approach to calculate the fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specified milestone. The Company estimated the fair value of the contingent consideration to be $13.1 million at the acquisition date. The estimated fair value as of March 31, 2020 was $13.2 million. This amount is included in other liabilities at March 31, 2020 in the consolidated balance sheets of the Company.
Deferred Tax Liabilities
Deferred tax liabilities result from identifiable intangible assets’ fair value adjustments. These adjustments create excess book basis over tax basis which is tax-effected by the statutory tax rates of applicable jurisdictions.
The pro forma results are not presented for this acquisition as they are not material.
Rebound Therapeutics Corporation
On September 9, 2019, the Company acquired Rebound Therapeutics Corporation (“Rebound”), developers of a single-use medical device known as the AURORA Surgiscope® System ("Aurora") which enables minimally invasive access, using optics and illumination, for visualization, diagnostic and therapeutic use in neurosurgery (the “Rebound transaction”). Under the terms of the Rebound transaction, the Company made an upfront payment of $67.1 million and are committed to pay up to $35.0 million of contingent development milestones upon achievement of certain regulatory milestones. The acquisition of Rebound was primarily concentrated in one single identifiable asset and thus, for accounting purposes, the Company has concluded that the acquired assets do not meet the accounting definition of a business. The initial payment was allocated primarily to Aurora, resulting in a $59.9 million in-process research and development expense. The balance of approximately $7.2 million, which included $2.1 million of cash and cash equivalents and a net deferred tax asset of $4.2 million, was allocated to the remaining net assets acquired. The deferred tax asset primarily resulted from a federal net operating loss carry forward.
During the fourth quarter of 2019, the Company achieved the first developmental milestone which triggered a $5.0 million obligation to be paid to former shareholders of Rebound. The Company recorded $5.0 million as in-process research and development expense in the consolidated statements of operations during the year ended December 31, 2019. The obligation was included in accrued expenses and other current liabilities at December 31, 2019 in the consolidated balance sheets. The milestone was paid during the first quarter of 2020.
Integrated Shoulder Collaboration, Inc.
On January 4, 2019, the Company entered into a licensing agreement with Integrated Shoulder Collaboration, Inc ("ISC"). Under the terms of the agreement, the Company paid ISC $1.7 million for the exclusive, worldwide license to commercialize its short stem and stemless shoulder system. A patent related to short stem and stemless shoulder systems was issued to ISC during the first quarter of 2019. ISC is eligible to receive royalties on sales of the short stem and stemless shoulder system. The Company has the option to acquire ISC at a date four years subsequent to the first commercial sale, which becomes mandatory upon the achievement of a certain sales thresholds of the short stem and stemless shoulder system, for an amount not to exceed $80.0 million. The transaction was accounted for as an asset acquisition as the Company concluded that it acquired primarily one asset. During the quarter ended March 31, 2019, The total upfront payment of $1.7 million was expensed as a component of research and development expense and the future milestone and option payments will be recorded if the corresponding events become probable.
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.20.1
COMMITMENTS AND CONTINGENCIES
 3 Months Ended
Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES
In consideration for certain technology, manufacturing, distribution, and selling rights and licenses granted to the Company, the Company has agreed to pay royalties on sales of certain products that it sells. The royalty payments that the Company made under these agreements were not significant for any of the periods presented.
The Company is subject to various claims, lawsuits and proceedings in the ordinary course of the Company's business, including claims by current or former employees, distributors and competitors and with respect to its products and product liability claims, lawsuits and proceedings, some of which have been settled by the Company. In the opinion of management, such claims are either adequately covered by insurance or otherwise indemnified, or are not expected, individually or in the aggregate, to result in a material, adverse effect on the Company's financial condition. However, it is possible that the Company's results of operations, financial position and cash flows in a particular period could be materially affected by these contingencies.
The Company accrues for loss contingencies when it is deemed probable that a loss has been incurred and that loss is estimable. The amounts accrued are based on the full amount of the estimated loss before considering insurance proceeds and do not include an estimate for legal fees expected to be incurred in connection with the loss contingency. The Company consistently accrues legal fees expected to be incurred in connection with loss contingencies as those fees are incurred by outside counsel as a period cost.
Contingent Consideration
The Company determined the fair value of contingent consideration during the three-month period ended March 31, 2020 and March 31, 2019 to reflect the change in estimates, additions, payments, transfers and the time value of money during the period.
A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the three months ended March 31, 2020 and March 31, 2019 is as follows (in thousands):
Three Months Ended March 31, 2020
Contingent Consideration Liability Related to Acquisition of Arkis (See Note 2)
 
Contingent Consideration
 Liability Related to Acquisition of Derma Sciences
Location in Financial Statements
 
Long-term
 
Long-term
 
Balance as of January 1, 2020
$
14,210

 
$
230

 
Payments
—

 
—

 
Loss from change in fair value of contingent consideration liabilities
(1,051
)
 
—

Research and development
Balance as of March 31, 2020
$
13,159

 
$
230

 

Three Months Ended March 31, 2019
 
Contingent Consideration
 Liability Related to Acquisition of Derma Sciences
Location in Financial Statements
 
 
Long-term
 
Balance as of January 1, 2019
 
$
230

 
Payments
 
—

 
Loss from change in fair value of contingent consideration liabilities
 
—

Research and development
Balance as of March 31, 2019
 
$
230

 

Derma Sciences
The Company assumed contingent consideration incurred by Derma Sciences, Inc. ("Derma Sciences") related to its acquisitions of BioD and the intellectual property related to Medihoney products. The Company accounted for the contingent liabilities by recording their fair value on the date of the acquisition based on a probability weighted income approach. The Company has already paid $33.3 million related to the aforementioned contingent liabilities. One contingent liability remains which relates to net sales of Medihoney products exceeding certain amounts defined in the agreement between the Company and Derma Sciences. The potential maximum undiscounted payment amounts to $3.0 million. The estimated fair value as of March 31, 2020 and March 31, 2019 was $0.2 million.
XML 34 R26.htm IDEA: XBRL DOCUMENT v3.20.1
INVENTORIES (Tables)
 3 Months Ended
Mar. 31, 2020
Inventory, Net [Abstract]  
Schedule of Inventories, Net
Inventories, net consisted of the following:
 
March 31, 2020
 
December 31, 2019
 
(In thousands)
Finished goods
$
217,078

 
$
201,870

Work in process
53,624

 
48,333

Raw materials
67,380

 
65,851

Total inventories
$
338,082

 
$
316,054
XML 35 R68.htm IDEA: XBRL DOCUMENT v3.20.1
COMPREHENSIVE INCOME (LOSS) - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Accumulated Other Comprehensive Income (Loss) [Roll Forward]    
Balance, Beginning of Period $ 1,416,736 $ 1,375,796
Other comprehensive loss (27,458)  
Less: Amounts reclassified from accumulated other comprehensive loss 729  
Net current-period other comprehensive loss (28,187) (11,236)
Balance, End of Period 1,341,803 1,397,030
Gains and Losses on Derivatives    
Accumulated Other Comprehensive Income (Loss) [Roll Forward]    
Balance, Beginning of Period (26,625)  
Other comprehensive loss (20,577)  
Less: Amounts reclassified from accumulated other comprehensive loss 729  
Net current-period other comprehensive loss (21,306)  
Balance, End of Period (47,931)  
Defined Benefit Pension Items    
Accumulated Other Comprehensive Income (Loss) [Roll Forward]    
Balance, Beginning of Period (9,709)  
Other comprehensive loss (68)  
Less: Amounts reclassified from accumulated other comprehensive loss 0  
Net current-period other comprehensive loss (68)  
Balance, End of Period (9,777)  
Foreign Currency Items    
Accumulated Other Comprehensive Income (Loss) [Roll Forward]    
Balance, Beginning of Period (40,067)  
Other comprehensive loss (6,813)  
Less: Amounts reclassified from accumulated other comprehensive loss 0  
Net current-period other comprehensive loss (6,813)  
Balance, End of Period (46,880)  
Total    
Accumulated Other Comprehensive Income (Loss) [Roll Forward]    
Balance, Beginning of Period (76,401) (45,443)
Net current-period other comprehensive loss (28,187) (11,236)
Balance, End of Period $ (104,588) $ (56,679)
XML 36 R60.htm IDEA: XBRL DOCUMENT v3.20.1
LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2020
USD ($)
Cash paid for amounts included in the measurement of lease liabilities:  
Operating cash flows from operating leases $ 3,229
ROU assets obtained in exchange for lease liabilities:  
Operating leases $ 5,808
XML 37 R64.htm IDEA: XBRL DOCUMENT v3.20.1
INCOME TAXES - Narrative (Details)
$ / shares in Units, SFr in Millions, $ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2020
USD ($)
Mar. 31, 2019
USD ($)
$ / shares
Dec. 31, 2019
CHF (SFr)
Income Tax Contingency [Line Items]      
Effective income tax rate 19.80% (32.00%)  
Valuation Allowance, foreign deferred tax assets $ 3.3    
Tax benefit related to equity compensation   $ 0.7  
Foreign Tax Authority | Swiss Federal Tax Administration (FTA)      
Income Tax Contingency [Line Items]      
Effective income tax rate reconciliation, tax benefit, federal tax holiday   $ 10.8  
Effective income tax rate reconciliation, tax benefit, federal tax holiday (in dollars per share) | $ / shares   $ 0.13  
Federal tax credit | SFr     SFr 12.0
XML 38 R9.htm IDEA: XBRL DOCUMENT v3.20.1
REVENUES FROM CONTRACTS WITH CUSTOMERS
 3 Months Ended
Mar. 31, 2020
Revenue from Contract with Customer [Abstract]  
REVENUES FROM CONTRACTS WITH CUSTOMERS REVENUES FROM CONTRACTS WITH CUSTOMERS
Summary of Accounting Policies on Revenue Recognition
Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services.
Total revenue, net, includes product sales, product royalties and other revenues, such as fees received for services.
For products shipped with FOB shipping point terms, the control of the product passes to the customer at the time of shipment. For shipments in which the control of the product is transferred when the customer receives the product, the Company recognizes revenue upon receipt by the customer. Certain products that the Company produces for private label customers have no alternative use and the Company has a right of payment for performance to date. Revenues from those products are recognized over the period that the Company manufactures these products, which is typically one to three months. The Company uses the input method to
measure the manufacturing activities completed to date, which depicts the progress of the Company's performance obligation of transferring control of goods being manufactured for private label customers.
A portion of the Company's product revenue is generated from consigned inventory maintained at hospitals and distributors, and also from inventory physically held by field sales representatives. For these types of product sales, the Company retains control until the product has been used or implanted, at which time revenue is recognized.   
Revenues from sale of products and services are evidenced by either a contract with the customer or a valid purchase order and an invoice which includes all relevant terms of sale. For product sales, invoices are generally issued upon the transfer of control (or upon the completion of the manufacturing in the case of the private label transactions recognized over time) and are typically payable thirty days after the invoice date. The Company performs a review of each specific customer's creditworthiness and ability to pay prior to acceptance as a customer. Further, the Company performs periodic reviews of its customers' creditworthiness prospectively.
Performance Obligations
The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.
Significant Judgments
Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant.
The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract.
The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally ninety days.
The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.
Contract Asset and Liability
Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheet.
Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.
The following table summarizes the changes in the contract asset and liability balances for the three months ended March 31, 2020:
Contract Asset
 
Contract asset, January 1, 2020
$
8,680

Transferred to trade receivable of contract asset included
     in beginning of the year contract asset
(8,680
)
Contract asset, net of transferred to trade receivables on contracts during the period
7,944

Contract asset, March 31, 2020
$
7,944

 
 
Contract Liability
 
Contract liability, January 1, 2020
$
11,946

Recognition of revenue included in beginning of year contract liability
(1,291
)
Contract liability, net of revenue recognized on contracts during the period
1,691

Foreign currency translation
(147
)
Contract liability, March 31, 2020
$
12,199


At March 31, 2020, the short-term portion of the contract liability of $4.9 million and the long-term portion of $7.3 million were included in accrued expenses and other current liabilities and other liabilities in the consolidated balance sheet.
As of March 31, 2020, the Company is expected to recognize approximately 40% of unsatisfied (or partially unsatisfied) performance obligations as revenue through 2020, with the remaining balance to be recognized in 2021 and thereafter.
Shipping and Handling Fees
The Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.
Product Warranties
Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.
Taxes Collected from Customers
The Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer.
Disaggregated Revenue
The following table presents revenues disaggregated by the major sources of revenues for the three months ended March 31, 2020 and 2019 (amounts in thousands):
 
Three Months Ended March 31, 2020
Three Months Ended March 31, 2019
 
(amounts in thousands)
Neurosurgery
$
184,943

$
179,520

Instruments
46,497

55,048

Total Codman Specialty Surgical
231,440

234,568

 
 
 
Wound Reconstruction and Care
72,267

74,963

Extremity Orthopedics
21,472

22,685

Private Label
29,145

27,474

Total Orthopedics and Tissue Technologies
122,884

125,122

Total revenue
$
354,324

$
359,690


Prior period amounts were reclassified between categories within the Codman Specialty Surgical segment to conform to the current period presentation.
See Note 15, Segment and Geographical Information, for details of revenues based on the location of the customer.
XML 39 R47.htm IDEA: XBRL DOCUMENT v3.20.1
DEBT - Narrative (Details)
 3 Months Ended
Feb. 04, 2020
USD ($)
$ / shares
Mar. 31, 2020
USD ($)
Mar. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Feb. 03, 2020
USD ($)
Dec. 31, 2019
USD ($)
Debt Instrument [Line Items]            
Carrying amount, liability component   $ 460,159,000       $ 0
Cost of call transactions   104,248,000 $ 0      
Proceeds from warrant transactions   44,562,000 $ 0      
Securitization program outstanding borrowings, maximum limit       $ 150,000,000.0    
Securitization program, term       3 years    
Long-term borrowings under securitization facility   $ 98,500,000       $ 104,500,000
Weighted average interest rate, accounts receivable securitization revolving loan facility   2.60%       2.80%
Fair Value, Inputs, Level 2            
Debt Instrument [Line Items]            
Securitization facility, outstanding borrowings, fair value   $ 94,500,000        
Senior Credit Facility            
Debt Instrument [Line Items]            
Maximum borrowing capacity         $ 2,200,000,000  
Incremental financing costs capitalized         4,600,000  
Previously capitalized financing costs, written-off   $ 1,200,000        
Senior Credit Facility | Minimum            
Debt Instrument [Line Items]            
Line of credit, commitment fee percentage   0.15%        
Senior Credit Facility | Maximum            
Debt Instrument [Line Items]            
Line of credit, commitment fee percentage   0.30%        
2025 Notes | Convertible Debt            
Debt Instrument [Line Items]            
Incremental financing costs capitalized $ 13,200,000          
Convertible notes, maximum borrowing capacity $ 575,000,000.0 $ 575,000,000.0        
Convertible notes, interest rate 0.50%          
Debt proceeds, classified as equity at time of offering $ 104,500,000          
Effective interest rate 4.20%          
Carrying amount, liability component   473,000,000.0        
Unamortized discount   102,000,000.0        
Fair value   507,700,000        
Initial conversion rate 13.5739          
Initial conversion price (in dollars per share) | $ / shares $ 73.67          
Maximum selling price of the company's common stock of the conversion price 130.00%          
Maximum average conversion value of notes 98.00%          
Redemption price, percentage 100.00%          
Warrant strike price (in dollars per share) | $ / shares $ 113.34          
Cash interest   400,000        
Amortization of discount   2,500,000        
Interest expense   2,900,000        
2025 Notes | Convertible Debt | Call Option            
Debt Instrument [Line Items]            
Cost of call transactions   104,200,000        
Proceeds from warrant transactions   $ 44,500,000        
Initial strike price (in dollars per share) | $ / shares $ 73.67          
Eurodollar | Senior Credit Facility | Minimum            
Debt Instrument [Line Items]            
Interest rates available   1.00%        
Eurodollar | Senior Credit Facility | Maximum            
Debt Instrument [Line Items]            
Interest rates available   1.75%        
Overnight Federal Funds | Senior Credit Facility            
Debt Instrument [Line Items]            
Interest rates available   0.50%        
One Month Eurodollar Rate | Senior Credit Facility            
Debt Instrument [Line Items]            
Interest rates available   1.00%        
Secured Debt | Term Loan A            
Debt Instrument [Line Items]            
Line of credit facility outstanding   $ 877,500,000       $ 877,500,000
Weighted average interest rate on debt   2.40%       3.20%
Secured Debt | Term Loan A | Secured Debt, Current            
Debt Instrument [Line Items]            
Line of credit facility outstanding   $ 0        
Secured Debt | Term Loan Facility            
Debt Instrument [Line Items]            
Maximum borrowing capacity         877,500,000  
Secured Debt | Term Loan Facility | Fair Value, Inputs, Level 2            
Debt Instrument [Line Items]            
Line of credit facility, fair value of amount outstanding   771,300,000        
Revolving Credit Facility            
Debt Instrument [Line Items]            
Maximum borrowing capacity         1,300,000,000  
Line of credit facility outstanding   $ 150,000,000.0       $ 375,000,000.0
Weighted average interest rate on debt   2.50%       3.20%
Revolving Credit Facility | Fair Value, Inputs, Level 2            
Debt Instrument [Line Items]            
Line of credit facility, fair value of amount outstanding   $ 130,400,000        
Standby Letters of Credit            
Debt Instrument [Line Items]            
Maximum borrowing capacity         60,000,000  
Standby Letters of Credit | Senior Credit Facility            
Debt Instrument [Line Items]            
Line of credit facility outstanding   0        
Letters of credit outstanding   $ 800,000       $ 800,000
Swingline Loans            
Debt Instrument [Line Items]            
Maximum borrowing capacity         $ 60,000,000  
XML 40 R5.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
OPERATING ACTIVITIES:    
Net income $ 9,180 $ 32,756
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 29,151 27,093
Deferred income tax benefit/provision 5,068 (6,843)
Share-based compensation 3,750 4,083
Amortization of debt issuance costs and expenses associated with debt refinancing 4,246 1,357
Accretion of bond issuance discount 2,529 0
Loss on disposal of property and equipment 374 367
Change in fair value of contingent consideration and others (1,051) 194
Changes in assets and liabilities:    
Accounts receivable 28,301 (13,705)
Inventories (26,236) (12,048)
Prepaid expenses and other current assets 4,683 (12,949)
Other non-current assets 3,000 (628)
Accounts payable, accrued expenses and other current liabilities (40,235) 5,387
Contract liabilities 338 (188)
Other non-current liabilities (2,284) 4,608
Net cash provided by operating activities 20,814 29,484
INVESTING ACTIVITIES:    
Purchases of property and equipment (16,519) (16,086)
Acquired in-process research and development (5,000) 0
Proceeds from note receivable 0 245
Proceeds from sale of property and equipment 34 35
Net cash used in investing activities (21,485) (15,806)
FINANCING ACTIVITIES:    
Proceeds from borrowings of long-term indebtedness 113,200 67,200
Payments on debt (344,200) (57,400)
Purchase of option hedge on convertible notes (104,248) 0
Proceeds from convertible notes issuance 575,000 0
Proceeds from sale of stock purchase warrants 44,562 0
Payment of debt issuance costs (20,264) 0
Purchases of treasury stock (100,000) 0
Proceeds from exercised stock options 2,303 1,750
Cash taxes paid in net equity settlement (4,348) (6,157)
Net cash provided by financing activities 162,005 5,393
Effect of exchange rate changes on cash and cash equivalents (2,533) (884)
Net increase in cash and cash equivalents 158,801 18,187
Cash and cash equivalents at beginning of period 198,911 138,838
Cash and cash equivalents at end of period $ 357,712 $ 157,025
XML 41 R43.htm IDEA: XBRL DOCUMENT v3.20.1
INVENTORIES - Schedule of Net Inventories (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Inventory, Net [Abstract]    
Finished goods $ 217,078 $ 201,870
Work in process 53,624 48,333
Raw materials 67,380 65,851
Inventories, net $ 338,082 $ 316,054
XML 42 R1.htm IDEA: XBRL DOCUMENT v3.20.1
DOCUMENT AND ENTITY INFORMATION - shares
 3 Months Ended
Mar. 31, 2020
May 05, 2020
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2020  
Document Transition Report false  
Entity File Number 0-26224  
Entity Registrant Name INTEGRA LIFESCIENCES HOLDINGS CORP  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 51-0317849  
Entity Address 1100 Campus Road  
Entity City Princeton  
Entity State NJ  
Entity Postal Zip Code 08540  
City Area Code 609  
Local Phone Number 275-0500  
Title of 12(b) Security Common Stock, Par Value $.01 Per Share  
Trading Symbol IART  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Smaller Reporting Company false  
Emerging Growth Company false  
Entity Shell Company false  
Entity Bankruptcy Proceedings, Reporting Current false  
Entity Common Stock, Shares Outstanding (in shares)   84,843,053
Amendment Flag false  
Document Fiscal Year Focus 2020  
Document Fiscal Period Focus Q1  
Entity Central Index Key 0000917520  
Current Fiscal Year End Date --12-31  
XML 43 R71.htm IDEA: XBRL DOCUMENT v3.20.1
SEGMENT AND GEOGRAPHIC INFORMATION - Net Sales and Profit by Reportable Segment (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Segment Net Sales    
Total Revenues $ 354,324 $ 359,690
Segment Profit    
Operating income 27,103 32,308
Amortization (6,977) (5,279)
Operating Segments    
Segment Profit    
Operating income 118,506 131,875
Corporate and other    
Segment Profit    
Operating income (84,426) (94,288)
Codman Specialty Surgical    
Segment Net Sales    
Total Revenues 231,440 234,568
Codman Specialty Surgical | Operating Segments    
Segment Profit    
Operating income 87,235 91,380
Orthopedics and Tissue Technologies    
Segment Net Sales    
Total Revenues 122,884 125,122
Orthopedics and Tissue Technologies | Operating Segments    
Segment Profit    
Operating income $ 31,271 $ 40,495
XML 44 R52.htm IDEA: XBRL DOCUMENT v3.20.1
DERIVATIVE INSTRUMENTS - Schedule of Cross Currency Swap Derivatives (Details)
Mar. 31, 2020
CHF (SFr)
Mar. 31, 2020
USD ($)
Dec. 31, 2019
CHF (SFr)
Dec. 31, 2019
USD ($)
Oct. 02, 2017
CHF (SFr)
Oct. 02, 2017
USD ($)
Codman | Cross-currency swap | Long            
Derivative [Line Items]            
Aggregate Notional Amount | SFr         SFr 291,200,000  
Codman | Cross-currency swap | Short            
Derivative [Line Items]            
Aggregate Notional Amount           $ 300,000,000.0
Cash Flow Hedges | Designated as Hedging Instrument            
Derivative [Line Items]            
Aggregate Notional Amount   $ 1,325,000,000   $ 1,325,000,000    
Fair Value Asset (Liability)   (95,752,000)   (45,145,000)    
Cash Flow Hedges | Designated as Hedging Instrument | Codman | Cross-currency swap            
Derivative [Line Items]            
Fair Value Asset (Liability)   3,874,000   (509,000)    
Cash Flow Hedges | Swap One | Designated as Hedging Instrument | Codman | Cross-currency swap            
Derivative [Line Items]            
Fair Value Asset (Liability)   $ (74,000)   $ (101,000)    
Cash Flow Hedges | Swap One | Designated as Hedging Instrument | Codman | Cross-currency swap | Long            
Derivative [Line Items]            
Fixed Rate 1.75% 1.75% 1.75% 1.75%    
Aggregate Notional Amount | SFr SFr 32,355,000   SFr 32,355,000      
Cash Flow Hedges | Swap One | Designated as Hedging Instrument | Codman | Cross-currency swap | Short            
Derivative [Line Items]            
Fixed Rate 4.38% 4.38% 4.38% 4.38%    
Aggregate Notional Amount   $ 33,333,000   $ 33,333,000    
Cash Flow Hedges | Swap Two | Designated as Hedging Instrument | Codman | Cross-currency swap            
Derivative [Line Items]            
Fair Value Asset (Liability)   $ 531,000   $ (119,000)    
Cash Flow Hedges | Swap Two | Designated as Hedging Instrument | Codman | Cross-currency swap | Long            
Derivative [Line Items]            
Fixed Rate 1.85% 1.85% 1.85% 1.85%    
Aggregate Notional Amount | SFr SFr 48,533,000   SFr 48,533,000      
Cash Flow Hedges | Swap Two | Designated as Hedging Instrument | Codman | Cross-currency swap | Short            
Derivative [Line Items]            
Fixed Rate 4.46% 4.46% 4.46% 4.46%    
Aggregate Notional Amount   $ 50,000,000   $ 50,000,000    
Cash Flow Hedges | Swap Three | Designated as Hedging Instrument | Codman | Cross-currency swap            
Derivative [Line Items]            
Fair Value Asset (Liability)   $ 3,416,000   $ (289,000)    
Cash Flow Hedges | Swap Three | Designated as Hedging Instrument | Codman | Cross-currency swap | Long            
Derivative [Line Items]            
Fixed Rate 1.95% 1.95% 1.95% 1.95%    
Aggregate Notional Amount | SFr SFr 145,597,000   SFr 145,598,000      
Cash Flow Hedges | Swap Three | Designated as Hedging Instrument | Codman | Cross-currency swap | Short            
Derivative [Line Items]            
Fixed Rate 4.52% 4.52% 4.52% 4.52%    
Aggregate Notional Amount   $ 150,000,000   $ 150,000,000    
XML 45 R56.htm IDEA: XBRL DOCUMENT v3.20.1
STOCK-BASED COMPENSATION - Narrative (Details)
$ / shares in Units, $ in Millions
 3 Months Ended
Mar. 31, 2020
USD ($)
plan
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Share-based compensation arrangement by share-based payment award, number of plans | plan 2
Grants in period, net of forfeitures (in shares) | shares 348,587
Options, weighted average grant date fair value (in dollars per share) | $ / shares $ 13.03
Stock options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Total unrecognized compensation costs | $ $ 8.2
Weighted-average period for cost recognition 3 years
Stock options | Directors  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock options exercisable, vesting period 1 year
Stock options | Employees  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Expiration period 8 years
Restricted stock awards/stock units  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock options exercisable, vesting period 3 years
Total unrecognized compensation costs | $ $ 37.3
Weighted-average period for cost recognition 2 years
Awards granted during the period (in shares) | shares 262,623
Other than options, weighted average grant date fair value (in dollars per share) | $ / shares $ 43.89
Performance stock and Restricted stock awards  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Requisite service periods of awards 3 years
Performance shares  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Awards granted during the period (in shares) | shares 180,875
Other than options, weighted average grant date fair value (in dollars per share) | $ / shares $ 43.39
Minimum | Stock options | Directors and Certain Executive Officers  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Expiration period 6 years
Maximum | Stock options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock options exercisable, vesting period 4 years
Maximum | Stock options | Directors and Certain Executive Officers  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Expiration period 10 years
XML 46 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 341 407 1 false 123 0 false 13 false false R1.htm 0001000 - Document - DOCUMENT AND ENTITY INFORMATION Sheet http://integralife.com/role/DocumentAndEntityInformation DOCUMENT AND ENTITY INFORMATION Cover 1 false false R2.htm 1001000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME / (LOSS) Sheet http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME / (LOSS) Statements 2 false false R3.htm 1002000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://integralife.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 3 false false R4.htm 1002501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://integralife.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 4 false false R5.htm 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 5 false false R6.htm 1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDER'S EQUITY Sheet http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDER'S EQUITY Statements 6 false false R7.htm 2101100 - Disclosure - BASIS OF PRESENTATION Sheet http://integralife.com/role/BasisOfPresentation BASIS OF PRESENTATION Notes 7 false false R8.htm 2105100 - Disclosure - BUSINESS DEVELOPMENT Sheet http://integralife.com/role/BusinessDevelopment BUSINESS DEVELOPMENT Notes 8 false false R9.htm 2111100 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS Sheet http://integralife.com/role/RevenuesFromContractsWithCustomers REVENUES FROM CONTRACTS WITH CUSTOMERS Notes 9 false false R10.htm 2113100 - Disclosure - INVENTORIES Sheet http://integralife.com/role/Inventories INVENTORIES Notes 10 false false R11.htm 2114100 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Sheet http://integralife.com/role/GoodwillAndOtherIntangibleAssets GOODWILL AND OTHER INTANGIBLE ASSETS Notes 11 false false R12.htm 2118100 - Disclosure - DEBT Sheet http://integralife.com/role/Debt DEBT Notes 12 false false R13.htm 2121100 - Disclosure - DERIVATIVE INSTRUMENTS Sheet http://integralife.com/role/DerivativeInstruments DERIVATIVE INSTRUMENTS Notes 13 false false R14.htm 2123100 - Disclosure - STOCK-BASED COMPENSATION Sheet http://integralife.com/role/StockBasedCompensation STOCK-BASED COMPENSATION Notes 14 false false R15.htm 2124100 - Disclosure - RETIREMENT PLANS Sheet http://integralife.com/role/RetirementPlans RETIREMENT PLANS Notes 15 false false R16.htm 2125100 - Disclosure - LEASES AND RELATED PARTY LEASES Sheet http://integralife.com/role/LeasesAndRelatedPartyLeases LEASES AND RELATED PARTY LEASES Notes 16 false false R17.htm 2126100 - Disclosure - TREASURY STOCK Sheet http://integralife.com/role/TreasuryStock TREASURY STOCK Notes 17 false false R18.htm 2127100 - Disclosure - INCOME TAXES Sheet http://integralife.com/role/IncomeTaxes INCOME TAXES Notes 18 false false R19.htm 2128100 - Disclosure - NET INCOME PER SHARE Sheet http://integralife.com/role/NetIncomePerShare NET INCOME PER SHARE Notes 19 false false R20.htm 2129100 - Disclosure - COMPREHENSIVE INCOME (LOSS) Sheet http://integralife.com/role/ComprehensiveIncomeLoss COMPREHENSIVE INCOME (LOSS) Notes 20 false false R21.htm 2130100 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION Sheet http://integralife.com/role/SegmentAndGeographicInformation SEGMENT AND GEOGRAPHIC INFORMATION Notes 21 false false R22.htm 2131100 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://integralife.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 22 false false R23.htm 2201201 - Disclosure - BASIS OF PRESENTATION (Policies) Sheet http://integralife.com/role/BasisOfPresentationPolicies BASIS OF PRESENTATION (Policies) Policies 23 false false R24.htm 2305301 - Disclosure - BUSINESS DEVELOPMENT (Tables) Sheet http://integralife.com/role/BusinessDevelopmentTables BUSINESS DEVELOPMENT (Tables) Tables http://integralife.com/role/BusinessDevelopment 24 false false R25.htm 2311301 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables) Sheet http://integralife.com/role/RevenuesFromContractsWithCustomersTables REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables) Tables http://integralife.com/role/RevenuesFromContractsWithCustomers 25 false false R26.htm 2313301 - Disclosure - INVENTORIES (Tables) Sheet http://integralife.com/role/InventoriesTables INVENTORIES (Tables) Tables http://integralife.com/role/Inventories 26 false false R27.htm 2314301 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) Sheet http://integralife.com/role/GoodwillAndOtherIntangibleAssetsTables GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) Tables http://integralife.com/role/GoodwillAndOtherIntangibleAssets 27 false false R28.htm 2318301 - Disclosure - DEBT (Tables) Sheet http://integralife.com/role/DebtTables DEBT (Tables) Tables http://integralife.com/role/Debt 28 false false R29.htm 2321301 - Disclosure - DERIVATIVE INSTRUMENTS (Tables) Sheet http://integralife.com/role/DerivativeInstrumentsTables DERIVATIVE INSTRUMENTS (Tables) Tables http://integralife.com/role/DerivativeInstruments 29 false false R30.htm 2325301 - Disclosure - LEASES AND RELATED PARTY LEASES (Tables) Sheet http://integralife.com/role/LeasesAndRelatedPartyLeasesTables LEASES AND RELATED PARTY LEASES (Tables) Tables http://integralife.com/role/LeasesAndRelatedPartyLeases 30 false false R31.htm 2327301 - Disclosure - INCOME TAXES (Tables) Sheet http://integralife.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://integralife.com/role/IncomeTaxes 31 false false R32.htm 2328301 - Disclosure - NET INCOME PER SHARE (Tables) Sheet http://integralife.com/role/NetIncomePerShareTables NET INCOME PER SHARE (Tables) Tables http://integralife.com/role/NetIncomePerShare 32 false false R33.htm 2329301 - Disclosure - COMPREHENSIVE INCOME (LOSS) (Tables) Sheet http://integralife.com/role/ComprehensiveIncomeLossTables COMPREHENSIVE INCOME (LOSS) (Tables) Tables http://integralife.com/role/ComprehensiveIncomeLoss 33 false false R34.htm 2330301 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Tables) Sheet http://integralife.com/role/SegmentAndGeographicInformationTables SEGMENT AND GEOGRAPHIC INFORMATION (Tables) Tables http://integralife.com/role/SegmentAndGeographicInformation 34 false false R35.htm 2331301 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://integralife.com/role/CommitmentsAndContingenciesTables COMMITMENTS AND CONTINGENCIES (Tables) Tables http://integralife.com/role/CommitmentsAndContingencies 35 false false R36.htm 2405402 - Disclosure - BUSINESS DEVELOPMENT - Business Combination, Narrative (Details) Sheet http://integralife.com/role/BusinessDevelopmentBusinessCombinationNarrativeDetails BUSINESS DEVELOPMENT - Business Combination, Narrative (Details) Details 36 false false R37.htm 2405403 - Disclosure - BUSINESS DEVELOPMENT - Business Combination, Schedule of Purchase Price Allocation (Details) Sheet http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails BUSINESS DEVELOPMENT - Business Combination, Schedule of Purchase Price Allocation (Details) Details 37 false false R38.htm 2405404 - Disclosure - BUSINESS DEVELOPMENT - Asset Acquisition, Narrative (Details) Sheet http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails BUSINESS DEVELOPMENT - Asset Acquisition, Narrative (Details) Details 38 false false R39.htm 2411402 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative (Details) Sheet http://integralife.com/role/RevenuesFromContractsWithCustomersNarrativeDetails REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative (Details) Details 39 false false R40.htm 2411403 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative, Revenue Remaining Performance Obligation (Details) Sheet http://integralife.com/role/RevenuesFromContractsWithCustomersNarrativeRevenueRemainingPerformanceObligationDetails REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative, Revenue Remaining Performance Obligation (Details) Details 40 false false R41.htm 2411404 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Changes in Contract Assets and Liabilities (Details) Sheet http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfChangesInContractAssetsAndLiabilitiesDetails REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Changes in Contract Assets and Liabilities (Details) Details 41 false false R42.htm 2411405 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Revenues Disaggregated by Major Source (Details) Sheet http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfRevenuesDisaggregatedByMajorSourceDetails REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Revenues Disaggregated by Major Source (Details) Details 42 false false R43.htm 2413402 - Disclosure - INVENTORIES - Schedule of Net Inventories (Details) Sheet http://integralife.com/role/InventoriesScheduleOfNetInventoriesDetails INVENTORIES - Schedule of Net Inventories (Details) Details 43 false false R44.htm 2414402 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in Carrying Amount of Goodwill (Details) Sheet http://integralife.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfChangesInCarryingAmountOfGoodwillDetails GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in Carrying Amount of Goodwill (Details) Details 44 false false R45.htm 2414403 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Components of Company's Identifiable Intangible Assets (Details) Sheet http://integralife.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfCompanysIdentifiableIntangibleAssetsDetails GOODWILL AND OTHER INTANGIBLE ASSETS - Components of Company's Identifiable Intangible Assets (Details) Details 45 false false R46.htm 2414404 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) Sheet http://integralife.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) Details 46 false false R47.htm 2418402 - Disclosure - DEBT - Narrative (Details) Sheet http://integralife.com/role/DebtNarrativeDetails DEBT - Narrative (Details) Details 47 false false R48.htm 2418403 - Disclosure - DEBT - Maximum Total Leverage Ratio Table (Details) Sheet http://integralife.com/role/DebtMaximumTotalLeverageRatioTableDetails DEBT - Maximum Total Leverage Ratio Table (Details) Details 48 false false R49.htm 2418404 - Disclosure - DEBT - Contractual Maturity Table (Details) Sheet http://integralife.com/role/DebtContractualMaturityTableDetails DEBT - Contractual Maturity Table (Details) Details 49 false false R50.htm 2421402 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Derivatives (Details) Sheet http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails DERIVATIVE INSTRUMENTS - Schedule of Derivatives (Details) Details 50 false false R51.htm 2421403 - Disclosure - DERIVATIVE INSTRUMENTS - Narrative (Details) Sheet http://integralife.com/role/DerivativeInstrumentsNarrativeDetails DERIVATIVE INSTRUMENTS - Narrative (Details) Details 51 false false R52.htm 2421404 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Cross Currency Swap Derivatives (Details) Sheet http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails DERIVATIVE INSTRUMENTS - Schedule of Cross Currency Swap Derivatives (Details) Details 52 false false R53.htm 2421405 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Net Investment Hedges Derivatives (Details) Sheet http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails DERIVATIVE INSTRUMENTS - Schedule of Net Investment Hedges Derivatives (Details) Details 53 false false R54.htm 2421406 - Disclosure - DERIVATIVE INSTRUMENTS - Fair Value of Derivative Instruments By Balance Sheet Location (Details) Sheet http://integralife.com/role/DerivativeInstrumentsFairValueOfDerivativeInstrumentsByBalanceSheetLocationDetails DERIVATIVE INSTRUMENTS - Fair Value of Derivative Instruments By Balance Sheet Location (Details) Details 54 false false R55.htm 2421407 - Disclosure - DERIVATIVE INSTRUMENTS - Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations (Details) Sheet http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails DERIVATIVE INSTRUMENTS - Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations (Details) Details 55 false false R56.htm 2423401 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details) Sheet http://integralife.com/role/StockBasedCompensationNarrativeDetails STOCK-BASED COMPENSATION - Narrative (Details) Details 56 false false R57.htm 2424401 - Disclosure - RETIREMENT PLANS - Narrative (Details) Sheet http://integralife.com/role/RetirementPlansNarrativeDetails RETIREMENT PLANS - Narrative (Details) Details 57 false false R58.htm 2425402 - Disclosure - LEASES AND RELATED PARTY LEASES - Narrative (Details) Sheet http://integralife.com/role/LeasesAndRelatedPartyLeasesNarrativeDetails LEASES AND RELATED PARTY LEASES - Narrative (Details) Details 58 false false R59.htm 2425403 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details) Sheet http://integralife.com/role/LeasesAndRelatedPartyLeasesSupplementalBalanceSheetInformationDetails LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details) Details 59 false false R60.htm 2425404 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details) Sheet http://integralife.com/role/LeasesAndRelatedPartyLeasesSupplementalCashFlowInformationDetails LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details) Details 60 false false R61.htm 2425405 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases, After Adoption of 842 (Details) Sheet http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases, After Adoption of 842 (Details) Details 61 false false R62.htm 2426401 - Disclosure - TREASURY STOCK - Narrative (Details) Sheet http://integralife.com/role/TreasuryStockNarrativeDetails TREASURY STOCK - Narrative (Details) Details 62 false false R63.htm 2427402 - Disclosure - INCOME TAXES - Summary of Effective Tax Rate (Details) Sheet http://integralife.com/role/IncomeTaxesSummaryOfEffectiveTaxRateDetails INCOME TAXES - Summary of Effective Tax Rate (Details) Details 63 false false R64.htm 2427403 - Disclosure - INCOME TAXES - Narrative (Details) Sheet http://integralife.com/role/IncomeTaxesNarrativeDetails INCOME TAXES - Narrative (Details) Details 64 false false R65.htm 2428402 - Disclosure - NET INCOME PER SHARE - Basic and Diluted Net Income Per Share (Details) Sheet http://integralife.com/role/NetIncomePerShareBasicAndDilutedNetIncomePerShareDetails NET INCOME PER SHARE - Basic and Diluted Net Income Per Share (Details) Details 65 false false R66.htm 2428403 - Disclosure - NET INCOME PER SHARE - Narrative (Details) Sheet http://integralife.com/role/NetIncomePerShareNarrativeDetails NET INCOME PER SHARE - Narrative (Details) Details 66 false false R67.htm 2429402 - Disclosure - COMPREHENSIVE INCOME (LOSS) - Schedule of Comprehensive Income (Details) Sheet http://integralife.com/role/ComprehensiveIncomeLossScheduleOfComprehensiveIncomeDetails COMPREHENSIVE INCOME (LOSS) - Schedule of Comprehensive Income (Details) Details http://integralife.com/role/ComprehensiveIncomeLossTables 67 false false R68.htm 2429403 - Disclosure - COMPREHENSIVE INCOME (LOSS) - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details) Sheet http://integralife.com/role/ComprehensiveIncomeLossScheduleOfChangesInAccumulatedOtherComprehensiveIncomeByComponentDetails COMPREHENSIVE INCOME (LOSS) - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details) Details http://integralife.com/role/ComprehensiveIncomeLossTables 68 false false R69.htm 2429404 - Disclosure - COMPREHENSIVE INCOME (LOSS) - Narrative (Details) Sheet http://integralife.com/role/ComprehensiveIncomeLossNarrativeDetails COMPREHENSIVE INCOME (LOSS) - Narrative (Details) Details http://integralife.com/role/ComprehensiveIncomeLossTables 69 false false R70.htm 2430402 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details) Sheet http://integralife.com/role/SegmentAndGeographicInformationNarrativeDetails SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details) Details 70 false false R71.htm 2430403 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Net Sales and Profit by Reportable Segment (Details) Sheet http://integralife.com/role/SegmentAndGeographicInformationNetSalesAndProfitByReportableSegmentDetails SEGMENT AND GEOGRAPHIC INFORMATION - Net Sales and Profit by Reportable Segment (Details) Details 71 false false R72.htm 2430404 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Total Revenue by Major Geographic Area (Details) Sheet http://integralife.com/role/SegmentAndGeographicInformationTotalRevenueByMajorGeographicAreaDetails SEGMENT AND GEOGRAPHIC INFORMATION - Total Revenue by Major Geographic Area (Details) Details 72 false false R73.htm 2431402 - Disclosure - COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details) Sheet http://integralife.com/role/CommitmentsAndContingenciesFairValueContingentConsiderationBalanceInformationDetails COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details) Details 73 false false R74.htm 2431403 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details) Sheet http://integralife.com/role/CommitmentsAndContingenciesNarrativeDetails COMMITMENTS AND CONTINGENCIES - Narrative (Details) Details 74 false false R9999.htm Uncategorized Items - iart-2020033110xq.htm Sheet http://xbrl.sec.gov/role/uncategorizedFacts Uncategorized Items - iart-2020033110xq.htm Cover 75 false false All Reports Book All Reports iart-2020033110xq.htm iart-20200331.xsd iart-20200331_cal.xml iart-20200331_def.xml iart-20200331_lab.xml iart-20200331_pre.xml iart-20200331xexx311.htm iart-20200331xexx312.htm iart-20200331xexx321.htm iart-20200331xexx322.htm chart.jpg http://xbrl.sec.gov/country/2017-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2019-01-31 http://fasb.org/us-gaap/2019-01-31 true true XML 47 R37.htm IDEA: XBRL DOCUMENT v3.20.1
BUSINESS DEVELOPMENT - Business Combination, Schedule of Purchase Price Allocation (Details) - USD ($)
$ in Thousands
Jul. 29, 2019
Mar. 31, 2020
Dec. 31, 2019
Intangible assets:      
Goodwill   $ 951,554 $ 954,280
Arkis      
Business Acquisition [Line Items]      
Cash $ 90    
Other current assets 751    
Property, plant and equipment 159    
Deferred tax assets 1,535    
Intangible assets:      
Goodwill 27,600    
Total assets acquired 52,215    
Accounts payable, accrued expenses and other liabilities 2,926    
Contingent consideration 13,100   $ 13,200
Deferred tax liabilities 5,305    
Net assets acquired 30,884    
Arkis | CerebroFlo developed technology      
Intangible assets:      
Intangible assets $ 20,100    
Weighted Average Life 15 years    
Arkis | Enabling technology license      
Intangible assets:      
Intangible assets $ 1,980    
Weighted Average Life 14 years    
XML 48 R33.htm IDEA: XBRL DOCUMENT v3.20.1
COMPREHENSIVE INCOME (LOSS) (Tables)
 3 Months Ended
Mar. 31, 2020
Equity [Abstract]  
Schedule of Comprehensive Income (Loss)

Comprehensive income (loss) was as follows:
 
Three Months Ended March 31,
 
2020
 
2019
 
(In thousands)
Net income
$
9,180

 
$
32,756

Foreign currency translation adjustment
(6,813
)
 
(7,009
)
Change in unrealized loss on derivatives, net of tax
(21,306
)
 
(4,236
)
Pension liability adjustment, net of tax
(68
)
 
9

Comprehensive income (loss), net
$
(19,007
)
 
$
21,520
Schedule of Changes in Accumulated Other Comprehensive Loss by Component
Changes in accumulated other comprehensive loss by component between December 31, 2019 and March 31, 2020 are presented in the table below, net of tax:
 
 
Gains and Losses on Derivatives
 
Defined Benefit Pension Items
 
Foreign Currency Items
 
Total
 
 
(In thousands)
Balance at January 1, 2020
 
$
(26,625
)
 
$
(9,709
)
 
$
(40,067
)
 
$
(76,401
)
Other comprehensive loss
 
(20,577
)
 
(68
)
 
(6,813
)
 
(27,458
)
Less: Amounts reclassified from accumulated other comprehensive loss
 
729

 
—

 
—

 
729

Net current-period other comprehensive loss
 
(21,306
)
 
(68
)
 
(6,813
)
 
(28,187
)
Balance at March 31, 2020
 
$
(47,931
)
 
$
(9,777
)
 
$
(46,880
)
 
$
(104,588
)
XML 49 R18.htm IDEA: XBRL DOCUMENT v3.20.1
INCOME TAXES
 3 Months Ended
Mar. 31, 2020
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXES
The following table provides a summary of the Company's effective tax rate:
 
Three Months Ended March 31,
 
2020
 
2019
Reported tax rate
19.8
%
 
(32.0
)%


The Company’s effective income tax rates for the three months ended March 31, 2020 and 2019 were 19.8% and (32.0)%, respectively. For the three months ended March 31, 2020, the primary drivers of the higher tax rate were lower book income in lower-taxed jurisdictions and a $3.3 million valuation allowance on certain foreign deferred tax assets as the Company determined that it is no longer more likely than not that these foreign deferred tax assets would be realized due to the adverse impact of the COVID-19 pandemic in certain jurisdictions. For the three months ended March 31, 2019, the primary drivers of the lower rate were a $0.7 million higher tax benefit related to equity compensation and a tax benefit of $10.8 million ($0.13 per share) related to a federal tax holiday in Switzerland, which was finalized during the quarter ended March 31, 2019. The Company received a Switzerland federal tax credit of $12.0 million CHF, which can be used over a seven-year period, ending in 2024.
As of March 31, 2020, the Company has not provided deferred income taxes on unrepatriated earnings from foreign subsidiaries as they are deemed indefinitely reinvested. Such taxes would primarily be attributable to foreign withholding taxes and local income taxes when such earnings are distributed. As such, the Company has determined the tax impact of repatriating these earnings would not be material as of March 31, 2020. The company does not anticipate the need to repatriate earnings from foreign subsidiaries as a result of the impact of the COVID-19 pandemic.
On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was signed into law. The CARES Act includes certain income tax provisions for corporations and individuals, among other provisions. The Company does not expect the CARES Act to have a significant impact on the tax provision for income.
XML 50 R10.htm IDEA: XBRL DOCUMENT v3.20.1
INVENTORIES
 3 Months Ended
Mar. 31, 2020
Inventory, Net [Abstract]  
INVENTORIES INVENTORIES
Inventories, net consisted of the following:
 
March 31, 2020
 
December 31, 2019
 
(In thousands)
Finished goods
$
217,078

 
$
201,870

Work in process
53,624

 
48,333

Raw materials
67,380

 
65,851

Total inventories
$
338,082

 
$
316,054
XML 51 R14.htm IDEA: XBRL DOCUMENT v3.20.1
STOCK-BASED COMPENSATION
 3 Months Ended
Mar. 31, 2020
Share-based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION STOCK-BASED COMPENSATION
As of March 31, 2020, the Company had stock options, restricted stock awards, performance stock units, contract stock awards and restricted stock unit awards outstanding under two plans, the 2001 Equity Incentive Plan (the “2001 Plan”) and the 2003 Equity Incentive Plan (the “2003 Plan,” and collectively, the “Plans”).
Stock options issued under the Plans become exercisable over specified periods, generally within four years from the date of grant for officers and employees, and within one year from date of grant for directors and generally expire eight years from the grant date for employees, and from six to ten years for directors and certain executive officers. The Company values stock option grants using the binomial distribution model. Restricted stock issued under the Plans vests over specified periods, generally three years after the date of grant. The vesting of performance stock issued under the Plans is subject to service and performance conditions.
Stock Options
As of March 31, 2020, there were approximately $8.2 million of total unrecognized compensation costs related to unvested stock options. These costs are expected to be recognized over a weighted-average period of approximately three years. There were 348,587 stock options granted during the three months ended March 31, 2020. For the three months ended March 31, 2020, the weighted average grant date fair value for stock options was $13.03 per option.
Awards of Restricted Stock and Performance Stock
Performance stock and restricted stock awards generally have requisite service periods of three years. Performance stock units are subject to graded vesting conditions based on revenue goals of the Company. The Company expenses the fair value of restricted stock awards on a straight-line basis over the requisite service period. As of March 31, 2020, there was approximately $37.3 million of total unrecognized compensation costs related to these unvested awards. The Company expects to recognize these costs over a weighted-average period of approximately two years. The Company granted 262,623 restricted stock awards and 180,875 performance stock awards during the three months ended March 31, 2020. For the three months ended March 31, 2020, the weighted average grant date fair value for restricted stock awards and performance stock units was $43.89 and $43.39 per award, respectively.
The Company has no formal policy related to the repurchase of stock for the purpose of satisfying stock-based compensation obligations.
The Company also maintains an Employee Stock Purchase Plan (the “ESPP”), which provides eligible employees with the opportunity to acquire shares of common stock at periodic intervals by means of accumulated payroll deductions. The ESPP is a non-compensatory plan based on its terms.
XML 52 R20.htm IDEA: XBRL DOCUMENT v3.20.1
COMPREHENSIVE INCOME (LOSS)
 3 Months Ended
Mar. 31, 2020
Equity [Abstract]  
COMPREHENSIVE INCOME (LOSS) COMPREHENSIVE INCOME (LOSS)

Comprehensive income (loss) was as follows:
 
Three Months Ended March 31,
 
2020
 
2019
 
(In thousands)
Net income
$
9,180

 
$
32,756

Foreign currency translation adjustment
(6,813
)
 
(7,009
)
Change in unrealized loss on derivatives, net of tax
(21,306
)
 
(4,236
)
Pension liability adjustment, net of tax
(68
)
 
9

Comprehensive income (loss), net
$
(19,007
)
 
$
21,520


Changes in accumulated other comprehensive loss by component between December 31, 2019 and March 31, 2020 are presented in the table below, net of tax:
 
 
Gains and Losses on Derivatives
 
Defined Benefit Pension Items
 
Foreign Currency Items
 
Total
 
 
(In thousands)
Balance at January 1, 2020
 
$
(26,625
)
 
$
(9,709
)
 
$
(40,067
)
 
$
(76,401
)
Other comprehensive loss
 
(20,577
)
 
(68
)
 
(6,813
)
 
(27,458
)
Less: Amounts reclassified from accumulated other comprehensive loss
 
729

 
—

 
—

 
729

Net current-period other comprehensive loss
 
(21,306
)
 
(68
)
 
(6,813
)
 
(28,187
)
Balance at March 31, 2020
 
$
(47,931
)
 
$
(9,777
)
 
$
(46,880
)
 
$
(104,588
)

For the three months ended March 31, 2020, the Company reclassified a loss of $0.1 million from accumulated other comprehensive loss to other income (expense), net and $0.9 million from interest income.
XML 53 R24.htm IDEA: XBRL DOCUMENT v3.20.1
BUSINESS DEVELOPMENT (Tables)
 3 Months Ended
Mar. 31, 2020
Business Combinations [Abstract]  
Schedule of Assets Acquired and Liabilities Assumed
The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date:
 
Preliminary Valuation as of March 31, 2020
 
Weighted Average Life
 
(Dollars in thousands)
 
 
Cash
$
90

 
 
Other current assets
751

 
 
Property, plant and equipment
159

 
 
Deferred tax assets
1,535

 
 
Intangible assets:
 
 
 
CerebroFlo developed technology
20,100

 
15 years
Enabling technology license
1,980

 
14 years
Goodwill
27,600

 
 
Total assets acquired
52,215

 
 
 
 
 
 
Accounts payable, accrued expenses and other liabilities
2,926

 
 
Contingent consideration
13,100

 
 
Deferred tax liabilities
5,305

 
 
     Net assets acquired
$
30,884

 
 
XML 54 R28.htm IDEA: XBRL DOCUMENT v3.20.1
DEBT (Tables)
 3 Months Ended
Mar. 31, 2020
Debt Disclosure [Abstract]  
Schedule of Long-term Debt Maximum Leverage Ratios
In connection with the February 2020 Amendment, the Company’s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:
Fiscal Quarter
 
Maximum Consolidated Total Leverage Ratio
 
 
 
First fiscal quarter ending after the Closing Date through June 30, 2022
 
5.00 to 1.00
September 30, 2022 through June 30, 2023
 
4.50 to 1.00
September 30, 2023 and the last day of each fiscal quarter thereafter
 
4.00 to 1.00
Schedule of Maturities of Long-term Debt
Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:
Quarter Ended March 31, 2020
 
Principal Repayment
 
 
(In thousands)
Remainder of 2020
 
$
—

2021
 
33,750

2022
 
45,000

2023
 
61,875

2024
 
67,500

2025
 
669,375

 
 
$
877,500
XML 55 R49.htm IDEA: XBRL DOCUMENT v3.20.1
DEBT - Contractual Maturity Table (Details)
$ in Thousands
Mar. 31, 2020
USD ($)
Debt Disclosure [Abstract]  
Remainder of 2020 $ 0
2021 33,750
2022 45,000
2023 61,875
2024 67,500
2025 669,375
Principal Repayment $ 877,500
XML 56 R7.htm IDEA: XBRL DOCUMENT v3.20.1
BASIS OF PRESENTATION
 3 Months Ended
Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
BASIS OF PRESENTATION BASIS OF PRESENTATION
General
The terms “we,” “our,” “us,” “Company” and “Integra” refer to Integra LifeSciences Holdings Corporation, a Delaware corporation, and its subsidiaries unless the context suggests otherwise.
In the opinion of management, the March 31, 2020 unaudited condensed consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the financial position, statement of changes in shareholder's equity, results of operations and cash flows of the Company. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements for the year ended December 31, 2019 included in the Company’s Annual Report on Form 10-K. The December 31, 2019 consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States. Operating results for the three month period ended March 31, 2020 are not necessarily indicative of the results to be expected for the entire year.
The preparation of consolidated financial statements is in conformity with generally accepted accounting principles in the United States ("GAAP") which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of the equity component of convertible debt instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates. The novel coronavirus (“COVID-19”) pandemic and the resulting adverse impacts to global economic conditions, as well as our operations, may impact future estimates including, but not limited to, inventory valuations, fair value measurements, goodwill and long-lived asset impairments, the effectiveness of the Company’s hedging instruments, deferred tax valuation allowances, and allowances for doubtful accounts receivable.
Risks and Uncertainties
The Company is subject to risks and uncertainties as a result of the COVID-19 pandemic. The extent of the impact of the COVID-19 pandemic on the Company's business is highly uncertain and difficult to predict, as the response to the pandemic is in its incipient stages and information is rapidly evolving. The Company's customers are diverting resources to treat COVID-19 patients and deferring elective surgical procedures, both of which are likely to impact hospitals' abilities to meet their obligations, including to the Company. Furthermore, capital markets and economies worldwide have also been negatively impacted by the COVID-19 pandemic, and it is likely that it could cause a local and/or global economic recession. Such economic disruption has had an adverse effect on our business as hospitals curtail and reduce capital and overall spending. Policymakers around the globe have responded with fiscal policy actions to support the healthcare industry and economy as a whole. The magnitude and overall effectiveness of these actions remains uncertain.The severity of the impact of the COVID-19 pandemic on the Company's business will depend on a number of factors, including, but not limited to, the duration and severity of the pandemic and the extent and severity of the impact on the Company's customers, all of which are uncertain and cannot be predicted with certainty. The Company's future results of operations and liquidity could be adversely impacted by delays in payments of outstanding receivable amounts beyond normal payment terms, supply chain disruptions and uncertain demand, and the impact of any initiatives or programs that the Company may undertake to address financial and operations challenges faced by its customers. The Company has implemented contingency plans to address the operational impact of COVID-19 and ensure ongoing operations.
Recently Issued Accounting Standards
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The ASU is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The ASU requires the measurement of all expected credit losses for financial assets including trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other
organizations will now use forward-looking information to better inform their credit loss estimates. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a modified retrospective transition method which requires a cumulative-effect adjustment to the opening balance of retained earnings to be recognized on the date of adoption with no change to financial results reported in prior periods. The cumulative-effect adjustment recorded on January 1, 2020, is not material. The adoption of this ASU did not have a significant impact on the Company's consolidated financial statements and related disclosures.
The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the current COVID-19 pandemic, or other customer-specific factors. Although the Company has historically not experienced significant credit losses, it is possible that there could be a adverse impact from potential as hospital's cash flows are impacted by their response to the COVID-19 pandemic and deferral of elective surgical procedures.
In August 2018, the FASB issued ASU 2018-14, Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans. The new guidance modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans, including removing certain previous disclosure requirements, adding certain new disclosure requirements, and clarifying certain other disclosure requirements. The ASU will be effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption is permitted. The adoption is not expected to have a material impact on the Condensed and Consolidated Financial Statements.
In August 2018, the FASB issued ASU No. 2018-15, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40), relating to a customer's accounting for implementation, set-up, and other upfront costs incurred in a cloud computing arrangement that is hosted by a vendor (e.g., a service contract). Under the new guidance, a customer will apply the same criteria for capitalizing implementation costs as it would for an arrangement that has a software license. The new guidance also prescribes the balance sheet, income statement, and cash flow classification of the capitalized implementation costs and related amortization expense, and requires additional quantitative and qualitative disclosures. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a prospective transition method. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.
In December 2019, the FASB issued ASU No. 2019-12, Income Taxes: Simplifying the Accounting for Income Taxes intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The new guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively. The Company is currently assessing the impact of this standard on the financial condition and results of operations.
In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform, which provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. This amendment applies to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This ASU is effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. The Company is currently assessing the impact that this ASU will have on its consolidated financial statements.
There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.
XML 57 R45.htm IDEA: XBRL DOCUMENT v3.20.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Components of Company's Identifiable Intangible Assets (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2020
Dec. 31, 2019
Acquired Finite-Lived Intangible Assets [Line Items]    
Cost $ 1,415,709 $ 1,415,787
Accumulated Amortization (401,482) (384,196)
Net 1,014,227 1,031,591
Codman tradename    
Acquired Finite-Lived Intangible Assets [Line Items]    
Cost 163,680 163,126
Net 163,680 163,126
IPR&D    
Acquired Finite-Lived Intangible Assets [Line Items]    
Other Indefinite-lived Intangible Assets $ 1,000 $ 1,000
Completed technology    
Acquired Finite-Lived Intangible Assets [Line Items]    
Weighted Average Life 19 years 19 years
Cost $ 881,856 $ 880,623
Accumulated Amortization (225,350) (213,702)
Net $ 656,506 $ 666,921
Customer relationships    
Acquired Finite-Lived Intangible Assets [Line Items]    
Weighted Average Life 12 years 12 years
Cost $ 221,193 $ 222,575
Accumulated Amortization (123,896) (119,393)
Net $ 97,297 $ 103,182
Trademarks/brand names    
Acquired Finite-Lived Intangible Assets [Line Items]    
Weighted Average Life 28 years 28 years
Cost $ 103,472 $ 103,873
Accumulated Amortization (29,190) (28,514)
Net $ 74,282 $ 75,359
Supplier relationships    
Acquired Finite-Lived Intangible Assets [Line Items]    
Weighted Average Life 27 years 27 years
Cost $ 34,721 $ 34,721
Accumulated Amortization (18,304) (17,947)
Net $ 16,417 $ 16,774
All other    
Acquired Finite-Lived Intangible Assets [Line Items]    
Weighted Average Life 4 years 4 years
Cost $ 10,787 $ 10,869
Accumulated Amortization (4,742) (4,640)
Net $ 6,045 $ 6,229
EXCEL 58 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 357,712 $ 198,911
Trade accounts receivable, net of allowances of $6,652 and $4,303 245,546 275,296
Inventories, net 338,082 316,054
Prepaid expenses and other current assets 67,332 67,907
Total current assets 1,008,672 858,168
Property, plant and equipment, net 335,903 337,404
Right of use asset - operating leases 95,890 94,530
Intangible assets, net 1,014,227 1,031,591
Goodwill 951,554 954,280
Deferred tax assets, net 2,330 12,623
Other assets 38,989 14,644
Total assets 3,447,565 3,303,240
Current liabilities:    
Current portion of borrowings under senior credit facility 0 45,000
Current portion of lease liability - operating leases 12,964 12,253
Accounts payable, trade 97,061 113,090
Contract liabilities 4,860 4,772
Accrued compensation 55,630 79,385
Accrued expenses and other current liabilities 75,970 76,809
Total current liabilities 246,485 331,309
Long-term borrowings under senior credit facility 1,018,032 1,198,561
Long-term borrowings under securitization facility 98,500 104,500
Long-term convertible securities 460,159 0
Lease liability - operating leases 100,328 97,504
Deferred tax liabilities 24,221 36,553
Other liabilities 158,037 118,077
Total liabilities 2,105,762 1,886,504
Commitments and contingencies (Refer to Note 16)
Stockholders’ equity:    
Preferred stock; no par value; 15,000 authorized shares; none outstanding 0 0
Common stock; $0.01 par value; 240,000 authorized shares; 89,104 and 88,735 issued at March 31, 2020 and December 31, 2019, respectively 889 887
Additional paid-in capital 1,240,455 1,213,620
Treasury stock, at cost; 4,294 shares and 2,865 shares at March 31, 2020 and December 31, 2019, respectively (202,506) (119,943)
Accumulated other comprehensive loss (104,588) (76,402)
Retained earnings 407,553 398,574
Total stockholders’ equity 1,341,803 1,416,736
Total liabilities and stockholders’ equity $ 3,447,565 $ 3,303,240

XML 61 R41.htm IDEA: XBRL DOCUMENT v3.20.1
REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Changes in Contract Assets and Liabilities (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2020
USD ($)
Contract Asset  
Contract asset, Beginning of period $ 8,680
Transferred to trade receivable of contract asset included in beginning of the year contract asset (8,680)
Contract asset, net of transferred to trade receivables on contracts during the period 7,944
Contract asset, End of Period 7,944
Contract Liability  
Contract liability, Beginning of Period 11,946
Recognition of revenue included in beginning of year contract liability (1,291)
Contract liability, net of revenue recognized on contracts during the period 1,691
Foreign currency translation (147)
Contract liability, End of Period $ 12,199
XML 62 R62.htm IDEA: XBRL DOCUMENT v3.20.1
TREASURY STOCK - Narrative (Details) - USD ($)
 3 Months Ended 12 Months Ended
Feb. 05, 2020
Jun. 30, 2020
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Dec. 11, 2018
Equity, Class of Treasury Stock [Line Items]            
Treasury stock (in shares)     4,300,000   2,900,000  
Treasury stock     $ 202,500,000   $ 119,900,000  
Treasury stock, average cost per share (in dollars per share)     $ 47.17   $ 41.87  
Stock repurchase program, authorized amount (up to)           $ 225,000,000.0
Stock repurchased during period (in shares) 1,300,000   1,400,000      
Net proceeds from offering of convertible senior notes     $ 575,000,000 $ 0    
Accelerated share repurchase program, payment $ 92,400,000          
Accelerated shares repurchased, amount $ 100,000,000.0   92,368,000      
Accelerated share repurchases, percentage of expected total repurchased 80.00%          
Remaining amount under share repurchase     125,000,000.0      
Forecast | Subsequent Event            
Equity, Class of Treasury Stock [Line Items]            
Accelerated share repurchases, percentage of expected total repurchased   20.00%        
Convertible Debt            
Equity, Class of Treasury Stock [Line Items]            
Net proceeds from offering of convertible senior notes     100,000,000.0      
Convertible Debt | Certain Purchasers            
Equity, Class of Treasury Stock [Line Items]            
Net proceeds from offering of convertible senior notes     $ 7,600,000      
XML 63 R66.htm IDEA: XBRL DOCUMENT v3.20.1
NET INCOME PER SHARE - Narrative (Details) - shares
shares in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2019
Dec. 31, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Shares excluded from computation as their effect would be antidilutive (in shares) 0.4 0.4
Performance Shares and Restricted Units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Additional EPS shares (in shares)   0.5
XML 64 R50.htm IDEA: XBRL DOCUMENT v3.20.1
DERIVATIVE INSTRUMENTS - Schedule of Derivatives (Details) - Cash Flow Hedges - Designated as Hedging Instrument - USD ($)
Mar. 31, 2020
Dec. 31, 2019
Derivative [Line Items]    
Current Notional Amount $ 1,325,000,000 $ 1,325,000,000
Estimated Fair Value, Assets (Liabilities) (95,752,000) (45,145,000)
3-Month USD LIBOR | Interest Rate Swap Designated February 6, 2017 Tranche 1    
Derivative [Line Items]    
Current Notional Amount $ 50,000,000 $ 50,000,000
Fixed Interest Rate 1.834% 1.834%
Estimated Fair Value, Assets (Liabilities) $ (48,000) $ (2,000)
1-Month USD LIBOR | Interest Rate Swap Designated February 6, 2017 Tranche 2    
Derivative [Line Items]    
Current Notional Amount $ 100,000,000 $ 100,000,000
Fixed Interest Rate 1.652% 1.652%
Estimated Fair Value, Assets (Liabilities) $ (233,000) $ 12,000
1-Month USD LIBOR | Interest Rate Swap Designated March 27, 2017    
Derivative [Line Items]    
Current Notional Amount $ 100,000,000 $ 100,000,000
Fixed Interest Rate 1.971% 1.971%
Estimated Fair Value, Assets (Liabilities) $ (2,024,000) $ (581,000)
1-Month USD LIBOR | Interest Rate Swap Designated December 13, 2017 Tranche 1    
Derivative [Line Items]    
Current Notional Amount $ 150,000,000 $ 150,000,000
Fixed Interest Rate 2.201% 2.201%
Estimated Fair Value, Assets (Liabilities) $ (7,467,000) $ (2,880,000)
1-Month USD LIBOR | Interest Rate Swap Designated December 13, 2017 Tranche 2    
Derivative [Line Items]    
Current Notional Amount $ 150,000,000 $ 150,000,000
Fixed Interest Rate 2.201% 2.201%
Estimated Fair Value, Assets (Liabilities) $ (7,388,000) $ (2,880,000)
1-Month USD LIBOR | Interest Rate Swap Designated December 13, 2017 Tranche 3    
Derivative [Line Items]    
Current Notional Amount $ 100,000,000 $ 100,000,000
Fixed Interest Rate 2.423% 2.423%
Estimated Fair Value, Assets (Liabilities) $ (8,475,000) $ (3,517,000)
1-Month USD LIBOR | Interest Rate Swap Designated December 13, 2017 Tranche 4    
Derivative [Line Items]    
Current Notional Amount $ 50,000,000 $ 50,000,000
Fixed Interest Rate 2.423% 2.423%
Estimated Fair Value, Assets (Liabilities) $ (3,994,000) $ (1,778,000)
1-Month USD LIBOR | Interest Rate Swap Designated December 13, 2017 Tranche 5    
Derivative [Line Items]    
Current Notional Amount $ 200,000,000 $ 200,000,000
Fixed Interest Rate 2.313% 2.313%
Estimated Fair Value, Assets (Liabilities) $ (16,279,000) $ (6,595,000)
1-Month USD LIBOR | Interest Rate Swap Designated October 10, 2018 Tranche 1    
Derivative [Line Items]    
Current Notional Amount $ 75,000,000 $ 75,000,000
Fixed Interest Rate 3.22% 3.22%
Estimated Fair Value, Assets (Liabilities) $ (10,186,000) $ (5,750,000)
1-Month USD LIBOR | Interest Rate Swap Designated October 10, 2018 Tranche 2    
Derivative [Line Items]    
Current Notional Amount $ 75,000,000 $ 75,000,000
Fixed Interest Rate 3.199% 3.199%
Estimated Fair Value, Assets (Liabilities) $ (10,165,000) $ (5,747,000)
1-Month USD LIBOR | Interest Rate Swap Designated October 10, 2018 Tranche 3    
Derivative [Line Items]    
Current Notional Amount $ 75,000,000 $ 75,000,000
Fixed Interest Rate 3.209% 3.209%
Estimated Fair Value, Assets (Liabilities) $ (10,185,000) $ (5,807,000)
1-Month USD LIBOR | Interest Rate Swap Designated December 18, 2018 Tranche 1    
Derivative [Line Items]    
Current Notional Amount $ 100,000,000 $ 100,000,000
Fixed Interest Rate 2.885% 2.885%
Estimated Fair Value, Assets (Liabilities) $ (9,453,000) $ (4,930,000)
1-Month USD LIBOR | Interest Rate Swap Designated December 18, 2018 Tranche 2    
Derivative [Line Items]    
Current Notional Amount $ 100,000,000 $ 100,000,000
Fixed Interest Rate 2.867% 2.867%
Estimated Fair Value, Assets (Liabilities) $ (9,855,000) $ (4,691,000)
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.20.1
DERIVATIVE INSTRUMENTS - Fair Value of Derivative Instruments By Balance Sheet Location (Details) - USD ($)
Mar. 31, 2020
Dec. 31, 2019
Designated as Hedging Instrument    
Derivatives, Fair Value [Line Items]    
Total derivatives designated as hedges — Assets $ 39,536,000 $ 16,461,000
Total derivatives designated as hedges — Liabilities 106,052,000 53,470,000
Interest Rate Swap    
Derivatives, Fair Value [Line Items]    
Current notional amount 1,300,000,000 1,300,000,000
Interest Rate Swap | Designated as Hedging Instrument | Prepaid expenses and other current assets    
Derivatives, Fair Value [Line Items]    
Total derivatives designated as hedges — Assets 0 12,000
Interest Rate Swap | Designated as Hedging Instrument | Other assets    
Derivatives, Fair Value [Line Items]    
Total derivatives designated as hedges — Assets 0 0
Interest Rate Swap | Designated as Hedging Instrument | Accrued expenses and other current liabilities    
Derivatives, Fair Value [Line Items]    
Total derivatives designated as hedges — Liabilities 19,793,000 6,635,000
Interest Rate Swap | Designated as Hedging Instrument | Other liabilities    
Derivatives, Fair Value [Line Items]    
Total derivatives designated as hedges — Liabilities 75,959,000 38,522,000
Cross-currency swap | Designated as Hedging Instrument | Prepaid expenses and other current assets    
Derivatives, Fair Value [Line Items]    
Total derivatives designated as hedges — Assets 5,065,000 5,032,000
Cross-currency swap | Designated as Hedging Instrument | Other assets    
Derivatives, Fair Value [Line Items]    
Total derivatives designated as hedges — Assets 0 0
Cross-currency swap | Designated as Hedging Instrument | Accrued expenses and other current liabilities    
Derivatives, Fair Value [Line Items]    
Total derivatives designated as hedges — Liabilities 74,000 101,000
Cross-currency swap | Designated as Hedging Instrument | Other liabilities    
Derivatives, Fair Value [Line Items]    
Total derivatives designated as hedges — Liabilities 1,117,000 5,440,000
Cross-currency swap | Net Investment Hedges | Designated as Hedging Instrument | Prepaid expenses and other current assets    
Derivatives, Fair Value [Line Items]    
Total derivatives designated as hedges — Assets 8,164,000 7,952,000
Cross-currency swap | Net Investment Hedges | Designated as Hedging Instrument | Other assets    
Derivatives, Fair Value [Line Items]    
Total derivatives designated as hedges — Assets 26,307,000 3,465,000
Cross-currency swap | Net Investment Hedges | Designated as Hedging Instrument | Other liabilities    
Derivatives, Fair Value [Line Items]    
Total derivatives designated as hedges — Liabilities $ 9,109,000 $ 2,772,000
XML 66 R58.htm IDEA: XBRL DOCUMENT v3.20.1
LEASES AND RELATED PARTY LEASES - Narrative (Details)
 3 Months Ended
Mar. 31, 2020
USD ($)
renewal_option
Mar. 31, 2019
USD ($)
Dec. 31, 2019
USD ($)
Operating Leased Assets [Line Items]      
Number of renewal options (or more) | renewal_option 1    
Operating lease expense $ 4,800,000 $ 4,400,000  
Future minimum lease payments capital leases     $ 0
Affiliated Entity      
Operating Leased Assets [Line Items]      
Operating lease expense $ 100,000 $ 100,000  
Percent of manufacturing facility owned by corporation whose shareholders are trusts whose beneficiaries include family members of company's former director 50.00%    
Annual rate of lease agreement $ 300,000    
Affiliated Entity | Five Year Option Lease From November 1, 2032 Through October 31, 2037      
Operating Leased Assets [Line Items]      
Option to extend lease, years 5 years    
Period for extended lease November 1, 2032 through October 31, 2037    
Affiliated Entity | Five Year Option Lease From November 1, 2037 Through October 31, 2042      
Operating Leased Assets [Line Items]      
Option to extend lease, years 5 years    
Period for extended lease November 1, 2037 through October 31, 2042    
XML 67 R73.htm IDEA: XBRL DOCUMENT v3.20.1
COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details) - Contingent Consideration Liability - Fair Value, Inputs, Level 3 - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Arkis    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, Beginning of Period $ 14,210  
Payments 0  
Loss from change in fair value of contingent consideration liabilities (1,051)  
Balance, End of Period 13,159  
Derma Sciences    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, Beginning of Period 230 $ 230
Payments 0 0
Loss from change in fair value of contingent consideration liabilities 0 0
Balance, End of Period $ 230 $ 230
XML 69 R12.htm IDEA: XBRL DOCUMENT v3.20.1
DEBT
 3 Months Ended
Mar. 31, 2020
Debt Disclosure [Abstract]  
DEBT DEBT
Sixth Amended and Restated Senior Credit Agreement
On February 3, 2020, the Company entered into the sixth amendment and restatement (the "February 2020 Amendment") of its Senior Credit Facility (the "Senior Credit Facility") with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. The February 2020 Amendment extended the maturity date to February 3, 2025. The Company continues to have the aggregate principal amount of up to approximately $2.2 billion available to it through the following facilities: (i) a $877.5 million Term Loan facility, and (ii) a $1.3 billion revolving credit facility, which includes a $60 million sublimit for the issuance of standby letters of credit and a $60 million sublimit for swingline loans. The first mandatory repayment under the Term Loan portion of the February 2020 Amendment is due June 30, 2021.
In connection with the February 2020 Amendment, the Company’s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:
Fiscal Quarter
 
Maximum Consolidated Total Leverage Ratio
 
 
 
First fiscal quarter ending after the Closing Date through June 30, 2022
 
5.00 to 1.00
September 30, 2022 through June 30, 2023
 
4.50 to 1.00
September 30, 2023 and the last day of each fiscal quarter thereafter
 
4.00 to 1.00

Borrowings under the Senior Credit Facility bear interest, at the Company’s option, at a rate equal to the following:
i.
the Eurodollar Rate (as defined in the amendment and restatement) in effect from time to time plus the applicable rate (ranging from 1.00% to 1.75%), or
ii.
the highest of:
1.
the weighted average overnight Federal funds rate, as published by the Federal Reserve Bank of New York, plus 0.50%
2.
the prime lending rate of Bank of America, N.A. or
3.
the one-month Eurodollar Rate plus 1.00%

The applicable rates are based on the Company’s consolidated total leverage ratio (defined as the ratio of (a) consolidated funded indebtedness as of such date less cash that is not subject to any restriction on the use or investment thereof (b) consolidated EBITDA as defined by the February 2020 amendment, for the period of four consecutive fiscal quarters ending on such date).
The Company will pay an annual commitment fee (ranging from 0.15% to 0.30%), based on the Company's consolidated total leverage ratio, on the amount available for borrowing under the revolving credit facility.
The Senior Credit Facility is collateralized by substantially all of the assets of the Company’s U.S. subsidiaries, excluding intangible assets. The Senior Credit Facility is subject to various financial and negative covenants and at March 31, 2020, the Company was in compliance with all such covenants. The Company capitalized $4.6 million of financing costs in connection with modification of the Senior Credit Facility and wrote off $1.2 million of previously capitalized financing costs during the first quarter of 2020.
At March 31, 2020 and December 31, 2019, there was $150.0 million and $375.0 million outstanding, respectively, under the revolving credit component of the Senior Credit Facility at weighted average interest rates of 2.5% and 3.2%, respectively. At March 31, 2020 and December 31, 2019, there was $877.5 million outstanding, respectively, under the Term Loan component of the Senior Credit Facility at a weighted average interest rate of 2.4% and 3.2%, respectively. At March 31, 2020, there is no current portion of the Term Loan component of the Senior Credit Facility as the first mandatory repayment is due June 30, 2021.
Convertible Senior Notes
On February 4, 2020, the Company issued $575.0 million aggregate principal amount of its of 0.5% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes will mature on August 15, 2025 and bear interest at a rate of 0.5% per annum payable semi-annually in arrears, unless earlier converted, repurchased or redeemed in accordance with the terms of the Notes. The portion of debt proceeds that was classified as equity at the time of the offering was $104.5 million, and that amount is being amortized to interest expense using the effective interest method through August 2025. The effective interest rate implicit in the liability component is 4.2%. In connection with this offering, the Company capitalized $13.2 million of financing fees. At March 31, 2020, the carrying amount of the liability component was $473.0 million, the remaining unamortized discount was $102.0 million, and the principal amount outstanding was $575.0 million. The fair value of the 2025 Notes at March 31, 2020 was $507.7 million.
The 2025 Notes are senior, unsecured obligations of the Company, and are convertible into cash and shares of its common stock based on initial conversion rate, subject to adjustment of 13.5739 shares per $1,000 principal amounts of the 2025 Notes (which represents an initial conversion price of $73.67 per share). The 2025 Notes convert only in the following circumstances: (1) if the closing price of the Company's common stock has been at least 130% of the conversion price during the period; (2) if the average trading price per $1000 principal amount of the 2025 Notes is less than or equal to 98% of the average conversion value of the 2025 Notes during a period as defined in the indenture; (3) at any time on or after February 20, 2023; or (4) if specified corporate transactions occur. As of March 31, 2020, none of these conditions existed with respect to the 2025 Notes and as a result the 2025 Notes are classified as long term.
Holders of the Notes will have the right to require the Company to repurchase for cash all or a portion of their Notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the Notes). The Company will also be required to increase the conversion rate for holders who convert their Notes in connection with certain fundamental changes occurring prior to the maturity date or following delivery by the Company of a notice of redemption.

In connection with the issuance of the 2025 Notes, the Company entered into call transactions and warrant transactions, primarily with affiliates of the initial purchasers of the 2025 Notes (the “hedge participants”). The cost of the call transactions was $104.2 million for the 2025 Notes. The Company received $44.5 million of proceeds from the warrant transactions for the 2025 Notes. The call transactions involved purchasing call options from the hedge participants, and the warrant transactions involved selling call options to the hedge participants with a higher strike price than the purchased call options. The initial strike price of the call transactions was $73.67, subject to anti-dilution adjustments substantially similar to those in the 2025 Notes. The initial strike price of the warrant transactions was $113.34 for the 2025 Notes, subject to customary anti-dilution adjustments.
During the three months ended March 31, 2020, the Company recognized cash interest of $0.4 million and amortization of the discount on the liability component of $2.5 million for a total interest charge of $2.9 million on the 2020 Notes.
Securitization Facility
During the fourth quarter of 2018, the Company entered into an accounts receivable securitization facility (the "Securitization Facility") under which accounts receivable of certain domestic subsidiaries are sold on a non-recourse basis to a special purpose entity (“SPE”), which is a bankruptcy-remote, consolidated subsidiary of the Company. Accordingly, the assets of the SPE are not available to satisfy the obligations of the Company or any of its subsidiaries. From time to time, the SPE may finance such accounts receivable with a revolving loan facility secured by a pledge of such accounts receivable. The amount of outstanding borrowings on the Securitization Facility at any one time is limited to $150.0 million. The Securitization Facility Agreement ("Securitization Agreement") is for an initial three-year term and may be extended. The Securitization Agreement governing the Securitization Facility contains certain covenants and termination events. An occurrence of an event of default or a termination event under this Securitization Agreement may give rise to the right of its counterparty to terminate this facility. As of March 31, 2020, the Company was in compliance with the covenants and none of the termination events had occurred. At
March 31, 2020 and December 31, 2019, the Company had $98.5 million and $104.5 million, respectively, of outstanding borrowings under its Securitization Facility at a weighted average interest rate of 2.6% and 2.8%, respectively.
The fair value of outstanding borrowings of the Senior Credit Facility's revolving credit and Term Loan components at March 31, 2020 were $130.4 million and, $771.3 million, respectively. The fair value of the outstanding borrowing of the Securitization Facility at March 31, 2020 was $94.5 million. These fair values were determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable inputs that reflect unadjusted quoted prices for identical assets or liabilities.
Letters of credit outstanding as of March 31, 2020 and December 31, 2019 totaled $0.8 million. There were no amounts drawn as of March 31, 2020.
Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:
Quarter Ended March 31, 2020
 
Principal Repayment
 
 
(In thousands)
Remainder of 2020
 
$
—

2021
 
33,750

2022
 
45,000

2023
 
61,875

2024
 
67,500

2025
 
669,375

 
 
$
877,500


The outstanding balance of the revolving credit component of the Senior Credit Facility is due on February 3, 2025.
XML 70 R16.htm IDEA: XBRL DOCUMENT v3.20.1
LEASES AND RELATED PARTY LEASES
 3 Months Ended
Mar. 31, 2020
Leases [Abstract]  
LEASES AND RELATED PARTY LEASES LEASES AND RELATED PARTY LEASES
The Company leases administrative, manufacturing, research and distribution facilities and vehicles through operating lease agreements. The Company has no finance leases as of March 31, 2020. Many of the Company's leases include both lease (e.g., fixed payments including rent) and non-lease components (e.g., common-area or other maintenance costs). For vehicles, the Company has elected the practical expedient to group lease and non-lease components. 
Most facility leases include one or more options to renew. The exercise of lease renewal options is typically at the Company's sole discretion, therefore, the majority of renewals to extend the lease terms are not included in the ROU assets and lease liabilities as they are not reasonably certain of exercise. The Company regularly evaluates renewal options and when they are reasonably certain of exercise, the renewal period is included in the lease term.
As most of the Company's leases do not provide an implicit rate, the Company uses a collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of the lease payments.
Total operating lease expense for the three months ended March 31, 2020 and March 31, 2019, was $4.8 million and $4.4 million respectively, which includes $0.1 million, in related party operating lease expense.
Supplemental balance sheet information related to operating leases at March 31, 2020 were as follows:
 
March 31, 2020
 
(In thousands, except lease term and discount rate)
ROU assets
$
95,890

 
 
Current lease liabilities
$
12,964

Non-current lease liabilities
100,328

Total lease liabilities
$
113,292

 
 
Weighted average remaining lease term (in years):
 
Leased facilities
12.5

Leased vehicles
1.7

 
 
Weighted average discount rate:
 
Leased facilities
5.2
%
Leased vehicles
2.4
%

Supplemental cash flow information related to leases was as follows for the three months ended March 31, 2020 (in thousands):
 
March 31, 2020
 
(In thousands)
Cash paid for amounts included in the measurement of lease liabilities:
 
Operating cash flows from operating leases
$
3,229

 
 
ROU assets obtained in exchange for lease liabilities:
 
Operating leases
$
5,808


Future minimum lease payments under operating leases at March 31, 2020 were as follows:
 
Related Parties
 
Third Parties
 
Total
 
(In thousands)
2020
$
222

 
$
10,334

 
$
10,556

2021
296

 
13,018

 
13,314

2022
296

 
14,198

 
14,494

2023
296

 
11,658

 
11,954

2024
296

 
11,022

 
11,318

Thereafter
1,429

 
91,026

 
92,455

Total minimum lease payments
$
2,835

 
$
151,256

 
$
154,091

Less: Imputed interest
 
 
 
 
40,799

Total lease liabilities
 
 
 
 
113,292

Less: Current lease liabilities
 
 
 
 
12,964

Long-term lease liabilities
 
 
 
 
100,328








Future minimum lease payments under operating leases at December 31, 2019 were as follows:
 
Related Parties
 
Third Parties
 
Total
 
(In thousands)
2020
$
296

 
$
12,100

 
$
12,396

2021
296

 
12,951

 
13,247

2022
296

 
13,753

 
14,049

2023
296

 
11,386

 
11,682

2024
296

 
11,060

 
11,356

Thereafter
1,428

 
91,235

 
92,663

Total minimum lease payments
$
2,908

 
$
152,485

 
$
155,393

Less: Imputed interest
 
 
 
 
45,636

Total lease liabilities
 
 
 
 
109,757

Less: Current lease liabilities
 
 
 
 
12,253

Long-term lease liabilities
 
 
 
 
97,504


There were no future minimum lease payments under capital leases at December 31, 2019.
Related Party Leases
The Company leases its manufacturing facility in Plainsboro, New Jersey, from a general partnership that is 50% owned by a corporation whose shareholders are trusts, whose beneficiaries include family members of the Company’s principal stockholder and former director. The term of the current lease agreement is through October 31, 2032 at an annual rate of approximately $0.3 million per year. The current lease agreement also provides (i) a 5-year renewal option for the Company to extend the lease from November 1, 2032 through October 31, 2037 at the fair market rental rate of the premises, and (ii) another 5-year renewal option to extend the lease from November 1, 2037 through October 31, 2042 at the fair market rental rate of the premises.
XML 71 R39.htm IDEA: XBRL DOCUMENT v3.20.1
REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2020
Dec. 31, 2019
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Number of days from shipment to issue a credit 90 days  
Short-term portion of contract liability $ 4,860 $ 4,772
Long-term portion of contract liability $ 7,300  
Product warranty period (up to) 2 years  
Minimum    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Manufacturing period for products shipped with no alternative use and right of payment for performance 1 month  
Maximum    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Manufacturing period for products shipped with no alternative use and right of payment for performance 3 months  
XML 72 R35.htm IDEA: XBRL DOCUMENT v3.20.1
COMMITMENTS AND CONTINGENCIES (Tables)
 3 Months Ended
Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Contingent Consideration
A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the three months ended March 31, 2020 and March 31, 2019 is as follows (in thousands):
Three Months Ended March 31, 2020
Contingent Consideration Liability Related to Acquisition of Arkis (See Note 2)
 
Contingent Consideration
 Liability Related to Acquisition of Derma Sciences
Location in Financial Statements
 
Long-term
 
Long-term
 
Balance as of January 1, 2020
$
14,210

 
$
230

 
Payments
—

 
—

 
Loss from change in fair value of contingent consideration liabilities
(1,051
)
 
—

Research and development
Balance as of March 31, 2020
$
13,159

 
$
230

 

Three Months Ended March 31, 2019
 
Contingent Consideration
 Liability Related to Acquisition of Derma Sciences
Location in Financial Statements
 
 
Long-term
 
Balance as of January 1, 2019
 
$
230

 
Payments
 
—

 
Loss from change in fair value of contingent consideration liabilities
 
—

Research and development
Balance as of March 31, 2019
 
$
230

 
XML 73 R31.htm IDEA: XBRL DOCUMENT v3.20.1
INCOME TAXES (Tables)
 3 Months Ended
Mar. 31, 2020
Income Tax Disclosure [Abstract]  
Schedule of Effective Income Tax Rate Reconciliation
The following table provides a summary of the Company's effective tax rate:
 
Three Months Ended March 31,
 
2020
 
2019
Reported tax rate
19.8
%
 
(32.0
)%
XML 74 R59.htm IDEA: XBRL DOCUMENT v3.20.1
LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Lessee, Lease, Description [Line Items]    
ROU assets $ 95,890 $ 94,530
Current lease liabilities 12,964 12,253
Non-current lease liabilities 100,328 97,504
Total lease liabilities $ 113,292 $ 109,757
Leased facilities    
Lessee, Lease, Description [Line Items]    
Weighted average remaining lease term (in years) 12 years 6 months  
Weighted average discount rate 5.20%  
Leased vehicles    
Lessee, Lease, Description [Line Items]    
Weighted average remaining lease term (in years) 1 year 8 months 12 days  
Weighted average discount rate 2.40%  
XML 75 R51.htm IDEA: XBRL DOCUMENT v3.20.1
DERIVATIVE INSTRUMENTS - Narrative (Details)
 3 Months Ended
Mar. 31, 2020
USD ($)
Mar. 31, 2019
USD ($)
Dec. 31, 2019
USD ($)
Oct. 02, 2017
CHF (SFr)
Oct. 02, 2017
USD ($)
Designated as Hedging Instrument          
Derivative [Line Items]          
Gain recorded in AOCI, change in fair value $ (26,847,000) $ 1,803,000      
Cash Flow Hedges | Designated as Hedging Instrument          
Derivative [Line Items]          
Current notional amount 1,325,000,000   $ 1,325,000,000    
Cross-currency swap | Net Investment Hedges | Designated as Hedging Instrument          
Derivative [Line Items]          
Gain reclassified into other income 2,200,000 2,300,000      
Gain expected to be reclassified to earnings in the next twelve months 8,200,000        
Gain recorded in AOCL, net investment hedge, change in fair value 16,700,000 7,900,000      
Codman | Cross-currency swap | Cash Flow Hedges | Designated as Hedging Instrument          
Derivative [Line Items]          
Gain (loss) recorded in other income, net (1,700,000) 3,300,000      
Gain recorded in AOCI, change in fair value 5,900,000 5,500,000      
Gain reclassified into other income 1,500,000 $ 1,900,000      
Gain expected to be reclassified to earnings in the next twelve months $ 5,100,000        
Codman | Cross-currency swap | Short          
Derivative [Line Items]          
Current notional amount         $ 300,000,000.0
Codman | Cross-currency swap | Long          
Derivative [Line Items]          
Current notional amount | SFr       SFr 291,200,000  
XML 76 R55.htm IDEA: XBRL DOCUMENT v3.20.1
DERIVATIVE INSTRUMENTS - Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Derivative Instruments, Gain (Loss) [Roll Forward]    
Balance, Beginning of Period $ 1,416,736 $ 1,375,796
Balance, End of Period 1,341,803 1,397,030
Accumulated Other Comprehensive Loss    
Derivative Instruments, Gain (Loss) [Roll Forward]    
Balance, Beginning of Period (76,401) (45,443)
Balance, End of Period (104,588) (56,679)
Designated as Hedging Instrument    
Derivative Instruments, Gain (Loss) [Roll Forward]    
Amount of Gain (Loss) Recognized in AOCL (26,847) 1,803
Amount of Gain (Loss) Reclassified from AOCL into Earnings 955 8,911
Designated as Hedging Instrument | Accumulated Other Comprehensive Loss    
Derivative Instruments, Gain (Loss) [Roll Forward]    
Balance, Beginning of Period (34,739) (6,203)
Balance, End of Period (62,541) (13,311)
Designated as Hedging Instrument | Interest rate swap | Cash Flow Hedges | Interest expense    
Derivative Instruments, Gain (Loss) [Roll Forward]    
Balance, Beginning of Period (45,145) 619
Amount of Gain (Loss) Recognized in AOCL (51,651) (15,891)
Amount of Gain (Loss) Reclassified from AOCL into Earnings (1,043) 1,406
Balance, End of Period (95,753) (16,678)
Designated as Hedging Instrument | Cross-currency swap | Cash Flow Hedges | Other income (expense), net    
Derivative Instruments, Gain (Loss) [Roll Forward]    
Balance, Beginning of Period 177 (6,190)
Amount of Gain (Loss) Recognized in AOCL 5,907 7,473
Amount of Gain (Loss) Reclassified from AOCL into Earnings (182) 5,178
Balance, End of Period 6,266 (3,895)
Designated as Hedging Instrument | Cross-currency swap | Net Investment Hedges | Interest income    
Derivative Instruments, Gain (Loss) [Roll Forward]    
Balance, Beginning of Period 10,229 (632)
Amount of Gain (Loss) Recognized in AOCL 18,897 10,221
Amount of Gain (Loss) Reclassified from AOCL into Earnings 2,180 2,327
Balance, End of Period $ 26,946 $ 7,262
XML 77 R72.htm IDEA: XBRL DOCUMENT v3.20.1
SEGMENT AND GEOGRAPHIC INFORMATION - Total Revenue by Major Geographic Area (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Segment Reporting Information [Line Items]    
Total Revenues $ 354,324 $ 359,690
United States    
Segment Reporting Information [Line Items]    
Total Revenues 246,852 256,726
Europe    
Segment Reporting Information [Line Items]    
Total Revenues 45,896 48,640
Asia Pacific    
Segment Reporting Information [Line Items]    
Total Revenues 39,960 35,700
Rest of World    
Segment Reporting Information [Line Items]    
Total Revenues $ 21,616 $ 18,624
XML 78 R13.htm IDEA: XBRL DOCUMENT v3.20.1
DERIVATIVE INSTRUMENTS
 3 Months Ended
Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE INSTRUMENTS DERIVATIVE INSTRUMENTS
Interest Rate Hedging
The Company’s interest rate risk relates to U.S. dollar denominated variable interest rate borrowings. The Company uses interest rate swap derivative instruments to manage earnings and cash flow exposure resulting from changes in interest rates. These interest rate swaps apply a fixed interest rate on a portion of the Company's expected LIBOR-indexed floating-rate borrowings.
The Company held the following interest rate swaps as of March 31, 2020 (dollar amounts in thousands):
Hedged Item
 
Current Notional Amount
 
Designation Date
 
Effective Date
 
Termination Date
 
Fixed Interest Rate
 
Estimated Fair Value
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
3-month USD LIBOR Loan
 
50,000

 
February 6, 2017
 
June 30, 2017
 
June 30, 2020
 
1.834
%
 
$
(48
)
1-month USD LIBOR Loan
 
100,000

 
February 6, 2017
 
June 30, 2017
 
June 30, 2020
 
1.652
%
 
(233
)
1-month USD LIBOR Loan
 
100,000

 
March 27, 2017
 
December 31, 2017
 
June 30, 2021
 
1.971
%
 
(2,024
)
1-month USD LIBOR Loan
 
150,000

 
December 13, 2017
 
January 1, 2018
 
December 31, 2022
 
2.201
%
 
(7,467
)
1-month USD LIBOR Loan
 
150,000

 
December 13, 2017
 
January 1, 2018
 
December 31, 2022
 
2.201
%
 
(7,388
)
1-month USD LIBOR Loan
 
100,000

 
December 13, 2017
 
July 1, 2019
 
June 30, 2024
 
2.423
%
 
(8,475
)
1-month USD LIBOR Loan
 
50,000

 
December 13, 2017
 
July 1, 2019
 
June 30, 2024
 
2.423
%
 
(3,994
)
1-month USD LIBOR Loan
 
200,000

 
December 13, 2017
 
January 1, 2018
 
December 31, 2024
 
2.313
%
 
(16,279
)
1-month USD LIBOR Loan
 
75,000

 
October 10, 2018
 
July 1, 2020
 
June 30, 2025
 
3.220
%
 
(10,186
)
1-month USD LIBOR Loan
 
75,000

 
October 10, 2018
 
July 1, 2020
 
June 30, 2025
 
3.199
%
 
(10,165
)
1-month USD LIBOR Loan
 
75,000

 
October 10, 2018
 
July 1, 2020
 
June 30, 2025
 
3.209
%
 
(10,185
)
1-month USD LIBOR Loan
 
100,000

 
December 18, 2018
 
December 30, 2022
 
December 31, 2027
 
2.885
%
 
(9,453
)
1-month USD LIBOR Loan
 
100,000

 
December 18, 2018
 
December 30, 2022
 
December 31, 2027
 
2.867
%
 
(9,855
)
Total interest rate derivatives designated as cash flow hedge
 
$
1,325,000

 
 
 
 
 
 
 
 
 
$
(95,752
)

The Company held the following interest rate swaps as of December 31, 2019 (dollar amounts in thousands):
Hedged Item
 
Current Notional Amount
 
Designation Date
 
Effective Date
 
Termination Date
 
Fixed Interest Rate
 
Estimated Fair Value
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
3-month USD LIBOR
 
50,000

 
February 6, 2017
 
June 30, 2017
 
June 30, 2020
 
1.834
%
 
(2
)
1-month USD LIBOR
 
100,000

 
February 6, 2017
 
June 30, 2017
 
June 30, 2020
 
1.652
%
 
12

1-month USD LIBOR
 
100,000

 
March 27, 2017
 
December 31, 2017
 
June 30, 2021
 
1.971
%
 
(581
)
1-month USD LIBOR
 
150,000

 
December 13, 2017
 
January 1, 2018
 
December 31, 2022
 
2.201
%
 
(2,880
)
1-month USD LIBOR
 
150,000

 
December 13, 2017
 
January 1, 2018
 
December 31, 2022
 
2.201
%
 
(2,880
)
1-month USD LIBOR
 
100,000

 
December 13, 2017
 
July 1, 2019
 
June 30, 2024
 
2.423
%
 
(3,517
)
1-month USD LIBOR
 
50,000

 
December 13, 2017
 
July 1, 2019
 
June 30, 2024
 
2.423
%
 
(1,778
)
1-month USD LIBOR
 
200,000

 
December 13, 2017
 
January 1, 2018
 
December 31, 2024
 
2.313
%
 
(6,595
)
1-month USD LIBOR
 
75,000

 
October 10, 2018
 
July 1, 2020
 
June 30, 2025
 
3.220
%
 
(5,750
)
1-month USD LIBOR
 
75,000

 
October 10, 2018
 
July 1, 2020
 
June 30, 2025
 
3.199
%
 
(5,747
)
1-month USD LIBOR
 
75,000

 
October 10, 2018
 
July 1, 2020
 
June 30, 2025
 
3.209
%
 
(5,807
)
1-month USD LIBOR
 
100,000

 
December 18, 2018
 
December 30, 2022
 
December 31, 2027
 
2.885
%
 
(4,930
)
1-month USD LIBOR
 
100,000

 
December 18, 2018
 
December 30, 2022
 
December 31, 2027
 
2.867
%
 
(4,691
)
Total interest rate derivatives designated as cash flow hedge
 
$
1,325,000

 
 
 
 
 
 
 
 
 
(45,145
)

The Company has designated these derivative instruments as cash flow hedges. The Company assesses the effectiveness of these derivative instruments and has recorded the changes in the fair value of the derivative instrument designated as a cash flow hedge as unrealized gains or losses in accumulated other comprehensive loss (“AOCL”), net of tax, until the hedged item affected earnings, at which point any gain or loss was reclassified to earnings. If the hedged cash flow does not occur, or if it becomes probable that it will not occur, the Company will reclassify the remaining amount of any gain or loss on the related cash flow hedge recorded in AOCL to interest expense at that time.


Foreign Currency Hedging
From time to time the Company enters into foreign currency hedge contracts intended to protect the U.S. dollar value of certain forecasted foreign currency denominated transactions. The Company assesses the effectiveness of the contracts that are designated as hedging instruments. The changes in fair value of foreign currency cash flow hedges are recorded in AOCL, net of tax, until the hedged item affects earnings. Once the related hedged item affects earnings, the Company reclassifies amounts recorded in AOCL to earnings. If the hedged forecasted transaction does not occur, or if it becomes probable that it will not occur, the Company will reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. For contracts not designated as hedging instruments, the changes in fair value of the contracts are recognized in other income (expense), net in the consolidated statements of operation, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.
The success of the Company’s hedging program depends, in part, on forecasts of certain activity denominated in foreign currency. The Company may experience unanticipated currency exchange gains or losses to the extent that there are differences between forecasted and actual activities during periods of currency volatility. In addition, changes in currency exchange rates related to any unhedged transactions may affect earnings and cash flows.
Cross-Currency Rate Swaps
On October 2, 2017, the Company entered into cross-currency swap agreements to convert a notional amount of $300.0 million equivalent to 291.2 million of CHF denominated intercompany loans into U.S. dollars. The CHF-denominated intercompany loans were the result of the purchase of intellectual property by a subsidiary in Switzerland as part of an acquisition. The objective of these cross-currency swaps is to reduce volatility of earnings and cash flows associated with changes in the foreign currency exchange rate. Under the terms of these contracts, which have been designated as cash flow hedges, the Company will make interest payments in Swiss Francs and receive interest in U.S. dollars. Upon the maturity of these contracts, the Company will pay the principal amount of the loans in Swiss Francs and receive U.S. dollars from the counterparties.
The Company held the following cross-currency rate swaps as of March 31, 2020 (dollar amounts in thousands):
 
 
 
 
 
 
 
 
 
 
 
March 31, 2020
 
 
Effective Date
 
Termination Date
 
Fixed Rate
 
Aggregate Notional Amount
 
Fair Value
Asset (Liability)
 
 
 
 
 
 
 
 
 
 
 
Pay CHF
 
October 2, 2017
 
October 2, 2020
 
1.75%
 
CHF
32,355

 
$
(74
)
Receive U.S.$
 
 
4.38%
 
$
33,333

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay CHF
 
October 2, 2017
 
October 2, 2021
 
1.85%
 
CHF
48,533

 
531

Receive U.S.$
 
 
4.46%
 
$
50,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay CHF
 
October 2, 2017
 
October 2, 2022
 
1.95%
 
CHF
145,597

 
3,416

Receive U.S.$
 
 
4.52%
 
$
150,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Total
 
 
 
 
 
 
 
 
 
 
$
3,874


The Company held the following cross-currency rate swaps as of December 31, 2019 (dollar amounts in thousands):
 
 
 
 
 
 
 
 
 
 
 
December 31, 2019
 
 
Effective Date
 
Termination Date
 
Fixed Rate
 
Aggregate Notional Amount
 
Fair Value
Asset (Liability)
 
 
 
 
 
 
 
 
 
 
 
Pay CHF
 
October 2, 2017
 
October 2, 2020
 
1.75%
 
CHF
32,355

 
$
(101
)
Receive U.S.$
 
 
4.38%
 
$
33,333

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay CHF
 
October 2, 2017
 
October 2, 2021
 
1.85%
 
CHF
48,533

 
(119
)
Receive U.S.$
 
 
4.46%
 
$
50,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay CHF
 
October 2, 2017
 
October 2, 2022
 
1.95%
 
CHF
145,598

 
(289
)
Receive U.S.$
 
 
4.52%
 
$
150,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Total
 
 
 
 
 
 
 
 
 
 
$
(509
)


The cross- currency swaps are carried on the consolidated balance sheet at fair value, and changes in the fair values are recorded as unrealized gains or losses in AOCL. For the three months ended March 31, 2020 and 2019, the Company recorded a loss of $1.7 million and a gain of $3.3 million, respectively, in other income(expense), net related to change in fair value related to the foreign currency rate translation to offset the gains or losses recognized on the intercompany loan.
For the three months ended March 31, 2020 and 2019, the Company recorded gains of $5.9 million and $5.5 million, respectively, in AOCL related to change in fair value of the cross-currency swaps.
For the three months ended March 31, 2020 and 2019, the Company recorded gains of $1.5 million and $1.9 million, respectively, in other income (expense), net included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps.
The estimated gain that is expected to be reclassified to other income (expense), net from AOCL as of March 31, 2020 within the next twelve months is $5.1 million. As of March 31, 2020, the Company does not expect any gains or losses will be reclassified into earnings as a result of the discontinuance of these cash flow hedges because the original forecasted transaction will not occur.
Net Investment Hedges
The Company manages certain foreign exchange risks through a variety of strategies, including hedging. The Company is exposed to foreign exchange risk from its international operations through foreign currency purchases, net investments in foreign subsidiaries, and foreign currency assets and liabilities created in the normal course of business. On October 1, 2018, the Company entered into cross-currency swap agreements designated as net investment hedges to partially offset the effects of foreign currency on foreign subsidiaries.
The Company held the following cross-currency rate swaps designated as net investment hedges as of March 31, 2020 and December 31, 2019, respectively (dollar amounts in thousands):
 
 
 
 
 
 
 
 
 
 
 
March 31, 2020
 
 
Effective Date
 
Termination Date
 
Fixed Rate
 
Aggregate Notional Amount
 
Fair Value
Asset (Liability)
 
 
 
 
 
 
 
 
 
 
 
Pay EUR
 
October 3, 2018
 
September 30, 2021
 
—%
 
EUR
44,859

 
$
4,082

Receive U.S.$
 
 
 
3.01%
 
$
52,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay EUR
 
October 3, 2018
 
September 30, 2023
 
—%
 
EUR
51,760

 
6,298

Receive U.S.$
 
 
 
2.57%
 
$
60,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay EUR
 
October 3, 2018
 
September 30, 2025
 
—%
 
EUR
38,820

 
5,174

Receive U.S.$
 
 
 
2.19%
 
$
45,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay GBP
 
October 3, 2018
 
September 30, 2025
 
1.67%
 
GBP
128,284

 
16,773

Receive U.S.$
 
 
 
2.71%
 
$
167,500

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay CHF
 
October 3, 2018
 
September 30, 2025
 
—%
 
CHF
165,172

 
(6,965
)
Receive GBP
 
 
 
1.67%
 
GBP
128,284

 
 
 
 
 
 
 
 
 
 
 
 
 
Total
 
 
 
 
 
 
 
 
 
 
$
25,362



 
 
 
 
 
 
 
 
 
 
 
December 31, 2019
 
 
Effective Date
 
Termination Date
 
Fixed Rate
 
Aggregate Notional Amount
 
Fair Value
Asset (Liability)
 
 
 
 
 
 
 
 
 
 
 
Pay EUR
 
October 3, 2018
 
September 30, 2021
 
—%
 
EUR
44,859

 
$
2,459

Receive U.S.$
 
 
 
3.01%
 
$
52,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay EUR
 
October 3, 2018
 
September 30, 2023
 
—%
 
EUR
51,760

 
3,087

Receive U.S.$
 
 
 
2.57%
 
$
60,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay EUR
 
October 3, 2018
 
September 30, 2025
 
—%
 
EUR
38,820

 
2,032

Receive U.S.$
 
 
 
2.19%
 
$
45,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay GBP
 
October 3, 2018
 
September 30, 2025
 
1.67%
 
GBP
128,284

 
(154
)
Receive U.S.$
 
 
 
2.71%
 
$
167,500

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay CHF
 
October 3, 2018
 
September 30, 2025
 
—%
 
CHF
165,172

 
1,221

Receive GBP
 
 
 
1.67%
 
GBP
128,284

 
 
 
 
 
 
 
 
 
 
 
 
 
Total
 
 
 
 
 
 
 
 
 
 
$
8,645



The cross-currency swaps were carried on the consolidated balance sheet at fair value and changes in the fair values were recorded as unrealized gains or losses in AOCL. For the three months ended March 31, 2020 and 2019, the Company recorded gains of $16.7 million and $7.9 million in AOCL related to the change in fair value of the cross-currency swaps.
For the three months ended March 31, 2020 and 2019, the Company recorded gains of $2.2 million and $2.3 million in interest income included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps.
The estimated gain that is expected to be reclassified to interest income from AOCL as of March 31, 2020 within the next twelve months is $8.2 million.
Counterparty Credit Risk
The Company manages its concentration of counterparty credit risk on its derivative instruments by limiting acceptable counterparties to a group of major financial institutions with investment grade credit ratings, and by actively monitoring their credit ratings and outstanding positions on an ongoing basis. Therefore, the Company considers the credit risk of the counterparties
to be low. Furthermore, none of the Company’s derivative transactions are subject to collateral or other security arrangements, and none contain provisions that depend upon the Company’s credit ratings from any credit rating agency.
Fair Value of Derivative Instruments
The Company has classified all of its derivative instruments within Level 2 of the fair value hierarchy because observable inputs are available for substantially the full term of the derivative instruments. The fair values of the interest rate swaps and cross-currency swaps were developed using a market approach based on publicly available market yield curves and the terms of the swap. The Company performs ongoing assessments of counterparty credit risk.

The following table summarizes the fair value for derivatives designated as hedging instruments in the condensed consolidated balance sheets as of March 31, 2020 and December 31, 2019:
 
 
Fair Value as of
Location on Balance Sheet (1):
 
March 31, 2020
 
December 31, 2019
 
 
(In thousands)
Derivatives designated as hedges — Assets:
 
 
 
 
Prepaid expenses and other current assets
 
 
 
 
Cash Flow Hedges
 
 
 
 
Interest rate swap(2)
 
$
—

 
$
12

Cross-currency swap
 
5,065

 
5,032

Net Investment Hedges
 
 
 
 
Cross-currency swap
 
8,164

 
7,952

Other assets
 
 
 
 
Cash Flow Hedges
 
 
 
 
Interest rate swap(2)
 
—

 
—

Cross-currency swap
 
—

 
—

Net Investment Hedges
 
 
 
 
Cross-currency swap
 
26,307

 
3,465

Total derivatives designated as hedges — Assets
 
$
39,536

 
$
16,461

 
 
 
 
 
Derivatives designated as hedges — Liabilities:
 
 
 
 
Accrued expenses and other current liabilities
 
 
 
 
Cash Flow Hedges
 
 
 
 
Interest rate swap(2)
 
$
19,793

 
$
6,635

Cross-currency swap
 
74

 
101

Other liabilities
 
 
 
 
Cash Flow Hedges
 
 
 
 
Interest rate swap(2)
 
75,959

 
38,522

Cross-currency swap
 
1,117

 
5,440

Net Investment Hedges
 
 
 
 
Cross-currency swap
 
9,109

 
2,772

Total derivatives designated as hedges — Liabilities
 
$
106,052

 
$
53,470

 
(1) 
The Company classifies derivative assets and liabilities as non-current based on the cash flows expected to be incurred within the following 12 months.
(2) 
At March 31, 2020 and December 31, 2019, the notional amount related to the Company’s interest rate swaps were $1.3 billion and $1.3 billion, respectively.
The following presents the effect of derivative instruments designated as cash flow hedges on the accompanying condensed consolidated statement of operations during the three months ended March 31, 2020 and 2019:
 
Balance in AOCL
Beginning of
Quarter
 
Amount of
Gain (Loss)
Recognized in
AOCL
 
Amount of Gain (Loss)
Reclassified from
AOCL into
Earnings
 
Balance in AOCL
End of Quarter
 
Location in
Statements of
Operations
 
(In thousands)
Three Months Ended March 31, 2020
 
 
 
 
 
 
 
 
 
Cash Flow Hedges
 
 
 
 
 
 
 
 
 
Interest rate swap
$
(45,145
)
 
$
(51,651
)
 
$
(1,043
)
 
$
(95,753
)
 
Interest expense
Cross-currency swap
177

 
5,907

 
(182
)
 
6,266

 
Other income (expense), net
Net Investment Hedges
 
 
 
 
 
 
 
 
 
Cross-currency swap
10,229

 
18,897

 
2,180

 
26,946

 
Interest income
 
$
(34,739
)
 
$
(26,847
)
 
$
955

 
$
(62,541
)
 
 
Three Months Ended March 31, 2019
 
 
 
 
 
 
 
 
 
Cash Flow Hedges
 
 
 
 
 
 
 
 
 
Interest rate swap
$
619

 
$
(15,891
)
 
$
1,406

 
$
(16,678
)
 
Interest expense
Cross-currency swap
(6,190
)
 
7,473

 
5,178

 
(3,895
)
 
Other income (expense), net
Net Investment Hedges
 
 
 
 
 
 
 
 
 
Cross-currency swap
(632
)
 
10,221

 
2,327

 
7,262

 
Interest income
 
$
(6,203
)
 
$
1,803

 
$
8,911

 
$
(13,311
)
 
 
XML 79 R17.htm IDEA: XBRL DOCUMENT v3.20.1
TREASURY STOCK
 3 Months Ended
Mar. 31, 2020
Treasury Stock Transactions, Excluding Value of Shares Reissued [Abstract]  
TREASURY STOCK TREASURY STOCK
As of March 31, 2020 and December 31, 2019, there were 4.3 million and 2.9 million shares of treasury stock outstanding with a cost of $202.5 million and $119.9 million, at a weighted average cost per share of $47.17 and $41.87, respectively.
On December 11, 2018, the Board of Directors authorized the Company to repurchase up to $225.0 million of the Company’s common stock. The program allows the Company to repurchase its shares opportunistically from time to time. The repurchase authorization expires in December 2020.

During the three months ended March 31, 2020, the Company repurchased 1.4 million shares of Integra’s common stock as part of our existing share repurchase authorization. The Company utilized $100.0 million of net proceeds from the offering of the Convertible Senior Notes to execute the share repurchase transactions. This included $7.6 million from certain purchasers of the convertible notes in conjunction with the closing of the offering. On February 5, 2020, the Company entered into a
$92.4 million accelerated share repurchase ("ASR") to complete the remaining $100.0 million of share repurchase. The Company received 1.3 million shares at inception of the ASR, which represented approximately 80% of the expected total shares. The remaining 20% of the expected total shares is expected to settle during the second quarter of 2020, upon which additional shares of common stock may be delivered to the Company or, under certain circumstances, the Company may be required to make a cash payment or may elect to deliver shares of our common stock to the ASR counterparty. The total number of shares to be delivered or the amount of such payment, as well as the final average price per share, will be based on the volume-weighted average price, less a discount, of the Company's common stock during the term of the transaction.

The Company has $125.0 million remaining under the share repurchase of its Common Stock. The price and timing of any future purchases under the share repurchase program will depend on factors such as levels of cash generation from operations, the volume of stock option exercises by employees, cash requirements for acquisitions, dividends, economic and market conditions and stock price.
JSON 80 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "iart-2020033110xq.htm": { "axisCustom": 3, "axisStandard": 35, "contextCount": 341, "dts": { "calculationLink": { "local": [ "iart-20200331_cal.xml" ] }, "definitionLink": { "local": [ "iart-20200331_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "iart-2020033110xq.htm" ] }, "labelLink": { "local": [ "iart-20200331_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "iart-20200331_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml", "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "iart-20200331.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 629, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2019-01-31": 22, "http://integralife.com/20200331": 5, "http://xbrl.sec.gov/dei/2019-01-31": 5, "total": 32 }, "keyCustom": 45, "keyStandard": 362, "memberCustom": 67, "memberStandard": 55, "nsprefix": "iart", "nsuri": "http://integralife.com/20200331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - DOCUMENT AND ENTITY INFORMATION", "role": "http://integralife.com/role/DocumentAndEntityInformation", "shortName": "DOCUMENT AND ENTITY INFORMATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2113100 - Disclosure - INVENTORIES", "role": "http://integralife.com/role/Inventories", "shortName": "INVENTORIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2114100 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS", "role": "http://integralife.com/role/GoodwillAndOtherIntangibleAssets", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2118100 - Disclosure - DEBT", "role": "http://integralife.com/role/Debt", "shortName": "DEBT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2121100 - Disclosure - DERIVATIVE INSTRUMENTS", "role": "http://integralife.com/role/DerivativeInstruments", "shortName": "DERIVATIVE INSTRUMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2123100 - Disclosure - STOCK-BASED COMPENSATION", "role": "http://integralife.com/role/StockBasedCompensation", "shortName": "STOCK-BASED COMPENSATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2124100 - Disclosure - RETIREMENT PLANS", "role": "http://integralife.com/role/RetirementPlans", "shortName": "RETIREMENT PLANS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2125100 - Disclosure - LEASES AND RELATED PARTY LEASES", "role": "http://integralife.com/role/LeasesAndRelatedPartyLeases", "shortName": "LEASES AND RELATED PARTY LEASES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TreasuryStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2126100 - Disclosure - TREASURY STOCK", "role": "http://integralife.com/role/TreasuryStock", "shortName": "TREASURY STOCK", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TreasuryStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2127100 - Disclosure - INCOME TAXES", "role": "http://integralife.com/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2128100 - Disclosure - NET INCOME PER SHARE", "role": "http://integralife.com/role/NetIncomePerShare", "shortName": "NET INCOME PER SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME / (LOSS)", "role": "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME / (LOSS)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2129100 - Disclosure - COMPREHENSIVE INCOME (LOSS)", "role": "http://integralife.com/role/ComprehensiveIncomeLoss", "shortName": "COMPREHENSIVE INCOME (LOSS)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2130100 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION", "role": "http://integralife.com/role/SegmentAndGeographicInformation", "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2131100 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://integralife.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2201201 - Disclosure - BASIS OF PRESENTATION (Policies)", "role": "http://integralife.com/role/BasisOfPresentationPolicies", "shortName": "BASIS OF PRESENTATION (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2305301 - Disclosure - BUSINESS DEVELOPMENT (Tables)", "role": "http://integralife.com/role/BusinessDevelopmentTables", "shortName": "BUSINESS DEVELOPMENT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2311301 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)", "role": "http://integralife.com/role/RevenuesFromContractsWithCustomersTables", "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2313301 - Disclosure - INVENTORIES (Tables)", "role": "http://integralife.com/role/InventoriesTables", "shortName": "INVENTORIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2314301 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)", "role": "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsTables", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2318301 - Disclosure - DEBT (Tables)", "role": "http://integralife.com/role/DebtTables", "shortName": "DEBT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2321301 - Disclosure - DERIVATIVE INSTRUMENTS (Tables)", "role": "http://integralife.com/role/DerivativeInstrumentsTables", "shortName": "DERIVATIVE INSTRUMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS", "role": "http://integralife.com/role/CondensedConsolidatedBalanceSheets", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "iart:AssetsAndLiabilitiesLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2325301 - Disclosure - LEASES AND RELATED PARTY LEASES (Tables)", "role": "http://integralife.com/role/LeasesAndRelatedPartyLeasesTables", "shortName": "LEASES AND RELATED PARTY LEASES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "iart:AssetsAndLiabilitiesLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2327301 - Disclosure - INCOME TAXES (Tables)", "role": "http://integralife.com/role/IncomeTaxesTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2328301 - Disclosure - NET INCOME PER SHARE (Tables)", "role": "http://integralife.com/role/NetIncomePerShareTables", "shortName": "NET INCOME PER SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2329301 - Disclosure - COMPREHENSIVE INCOME (LOSS) (Tables)", "role": "http://integralife.com/role/ComprehensiveIncomeLossTables", "shortName": "COMPREHENSIVE INCOME (LOSS) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2330301 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Tables)", "role": "http://integralife.com/role/SegmentAndGeographicInformationTables", "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2331301 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)", "role": "http://integralife.com/role/CommitmentsAndContingenciesTables", "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "D2019Q3Jul29-Jul29_us-gaap_BusinessAcquisitionAxis_iart_ArkisBioSciencesInc.Member", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405402 - Disclosure - BUSINESS DEVELOPMENT - Business Combination, Narrative (Details)", "role": "http://integralife.com/role/BusinessDevelopmentBusinessCombinationNarrativeDetails", "shortName": "BUSINESS DEVELOPMENT - Business Combination, Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "D2019Q3Jul29-Jul29_us-gaap_BusinessAcquisitionAxis_iart_ArkisBioSciencesInc.Member", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405403 - Disclosure - BUSINESS DEVELOPMENT - Business Combination, Schedule of Purchase Price Allocation (Details)", "role": "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails", "shortName": "BUSINESS DEVELOPMENT - Business Combination, Schedule of Purchase Price Allocation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "I2019Q3Jul29_us-gaap_BusinessAcquisitionAxis_iart_ArkisBioSciencesInc.Member", "decimals": "-3", "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405404 - Disclosure - BUSINESS DEVELOPMENT - Asset Acquisition, Narrative (Details)", "role": "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails", "shortName": "BUSINESS DEVELOPMENT - Asset Acquisition, Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "D2019Q3Sep09-Sep09_iart_AssetAcquisitionAxis_iart_ReboundTherapeuticsCorporationMember", "decimals": "-5", "lang": null, "name": "iart:AssetAcquisitionConsiderationTransferred", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "iart:ReturnPolicyIssueOfCreditNumberOfDaysFromShipment", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411402 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative (Details)", "role": "http://integralife.com/role/RevenuesFromContractsWithCustomersNarrativeDetails", "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "iart:ReturnPolicyIssueOfCreditNumberOfDaysFromShipment", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": null, "groupType": "statement", "isDefault": "false", "longName": "1002501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "role": "http://integralife.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R40": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain_2020-04-01", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411403 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative, Revenue Remaining Performance Obligation (Details)", "role": "http://integralife.com/role/RevenuesFromContractsWithCustomersNarrativeRevenueRemainingPerformanceObligationDetails", "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative, Revenue Remaining Performance Obligation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain_2020-04-01", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2019Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerAssetNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411404 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Changes in Contract Assets and Liabilities (Details)", "role": "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfChangesInContractAssetsAndLiabilitiesDetails", "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Changes in Contract Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2019Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerAssetNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411405 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Revenues Disaggregated by Major Source (Details)", "role": "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfRevenuesDisaggregatedByMajorSourceDetails", "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Revenues Disaggregated by Major Source (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1QTD_srt_ProductOrServiceAxis_iart_NeurosurgeryMember_us-gaap_StatementBusinessSegmentsAxis_iart_CodmanSpecialtySurgicalMember", "decimals": "-3", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413402 - Disclosure - INVENTORIES - Schedule of Net Inventories (Details)", "role": "http://integralife.com/role/InventoriesScheduleOfNetInventoriesDetails", "shortName": "INVENTORIES - Schedule of Net Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2019Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414402 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in Carrying Amount of Goodwill (Details)", "role": "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfChangesInCarryingAmountOfGoodwillDetails", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in Carrying Amount of Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "-3", "lang": null, "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1", "decimals": "-3", "first": true, "lang": null, "name": "iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414403 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Components of Company's Identifiable Intangible Assets (Details)", "role": "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfCompanysIdentifiableIntangibleAssetsDetails", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Components of Company's Identifiable Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1", "decimals": "-3", "first": true, "lang": null, "name": "iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414404 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)", "role": "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ConvertibleDebtNoncurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2418402 - Disclosure - DEBT - Narrative (Details)", "role": "http://integralife.com/role/DebtNarrativeDetails", "shortName": "DEBT - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2018Q4", "decimals": "INF", "lang": null, "name": "iart:TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": null, "groupType": "disclosure", "isDefault": "false", "longName": "2418403 - Disclosure - DEBT - Maximum Total Leverage Ratio Table (Details)", "role": "http://integralife.com/role/DebtMaximumTotalLeverageRatioTableDetails", "shortName": "DEBT - Maximum Total Leverage Ratio Table (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R49": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2418404 - Disclosure - DEBT - Contractual Maturity Table (Details)", "role": "http://integralife.com/role/DebtContractualMaturityTableDetails", "shortName": "DEBT - Contractual Maturity Table (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "-3", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2421402 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Derivatives (Details)", "role": "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails", "shortName": "DERIVATIVE INSTRUMENTS - Schedule of Derivatives (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1_us-gaap_DerivativeInstrumentRiskAxis_iart_InterestRateSwapDesignatedFebruary62017Tranche1Member_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_VariableRateAxis_iart_ThreeMonthUSDLIBORMember", "decimals": "INF", "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1QTD_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2421403 - Disclosure - DERIVATIVE INSTRUMENTS - Narrative (Details)", "role": "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails", "shortName": "DERIVATIVE INSTRUMENTS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CrossCurrencyInterestRateContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_NetInvestmentHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember", "decimals": "-5", "lang": null, "name": "us-gaap:GainLossOnDerivativeInstrumentsNetPretax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "I2017Q4Oct02_us-gaap_BusinessAcquisitionAxis_iart_CodmanMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CrossCurrencyInterestRateContractMember_us-gaap_PositionAxis_us-gaap_LongMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unitRef": "chf", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2421404 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Cross Currency Swap Derivatives (Details)", "role": "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails", "shortName": "DERIVATIVE INSTRUMENTS - Schedule of Cross Currency Swap Derivatives (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1_us-gaap_BusinessAcquisitionAxis_iart_CodmanMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CrossCurrencyInterestRateContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember", "decimals": "-3", "lang": null, "name": "us-gaap:DerivativeFairValueOfDerivativeNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1_us-gaap_DerivativeInstrumentRiskAxis_iart_CrossCurrencyInterestRateContractOneMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_NetInvestmentHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DerivativeFairValueOfDerivativeNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2421405 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Net Investment Hedges Derivatives (Details)", "role": "http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails", "shortName": "DERIVATIVE INSTRUMENTS - Schedule of Net Investment Hedges Derivatives (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1_us-gaap_DerivativeInstrumentRiskAxis_iart_CrossCurrencyInterestRateContractOneMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_NetInvestmentHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DerivativeFairValueOfDerivativeNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2421406 - Disclosure - DERIVATIVE INSTRUMENTS - Fair Value of Derivative Instruments By Balance Sheet Location (Details)", "role": "http://integralife.com/role/DerivativeInstrumentsFairValueOfDerivativeInstrumentsByBalanceSheetLocationDetails", "shortName": "DERIVATIVE INSTRUMENTS - Fair Value of Derivative Instruments By Balance Sheet Location (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2019Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2421407 - Disclosure - DERIVATIVE INSTRUMENTS - Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations (Details)", "role": "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails", "shortName": "DERIVATIVE INSTRUMENTS - Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1QTD_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember", "decimals": "-3", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "INF", "first": true, "lang": null, "name": "iart:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans", "reportCount": 1, "unique": true, "unitRef": "plan", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2423401 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)", "role": "http://integralife.com/role/StockBasedCompensationNarrativeDetails", "shortName": "STOCK-BASED COMPENSATION - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "INF", "first": true, "lang": null, "name": "iart:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans", "reportCount": 1, "unique": true, "unitRef": "plan", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2424401 - Disclosure - RETIREMENT PLANS - Narrative (Details)", "role": "http://integralife.com/role/RetirementPlansNarrativeDetails", "shortName": "RETIREMENT PLANS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "INF", "first": true, "lang": null, "name": "iart:LesseeOperatingLeaseNumberOfRenewalOptions", "reportCount": 1, "unique": true, "unitRef": "renewal_option", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2425402 - Disclosure - LEASES AND RELATED PARTY LEASES - Narrative (Details)", "role": "http://integralife.com/role/LeasesAndRelatedPartyLeasesNarrativeDetails", "shortName": "LEASES AND RELATED PARTY LEASES - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "INF", "first": true, "lang": null, "name": "iart:LesseeOperatingLeaseNumberOfRenewalOptions", "reportCount": 1, "unique": true, "unitRef": "renewal_option", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2425403 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details)", "role": "http://integralife.com/role/LeasesAndRelatedPartyLeasesSupplementalBalanceSheetInformationDetails", "shortName": "LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember", "decimals": null, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDER'S EQUITY", "role": "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDER'S EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "iart:CashFlowLesseeTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2425404 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)", "role": "http://integralife.com/role/LeasesAndRelatedPartyLeasesSupplementalCashFlowInformationDetails", "shortName": "LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "iart:CashFlowLesseeTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2019Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2425405 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases, After Adoption of 842 (Details)", "role": "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details", "shortName": "LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases, After Adoption of 842 (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2019Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:TreasuryStockCommonShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2426401 - Disclosure - TREASURY STOCK - Narrative (Details)", "role": "http://integralife.com/role/TreasuryStockNarrativeDetails", "shortName": "TREASURY STOCK - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:TreasuryStockCommonShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2427402 - Disclosure - INCOME TAXES - Summary of Effective Tax Rate (Details)", "role": "http://integralife.com/role/IncomeTaxesSummaryOfEffectiveTaxRateDetails", "shortName": "INCOME TAXES - Summary of Effective Tax Rate (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R64": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2427403 - Disclosure - INCOME TAXES - Narrative (Details)", "role": "http://integralife.com/role/IncomeTaxesNarrativeDetails", "shortName": "INCOME TAXES - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1", "decimals": "-5", "lang": null, "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2428402 - Disclosure - NET INCOME PER SHARE - Basic and Diluted Net Income Per Share (Details)", "role": "http://integralife.com/role/NetIncomePerShareBasicAndDilutedNetIncomePerShareDetails", "shortName": "NET INCOME PER SHARE - Basic and Diluted Net Income Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "-3", "lang": null, "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2428403 - Disclosure - NET INCOME PER SHARE - Narrative (Details)", "role": "http://integralife.com/role/NetIncomePerShareNarrativeDetails", "shortName": "NET INCOME PER SHARE - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2429402 - Disclosure - COMPREHENSIVE INCOME (LOSS) - Schedule of Comprehensive Income (Details)", "role": "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfComprehensiveIncomeDetails", "shortName": "COMPREHENSIVE INCOME (LOSS) - Schedule of Comprehensive Income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "-3", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2019Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2429403 - Disclosure - COMPREHENSIVE INCOME (LOSS) - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details)", "role": "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfChangesInAccumulatedOtherComprehensiveIncomeByComponentDetails", "shortName": "COMPREHENSIVE INCOME (LOSS) - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "-3", "lang": null, "name": "us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2429404 - Disclosure - COMPREHENSIVE INCOME (LOSS) - Narrative (Details)", "role": "http://integralife.com/role/ComprehensiveIncomeLossNarrativeDetails", "shortName": "COMPREHENSIVE INCOME (LOSS) - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherExpenseMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember", "decimals": "-5", "lang": null, "name": "us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101100 - Disclosure - BASIS OF PRESENTATION", "role": "http://integralife.com/role/BasisOfPresentation", "shortName": "BASIS OF PRESENTATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "Segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2430402 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details)", "role": "http://integralife.com/role/SegmentAndGeographicInformationNarrativeDetails", "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "Segment", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2430403 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Net Sales and Profit by Reportable Segment (Details)", "role": "http://integralife.com/role/SegmentAndGeographicInformationNetSalesAndProfitByReportableSegmentDetails", "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION - Net Sales and Profit by Reportable Segment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember", "decimals": "-3", "lang": null, "name": "us-gaap:OperatingIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2430404 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Total Revenue by Major Geographic Area (Details)", "role": "http://integralife.com/role/SegmentAndGeographicInformationTotalRevenueByMajorGeographicAreaDetails", "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION - Total Revenue by Major Geographic Area (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1QTD_srt_StatementGeographicalAxis_country_US", "decimals": "-3", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2019Q4_us-gaap_BusinessAcquisitionAxis_iart_ArkisBioSciencesInc.Member_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_iart_ContingentConsiderationLiabilityMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2431402 - Disclosure - COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details)", "role": "http://integralife.com/role/CommitmentsAndContingenciesFairValueContingentConsiderationBalanceInformationDetails", "shortName": "COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2019Q4_us-gaap_BusinessAcquisitionAxis_iart_ArkisBioSciencesInc.Member_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_iart_ContingentConsiderationLiabilityMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "span", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1_us-gaap_BusinessAcquisitionAxis_iart_DermaSciencesMember", "decimals": "INF", "first": true, "lang": null, "name": "iart:BusinessCombinationContingentConsiderationNumberOfLiabilities", "reportCount": 1, "unique": true, "unitRef": "liability", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2431403 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details)", "role": "http://integralife.com/role/CommitmentsAndContingenciesNarrativeDetails", "shortName": "COMMITMENTS AND CONTINGENCIES - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FI2020Q1_us-gaap_BusinessAcquisitionAxis_iart_DermaSciencesMember", "decimals": "INF", "first": true, "lang": null, "name": "iart:BusinessCombinationContingentConsiderationNumberOfLiabilities", "reportCount": 1, "unique": true, "unitRef": "liability", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "iart:BusinessCombinationAndAssetAcquisitionDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2105100 - Disclosure - BUSINESS DEVELOPMENT", "role": "http://integralife.com/role/BusinessDevelopment", "shortName": "BUSINESS DEVELOPMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "iart:BusinessCombinationAndAssetAcquisitionDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2111100 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS", "role": "http://integralife.com/role/RevenuesFromContractsWithCustomers", "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9999": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "iart-2020033110xq.htm", "contextRef": "I2020Q1Jan01-2020_iart_CumulativeEffectPeriodOfAdoptionAxis_iart_CumulativeEffectPeriodOfAdoptionAdjustmentMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "", "isDefault": "false", "longName": "Uncategorized Items - iart-2020033110xq.htm", "role": "http://xbrl.sec.gov/role/uncategorizedFacts", "shortName": "Uncategorized Items - iart-2020033110xq.htm", "subGroupType": "", "uniqueAnchor": null } }, "segmentCount": 123, "tag": { "country_US": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://integralife.com/role/SegmentAndGeographicInformationTotalRevenueByMajorGeographicAreaDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r415" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r416" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity City" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity State" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r414" ], "lang": { "en-US": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current", "terseLabel": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r417" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r417" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r417" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r418" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r417" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r417" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r417" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Smaller Reporting Company" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r417" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r412" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r413" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://integralife.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Accelerated Share Repurchases, Percentage Of Expected Total Repurchased", "label": "Accelerated Share Repurchases, Percentage Of Expected Total Repurchased", "terseLabel": "Accelerated share repurchases, percentage of expected total repurchased" } } }, "localname": "AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/TreasuryStockNarrativeDetails" ], "xbrltype": "percentItemType" }, "iart_AccruedExpensesAndOtherCurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Accrued expenses and other current liabilities.", "label": "Accrued Expenses And Other Current Liabilities [Member]", "terseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "AccruedExpensesAndOtherCurrentLiabilitiesMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsFairValueOfDerivativeInstrumentsByBalanceSheetLocationDetails" ], "xbrltype": "domainItemType" }, "iart_AcquiredFinitelivedIntangibleAssetsDiscountRate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Acquired Finite-lived Intangible Assets, Discount Rate", "label": "Acquired Finite-lived Intangible Assets, Discount Rate", "terseLabel": "Acquired intangible assets, discount rate" } } }, "localname": "AcquiredFinitelivedIntangibleAssetsDiscountRate", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationNarrativeDetails" ], "xbrltype": "percentItemType" }, "iart_AdditionalEPSShares": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Additional shares included in the basic and diluted calculation from their date of issuance because no further consideration is due related to the issuance of the underlying common shares", "label": "Additional EPS Shares", "terseLabel": "Additional EPS shares (in shares)" } } }, "localname": "AdditionalEPSShares", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/NetIncomePerShareNarrativeDetails" ], "xbrltype": "sharesItemType" }, "iart_AllOtherMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "All Other [Member]", "label": "All Other [Member]", "terseLabel": "All other" } } }, "localname": "AllOtherMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees": { "auth_ref": [], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amortization Of Debt Issuance Costs And Debt Refinanced Fees", "label": "Amortization Of Debt Issuance Costs And Debt Refinanced Fees", "terseLabel": "Amortization of debt issuance costs and expenses associated with debt refinancing" } } }, "localname": "AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "iart_AnnualRateOfLeaseAgreement": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Annual rate of lease agreement.", "label": "Annual Rate Of Lease Agreement", "terseLabel": "Annual rate of lease agreement" } } }, "localname": "AnnualRateOfLeaseAgreement", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_ArkisBioSciencesInc.Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Arkis BioSciences Inc. [Member]", "label": "Arkis BioSciences Inc. [Member]", "terseLabel": "Arkis" } } }, "localname": "ArkisBioSciencesInc.Member", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationNarrativeDetails", "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails", "http://integralife.com/role/CommitmentsAndContingenciesFairValueContingentConsiderationBalanceInformationDetails" ], "xbrltype": "domainItemType" }, "iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Asset Acquisition, Assets Acquired And Liabilities Assumed, Net", "label": "Asset Acquisition, Assets Acquired And Liabilities Assumed, Net", "terseLabel": "Remaining net assets acquired" } } }, "localname": "AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_AssetAcquisitionAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Asset Acquisition [Axis]", "label": "Asset Acquisition [Axis]", "terseLabel": "Asset Acquisition [Axis]" } } }, "localname": "AssetAcquisitionAxis", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "iart_AssetAcquisitionConsiderationTransferred": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Asset Acquisition, Consideration Transferred", "label": "Asset Acquisition, Consideration Transferred", "terseLabel": "Upfront payment" } } }, "localname": "AssetAcquisitionConsiderationTransferred", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Asset Acquisition, Development Milestone Payment", "label": "Asset Acquisition, Development Milestone Payment To Be Paid", "terseLabel": "Development milestone" } } }, "localname": "AssetAcquisitionDevelopmentMilestonePaymentToBePaid", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_AssetAcquisitionDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Domain] for Asset Acquisition [Axis]", "label": "Asset Acquisition [Domain]", "terseLabel": "Asset Acquisition [Domain]" } } }, "localname": "AssetAcquisitionDomain", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Asset Acquisition, Maximum Contingent Development Milestone Payments", "label": "Asset Acquisition, Maximum Contingent Development Milestone Payments, If Circumstances Met", "terseLabel": "Contingent development milestone payments commitment (up to)" } } }, "localname": "AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Asset Acquisition, Maximum Future Consideration Transferred, If Circumstances Met", "label": "Asset Acquisition, Maximum Future Consideration Transferred, If Circumstances Met", "terseLabel": "Maximum future purchase price, if circumstances met (not to exceed)" } } }, "localname": "AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_AssetAcquisitionNumberOfAssetsAcquired": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Asset Acquisition, Number Of Assets Acquired", "label": "Asset Acquisition, Number Of Assets Acquired", "terseLabel": "Number of assets acquired" } } }, "localname": "AssetAcquisitionNumberOfAssetsAcquired", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails" ], "xbrltype": "integerItemType" }, "iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Asset Acquisition, Option To Acquire, Period Subsequent To Commercial Sale, If Circumstances Met", "label": "Asset Acquisition, Option To Acquire, Period Subsequent To Commercial Sale, If Circumstances Met", "terseLabel": "Option to acquire, period subsequent to first commercial sale" } } }, "localname": "AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails" ], "xbrltype": "durationItemType" }, "iart_AssetsAndLiabilitiesLesseeTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Assets And Liabilities, Lessee [Table Text Block]", "label": "Assets And Liabilities, Lessee [Table Text Block]", "terseLabel": "Supplemental Balance Sheet Information" } } }, "localname": "AssetsAndLiabilitiesLesseeTableTextBlock", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesTables" ], "xbrltype": "textBlockItemType" }, "iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "BioD Earnout Payments and Medihoney Earnout Payments [Member]", "label": "BioD Earnout Payments and Medihoney Earnout Payments [Member]", "terseLabel": "BioD Earnout Payments and Medihoney Earnout Payments" } } }, "localname": "BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_BusinessCombinationAndAssetAcquisitionDisclosureTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Business Combination And Asset Acquisition Disclosure [Text Block]", "label": "Business Combination And Asset Acquisition Disclosure [Text Block]", "terseLabel": "BUSINESS DEVELOPMENT" } } }, "localname": "BusinessCombinationAndAssetAcquisitionDisclosureTextBlock", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/BusinessDevelopment" ], "xbrltype": "textBlockItemType" }, "iart_BusinessCombinationContingentConsiderationNumberOfLiabilities": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Business Combination, Contingent Consideration, Number Of Liabilities", "label": "Business Combination, Contingent Consideration, Number Of Liabilities", "terseLabel": "Number of contingent liabilities remaining" } } }, "localname": "BusinessCombinationContingentConsiderationNumberOfLiabilities", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities": { "auth_ref": [], "calculation": { "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accounts Payable, Accrued Expenses And Other Liabilities", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accounts Payable, Accrued Expenses And Other Liabilities", "terseLabel": "Accounts payable, accrued expenses and other liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill": { "auth_ref": [], "calculation": { "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill", "totalLabel": "Total assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "iart_CashFlowLesseeAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cash Flow, Lessee [Abstract]", "label": "Cash Flow, Lessee [Abstract]", "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:" } } }, "localname": "CashFlowLesseeAbstract", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesSupplementalCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "iart_CashFlowLesseeTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cash Flow, Lessee [Table Text Block]", "label": "Cash Flow, Lessee [Table Text Block]", "terseLabel": "Supplemental Cash Flow Information" } } }, "localname": "CashFlowLesseeTableTextBlock", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesTables" ], "xbrltype": "textBlockItemType" }, "iart_CertainPurchasersMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Certain Purchasers [Member]", "label": "Certain Purchasers [Member]", "terseLabel": "Certain Purchasers" } } }, "localname": "CertainPurchasersMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/TreasuryStockNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_ChangeInContractWithCustomerAssetRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Change In Contract With Customer, Asset [Roll Forward]", "label": "Change In Contract With Customer, Asset [Roll Forward]", "terseLabel": "Contract Asset" } } }, "localname": "ChangeInContractWithCustomerAssetRollForward", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfChangesInContractAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "iart_ChangeInContractWithCustomerLiabilityRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Change In Contract With Customer, Liability [Roll Forward]", "label": "Change In Contract With Customer, Liability [Roll Forward]", "terseLabel": "Contract Liability" } } }, "localname": "ChangeInContractWithCustomerLiabilityRollForward", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfChangesInContractAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "iart_ChangesInAssetsAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Changes In Assets And Liabilities [Abstract]", "label": "Changes In Assets And Liabilities [Abstract]", "terseLabel": "Changes in assets and liabilities:" } } }, "localname": "ChangesInAssetsAndLiabilitiesAbstract", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "iart_CodmanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Codman [Member]", "label": "Codman [Member]", "terseLabel": "Codman" } } }, "localname": "CodmanMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_CodmanSpecialtySurgicalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Codman Specialty Surgical [Member]", "label": "Codman Specialty Surgical [Member]", "terseLabel": "Codman Specialty Surgical", "verboseLabel": "Codman Specialty Surgical" } } }, "localname": "CodmanSpecialtySurgicalMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfChangesInCarryingAmountOfGoodwillDetails", "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfRevenuesDisaggregatedByMajorSourceDetails", "http://integralife.com/role/SegmentAndGeographicInformationNarrativeDetails", "http://integralife.com/role/SegmentAndGeographicInformationNetSalesAndProfitByReportableSegmentDetails" ], "xbrltype": "domainItemType" }, "iart_CompletedTechnologyMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Completed technology.", "label": "Completed Technology [Member]", "terseLabel": "Completed technology" } } }, "localname": "CompletedTechnologyMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "iart_ContingentConsiderationLiabilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Contingent Consideration Liability [Member]", "label": "Contingent Consideration Liability [Member]", "terseLabel": "Contingent Consideration Liability" } } }, "localname": "ContingentConsiderationLiabilityMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/CommitmentsAndContingenciesFairValueContingentConsiderationBalanceInformationDetails" ], "xbrltype": "domainItemType" }, "iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Contract With Customer, Asset, Net Of Reclassified To Receivable", "label": "Contract With Customer, Asset, Net Of Reclassified To Receivable", "terseLabel": "Contract asset, net of transferred to trade receivables on contracts during the period" } } }, "localname": "ContractWithCustomerAssetNetOfReclassifiedToReceivable", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfChangesInContractAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Contract With Customer, Liability, Increase From Foreign Currency Translation", "label": "Contract With Customer, Liability, Increase From Foreign Currency Translation", "terseLabel": "Foreign currency translation" } } }, "localname": "ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfChangesInContractAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Contract With Customer, Liability, Net Of Revenue Recognized And Foreign Currency Translation", "label": "Contract With Customer, Liability, Net Of Revenue Recognized And Foreign Currency Translation", "terseLabel": "Contract liability, net of revenue recognized on contracts during the period" } } }, "localname": "ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfChangesInContractAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [], "calculation": { "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfCompanysIdentifiableIntangibleAssetsDetails": { "order": 1.0, "parentTag": "iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill.", "label": "Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill", "terseLabel": "Cost" } } }, "localname": "CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "iart_CrossCurrencyInterestRateContractFiveMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cross Currency Interest Rate Contract Five [Member]", "label": "Cross Currency Interest Rate Contract Five [Member]", "terseLabel": "Cross Currency Interest Rate Swap Five" } } }, "localname": "CrossCurrencyInterestRateContractFiveMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_CrossCurrencyInterestRateContractFourMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cross Currency Interest Rate Contract Four [Member]", "label": "Cross Currency Interest Rate Contract Four [Member]", "terseLabel": "Cross Currency Interest Rate Swap Four" } } }, "localname": "CrossCurrencyInterestRateContractFourMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_CrossCurrencyInterestRateContractOneMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cross Currency Interest Rate Contract One [Member]", "label": "Cross Currency Interest Rate Contract One [Member]", "terseLabel": "Cross Currency Interest Rate Swap One" } } }, "localname": "CrossCurrencyInterestRateContractOneMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_CrossCurrencyInterestRateContractThreeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cross Currency Interest Rate Contract Three [Member]", "label": "Cross Currency Interest Rate Contract Three [Member]", "terseLabel": "Cross Currency Interest Rate Swap Three" } } }, "localname": "CrossCurrencyInterestRateContractThreeMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_CrossCurrencyInterestRateContractTwoMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cross Currency Interest Rate Contract Two [Member]", "label": "Cross Currency Interest Rate Contract Two [Member]", "terseLabel": "Cross Currency Interest Rate Swap Two" } } }, "localname": "CrossCurrencyInterestRateContractTwoMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cumulative Effect, Period Of Adoption, Adjustment [Member]", "label": "Cumulative Effect, Period Of Adoption, Adjustment [Member]", "terseLabel": "Cumulative Effect, Period Of Adoption, Adjustment" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "iart_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cumulative Effect, Period Of Adoption [Axis]", "label": "Cumulative Effect, Period Of Adoption [Axis]", "terseLabel": "Cumulative Effect, Period Of Adoption [Axis]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "iart_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Domain] for Cumulative Effect, Period Of Adoption [Axis]", "label": "Cumulative Effect, Period Of Adoption [Domain]", "terseLabel": "Cumulative Effect, Period Of Adoption [Domain]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "iart_DebtAccountsReceivableSecuritizationTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt, Accounts Receivable Securitization, Term", "label": "Debt, Accounts Receivable Securitization, Term", "terseLabel": "Securitization program, term" } } }, "localname": "DebtAccountsReceivableSecuritizationTerm", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "iart_DebtCovenantPeriod1Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Covenant Period 1 [Member]", "label": "Debt Covenant Period 1 [Member]", "terseLabel": "First fiscal quarter ending after the Closing Date through June 30, 2022" } } }, "localname": "DebtCovenantPeriod1Member", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DebtMaximumTotalLeverageRatioTableDetails" ], "xbrltype": "domainItemType" }, "iart_DebtCovenantPeriod2Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Covenant Period 2 [Member]", "label": "Debt Covenant Period 2 [Member]", "terseLabel": "September 30, 2022 through June 30, 2023" } } }, "localname": "DebtCovenantPeriod2Member", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DebtMaximumTotalLeverageRatioTableDetails" ], "xbrltype": "domainItemType" }, "iart_DebtCovenantPeriod3Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Covenant Period 3 [Member]", "label": "Debt Covenant Period 3 [Member]", "terseLabel": "September 30, 2023 and the last day of each fiscal quarter thereafter" } } }, "localname": "DebtCovenantPeriod3Member", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DebtMaximumTotalLeverageRatioTableDetails" ], "xbrltype": "domainItemType" }, "iart_DebtCovenantPeriodAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Covenant Period [Axis]", "label": "Debt Covenant Period [Axis]", "terseLabel": "Debt Covenant Period [Axis]" } } }, "localname": "DebtCovenantPeriodAxis", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DebtMaximumTotalLeverageRatioTableDetails" ], "xbrltype": "stringItemType" }, "iart_DebtCovenantPeriodDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Domain] for Debt Covenant Period [Axis]", "label": "Debt Covenant Period [Domain]", "terseLabel": "Debt Covenant Period [Domain]" } } }, "localname": "DebtCovenantPeriodDomain", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DebtMaximumTotalLeverageRatioTableDetails" ], "xbrltype": "domainItemType" }, "iart_DebtInstrumentCovenantMaximumLeverageRatio": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Covenant, Maximum Leverage Ratio", "label": "Debt Instrument, Covenant, Maximum Leverage Ratio", "terseLabel": "Maximum Consolidated Total Leverage Ratio" } } }, "localname": "DebtInstrumentCovenantMaximumLeverageRatio", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DebtMaximumTotalLeverageRatioTableDetails" ], "xbrltype": "pureItemType" }, "iart_DebtInstrumentMaximumAverageConversionValueOfNotes": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Maximum Average Conversion Value Of Notes", "label": "Debt Instrument, Maximum Average Conversion Value Of Notes", "terseLabel": "Maximum average conversion value of notes" } } }, "localname": "DebtInstrumentMaximumAverageConversionValueOfNotes", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period", "label": "Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period", "terseLabel": "Maximum selling price of the company's common stock of the conversion price" } } }, "localname": "DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "iart_DebtWeightedAverageInterestRateFromSecuritization": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt, Weighted Average Interest Rate, From Securitization", "label": "Debt, Weighted Average Interest Rate, From Securitization", "terseLabel": "Weighted average interest rate, accounts receivable securitization revolving loan facility" } } }, "localname": "DebtWeightedAverageInterestRateFromSecuritization", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "iart_DeferredTaxAssetMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Deferred Tax Asset [Member]", "label": "Deferred Tax Asset [Member]", "terseLabel": "Deferred Tax Asset" } } }, "localname": "DeferredTaxAssetMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage", "label": "Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage", "terseLabel": "Defer payment and taxation, base salary, percentage (up to)" } } }, "localname": "DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/RetirementPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage", "label": "Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage", "terseLabel": "Defer payment and taxation, bonus and other eligible cash compensation, percentage (up to)" } } }, "localname": "DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/RetirementPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill": { "auth_ref": [], "calculation": { "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfCompanysIdentifiableIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill.", "label": "Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill", "totalLabel": "Net" } } }, "localname": "DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "iart_DermaSciencesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Derma Sciences [Member]", "label": "Derma Sciences [Member]", "terseLabel": "Derma Sciences" } } }, "localname": "DermaSciencesMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/CommitmentsAndContingenciesFairValueContingentConsiderationBalanceInformationDetails", "http://integralife.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_DirectorsandCertainExecutiveOfficersMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Directors and Certain Executive Officers [Member]", "label": "Directors and Certain Executive Officers [Member]", "terseLabel": "Directors and Certain Executive Officers" } } }, "localname": "DirectorsandCertainExecutiveOfficersMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_EffectiveIncomeTaxRateReconciliationTaxHolidayPerShare": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Tax Holiday, Per Share", "label": "Effective Income Tax Rate Reconciliation, Tax Holiday, Per Share", "terseLabel": "Effective income tax rate reconciliation, tax benefit, federal tax holiday (in dollars per share)" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxHolidayPerShare", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "perShareItemType" }, "iart_EmployeeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Employee [Member]", "label": "Employee [Member]", "terseLabel": "Employees" } } }, "localname": "EmployeeMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_ExtremityOrthopedicsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Extremity Orthopedics [Member]", "label": "Extremity Orthopedics [Member]", "terseLabel": "Extremity Orthopedics" } } }, "localname": "ExtremityOrthopedicsMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfRevenuesDisaggregatedByMajorSourceDetails" ], "xbrltype": "domainItemType" }, "iart_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearSix": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Finite-Lived Intangible Assets, Amortization Expense, After Year Six", "label": "Finite-Lived Intangible Assets, Amortization Expense, After Year Six", "terseLabel": "Expected annual amortization expense, thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearSix", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Finite-Lived Intangible Assets, Amortization Expense, Year Six", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Six", "terseLabel": "Expected annual amortization expense, in 2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearSix", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_FiveYearOptionLeaseFromNovember12032ThroughOctober312037Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Five-Year Option Lease From November 1, 2032 Through October 31, 2037 member", "label": "Five Year Option Lease From November12032 Through October312037 [Member]", "terseLabel": "Five Year Option Lease From November 1, 2032 Through October 31, 2037" } } }, "localname": "FiveYearOptionLeaseFromNovember12032ThroughOctober312037Member", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_FiveYearOptionLeaseFromNovember12037ThroughOctober312042Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Five-Year Option Lease From November 1, 2037 Through October 31, 2042 [Member]", "label": "Five Year Option Lease From November12037 Through October312042 [Member]", "terseLabel": "Five Year Option Lease From November 1, 2037 Through October 31, 2042" } } }, "localname": "FiveYearOptionLeaseFromNovember12037ThroughOctober312042Member", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_InstrumentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Instruments [Member]", "label": "Instruments [Member]", "terseLabel": "Instruments" } } }, "localname": "InstrumentsMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfRevenuesDisaggregatedByMajorSourceDetails" ], "xbrltype": "domainItemType" }, "iart_IntegratedShoulderCollaborationInc.Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Integrated Shoulder Collaboration, Inc. [Member]", "label": "Integrated Shoulder Collaboration, Inc. [Member]", "terseLabel": "ISC" } } }, "localname": "IntegratedShoulderCollaborationInc.Member", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_InterestRateSwapDesignatedDecember132017Tranche1Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest Rate Swap Designated December 13, 2017 Tranche 1 [Member]", "label": "Interest Rate Swap Designated December 13, 2017 Tranche 1 [Member]", "terseLabel": "Interest Rate Swap Designated December 13, 2017 Tranche 1" } } }, "localname": "InterestRateSwapDesignatedDecember132017Tranche1Member", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_InterestRateSwapDesignatedDecember132017Tranche2Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest Rate Swap Designated December 13, 2017 Tranche 2 [Member]", "label": "Interest Rate Swap Designated December 13, 2017 Tranche 2 [Member]", "terseLabel": "Interest Rate Swap Designated December 13, 2017 Tranche 2" } } }, "localname": "InterestRateSwapDesignatedDecember132017Tranche2Member", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_InterestRateSwapDesignatedDecember132017Tranche3Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest Rate Swap Designated December 13, 2017 Tranche 3 [Member]", "label": "Interest Rate Swap Designated December 13, 2017 Tranche 3 [Member]", "terseLabel": "Interest Rate Swap Designated December 13, 2017 Tranche 3" } } }, "localname": "InterestRateSwapDesignatedDecember132017Tranche3Member", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_InterestRateSwapDesignatedDecember132017Tranche4Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest Rate Swap Designated December 13, 2017 Tranche 4 [Member]", "label": "Interest Rate Swap Designated December 13, 2017 Tranche 4 [Member]", "terseLabel": "Interest Rate Swap Designated December 13, 2017 Tranche 4" } } }, "localname": "InterestRateSwapDesignatedDecember132017Tranche4Member", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_InterestRateSwapDesignatedDecember132017Tranche5Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest Rate Swap Designated December 13, 2017 Tranche 5 [Member]", "label": "Interest Rate Swap Designated December 13, 2017 Tranche 5 [Member]", "terseLabel": "Interest Rate Swap Designated December 13, 2017 Tranche 5" } } }, "localname": "InterestRateSwapDesignatedDecember132017Tranche5Member", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_InterestRateSwapDesignatedDecember182018Tranche1Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest Rate Swap Designated December 18, 2018 Tranche 1 [Member]", "label": "Interest Rate Swap Designated December 18, 2018 Tranche 1 [Member]", "terseLabel": "Interest Rate Swap Designated December 18, 2018 Tranche 1" } } }, "localname": "InterestRateSwapDesignatedDecember182018Tranche1Member", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_InterestRateSwapDesignatedDecember182018Tranche2Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest Rate Swap Designated December 18, 2018 Tranche 2 [Member]", "label": "Interest Rate Swap Designated December 18, 2018 Tranche 2 [Member]", "terseLabel": "Interest Rate Swap Designated December 18, 2018 Tranche 2" } } }, "localname": "InterestRateSwapDesignatedDecember182018Tranche2Member", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_InterestRateSwapDesignatedFebruary62017Tranche1Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest Rate Swap Designated February 6, 2017 Tranche 1 [Member]", "label": "Interest Rate Swap Designated February 6, 2017 Tranche 1 [Member]", "terseLabel": "Interest Rate Swap Designated February 6, 2017 Tranche 1" } } }, "localname": "InterestRateSwapDesignatedFebruary62017Tranche1Member", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_InterestRateSwapDesignatedFebruary62017Tranche2Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest Rate Swap Designated February 6, 2017 Tranche 2 [Member]", "label": "Interest Rate Swap Designated February 6, 2017 Tranche 2 [Member]", "terseLabel": "Interest Rate Swap Designated February 6, 2017 Tranche 2" } } }, "localname": "InterestRateSwapDesignatedFebruary62017Tranche2Member", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_InterestRateSwapDesignatedMarch272017Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest Rate Swap Designated March 27, 2017 [Member]", "label": "Interest Rate Swap Designated March 27, 2017 [Member]", "terseLabel": "Interest Rate Swap Designated March 27, 2017" } } }, "localname": "InterestRateSwapDesignatedMarch272017Member", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_InterestRateSwapDesignatedOctober102018Tranche1Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest Rate Swap Designated October 10, 2018 Tranche 1 [Member]", "label": "Interest Rate Swap Designated October 10, 2018 Tranche 1 [Member]", "terseLabel": "Interest Rate Swap Designated October 10, 2018 Tranche 1" } } }, "localname": "InterestRateSwapDesignatedOctober102018Tranche1Member", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_InterestRateSwapDesignatedOctober102018Tranche2Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest Rate Swap Designated October 10, 2018 Tranche 2 [Member]", "label": "Interest Rate Swap Designated October 10, 2018 Tranche 2 [Member]", "terseLabel": "Interest Rate Swap Designated October 10, 2018 Tranche 2" } } }, "localname": "InterestRateSwapDesignatedOctober102018Tranche2Member", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_InterestRateSwapDesignatedOctober102018Tranche3Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest Rate Swap Designated October 10, 2018 Tranche 3 [Member]", "label": "Interest Rate Swap Designated October 10, 2018 Tranche 3 [Member]", "terseLabel": "Interest Rate Swap Designated October 10, 2018 Tranche 3" } } }, "localname": "InterestRateSwapDesignatedOctober102018Tranche3Member", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_LesseeOperatingLeaseNumberOfRenewalOptions": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lessee, Operating Lease, Number Of Renewal Options", "label": "Lessee, Operating Lease, Number Of Renewal Options", "terseLabel": "Number of renewal options (or more)" } } }, "localname": "LesseeOperatingLeaseNumberOfRenewalOptions", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesNarrativeDetails" ], "xbrltype": "integerItemType" }, "iart_MilestonePaymentOneMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Milestone Payment One [Member]", "label": "Milestone Payment One [Member]", "terseLabel": "Development Milestones" } } }, "localname": "MilestonePaymentOneMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_MilestonePaymentTwoMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Milestone Payment Two [Member]", "label": "Milestone Payment Two [Member]", "terseLabel": "Commercial Sales Milestones" } } }, "localname": "MilestonePaymentTwoMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_NeurosurgeryMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Neurosurgery [Member]", "label": "Neurosurgery [Member]", "terseLabel": "Neurosurgery" } } }, "localname": "NeurosurgeryMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfRevenuesDisaggregatedByMajorSourceDetails" ], "xbrltype": "domainItemType" }, "iart_OneMonthEurodollarRateMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "One Month Eurodollar Rate [Member]", "label": "One Month Eurodollar Rate [Member]", "terseLabel": "One Month Eurodollar Rate" } } }, "localname": "OneMonthEurodollarRateMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_OneMonthUSDLIBORMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "One Month USD LIBOR [Member]", "label": "One Month USD LIBOR [Member]", "terseLabel": "1-Month USD LIBOR" } } }, "localname": "OneMonthUSDLIBORMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_OptionToExtendLeaseYears": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Option to extend lease, years.", "label": "Option To Extend Lease, Years", "terseLabel": "Option to extend lease, years" } } }, "localname": "OptionToExtendLeaseYears", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "iart_OrthopedicsandTissueTechnologiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Orthopedics and Tissue Technologies [Member]", "label": "Orthopedics and Tissue Technologies [Member]", "terseLabel": "Orthopedics and Tissue Technologies" } } }, "localname": "OrthopedicsandTissueTechnologiesMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfChangesInCarryingAmountOfGoodwillDetails", "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfRevenuesDisaggregatedByMajorSourceDetails", "http://integralife.com/role/SegmentAndGeographicInformationNetSalesAndProfitByReportableSegmentDetails" ], "xbrltype": "domainItemType" }, "iart_PaymentsForOptionIndexToIssuersEquity": { "auth_ref": [], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Payments For Options Indexed to Issuer's Equity", "label": "Payments For Option Index To Issuers Equity", "negatedLabel": "Purchase of option hedge on convertible notes", "terseLabel": "Cost of call transactions" } } }, "localname": "PaymentsForOptionIndexToIssuersEquity", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director", "label": "Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director", "terseLabel": "Percent of manufacturing facility owned by corporation whose shareholders are trusts whose beneficiaries include family members of company's former director" } } }, "localname": "PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesNarrativeDetails" ], "xbrltype": "percentItemType" }, "iart_PerformanceSharesandRestrictedUnitsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Performance Shares and Restricted Units", "label": "Performance Shares and Restricted Units [Member]", "terseLabel": "Performance Shares and Restricted Units" } } }, "localname": "PerformanceSharesandRestrictedUnitsMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/NetIncomePerShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_PerformanceStockAndRestrictedStockAwardsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Performance Stock And Restricted Stock Awards [Member]", "label": "Performance Stock And Restricted Stock Awards [Member]", "terseLabel": "Performance stock and Restricted stock awards" } } }, "localname": "PerformanceStockAndRestrictedStockAwardsMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_PrivateLabelMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Private Label [Member]", "label": "Private Label [Member]", "terseLabel": "Private Label" } } }, "localname": "PrivateLabelMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfRevenuesDisaggregatedByMajorSourceDetails" ], "xbrltype": "domainItemType" }, "iart_ReboundTherapeuticsCorporationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Rebound Therapeutics Corporation [Member]", "label": "Rebound Therapeutics Corporation [Member]", "terseLabel": "Rebound" } } }, "localname": "ReboundTherapeuticsCorporationMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_RegenerativeSkinAndWoundMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Regenerative Skin And Wound [Member]", "label": "Regenerative Skin And Wound [Member]", "terseLabel": "Wound Reconstruction and Care" } } }, "localname": "RegenerativeSkinAndWoundMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfRevenuesDisaggregatedByMajorSourceDetails" ], "xbrltype": "domainItemType" }, "iart_RelatedPartiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Related Parties [Member]", "label": "Related Parties [Member]", "terseLabel": "Related Parties" } } }, "localname": "RelatedPartiesMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details" ], "xbrltype": "domainItemType" }, "iart_RestOfWorldMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Revenues from rest of the world.", "label": "Rest Of World [Member]", "terseLabel": "Rest of World" } } }, "localname": "RestOfWorldMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/SegmentAndGeographicInformationTotalRevenueByMajorGeographicAreaDetails" ], "xbrltype": "domainItemType" }, "iart_RestrictedStockAwardsAndUnitsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Restricted Stock Awards And Units [Member]", "label": "Restricted Stock Awards And Units [Member]", "terseLabel": "Restricted stock awards/stock units" } } }, "localname": "RestrictedStockAwardsAndUnitsMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Return Policy, Issue of Credit, Number of Days from Shipment", "label": "Return Policy, Issue Of Credit, Number Of Days From Shipment", "terseLabel": "Number of days from shipment to issue a credit" } } }, "localname": "ReturnPolicyIssueOfCreditNumberOfDaysFromShipment", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersNarrativeDetails" ], "xbrltype": "durationItemType" }, "iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Revenue From Contract With Customer, Products Shipped With No Alternative Use And Right Of Payment For Performance, Manufacturing Period", "label": "Revenue From Contract With Customer, Products Shipped With No Alternative Use And Right Of Payment For Performance, Manufacturing Period", "terseLabel": "Manufacturing period for products shipped with no alternative use and right of payment for performance" } } }, "localname": "RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersNarrativeDetails" ], "xbrltype": "durationItemType" }, "iart_RevenueProductWarrantyPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Revenue, Product Warranty Period", "label": "Revenue, Product Warranty Period", "terseLabel": "Product warranty period (up to)" } } }, "localname": "RevenueProductWarrantyPeriod", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersNarrativeDetails" ], "xbrltype": "durationItemType" }, "iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]", "label": "Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]", "terseLabel": "ROU assets obtained in exchange for lease liabilities:" } } }, "localname": "RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesSupplementalCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "iart_ScheduleOfAssetAcquisitionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Line Items] for Schedule Of Asset Acquisition [Table]", "label": "Schedule Of Asset Acquisition [Line Items]", "terseLabel": "Schedule Of Asset Acquisition [Line Items]" } } }, "localname": "ScheduleOfAssetAcquisitionLineItems", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "iart_ScheduleOfAssetAcquisitionTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule Of Asset Acquisition [Table]", "label": "Schedule Of Asset Acquisition [Table]", "terseLabel": "Schedule Of Asset Acquisition [Table]" } } }, "localname": "ScheduleOfAssetAcquisitionTable", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "iart_SecuredDebtCurrentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Secured Debt, Current [Member]", "label": "Secured Debt, Current [Member]", "terseLabel": "Secured Debt, Current" } } }, "localname": "SecuredDebtCurrentMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_SecuredLongTermDebtSecuritizationProgramNoncurrent": { "auth_ref": [], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Secured Long-Term Debt, Securitization Program, Noncurrent", "label": "Secured Long-Term Debt, Securitization Program, Noncurrent", "terseLabel": "Long-term borrowings under securitization facility" } } }, "localname": "SecuredLongTermDebtSecuritizationProgramNoncurrent", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets", "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_SecuritizationFacilityFairValueOfAmountOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Securitization Facility, Fair Value Of Amount Outstanding", "label": "Securitization Facility, Fair Value Of Amount Outstanding", "terseLabel": "Securitization facility, outstanding borrowings, fair value" } } }, "localname": "SecuritizationFacilityFairValueOfAmountOutstanding", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_SegmentReportingInformationNumberOfProductsOffered": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of products sold by a segment", "label": "Segment Reporting Information, Number Of Products Offered", "terseLabel": "Number of products offered (more than)" } } }, "localname": "SegmentReportingInformationNumberOfProductsOffered", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/SegmentAndGeographicInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "iart_SeniorCreditFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Credit Facility.", "label": "Senior Credit Facility [Member]", "terseLabel": "Senior Credit Facility" } } }, "localname": "SeniorCreditFacilityMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DebtMaximumTotalLeverageRatioTableDetails", "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Plans", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Plans", "terseLabel": "Share-based compensation arrangement by share-based payment award, number of plans" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "integerItemType" }, "iart_SupplierRelationShipsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Supplier Relation Ships [Member]", "label": "Supplier Relation Ships [Member]", "terseLabel": "Supplier relationships" } } }, "localname": "SupplierRelationShipsMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "iart_SwapOneMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Swap One [Member]", "label": "Swap One [Member]", "terseLabel": "Swap One" } } }, "localname": "SwapOneMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_SwapThreeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Swap Three [Member]", "label": "Swap Three [Member]", "terseLabel": "Swap Three" } } }, "localname": "SwapThreeMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_SwapTwoMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Swap Two [Member]", "label": "Swap Two [Member]", "terseLabel": "Swap Two" } } }, "localname": "SwapTwoMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_SwinglineLoanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Swingline Loan [Member]", "label": "Swingline Loan [Member]", "terseLabel": "Swingline Loans" } } }, "localname": "SwinglineLoanMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_TermLoanAFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Term Loan A Facility [Member]", "label": "Term Loan A Facility [Member]", "terseLabel": "Term Loan A" } } }, "localname": "TermLoanAFacilityMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_TermLoanFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Term Loan Facility [Member]", "label": "Term Loan Facility [Member]", "terseLabel": "Term Loan Facility" } } }, "localname": "TermLoanFacilityMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_ThirdPartiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Third Parties [Member]", "label": "Third Parties [Member]", "verboseLabel": "Third Parties" } } }, "localname": "ThirdPartiesMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details" ], "xbrltype": "domainItemType" }, "iart_ThreeMonthUSDLIBORMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Three Month USD LIBOR [Member]", "label": "Three Month USD LIBOR [Member]", "terseLabel": "3-Month USD LIBOR" } } }, "localname": "ThreeMonthUSDLIBORMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_TrademarksBrandNamesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trademarks Brand Names.", "label": "Trademarks Brand Names [Member]", "terseLabel": "Trademarks/brand names" } } }, "localname": "TrademarksBrandNamesMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit", "label": "Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit", "terseLabel": "Securitization program outstanding borrowings, maximum limit" } } }, "localname": "TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two Thousand Twenty Five Senior Convertible Notes [Member]", "label": "Two Thousand Twenty Five Senior Convertible Notes [Member]", "terseLabel": "2025 Notes" } } }, "localname": "TwoThousandTwentyFiveSeniorConvertibleNotesMember", "nsuri": "http://integralife.com/20200331", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_AffiliatedEntityMember": { "auth_ref": [ "r234", "r361", "r363", "r410" ], "lang": { "en-US": { "role": { "label": "Affiliated Entity [Member]", "terseLabel": "Affiliated Entity" } } }, "localname": "AffiliatedEntityMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Asia Pacific [Member]", "terseLabel": "Asia Pacific" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://integralife.com/role/SegmentAndGeographicInformationTotalRevenueByMajorGeographicAreaDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r120", "r128" ], "lang": { "en-US": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://integralife.com/role/SegmentAndGeographicInformationNetSalesAndProfitByReportableSegmentDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Operating Activities [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://integralife.com/role/SegmentAndGeographicInformationNetSalesAndProfitByReportableSegmentDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r49", "r100" ], "lang": { "en-US": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details", "http://integralife.com/role/TreasuryStockNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_DirectorMember": { "auth_ref": [ "r133" ], "lang": { "en-US": { "role": { "label": "Director [Member]", "terseLabel": "Directors" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Investment, Name [Domain]", "terseLabel": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails" ], "xbrltype": "domainItemType" }, "srt_EuropeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Europe [Member]", "terseLabel": "Europe" } } }, "localname": "EuropeMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://integralife.com/role/SegmentAndGeographicInformationTotalRevenueByMajorGeographicAreaDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails", "http://integralife.com/role/RevenuesFromContractsWithCustomersNarrativeDetails", "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails", "http://integralife.com/role/RevenuesFromContractsWithCustomersNarrativeDetails", "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r130", "r221", "r224", "r404", "r405" ], "lang": { "en-US": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfRevenuesDisaggregatedByMajorSourceDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfRevenuesDisaggregatedByMajorSourceDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails", "http://integralife.com/role/RevenuesFromContractsWithCustomersNarrativeDetails", "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails", "http://integralife.com/role/RevenuesFromContractsWithCustomersNarrativeDetails", "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details", "http://integralife.com/role/TreasuryStockNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Forecast [Member]", "terseLabel": "Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://integralife.com/role/TreasuryStockNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://integralife.com/role/TreasuryStockNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r138" ], "lang": { "en-US": { "role": { "label": "Investment, Name [Axis]", "terseLabel": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://integralife.com/role/SegmentAndGeographicInformationTotalRevenueByMajorGeographicAreaDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r131", "r221", "r225", "r406", "r408", "r409" ], "lang": { "en-US": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://integralife.com/role/SegmentAndGeographicInformationTotalRevenueByMajorGeographicAreaDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r176", "r366" ], "lang": { "en-US": { "role": { "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://integralife.com/role/TreasuryStockNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r133", "r362" ], "lang": { "en-US": { "role": { "label": "Title of Individual [Axis]", "terseLabel": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Title of Individual [Domain]", "terseLabel": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "terseLabel": "Derivative Instruments, Gain (Loss) [Roll Forward]", "verboseLabel": "Accumulated Other Comprehensive Income (Loss) [Roll Forward]" } } }, "localname": "AOCIAttributableToParentNetOfTaxRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfChangesInAccumulatedOtherComprehensiveIncomeByComponentDetails", "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt": { "auth_ref": [ "r207" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash receipt from (payment to) bank; or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement.", "label": "Accelerated Share Repurchases, Settlement (Payment) or Receipt", "negatedTerseLabel": "Accelerated share repurchase program, payment" } } }, "localname": "AcceleratedShareRepurchasesSettlementPaymentOrReceipt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/TreasuryStockNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r7", "r33" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Trade, Current", "terseLabel": "Accounts payable, trade" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r4", "r16", "r134", "r135", "r222" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Trade accounts receivable, net of allowances of $6,652 and $4,303" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccretionExpense": { "auth_ref": [ "r170", "r171" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.", "label": "Accretion Expense", "terseLabel": "Accretion of bond issuance discount" } } }, "localname": "AccretionExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r36" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r54", "r59", "r61", "r233", "r295" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "terseLabel": "Defined Benefit Pension Items" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfChangesInAccumulatedOtherComprehensiveIncomeByComponentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "auth_ref": [ "r59", "r68", "r294" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "terseLabel": "Gains and Losses on Derivatives" } } }, "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/ComprehensiveIncomeLossNarrativeDetails", "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfChangesInAccumulatedOtherComprehensiveIncomeByComponentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/ComprehensiveIncomeLossNarrativeDetails", "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfChangesInAccumulatedOtherComprehensiveIncomeByComponentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r57", "r58", "r59" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/ComprehensiveIncomeLossNarrativeDetails", "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfChangesInAccumulatedOtherComprehensiveIncomeByComponentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r56", "r59", "r61", "r295" ], "lang": { "en-US": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Total", "verboseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfChangesInAccumulatedOtherComprehensiveIncomeByComponentDetails", "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity", "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r52", "r59", "r61", "r295" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Foreign Currency Items" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfChangesInAccumulatedOtherComprehensiveIncomeByComponentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Acquired Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r152" ], "lang": { "en-US": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Weighted Average Life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r17" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": { "auth_ref": [ "r191" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.", "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt", "terseLabel": "Share repurchase and equity component of the convertible note issuance, net" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r239", "r241", "r254", "r255" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Share-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r22", "r136", "r139" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Trade accounts receivable, allowance" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r76", "r93", "r343" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Amortization of discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r93", "r150", "r158" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "negatedTerseLabel": "Amortization", "terseLabel": "Intangible asset amortization" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://integralife.com/role/SegmentAndGeographicInformationNetSalesAndProfitByReportableSegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r115" ], "lang": { "en-US": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Shares excluded from computation as their effect would be antidilutive (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/NetIncomePerShareNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/NetIncomePerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Assets": { "auth_ref": [ "r125", "r384", "r395" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r6", "r47" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r243", "r252" ], "lang": { "en-US": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/NetIncomePerShareNarrativeDetails", "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails", "http://integralife.com/role/DebtNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsFairValueOfDerivativeInstrumentsByBalanceSheetLocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r305", "r310" ], "lang": { "en-US": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails", "http://integralife.com/role/DebtNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsFairValueOfDerivativeInstrumentsByBalanceSheetLocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis Of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r165" ], "lang": { "en-US": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "Leased facilities" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationNarrativeDetails", "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails", "http://integralife.com/role/CommitmentsAndContingenciesFairValueContingentConsiderationBalanceInformationDetails", "http://integralife.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r274", "r275" ], "lang": { "en-US": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationNarrativeDetails", "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails", "http://integralife.com/role/CommitmentsAndContingenciesFairValueContingentConsiderationBalanceInformationDetails", "http://integralife.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationNarrativeDetails", "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r284", "r285", "r287" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Purchase price of business combination" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": { "auth_ref": [ "r92", "r290" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.", "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability", "verboseLabel": "Change in fair value of contingent consideration and others" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": { "auth_ref": [ "r289" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.", "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High", "terseLabel": "Maximum contingent consideration" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [ "r283", "r286", "r288" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.", "label": "Business Combination, Contingent Consideration, Liability", "terseLabel": "Contingent consideration, liability (up to)", "verboseLabel": "Contingent consideration, liability" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationNarrativeDetails", "http://integralife.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r277" ], "calculation": { "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails": { "order": 1.0, "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "verboseLabel": "Cash" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability": { "auth_ref": [ "r276", "r277" ], "calculation": { "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability", "terseLabel": "Contingent consideration", "verboseLabel": "Contingent consideration, fair value" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationNarrativeDetails", "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": { "auth_ref": [ "r277" ], "calculation": { "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails": { "order": 2.0, "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other", "terseLabel": "Other current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": { "auth_ref": [ "r259", "r277" ], "calculation": { "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails": { "order": 4.0, "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets", "terseLabel": "Deferred tax assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [ "r259", "r277" ], "calculation": { "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "terseLabel": "Deferred tax liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill [Abstract]", "terseLabel": "Intangible assets:" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "auth_ref": [ "r276", "r277" ], "calculation": { "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails": { "order": 6.0, "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles", "terseLabel": "Intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r276", "r277" ], "calculation": { "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails": { "order": 3.0, "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Property, plant and equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "auth_ref": [ "r277" ], "calculation": { "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "totalLabel": "Net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_CallOptionMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financial contract between two parties, the buyer and the seller of the option, where the buyer has the right but not the obligation to buy an agreed quantity of a particular commodity or financial instrument (the underlying instrument) from the seller of the option for a certain price (the strike price). Seller is obligated to sell the asset to the buyer, if the buyer exercises the option.", "label": "Call Option [Member]", "terseLabel": "Call Option" } } }, "localname": "CallOptionMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r30", "r95" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Member]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r90", "r95", "r96" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r90", "r341" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r301" ], "lang": { "en-US": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash Flow Hedges" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails", "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfTreasuryStockTable": { "auth_ref": [ "r208", "r209", "r210", "r211" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Class of Treasury Stock [Table]", "terseLabel": "Class of Treasury Stock [Table]" } } }, "localname": "ClassOfTreasuryStockTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/TreasuryStockNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r104" ], "lang": { "en-US": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Warrant strike price (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r42", "r175", "r388", "r401" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Refer to Note 16)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r174", "r182" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, authorized shares (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, issued shares (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r15" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock; $0.01 par value; 240,000 authorized shares; 89,104 and 88,735 issued at March 31, 2020 and December 31, 2019, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r64", "r66", "r67" ], "calculation": { "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfComprehensiveIncomeDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "terseLabel": "Comprehensive income (loss) (See Note 14)", "totalLabel": "Comprehensive income (loss), net" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfComprehensiveIncomeDetails", "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r79" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "COMPREHENSIVE INCOME (LOSS)" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/ComprehensiveIncomeLoss" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContingentConsiderationByTypeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of contingent consideration.", "label": "Contingent Consideration by Type [Axis]", "terseLabel": "Contingent Consideration by Type [Axis]" } } }, "localname": "ContingentConsiderationByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationNarrativeDetails", "http://integralife.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ContingentConsiderationTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of contingent payment arrangement.", "label": "Contingent Consideration Type [Domain]", "terseLabel": "Contingent Consideration Type [Domain]" } } }, "localname": "ContingentConsiderationTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationNarrativeDetails", "http://integralife.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r218" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of contract balances and changes in contract balances.", "label": "Contract with Customer, Asset and Liability [Table Text Block]", "terseLabel": "Schedule of Changes in Contract Assets and Contract Liabilities" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetNet": { "auth_ref": [ "r214", "r216", "r222" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Contract with Customer, Asset, after Allowance for Credit Loss", "periodEndLabel": "Contract asset, End of Period", "periodStartLabel": "Contract asset, Beginning of period" } } }, "localname": "ContractWithCustomerAssetNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfChangesInContractAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerAssetReclassifiedToReceivable": { "auth_ref": [ "r217" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time from transfer to receivable due to right to consideration becoming unconditional.", "label": "Contract with Customer, Asset, Reclassified to Receivable", "negatedTerseLabel": "Transferred to trade receivable of contract asset included in beginning of the year contract asset" } } }, "localname": "ContractWithCustomerAssetReclassifiedToReceivable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfChangesInContractAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r214", "r215", "r222" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "periodEndLabel": "Contract liability, End of Period", "periodStartLabel": "Contract liability, Beginning of Period" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfChangesInContractAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r214", "r215", "r222" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "terseLabel": "Contract liabilities", "verboseLabel": "Short-term portion of contract liability" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets", "http://integralife.com/role/RevenuesFromContractsWithCustomersNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "auth_ref": [ "r214", "r215", "r222" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Contract with Customer, Liability, Noncurrent", "terseLabel": "Long-term portion of contract liability" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r223" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "negatedLabel": "Recognition of revenue included in beginning of year contract liability" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfChangesInContractAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r190" ], "lang": { "en-US": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]", "terseLabel": "Convertible Debt" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails", "http://integralife.com/role/TreasuryStockNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleDebtNoncurrent": { "auth_ref": [ "r40" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.", "label": "Convertible Debt, Noncurrent", "terseLabel": "Long-term convertible securities", "verboseLabel": "Carrying amount, liability component" } } }, "localname": "ConvertibleDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets", "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r129" ], "lang": { "en-US": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate, Non-Segment [Member]", "terseLabel": "Corporate and other" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/SegmentAndGeographicInformationNetSalesAndProfitByReportableSegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r73" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r72" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total costs and expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Costs and Expenses [Abstract]", "terseLabel": "Costs and expenses:" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CrossCurrencyInterestRateContractMember": { "auth_ref": [ "r229", "r317" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.", "label": "Cross Currency Interest Rate Contract [Member]", "terseLabel": "Cross-currency swap", "verboseLabel": "Cross Currency Interest Rate Swap" } } }, "localname": "CrossCurrencyInterestRateContractMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails", "http://integralife.com/role/DerivativeInstrumentsFairValueOfDerivativeInstrumentsByBalanceSheetLocationDetails", "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r280" ], "lang": { "en-US": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "verboseLabel": "Customer relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r197" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "DEBT" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r11", "r12", "r13", "r385", "r386", "r394" ], "lang": { "en-US": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtMaximumTotalLeverageRatioTableDetails", "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Interest rates available" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": { "auth_ref": [ "r192" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.", "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component", "terseLabel": "Debt proceeds, classified as equity at time of offering" } } }, "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r194" ], "lang": { "en-US": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Initial conversion price (in dollars per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleConversionRatio1": { "auth_ref": [ "r39", "r201", "r202", "r204" ], "lang": { "en-US": { "role": { "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.", "label": "Debt Instrument, Convertible, Conversion Ratio", "terseLabel": "Initial conversion rate" } } }, "localname": "DebtInstrumentConvertibleConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "pureItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r344", "r346" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Convertible notes, maximum borrowing capacity" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r340" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "terseLabel": "Fair value" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r38", "r195", "r344" ], "lang": { "en-US": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Effective interest rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r38" ], "lang": { "en-US": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Convertible notes, interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtMaximumTotalLeverageRatioTableDetails", "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r40" ], "lang": { "en-US": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtMaximumTotalLeverageRatioTableDetails", "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r392" ], "lang": { "en-US": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument, Redemption Price, Percentage", "terseLabel": "Redemption price, percentage" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r40", "r101", "r201", "r203", "r204", "r205", "r343", "r344", "r346", "r393" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtMaximumTotalLeverageRatioTableDetails", "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r343", "r346" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "terseLabel": "Unamortized discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average interest rate of debt outstanding.", "label": "Debt, Weighted Average Interest Rate", "terseLabel": "Weighted average interest rate on debt" } } }, "localname": "DebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DeferredCompensationPlanAssets": { "auth_ref": [ "r32" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.", "label": "Deferred Compensation Plan Assets", "terseLabel": "Deferred compensation plan, fair value of assets" } } }, "localname": "DeferredCompensationPlanAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/RetirementPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsGross": { "auth_ref": [ "r345" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Gross", "terseLabel": "Incremental financing costs capitalized" } } }, "localname": "DeferredFinanceCostsGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r268" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Deferred tax assets, net" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r93", "r99", "r269", "r271" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "Deferred income tax benefit/provision" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r260", "r268" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r267" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "terseLabel": "Valuation Allowance, foreign deferred tax assets" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": { "auth_ref": [ "r228", "r229", "r230", "r237" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.", "label": "Defined Benefit Plan, Plan Assets, Amount", "terseLabel": "Estimated fair value of plan assets" } } }, "localname": "DefinedBenefitPlanFairValueOfPlanAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/RetirementPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r231", "r235", "r237" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "terseLabel": "Net periodic benefit costs" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/RetirementPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r227", "r232", "r236", "r237" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Service Cost", "verboseLabel": "Service cost component" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/RetirementPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r93", "r123" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]", "verboseLabel": "Derivative, Name [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails", "http://integralife.com/role/DerivativeInstrumentsFairValueOfDerivativeInstrumentsByBalanceSheetLocationDetails", "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "auth_ref": [ "r48", "r50", "r308", "r370" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.", "label": "Derivative Asset, Fair Value, Gross Asset", "terseLabel": "Total derivatives designated as hedges \u2014 Assets" } } }, "localname": "DerivativeFairValueOfDerivativeAsset", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsFairValueOfDerivativeInstrumentsByBalanceSheetLocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "auth_ref": [ "r48", "r50", "r308", "r370" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Fair Value, Gross Liability", "terseLabel": "Total derivatives designated as hedges \u2014 Liabilities" } } }, "localname": "DerivativeFairValueOfDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsFairValueOfDerivativeInstrumentsByBalanceSheetLocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeNet": { "auth_ref": [ "r340" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives.", "label": "Derivative, Fair Value, Net", "terseLabel": "Fair Value Asset (Liability)", "verboseLabel": "Estimated Fair Value, Assets (Liabilities)" } } }, "localname": "DerivativeFairValueOfDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFixedInterestRate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fixed interest rate related to the interest rate derivative.", "label": "Derivative, Fixed Interest Rate", "terseLabel": "Fixed Interest Rate", "verboseLabel": "Fixed Rate" } } }, "localname": "DerivativeFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r306", "r309", "r314", "r319" ], "lang": { "en-US": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]", "verboseLabel": "Derivative, by Nature [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails", "http://integralife.com/role/DerivativeInstrumentsFairValueOfDerivativeInstrumentsByBalanceSheetLocationDetails", "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r333" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "DERIVATIVE INSTRUMENTS" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r303", "r306", "r314" ], "lang": { "en-US": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails", "http://integralife.com/role/DerivativeInstrumentsFairValueOfDerivativeInstrumentsByBalanceSheetLocationDetails", "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r303", "r306", "r314", "r319", "r320", "r323", "r326" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r298", "r300" ], "lang": { "en-US": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "netLabel": "Aggregate Notional Amount", "terseLabel": "Current notional amount", "verboseLabel": "Current Notional Amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsFairValueOfDerivativeInstrumentsByBalanceSheetLocationDetails", "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r105", "r297", "r299", "r300", "r303", "r304", "r311", "r314", "r321", "r322", "r326" ], "lang": { "en-US": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesFairValueLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivatives, Fair Value [Line Items]", "terseLabel": "Derivatives, Fair Value [Line Items]" } } }, "localname": "DerivativesFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsFairValueOfDerivativeInstrumentsByBalanceSheetLocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r303" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Designated as Hedging Instrument" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails", "http://integralife.com/role/DerivativeInstrumentsFairValueOfDerivativeInstrumentsByBalanceSheetLocationDetails", "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [ "r282" ], "lang": { "en-US": { "role": { "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.", "label": "Developed Technology Rights [Member]", "terseLabel": "CerebroFlo developed technology" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DilutiveSecuritiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]", "terseLabel": "Effect of dilutive securities:" } } }, "localname": "DilutiveSecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/NetIncomePerShareBasicAndDilutedNetIncomePerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfRevenuesDisaggregatedByMajorSourceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfRevenuesDisaggregatedByMajorSourceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r221" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of Disaggregation of Revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r257" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "terseLabel": "STOCK-BASED COMPENSATION" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/StockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share [Abstract]", "verboseLabel": "Net income per share" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r71", "r107", "r110", "r112", "r113", "r114", "r117", "r390", "r403" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic (in dollars per share)", "verboseLabel": "Basic net income per common share (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://integralife.com/role/NetIncomePerShareBasicAndDilutedNetIncomePerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Basic net income per share:" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/NetIncomePerShareBasicAndDilutedNetIncomePerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r71", "r107", "r110", "r112", "r113", "r114", "r117", "r390", "r403" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted (in dollars per share)", "verboseLabel": "Diluted net income per common share (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://integralife.com/role/NetIncomePerShareBasicAndDilutedNetIncomePerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Diluted net income per share:" } } }, "localname": "EarningsPerShareDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/NetIncomePerShareBasicAndDilutedNetIncomePerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r118" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "NET INCOME PER SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/NetIncomePerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r341" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Effect of exchange rate changes on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r103", "r261", "r262" ], "lang": { "en-US": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective income tax rate", "verboseLabel": "Reported tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/IncomeTaxesNarrativeDetails", "http://integralife.com/role/IncomeTaxesSummaryOfEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": { "auth_ref": [ "r256", "r261" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.", "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount", "negatedLabel": "Tax benefit related to equity compensation" } } }, "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r36" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Accrued compensation" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r251" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Total unrecognized compensation costs" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r251" ], "lang": { "en-US": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted-average period for cost recognition" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r250" ], "lang": { "en-US": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Stock options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityClassOfTreasuryStockLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Equity, Class of Treasury Stock [Line Items]", "terseLabel": "Equity, Class of Treasury Stock [Line Items]" } } }, "localname": "EquityClassOfTreasuryStockLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/TreasuryStockNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r200" ], "lang": { "en-US": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/ComprehensiveIncomeLossNarrativeDetails", "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfChangesInAccumulatedOtherComprehensiveIncomeByComponentDetails", "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity", "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EurodollarMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest rate based on U.S. dollar denominated deposits at foreign banks or foreign branches of U.S. banks.", "label": "Eurodollar [Member]", "terseLabel": "Eurodollar" } } }, "localname": "EurodollarMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ExtendedProductWarrantyPolicy": { "auth_ref": [ "r97", "r175", "r186" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for extended product warranties and other guarantee contracts including the methodology for measuring the liability.", "label": "Extended Product Warranty, Policy [Policy Text Block]", "terseLabel": "Product Warranties" } } }, "localname": "ExtendedProductWarrantyPolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r229", "r230", "r237", "r334", "r367" ], "lang": { "en-US": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CommitmentsAndContingenciesFairValueContingentConsiderationBalanceInformationDetails", "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r338", "r339" ], "lang": { "en-US": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]", "terseLabel": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CommitmentsAndContingenciesFairValueContingentConsiderationBalanceInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r229", "r230", "r237", "r334", "r368" ], "lang": { "en-US": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Fair Value, Inputs, Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r229", "r230", "r237", "r334", "r369" ], "lang": { "en-US": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Fair Value, Inputs, Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CommitmentsAndContingenciesFairValueContingentConsiderationBalanceInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r335" ], "lang": { "en-US": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]", "terseLabel": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CommitmentsAndContingenciesFairValueContingentConsiderationBalanceInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CommitmentsAndContingenciesFairValueContingentConsiderationBalanceInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CommitmentsAndContingenciesFairValueContingentConsiderationBalanceInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r335", "r339" ], "lang": { "en-US": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CommitmentsAndContingenciesFairValueContingentConsiderationBalanceInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r335", "r339" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of Contingent Consideration" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r336" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "negatedNetLabel": "Loss from change in fair value of contingent consideration liabilities" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CommitmentsAndContingenciesFairValueContingentConsiderationBalanceInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "auth_ref": [ "r337" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements", "negatedTerseLabel": "Payments" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CommitmentsAndContingenciesFairValueContingentConsiderationBalanceInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r335" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Balance, End of Period", "periodStartLabel": "Balance, Beginning of Period" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CommitmentsAndContingenciesFairValueContingentConsiderationBalanceInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CommitmentsAndContingenciesFairValueContingentConsiderationBalanceInformationDetails", "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r305", "r311", "r323" ], "lang": { "en-US": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsFairValueOfDerivativeInstrumentsByBalanceSheetLocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FederalFundsEffectiveSwapRateMember": { "auth_ref": [ "r324" ], "lang": { "en-US": { "role": { "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.", "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]", "terseLabel": "Overnight Federal Funds" } } }, "localname": "FederalFundsEffectiveSwapRateMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "auth_ref": [ "r358" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Payment, Due", "terseLabel": "Future minimum lease payments capital leases" } } }, "localname": "FinanceLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Weighted Average Life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r157" ], "calculation": { "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfCompanysIdentifiableIntangibleAssetsDetails": { "order": 2.0, "parentTag": "iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year", "terseLabel": "Expected annual amortization expense, remainder of 2020" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r159" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Five", "terseLabel": "Expected annual amortization expense, in 2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r159" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Four", "terseLabel": "Expected annual amortization expense, in 2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r159" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Three", "terseLabel": "Expected annual amortization expense, in 2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r159" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Two", "terseLabel": "Expected annual amortization expense, in 2021" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r151", "r154", "r157", "r161", "r371" ], "lang": { "en-US": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails", "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails", "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r151", "r156" ], "lang": { "en-US": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails", "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails", "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]", "terseLabel": "Foreign Tax Authority" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": { "auth_ref": [ "r306" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.", "label": "Gain (Loss) on Derivative Instruments, Net, Pretax", "terseLabel": "Gain reclassified into other income" } } }, "localname": "GainLossOnDerivativeInstrumentsNetPretax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnDispositionOfAssets": { "auth_ref": [ "r93", "r164", "r167" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property", "negatedLabel": "Loss on disposal of property and equipment" } } }, "localname": "GainLossOnDispositionOfAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r144", "r145" ], "calculation": { "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails": { "order": 5.0, "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill", "weight": 1.0 }, "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "End of Period", "periodStartLabel": "Beginning of Period", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails", "http://integralife.com/role/CondensedConsolidatedBalanceSheets", "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfChangesInCarryingAmountOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r163" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r146" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "terseLabel": "Foreign currency translation" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfChangesInCarryingAmountOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfChangesInCarryingAmountOfGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfChangesInCarryingAmountOfGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r303", "r320" ], "lang": { "en-US": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails", "http://integralife.com/role/DerivativeInstrumentsFairValueOfDerivativeInstrumentsByBalanceSheetLocationDetails", "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r303" ], "lang": { "en-US": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails", "http://integralife.com/role/DerivativeInstrumentsFairValueOfDerivativeInstrumentsByBalanceSheetLocationDetails", "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r303" ], "lang": { "en-US": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails", "http://integralife.com/role/DerivativeInstrumentsFairValueOfDerivativeInstrumentsByBalanceSheetLocationDetails", "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InProcessResearchAndDevelopmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.", "label": "In Process Research and Development [Member]", "terseLabel": "In-Process Research and Development Expense", "verboseLabel": "IPR&D" } } }, "localname": "InProcessResearchAndDevelopmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails", "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r102" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "totalLabel": "Income before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r168" ], "lang": { "en-US": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails", "http://integralife.com/role/ComprehensiveIncomeLossNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails", "http://integralife.com/role/ComprehensiveIncomeLossNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r263" ], "lang": { "en-US": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityNameAxis": { "auth_ref": [ "r263" ], "lang": { "en-US": { "role": { "documentation": "Information by name of taxing authority.", "label": "Income Tax Authority, Name [Axis]", "terseLabel": "Income Tax Authority, Name [Axis]" } } }, "localname": "IncomeTaxAuthorityNameAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority, Name [Domain]", "terseLabel": "Income Tax Authority, Name [Domain]" } } }, "localname": "IncomeTaxAuthorityNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxContingencyLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Tax Contingency [Line Items]", "terseLabel": "Income Tax Contingency [Line Items]" } } }, "localname": "IncomeTaxContingencyLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxContingencyTable": { "auth_ref": [ "r264", "r265", "r266", "r270" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.", "label": "Income Tax Contingency [Table]", "terseLabel": "Income Tax Contingency [Table]" } } }, "localname": "IncomeTaxContingencyTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r273" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r99", "r124", "r272" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Provision (benefit) for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationTaxCreditsForeign": { "auth_ref": [ "r261", "r262" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount", "terseLabel": "Federal tax credit" } } }, "localname": "IncomeTaxReconciliationTaxCreditsForeign", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationTaxHolidays": { "auth_ref": [ "r261", "r262" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income exempt from income tax because of a tax holiday.", "label": "Effective Income Tax Rate Reconciliation, Tax Holiday, Amount", "terseLabel": "Effective income tax rate reconciliation, tax benefit, federal tax holiday" } } }, "localname": "IncomeTaxReconciliationTaxHolidays", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r92" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable, accrued expenses and other current liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r92" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r92" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Contract liabilities" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r92" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": { "auth_ref": [], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.", "label": "Increase (Decrease) in Other Noncurrent Liabilities", "terseLabel": "Other non-current liabilities" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r92" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other non-current assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r92" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r111", "r116" ], "calculation": { "http://integralife.com/role/NetIncomePerShareBasicAndDilutedNetIncomePerShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements", "terseLabel": "Stock options and restricted stock (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/NetIncomePerShareBasicAndDilutedNetIncomePerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r153", "r160" ], "lang": { "en-US": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets [Axis]", "terseLabel": "Indefinite-lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r153", "r160" ], "lang": { "en-US": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r149", "r155" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r69", "r122", "r342", "r345", "r391" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedTerseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r76", "r196" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt", "terseLabel": "Interest expense" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebtExcludingAmortization": { "auth_ref": [ "r78" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.", "label": "Interest Expense, Debt, Excluding Amortization", "terseLabel": "Cash interest" } } }, "localname": "InterestExpenseDebtExcludingAmortization", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseMember": { "auth_ref": [ "r318" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing interest expense.", "label": "Interest Expense [Member]", "terseLabel": "Interest expense" } } }, "localname": "InterestExpenseMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestIncomeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption in which reported facts about interest income have been included.", "label": "Interest Income [Member]", "terseLabel": "Interest income", "verboseLabel": "Interest income" } } }, "localname": "InterestIncomeMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/ComprehensiveIncomeLossNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": { "auth_ref": [ "r327" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.", "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net", "terseLabel": "Gain expected to be reclassified to earnings in the next twelve months" } } }, "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r316" ], "lang": { "en-US": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]", "terseLabel": "Interest Rate Swap", "verboseLabel": "Interest rate swap" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails", "http://integralife.com/role/DerivativeInstrumentsFairValueOfDerivativeInstrumentsByBalanceSheetLocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r143" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "INVENTORIES" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r23", "r142" ], "calculation": { "http://integralife.com/role/InventoriesScheduleOfNetInventoriesDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/InventoriesScheduleOfNetInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r3", "r46", "r141" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://integralife.com/role/InventoriesScheduleOfNetInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories, net", "totalLabel": "Inventories, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets", "http://integralife.com/role/InventoriesScheduleOfNetInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNetAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Inventory, Net [Abstract]" } } }, "localname": "InventoryNetAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryRawMaterialsAndPurchasedPartsNetOfReserves": { "auth_ref": [ "r25", "r142" ], "calculation": { "http://integralife.com/role/InventoriesScheduleOfNetInventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of items purchased for use as components of a finished product or pieces of machinery and equipment plus any items in their natural and unrefined state. This element may be used when the reporting entity combines raw materials and purchased parts into an aggregate amount.", "label": "Inventory, Raw Materials and Purchased Parts, Net of Reserves", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterialsAndPurchasedPartsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/InventoriesScheduleOfNetInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r24", "r142" ], "calculation": { "http://integralife.com/role/InventoriesScheduleOfNetInventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work in process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/InventoriesScheduleOfNetInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r75", "r121" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r353" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r358" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Schedule of Operating Lease Maturities" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r358" ], "calculation": { "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842DetailsCalc2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Payments, Due", "totalLabel": "Total minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r358" ], "calculation": { "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r358" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months", "terseLabel": "2020" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r358" ], "calculation": { "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Five", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r358" ], "calculation": { "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Four", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r358" ], "calculation": { "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Three", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r358" ], "calculation": { "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Two", "terseLabel": "2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r358" ], "calculation": { "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease having an initial or remaining lease term in excess of one year due in remainder of fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year", "terseLabel": "2020" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r358" ], "calculation": { "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842DetailsCalc2": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "terseLabel": "Less: Imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseOptionToExtend": { "auth_ref": [ "r352" ], "lang": { "en-US": { "role": { "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.", "label": "Lessee, Operating Lease, Option to Extend", "terseLabel": "Period for extended lease" } } }, "localname": "LesseeOperatingLeaseOptionToExtend", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r360" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "LEASES AND RELATED PARTY LEASES" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LettersOfCreditOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.", "label": "Letters of Credit Outstanding, Amount", "terseLabel": "Letters of credit outstanding" } } }, "localname": "LettersOfCreditOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r35" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r21", "r387", "r399" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r37" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LicensingAgreementsMember": { "auth_ref": [ "r281" ], "lang": { "en-US": { "role": { "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).", "label": "Licensing Agreements [Member]", "terseLabel": "Enabling technology license" } } }, "localname": "LicensingAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails", "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r13", "r386", "r394" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term Line of Credit", "terseLabel": "Line of credit facility outstanding" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.", "label": "Line of Credit Facility, Commitment Fee Percentage", "terseLabel": "Line of credit, commitment fee percentage" } } }, "localname": "LineOfCreditFacilityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": { "auth_ref": [ "r340" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value of the amount outstanding under the credit facility.", "label": "Line of Credit Facility, Fair Value of Amount Outstanding", "terseLabel": "Line of credit facility, fair value of amount outstanding" } } }, "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r34" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicates an ownership position in, or purchase of, a security.", "label": "Long [Member]", "terseLabel": "Long" } } }, "localname": "LongMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r13", "r193", "r386", "r397" ], "calculation": { "http://integralife.com/role/DebtContractualMaturityTableDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "totalLabel": "Principal Repayment" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtContractualMaturityTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": { "auth_ref": [ "r106", "r188" ], "calculation": { "http://integralife.com/role/DebtContractualMaturityTableDetails": { "order": 6.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Long-term Debt, Maturities, Repayments of Principal after Year Five", "terseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtContractualMaturityTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "auth_ref": [ "r106", "r188" ], "calculation": { "http://integralife.com/role/DebtContractualMaturityTableDetails": { "order": 5.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Long-term Debt, Maturities, Repayments of Principal in Year Five", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtContractualMaturityTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r106", "r188" ], "calculation": { "http://integralife.com/role/DebtContractualMaturityTableDetails": { "order": 4.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Long-term Debt, Maturities, Repayments of Principal in Year Four", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtContractualMaturityTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r106", "r188" ], "calculation": { "http://integralife.com/role/DebtContractualMaturityTableDetails": { "order": 3.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Long-term Debt, Maturities, Repayments of Principal in Year Three", "terseLabel": "2022" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtContractualMaturityTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r106", "r188" ], "calculation": { "http://integralife.com/role/DebtContractualMaturityTableDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Long-term Debt, Maturities, Repayments of Principal in Year Two", "terseLabel": "2021" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtContractualMaturityTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "auth_ref": [ "r106" ], "calculation": { "http://integralife.com/role/DebtContractualMaturityTableDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year", "terseLabel": "Remainder of 2020" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtContractualMaturityTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r40" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails", "http://integralife.com/role/TreasuryStockNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r40", "r189" ], "lang": { "en-US": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails", "http://integralife.com/role/TreasuryStockNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r184", "r185" ], "lang": { "en-US": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r90" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "FINANCING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r90" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "INVESTING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r90", "r91", "r94" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "OPERATING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r62", "r65", "r70", "r94", "r116", "r389", "r402" ], "calculation": { "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfComprehensiveIncomeDetails": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income", "totalLabel": "Net income", "verboseLabel": "Net income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfComprehensiveIncomeDetails", "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity", "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://integralife.com/role/NetIncomePerShareBasicAndDilutedNetIncomePerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgingMember": { "auth_ref": [ "r302" ], "lang": { "en-US": { "role": { "documentation": "Hedges of a net investment in a foreign operation.", "label": "Net Investment Hedging [Member]", "terseLabel": "Net Investment Hedges" } } }, "localname": "NetInvestmentHedgingMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails", "http://integralife.com/role/DerivativeInstrumentsFairValueOfDerivativeInstrumentsByBalanceSheetLocationDetails", "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recently Issued Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of reportable segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/SegmentAndGeographicInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": { "auth_ref": [ "r59", "r68" ], "calculation": { "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfChangesInAccumulatedOtherComprehensiveIncomeByComponentDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.", "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent", "terseLabel": "Other comprehensive loss" } } }, "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfChangesInAccumulatedOtherComprehensiveIncomeByComponentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating income", "verboseLabel": "Operating income" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://integralife.com/role/SegmentAndGeographicInformationNetSalesAndProfitByReportableSegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r350" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "terseLabel": "Operating lease expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r349" ], "calculation": { "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842DetailsCalc2": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 }, "http://integralife.com/role/LeasesAndRelatedPartyLeasesSupplementalBalanceSheetInformationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "totalLabel": "Total lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details", "http://integralife.com/role/LeasesAndRelatedPartyLeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r349" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://integralife.com/role/LeasesAndRelatedPartyLeasesSupplementalBalanceSheetInformationDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "netLabel": "Less: Current lease liabilities", "terseLabel": "Current lease liabilities", "verboseLabel": "Current portion of lease liability - operating leases" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets", "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details", "http://integralife.com/role/LeasesAndRelatedPartyLeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r349" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://integralife.com/role/LeasesAndRelatedPartyLeasesSupplementalBalanceSheetInformationDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "netLabel": "Long-term lease liabilities", "terseLabel": "Non-current lease liabilities", "verboseLabel": "Lease liability - operating leases" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets", "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details", "http://integralife.com/role/LeasesAndRelatedPartyLeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r351", "r354" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Operating cash flows from operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r348" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "ROU assets", "verboseLabel": "Right of use asset - operating leases" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets", "http://integralife.com/role/LeasesAndRelatedPartyLeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r357", "r359" ], "lang": { "en-US": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r356", "r359" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term (in years)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasedAssetsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Leased Assets [Line Items]", "terseLabel": "Operating Leased Assets [Line Items]" } } }, "localname": "OperatingLeasedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details", "http://integralife.com/role/LeasesAndRelatedPartyLeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r120", "r128" ], "lang": { "en-US": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/SegmentAndGeographicInformationNetSalesAndProfitByReportableSegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OptionIndexedToIssuersEquityEquityAxis": { "auth_ref": [ "r199", "r328", "r329", "r331" ], "lang": { "en-US": { "role": { "documentation": "Information by type of options indexed to an issuer's equity.", "label": "Option Indexed to Issuer's Equity [Axis]", "terseLabel": "Option Indexed to Issuer's Equity [Axis]" } } }, "localname": "OptionIndexedToIssuersEquityEquityAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OptionIndexedToIssuersEquityStrikePrice1": { "auth_ref": [ "r198", "r330" ], "lang": { "en-US": { "role": { "documentation": "Exercise or strike price stated in the contract for options indexed to the issuer's equity shares.", "label": "Option Indexed to Issuer's Equity, Strike Price", "terseLabel": "Initial strike price (in dollars per share)" } } }, "localname": "OptionIndexedToIssuersEquityStrikePrice1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_OptionIndexedToIssuersEquityTypeDomain": { "auth_ref": [ "r332" ], "lang": { "en-US": { "role": { "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding.", "label": "Option Indexed to Issuer's Equity, Type [Domain]", "terseLabel": "Option Indexed to Issuer's Equity, Type [Domain]" } } }, "localname": "OptionIndexedToIssuersEquityTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r1", "r296" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "BASIS OF PRESENTATION" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r305", "r323" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other Assets [Member]", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsFairValueOfDerivativeInstrumentsByBalanceSheetLocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r32" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r55", "r57", "r292", "r294" ], "calculation": { "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfComprehensiveIncomeDetails": { "order": 4.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent", "negatedTerseLabel": "Pension liability adjustment, net of tax" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r292", "r293", "r294" ], "calculation": { "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfComprehensiveIncomeDetails": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent", "terseLabel": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent": { "auth_ref": [ "r57" ], "calculation": { "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfComprehensiveIncomeDetails": { "order": 3.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent", "terseLabel": "Change in unrealized loss on derivatives, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r53", "r57", "r307", "r312", "r325" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "terseLabel": "Gain recorded in AOCI, change in fair value", "verboseLabel": "Amount of Gain (Loss) Recognized in AOCL" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails", "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": { "auth_ref": [ "r57", "r60" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax", "terseLabel": "Amount of Gain (Loss) Reclassified from AOCL into Earnings" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": { "auth_ref": [ "r57", "r60", "r313" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax", "terseLabel": "Gain (loss) recorded in other income, net" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r315" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.", "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax", "terseLabel": "Gain recorded in AOCL, net investment hedge, change in fair value" } } }, "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r63", "r66", "r292", "r293", "r294" ], "calculation": { "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfChangesInAccumulatedOtherComprehensiveIncomeByComponentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "terseLabel": "Other comprehensive loss, net of tax", "totalLabel": "Net current-period other comprehensive loss" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfChangesInAccumulatedOtherComprehensiveIncomeByComponentDetails", "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherExpenseMember": { "auth_ref": [ "r318" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other expense.", "label": "Other Expense [Member]", "terseLabel": "Other Income (Expense), net" } } }, "localname": "OtherExpenseMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/ComprehensiveIncomeLossNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherIndefiniteLivedIntangibleAssets": { "auth_ref": [ "r160" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after impairment of indefinite-lived intangible assets classified as other. Excludes financial assets and goodwill.", "label": "Other Indefinite-lived Intangible Assets", "terseLabel": "Other Indefinite-lived Intangible Assets" } } }, "localname": "OtherIndefiniteLivedIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesMember": { "auth_ref": [ "r305", "r323" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other liabilities.", "label": "Other Liabilities [Member]", "terseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsFairValueOfDerivativeInstrumentsByBalanceSheetLocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r41" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r77" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income(expense), net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).", "label": "Other Nonoperating Income (Expense) [Member]", "terseLabel": "Other income (expense), net" } } }, "localname": "OtherNonoperatingIncomeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": { "auth_ref": [ "r89" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.", "label": "Payment for Contingent Consideration Liability, Financing Activities", "terseLabel": "Payment for contingent consideration" } } }, "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r86" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Purchases of treasury stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r88" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedLabel": "Payment of debt issuance costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r86" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-based Payment Arrangement", "negatedTerseLabel": "Cash taxes paid in net equity settlement" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment": { "auth_ref": [ "r82" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination.", "label": "Payments to Acquire in Process Research and Development", "negatedTerseLabel": "Acquired in-process research and development" } } }, "localname": "PaymentsToAcquireInProcessResearchAndDevelopment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r83" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "terseLabel": "Upfront payment, intangible assets" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r83" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r238" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for pension and other postretirement benefits.", "label": "Pension and Other Postretirement Benefits Disclosure [Text Block]", "terseLabel": "RETIREMENT PLANS" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/RetirementPlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Shares [Member]", "terseLabel": "Performance shares" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PositionAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by position taken for a security.", "label": "Position [Axis]", "terseLabel": "Position [Axis]" } } }, "localname": "PositionAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PositionDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicates position taken for a security.", "label": "Position [Domain]", "terseLabel": "Position [Domain]" } } }, "localname": "PositionDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, authorized shares (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, outstanding shares (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r14" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock; no par value; 15,000 authorized shares; none outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r5", "r28", "r29" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.", "label": "Prepaid Expenses and Other Current Assets [Member]", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpensesAndOtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsFairValueOfDerivativeInstrumentsByBalanceSheetLocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromCollectionOfNotesReceivable": { "auth_ref": [ "r80" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from Collection of Notes Receivable", "terseLabel": "Proceeds from note receivable" } } }, "localname": "ProceedsFromCollectionOfNotesReceivable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r85" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from Convertible Debt", "terseLabel": "Proceeds from convertible notes issuance", "verboseLabel": "Net proceeds from offering of convertible senior notes" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://integralife.com/role/TreasuryStockNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSecuredDebt": { "auth_ref": [ "r85" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.", "label": "Proceeds from Issuance of Secured Debt", "terseLabel": "Proceeds from borrowings of long-term indebtedness" } } }, "localname": "ProceedsFromIssuanceOfSecuredDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r84" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "terseLabel": "Proceeds from sale of stock purchase warrants", "verboseLabel": "Proceeds from warrant transactions" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r81" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from Sale of Property, Plant, and Equipment", "terseLabel": "Proceeds from sale of property and equipment" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r84", "r253" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from exercised stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r31", "r166" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property, Plant and Equipment, Type [Axis]", "terseLabel": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r9", "r10", "r166", "r400" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r9", "r165" ], "lang": { "en-US": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property, Plant and Equipment, Type [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis": { "auth_ref": [ "r347" ], "lang": { "en-US": { "role": { "documentation": "Information by property that could be leased or is available for lease.", "label": "Property Subject to or Available for Operating Lease [Axis]", "terseLabel": "Property Subject to or Available for Operating Lease [Axis]" } } }, "localname": "PropertySubjectToOrAvailableForOperatingLeaseAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain": { "auth_ref": [ "r347" ], "lang": { "en-US": { "role": { "documentation": "A descriptive title of whether the property is subject to or available for operating lease.", "label": "Property Subject to or Available for Operating Lease [Domain]", "terseLabel": "Property Subject to or Available for Operating Lease [Domain]" } } }, "localname": "PropertySubjectToOrAvailableForOperatingLeaseDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": { "auth_ref": [ "r59", "r68" ], "calculation": { "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfChangesInAccumulatedOtherComprehensiveIncomeByComponentDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.", "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent", "terseLabel": "Less: Amounts reclassified from accumulated other comprehensive loss", "verboseLabel": "Amounts gain (loss) reclassified from accumulated other comprehensive loss" } } }, "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/ComprehensiveIncomeLossNarrativeDetails", "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfChangesInAccumulatedOtherComprehensiveIncomeByComponentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r364" ], "lang": { "en-US": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r234", "r361", "r363", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383" ], "lang": { "en-US": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfSecuredDebt": { "auth_ref": [ "r87" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.", "label": "Repayments of Secured Debt", "negatedTerseLabel": "Payments on debt" } } }, "localname": "RepaymentsOfSecuredDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r258", "r411" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails", "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentInProcess": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.", "label": "Research and Development in Process", "terseLabel": "In-process research and development" } } }, "localname": "ResearchAndDevelopmentInProcess", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentAssetAcquisitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r18", "r206", "r398" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r220", "r221" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Total Revenues", "verboseLabel": "Total revenue, net" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfRevenuesDisaggregatedByMajorSourceDetails", "http://integralife.com/role/SegmentAndGeographicInformationNetSalesAndProfitByReportableSegmentDetails", "http://integralife.com/role/SegmentAndGeographicInformationTotalRevenueByMajorGeographicAreaDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r98", "r226" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Summary of Accounting Policies on Revenue Recognition and Shipping and Handling Fees" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r226" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "REVENUES FROM CONTRACTS WITH CUSTOMERS" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomers" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]", "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]" } } }, "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information when using transition method for cumulative effect in initial period of application for revenue from contract with customer.", "label": "Revenue, Initial Application Period Cumulative Effect Transition [Table]", "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Table]" } } }, "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersNarrativeRevenueRemainingPerformanceObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r219" ], "lang": { "en-US": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Performance obligations expected to be satisfied, expected timing" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersNarrativeRevenueRemainingPerformanceObligationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "auth_ref": [ "r219" ], "lang": { "en-US": { "role": { "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in CCYY-MM-DD format.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersNarrativeRevenueRemainingPerformanceObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersNarrativeRevenueRemainingPerformanceObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationPercentage": { "auth_ref": [ "r219" ], "lang": { "en-US": { "role": { "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Percentage", "terseLabel": "Expected performance obligation through 2020, percentage" } } }, "localname": "RevenueRemainingPerformanceObligationPercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/RevenuesFromContractsWithCustomersNarrativeRevenueRemainingPerformanceObligationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock": { "auth_ref": [ "r213" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for election to exclude from measurement of transaction price tax assessed by governmental authority that are both imposed on and concurrent with specific revenue-producing transaction, and collected from customer. Includes, but is not limited to, sales, use, value-added and excise tax.", "label": "Revenue, Transaction Price Measurement, Tax Exclusion [Policy Text Block]", "terseLabel": "Taxes Collected from Customers" } } }, "localname": "RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r355", "r359" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Operating leases" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r59" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Changes in Accumulated Other Comprehensive Loss by Component" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/ComprehensiveIncomeLossTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": { "auth_ref": [ "r151" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.", "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]", "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]" } } }, "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r115" ], "lang": { "en-US": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/NetIncomePerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r274", "r275" ], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentBusinessCombinationNarrativeDetails", "http://integralife.com/role/BusinessDevelopmentBusinessCombinationScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r51" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.", "label": "Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/ComprehensiveIncomeLossTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r40", "r101", "r201", "r203", "r204", "r205", "r343", "r344", "r346", "r393" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of Long-term Debt Maximum Leverage Ratios" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r306", "r314", "r320" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "terseLabel": "Effect of Derivative Instruments Designated as Cash Flow Hedges on Statements of Operations" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "auth_ref": [ "r311" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "terseLabel": "Schedule of Fair Value and Presentation of Derivatives" } } }, "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": { "auth_ref": [ "r105", "r297", "r299", "r300", "r303", "r304", "r311", "r314", "r321", "r322" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Schedule of Derivative Instruments [Table Text Block]", "terseLabel": "Schedule of Derivative Instruments" } } }, "localname": "ScheduleOfDerivativeInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r116" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Basic and Diluted Net Income Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/NetIncomePerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r261" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r151", "r156" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r147", "r148" ], "lang": { "en-US": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfChangesInCarryingAmountOfGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r147", "r148" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Schedule of Changes in Carrying Amount of Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r160", "r162" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Indefinite-Lived Intangible Assets" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r8", "r25", "r26", "r27" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of Inventories, Net" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r188" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term borrowings for each of the five years following the date of the latest balance sheet date presented.", "label": "Schedule of Maturities of Long-term Debt [Table Text Block]", "terseLabel": "Schedule of Maturities of Long-term Debt" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOperatingLeasedAssetsTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Schedule of Operating Leased Assets [Table]", "terseLabel": "Schedule of Operating Leased Assets [Table]" } } }, "localname": "ScheduleOfOperatingLeasedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesFutureMinimumLeasePaymentUnderOperatingLeasesAfterAdoptionOf842Details", "http://integralife.com/role/LeasesAndRelatedPartyLeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r278" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Schedule of Assets Acquired and Liabilities Assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/BusinessDevelopmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r119", "r125", "r126", "r127", "r147" ], "lang": { "en-US": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/SegmentAndGeographicInformationNarrativeDetails", "http://integralife.com/role/SegmentAndGeographicInformationNetSalesAndProfitByReportableSegmentDetails", "http://integralife.com/role/SegmentAndGeographicInformationTotalRevenueByMajorGeographicAreaDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r119", "r125", "r126", "r127", "r147" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Total Revenue By Major Geographic Area" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/SegmentAndGeographicInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r243", "r252" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SecuredDebtCurrent": { "auth_ref": [ "r11", "r385", "r396" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.", "label": "Secured Debt, Current", "terseLabel": "Current portion of borrowings under senior credit facility" } } }, "localname": "SecuredDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_SecuredDebtMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.", "label": "Secured Debt [Member]", "terseLabel": "Secured Debt" } } }, "localname": "SecuredDebtMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SecuredLongTermDebt": { "auth_ref": [ "r40" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying amount of collateralized debt obligations with maturities initially due after one year or beyond the operating cycle, if longer, excluding the current portion. Obligations include, but not limited to, mortgage loans, chattel loans, and other borrowings secured by assets.", "label": "Secured Long-term Debt, Noncurrent", "terseLabel": "Long-term borrowings under senior credit facility" } } }, "localname": "SecuredLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfChangesInCarryingAmountOfGoodwillDetails", "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfRevenuesDisaggregatedByMajorSourceDetails", "http://integralife.com/role/SegmentAndGeographicInformationNarrativeDetails", "http://integralife.com/role/SegmentAndGeographicInformationNetSalesAndProfitByReportableSegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r132" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "SEGMENT AND GEOGRAPHIC INFORMATION" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/SegmentAndGeographicInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/SegmentAndGeographicInformationNarrativeDetails", "http://integralife.com/role/SegmentAndGeographicInformationNetSalesAndProfitByReportableSegmentDetails", "http://integralife.com/role/SegmentAndGeographicInformationTotalRevenueByMajorGeographicAreaDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Segment Reporting Information, Operating Income (Loss) [Abstract]", "terseLabel": "Segment Net Sales" } } }, "localname": "SegmentReportingInformationOperatingIncomeLossAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/SegmentAndGeographicInformationNetSalesAndProfitByReportableSegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingInformationProfitLossAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Segment Reporting Information, Profit (Loss) [Abstract]", "terseLabel": "Segment Profit" } } }, "localname": "SegmentReportingInformationProfitLossAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/SegmentAndGeographicInformationNetSalesAndProfitByReportableSegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r74", "r140" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r92" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Share-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": { "auth_ref": [ "r244" ], "lang": { "en-US": { "role": { "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period", "terseLabel": "Requisite service periods of awards" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r244" ], "lang": { "en-US": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Stock options exercisable, vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r248" ], "lang": { "en-US": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Awards granted during the period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r248" ], "lang": { "en-US": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Other than options, weighted average grant date fair value (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r247" ], "lang": { "en-US": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures", "terseLabel": "Grants in period, net of forfeitures (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r249" ], "lang": { "en-US": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Options, weighted average grant date fair value (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r240", "r246" ], "lang": { "en-US": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/NetIncomePerShareNarrativeDetails", "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r245" ], "lang": { "en-US": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period", "terseLabel": "Expiration period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r200" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "periodEndLabel": "Balance End of Period, Shares (in shares)", "periodStartLabel": "Balance Beginning of Period, Shares (in shares)" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicates the sale of a borrowed security or written option.", "label": "Short [Member]", "terseLabel": "Short" } } }, "localname": "ShortMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DerivativeInstrumentsNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StandbyLettersOfCreditMember": { "auth_ref": [ "r183", "r187", "r291", "r407" ], "lang": { "en-US": { "role": { "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation.", "label": "Standby Letters of Credit [Member]", "terseLabel": "Standby Letters of Credit" } } }, "localname": "StandbyLettersOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r0", "r125", "r147", "r169", "r172", "r173", "r404" ], "lang": { "en-US": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfChangesInCarryingAmountOfGoodwillDetails", "http://integralife.com/role/RevenuesFromContractsWithCustomersScheduleOfRevenuesDisaggregatedByMajorSourceDetails", "http://integralife.com/role/SegmentAndGeographicInformationNarrativeDetails", "http://integralife.com/role/SegmentAndGeographicInformationNetSalesAndProfitByReportableSegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r44", "r200" ], "lang": { "en-US": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/ComprehensiveIncomeLossNarrativeDetails", "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfChangesInAccumulatedOtherComprehensiveIncomeByComponentDetails", "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity", "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r14", "r15", "r200", "r206" ], "lang": { "en-US": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "terseLabel": "Issuance of common stock through employee stock purchase plan (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r14", "r15", "r200", "r206" ], "lang": { "en-US": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Issuance of common stock for vesting of share based awards, net of shares withheld for taxes (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued": { "auth_ref": [ "r15", "r200", "r206" ], "lang": { "en-US": { "role": { "documentation": "Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.", "label": "Stock Issued During Period, Shares, Treasury Stock Reissued", "negatedTerseLabel": "Share repurchase and equity component of the convertible note issuance, net (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesTreasuryStockReissued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "auth_ref": [ "r14", "r15", "r200", "r206" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.", "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan", "terseLabel": "Issuance of common stock through employee stock purchase plan" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r14", "r15", "r206", "r242", "r249" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Issuance of common stock for vesting of share based awards, net of shares withheld for taxes" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "verboseLabel": "Stock repurchase program, authorized amount (up to)" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/TreasuryStockNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount remaining of a stock repurchase plan authorized.", "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount", "terseLabel": "Remaining amount under share repurchase" } } }, "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/TreasuryStockNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r14", "r15", "r200", "r206" ], "lang": { "en-US": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "negatedTerseLabel": "Accelerated shares repurchased (in shares)", "terseLabel": "Stock repurchased during period (in shares)" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity", "http://integralife.com/role/TreasuryStockNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r14", "r15", "r200", "r206" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedTerseLabel": "Accelerated shares repurchased", "terseLabel": "Accelerated shares repurchased, amount" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity", "http://integralife.com/role/TreasuryStockNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r15", "r19", "r20", "r137" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance, End of Period", "periodStartLabel": "Balance, Beginning of Period", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/ComprehensiveIncomeLossScheduleOfChangesInAccumulatedOtherComprehensiveIncomeByComponentDetails", "http://integralife.com/role/CondensedConsolidatedBalanceSheets", "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity", "http://integralife.com/role/DerivativeInstrumentsEffectOfDerivativeInstrumentsDesignatedCashFlowHedgesOnStatementsOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/TreasuryStockNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r365" ], "lang": { "en-US": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/TreasuryStockNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r365" ], "lang": { "en-US": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/TreasuryStockNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SwissFederalTaxAdministrationFTAMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Designated tax department of the government of Switzerland.", "label": "Swiss Federal Tax Administration (FTA) [Member]", "terseLabel": "Swiss Federal Tax Administration (FTA)" } } }, "localname": "SwissFederalTaxAdministrationFTAMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r279" ], "lang": { "en-US": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]", "terseLabel": "Codman tradename" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockAcquiredAverageCostPerShare": { "auth_ref": [ "r208" ], "lang": { "en-US": { "role": { "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.", "label": "Treasury Stock Acquired, Average Cost Per Share", "terseLabel": "Treasury stock, average cost per share (in dollars per share)" } } }, "localname": "TreasuryStockAcquiredAverageCostPerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/TreasuryStockNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_TreasuryStockCommonShares": { "auth_ref": [ "r45", "r208" ], "lang": { "en-US": { "role": { "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Shares", "terseLabel": "Treasury stock (in shares)" } } }, "localname": "TreasuryStockCommonShares", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/TreasuryStockNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockCommonValue": { "auth_ref": [ "r45", "r208", "r211" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Value", "terseLabel": "Treasury stock" } } }, "localname": "TreasuryStockCommonValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/TreasuryStockNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r43", "r208" ], "lang": { "en-US": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Stock" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r43", "r208" ], "lang": { "en-US": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury Stock, Shares", "negatedPeriodEndLabel": "Balance, End of Period, Treasury Stock, Shares (in shares)", "negatedPeriodStartLabel": "Balance, Beginning of Period, Treasury Stock, Shares (in shares)", "terseLabel": "Treasury stock, shares (in shares)" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://integralife.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockTextBlock": { "auth_ref": [ "r212" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Treasury Stock [Text Block]", "terseLabel": "TREASURY STOCK" } } }, "localname": "TreasuryStockTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/TreasuryStock" ], "xbrltype": "textBlockItemType" }, "us-gaap_TreasuryStockTransactionsExcludingValueOfSharesReissuedAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Treasury Stock Transactions, Excluding Value of Shares Reissued [Abstract]" } } }, "localname": "TreasuryStockTransactionsExcludingValueOfSharesReissuedAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r43", "r208", "r211" ], "calculation": { "http://integralife.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury stock, at cost; 4,294 shares and 2,865 shares at March 31, 2020 and December 31, 2019, respectively" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails", "http://integralife.com/role/DerivativeInstrumentsScheduleOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VehiclesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equipment used primarily for road transportation.", "label": "Vehicles [Member]", "terseLabel": "Leased vehicles" } } }, "localname": "VehiclesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/LeasesAndRelatedPartyLeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r109", "r114" ], "calculation": { "http://integralife.com/role/NetIncomePerShareBasicAndDilutedNetIncomePerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-US": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average common shares for diluted earnings per share (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://integralife.com/role/NetIncomePerShareBasicAndDilutedNetIncomePerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Weighted average common shares outstanding (See Note 13):" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r108", "r114" ], "calculation": { "http://integralife.com/role/NetIncomePerShareBasicAndDilutedNetIncomePerShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted average common shares outstanding - Basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://integralife.com/role/NetIncomePerShareBasicAndDilutedNetIncomePerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WriteOffOfDeferredDebtIssuanceCost": { "auth_ref": [ "r76" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.", "label": "Write off of Deferred Debt Issuance Cost", "verboseLabel": "Previously capitalized financing costs, written-off" } } }, "localname": "WriteOffOfDeferredDebtIssuanceCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://integralife.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" } }, "unitCount": 13 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1)(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(i)(4))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(n)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04.(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1500-109256" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258" }, "r118": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8475-108599" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599" }, "r132": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4647-111522" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5074-111524" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118955202&loc=SL82895884-210446" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r143": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b),(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r163": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "410", "URI": "http://asc.fasb.org/extlink&oid=6392676&loc=d3e7480-110848" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394232&loc=d3e17558-110866" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r174": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14615-108349" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14394-108349" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14453-108349" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14472-108349" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349" }, "r182": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12021-110248" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12021-110248" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12053-110248" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=118956092&loc=d3e12803-110250" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4852-112606" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=51819886&loc=SL6014347-161799" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031898-161870" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6036836-161870" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6036836-161870" }, "r197": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "63", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=117411753&loc=d3e23176-110880" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r212": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/subtopic&trid=2208821" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "32", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=116855152&loc=SL82860478-203043" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130531-203044" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130532-203044" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130533-203044" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130551-203045" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130551-203045" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130556-203045" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r226": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r238": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116855982&loc=d3e4534-113899" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=SL79508275-113901" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11149-113907" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11178-113907" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "740", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=117330312&loc=d3e23163-113944" }, "r257": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31917-109318" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31931-109318" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=117331294&loc=d3e36027-109320" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324" }, "r273": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868840&loc=d3e2207-128464" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5263-128473" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5333-128473" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5419-128473" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5504-128473" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116873149&loc=d3e923-111674" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r296": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(iii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "4CCC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL109998896-113959" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(6)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=116861445&loc=SL5629052-113961" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=118875152&loc=SL5864739-113975" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109974929&loc=SL110061190-113977" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=112277219&loc=d3e80748-113994" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=6445032&loc=d3e90193-114008" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=6445032&loc=d3e90198-114008" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=6445032&loc=d3e90205-114008" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=6445032&loc=d3e90205-114008" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=116862287&loc=d3e90476-114009" }, "r333": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13433-108611" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=84164653&loc=d3e41551-112718" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918638-209977" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918643-209977" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r364": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=SL51823488-111719" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=66023616&loc=SL35737432-115832" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r412": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r413": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r414": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r415": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-13" }, "r416": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1-" }, "r417": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r418": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e526-108580" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e689-108580" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118951672&loc=d3e1436-108581" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6935-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "8", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r79": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "http://asc.fasb.org/topic&trid=2134417" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" } }, "version": "2.1" } XML 81 R34.htm IDEA: XBRL DOCUMENT v3.20.1
SEGMENT AND GEOGRAPHIC INFORMATION (Tables)
 3 Months Ended
Mar. 31, 2020
Segment Reporting [Abstract]  
Total Revenue By Major Geographic Area Net sales and profit by each reportable segment for the three months ended March 31, 2020 and 2019 are as follows:
 
Three Months Ended March 31,
 
2020
 
2019
 
(In thousands)
Segment Net Sales
 
 
 
Codman Specialty Surgical
$
231,440

 
$
234,568

Orthopedics and Tissue Technologies
122,884

 
125,122

Total revenues
$
354,324

 
$
359,690

Segment Profit
 
 
 
Codman Specialty Surgical
$
87,235

 
$
91,380

Orthopedics and Tissue Technologies
31,271

 
40,495

Segment profit
118,506

 
131,875

Amortization
(6,977
)
 
(5,279)

Corporate and other
(84,426
)
 
(94,288
)
Operating income
$
27,103

 
$
32,308


The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment.
The Company attributes revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following:
 
Three Months Ended March 31,
 
2020
 
2019
 
(In thousands)
United States
$
246,852

 
$
256,726

Europe
45,896

 
48,640

Asia Pacific
39,960

 
35,700

Rest of World
21,616

 
18,624

Total Revenues
$
354,324

 
$
359,690
XML 82 R30.htm IDEA: XBRL DOCUMENT v3.20.1
LEASES AND RELATED PARTY LEASES (Tables)
 3 Months Ended
Mar. 31, 2020
Leases [Abstract]  
Supplemental Balance Sheet Information
Supplemental balance sheet information related to operating leases at March 31, 2020 were as follows:
 
March 31, 2020
 
(In thousands, except lease term and discount rate)
ROU assets
$
95,890

 
 
Current lease liabilities
$
12,964

Non-current lease liabilities
100,328

Total lease liabilities
$
113,292

 
 
Weighted average remaining lease term (in years):
 
Leased facilities
12.5

Leased vehicles
1.7

 
 
Weighted average discount rate:
 
Leased facilities
5.2
%
Leased vehicles
2.4
%
Supplemental Cash Flow Information
Supplemental cash flow information related to leases was as follows for the three months ended March 31, 2020 (in thousands):
 
March 31, 2020
 
(In thousands)
Cash paid for amounts included in the measurement of lease liabilities:
 
Operating cash flows from operating leases
$
3,229

 
 
ROU assets obtained in exchange for lease liabilities:
 
Operating leases
$
5,808
Schedule of Operating Lease Maturities
Future minimum lease payments under operating leases at March 31, 2020 were as follows:
 
Related Parties
 
Third Parties
 
Total
 
(In thousands)
2020
$
222

 
$
10,334

 
$
10,556

2021
296

 
13,018

 
13,314

2022
296

 
14,198

 
14,494

2023
296

 
11,658

 
11,954

2024
296

 
11,022

 
11,318

Thereafter
1,429

 
91,026

 
92,455

Total minimum lease payments
$
2,835

 
$
151,256

 
$
154,091

Less: Imputed interest
 
 
 
 
40,799

Total lease liabilities
 
 
 
 
113,292

Less: Current lease liabilities
 
 
 
 
12,964

Long-term lease liabilities
 
 
 
 
100,328








Future minimum lease payments under operating leases at December 31, 2019 were as follows:
 
Related Parties
 
Third Parties
 
Total
 
(In thousands)
2020
$
296

 
$
12,100

 
$
12,396

2021
296

 
12,951

 
13,247

2022
296

 
13,753

 
14,049

2023
296

 
11,386

 
11,682

2024
296

 
11,060

 
11,356

Thereafter
1,428

 
91,235

 
92,663

Total minimum lease payments
$
2,908

 
$
152,485

 
$
155,393

Less: Imputed interest
 
 
 
 
45,636

Total lease liabilities
 
 
 
 
109,757

Less: Current lease liabilities
 
 
 
 
12,253

Long-term lease liabilities
 
 
 
 
97,504
XML 83 R38.htm IDEA: XBRL DOCUMENT v3.20.1
BUSINESS DEVELOPMENT - Asset Acquisition, Narrative (Details)
 3 Months Ended 12 Months Ended
Sep. 09, 2019
USD ($)
asset
Jan. 04, 2019
USD ($)
Mar. 31, 2020
USD ($)
Mar. 31, 2019
USD ($)
Dec. 31, 2019
USD ($)
Schedule Of Asset Acquisition [Line Items]          
Research and development     $ 20,816,000 $ 18,321,000  
Rebound          
Schedule Of Asset Acquisition [Line Items]          
Upfront payment $ 67,100,000        
Contingent development milestone payments commitment (up to) $ 35,000,000.0        
Number of assets acquired | asset 1        
Remaining net assets acquired $ 7,200,000        
Development milestone         $ 5,000,000.0
In-process research and development         $ 5,000,000.0
Research and development       $ 1,700,000  
Rebound | Cash and Cash Equivalents          
Schedule Of Asset Acquisition [Line Items]          
Remaining net assets acquired 2,100,000        
Rebound | Deferred Tax Asset          
Schedule Of Asset Acquisition [Line Items]          
Remaining net assets acquired 4,200,000        
Rebound | In-Process Research and Development Expense          
Schedule Of Asset Acquisition [Line Items]          
Upfront payment $ 59,900,000        
ISC | Enabling technology license          
Schedule Of Asset Acquisition [Line Items]          
Upfront payment, intangible assets   $ 1,700,000      
Option to acquire, period subsequent to first commercial sale   4 years      
Maximum future purchase price, if circumstances met (not to exceed)   $ 80,000,000.0      
XML 84 iart-2020033110xq_htm.xml IDEA: XBRL DOCUMENT 0000917520 2020-01-01 2020-03-31 0000917520 2020-05-05 0000917520 2019-01-01 2019-03-31 0000917520 2019-12-31 0000917520 2020-03-31 0000917520 2018-12-31 0000917520 2019-03-31 0000917520 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000917520 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000917520 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000917520 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0000917520 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0000917520 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000917520 us-gaap:TreasuryStockMember 2020-01-01 2020-03-31 0000917520 us-gaap:CommonStockMember 2019-12-31 0000917520 us-gaap:CommonStockMember 2020-03-31 0000917520 us-gaap:TreasuryStockMember 2020-03-31 0000917520 us-gaap:TreasuryStockMember 2019-12-31 0000917520 us-gaap:RetainedEarningsMember iart:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-01-01 0000917520 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000917520 us-gaap:RetainedEarningsMember 2019-12-31 0000917520 us-gaap:RetainedEarningsMember 2020-03-31 0000917520 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000917520 iart:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-01-01 0000917520 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0000917520 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000917520 us-gaap:TreasuryStockMember 2018-12-31 0000917520 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000917520 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0000917520 us-gaap:CommonStockMember 2019-03-31 0000917520 us-gaap:RetainedEarningsMember 2019-03-31 0000917520 us-gaap:TreasuryStockMember 2019-01-01 2019-03-31 0000917520 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0000917520 us-gaap:CommonStockMember 2018-12-31 0000917520 us-gaap:TreasuryStockMember 2019-03-31 0000917520 us-gaap:RetainedEarningsMember 2018-12-31 0000917520 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000917520 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000917520 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000917520 iart:ArkisBioSciencesInc.Member 2019-07-29 2019-07-29 0000917520 iart:ReboundTherapeuticsCorporationMember 2019-09-09 2019-09-09 0000917520 us-gaap:LicensingAgreementsMember iart:IntegratedShoulderCollaborationInc.Member 2019-01-04 2019-01-04 0000917520 iart:ArkisBioSciencesInc.Member iart:MilestonePaymentTwoMember 2019-07-29 0000917520 iart:ArkisBioSciencesInc.Member 2019-07-29 0000917520 iart:DeferredTaxAssetMember iart:ReboundTherapeuticsCorporationMember 2019-09-09 2019-09-09 0000917520 iart:ReboundTherapeuticsCorporationMember 2019-12-31 0000917520 iart:ArkisBioSciencesInc.Member iart:MilestonePaymentOneMember 2019-07-29 0000917520 iart:ReboundTherapeuticsCorporationMember 2019-01-01 2019-12-31 0000917520 iart:ReboundTherapeuticsCorporationMember 2019-09-09 0000917520 iart:ReboundTherapeuticsCorporationMember 2019-01-01 2019-03-31 0000917520 us-gaap:CashAndCashEquivalentsMember iart:ReboundTherapeuticsCorporationMember 2019-09-09 2019-09-09 0000917520 iart:ArkisBioSciencesInc.Member 2019-12-31 0000917520 us-gaap:InProcessResearchAndDevelopmentMember iart:ReboundTherapeuticsCorporationMember 2019-09-09 2019-09-09 0000917520 iart:ArkisBioSciencesInc.Member us-gaap:DevelopedTechnologyRightsMember 2019-07-29 0000917520 iart:ArkisBioSciencesInc.Member us-gaap:DevelopedTechnologyRightsMember 2019-07-29 2019-07-29 0000917520 iart:ArkisBioSciencesInc.Member us-gaap:LicensingAgreementsMember 2019-07-29 0000917520 iart:ArkisBioSciencesInc.Member us-gaap:LicensingAgreementsMember 2019-07-29 2019-07-29 0000917520 iart:PrivateLabelMember iart:OrthopedicsandTissueTechnologiesMember 2020-01-01 2020-03-31 0000917520 iart:InstrumentsMember iart:CodmanSpecialtySurgicalMember 2019-01-01 2019-03-31 0000917520 iart:RegenerativeSkinAndWoundMember iart:OrthopedicsandTissueTechnologiesMember 2020-01-01 2020-03-31 0000917520 iart:NeurosurgeryMember iart:CodmanSpecialtySurgicalMember 2019-01-01 2019-03-31 0000917520 iart:ExtremityOrthopedicsMember iart:OrthopedicsandTissueTechnologiesMember 2020-01-01 2020-03-31 0000917520 iart:OrthopedicsandTissueTechnologiesMember 2020-01-01 2020-03-31 0000917520 iart:OrthopedicsandTissueTechnologiesMember 2019-01-01 2019-03-31 0000917520 iart:InstrumentsMember iart:CodmanSpecialtySurgicalMember 2020-01-01 2020-03-31 0000917520 iart:RegenerativeSkinAndWoundMember iart:OrthopedicsandTissueTechnologiesMember 2019-01-01 2019-03-31 0000917520 iart:ExtremityOrthopedicsMember iart:OrthopedicsandTissueTechnologiesMember 2019-01-01 2019-03-31 0000917520 iart:CodmanSpecialtySurgicalMember 2019-01-01 2019-03-31 0000917520 iart:NeurosurgeryMember iart:CodmanSpecialtySurgicalMember 2020-01-01 2020-03-31 0000917520 iart:CodmanSpecialtySurgicalMember 2020-01-01 2020-03-31 0000917520 iart:PrivateLabelMember iart:OrthopedicsandTissueTechnologiesMember 2019-01-01 2019-03-31 0000917520 srt:MaximumMember 2020-01-01 2020-03-31 0000917520 2020-04-01 2020-03-31 0000917520 srt:MinimumMember 2020-01-01 2020-03-31 0000917520 us-gaap:InProcessResearchAndDevelopmentMember 2020-03-31 0000917520 iart:AllOtherMember 2019-01-01 2019-12-31 0000917520 iart:TrademarksBrandNamesMember 2019-12-31 0000917520 us-gaap:CustomerRelationshipsMember 2019-12-31 0000917520 iart:TrademarksBrandNamesMember 2019-01-01 2019-12-31 0000917520 iart:AllOtherMember 2019-12-31 0000917520 iart:CompletedTechnologyMember 2019-12-31 0000917520 us-gaap:TradeNamesMember 2019-12-31 0000917520 iart:SupplierRelationShipsMember 2019-01-01 2019-12-31 0000917520 iart:SupplierRelationShipsMember 2019-12-31 0000917520 iart:CompletedTechnologyMember 2019-01-01 2019-12-31 0000917520 us-gaap:CustomerRelationshipsMember 2019-01-01 2019-12-31 0000917520 iart:OrthopedicsandTissueTechnologiesMember 2019-12-31 0000917520 iart:CodmanSpecialtySurgicalMember 2020-03-31 0000917520 iart:OrthopedicsandTissueTechnologiesMember 2020-03-31 0000917520 iart:CodmanSpecialtySurgicalMember 2019-12-31 0000917520 us-gaap:CustomerRelationshipsMember 2020-03-31 0000917520 iart:CompletedTechnologyMember 2020-03-31 0000917520 iart:SupplierRelationShipsMember 2020-03-31 0000917520 us-gaap:TradeNamesMember 2020-03-31 0000917520 iart:CompletedTechnologyMember 2020-01-01 2020-03-31 0000917520 iart:AllOtherMember 2020-03-31 0000917520 iart:TrademarksBrandNamesMember 2020-03-31 0000917520 us-gaap:CustomerRelationshipsMember 2020-01-01 2020-03-31 0000917520 iart:AllOtherMember 2020-01-01 2020-03-31 0000917520 iart:SupplierRelationShipsMember 2020-01-01 2020-03-31 0000917520 iart:TrademarksBrandNamesMember 2020-01-01 2020-03-31 0000917520 us-gaap:InProcessResearchAndDevelopmentMember 2019-12-31 0000917520 iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember us-gaap:ConvertibleDebtMember 2020-02-04 0000917520 us-gaap:StandbyLettersOfCreditMember 2020-02-03 0000917520 us-gaap:SecuredDebtMember iart:TermLoanFacilityMember us-gaap:FairValueInputsLevel2Member 2020-03-31 0000917520 iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember us-gaap:ConvertibleDebtMember 2020-02-04 2020-02-04 0000917520 us-gaap:RevolvingCreditFacilityMember us-gaap:FairValueInputsLevel2Member 2020-03-31 0000917520 iart:SwinglineLoanMember 2020-02-03 0000917520 iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember us-gaap:ConvertibleDebtMember 2020-01-01 2020-03-31 0000917520 srt:MaximumMember iart:SeniorCreditFacilityMember 2020-01-01 2020-03-31 0000917520 srt:MaximumMember iart:SeniorCreditFacilityMember us-gaap:EurodollarMember 2020-01-01 2020-03-31 0000917520 us-gaap:RevolvingCreditFacilityMember 2020-03-31 0000917520 us-gaap:StandbyLettersOfCreditMember iart:SeniorCreditFacilityMember 2020-03-31 0000917520 iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember us-gaap:ConvertibleDebtMember 2020-03-31 0000917520 us-gaap:RevolvingCreditFacilityMember 2019-12-31 0000917520 iart:SeniorCreditFacilityMember 2020-02-03 0000917520 iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:CallOptionMember 2020-01-01 2020-03-31 0000917520 us-gaap:SecuredDebtMember iart:TermLoanAFacilityMember 2020-03-31 0000917520 iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:CallOptionMember 2020-02-04 2020-02-04 0000917520 us-gaap:RevolvingCreditFacilityMember 2020-02-03 0000917520 iart:SecuredDebtCurrentMember us-gaap:SecuredDebtMember iart:TermLoanAFacilityMember 2020-03-31 0000917520 iart:SeniorCreditFacilityMember iart:OneMonthEurodollarRateMember 2020-01-01 2020-03-31 0000917520 srt:MinimumMember iart:SeniorCreditFacilityMember 2020-01-01 2020-03-31 0000917520 iart:SeniorCreditFacilityMember us-gaap:FederalFundsEffectiveSwapRateMember 2020-01-01 2020-03-31 0000917520 us-gaap:SecuredDebtMember iart:TermLoanFacilityMember 2020-02-03 0000917520 us-gaap:SecuredDebtMember iart:TermLoanAFacilityMember 2019-12-31 0000917520 srt:MinimumMember iart:SeniorCreditFacilityMember us-gaap:EurodollarMember 2020-01-01 2020-03-31 0000917520 iart:SeniorCreditFacilityMember 2020-01-01 2020-03-31 0000917520 us-gaap:FairValueInputsLevel2Member 2020-03-31 0000917520 2018-10-01 2018-12-31 0000917520 us-gaap:StandbyLettersOfCreditMember iart:SeniorCreditFacilityMember 2019-12-31 0000917520 iart:SeniorCreditFacilityMember iart:DebtCovenantPeriod2Member 2020-02-03 0000917520 iart:SeniorCreditFacilityMember iart:DebtCovenantPeriod1Member 2020-02-03 0000917520 iart:SeniorCreditFacilityMember iart:DebtCovenantPeriod3Member 2020-02-03 0000917520 iart:SwapOneMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-12-31 0000917520 iart:SwapOneMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 iart:SwapThreeMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 iart:SwapTwoMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-12-31 0000917520 iart:SwapThreeMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-12-31 0000917520 iart:SwapOneMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-12-31 0000917520 iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 iart:SwapTwoMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-12-31 0000917520 iart:SwapThreeMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-12-31 0000917520 iart:SwapTwoMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2020-01-01 2020-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2018-12-31 0000917520 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2020-01-01 2020-03-31 0000917520 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2019-01-01 2019-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2020-01-01 2020-03-31 0000917520 us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-03-31 0000917520 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-12-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-03-31 0000917520 us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2019-01-01 2019-03-31 0000917520 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2020-03-31 0000917520 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000917520 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2020-03-31 0000917520 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2018-12-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-12-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2020-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2019-12-31 0000917520 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2019-03-31 0000917520 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2019-12-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2019-03-31 0000917520 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedFebruary62017Tranche1Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:ThreeMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedOctober102018Tranche2Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedDecember182018Tranche1Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedDecember182018Tranche2Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedFebruary62017Tranche2Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedDecember132017Tranche5Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedOctober102018Tranche1Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedDecember132017Tranche3Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedOctober102018Tranche3Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedMarch272017Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedDecember132017Tranche1Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedDecember132017Tranche4Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedDecember132017Tranche2Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2020-03-31 0000917520 iart:InterestRateSwapDesignatedOctober102018Tranche1Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2019-12-31 0000917520 iart:InterestRateSwapDesignatedDecember182018Tranche1Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2019-12-31 0000917520 iart:InterestRateSwapDesignatedDecember132017Tranche3Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2019-12-31 0000917520 iart:InterestRateSwapDesignatedOctober102018Tranche2Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2019-12-31 0000917520 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 iart:InterestRateSwapDesignatedFebruary62017Tranche1Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:ThreeMonthUSDLIBORMember 2019-12-31 0000917520 iart:InterestRateSwapDesignatedDecember132017Tranche2Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2019-12-31 0000917520 iart:InterestRateSwapDesignatedDecember132017Tranche5Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2019-12-31 0000917520 iart:InterestRateSwapDesignatedOctober102018Tranche3Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2019-12-31 0000917520 iart:InterestRateSwapDesignatedMarch272017Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2019-12-31 0000917520 iart:InterestRateSwapDesignatedDecember182018Tranche2Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2019-12-31 0000917520 iart:InterestRateSwapDesignatedDecember132017Tranche1Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2019-12-31 0000917520 iart:InterestRateSwapDesignatedFebruary62017Tranche2Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2019-12-31 0000917520 iart:InterestRateSwapDesignatedDecember132017Tranche4Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember iart:OneMonthUSDLIBORMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractTwoMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractFiveMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractThreeMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractOneMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractThreeMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractFourMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractFourMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractThreeMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractOneMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractTwoMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractFourMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractFiveMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2020-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractOneMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractFiveMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractTwoMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:SwapTwoMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2020-03-31 0000917520 iart:SwapTwoMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:SwapThreeMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-03-31 0000917520 iart:SwapTwoMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-03-31 0000917520 iart:SwapOneMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-03-31 0000917520 iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:SwapOneMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:SwapThreeMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2020-03-31 0000917520 iart:SwapOneMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2020-03-31 0000917520 iart:SwapThreeMember iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 us-gaap:OtherLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 iart:AccruedExpensesAndOtherCurrentLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 us-gaap:OtherLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:AccruedExpensesAndOtherCurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 us-gaap:OtherAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 us-gaap:OtherAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 us-gaap:OtherAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:AccruedExpensesAndOtherCurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 us-gaap:OtherLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 us-gaap:OtherAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 iart:AccruedExpensesAndOtherCurrentLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 us-gaap:OtherAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 us-gaap:OtherAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 us-gaap:OtherLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000917520 iart:CrossCurrencyInterestRateContractTwoMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractOneMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractFiveMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractThreeMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractFourMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractTwoMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractFourMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractFiveMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractFourMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractThreeMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractOneMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractTwoMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractFiveMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractThreeMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-12-31 0000917520 iart:CrossCurrencyInterestRateContractOneMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-12-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000917520 iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-03-31 0000917520 us-gaap:InterestRateSwapMember 2020-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-03-31 0000917520 us-gaap:InterestRateSwapMember 2019-12-31 0000917520 iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-03-31 0000917520 iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:ShortMember 2017-10-02 0000917520 iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:LongMember 2017-10-02 0000917520 iart:RestrictedStockAwardsAndUnitsMember 2020-01-01 2020-03-31 0000917520 srt:DirectorMember us-gaap:EmployeeStockOptionMember 2020-01-01 2020-03-31 0000917520 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-03-31 0000917520 iart:EmployeeMember us-gaap:EmployeeStockOptionMember 2020-01-01 2020-03-31 0000917520 srt:MaximumMember iart:DirectorsandCertainExecutiveOfficersMember us-gaap:EmployeeStockOptionMember 2020-01-01 2020-03-31 0000917520 iart:RestrictedStockAwardsAndUnitsMember 2020-03-31 0000917520 us-gaap:EmployeeStockOptionMember 2020-03-31 0000917520 iart:PerformanceStockAndRestrictedStockAwardsMember 2020-01-01 2020-03-31 0000917520 us-gaap:PerformanceSharesMember 2020-01-01 2020-03-31 0000917520 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2020-01-01 2020-03-31 0000917520 srt:MinimumMember iart:DirectorsandCertainExecutiveOfficersMember us-gaap:EmployeeStockOptionMember 2020-01-01 2020-03-31 0000917520 2019-05-01 2019-05-31 0000917520 us-gaap:BuildingMember 2020-03-31 0000917520 us-gaap:VehiclesMember 2020-03-31 0000917520 srt:AffiliatedEntityMember 2020-01-01 2020-03-31 0000917520 iart:FiveYearOptionLeaseFromNovember12032ThroughOctober312037Member srt:AffiliatedEntityMember 2020-01-01 2020-03-31 0000917520 iart:FiveYearOptionLeaseFromNovember12037ThroughOctober312042Member srt:AffiliatedEntityMember 2020-01-01 2020-03-31 0000917520 iart:RelatedPartiesMember 2019-12-31 0000917520 iart:ThirdPartiesMember 2019-12-31 0000917520 iart:ThirdPartiesMember 2020-03-31 0000917520 iart:RelatedPartiesMember 2020-03-31 0000917520 srt:AffiliatedEntityMember 2019-01-01 2019-03-31 0000917520 iart:CertainPurchasersMember us-gaap:ConvertibleDebtMember 2020-01-01 2020-03-31 0000917520 2020-02-05 2020-02-05 0000917520 2018-12-11 0000917520 srt:ScenarioForecastMember us-gaap:SubsequentEventMember 2020-04-01 2020-06-30 0000917520 2019-01-01 2019-12-31 0000917520 us-gaap:ConvertibleDebtMember 2020-01-01 2020-03-31 0000917520 2020-02-05 0000917520 us-gaap:ForeignCountryMember us-gaap:SwissFederalTaxAdministrationFTAMember 2019-01-01 2019-03-31 0000917520 us-gaap:ForeignCountryMember us-gaap:SwissFederalTaxAdministrationFTAMember 2019-01-01 2019-12-31 0000917520 iart:PerformanceSharesandRestrictedUnitsMember 2019-12-31 0000917520 us-gaap:OtherExpenseMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-03-31 0000917520 us-gaap:InterestIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-03-31 0000917520 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-03-31 0000917520 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0000917520 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-31 0000917520 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-03-31 0000917520 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-31 0000917520 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-03-31 0000917520 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000917520 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-03-31 0000917520 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-31 0000917520 us-gaap:OperatingSegmentsMember 2019-01-01 2019-03-31 0000917520 us-gaap:OperatingSegmentsMember iart:OrthopedicsandTissueTechnologiesMember 2020-01-01 2020-03-31 0000917520 us-gaap:OperatingSegmentsMember iart:CodmanSpecialtySurgicalMember 2020-01-01 2020-03-31 0000917520 us-gaap:OperatingSegmentsMember 2020-01-01 2020-03-31 0000917520 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-03-31 0000917520 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-03-31 0000917520 us-gaap:OperatingSegmentsMember iart:CodmanSpecialtySurgicalMember 2019-01-01 2019-03-31 0000917520 us-gaap:OperatingSegmentsMember iart:OrthopedicsandTissueTechnologiesMember 2019-01-01 2019-03-31 0000917520 country:US 2020-01-01 2020-03-31 0000917520 srt:AsiaPacificMember 2020-01-01 2020-03-31 0000917520 srt:EuropeMember 2020-01-01 2020-03-31 0000917520 srt:AsiaPacificMember 2019-01-01 2019-03-31 0000917520 srt:EuropeMember 2019-01-01 2019-03-31 0000917520 country:US 2019-01-01 2019-03-31 0000917520 iart:RestOfWorldMember 2019-01-01 2019-03-31 0000917520 iart:RestOfWorldMember 2020-01-01 2020-03-31 0000917520 iart:DermaSciencesMember iart:BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember 2020-01-01 2020-03-31 0000917520 iart:DermaSciencesMember 2020-03-31 0000917520 iart:DermaSciencesMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2019-01-01 2019-03-31 0000917520 iart:DermaSciencesMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2018-12-31 0000917520 iart:DermaSciencesMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2019-03-31 0000917520 iart:DermaSciencesMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2019-12-31 0000917520 iart:ArkisBioSciencesInc.Member us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2019-12-31 0000917520 iart:ArkisBioSciencesInc.Member us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2020-01-01 2020-03-31 0000917520 iart:DermaSciencesMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2020-01-01 2020-03-31 0000917520 iart:DermaSciencesMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2020-03-31 0000917520 iart:ArkisBioSciencesInc.Member us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2020-03-31 0000917520 iart:DermaSciencesMember 2019-03-31 iart:plan iso4217:GBP pure iart:asset iso4217:CHF iso4217:EUR iso4217:USD shares iso4217:USD shares iart:liability iart:renewal_option iart:Segment iart:product false --12-31 Q1 2020 0000917520 P3Y 5.00 4.50 4.00 P1M 4303000 6652000 400000 200000 0.01 0.01 240000000 240000000 88735000 89104000 800000 877500000 100000 1000000 15000000 15000000 0 0 P9M P6Y 2865000 4294000 10-Q true 2020-03-31 false 0-26224 INTEGRA LIFESCIENCES HOLDINGS CORP DE 51-0317849 1100 Campus Road 08540 Princeton NJ 609 275-0500 Common Stock, Par Value $.01 Per Share IART NASDAQ Yes Yes Large Accelerated Filer false false false false 84843053 354324000 359690000 133476000 128912000 20816000 18321000 165952000 174870000 6977000 5279000 327221000 327382000 27103000 32308000 2570000 2428000 17752000 13149000 -479000 3236000 11442000 24823000 2262000 -7933000 9180000 32756000 0.11 0.38 0.11 0.38 85188000 85343000 85892000 86258000 -19007000 21520000 357712000 198911000 245546000 275296000 338082000 316054000 67332000 67907000 1008672000 858168000 335903000 337404000 95890000 94530000 1014227000 1031591000 951554000 954280000 2330000 12623000 38989000 14644000 3447565000 3303240000 0 45000000 12964000 12253000 97061000 113090000 4860000 4772000 55630000 79385000 75970000 76809000 246485000 331309000 1018032000 1198561000 98500000 104500000 460159000 0 100328000 97504000 24221000 36553000 158037000 118077000 2105762000 1886504000 0 0 889000 887000 1240455000 1213620000 202506000 119943000 -104588000 -76402000 407553000 398574000 1341803000 1416736000 3447565000 3303240000 9180000 32756000 29151000 27093000 5068000 -6843000 3750000 4083000 4246000 1357000 2529000 0 -374000 -367000 -1051000 194000 -28301000 13705000 26236000 12048000 -4683000 12949000 -3000000 628000 -40235000 5387000 338000 -188000 -2284000 4608000 20814000 29484000 16519000 16086000 5000000 0 0 245000 34000 35000 -21485000 -15806000 113200000 67200000 344200000 57400000 104248000 0 575000000 0 44562000 0 20264000 0 100000000 0 2303000 1750000 4348000 6157000 162005000 5393000 -2533000 -884000 158801000 18187000 198911000 138838000 357712000 157025000 88735000 887000 2865000 -119943000 1213620000 -76401000 398573000 1416736000 9180000 9180000 -28187000 -28187000 13000 694000 694000 357000 2000 10000 476000 -3217000 -2739000 3781000 3781000 135000 -7632000 42538000 34906000 1304000 75407000 16961000 92368000 -200000 -200000 89105000 889000 4294000 -202506000 1240455000 -104588000 407553000 1341803000 88044000 880000 2881000 -120615000 1192601000 -45443000 348373000 1375796000 32756000 32756000 -11236000 -11236000 17000 716000 716000 243000 2000 12000 506000 -5629000 -5121000 4119000 4119000 88304000 882000 2869000 -120109000 1191807000 -56679000 381129000 1397030000 BASIS OF PRESENTATION<div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">General</span></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The terms “we,” “our,” “us,” “Company” and “Integra” refer to Integra LifeSciences Holdings Corporation, a Delaware corporation, and its subsidiaries unless the context suggests otherwise.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In the opinion of management, the </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> unaudited condensed consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the financial position, statement of changes in shareholder's equity, results of operations and cash flows of the Company. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements for the year ended </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> included in the Company’s Annual Report on Form 10-K. The </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States. Operating results for the three month period ended </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> are not necessarily indicative of the results to be expected for the entire year.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements is in conformity with generally accepted accounting principles in the United States ("GAAP") which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of the equity component of convertible debt instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates. The novel coronavirus (“COVID-19”) pandemic and the resulting adverse impacts to global economic conditions, as well as our operations, may impact future estimates including, but not limited to, inventory valuations, fair value measurements, goodwill and long-lived asset impairments, the effectiveness of the Company’s hedging instruments, deferred tax valuation allowances, and allowances for doubtful accounts receivable.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Risks and Uncertainties</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company is subject to risks and uncertainties as a result of the COVID-19 pandemic. The extent of the impact of the COVID-19 pandemic on the Company's business is highly uncertain and difficult to predict, as the response to the pandemic is in its incipient stages and information is rapidly evolving. The Company's customers are diverting resources to treat COVID-19 patients and deferring elective surgical procedures, both of which are likely to impact hospitals' abilities to meet their obligations, including to the Company. Furthermore, capital markets and economies worldwide have also been negatively impacted by the COVID-19 pandemic, and it is likely that it could cause a local and/or global economic recession. Such economic disruption has had an adverse effect on our business as hospitals curtail and reduce capital and overall spending. Policymakers around the globe have responded with fiscal policy actions to support the healthcare industry and economy as a whole. The magnitude and overall effectiveness of these actions remains uncertain.The severity of the impact of the COVID-19 pandemic on the Company's business will depend on a number of factors, including, but not limited to, the duration and severity of the pandemic and the extent and severity of the impact on the Company's customers, all of which are uncertain and cannot be predicted with certainty. The Company's future results of operations and liquidity could be adversely impacted by delays in payments of outstanding receivable amounts beyond normal payment terms, supply chain disruptions and uncertain demand, and the impact of any initiatives or programs that the Company may undertake to address financial and operations challenges faced by its customers. The Company has implemented contingency plans to address the operational impact of COVID-19 and ensure ongoing operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Recently Issued Accounting Standards</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments - Credit Losses (Topic 326)</span><span style="font-family:inherit;font-size:10pt;">:</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> Measurement of Credit Losses on Financial Instruments.</span><span style="font-family:inherit;font-size:10pt;"> The ASU is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The ASU requires the measurement of all expected credit losses for financial assets including trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">organizations will now use forward-looking information to better inform their credit loss estimates. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a modified retrospective transition method which requires a cumulative-effect adjustment to the opening balance of retained earnings to be recognized on the date of adoption with no change to financial results reported in prior periods. The cumulative-effect adjustment recorded on January 1, 2020, is not material. The adoption of this ASU did not have a significant impact on the Company's consolidated financial statements and related disclosures.</span></div><div style="line-height:120%;padding-bottom:2px;padding-top:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the current COVID-19 pandemic, or other customer-specific factors. Although the Company has historically not experienced significant credit losses, it is possible that there could be a adverse impact from potential as hospital's cash flows are impacted by their response to the COVID-19 pandemic and deferral of elective surgical procedures. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU 2018-14, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans.</span><span style="font-family:inherit;font-size:10pt;"> The new guidance modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans, including removing certain previous disclosure requirements, adding certain new disclosure requirements, and clarifying certain other disclosure requirements. The ASU will be effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption is permitted. The adoption is not expected to have a material impact on the Condensed and Consolidated Financial Statements. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> In August 2018, the FASB issued ASU No. 2018-15, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)</span><span style="font-family:inherit;font-size:10pt;">, relating to a customer's accounting for implementation, set-up, and other upfront costs incurred in a cloud computing arrangement that is hosted by a vendor (e.g., a service contract). Under the new guidance, a customer will apply the same criteria for capitalizing implementation costs as it would for an arrangement that has a software license. The new guidance also prescribes the balance sheet, income statement, and cash flow classification of the capitalized implementation costs and related amortization expense, and requires additional quantitative and qualitative disclosures. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a prospective transition method. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In December 2019, the FASB issued ASU No. 2019-12,</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> Income Taxes: Simplifying the Accounting for Income Taxes</span><span style="font-family:inherit;font-size:10pt;"> intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The new guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively. The Company is currently assessing the impact of this standard on the financial condition and results of operations.</span></div><div style="line-height:120%;padding-top:13px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In March 2020, the FASB issued ASU 2020-04, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Reference Rate Reform</span><span style="font-family:inherit;font-size:10pt;">, which provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. This amendment applies to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This ASU is effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. The Company is currently assessing the impact that this ASU will have on its consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.</span></div> BASIS OF PRESENTATION<div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">General</span></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The terms “we,” “our,” “us,” “Company” and “Integra” refer to Integra LifeSciences Holdings Corporation, a Delaware corporation, and its subsidiaries unless the context suggests otherwise.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In the opinion of management, the </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> unaudited condensed consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the financial position, statement of changes in shareholder's equity, results of operations and cash flows of the Company. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements for the year ended </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> included in the Company’s Annual Report on Form 10-K. The </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States. Operating results for the three month period ended </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> are not necessarily indicative of the results to be expected for the entire year.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements is in conformity with generally accepted accounting principles in the United States ("GAAP") which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of the equity component of convertible debt instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates. The novel coronavirus (“COVID-19”) pandemic and the resulting adverse impacts to global economic conditions, as well as our operations, may impact future estimates including, but not limited to, inventory valuations, fair value measurements, goodwill and long-lived asset impairments, the effectiveness of the Company’s hedging instruments, deferred tax valuation allowances, and allowances for doubtful accounts receivable.</span></div> <div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Recently Issued Accounting Standards</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments - Credit Losses (Topic 326)</span><span style="font-family:inherit;font-size:10pt;">:</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> Measurement of Credit Losses on Financial Instruments.</span><span style="font-family:inherit;font-size:10pt;"> The ASU is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The ASU requires the measurement of all expected credit losses for financial assets including trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">organizations will now use forward-looking information to better inform their credit loss estimates. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a modified retrospective transition method which requires a cumulative-effect adjustment to the opening balance of retained earnings to be recognized on the date of adoption with no change to financial results reported in prior periods. The cumulative-effect adjustment recorded on January 1, 2020, is not material. The adoption of this ASU did not have a significant impact on the Company's consolidated financial statements and related disclosures.</span></div><div style="line-height:120%;padding-bottom:2px;padding-top:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the current COVID-19 pandemic, or other customer-specific factors. Although the Company has historically not experienced significant credit losses, it is possible that there could be a adverse impact from potential as hospital's cash flows are impacted by their response to the COVID-19 pandemic and deferral of elective surgical procedures. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU 2018-14, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans.</span><span style="font-family:inherit;font-size:10pt;"> The new guidance modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans, including removing certain previous disclosure requirements, adding certain new disclosure requirements, and clarifying certain other disclosure requirements. The ASU will be effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption is permitted. The adoption is not expected to have a material impact on the Condensed and Consolidated Financial Statements. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> In August 2018, the FASB issued ASU No. 2018-15, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)</span><span style="font-family:inherit;font-size:10pt;">, relating to a customer's accounting for implementation, set-up, and other upfront costs incurred in a cloud computing arrangement that is hosted by a vendor (e.g., a service contract). Under the new guidance, a customer will apply the same criteria for capitalizing implementation costs as it would for an arrangement that has a software license. The new guidance also prescribes the balance sheet, income statement, and cash flow classification of the capitalized implementation costs and related amortization expense, and requires additional quantitative and qualitative disclosures. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a prospective transition method. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In December 2019, the FASB issued ASU No. 2019-12,</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> Income Taxes: Simplifying the Accounting for Income Taxes</span><span style="font-family:inherit;font-size:10pt;"> intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The new guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively. The Company is currently assessing the impact of this standard on the financial condition and results of operations.</span></div><div style="line-height:120%;padding-top:13px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In March 2020, the FASB issued ASU 2020-04, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Reference Rate Reform</span><span style="font-family:inherit;font-size:10pt;">, which provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. This amendment applies to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This ASU is effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. The Company is currently assessing the impact that this ASU will have on its consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.</span></div> BUSINESS DEVELOPMENT<div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Arkis BioSciences Inc.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On July 29, 2019, the Company acquired Arkis BioSciences Inc. ("Arkis") for an acquisition purchase price of </span><span style="font-family:inherit;font-size:10pt;"><span>$30.9</span></span><span style="font-family:inherit;font-size:10pt;"> million (the "Arkis Acquisition") plus contingent consideration of up to </span><span style="font-family:inherit;font-size:10pt;"><span>$25.5</span></span><span style="font-family:inherit;font-size:10pt;"> million, that may be payable based on the successful completion of certain development and commercial milestones. The contingent consideration had an acquisition date fair value of </span><span style="font-family:inherit;font-size:10pt;"><span>$13.1</span></span><span style="font-family:inherit;font-size:10pt;"> million. Arkis was a privately-held company that marketed the CerebroFlo® external ventricular drainage (EVD) catheter with Endexo® technology, a permanent additive designed to reduce the potential for catheter obstruction due to thrombus formation. </span></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Assets Acquired and Liabilities Assumed at Fair Value</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Arkis Acquisition has been accounted for using the acquisition method of accounting. This method requires that assets acquired and liabilities assumed in a business combination to be recognized at their fair values as of the acquisition date. As of March 31, 2020 certain amounts relating to tax related matters have not been finalized. The finalization of these matters could result in changes to goodwill. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:63%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:16%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Preliminary Valuation as of March 31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted Average Life</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in thousands)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>90</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>751</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property, plant and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>159</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred tax assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,535</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Intangible assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">CerebroFlo developed technology </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20,100</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15 years</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Enabling technology license</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,980</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14 years</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27,600</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets acquired</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>52,215</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts payable, accrued expenses and other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,926</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contingent consideration</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13,100</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred tax liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,305</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">     Net assets acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>30,884</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Intangible Assets</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The estimated fair value of the intangible assets was determined using the income approach, which is a valuation technique that provides an estimate of the fair value of an asset based on market participant expectations of the cash flows an asset would generate over its remaining useful life. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each asset (including net revenues, cost of sales, R&amp;D costs, selling and marketing costs, and working capital/contributory asset charges), the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of each asset’s life cycle, and competitive trends impacting the asset and each cash flow stream.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company used a discount rate of </span><span style="font-family:inherit;font-size:10pt;"><span>14.5%</span></span><span style="font-family:inherit;font-size:10pt;"> to arrive at the present value for the acquired intangible assets to reflect the rate of return a market participant would expect to earn and incremental commercial uncertainty in the cash flow projections. No assurances can be given that the underlying assumptions used to prepare the discounted cash flow analysis will not change. For these and other reasons, actual results may vary significantly from estimated results.  </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Goodwill</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company allocated goodwill related to the Arkis Acquisition to the Codman Specialty Surgical segment. Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected revenue and cost synergies of the combined company and assembled workforce. One of the key factors that contributes to the recognition of goodwill, and a driver for the Company's acquisition of Arkis, is the planned expansion of the Endexo technology with the existing products within the Codman Specialty Surgical segment. Goodwill recognized as a result of this acquisition is non-deductible for income tax purposes. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Contingent Consideration</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company determines the acquisition date fair value of contingent consideration obligations based on a probability-weighted income approach derived from revenue estimates and a probability assessment with respect to the likelihood of achieving contingent obligations. The fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined using the fair value concepts in ASC 820. The resultant probability-weighted cash flows are discounted using an appropriate effective annual interest rate. At each reporting date, the contingent consideration obligation will be revalued to estimated fair value and changes in fair value will be reflected as income or expense in the Company's consolidated statement of operations. Changes in the fair value of the contingent consideration obligations may result from changes in discount periods and rates, changes in the timing and amount of revenue estimates and changes in probability assumptions with respect to the likelihood of achieving the various contingent payment obligations. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Adverse changes in assumptions utilized in the contingent consideration fair value estimates could result in an increase in the contingent consideration obligation and a corresponding charge to operating results.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As part of the acquisition, the Company is required to pay the former shareholders of Arkis up to </span><span style="font-family:inherit;font-size:10pt;"><span>$25.5</span></span><span style="font-family:inherit;font-size:10pt;"> million based on the timing of certain development milestones of </span><span style="font-family:inherit;font-size:10pt;"><span>$10.0</span></span><span style="font-family:inherit;font-size:10pt;"> million and commercial sales milestones of </span><span style="font-family:inherit;font-size:10pt;"><span>$15.5</span></span><span style="font-family:inherit;font-size:10pt;"> million, respectively. The Company used a probability weighted income approach to calculate the fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specified milestone. The Company estimated the fair value of the contingent consideration to be </span><span style="font-family:inherit;font-size:10pt;"><span>$13.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> at the acquisition date. The estimated fair value as of March 31, 2020 was </span><span style="font-family:inherit;font-size:10pt;"><span>$13.2</span></span><span style="font-family:inherit;font-size:10pt;"> million. This amount is included in other liabilities at March 31, 2020 in the consolidated balance sheets of the Company.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Deferred Tax Liabilities</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred tax liabilities result from identifiable intangible assets’ fair value adjustments. These adjustments create excess book basis over tax basis which is tax-effected by the statutory tax rates of applicable jurisdictions.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The pro forma results are not presented for this acquisition as they are not material.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Rebound Therapeutics Corporation</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On September 9, 2019, the Company acquired Rebound Therapeutics Corporation (“Rebound”), developers of a single-use medical device known as the AURORA Surgiscope® System ("Aurora") which enables minimally invasive access, using optics and illumination, for visualization, diagnostic and therapeutic use in neurosurgery (the “Rebound transaction”). Under the terms of the Rebound transaction, the Company made an upfront payment of </span><span style="font-family:inherit;font-size:10pt;"><span>$67.1</span></span><span style="font-family:inherit;font-size:10pt;"> million and are committed to pay up to </span><span style="font-family:inherit;font-size:10pt;"><span>$35.0</span></span><span style="font-family:inherit;font-size:10pt;"> million of contingent development milestones upon achievement of certain regulatory milestones. The acquisition of Rebound was primarily concentrated in </span><span style="font-family:inherit;font-size:10pt;text-align:left;"><span>one</span></span><span style="font-family:inherit;font-size:10pt;"> single identifiable asset and thus, for accounting purposes, the Company has concluded that the acquired assets do not meet the accounting definition of a business. The initial payment was allocated primarily to Aurora, resulting in a </span><span style="font-family:inherit;font-size:10pt;"><span>$59.9</span></span><span style="font-family:inherit;font-size:10pt;"> million in-process research and development expense. The balance of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$7.2</span></span><span style="font-family:inherit;font-size:10pt;"> million, which included </span><span style="font-family:inherit;font-size:10pt;"><span>$2.1</span></span><span style="font-family:inherit;font-size:10pt;"> million of cash and cash equivalents and a net deferred tax asset of </span><span style="font-family:inherit;font-size:10pt;"><span>$4.2</span></span><span style="font-family:inherit;font-size:10pt;"> million, was allocated to the remaining net assets acquired. The deferred tax asset primarily resulted from a federal net operating loss carry forward. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the fourth quarter of 2019, the Company achieved the first developmental milestone which triggered a </span><span style="font-family:inherit;font-size:10pt;"><span>$5.0</span></span><span style="font-family:inherit;font-size:10pt;"> million obligation to be paid to former shareholders of Rebound. The Company recorded </span><span style="font-family:inherit;font-size:10pt;"><span>$5.0</span></span><span style="font-family:inherit;font-size:10pt;"> million as in-process research and development expense in the consolidated statements of operations during the year ended December 31, 2019. The obligation was included in accrued expenses and other current liabilities at </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> in the consolidated balance sheets. The milestone was paid during the first quarter of 2020.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Integrated Shoulder Collaboration, Inc.</span></div><span style="font-family:inherit;font-size:10pt;">On January 4, 2019, the Company entered into a licensing agreement with Integrated Shoulder Collaboration, Inc ("ISC"). Under the terms of the agreement, the Company paid ISC </span><span style="font-family:inherit;font-size:10pt;"><span>$1.7</span></span><span style="font-family:inherit;font-size:10pt;"> million for the exclusive, worldwide license to commercialize its short stem and stemless shoulder system. A patent related to short stem and stemless shoulder systems was issued to ISC during the first quarter of 2019. ISC is eligible to receive royalties on sales of the short stem and stemless shoulder system. The Company has the option to acquire ISC at a date </span><span style="font-family:inherit;font-size:10pt;"><span>four years</span></span><span style="font-family:inherit;font-size:10pt;"> subsequent to the first commercial sale, which becomes mandatory upon the achievement of a certain sales thresholds of the short stem and stemless shoulder system, for an amount not to exceed </span><span style="font-family:inherit;font-size:10pt;"><span>$80.0</span></span><span style="font-family:inherit;font-size:10pt;"> million. The transaction was accounted for as an asset acquisition as the Company concluded that it acquired primarily </span><span style="font-family:inherit;font-size:10pt;">one</span><span style="font-family:inherit;font-size:10pt;"> asset. During the quarter ended March 31, 2019, The total upfront payment of </span><span style="font-family:inherit;font-size:10pt;"><span>$1.7</span></span> million was expensed as a component of research and development expense and the future milestone and option payments will be recorded if the corresponding events become probable. 30900000 25500000 13100000 <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:63%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:16%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Preliminary Valuation as of March 31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted Average Life</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in thousands)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>90</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>751</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property, plant and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>159</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred tax assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,535</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Intangible assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">CerebroFlo developed technology </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20,100</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15 years</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Enabling technology license</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,980</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14 years</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27,600</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets acquired</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>52,215</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts payable, accrued expenses and other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,926</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contingent consideration</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13,100</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred tax liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,305</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">     Net assets acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>30,884</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 90000 751000 159000 1535000 20100000 P15Y 1980000 P14Y 27600000 52215000 2926000 13100000 5305000 30884000 0.145 25500000 10000000.0 15500000 13100000 13200000 67100000 35000000.0 1 59900000 7200000 2100000 4200000 5000000.0 5000000.0 1700000 P4Y 80000000.0 1700000 REVENUES FROM CONTRACTS WITH CUSTOMERS <div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Summary of Accounting Policies on Revenue Recognition</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total revenue, net, includes product sales, product royalties and other revenues, such as fees received for services. </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For products shipped with FOB shipping point terms, the control of the product passes to the customer at the time of shipment. For shipments in which the control of the product is transferred when the customer receives the product, the Company recognizes revenue upon receipt by the customer. Certain products that the Company produces for private label customers have no alternative use and the Company has a right of payment for performance to date. Revenues from those products are recognized over the period that the Company manufactures these products, which is typically </span><span style="font-family:inherit;font-size:10pt;">one</span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>three months</span></span><span style="font-family:inherit;font-size:10pt;">. The Company uses the input method to </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">measure the manufacturing activities completed to date, which depicts the progress of the Company's performance obligation of transferring control of goods being manufactured for private label customers.</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A portion of the Company's product revenue is generated from consigned inventory maintained at hospitals and distributors, and also from inventory physically held by field sales representatives. For these types of product sales, the Company retains control until the product has been used or implanted, at which time revenue is recognized.   </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenues from sale of products and services are evidenced by either a contract with the customer or a valid purchase order and an invoice which includes all relevant terms of sale. For product sales, invoices are generally issued upon the transfer of control (or upon the completion of the manufacturing in the case of the private label transactions recognized over time) and are typically payable thirty days after the invoice date. The Company performs a review of each specific customer's creditworthiness and ability to pay prior to acceptance as a customer. Further, the Company performs periodic reviews of its customers' creditworthiness prospectively. </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Performance Obligations</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Significant Judgments</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant. </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract. </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally </span><span style="font-family:inherit;font-size:10pt;"><span>ninety days</span></span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Contract Asset and Liability</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheet. </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the changes in the contract asset and liability balances for the </span><span style="font-family:inherit;font-size:10pt;">three months ended March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">: </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:81%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Contract Asset</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract asset, January 1, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,680</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Transferred to trade receivable of contract asset included</span></div><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">     in beginning of the year contract asset </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8,680</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract asset, net of transferred to trade receivables on contracts during the period</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,944</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract asset, March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,944</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Contract Liability</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract liability, January 1, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,946</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Recognition of revenue included in beginning of year contract liability</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,291</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract liability, net of revenue recognized on contracts during the period</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,691</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency translation</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(147</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract liability, March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,199</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, the short-term portion of the contract liability of </span><span style="font-family:inherit;font-size:10pt;"><span>$4.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> and the long-term portion of </span><span style="font-family:inherit;font-size:10pt;"><span>$7.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> were included in accrued expenses and other current liabilities and other liabilities in the consolidated balance sheet.</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, the Company is expected to recognize approximately </span><span style="font-family:inherit;font-size:10pt;"><span>40%</span></span><span style="font-family:inherit;font-size:10pt;"> of unsatisfied (or partially unsatisfied) performance obligations as revenue through 2020, with the remaining balance to be recognized in 2021 and thereafter.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Shipping and Handling Fees</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Product Warranties</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to </span><span style="font-family:inherit;font-size:10pt;"><span>two years</span></span><span style="font-family:inherit;font-size:10pt;"> from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Taxes Collected from Customers</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Disaggregated Revenue</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents revenues disaggregated by the major sources of revenues for the </span><span style="font-family:inherit;font-size:10pt;">three months ended March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> (amounts in thousands):</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.921875%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:66%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(amounts in thousands)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Neurosurgery</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>184,943</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>179,520</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Instruments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>46,497</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>55,048</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total Codman Specialty Surgical</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>231,440</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>234,568</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Wound Reconstruction and Care</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>72,267</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>74,963</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Extremity Orthopedics</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21,472</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22,685</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Private Label</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29,145</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27,474</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total Orthopedics and Tissue Technologies</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>122,884</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>125,122</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>354,324</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>359,690</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prior period amounts were reclassified between categories within the Codman Specialty Surgical segment to conform to the current period presentation.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">See Note 15, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Segment and Geographical Information</span><span style="font-family:inherit;font-size:10pt;">, for details of revenues based on the location of the customer.</span></div> P3M P90D <div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the changes in the contract asset and liability balances for the </span><span style="font-family:inherit;font-size:10pt;">three months ended March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">: </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:81%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Contract Asset</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract asset, January 1, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,680</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Transferred to trade receivable of contract asset included</span></div><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">     in beginning of the year contract asset </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8,680</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract asset, net of transferred to trade receivables on contracts during the period</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,944</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract asset, March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,944</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Contract Liability</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract liability, January 1, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,946</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Recognition of revenue included in beginning of year contract liability</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,291</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract liability, net of revenue recognized on contracts during the period</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,691</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency translation</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(147</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract liability, March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,199</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 8680000 8680000 7944000 7944000 11946000 1291000 1691000 -147000 12199000 4900000 7300000 0.40 <div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Shipping and Handling Fees</span></div>The Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.<div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Summary of Accounting Policies on Revenue Recognition</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total revenue, net, includes product sales, product royalties and other revenues, such as fees received for services. </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For products shipped with FOB shipping point terms, the control of the product passes to the customer at the time of shipment. For shipments in which the control of the product is transferred when the customer receives the product, the Company recognizes revenue upon receipt by the customer. Certain products that the Company produces for private label customers have no alternative use and the Company has a right of payment for performance to date. Revenues from those products are recognized over the period that the Company manufactures these products, which is typically </span><span style="font-family:inherit;font-size:10pt;">one</span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>three months</span></span><span style="font-family:inherit;font-size:10pt;">. The Company uses the input method to </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">measure the manufacturing activities completed to date, which depicts the progress of the Company's performance obligation of transferring control of goods being manufactured for private label customers.</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A portion of the Company's product revenue is generated from consigned inventory maintained at hospitals and distributors, and also from inventory physically held by field sales representatives. For these types of product sales, the Company retains control until the product has been used or implanted, at which time revenue is recognized.   </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenues from sale of products and services are evidenced by either a contract with the customer or a valid purchase order and an invoice which includes all relevant terms of sale. For product sales, invoices are generally issued upon the transfer of control (or upon the completion of the manufacturing in the case of the private label transactions recognized over time) and are typically payable thirty days after the invoice date. The Company performs a review of each specific customer's creditworthiness and ability to pay prior to acceptance as a customer. Further, the Company performs periodic reviews of its customers' creditworthiness prospectively. </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Performance Obligations</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Significant Judgments</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant. </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract. </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally </span><span style="font-family:inherit;font-size:10pt;"><span>ninety days</span></span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Contract Asset and Liability</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheet. </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.</span></div> <div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Product Warranties</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to </span><span style="font-family:inherit;font-size:10pt;"><span>two years</span></span><span style="font-family:inherit;font-size:10pt;"> from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.</span></div> P2Y <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Taxes Collected from Customers</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer. </span></div> <div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents revenues disaggregated by the major sources of revenues for the </span><span style="font-family:inherit;font-size:10pt;">three months ended March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> (amounts in thousands):</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.921875%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:66%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(amounts in thousands)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Neurosurgery</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>184,943</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>179,520</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Instruments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>46,497</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>55,048</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total Codman Specialty Surgical</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>231,440</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>234,568</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Wound Reconstruction and Care</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>72,267</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>74,963</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Extremity Orthopedics</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21,472</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22,685</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Private Label</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29,145</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27,474</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total Orthopedics and Tissue Technologies</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>122,884</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>125,122</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>354,324</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>359,690</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 184943000 179520000 46497000 55048000 231440000 234568000 72267000 74963000 21472000 22685000 29145000 27474000 122884000 125122000 354324000 359690000 INVENTORIES<div style="line-height:120%;padding-top:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories, net consisted of the following:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:67%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finished goods</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>217,078</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>201,870</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Work in process</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>53,624</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48,333</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Raw materials</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>67,380</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>65,851</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total inventories</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>338,082</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>316,054</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;padding-top:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories, net consisted of the following:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:67%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finished goods</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>217,078</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>201,870</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Work in process</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>53,624</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48,333</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Raw materials</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>67,380</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>65,851</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total inventories</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>338,082</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>316,054</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 217078000 201870000 53624000 48333000 67380000 65851000 338082000 316054000 GOODWILL AND OTHER INTANGIBLE ASSETS<div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Goodwill</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Changes in the carrying amount of goodwill for the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;">-month period ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Codman Specialty </span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Surgical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Orthopedics and</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Tissue Technologies</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill at December 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>653,500</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>300,780</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>954,280</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency translation</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,867</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(859</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,726</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>651,633</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>299,921</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>951,554</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The components of the Company’s identifiable intangible assets were as follows:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:42%;"/><td style="width:13%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Life</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="13" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in thousands)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Completed technology</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>881,856</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(225,350</span></span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>656,506</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Customer relationships</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12 years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>221,193</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(123,896</span></span></div></td><td style="vertical-align:top;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>97,297</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Trademarks/brand names</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>103,472</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(29,190</span></span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>74,282</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Codman tradename</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Indefinite</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>163,680</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>163,680</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Supplier relationships</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34,721</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(18,304</span></span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,417</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">All other</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4 years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10,787</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4,742</span></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,045</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,415,709</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(401,482</span></span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,014,227</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:43%;"/><td style="width:12%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Life</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="13" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in thousands)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Completed technology</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>880,623</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(213,702</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>666,921</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Customer relationships</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12 years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>222,575</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(119,393</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>103,182</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Trademarks/brand names</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>103,873</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(28,514</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75,359</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Codman tradename</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Indefinite</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>163,126</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>163,126</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Supplier relationships</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34,721</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(17,947</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,774</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">All other</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> (1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4 years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10,869</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4,640</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,229</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,415,787</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(384,196</span></span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,031,591</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, all other included IPR&amp;D of </span><span style="font-family:inherit;font-size:10pt;"><span>$1.0 million</span></span><span style="font-family:inherit;font-size:10pt;">, which was indefinite-lived. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Based on quarter-end exchange rates, amortization expense (including amounts reported in cost of product revenues) is expected to be approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$56.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the remainder of </span><span style="font-family:inherit;font-size:10pt;">2020</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$64.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;">2021</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$60.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;">2022</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$60.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;">2023</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$59.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;">2024</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$59.1</span></span><span style="font-family:inherit;font-size:10pt;"> million in 2025 and </span><span style="font-family:inherit;font-size:10pt;"><span>$491.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> thereafter.</span></div> <div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Changes in the carrying amount of goodwill for the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;">-month period ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Codman Specialty </span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Surgical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Orthopedics and</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Tissue Technologies</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill at December 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>653,500</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>300,780</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>954,280</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency translation</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,867</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(859</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,726</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>651,633</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>299,921</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>951,554</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 653500000 300780000 954280000 -1867000 -859000 -2726000 651633000 299921000 951554000 <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The components of the Company’s identifiable intangible assets were as follows:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:42%;"/><td style="width:13%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Life</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="13" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in thousands)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Completed technology</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>881,856</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(225,350</span></span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>656,506</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Customer relationships</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12 years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>221,193</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(123,896</span></span></div></td><td style="vertical-align:top;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>97,297</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Trademarks/brand names</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>103,472</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(29,190</span></span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>74,282</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Codman tradename</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Indefinite</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>163,680</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>163,680</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Supplier relationships</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34,721</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(18,304</span></span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,417</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">All other</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4 years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10,787</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4,742</span></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,045</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,415,709</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(401,482</span></span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,014,227</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:43%;"/><td style="width:12%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Life</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="13" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in thousands)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Completed technology</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>880,623</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(213,702</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>666,921</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Customer relationships</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12 years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>222,575</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(119,393</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>103,182</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Trademarks/brand names</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>103,873</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(28,514</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75,359</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Codman tradename</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Indefinite</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>163,126</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>163,126</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Supplier relationships</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34,721</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(17,947</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,774</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">All other</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> (1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4 years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10,869</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4,640</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,229</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,415,787</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(384,196</span></span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,031,591</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;">(1)</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, all other included IPR&amp;D of </span><span style="font-family:inherit;font-size:10pt;"><span>$1.0 million</span></span><span style="font-family:inherit;font-size:10pt;">, which was indefinite-lived. </span></div> <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The components of the Company’s identifiable intangible assets were as follows:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:42%;"/><td style="width:13%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Life</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="13" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in thousands)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Completed technology</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>881,856</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(225,350</span></span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>656,506</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Customer relationships</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12 years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>221,193</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(123,896</span></span></div></td><td style="vertical-align:top;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>97,297</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Trademarks/brand names</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>103,472</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(29,190</span></span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>74,282</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Codman tradename</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Indefinite</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>163,680</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>163,680</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Supplier relationships</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34,721</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(18,304</span></span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,417</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">All other</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4 years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10,787</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4,742</span></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,045</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,415,709</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(401,482</span></span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,014,227</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:43%;"/><td style="width:12%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Life</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="13" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in thousands)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Completed technology</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>880,623</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(213,702</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>666,921</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Customer relationships</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12 years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>222,575</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(119,393</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>103,182</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Trademarks/brand names</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>103,873</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(28,514</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75,359</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Codman tradename</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Indefinite</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>163,126</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>163,126</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Supplier relationships</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34,721</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(17,947</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,774</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">All other</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> (1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4 years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10,869</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4,640</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,229</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,415,787</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(384,196</span></span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,031,591</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;">(1)</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, all other included IPR&amp;D of </span><span style="font-family:inherit;font-size:10pt;"><span>$1.0 million</span></span><span style="font-family:inherit;font-size:10pt;">, which was indefinite-lived. </span></div> P19Y 881856000 225350000 656506000 P12Y 221193000 123896000 97297000 P28Y 103472000 29190000 74282000 163680000 163680000 P27Y 34721000 18304000 16417000 P4Y 10787000 4742000 6045000 1415709000 401482000 1014227000 P19Y 880623000 213702000 666921000 P12Y 222575000 119393000 103182000 P28Y 103873000 28514000 75359000 163126000 163126000 P27Y 34721000 17947000 16774000 P4Y 10869000 4640000 6229000 1415787000 384196000 1031591000 1000000.0 56100000 64400000 60800000 60000000.0 59200000 59100000 491900000 DEBT <div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Sixth Amended and Restated Senior Credit Agreement</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On February 3, 2020, the Company entered into the sixth amendment and restatement (the "February 2020 Amendment") of its Senior Credit Facility (the "Senior Credit Facility") with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. The February 2020 Amendment extended the maturity date to February 3, 2025. The Company continues to have the aggregate principal amount of up to approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$2.2 billion</span></span><span style="font-family:inherit;font-size:10pt;"> available to it through the following facilities: (i) a </span><span style="font-family:inherit;font-size:10pt;"><span>$877.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> Term Loan facility, and (ii) a </span><span style="font-family:inherit;font-size:10pt;"><span>$1.3 billion</span></span><span style="font-family:inherit;font-size:10pt;"> revolving credit facility, which includes a </span><span style="font-family:inherit;font-size:10pt;"><span>$60 million</span></span><span style="font-family:inherit;font-size:10pt;"> sublimit for the issuance of standby letters of credit and a </span><span style="font-family:inherit;font-size:10pt;"><span>$60 million</span></span><span style="font-family:inherit;font-size:10pt;"> sublimit for swingline loans. The first mandatory repayment under the Term Loan portion of the February 2020 Amendment is due June 30, 2021.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In connection with the February 2020 Amendment, the Company’s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:657px;border-collapse:collapse;text-align:left;"><tr><td colspan="3"/></tr><tr><td style="width:501px;"/><td style="width:5px;"/><td style="width:150px;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Quarter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Maximum Consolidated Total Leverage Ratio</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">First fiscal quarter ending after the Closing Date through June 30, 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">5.00 to 1.00</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, 2022 through June 30, 2023<br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">4.50 to 1.00<br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, 2023 and the last day of each fiscal quarter thereafter<br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">4.00 to 1.00<br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Borrowings under the Senior Credit Facility bear interest, at the Company’s option, at a rate equal to the following:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">i.</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the Eurodollar Rate (as defined in the amendment and restatement) in effect from time to time plus the applicable rate (ranging from </span><span style="font-family:inherit;font-size:10pt;"><span>1.00%</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>1.75%</span></span><span style="font-family:inherit;font-size:10pt;">), or </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">ii.</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the highest of: </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:inherit;font-size:10pt;">1.</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the weighted average overnight Federal funds rate, as published by the Federal Reserve Bank of New York, plus </span><span style="font-family:inherit;font-size:10pt;"><span>0.50%</span></span><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:inherit;font-size:10pt;">2.</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the prime lending rate of Bank of America, N.A. or</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:inherit;font-size:10pt;">3.</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the one-month Eurodollar Rate plus </span><span style="font-family:inherit;font-size:10pt;"><span>1.00%</span></span><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:96px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The applicable rates are based on the Company’s consolidated total leverage ratio (defined as the ratio of (a) consolidated funded indebtedness as of such date less cash that is not subject to any restriction on the use or investment thereof (b) consolidated EBITDA as defined by the February 2020 amendment, for the period of four consecutive fiscal quarters ending on such date).</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company will pay an annual commitment fee (ranging from </span><span style="font-family:inherit;font-size:10pt;"><span>0.15%</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>0.30%</span></span><span style="font-family:inherit;font-size:10pt;">), based on the Company's consolidated total leverage ratio, on the amount available for borrowing under the revolving credit facility.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Senior Credit Facility is collateralized by substantially all of the assets of the Company’s U.S. subsidiaries, excluding intangible assets. The Senior Credit Facility is subject to various financial and negative covenants and at </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, the Company was in compliance with all such covenants. The Company capitalized </span><span style="font-family:inherit;font-size:10pt;"><span>$4.6 million</span></span><span style="font-family:inherit;font-size:10pt;"> of financing costs in connection with modification of the Senior Credit Facility and wrote off </span><span style="font-family:inherit;font-size:10pt;"><span>$1.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> of previously capitalized financing costs during the first quarter of 2020.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, there was </span><span style="font-family:inherit;font-size:10pt;"><span>$150.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$375.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> outstanding, respectively, under the revolving credit component of the Senior Credit Facility at weighted average interest rates of </span><span style="font-family:inherit;font-size:10pt;"><span>2.5%</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>3.2%</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. At </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, there was </span><span style="font-family:inherit;font-size:10pt;"><span>$877.5</span></span><span style="font-family:inherit;font-size:10pt;"> million outstanding, respectively, under the Term Loan component of the Senior Credit Facility at a weighted average interest rate of </span><span style="font-family:inherit;font-size:10pt;"><span>2.4%</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>3.2%</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. At </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, there is </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> current portion of the Term Loan component of the Senior Credit Facility as the first mandatory repayment is due June 30, 2021.</span></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Convertible Senior Notes</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On February 4, 2020, the Company issued </span><span style="font-family:inherit;font-size:10pt;"><span>$575.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> aggregate principal amount of its of </span><span style="font-family:inherit;font-size:10pt;"><span>0.5%</span></span><span style="font-family:inherit;font-size:10pt;"> Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes will mature on August 15, 2025 and bear interest at a rate of </span><span style="font-family:inherit;font-size:10pt;"><span>0.5%</span></span><span style="font-family:inherit;font-size:10pt;"> per annum payable semi-annually in arrears, unless earlier converted, repurchased or redeemed in accordance with the terms of the Notes. The portion of debt proceeds that was classified as equity at the time of the offering was </span><span style="font-family:inherit;font-size:10pt;"><span>$104.5 million</span></span><span style="font-family:inherit;font-size:10pt;">, and that amount is being amortized to interest expense using the effective interest method through August 2025. The effective interest rate implicit in the liability component is </span><span style="font-family:inherit;font-size:10pt;"><span>4.2%</span></span><span style="font-family:inherit;font-size:10pt;">. In connection with this offering, the Company capitalized </span><span style="font-family:inherit;font-size:10pt;"><span>$13.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> of financing fees. At </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, the carrying amount of the liability component was </span><span style="font-family:inherit;font-size:10pt;"><span>$473.0 million</span></span><span style="font-family:inherit;font-size:10pt;">, the remaining unamortized discount was </span><span style="font-family:inherit;font-size:10pt;"><span>$102.0 million</span></span><span style="font-family:inherit;font-size:10pt;">, and the principal amount outstanding was </span><span style="font-family:inherit;font-size:10pt;"><span>$575.0 million</span></span><span style="font-family:inherit;font-size:10pt;">. The fair value of the 2025 Notes at </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> was </span><span style="font-family:inherit;font-size:10pt;"><span>$507.7</span></span><span style="font-family:inherit;font-size:10pt;"> million. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The 2025 Notes are senior, unsecured obligations of the Company, and are convertible into cash and shares of its common stock based on initial conversion rate, subject to adjustment of </span><span style="font-family:inherit;font-size:10pt;"><span>13.5739</span></span><span style="font-family:inherit;font-size:10pt;"> shares per $1,000 principal amounts of the 2025 Notes (which represents an initial conversion price of </span><span style="font-family:inherit;font-size:10pt;"><span>$73.67</span></span><span style="font-family:inherit;font-size:10pt;"> per share). The 2025 Notes convert only in the following circumstances: (1) if the closing price of the Company's common stock has been at least </span><span style="font-family:inherit;font-size:10pt;"><span>130%</span></span><span style="font-family:inherit;font-size:10pt;"> of the conversion price during the period; (2) if the average trading price per $1000 principal amount of the 2025 Notes is less than or equal to </span><span style="font-family:inherit;font-size:10pt;"><span>98%</span></span><span style="font-family:inherit;font-size:10pt;"> of the average conversion value of the 2025 Notes during a period as defined in the indenture; (3) at any time on or after February 20, 2023; or (4) if specified corporate transactions occur. As of March 31, 2020, none of these conditions existed with respect to the 2025 Notes and as a result the 2025 Notes are classified as long term.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Holders of the Notes will have the right to require the Company to repurchase for cash all or a portion of their Notes at </span><span style="font-family:inherit;font-size:10pt;"><span>100%</span></span><span style="font-family:inherit;font-size:10pt;"> of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the Notes). The Company will also be required to increase the conversion rate for holders who convert their Notes in connection with certain fundamental changes occurring prior to the maturity date or following delivery by the Company of a notice of redemption.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In connection with the issuance of the 2025 Notes, the Company entered into call transactions and warrant transactions, primarily with affiliates of the initial purchasers of the 2025 Notes (the “hedge participants”). The cost of the call transactions was </span><span style="font-family:inherit;font-size:10pt;"><span>$104.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the 2025 Notes. The Company received </span><span style="font-family:inherit;font-size:10pt;"><span>$44.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> of proceeds from the warrant transactions for the 2025 Notes. The call transactions involved purchasing call options from the hedge participants, and the warrant transactions involved selling call options to the hedge participants with a higher strike price than the purchased call options. The initial strike price of the call transactions was </span><span style="font-family:inherit;font-size:10pt;"><span>$73.67</span></span><span style="font-family:inherit;font-size:10pt;">, subject to anti-dilution adjustments substantially similar to those in the 2025 Notes. The initial strike price of the warrant transactions was </span><span style="font-family:inherit;font-size:10pt;"><span>$113.34</span></span><span style="font-family:inherit;font-size:10pt;"> for the 2025 Notes, subject to customary anti-dilution adjustments.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the three months ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, the Company recognized cash interest of </span><span style="font-family:inherit;font-size:10pt;"><span>$0.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> and amortization of the discount on the liability component of </span><span style="font-family:inherit;font-size:10pt;"><span>$2.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> for a total interest charge of </span><span style="font-family:inherit;font-size:10pt;"><span>$2.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> on the 2020 Notes.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Securitization Facility</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the fourth quarter of 2018, the Company entered into an accounts receivable securitization facility (the "Securitization Facility") under which accounts receivable of certain domestic subsidiaries are sold on a non-recourse basis to a special purpose entity (“SPE”), which is a bankruptcy-remote, consolidated subsidiary of the Company. Accordingly, the assets of the SPE are not available to satisfy the obligations of the Company or any of its subsidiaries. From time to time, the SPE may finance such accounts receivable with a revolving loan facility secured by a pledge of such accounts receivable. The amount of outstanding borrowings on the Securitization Facility at any one time is limited to </span><span style="font-family:inherit;font-size:10pt;"><span>$150.0 million</span></span><span style="font-family:inherit;font-size:10pt;">. The Securitization Facility Agreement ("Securitization Agreement") is for an initial three-year term and may be extended. The Securitization Agreement governing the Securitization Facility contains certain covenants and termination events. An occurrence of an event of default or a termination event under this Securitization Agreement may give rise to the right of its counterparty to terminate this facility. As of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, the Company was in compliance with the covenants and none of the termination events had occurred. At </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and December 31, 2019, the Company had </span><span style="font-family:inherit;font-size:10pt;"><span>$98.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$104.5 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, of outstanding borrowings under its Securitization Facility at a weighted average interest rate of </span><span style="font-family:inherit;font-size:10pt;"><span>2.6%</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>2.8%</span></span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The fair value of outstanding borrowings of the Senior Credit Facility's revolving credit and Term Loan components at </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> were </span><span style="font-family:inherit;font-size:10pt;"><span>$130.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> and, </span><span style="font-family:inherit;font-size:10pt;"><span>$771.3 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. The fair value of the outstanding borrowing of the Securitization Facility at </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> was </span><span style="font-family:inherit;font-size:10pt;"><span>$94.5 million</span></span><span style="font-family:inherit;font-size:10pt;">. These fair values were determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable inputs that reflect unadjusted quoted prices for identical assets or liabilities. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Letters of credit outstanding as of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> totaled </span><span style="font-family:inherit;font-size:10pt;"><span>$0.8 million</span></span><span style="font-family:inherit;font-size:10pt;">. There were </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> amounts drawn as of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:77%;"/><td style="width:3%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Quarter Ended March 31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Principal Repayment</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Remainder of 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33,750</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>45,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>61,875</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2024</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>67,500</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2025</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>669,375</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>877,500</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div>The outstanding balance of the revolving credit component of the Senior Credit Facility is due on February 3, 2025. 2200000000 877500000 1300000000 60000000 60000000 <div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In connection with the February 2020 Amendment, the Company’s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:657px;border-collapse:collapse;text-align:left;"><tr><td colspan="3"/></tr><tr><td style="width:501px;"/><td style="width:5px;"/><td style="width:150px;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Quarter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Maximum Consolidated Total Leverage Ratio</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">First fiscal quarter ending after the Closing Date through June 30, 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">5.00 to 1.00</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, 2022 through June 30, 2023<br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">4.50 to 1.00<br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, 2023 and the last day of each fiscal quarter thereafter<br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">4.00 to 1.00<br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0.0100 0.0175 0.0050 0.0100 0.0015 0.0030 4600000 1200000 150000000.0 375000000.0 0.025 0.032 877500000 0.024 0.032 0 575000000.0 0.005 0.005 104500000 0.042 13200000 473000000.0 102000000.0 575000000.0 507700000 13.5739 73.67 1.30 0.98 1 104200000 44500000 73.67 113.34 400000 2500000 2900000 150000000.0 98500000 104500000 0.026 0.028 130400000 771300000 94500000 800000 0 <div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:77%;"/><td style="width:3%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Quarter Ended March 31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Principal Repayment</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Remainder of 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33,750</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>45,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>61,875</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2024</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>67,500</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2025</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>669,375</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>877,500</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0 33750000 45000000 61875000 67500000 669375000 877500000 DERIVATIVE INSTRUMENTS <div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Interest Rate Hedging</span></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company’s interest rate risk relates to U.S. dollar denominated variable interest rate borrowings. The Company uses interest rate swap derivative instruments to manage earnings and cash flow exposure resulting from changes in interest rates. These interest rate swaps apply a fixed interest rate on a portion of the Company's expected LIBOR-indexed floating-rate borrowings. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company held the following interest rate swaps as of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> (dollar amounts in thousands):</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;padding-left:12px;text-indent:-12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.40625%;border-collapse:collapse;text-align:left;"><tr><td colspan="18"/></tr><tr><td style="width:23%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Hedged Item</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Current Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Designation Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Effective Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Termination Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Fixed Interest Rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Estimated Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Liabilities</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">3-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>50,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">February 6, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>1.834</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(48</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">1-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>100,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">February 6, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>1.652</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(233</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">1-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>100,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">March 27, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 31, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>1.971</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(2,024</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">1-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>150,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 13, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">January 1, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 31, 2022</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.201</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(7,467</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">1-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>150,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 13, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">January 1, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 31, 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.201</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(7,388</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">1-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>100,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 13, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">July 1, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2024</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.423</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(8,475</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">1-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>50,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 13, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">July 1, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2024</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.423</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(3,994</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">1-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>200,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 13, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">January 1, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 31, 2024</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.313</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(16,279</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">1-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>75,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">October 10, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">July 1, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2025</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>3.220</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(10,186</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">1-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>75,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">October 10, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">July 1, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2025</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>3.199</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(10,165</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">1-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>75,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">October 10, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">July 1, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2025</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>3.209</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(10,185</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">1-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>100,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 18, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 30, 2022</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 31, 2027</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.885</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(9,453</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">1-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>100,000</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 18, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 30, 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 31, 2027</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.867</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(9,855</span></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">Total interest rate derivatives designated as cash flow hedge</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>1,325,000</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(95,752</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company held the following interest rate swaps as of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> (dollar amounts in thousands):</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;padding-left:12px;text-indent:-12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:616px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:128px;"/><td style="width:5px;"/><td style="width:5px;"/><td style="width:47px;"/><td style="width:3px;"/><td style="width:5px;"/><td style="width:88px;"/><td style="width:5px;"/><td style="width:88px;"/><td style="width:5px;"/><td style="width:86px;"/><td style="width:5px;"/><td style="width:33px;"/><td style="width:8px;"/><td style="width:5px;"/><td style="width:93px;"/><td style="width:3px;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Hedged Item</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Current Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Designation Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Effective Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Termination Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Fixed Interest Rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Estimated Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Liabilities</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">3-month USD LIBOR</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>50,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">February 6, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>1.834</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">1-month USD LIBOR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>100,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">February 6, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>1.652</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">1-month USD LIBOR</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>100,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">March 27, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 31, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>1.971</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(581</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">1-month USD LIBOR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>150,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 13, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">January 1, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 31, 2022</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.201</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(2,880</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">1-month USD LIBOR</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>150,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 13, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">January 1, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 31, 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.201</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(2,880</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">1-month USD LIBOR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>100,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 13, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">July 1, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2024</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.423</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(3,517</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">1-month USD LIBOR</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>50,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 13, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">July 1, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2024</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.423</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(1,778</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">1-month USD LIBOR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>200,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 13, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">January 1, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 31, 2024</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.313</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(6,595</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">1-month USD LIBOR</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>75,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">October 10, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">July 1, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2025</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>3.220</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(5,750</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">1-month USD LIBOR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>75,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">October 10, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">July 1, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2025</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>3.199</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(5,747</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">1-month USD LIBOR</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>75,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">October 10, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">July 1, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2025</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>3.209</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(5,807</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">1-month USD LIBOR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>100,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 18, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 30, 2022</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 31, 2027</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.885</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(4,930</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">1-month USD LIBOR</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>100,000</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 18, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 30, 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 31, 2027</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.867</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(4,691</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">Total interest rate derivatives designated as cash flow hedge</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>1,325,000</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(45,145</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has designated these derivative instruments as cash flow hedges. The Company assesses the effectiveness of these derivative instruments and has recorded the changes in the fair value of the derivative instrument designated as a cash flow hedge as unrealized gains or losses in accumulated other comprehensive loss (“AOCL”), net of tax, until the hedged item affected earnings, at which point any gain or loss was reclassified to earnings. If the hedged cash flow does not occur, or if it becomes probable that it will not occur, the Company will reclassify the remaining amount of any gain or loss on the related cash flow hedge recorded in AOCL to interest expense at that time.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Foreign Currency Hedging</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">From time to time the Company enters into foreign currency hedge contracts intended to protect the U.S. dollar value of certain forecasted foreign currency denominated transactions. The Company assesses the effectiveness of the contracts that are designated as hedging instruments. The changes in fair value of foreign currency cash flow hedges are recorded in AOCL, net of tax, until the hedged item affects earnings. Once the related hedged item affects earnings, the Company reclassifies amounts recorded in AOCL to earnings. If the hedged forecasted transaction does not occur, or if it becomes probable that it will not occur, the Company will reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. For contracts not designated as hedging instruments, the changes in fair value of the contracts are recognized in other income (expense), net in the consolidated statements of operation, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The success of the Company’s hedging program depends, in part, on forecasts of certain activity denominated in foreign currency. The Company may experience unanticipated currency exchange gains or losses to the extent that there are differences between forecasted and actual activities during periods of currency volatility. In addition, changes in currency exchange rates related to any unhedged transactions may affect earnings and cash flows. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cross-Currency Rate Swaps</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On October 2, 2017, the Company entered into cross-currency swap agreements to convert a notional amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$300.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> equivalent to </span><span style="font-family:inherit;font-size:10pt;"><span>291.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> of CHF denominated intercompany loans into U.S. dollars. The CHF-denominated intercompany loans were the result of the purchase of intellectual property by a subsidiary in Switzerland as part of an acquisition. The objective of these cross-currency swaps is to reduce volatility of earnings and cash flows associated with changes in the foreign currency exchange rate. Under the terms of these contracts, which have been designated as cash flow hedges, the Company will make interest payments in Swiss Francs and receive interest in U.S. dollars. Upon the maturity of these contracts, the Company will pay the principal amount of the loans in Swiss Francs and receive U.S. dollars from the counterparties.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company held the following cross-currency rate swaps as of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> (dollar amounts in thousands):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"/></tr><tr><td style="width:37%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Effective Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Termination Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fixed Rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate Notional Amount</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Asset (Liability)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 2, 2017</span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 2, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.75%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32,355</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(74</span></span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.38%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33,333</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 2, 2017</span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 2, 2021</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.85%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48,533</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>531</span></span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.46%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>50,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 2, 2017</span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 2, 2022</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.95%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>145,597</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,416</span></span></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.52%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>150,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,874</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company held the following cross-currency rate swaps as of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> (dollar amounts in thousands):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"/></tr><tr><td style="width:33%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Effective Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Termination Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fixed Rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Asset (Liability)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 2, 2017</span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 2, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.75%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32,355</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(101</span></span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.38%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33,333</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 2, 2017</span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 2, 2021</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.85%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48,533</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(119</span></span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.46%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>50,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 2, 2017</span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 2, 2022</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.95%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>145,598</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(289</span></span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.52%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>150,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(509</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The cross- currency swaps are carried on the consolidated balance sheet at fair value, and changes in the fair values are recorded as unrealized gains or losses in AOCL. For the three months ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and 2019, the Company recorded a loss of </span><span style="font-family:inherit;font-size:10pt;"><span>$1.7 million</span></span><span style="font-family:inherit;font-size:10pt;"> and a gain of </span><span style="font-family:inherit;font-size:10pt;"><span>$3.3 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, in other income(expense), net related to change in fair value related to the foreign currency rate translation to offset the gains or losses recognized on the intercompany loan. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the three months ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and 2019, the Company recorded gains of </span><span style="font-family:inherit;font-size:10pt;"><span>$5.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$5.5 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, in AOCL related to change in fair value of the cross-currency swaps.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the three months ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and 2019, the Company recorded gains of </span><span style="font-family:inherit;font-size:10pt;"><span>$1.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$1.9 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, in other income (expense), net included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps. </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The estimated gain that is expected to be reclassified to other income (expense), net from AOCL as of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> within the next twelve months is </span><span style="font-family:inherit;font-size:10pt;"><span>$5.1 million</span></span><span style="font-family:inherit;font-size:10pt;">. As of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, the Company does not expect any gains or losses will be reclassified into earnings as a result of the discontinuance of these cash flow hedges because the original forecasted transaction will not occur.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Net Investment Hedges</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company manages certain foreign exchange risks through a variety of strategies, including hedging. The Company is exposed to foreign exchange risk from its international operations through foreign currency purchases, net investments in foreign subsidiaries, and foreign currency assets and liabilities created in the normal course of business. On October 1, 2018, the Company entered into cross-currency swap agreements designated as net investment hedges to partially offset the effects of foreign currency on foreign subsidiaries.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company held the following cross-currency rate swaps designated as net investment hedges as of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, respectively (dollar amounts in thousands):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:85.546875%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"/></tr><tr><td style="width:25%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Effective Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Termination Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fixed Rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate Notional Amount</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Asset (Liability)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay EUR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 3, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, 2021</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">EUR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>44,859</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,082</span></span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.01%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>52,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay EUR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 3, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, 2023</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">EUR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>51,760</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,298</span></span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.57%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>60,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay EUR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 3, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, 2025</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">EUR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38,820</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,174</span></span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.19%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>45,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay GBP</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 3, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, 2025</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.67%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">GBP</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>128,284</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,773</span></span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.71%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>167,500</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 3, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, 2025</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>165,172</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6,965</span></span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive GBP</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.67%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">GBP</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>128,284</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25,362</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:83.984375%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"/></tr><tr><td style="width:25%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Effective Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Termination Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fixed Rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate Notional Amount</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Asset (Liability)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay EUR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 3, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, 2021</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">EUR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>44,859</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,459</span></span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.01%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>52,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay EUR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 3, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, 2023</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">EUR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>51,760</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,087</span></span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.57%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>60,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay EUR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 3, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, 2025</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">EUR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38,820</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,032</span></span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.19%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>45,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay GBP</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 3, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, 2025</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.67%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">GBP</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>128,284</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(154</span></span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.71%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>167,500</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 3, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, 2025</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>165,172</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,221</span></span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive GBP</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.67%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">GBP</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>128,284</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,645</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The cross-currency swaps were carried on the consolidated balance sheet at fair value and changes in the fair values were recorded as unrealized gains or losses in AOCL. For the three months ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and 2019, the Company recorded gains of </span><span style="font-family:inherit;font-size:10pt;"><span>$16.7 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$7.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> in AOCL related to the change in fair value of the cross-currency swaps.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the three months ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and 2019, the Company recorded gains of </span><span style="font-family:inherit;font-size:10pt;"><span>$2.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$2.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> in interest income included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The estimated gain that is expected to be reclassified to interest income from AOCL as of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> within the next twelve months is </span><span style="font-family:inherit;font-size:10pt;"><span>$8.2 million</span></span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Counterparty Credit Risk</span></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company manages its concentration of counterparty credit risk on its derivative instruments by limiting acceptable counterparties to a group of major financial institutions with investment grade credit ratings, and by actively monitoring their credit ratings and outstanding positions on an ongoing basis. Therefore, the Company considers the credit risk of the counterparties </span></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">to be low. Furthermore, none of the Company’s derivative transactions are subject to collateral or other security arrangements, and none contain provisions that depend upon the Company’s credit ratings from any credit rating agency.</span></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fair Value of Derivative Instruments</span></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has classified all of its derivative instruments within Level 2 of the fair value hierarchy because observable inputs are available for substantially the full term of the derivative instruments. The fair values of the interest rate swaps and cross-currency swaps were developed using a market approach based on publicly available market yield curves and the terms of the swap. The Company performs ongoing assessments of counterparty credit risk. </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the fair value for derivatives designated as hedging instruments in the condensed consolidated balance sheets as of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:68%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value as of</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Location on Balance Sheet </span><span style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span><span style="font-family:inherit;font-size:8pt;font-weight:bold;">:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivatives designated as hedges — Assets:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;text-decoration:underline;">Cash Flow Hedges</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swap</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,065</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,032</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;text-decoration:underline;">Net Investment Hedges</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,164</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,952</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;text-decoration:underline;">Cash Flow Hedges</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swap</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;text-decoration:underline;">Net Investment Hedges</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26,307</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,465</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total derivatives designated as hedges — Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>39,536</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,461</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivatives designated as hedges — Liabilities:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued expenses and other current liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;text-decoration:underline;">Cash Flow Hedges</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swap</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19,793</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,635</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>74</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>101</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;text-decoration:underline;">Cash Flow Hedges</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swap</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75,959</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38,522</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,117</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,440</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;text-decoration:underline;">Net Investment Hedges</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,109</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,772</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total derivatives designated as hedges — Liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>106,052</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>53,470</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> </span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup> </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company classifies derivative assets and liabilities as non-current based on the cash flows expected to be incurred within the following 12 months.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup> </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, the notional amount related to the Company’s interest rate swaps were </span><span style="font-family:inherit;font-size:10pt;"><span>$1.3 billion</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$1.3 billion</span></span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following presents the effect of derivative instruments designated as cash flow hedges on the accompanying condensed consolidated statement of operations during the </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</span><span style="font-family:inherit;font-size:10pt;"> months ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">: </span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18"/></tr><tr><td style="width:26%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:23%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance in AOCL</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Beginning of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quarter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gain (Loss)</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Recognized in</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">AOCL</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount of Gain (Loss)</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Reclassified from</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">AOCL into</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance in AOCL</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">End of Quarter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Location in</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Statements of</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Operations</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="17" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2020</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;text-decoration:underline;">Cash Flow Hedges</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swap</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(45,145</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(51,651</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,043</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(95,753</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest expense</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>177</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,907</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(182</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,266</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other income (expense), net</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;text-decoration:underline;">Net Investment Hedges</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10,229</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,897</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,180</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26,946</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest income</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(34,739</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(26,847</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>955</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(62,541</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2019</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;text-decoration:underline;">Cash Flow Hedges</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swap</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>619</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(15,891</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,406</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16,678</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest expense</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6,190</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,473</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,178</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3,895</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other income (expense), net</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net Investment Hedges</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(632</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10,221</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,327</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,262</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest income</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6,203</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,803</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,911</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13,311</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company held the following interest rate swaps as of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> (dollar amounts in thousands):</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;padding-left:12px;text-indent:-12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.40625%;border-collapse:collapse;text-align:left;"><tr><td colspan="18"/></tr><tr><td style="width:23%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Hedged Item</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Current Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Designation Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Effective Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Termination Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Fixed Interest Rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Estimated Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Liabilities</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">3-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>50,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">February 6, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>1.834</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(48</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">1-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>100,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">February 6, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>1.652</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(233</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">1-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>100,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">March 27, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 31, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>1.971</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(2,024</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">1-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>150,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 13, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">January 1, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 31, 2022</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.201</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(7,467</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">1-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>150,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 13, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">January 1, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 31, 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.201</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(7,388</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">1-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>100,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 13, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">July 1, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2024</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.423</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(8,475</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">1-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>50,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 13, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">July 1, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2024</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.423</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(3,994</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">1-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>200,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 13, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">January 1, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 31, 2024</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.313</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(16,279</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">1-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>75,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">October 10, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">July 1, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2025</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>3.220</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(10,186</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">1-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>75,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">October 10, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">July 1, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2025</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>3.199</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(10,165</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">1-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>75,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">October 10, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">July 1, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2025</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>3.209</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(10,185</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">1-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>100,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 18, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 30, 2022</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 31, 2027</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.885</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(9,453</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">1-month USD LIBOR Loan</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>100,000</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 18, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 30, 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 31, 2027</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.867</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(9,855</span></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">Total interest rate derivatives designated as cash flow hedge</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>1,325,000</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>(95,752</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company held the following interest rate swaps as of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> (dollar amounts in thousands):</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;padding-left:12px;text-indent:-12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:616px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:128px;"/><td style="width:5px;"/><td style="width:5px;"/><td style="width:47px;"/><td style="width:3px;"/><td style="width:5px;"/><td style="width:88px;"/><td style="width:5px;"/><td style="width:88px;"/><td style="width:5px;"/><td style="width:86px;"/><td style="width:5px;"/><td style="width:33px;"/><td style="width:8px;"/><td style="width:5px;"/><td style="width:93px;"/><td style="width:3px;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Hedged Item</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Current Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Designation Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Effective Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Termination Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Fixed Interest Rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Estimated Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Liabilities</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">3-month USD LIBOR</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>50,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">February 6, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>1.834</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">1-month USD LIBOR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>100,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">February 6, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>1.652</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">1-month USD LIBOR</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>100,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">March 27, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 31, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>1.971</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(581</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">1-month USD LIBOR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>150,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 13, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">January 1, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 31, 2022</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.201</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(2,880</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">1-month USD LIBOR</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>150,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 13, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">January 1, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 31, 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.201</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(2,880</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">1-month USD LIBOR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>100,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 13, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">July 1, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2024</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.423</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(3,517</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">1-month USD LIBOR</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>50,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 13, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">July 1, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2024</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.423</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(1,778</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">1-month USD LIBOR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>200,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 13, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">January 1, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 31, 2024</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.313</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(6,595</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">1-month USD LIBOR</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>75,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">October 10, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">July 1, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2025</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>3.220</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(5,750</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">1-month USD LIBOR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>75,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">October 10, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">July 1, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2025</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>3.199</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(5,747</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">1-month USD LIBOR</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>75,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">October 10, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">July 1, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">June 30, 2025</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>3.209</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(5,807</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">1-month USD LIBOR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>100,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 18, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 30, 2022</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 31, 2027</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.885</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(4,930</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">1-month USD LIBOR</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>100,000</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 18, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 30, 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">December 31, 2027</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>2.867</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(4,691</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">Total interest rate derivatives designated as cash flow hedge</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;"><span>1,325,000</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(45,145</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company held the following cross-currency rate swaps as of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> (dollar amounts in thousands):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"/></tr><tr><td style="width:33%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Effective Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Termination Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fixed Rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Asset (Liability)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 2, 2017</span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 2, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.75%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32,355</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(101</span></span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.38%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33,333</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 2, 2017</span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 2, 2021</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.85%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48,533</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(119</span></span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.46%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>50,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 2, 2017</span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 2, 2022</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.95%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>145,598</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(289</span></span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.52%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>150,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(509</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company held the following cross-currency rate swaps designated as net investment hedges as of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, respectively (dollar amounts in thousands):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:85.546875%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"/></tr><tr><td style="width:25%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Effective Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Termination Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fixed Rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate Notional Amount</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Asset (Liability)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay EUR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 3, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, 2021</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">EUR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>44,859</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,082</span></span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.01%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>52,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay EUR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 3, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, 2023</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">EUR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>51,760</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,298</span></span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.57%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>60,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay EUR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 3, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, 2025</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">EUR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38,820</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,174</span></span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.19%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>45,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay GBP</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 3, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, 2025</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.67%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">GBP</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>128,284</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,773</span></span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.71%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>167,500</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 3, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, 2025</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>165,172</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6,965</span></span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive GBP</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.67%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">GBP</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>128,284</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25,362</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:83.984375%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"/></tr><tr><td style="width:25%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Effective Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Termination Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fixed Rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate Notional Amount</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Asset (Liability)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay EUR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 3, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, 2021</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">EUR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>44,859</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,459</span></span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.01%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>52,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay EUR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 3, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, 2023</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">EUR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>51,760</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,087</span></span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.57%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>60,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay EUR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 3, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, 2025</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">EUR</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38,820</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,032</span></span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.19%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>45,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay GBP</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 3, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, 2025</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.67%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">GBP</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>128,284</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(154</span></span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.71%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>167,500</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 3, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, 2025</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>165,172</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,221</span></span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive GBP</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.67%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">GBP</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>128,284</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,645</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company held the following cross-currency rate swaps as of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> (dollar amounts in thousands):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"/></tr><tr><td style="width:37%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Effective Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Termination Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fixed Rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate Notional Amount</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Asset (Liability)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 2, 2017</span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 2, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.75%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32,355</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(74</span></span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.38%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33,333</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 2, 2017</span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 2, 2021</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.85%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48,533</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>531</span></span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.46%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>50,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pay CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 2, 2017</span></div></td><td rowspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 2, 2022</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.95%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">CHF</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>145,597</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,416</span></span></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receive U.S.$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.52%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>150,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,874</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 50000000 0.01834 -48000 100000000 0.01652 -233000 100000000 0.01971 -2024000 150000000 0.02201 -7467000 150000000 0.02201 -7388000 100000000 0.02423 -8475000 50000000 0.02423 -3994000 200000000 0.02313 -16279000 75000000 0.03220 -10186000 75000000 0.03199 -10165000 75000000 0.03209 -10185000 100000000 0.02885 -9453000 100000000 0.02867 -9855000 1325000000 -95752000 50000000 0.01834 -2000 100000000 0.01652 12000 100000000 0.01971 -581000 150000000 0.02201 -2880000 150000000 0.02201 -2880000 100000000 0.02423 -3517000 50000000 0.02423 -1778000 200000000 0.02313 -6595000 75000000 0.03220 -5750000 75000000 0.03199 -5747000 75000000 0.03209 -5807000 100000000 0.02885 -4930000 100000000 0.02867 -4691000 1325000000 -45145000 300000000.0 291200000 0.0175 32355000 -74000 0.0438 33333000 0.0185 48533000 531000 0.0446 50000000 0.0195 145597000 3416000 0.0452 150000000 3874000 0.0175 32355000 -101000 0.0438 33333000 0.0185 48533000 -119000 0.0446 50000000 0.0195 145598000 -289000 0.0452 150000000 -509000 -1700000 3300000 5900000 5500000 1500000 1900000 5100000 0 44859000 4082000 0.0301 52000000 0 51760000 6298000 0.0257 60000000 0 38820000 5174000 0.0219 45000000 0.0167 128284000 16773000 0.0271 167500000 0 165172000 -6965000 0.0167 128284000 25362000 0 44859000 2459000 0.0301 52000000 0 51760000 3087000 0.0257 60000000 0 38820000 2032000 0.0219 45000000 0.0167 128284000 -154000 0.0271 167500000 0 165172000 1221000 0.0167 128284000 8645000 16700000 7900000 2200000 2300000 8200000 <div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the fair value for derivatives designated as hedging instruments in the condensed consolidated balance sheets as of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:68%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value as of</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Location on Balance Sheet </span><span style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span><span style="font-family:inherit;font-size:8pt;font-weight:bold;">:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivatives designated as hedges — Assets:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;text-decoration:underline;">Cash Flow Hedges</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swap</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,065</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,032</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;text-decoration:underline;">Net Investment Hedges</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,164</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,952</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;text-decoration:underline;">Cash Flow Hedges</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swap</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;text-decoration:underline;">Net Investment Hedges</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26,307</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,465</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total derivatives designated as hedges — Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>39,536</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,461</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivatives designated as hedges — Liabilities:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued expenses and other current liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;text-decoration:underline;">Cash Flow Hedges</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swap</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19,793</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,635</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>74</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>101</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;text-decoration:underline;">Cash Flow Hedges</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swap</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75,959</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38,522</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,117</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,440</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;text-decoration:underline;">Net Investment Hedges</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,109</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,772</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total derivatives designated as hedges — Liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>106,052</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>53,470</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> </span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup> </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company classifies derivative assets and liabilities as non-current based on the cash flows expected to be incurred within the following 12 months.</span></div></td></tr></table><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup> </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, the notional amount related to the Company’s interest rate swaps were </span><span style="font-family:inherit;font-size:10pt;"><span>$1.3 billion</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$1.3 billion</span></span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div> 0 12000 5065000 5032000 8164000 7952000 0 0 0 0 26307000 3465000 39536000 16461000 19793000 6635000 74000 101000 75959000 38522000 1117000 5440000 9109000 2772000 106052000 53470000 1300000000 1300000000 <div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following presents the effect of derivative instruments designated as cash flow hedges on the accompanying condensed consolidated statement of operations during the </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</span><span style="font-family:inherit;font-size:10pt;"> months ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">: </span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18"/></tr><tr><td style="width:26%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:23%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance in AOCL</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Beginning of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quarter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gain (Loss)</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Recognized in</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">AOCL</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount of Gain (Loss)</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Reclassified from</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">AOCL into</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance in AOCL</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">End of Quarter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Location in</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Statements of</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Operations</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="17" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2020</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;text-decoration:underline;">Cash Flow Hedges</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swap</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(45,145</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(51,651</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,043</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(95,753</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest expense</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>177</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,907</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(182</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,266</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other income (expense), net</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;text-decoration:underline;">Net Investment Hedges</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10,229</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,897</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,180</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26,946</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest income</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(34,739</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(26,847</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>955</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(62,541</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2019</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;text-decoration:underline;">Cash Flow Hedges</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swap</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>619</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(15,891</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,406</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16,678</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest expense</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6,190</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,473</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,178</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3,895</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other income (expense), net</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net Investment Hedges</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(632</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10,221</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,327</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,262</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest income</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6,203</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,803</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,911</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13,311</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> -45145000 -51651000 -1043000 -95753000 177000 5907000 -182000 6266000 10229000 18897000 2180000 26946000 -34739000 -26847000 955000 -62541000 619000 -15891000 1406000 -16678000 -6190000 7473000 5178000 -3895000 -632000 10221000 2327000 7262000 -6203000 1803000 8911000 -13311000 STOCK-BASED COMPENSATION<div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, the Company had stock options, restricted stock awards, performance stock units, contract stock awards and restricted stock unit awards outstanding under </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> plans, the 2001 Equity Incentive Plan (the “2001 Plan”) and the 2003 Equity Incentive Plan (the “2003 Plan,” and collectively, the “Plans”). </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock options issued under the Plans become exercisable over specified periods, generally within </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>four years</span></span><span style="font-family:inherit;font-size:10pt;"> from the date of grant for officers and employees, and within </span><span style="font-family:inherit;font-size:10pt;"><span>one year</span></span><span style="font-family:inherit;font-size:10pt;"> from date of grant for directors and generally expire </span><span style="font-family:inherit;font-size:10pt;"><span>eight years</span></span><span style="font-family:inherit;font-size:10pt;"> from the grant date for employees, and from </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">six</span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>ten years</span></span><span style="font-family:inherit;font-size:10pt;"> for directors and certain executive officers. The Company values stock option grants using the binomial distribution model. Restricted stock issued under the Plans vests over specified periods, generally </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>three years</span></span><span style="font-family:inherit;font-size:10pt;"> after the date of grant. The vesting of performance stock issued under the Plans is subject to service and performance conditions.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Stock Options</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, there were approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$8.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation costs related to unvested stock options. These costs are expected to be recognized over a weighted-average period of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>three years</span></span><span style="font-family:inherit;font-size:10pt;">. There were </span><span style="font-family:inherit;font-size:10pt;"><span>348,587</span></span><span style="font-family:inherit;font-size:10pt;"> stock options granted during the </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</span><span style="font-family:inherit;font-size:10pt;"> months ended </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">. For the three months ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, the weighted average grant date fair value for stock options was </span><span style="font-family:inherit;font-size:10pt;"><span>$13.03</span></span><span style="font-family:inherit;font-size:10pt;"> per option.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Awards of Restricted Stock and Performance Stock</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Performance stock and restricted stock awards generally have requisite service periods of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>three years</span></span><span style="font-family:inherit;font-size:10pt;">. Performance stock units are subject to graded vesting conditions based on revenue goals of the Company. The Company expenses the fair value of restricted stock awards on a straight-line basis over the requisite service period. As of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, there was approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$37.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation costs related to these unvested awards. The Company expects to recognize these costs over a weighted-average period of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>two years</span></span><span style="font-family:inherit;font-size:10pt;">. The Company granted </span><span style="font-family:inherit;font-size:10pt;"><span>262,623</span></span><span style="font-family:inherit;font-size:10pt;"> restricted stock awards and </span><span style="font-family:inherit;font-size:10pt;"><span>180,875</span></span><span style="font-family:inherit;font-size:10pt;"> performance stock awards during the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> months ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">. For the three months ended March 31, 2020, the weighted average grant date fair value for restricted stock awards and performance stock units was </span><span style="font-family:inherit;font-size:10pt;"><span>$43.89</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$43.39</span></span><span style="font-family:inherit;font-size:10pt;"> per award, respectively.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has no formal policy related to the repurchase of stock for the purpose of satisfying stock-based compensation obligations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company also maintains an Employee Stock Purchase Plan (the “ESPP”), which provides eligible employees with the opportunity to acquire shares of common stock at periodic intervals by means of accumulated payroll deductions. The ESPP is a non-compensatory plan based on its terms.</span></div> 2 P4Y P1Y P8Y P10Y P3Y 8200000 P3Y 348587 13.03 P3Y 37300000 P2Y 262623 180875 43.89 43.39 RETIREMENT PLANS<div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company maintains defined benefit pension plans that cover certain employees in Austria, France, Japan, Germany and Switzerland.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit costs for the Company’s defined benefit pension plans for the </span><span style="font-family:inherit;font-size:10pt;">three months ended March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> were </span><span style="font-family:inherit;font-size:10pt;"><span>$1.0 million</span></span><span style="font-family:inherit;font-size:10pt;">. The components of the net periodic benefit costs other than the service cost component of </span><span style="font-family:inherit;font-size:10pt;"><span>$0.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the three months ended March 31, 2020, are included in other income (expense), net in the consolidated statements of operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit costs for the Company’s defined benefit pension plans for the three months ended March 31, 2019 was </span><span style="font-family:inherit;font-size:10pt;"><span>$0.5 million</span></span><span style="font-family:inherit;font-size:10pt;">. The components of the net periodic benefit costs other than the service cost component of </span><span style="font-family:inherit;font-size:10pt;"><span>$0.7 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the three months ended March 31, 2019, respectively, are included in other income (expense), net in the consolidated statements of operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The estimated fair values of plan assets were </span><span style="font-family:inherit;font-size:10pt;"><span>$31.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$30.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, respectively. The net plan assets of the pension plans are invested in common trusts as of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">. Common trusts are classified as Level 2 in the fair value hierarchy. The fair value of common trusts is valued at the net asset value based on the fair values of the underlying investments of the trusts as determined by the sponsor of the trusts. The investment strategy of the Company's defined benefit plans is both to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within an appropriate risk profile.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Deferred Compensation Plan</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In May 2019, the Company adopted the Integra LifeSciences Deferred Compensation Plan (the “Plan”). Under the Plan, certain employees of the Company may defer the payment and taxation of up to </span><span style="font-family:inherit;font-size:10pt;"><span>75%</span></span><span style="font-family:inherit;font-size:10pt;"> of their base salary and up to </span><span style="font-family:inherit;font-size:10pt;"><span>100%</span></span><span style="font-family:inherit;font-size:10pt;"> of bonus amounts and other eligible cash compensation. </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the first quarter of 2020, employees participating in the Plan began to defer their compensation. This deferred compensation is invested in funds offered under the Plan and is valued based on Level 1 measurements in the fair value hierarchy. The purpose of the Plan is to retain key employees by providing them with an opportunity to defer a portion of their compensation as elected by the participant in accordance with the Plan. Any amounts set aside to defray the liabilities assumed by the Company will remain the general assets of the Company until such amounts are distributed to the participants. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices. The fair value of these assets at March 31, 2020 was </span><span style="font-family:inherit;font-size:10pt;"><span>$1.2 million</span></span><span style="font-family:inherit;font-size:10pt;">. Offsetting liabilities relating to the deferred compensation plan are included in Other liabilities.</span></div> 1000000.0 900000 500000 700000 31300000 30800000 0.75 1 1200000 LEASES AND RELATED PARTY LEASES<div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company leases administrative, manufacturing, research and distribution facilities and vehicles through operating lease agreements. The Company has no finance leases as of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">. Many of the Company's leases include both lease (e.g., fixed payments including rent) and non-lease components (e.g., common-area or other maintenance costs). For vehicles, the Company has elected the practical expedient to group lease and non-lease components. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Most facility leases include </span><span style="font-family:inherit;font-size:10pt;"><span>one</span></span><span style="font-family:inherit;font-size:10pt;"> or more options to renew. The exercise of lease renewal options is typically at the Company's sole discretion, therefore, the majority of renewals to extend the lease terms are not included in the ROU assets and lease liabilities as they are not reasonably certain of exercise. The Company regularly evaluates renewal options and when they are reasonably certain of exercise, the renewal period is included in the lease term.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As most of the Company's leases do not provide an implicit rate, the Company uses a collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of the lease payments. </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total operating lease expense for the </span><span style="font-family:inherit;font-size:10pt;">three months ended March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">March 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, was </span><span style="font-family:inherit;font-size:10pt;"><span>$4.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$4.4</span></span><span style="font-family:inherit;font-size:10pt;"> million respectively, which includes </span><span style="font-family:inherit;font-size:10pt;"><span>$0.1 million</span></span><span style="font-family:inherit;font-size:10pt;">, in related party operating lease expense. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Supplemental balance sheet information related to operating leases at </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:81%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands, except lease term and discount rate)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ROU assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95,890</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current lease liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,964</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-current lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100,328</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>113,292</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average remaining lease term (in years):</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Leased facilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Leased vehicles</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average discount rate:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Leased facilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Leased vehicles</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Supplemental cash flow information related to leases was as follows for the </span><span style="font-family:inherit;font-size:10pt;">three months ended March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:81%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash paid for amounts included in the measurement of lease liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating cash flows from operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,229</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ROU assets obtained in exchange for lease liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,808</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Future minimum lease payments under operating leases at </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:56%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Related Parties</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Third Parties</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>222</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10,334</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10,556</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13,018</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13,314</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14,198</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14,494</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,658</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,954</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2024</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,022</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,318</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,429</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>91,026</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>92,455</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total minimum lease payments</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,835</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>151,256</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>154,091</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Imputed interest</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>40,799</span></span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total lease liabilities</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>113,292</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Current lease liabilities</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,964</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term lease liabilities</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100,328</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Future minimum lease payments under operating leases at </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:56%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Related Parties</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Third Parties</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,100</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,396</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,951</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13,247</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13,753</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14,049</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,386</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,682</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2024</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,060</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,356</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,428</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>91,235</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>92,663</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total minimum lease payments</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,908</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>152,485</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>155,393</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Imputed interest</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>45,636</span></span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total lease liabilities</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>109,757</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Current lease liabilities</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,253</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term lease liabilities</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>97,504</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">There were </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> future minimum lease payments under capital leases at </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Related Party Leases </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company leases its manufacturing facility in Plainsboro, New Jersey, from a general partnership that is </span><span style="font-family:inherit;font-size:10pt;"><span>50%</span></span><span style="font-family:inherit;font-size:10pt;"> owned by a corporation whose shareholders are trusts, whose beneficiaries include family members of the Company’s principal stockholder and former director. The term of the current lease agreement is through October 31, 2032 at an annual rate of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$0.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> per year. The current lease agreement also provides (i) a </span><span style="font-family:inherit;font-size:10pt;"><span>5</span></span><span style="font-family:inherit;font-size:10pt;">-year renewal option for the Company to extend the lease from </span><span style="font-family:inherit;font-size:10pt;"><span>November 1, 2032 through October 31, 2037</span></span><span style="font-family:inherit;font-size:10pt;"> at the fair market rental rate of the premises, and (ii) another </span><span style="font-family:inherit;font-size:10pt;"><span>5</span></span><span style="font-family:inherit;font-size:10pt;">-year renewal option to extend the lease from </span><span style="font-family:inherit;font-size:10pt;"><span>November 1, 2037 through October 31, 2042</span></span><span style="font-family:inherit;font-size:10pt;"> at the fair market rental rate of the premises.</span></div> 1 4800000 4400000 100000 <div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Supplemental balance sheet information related to operating leases at </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:81%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands, except lease term and discount rate)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ROU assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95,890</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current lease liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,964</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-current lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100,328</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>113,292</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average remaining lease term (in years):</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Leased facilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Leased vehicles</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average discount rate:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Leased facilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Leased vehicles</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 95890000 12964000 100328000 113292000 P12Y6M P1Y8M12D 0.052 0.024 <div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Supplemental cash flow information related to leases was as follows for the </span><span style="font-family:inherit;font-size:10pt;">three months ended March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:81%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash paid for amounts included in the measurement of lease liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating cash flows from operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,229</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ROU assets obtained in exchange for lease liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,808</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 3229000 5808000 <div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Future minimum lease payments under operating leases at </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:56%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Related Parties</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Third Parties</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>222</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10,334</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10,556</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13,018</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13,314</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14,198</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14,494</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,658</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,954</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2024</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,022</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,318</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,429</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>91,026</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>92,455</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total minimum lease payments</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,835</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>151,256</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>154,091</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Imputed interest</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>40,799</span></span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total lease liabilities</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>113,292</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Current lease liabilities</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,964</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term lease liabilities</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100,328</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Future minimum lease payments under operating leases at </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:56%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Related Parties</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Third Parties</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,100</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,396</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,951</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13,247</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13,753</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14,049</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,386</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,682</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2024</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,060</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,356</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,428</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>91,235</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>92,663</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total minimum lease payments</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,908</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>152,485</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>155,393</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Imputed interest</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>45,636</span></span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total lease liabilities</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>109,757</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Current lease liabilities</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,253</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term lease liabilities</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>97,504</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 222000 10334000 10556000 296000 13018000 13314000 296000 14198000 14494000 296000 11658000 11954000 296000 11022000 11318000 1429000 91026000 92455000 2835000 151256000 154091000 40799000 113292000 12964000 100328000 296000 12100000 12396000 296000 12951000 13247000 296000 13753000 14049000 296000 11386000 11682000 296000 11060000 11356000 1428000 91235000 92663000 2908000 152485000 155393000 45636000 109757000 12253000 97504000 0 0.50 300000 P5Y November 1, 2032 through October 31, 2037 P5Y November 1, 2037 through October 31, 2042 TREASURY STOCK<div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of March 31, 2020 and December 31, 2019, there were </span><span style="font-family:inherit;font-size:10pt;"><span>4.3</span></span><span style="font-family:inherit;font-size:10pt;"> million and </span><span style="font-family:inherit;font-size:10pt;"><span>2.9</span></span><span style="font-family:inherit;font-size:10pt;"> million shares of treasury stock outstanding with a cost of </span><span style="font-family:inherit;font-size:10pt;"><span>$202.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$119.9</span></span><span style="font-family:inherit;font-size:10pt;"> million, at a weighted average cost per share of </span><span style="font-family:inherit;font-size:10pt;"><span>$47.17</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$41.87</span></span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On December 11, 2018, the Board of Directors authorized the Company to repurchase up to </span><span style="font-family:inherit;font-size:10pt;"><span>$225.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> of the Company’s common stock. The program allows the Company to repurchase its shares opportunistically from time to time. The repurchase authorization expires in December 2020. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the three months ended March 31, 2020, the Company repurchased </span><span style="font-family:inherit;font-size:10pt;"><span>1.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares of Integra’s common stock as part of our existing share repurchase authorization. The Company utilized </span><span style="font-family:inherit;font-size:10pt;"><span>$100.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> of net proceeds from the offering of the Convertible Senior Notes to execute the share repurchase transactions. This included </span><span style="font-family:inherit;font-size:10pt;"><span>$7.6 million</span></span><span style="font-family:inherit;font-size:10pt;"> from certain purchasers of the convertible notes in conjunction with the closing of the offering. On February 5, 2020, the Company entered into a </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><span>$92.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> accelerated share repurchase ("ASR") to complete the remaining </span><span style="font-family:inherit;font-size:10pt;"><span>$100.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> of share repurchase. The Company received </span><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span><span style="font-family:inherit;font-size:10pt;"> million shares at inception of the ASR, which represented approximately </span><span style="font-family:inherit;font-size:10pt;"><span>80%</span></span><span style="font-family:inherit;font-size:10pt;"> of the expected total shares. The remaining </span><span style="font-family:inherit;font-size:10pt;"><span>20%</span></span><span style="font-family:inherit;font-size:10pt;"> of the expected total shares is expected to settle during the second quarter of 2020, upon which additional shares of common stock may be delivered to the Company or, under certain circumstances, the Company may be required to make a cash payment or may elect to deliver shares of our common stock to the ASR counterparty. The total number of shares to be delivered or the amount of such payment, as well as the final average price per share, will be based on the volume-weighted average price, less a discount, of the Company's common stock during the term of the transaction. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has </span><span style="font-family:inherit;font-size:10pt;"><span>$125.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> remaining under the share repurchase of its Common Stock. The price and timing of any future purchases under the share repurchase program will depend on factors such as levels of cash generation from operations, the volume of stock option exercises by employees, cash requirements for acquisitions, dividends, economic and market conditions and stock price.</span></div> 4300000 2900000 202500000 119900000 47.17 41.87 225000000.0 1400000 100000000.0 7600000 -92400000 100000000.0 1300000 0.80 0.20 125000000.0 INCOME TAXES <div style="line-height:120%;padding-top:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table provides a summary of the Company's effective tax rate:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:73%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Reported tax rate</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(32.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company’s effective income tax rates for the three months ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> were </span><span style="font-family:inherit;font-size:10pt;"><span>19.8%</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>(32.0)%</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. For the </span><span style="font-family:inherit;font-size:10pt;">three months ended March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, the primary drivers of the higher tax rate were lower book income in lower-taxed jurisdictions and a </span><span style="font-family:inherit;font-size:10pt;"><span>$3.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> valuation allowance on certain foreign deferred tax assets as the Company determined that it is no longer more likely than not that these foreign deferred tax assets would be realized due to the adverse impact of the COVID-19 pandemic in certain jurisdictions. For the </span><span style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, the primary drivers of the lower rate were a </span><span style="font-family:inherit;font-size:10pt;"><span>$0.7 million</span></span><span style="font-family:inherit;font-size:10pt;"> higher tax benefit related to equity compensation and a tax benefit of </span><span style="font-family:inherit;font-size:10pt;"><span>$10.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> (</span><span style="font-family:inherit;font-size:10pt;"><span>$0.13</span></span><span style="font-family:inherit;font-size:10pt;"> per share) related to a federal tax holiday in Switzerland, which was finalized during the quarter ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2019</span><span style="font-family:inherit;font-size:10pt;">. The Company received a Switzerland federal tax credit of </span><span style="font-family:inherit;font-size:10pt;"><span>$12.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> CHF, which can be used over a seven-year period, ending in 2024. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, the Company has not provided deferred income taxes on unrepatriated earnings from foreign subsidiaries as they are deemed indefinitely reinvested. Such taxes would primarily be attributable to foreign withholding taxes and local income taxes when such earnings are distributed. As such, the Company has determined the tax impact of repatriating these earnings would not be material as of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">. The company does not anticipate the need to repatriate earnings from foreign subsidiaries as a result of the impact of the COVID-19 pandemic. </span></div>On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was signed into law. The CARES Act includes certain income tax provisions for corporations and individuals, among other provisions. The Company does not expect the CARES Act to have a significant impact on the tax provision for income. <div style="line-height:120%;padding-top:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table provides a summary of the Company's effective tax rate:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:73%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Reported tax rate</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(32.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0.198 -0.320 0.198 -0.320 3300000 -700000 10800000 0.13 12000000.0 NET INCOME PER SHARE<div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic and diluted net income per share was as follows:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:12px;text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands, except per share amounts)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Basic net income per share:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,180</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32,756</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average common shares outstanding</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>85,188</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>85,343</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic net income per common share</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.11</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.38</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Diluted net income per share:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,180</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32,756</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average common shares outstanding — Basic</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>85,188</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>85,343</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Effect of dilutive securities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock options and restricted stock</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>704</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>915</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average common shares for diluted earnings per share</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>85,892</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>86,258</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted net income per common share</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.11</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.38</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Common stock of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span><span style="font-family:inherit;font-size:10pt;"> million shares at </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> that are issuable through exercise of dilutive securities were not included in the computation of diluted net income per share because their effect would have been anti-dilutive. </span></div><span style="font-family:inherit;font-size:10pt;">Performance Shares and Restricted Units that entitle the holders to approximately </span><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span> million shares of common stock are included in the basic and diluted weighted average shares outstanding calculation from their date of issuance because no further consideration is due related to the issuance of the underlying common shares. <div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic and diluted net income per share was as follows:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:12px;text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands, except per share amounts)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Basic net income per share:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,180</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32,756</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average common shares outstanding</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>85,188</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>85,343</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic net income per common share</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.11</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.38</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Diluted net income per share:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,180</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32,756</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average common shares outstanding — Basic</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>85,188</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>85,343</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Effect of dilutive securities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock options and restricted stock</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>704</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>915</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average common shares for diluted earnings per share</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>85,892</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>86,258</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted net income per common share</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.11</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.38</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 9180000 32756000 85188000 85343000 0.11 0.38 9180000 32756000 85188000 85343000 704000 915000 85892000 86258000 0.11 0.38 400000 500000 COMPREHENSIVE INCOME (LOSS)<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Comprehensive income (loss) was as follows:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,180</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32,756</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency translation adjustment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6,813</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7,009</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change in unrealized loss on derivatives, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21,306</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4,236</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pension liability adjustment, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(68</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Comprehensive income (loss), net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19,007</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21,520</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Changes in accumulated other comprehensive loss by component between </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> are presented in the table below, net of tax:</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:54%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gains and Losses on Derivatives</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Defined Benefit Pension Items</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Foreign Currency Items</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at January 1, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(26,625</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9,709</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(40,067</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(76,401</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(20,577</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(68</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6,813</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(27,458</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Amounts reclassified from accumulated other comprehensive loss</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>729</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>729</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net current-period other comprehensive loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21,306</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(68</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6,813</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(28,187</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at March 31, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(47,931</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9,777</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(46,880</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(104,588</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the </span><span style="font-family:inherit;font-size:10pt;">three months ended March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, the Company reclassified a loss of </span><span style="font-family:inherit;font-size:10pt;"><span>$0.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> from accumulated other comprehensive loss to other income (expense), net and </span><span style="font-family:inherit;font-size:10pt;"><span>$0.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> from interest income.</span></div> <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Comprehensive income (loss) was as follows:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,180</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32,756</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency translation adjustment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6,813</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7,009</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change in unrealized loss on derivatives, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21,306</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4,236</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pension liability adjustment, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(68</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Comprehensive income (loss), net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19,007</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21,520</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 9180000 32756000 -6813000 -7009000 -21306000 -4236000 68000 -9000 -19007000 21520000 <div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Changes in accumulated other comprehensive loss by component between </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> are presented in the table below, net of tax:</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:54%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gains and Losses on Derivatives</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Defined Benefit Pension Items</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Foreign Currency Items</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at January 1, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(26,625</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9,709</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(40,067</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(76,401</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(20,577</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(68</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6,813</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(27,458</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Amounts reclassified from accumulated other comprehensive loss</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>729</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>729</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net current-period other comprehensive loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21,306</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(68</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6,813</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(28,187</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at March 31, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(47,931</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9,777</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(46,880</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(104,588</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> -26625000 -9709000 -40067000 -76401000 -20577000 -68000 -6813000 -27458000 729000 0 0 729000 -21306000 -68000 -6813000 -28187000 -47931000 -9777000 -46880000 -104588000 -100000 900000 SEGMENT AND GEOGRAPHIC INFORMATION<div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company internally manages </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> global reportable segments and reports the results of its businesses to its chief operating decision maker. The </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> reportable segments and their activities are described below.</span></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the instruments business, which sells more than </span><span style="font-family:inherit;font-size:10pt;"><span>40,000</span></span><span style="font-family:inherit;font-size:10pt;"> instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Orthopedics and Tissue Technologies segment includes such offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair products.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by each reportable segment for the </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</span><span style="font-family:inherit;font-size:10pt;"> months ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> are as follows: </span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:67%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Segment Net Sales</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Codman Specialty Surgical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>231,440</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>234,568</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Orthopedics and Tissue Technologies</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>122,884</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>125,122</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total revenues</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>354,324</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>359,690</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Segment Profit </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Codman Specialty Surgical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>87,235</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>91,380</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Orthopedics and Tissue Technologies</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31,271</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>40,495</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Segment profit</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>118,506</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>131,875</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6,977</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5,279)</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate and other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(84,426</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(94,288</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating income</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27,103</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32,308</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company attributes revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:67%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>246,852</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>256,726</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Europe</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>45,896</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48,640</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asia Pacific</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>39,960</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35,700</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Rest of World</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21,616</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,624</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total Revenues</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>354,324</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>359,690</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 2 2 40000 Net sales and profit by each reportable segment for the <span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</span><span style="font-family:inherit;font-size:10pt;"> months ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> are as follows: </span><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:67%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Segment Net Sales</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Codman Specialty Surgical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>231,440</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>234,568</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Orthopedics and Tissue Technologies</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>122,884</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>125,122</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total revenues</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>354,324</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>359,690</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Segment Profit </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Codman Specialty Surgical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>87,235</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>91,380</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Orthopedics and Tissue Technologies</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31,271</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>40,495</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Segment profit</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>118,506</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>131,875</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6,977</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5,279)</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate and other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(84,426</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(94,288</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating income</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27,103</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32,308</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company attributes revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:67%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>246,852</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>256,726</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Europe</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>45,896</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48,640</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asia Pacific</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>39,960</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35,700</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Rest of World</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21,616</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,624</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total Revenues</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>354,324</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>359,690</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 231440000 234568000 122884000 125122000 354324000 359690000 87235000 91380000 31271000 40495000 118506000 131875000 6977000 5279000 -84426000 -94288000 27103000 32308000 246852000 256726000 45896000 48640000 39960000 35700000 21616000 18624000 354324000 359690000 COMMITMENTS AND CONTINGENCIES<div style="line-height:120%;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In consideration for certain technology, manufacturing, distribution, and selling rights and licenses granted to the Company, the Company has agreed to pay royalties on sales of certain products that it sells. The royalty payments that the Company made under these agreements were not significant for any of the periods presented.</span></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company is subject to various claims, lawsuits and proceedings in the ordinary course of the Company's business, including claims by current or former employees, distributors and competitors and with respect to its products and product liability claims, lawsuits and proceedings, some of which have been settled by the Company. In the opinion of management, such claims are either adequately covered by insurance or otherwise indemnified, or are not expected, individually or in the aggregate, to result in a material, adverse effect on the Company's financial condition. However, it is possible that the Company's results of operations, financial position and cash flows in a particular period could be materially affected by these contingencies.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company accrues for loss contingencies when it is deemed probable that a loss has been incurred and that loss is estimable. The amounts accrued are based on the full amount of the estimated loss before considering insurance proceeds and do not include an estimate for legal fees expected to be incurred in connection with the loss contingency. The Company consistently accrues legal fees expected to be incurred in connection with loss contingencies as those fees are incurred by outside counsel as a period cost.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Contingent Consideration</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company determined the fair value of contingent consideration during the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;">-month period ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">March 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> to reflect the change in estimates, additions, payments, transfers and the time value of money during the period. </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the </span><span style="font-family:inherit;font-size:10pt;">three months ended March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">March 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> is as follows (in thousands):</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:39%;"/><td style="width:1%;"/><td style="width:20%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:17%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2020</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Contingent Consideration Liability Related to Acquisition of Arkis (See Note 2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Contingent Consideration</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> Liability Related to Acquisition of Derma Sciences</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Location in Financial Statements</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Long-term</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Long-term</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance as of January 1, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14,210</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>230</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Loss from change in fair value of contingent consideration liabilities </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,051</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Research and development</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance as of March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13,159</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>230</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:32%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:27%;"/><td style="width:1%;"/><td style="width:37%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Contingent Consideration</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> Liability Related to Acquisition of Derma Sciences</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Location in Financial Statements</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Long-term</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance as of January 1, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>230</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Payments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Loss from change in fair value of contingent consideration liabilities </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Research and development</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance as of March 31, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>230</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Derma Sciences</span></div><span style="font-family:inherit;font-size:10pt;">The Company assumed contingent consideration incurred by Derma Sciences, Inc. ("Derma Sciences") related to its acquisitions of BioD and the intellectual property related to Medihoney products. The Company accounted for the contingent liabilities by recording their fair value on the date of the acquisition based on a probability weighted income approach. The Company has already paid </span><span style="font-family:inherit;font-size:10pt;"><span>$33.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> related to the aforementioned contingent liabilities. </span><span style="font-family:inherit;font-size:10pt;"><span>One</span></span><span style="font-family:inherit;font-size:10pt;"> contingent liability remains which relates to net sales of Medihoney products exceeding certain amounts defined in the agreement between the Company and Derma Sciences. The potential maximum undiscounted payment amounts to </span><span style="font-family:inherit;font-size:10pt;"><span>$3.0 million</span></span><span style="font-family:inherit;font-size:10pt;">. The estimated fair value as of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">March 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> was </span><span style="font-family:inherit;font-size:10pt;"><span>$0.2 million</span></span>. <div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the </span><span style="font-family:inherit;font-size:10pt;">three months ended March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">March 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> is as follows (in thousands):</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:39%;"/><td style="width:1%;"/><td style="width:20%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:17%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2020</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Contingent Consideration Liability Related to Acquisition of Arkis (See Note 2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Contingent Consideration</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> Liability Related to Acquisition of Derma Sciences</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Location in Financial Statements</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Long-term</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Long-term</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance as of January 1, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14,210</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>230</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Loss from change in fair value of contingent consideration liabilities </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,051</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Research and development</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance as of March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13,159</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>230</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:32%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:27%;"/><td style="width:1%;"/><td style="width:37%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Contingent Consideration</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> Liability Related to Acquisition of Derma Sciences</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Location in Financial Statements</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Long-term</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance as of January 1, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>230</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Payments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Loss from change in fair value of contingent consideration liabilities </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Research and development</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance as of March 31, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>230</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 14210000 230000 0 0 1051000 0 13159000 230000 230000 0 0 230000 33300000 1 3000000.0 200000 2428000 13149000 3236000 -7933000 0.198 -0.320 XML 85 R29.htm IDEA: XBRL DOCUMENT v3.20.1
DERIVATIVE INSTRUMENTS (Tables)
 3 Months Ended
Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments
The Company held the following interest rate swaps as of March 31, 2020 (dollar amounts in thousands):
Hedged Item
 
Current Notional Amount
 
Designation Date
 
Effective Date
 
Termination Date
 
Fixed Interest Rate
 
Estimated Fair Value
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
3-month USD LIBOR Loan
 
50,000

 
February 6, 2017
 
June 30, 2017
 
June 30, 2020
 
1.834
%
 
$
(48
)
1-month USD LIBOR Loan
 
100,000

 
February 6, 2017
 
June 30, 2017
 
June 30, 2020
 
1.652
%
 
(233
)
1-month USD LIBOR Loan
 
100,000

 
March 27, 2017
 
December 31, 2017
 
June 30, 2021
 
1.971
%
 
(2,024
)
1-month USD LIBOR Loan
 
150,000

 
December 13, 2017
 
January 1, 2018
 
December 31, 2022
 
2.201
%
 
(7,467
)
1-month USD LIBOR Loan
 
150,000

 
December 13, 2017
 
January 1, 2018
 
December 31, 2022
 
2.201
%
 
(7,388
)
1-month USD LIBOR Loan
 
100,000

 
December 13, 2017
 
July 1, 2019
 
June 30, 2024
 
2.423
%
 
(8,475
)
1-month USD LIBOR Loan
 
50,000

 
December 13, 2017
 
July 1, 2019
 
June 30, 2024
 
2.423
%
 
(3,994
)
1-month USD LIBOR Loan
 
200,000

 
December 13, 2017
 
January 1, 2018
 
December 31, 2024
 
2.313
%
 
(16,279
)
1-month USD LIBOR Loan
 
75,000

 
October 10, 2018
 
July 1, 2020
 
June 30, 2025
 
3.220
%
 
(10,186
)
1-month USD LIBOR Loan
 
75,000

 
October 10, 2018
 
July 1, 2020
 
June 30, 2025
 
3.199
%
 
(10,165
)
1-month USD LIBOR Loan
 
75,000

 
October 10, 2018
 
July 1, 2020
 
June 30, 2025
 
3.209
%
 
(10,185
)
1-month USD LIBOR Loan
 
100,000

 
December 18, 2018
 
December 30, 2022
 
December 31, 2027
 
2.885
%
 
(9,453
)
1-month USD LIBOR Loan
 
100,000

 
December 18, 2018
 
December 30, 2022
 
December 31, 2027
 
2.867
%
 
(9,855
)
Total interest rate derivatives designated as cash flow hedge
 
$
1,325,000

 
 
 
 
 
 
 
 
 
$
(95,752
)

The Company held the following interest rate swaps as of December 31, 2019 (dollar amounts in thousands):
Hedged Item
 
Current Notional Amount
 
Designation Date
 
Effective Date
 
Termination Date
 
Fixed Interest Rate
 
Estimated Fair Value
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
3-month USD LIBOR
 
50,000

 
February 6, 2017
 
June 30, 2017
 
June 30, 2020
 
1.834
%
 
(2
)
1-month USD LIBOR
 
100,000

 
February 6, 2017
 
June 30, 2017
 
June 30, 2020
 
1.652
%
 
12

1-month USD LIBOR
 
100,000

 
March 27, 2017
 
December 31, 2017
 
June 30, 2021
 
1.971
%
 
(581
)
1-month USD LIBOR
 
150,000

 
December 13, 2017
 
January 1, 2018
 
December 31, 2022
 
2.201
%
 
(2,880
)
1-month USD LIBOR
 
150,000

 
December 13, 2017
 
January 1, 2018
 
December 31, 2022
 
2.201
%
 
(2,880
)
1-month USD LIBOR
 
100,000

 
December 13, 2017
 
July 1, 2019
 
June 30, 2024
 
2.423
%
 
(3,517
)
1-month USD LIBOR
 
50,000

 
December 13, 2017
 
July 1, 2019
 
June 30, 2024
 
2.423
%
 
(1,778
)
1-month USD LIBOR
 
200,000

 
December 13, 2017
 
January 1, 2018
 
December 31, 2024
 
2.313
%
 
(6,595
)
1-month USD LIBOR
 
75,000

 
October 10, 2018
 
July 1, 2020
 
June 30, 2025
 
3.220
%
 
(5,750
)
1-month USD LIBOR
 
75,000

 
October 10, 2018
 
July 1, 2020
 
June 30, 2025
 
3.199
%
 
(5,747
)
1-month USD LIBOR
 
75,000

 
October 10, 2018
 
July 1, 2020
 
June 30, 2025
 
3.209
%
 
(5,807
)
1-month USD LIBOR
 
100,000

 
December 18, 2018
 
December 30, 2022
 
December 31, 2027
 
2.885
%
 
(4,930
)
1-month USD LIBOR
 
100,000

 
December 18, 2018
 
December 30, 2022
 
December 31, 2027
 
2.867
%
 
(4,691
)
Total interest rate derivatives designated as cash flow hedge
 
$
1,325,000

 
 
 
 
 
 
 
 
 
(45,145
)

The Company held the following cross-currency rate swaps as of December 31, 2019 (dollar amounts in thousands):
 
 
 
 
 
 
 
 
 
 
 
December 31, 2019
 
 
Effective Date
 
Termination Date
 
Fixed Rate
 
Aggregate Notional Amount
 
Fair Value
Asset (Liability)
 
 
 
 
 
 
 
 
 
 
 
Pay CHF
 
October 2, 2017
 
October 2, 2020
 
1.75%
 
CHF
32,355

 
$
(101
)
Receive U.S.$
 
 
4.38%
 
$
33,333

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay CHF
 
October 2, 2017
 
October 2, 2021
 
1.85%
 
CHF
48,533

 
(119
)
Receive U.S.$
 
 
4.46%
 
$
50,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay CHF
 
October 2, 2017
 
October 2, 2022
 
1.95%
 
CHF
145,598

 
(289
)
Receive U.S.$
 
 
4.52%
 
$
150,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Total
 
 
 
 
 
 
 
 
 
 
$
(509
)

The Company held the following cross-currency rate swaps designated as net investment hedges as of March 31, 2020 and December 31, 2019, respectively (dollar amounts in thousands):
 
 
 
 
 
 
 
 
 
 
 
March 31, 2020
 
 
Effective Date
 
Termination Date
 
Fixed Rate
 
Aggregate Notional Amount
 
Fair Value
Asset (Liability)
 
 
 
 
 
 
 
 
 
 
 
Pay EUR
 
October 3, 2018
 
September 30, 2021
 
—%
 
EUR
44,859

 
$
4,082

Receive U.S.$
 
 
 
3.01%
 
$
52,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay EUR
 
October 3, 2018
 
September 30, 2023
 
—%
 
EUR
51,760

 
6,298

Receive U.S.$
 
 
 
2.57%
 
$
60,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay EUR
 
October 3, 2018
 
September 30, 2025
 
—%
 
EUR
38,820

 
5,174

Receive U.S.$
 
 
 
2.19%
 
$
45,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay GBP
 
October 3, 2018
 
September 30, 2025
 
1.67%
 
GBP
128,284

 
16,773

Receive U.S.$
 
 
 
2.71%
 
$
167,500

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay CHF
 
October 3, 2018
 
September 30, 2025
 
—%
 
CHF
165,172

 
(6,965
)
Receive GBP
 
 
 
1.67%
 
GBP
128,284

 
 
 
 
 
 
 
 
 
 
 
 
 
Total
 
 
 
 
 
 
 
 
 
 
$
25,362



 
 
 
 
 
 
 
 
 
 
 
December 31, 2019
 
 
Effective Date
 
Termination Date
 
Fixed Rate
 
Aggregate Notional Amount
 
Fair Value
Asset (Liability)
 
 
 
 
 
 
 
 
 
 
 
Pay EUR
 
October 3, 2018
 
September 30, 2021
 
—%
 
EUR
44,859

 
$
2,459

Receive U.S.$
 
 
 
3.01%
 
$
52,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay EUR
 
October 3, 2018
 
September 30, 2023
 
—%
 
EUR
51,760

 
3,087

Receive U.S.$
 
 
 
2.57%
 
$
60,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay EUR
 
October 3, 2018
 
September 30, 2025
 
—%
 
EUR
38,820

 
2,032

Receive U.S.$
 
 
 
2.19%
 
$
45,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay GBP
 
October 3, 2018
 
September 30, 2025
 
1.67%
 
GBP
128,284

 
(154
)
Receive U.S.$
 
 
 
2.71%
 
$
167,500

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay CHF
 
October 3, 2018
 
September 30, 2025
 
—%
 
CHF
165,172

 
1,221

Receive GBP
 
 
 
1.67%
 
GBP
128,284

 
 
 
 
 
 
 
 
 
 
 
 
 
Total
 
 
 
 
 
 
 
 
 
 
$
8,645


The Company held the following cross-currency rate swaps as of March 31, 2020 (dollar amounts in thousands):
 
 
 
 
 
 
 
 
 
 
 
March 31, 2020
 
 
Effective Date
 
Termination Date
 
Fixed Rate
 
Aggregate Notional Amount
 
Fair Value
Asset (Liability)
 
 
 
 
 
 
 
 
 
 
 
Pay CHF
 
October 2, 2017
 
October 2, 2020
 
1.75%
 
CHF
32,355

 
$
(74
)
Receive U.S.$
 
 
4.38%
 
$
33,333

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay CHF
 
October 2, 2017
 
October 2, 2021
 
1.85%
 
CHF
48,533

 
531

Receive U.S.$
 
 
4.46%
 
$
50,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Pay CHF
 
October 2, 2017
 
October 2, 2022
 
1.95%
 
CHF
145,597

 
3,416

Receive U.S.$
 
 
4.52%
 
$
150,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Total
 
 
 
 
 
 
 
 
 
 
$
3,874
Schedule of Fair Value and Presentation of Derivatives
The following table summarizes the fair value for derivatives designated as hedging instruments in the condensed consolidated balance sheets as of March 31, 2020 and December 31, 2019:
 
 
Fair Value as of
Location on Balance Sheet (1):
 
March 31, 2020
 
December 31, 2019
 
 
(In thousands)
Derivatives designated as hedges — Assets:
 
 
 
 
Prepaid expenses and other current assets
 
 
 
 
Cash Flow Hedges
 
 
 
 
Interest rate swap(2)
 
$
—

 
$
12

Cross-currency swap
 
5,065

 
5,032

Net Investment Hedges
 
 
 
 
Cross-currency swap
 
8,164

 
7,952

Other assets
 
 
 
 
Cash Flow Hedges
 
 
 
 
Interest rate swap(2)
 
—

 
—

Cross-currency swap
 
—

 
—

Net Investment Hedges
 
 
 
 
Cross-currency swap
 
26,307

 
3,465

Total derivatives designated as hedges — Assets
 
$
39,536

 
$
16,461

 
 
 
 
 
Derivatives designated as hedges — Liabilities:
 
 
 
 
Accrued expenses and other current liabilities
 
 
 
 
Cash Flow Hedges
 
 
 
 
Interest rate swap(2)
 
$
19,793

 
$
6,635

Cross-currency swap
 
74

 
101

Other liabilities
 
 
 
 
Cash Flow Hedges
 
 
 
 
Interest rate swap(2)
 
75,959

 
38,522

Cross-currency swap
 
1,117

 
5,440

Net Investment Hedges
 
 
 
 
Cross-currency swap
 
9,109

 
2,772

Total derivatives designated as hedges — Liabilities
 
$
106,052

 
$
53,470

 
(1) 
The Company classifies derivative assets and liabilities as non-current based on the cash flows expected to be incurred within the following 12 months.
(2) 
At March 31, 2020 and December 31, 2019, the notional amount related to the Company’s interest rate swaps were $1.3 billion and $1.3 billion, respectively.
Effect of Derivative Instruments Designated as Cash Flow Hedges on Statements of Operations
The following presents the effect of derivative instruments designated as cash flow hedges on the accompanying condensed consolidated statement of operations during the three months ended March 31, 2020 and 2019:
 
Balance in AOCL
Beginning of
Quarter
 
Amount of
Gain (Loss)
Recognized in
AOCL
 
Amount of Gain (Loss)
Reclassified from
AOCL into
Earnings
 
Balance in AOCL
End of Quarter
 
Location in
Statements of
Operations
 
(In thousands)
Three Months Ended March 31, 2020
 
 
 
 
 
 
 
 
 
Cash Flow Hedges
 
 
 
 
 
 
 
 
 
Interest rate swap
$
(45,145
)
 
$
(51,651
)
 
$
(1,043
)
 
$
(95,753
)
 
Interest expense
Cross-currency swap
177

 
5,907

 
(182
)
 
6,266

 
Other income (expense), net
Net Investment Hedges
 
 
 
 
 
 
 
 
 
Cross-currency swap
10,229

 
18,897

 
2,180

 
26,946

 
Interest income
 
$
(34,739
)
 
$
(26,847
)
 
$
955

 
$
(62,541
)
 
 
Three Months Ended March 31, 2019
 
 
 
 
 
 
 
 
 
Cash Flow Hedges
 
 
 
 
 
 
 
 
 
Interest rate swap
$
619

 
$
(15,891
)
 
$
1,406

 
$
(16,678
)
 
Interest expense
Cross-currency swap
(6,190
)
 
7,473

 
5,178

 
(3,895
)
 
Other income (expense), net
Net Investment Hedges
 
 
 
 
 
 
 
 
 
Cross-currency swap
(632
)
 
10,221

 
2,327

 
7,262

 
Interest income
 
$
(6,203
)
 
$
1,803

 
$
8,911

 
$
(13,311
)
 
 
XML 86 R21.htm IDEA: XBRL DOCUMENT v3.20.1
SEGMENT AND GEOGRAPHIC INFORMATION
 3 Months Ended
Mar. 31, 2020
Segment Reporting [Abstract]  
SEGMENT AND GEOGRAPHIC INFORMATION SEGMENT AND GEOGRAPHIC INFORMATION
The Company internally manages two global reportable segments and reports the results of its businesses to its chief operating decision maker. The two reportable segments and their activities are described below.
•
The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the instruments business, which sells more than 40,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.
•
The Orthopedics and Tissue Technologies segment includes such offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair products.
The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs.
The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by each reportable segment for the three months ended March 31, 2020 and 2019 are as follows:
 
Three Months Ended March 31,
 
2020
 
2019
 
(In thousands)
Segment Net Sales
 
 
 
Codman Specialty Surgical
$
231,440

 
$
234,568

Orthopedics and Tissue Technologies
122,884

 
125,122

Total revenues
$
354,324

 
$
359,690

Segment Profit
 
 
 
Codman Specialty Surgical
$
87,235

 
$
91,380

Orthopedics and Tissue Technologies
31,271

 
40,495

Segment profit
118,506

 
131,875

Amortization
(6,977
)
 
(5,279)

Corporate and other
(84,426
)
 
(94,288
)
Operating income
$
27,103

 
$
32,308


The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment.
The Company attributes revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following:
 
Three Months Ended March 31,
 
2020
 
2019
 
(In thousands)
United States
$
246,852

 
$
256,726

Europe
45,896

 
48,640

Asia Pacific
39,960

 
35,700

Rest of World
21,616

 
18,624

Total Revenues
$
354,324

 
$
359,690
XML 87 R25.htm IDEA: XBRL DOCUMENT v3.20.1
REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)
 3 Months Ended
Mar. 31, 2020
Revenue from Contract with Customer [Abstract]  
Schedule of Changes in Contract Assets and Contract Liabilities
The following table summarizes the changes in the contract asset and liability balances for the three months ended March 31, 2020:
Contract Asset
 
Contract asset, January 1, 2020
$
8,680

Transferred to trade receivable of contract asset included
     in beginning of the year contract asset
(8,680
)
Contract asset, net of transferred to trade receivables on contracts during the period
7,944

Contract asset, March 31, 2020
$
7,944

 
 
Contract Liability
 
Contract liability, January 1, 2020
$
11,946

Recognition of revenue included in beginning of year contract liability
(1,291
)
Contract liability, net of revenue recognized on contracts during the period
1,691

Foreign currency translation
(147
)
Contract liability, March 31, 2020
$
12,199
Schedule of Disaggregation of Revenue
The following table presents revenues disaggregated by the major sources of revenues for the three months ended March 31, 2020 and 2019 (amounts in thousands):
 
Three Months Ended March 31, 2020
Three Months Ended March 31, 2019
 
(amounts in thousands)
Neurosurgery
$
184,943

$
179,520

Instruments
46,497

55,048

Total Codman Specialty Surgical
231,440

234,568

 
 
 
Wound Reconstruction and Care
72,267

74,963

Extremity Orthopedics
21,472

22,685

Private Label
29,145

27,474

Total Orthopedics and Tissue Technologies
122,884

125,122

Total revenue
$
354,324

$
359,690
XML 88 R6.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDER'S EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Balance Beginning of Period, Shares (in shares) at Dec. 31, 2018   88,044,000        
Balance, Beginning of Period at Dec. 31, 2018 $ 1,375,796 $ 880 $ (120,615) $ 1,192,601 $ (45,443) $ 348,373
Balance, Beginning of Period, Treasury Stock, Shares (in shares) at Dec. 31, 2018     (2,881,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 32,756         32,756
Other comprehensive loss, net of tax (11,236)       (11,236)  
Issuance of common stock through employee stock purchase plan (in shares)   17,000        
Issuance of common stock through employee stock purchase plan 716     716    
Issuance of common stock for vesting of share based awards, net of shares withheld for taxes (in shares)   243,000 12,000      
Issuance of common stock for vesting of share based awards, net of shares withheld for taxes (5,121) $ 2 $ 506 (5,629)    
Share-based compensation 4,119     4,119    
Balance End of Period, Shares (in shares) at Mar. 31, 2019   88,304,000        
Balance, End of Period at Mar. 31, 2019 1,397,030 $ 882 $ (120,109) 1,191,807 (56,679) 381,129
Balance, End of Period, Treasury Stock, Shares (in shares) at Mar. 31, 2019     (2,869,000)      
Balance Beginning of Period, Shares (in shares) at Dec. 31, 2019   88,735,000        
Balance, Beginning of Period at Dec. 31, 2019 $ 1,416,736 $ 887 $ (119,943) 1,213,620 (76,401) 398,573
Balance, Beginning of Period, Treasury Stock, Shares (in shares) at Dec. 31, 2019 (2,865,000)   (2,865,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 9,180         9,180
Other comprehensive loss, net of tax (28,187)       (28,187)  
Issuance of common stock through employee stock purchase plan (in shares)   13,000        
Issuance of common stock through employee stock purchase plan 694     694    
Issuance of common stock for vesting of share based awards, net of shares withheld for taxes (in shares)   357,000 10,000      
Issuance of common stock for vesting of share based awards, net of shares withheld for taxes (2,739) $ 2 $ 476 (3,217)    
Share-based compensation 3,781     3,781    
Share repurchase and equity component of the convertible note issuance, net (in shares)     (135,000)      
Share repurchase and equity component of the convertible note issuance, net $ 34,906   $ (7,632) 42,538    
Accelerated shares repurchased (in shares) (1,400,000)   (1,304,000)      
Accelerated shares repurchased $ (92,368)   $ (75,407) (16,961)    
Balance End of Period, Shares (in shares) at Mar. 31, 2020   89,105,000        
Balance, End of Period at Mar. 31, 2020 $ 1,341,803 $ 889 $ (202,506) $ 1,240,455 $ (104,588) $ 407,553
Balance, End of Period, Treasury Stock, Shares (in shares) at Mar. 31, 2020 (4,294,000)   (4,294,000)      
XML 89 R44.htm IDEA: XBRL DOCUMENT v3.20.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in Carrying Amount of Goodwill (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2020
USD ($)
Goodwill [Roll Forward]  
Beginning of Period $ 954,280
Foreign currency translation (2,726)
End of Period 951,554
Codman Specialty Surgical  
Goodwill [Roll Forward]  
Beginning of Period 653,500
Foreign currency translation (1,867)
End of Period 651,633
Orthopedics and Tissue Technologies  
Goodwill [Roll Forward]  
Beginning of Period 300,780
Foreign currency translation (859)
End of Period $ 299,921
XML 90 R2.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME / (LOSS) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Total revenue, net $ 354,324 $ 359,690
Costs and expenses:    
Cost of goods sold 133,476 128,912
Research and development 20,816 18,321
Selling, general and administrative 165,952 174,870
Intangible asset amortization 6,977 5,279
Total costs and expenses 327,221 327,382
Operating income 27,103 32,308
Interest income 2,570 2,428
Interest expense (17,752) (13,149)
Other income(expense), net (479) 3,236
Income before income taxes 11,442 24,823
Provision (benefit) for income taxes 2,262 (7,933)
Net income $ 9,180 $ 32,756
Net income per share    
Basic (in dollars per share) $ 0.11 $ 0.38
Diluted (in dollars per share) $ 0.11 $ 0.38
Weighted average common shares outstanding (See Note 13):    
Basic (in shares) 85,188 85,343
Diluted (in shares) 85,892 86,258
Comprehensive income (loss) (See Note 14) $ (19,007) $ 21,520
XML 91 R40.htm IDEA: XBRL DOCUMENT v3.20.1
REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative, Revenue Remaining Performance Obligation (Details) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-04-01
Mar. 31, 2020
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected performance obligation through 2020, percentage 40.00%
Performance obligations expected to be satisfied, expected timing 9 months
XML 92 R48.htm IDEA: XBRL DOCUMENT v3.20.1
DEBT - Maximum Total Leverage Ratio Table (Details) - Senior Credit Facility
Feb. 03, 2020
First fiscal quarter ending after the Closing Date through June 30, 2022  
Debt Instrument [Line Items]  
Maximum Consolidated Total Leverage Ratio 5.00
September 30, 2022 through June 30, 2023  
Debt Instrument [Line Items]  
Maximum Consolidated Total Leverage Ratio 4.50
September 30, 2023 and the last day of each fiscal quarter thereafter  
Debt Instrument [Line Items]  
Maximum Consolidated Total Leverage Ratio 4.00
ZIP 93 0000917520-20-000020-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000917520-20-000020-xbrl.zip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`]H^?T-1]C=KJ%(/U9("&4Y@1D!PI&]@A4 M/SR7Q!ZLIG&IA#32&.62/=_QU4*S*K1%1.]AWA3GAPMW"!ZX\T4W1UMY%WMR M8]=;W=#<5ZD M)>K 'CTNV?^E>H2_XW7KA>, MC[ZP?M_OZ)V5.A-5^KT.0U"N09&RVT'/*]\?.,/.)NHC/>$#97+,$48<$,'S M?5],C(;:/G3TF5T] ZT#4*HO!6#%E[8V6""VDT#C#!8H<-D6O8; MHDF/,'1[W)EJ,$J8#&_ !]X*#!4Q)O7YHR33AW,B'<2.='.E%6Y('7JN]FEQ MV>_-3I)*'):,&,/50_TM58M^2';**K2$Z>KYF7;ERE_RIOE<:;XCH/KRIJ D MQX&$IQH/M1R^6NXFB=?KLC>737AC'=2CRZDY[N[NY=5IC$!02Z9C3Y$[# ]XQU[&"!WG@#+,LO]>=!>$UIOE\Q?$@-JFOV?/GQE!1; M],&BZ1\R2^D%F,>QIT8N/FA_Y*\=G39C42;N>XA;TP5?Z%R'$_!M11]T;Q6\ MV;7NG#>GDM@8OS='\D4O)2XHJ'DYZ-UMO]!0WIJ,6JK(%].X!:[ X+=XQ>!L M?)WL3>G56_.W%$I'9%\"VI#)BZ?^G$4<,V8L[Q[8W'-ZC30&2QX(N4VC5:BGR)X7%&F2==?/VF0WD?&*_^ ML>(A1DN=+\M R_-Q#')TVP:"O*)T;=OGH11KZOI=FCZ*D[0<7CBDD_V KN%( M>4F<>KA\8+CE^04A6G7B0B4V%C<6@5X)CPA 4KC@6PH+3XEX@5M!+,*)Z_*37SZNKD()4",L M.YG^L[0PY]IO?QS>56T.I!OO&>T#,\P6YP!<8H./-E(6_2O3>:J>\B<>XV!N MTH3?P6_ G)Z-IXHU^!B7AV3T6^O8^TJF5AW:UBBEGWBO&="IJH%8@]" MO/23F KU-0$3^&,@/0BFD3S+D=5*4843N7Y3E?.0=@L_MIB6,/.TLJ]&G2L/ M1T8N3M!DJ5K289)NV)?ET2F9"PY9IE5+F Q+Q[BY8^7^]T/:D0KO-O6.#'=D M'B$V.%E2?9O&-Q:+4<#ZY6MZ?IBQ"^)WWND$W< MY>OB E$:;Z06;$]C$28M. +-[LU++C?3B#2 M'G,'?/T;_$#)9?KGR*.EQ-%;A:0!2(=T>DC9DC3T?J"H>&A MYOP&V(-SN>&I 8;[CO@]YT+%T^3I6M5=3#D'=1$R.O"TK#M>&#\\)UR=7Q[D M=2QI"!$P:2I9H-GP]LQW@WN\9[V4RBY.3U>P0-3C6A\4\(M6!#,OH22U4V;$ MZ/Y1'*)W,]JTK-,4?1W#V:- M((0FXQK505=A@=XM,Y[+PBFW&G%?6D_2+\\ 5M7__5_=S_3?=6W&,#FXY5B@ MW9-4(!.Z'QQWNFP*8IV88'ZL$3GY%S7J+%'] >NAV^H M*&6*N+:==1Z9^][3+B[W8K+O5-E$5C;L[OYZ< Z4,HG#PQ.]!>FJN/$-QKXG M+!"#FL(4Q9.]F2_4T$RZ"85M:[T6OW;V ^"-K%B@;V+:>5ET[)(:HD9,@H0C MB@/#KY*6ZTKISH2(W=3V&K%3E3U)^'I!O%5!#S$W.0C6\/;YQ^MG)YPW=+"/ M.N".$7OI1ZD^X^# +:5Z:8Z6B%UTMFXZU'ICTO[-*BG= MP2N? @O34J>7I;Q'\Z%D>T\?;\6A/1O/(H!40XCPUK MI_-6C)-8H%@P$O"?$,83.&&$!1+$S?[6QP(M-[% EF4.UN892>Q[&/MB?+4H@^H M6_'C4B]SL"A)NW2DPI#=3JG7DQ6O+S<4SXZ('^2N0*2AA!@E)YF*](5^(!G^ MT[ 15 _T3R!9(!H9>:,NMIW=FD_J2I*-EKZC(B/M1([X(6DM&G)'CNK#[Y>WNG*M>>HOSP53P'_;BSZ"*A71R%5A\@6P'-C=KX"C M[.MHBO"T5+TO#R!Z7MQ3"$U]=Z4$ 'N_-( M6EDD/.4@%9WL\-AH;O CYO;=TN+8AV2E=S.[??9A/SC0GXZ?>IWD&)P@VI6I MB$%[86Z"_??P&5B>O?BO_S+_^S;K%LRO/U1C,Q;^](KT-;9N]Z]TFRXG!01' MC6A191^W;%1PO?]7$4@".".WO!0:MM4P&LF(I9AEQ3O+M8Y,73%ZK'CWO/K, M:F[H,:?"!]:6S=PSNUB@?;Y8@!U5 6MT!^9G(22X"0OTWA)8ZD_;MRL,WU=EZ5U5(W MP.,*J&"[=+M!A42@:X3.WK[U[^>(^,O+P65$NQW\& MQ)47G?EYF\FTA-PJVGG)T9QLAW(;_P=K6"'[8C#@D]A!/Z)U>PPKC%!/3[\Y M]BK=ZB'WC_.?6* "_&*7!TV-+D":\3O]8-VA7YY#H43)\&:Y6G>LC$2:5XW- M_0?W)L[GMC!Y19',YW$1S-TX:@?07SB@M8MZ@-9V(NEV*]U5:QR-O=W_=2VD MT_!'O9.L_O^:PU_4\&1#!WP;=+8_TR'UL MPJ9M"#\"$#Z#,N5]-[ZJM9_Y>V AV\!"MX&U^7GDR9^ );W;%I /$% 22%8B M1C?9RJ;_3NK_' 8=-/R1#5C=GZ3^.\7_(O7?*=Y[4FSFW=]+_6=8?Y7Z5UB7 M47[#J^ _"?T+KO^!S=LREE_]+S/8?YO#O\WAW^;P;W/XMSG\GV4.1[O5(?8J M:5D:ZA$9.B+N>X'VM7GMB]M; F.=E@%A('3IY'\FC8P1@*E<(@L4X!G(]*_ MT7=O:T5H'+(EL 30BH- G^70?ZS3-/LD0*<)RW2Y>OB:#)"^C(G_%+[] #!( MB0>@H0@F?\<_LRR!3 "2V#86J ZFP0+]-H)G[OP)+"<9S.#P0%/W;?].*/B/ MM?(_%>(H(W',>3/ZK[. _^-9)/? #R5:VBPW^#3YML'QVV_J&= @]6"Z2$Q M_\GQ7_6CX-UN+=8!HN+7+O>]%VAG\BO]IY>H'?-_F6U7N1+\$P;1SQ:3DTX> MC4*U?CL6915[:(7+"_*W$\*:4ZV\%#^,>9^TB=9)*YV9776N4.3?R*1\,>;UG_W/*XZ!7N*D<,"W1N1HN!(^O[)\X/+02@E M8(50*IS'1509>Z=DL+?+GDE>;K[\E;9O57?OKJ-1EV'7V#[U)=#1+- [!*.8 M!1ITGT22%H%D3)N7!DR<\!B^*5;D!N1^+4RA+JWP=B9O>Y 8C-D9IU,)I,L+ MR$'76\3K(L<<@XH0AF<>.6!WT3WI+) X)X+4/W\BN?K%2H0HH]A7U3-PC*U. MC^,:J=FV-7/!]WA7X8&MM.R8,Q=B##<=I6(.?Y;C'WM6>;\4"O;%>\#!6)C' M1^I6C4(+9B\UN:7N&I*JBW 1RU08-INXZ'AZY=SE4$65($RTY9XG:.)=FKR9 M;P\2O(8%6^)KK&VL+,IQU94^XF3P[V+_F\=7_&D)CP%CZB=PC8@!D0N MD"/J6" NJG/=-3NQ?9UTU7$SZ,&TXMC4)M'*'&?HNXZ7*6<_Q:@A$]QK>(:##\S? M2LI,]J*HS/D;GB=BAI UR3OIQ W0T_6/=AG W,@28SK4AAGA= M$D\5*=#/W2$+,'=1K)_[B)*AKH%[>G-JD$QWSF##3.G@W8?+W')5,<%+* >: MFZ?#ER=+68X>'SP_F8$Y=:T=Q_4,]SE:MM>YCCB>;7B((HOG!_XV/7+\!N>Y MGCI;.$DOA1#ASP+U#Z*#W>)E#/N:##R7$7'XNCMD-UK(2$3!+B@9_1@;;.%%E/O&(=/M"+Y^/^A^GI&RYRWYXEOCN2$#$83W&M9'R01[ WI"WT)AW&D0)?YJ T'!3:WO61 MKE (E'IR]H_$U+QOW&"Q33$O,I["UAX!^ _5;?Y/8HV6_H!!!/0'VF^C( M@1;*2-KS?3>5L%=*2EEL97)1A#J"JY]A8:F\.6 M9&^L%Z']I7&YQ7K$TS'2X8\+=2E6O#^A:?E\W)-<0U:OJKW0D%*JR3OT[N-FPMG= ;L? M*D[64K[B1A+3Z[ 1<8'UT*%S&Y>ZUMVJ2)I-3[-1FNF77AT!G]Z0K7[HDXR( M.X,[>5[L:5^928PG+\4AH@8"D2#7*U$.7F+R%9)JYQ15; 8<<^IY"I/NF;XN M/CI2J!GQ=L>J\+KP*$:A:N*DV7OC\" 6Z$CK769E'PMTY6CV?$<'?%(H&]T7 MQP+-79*?*1G9?.$AEY$MUO/U,9W2L"_,#,^ I3/ +O/@\]?4$ MG&\VNN2)8B*:D&.YH._@$&\G.A4N%*?P]LRKG?NN(0[SKBGTHVM[>W"S4H1V M^G9=R0B3Z<#P]2PLEV^7NG)%?BQQZ1A9]GWSK L+!#UG\FD64L@UG7;GH\G0 M&W&\B<+$R.*<03[>?P:#VF9N4./!6K*U&[0,V,^]Q4% M(M-)')6(NJ^N9 '>M$>K@!L7DM&]F+;TA2C<.[1)>C_M/,JHA\T"49?>?[,5 M:&J')CC8(]<._H"3>)!,5:0"7;9"'48R>4F_F.'I1Q/4(PV4\)8,W)H:_DX3 MW'_(H]&>!7J)8I\P@_#."]PRAP]%&Y\9' G[C)?T]ICJ6,3G-2A=QD*7^5R%C;D3")1-VZ\S966B?VA? .3500/R-HP_&T>" M/>WQ)KK>A?=J8)D@9N"3^ZZU;:",9S +)XM&V;9;PMULBYQN#9_/-!JU_F1:(D$QUWB MG7DP>^8YJD=:DW?VG(>B$A;?QE=G8X4E&1\]:^[>+3.P B,%&T,IV>.Z_B42L*;6C:Q$ M_,:]KSS'K&*O3VE13K$?&L\CKL&%^HMC7#[->12KW/_@[K"K[2;'!2EQJWO? M[GU5%GF:\E>UO:1F?9I)U*[#^R?@Z(\3MX,\4 MU9&LB_QQI#S:T\U[TY%'YVQ9[5GS!)>^,.!X.4)09:FIB:V-!MHC&";M?8[(6$,,_:JXQ$WM*4 M:^(EB^]J 5]1+S/;])M?HT$>H/8Q/B93Z\AL];>$%1)K9QT.FF79#BHD5!/[ M.5N_#/6I+?1)$[#4XR(SX[@0;8;J$ NTN+XAXVVJT^SV-JULQOB*G-T>/@.+ MXQ?_U6H+_]6GYS^?H/]"KV9[9N 0%FB:EP5RQ%$2W1!]Z9YP3.^]T>*\C/?>B2 MT&=MR<8"[5'JFJY@A,)NN @7-*6VW,T5+1L:@GVU& MUC=Q5T!_1*0["4)82Y(D"];A!%M23>T^VPM'46*]TEH<[W]/<9.>&:F!A68_ MIN?1Z\/>1P;7%C+*QC'C4Q]#X &8JZ2U@IJ[KIE(_$OL:2?K+A'#^NAD1362CG6L@X\\O_ITLA_3:$Y7KD3HTR&%\H6.0/A: YVT2HM M!5PA0>D]FUTO%KNG%N.N8)!0-;3.JVLT>^6O/[;^$JL4$G\I%9+L[8./-1AN M2PX^]>V7\W[_E$*K!&E/]:-+S6^@&O, \CU3<8'&!EX] CX3$H^]+*0L!0I^ C/))"9V$ MIHWUM;;YZ]M\6&A,539.3]IL9TQL=LS -R)F+ &"Q[F1A6X'K+&:"VAPJX1. MCF0RXB*LC#Y;=HJVHI]A1 N7_7%[83YIPX,#\RH?RQ]PA141/Y061S;'>\<( M@:R\Q-95F)V&GED$P08."]\M+]C%"9&9G]:JFJ29\)B,&(FC?4D-I!X\HM_R:_ M&9):>B#JHO %'=V7AYO#LWJ*RY_N6R2:^(HQNZO9>NC.'N.(@Y=E%!3))[J- MB+=0,;6J$OO$PT&IIYUV3DCEB45-P/^"0223*H^N4YO'K]8B:&,=BZ?0TF [ M[IGT!7AANW^1C!*B/'S=T#CO8[#8]/#?A+U47?*CDSD/,21VN-*Z+1OVW.[ MSD@J,H;5'6&!BN\#4&Z:>E_V4%I#"WKJ-N *%$,(CD;U^;9/:MZX3#G$Y/7Z#J8/7*U#4%;ZPZCP>;OIAJB\<4I_=>9QF*=HNVWJ>DT M7:H$M6 <$B*OYV#4ZTRW236;$]A2ZXELX*_N*UF5]("?W'%;\L*,K#TB&%[4 MYC^>Z'&C5S[,Z')>,5F-&#::EHZ^?5F!Z[/>X8^*9=^T3C3W'WFT5[4O#,#2 M'K/:C*!1[,"+ZY_0[4+PY0%@X$5@W._8B%&E0JH?N:3AUG2L!#9]?C!UP_C[ MO$&HTV2N]ET_\X@$%F@4GOCD .C 3+TQC WI!4FQP3IB>.09/WWI_H-ZA1 M-I,$6+PGT]V^=_F[17H&PZ$,4C#]"3X5BME8[ "LEI9EP[BZ_??BJ@Z7[(G\_@PIY_Y?+6KD5N2E$@E"X62$O!L^K7SUZ; M,:28S+X75*:VCB:?2<"37RH%6;J262"F%9P"A#J[OA2#6S^R%J?3[YS22(*E MM[F9=+PU26%D,O!-S!W?UN%R,RK2L\TGF-W,Y0D@&*NG3Z-F;JSKR0Z9=\F> MQCJ.5194A'U(8I_@T3QWID[ZY%?K(Z\NCODAKQAH4](WT!#J#J"+Z1P1K0+2 M4J2C5?K@D&G_P*4\LR&S^L^:N^W/9+Q\O^<:"+3CZ9Z;V)03*30C&BZ"#MK" MQ*XF7B-M^!>VL]]JW1N5;FKW:MA4ZATZ *LY*OEO1^8;] M.)M"0_Q_S?C7K/G0]F@/8(Y/(4:KZJ[)U:')$43$$A-.VC7O:]/F_J>BNZ.S MF='6[B3@Z[UYC^=1,YH^0IHF?Q%^YW^NQVW,#/X"&<@'\7VS+7CK'\ HJ M0+K F9L8Y0ZDUM\"\C_!='M4R"!FA(X>8^NFMR?,_AF._QU2Q-J0IL*ZTR:+ M_-^M2]IA2$%S^-49-@9)>F[P)-H.._G[O[W#$7B[<#-M8-K8]L/5)(#2J3]$ MXW=6)P("*M QOT]!D'[LB0=]LP;P4?OA?VUATE5HP/B(B_QC7G> X(S09X$P MY^'+S[3_ILG6XV!X8=^*[U^F^QWY5VE._&T+I'Z'-B6.B?@=A!#F0355)FH, MB#![('\K_PEF%_+;'\B<1==*I:/;$R ;7U+^IH&/*@"&PR;\=RN&4B^MX3=7 M_9A4/C#[7!W3?/N?_FM=9DK/]\W+D5+X;\/*!)#P?S?9AS_!2G0-.T%SJ(FO@?P!02P,$% @ 8X2G4#-F+:+< M& J0\! !$ !I87)T+3(P,C P,S,Q+GAS9.T]:W/BN++?]U?HYLO96[69 M/,@\:V=/$7!FJ$N B\G,[J=3QA:@,T9F9#L)Y]??EFR#L67Y 5G,=:JF:HBM M;O5+W2VI)?_^S^>EC1XQUCN]WMD___CE M]_\Z/__S=MQ'7C?/S B) M'\^N]Y_/?/K3-VPR(]@"$FS,N]AI$'OM M&6R.O8&QQ.[*,/'GLX7GK3Y=7!#JX3GCS? ;TUE>7%]>7UZV6E=G"+BD[B=B M,*]P8YO0'YO&3T]/;YZGS'[CL/D%;W?!7T\-%T?-J4.IOY0#6!Z[\-8K? &- MSJ$59L36:'WU\>/' M"_%VT]2U9 T![=7%G_=]7:CZ[(]?$!*J)\N5PSQ$4RJ;&>Y40+K,.^?LNH#C MZN/YY=4Y5T5@,GW'-#QAH'&FXZ "Z +;GKM%=+Y%] 9H.$,7Y<@Y!"'[D."[ MYW/#6)4G(PX8D!(^V9<01W MSA^=7UWO1\760Y6C(H([!!4?+PQFZ;W*I;DJP.B/\RV6BM3X MC$$VN,[UL&ERXI";OZIXUQVT%B;E:8F ^(^]*<#/YJ(\"1LH\6MO(JA!3#?7 M1K*A@I][FX=+3([NJ@P1$0S_<;X%KDB MV([P5P$!P Q?5LPT=\2&6'@[O+SF0O2MG'( M^=_.E(5G99D"$$))C7FRC6E9G@ $VS5E9\5P678 Q(49?"7#XP@FT 1F&/> M&BYQA[-1#-\9XBT>QKW,N;P@0089=11UM;6D/ZZOP!M=7J)SU"6N:3NNSS#\ M<=O6>SH:WJ'16-.UP:0]Z0T'OU\DH1-X?1=;0_J'^)T410@<-E$ )L9N8;C= MX2$%"Q]&DBXG_Y%C$Q-LI[H>-AA4^@#'#/\*Z0/]&F'\[R:IQG<)Q:[;Q8_8 M=E9\Q:RH2B20ZJ'Q5C8T'O3>0--UU-6^:?WAZ![4T6SQMUT7>VWSIT]_F\NW-Y4T1]<%CT1.*=?4;VG2&?@V[:_@PBQYU MG.644..PJBZ"/%?;UP6U'76&8KV]*KR(3O@2M^7;&"*;S\P%Y#UE(!$=R)FAB!(D2$%;6EZ-)]#CQ)C:Q;.E3'B52EN7;UN2 M7$FFTE\#=$W2"9CNDGAH3.,2V1PZHP*!.GEFQ.T1G>W_G1F<.6 M%=SMBW2M=+JM*TE45EH"O.>T($$,VE*#=LCY#84$H1A%C72]"IU6S,[*8,Q5 M?BKBYBF_V5F80O:E FH^'F5@;5U) JM:<\V,L,# H-?>@3/",+'?<-PWU!O"WAG[M#W7]51M[.,%"V)0.\/JC9 5"H:U7 M]R>7^G8"V%D8X,?<'FV;IK_D]$)'W@(S">3MFC]T*(CC(+H_&!6Y-B,+F@J; MB<]+0](0H2A&'!+4H1WR4$ ?FJ[1AL)7HY.J.]W@T :5W4.NL4B M4B@+TJ_K2Y&"Z2!)4; M=#7H@J(TD13KPWZOVY[ '[?M?GO0T9#^5=,FS5KC MR)/QR&# W@)[! @^F.9VL>:H\:T8H5F:K\)C4)_!?,(D=WJ%.6_^*[OK#[XT?G3M2C_);?0&FOG!L"S-7^^D3 M;WTPQ2JZ4*OZIJJJO[8'7S0=(BD,Y#9$UF&_JXW_H2/M?Q]ZD[]>];]5SG 5 M+K,&BT?[K7(IZ3)Q:+RYP&:QZ0TI6Z@%Y=>\;9%8BC=(GXP>1\=:Q6O>BJE&A4.CFZ_>%CH:3K]H85#1I#[[T;OL::NMZLPI1\B2\J7QT M@R(\@Z[=G@5_DQGA_B;9OEPP?*G>U0O0-Y()41&S$%M $4%1>2"0] \7Q8E" M6ZJ"8]/-#)MYNJTX(RZ--M<64O.D@K;0[*ERGAXDQ> =$-B:T'E[R6\B&\XB M%(E! $'\;D?1J2Q*5EDJV"R)3;YC=2/+N0CIO M8!8>E"%-C.?"*HI#J#?/WDLRN+#P:-+^LU''HF-"JQ@Z51C4*PKO)1E37 V- MCX8QT>K^ MH:6B3QI.O<#S7A)H=I33R(#R",0[K/A%''$(]9) 2QI0OFF#R7#'4:7%+ZJVVFFF@L^IC MP\6\-'^,Q4GBD<&\=?"PH!)4&-39L>SZQ;[6UK6@7G^L]451_Z@]GOP5OGC5 M#']XYWL@K7OH:^DOQ:.1L>:+^ _4PBRLA*+S$,/,PZQM.2M.UW#VX>:ZG%]\ M>3K4^=];R79@CI7PPA]!&@II0X($%%*'!'EH0U_PUOT-"1)11"/WSD!E(SWR MBRN] UQ>U\4" V)>S?"4S+#B(D(9C+D&D4KS\@VBV>L,"NGK_FH5?"#-L./% MH94OPSM,7[DVD%I8RK>!>/>)RM.FWW974&E1S?I+&X>BGUS#2.W+E32,;1-@XN FBRZ/EG*DRP^"ZQ?;#XU/MR7K,R>K6SE)VHE"F27_[,.T0&M5#8 M9;A^)FZV@EZ1Z+:17C(E_(H97&VF845E)?J/==<4LEE>7/Y#84D MH0U-*$84VE+U:EA2UK/M/'Q5Z3O7KE(; MAY7L*B(([5#$[W<7-*& J%>;DNJUU-RZ,#IUN9'L]&M!S3=P^JWC>7B2]0MV M0"6K!3'+'XC-PZ*<7+0N)9,+7?NR.13[11M^&;='7WN=AAZ,S1%OQ5E%6:Q* MA]NZE$PI\I78^.E$GA*PIQNVV#X;,6=&O-OU&*\5NLE.LPUB-2D MH9A!8 \)&D3B%E#!X^V6#A02\FHQ:066"KG%<"GC;>M2$F\+Z/DUUJ:DS>^7 M#9.@,./=MFLS;!QTH!?N+7>4I^9OA49Y<)MNM"*P2:>W-"!.1#-'N.>8/VX- M%XN;VS%U2Z5B]WX^T@=ZXO$LJRZKI5C%DZFV3 MEF3;)$M1C<^M)N! 0$9K(?F"6MJ%48^:=Y)1,QEK;?UA_%>@E:8*N^(04>-0 MCXQWDI&QJXPFC8??+YY=ZY.Q6A&(^/Q1^(!2)Z!>/../<%#Z*'1(#.;]JVV: M\(R)+XKP"@=(NWUF+GB]W@@SD[,_Q\.9]KS")K0)\XBHC76&J+'$G\_V1T-L MFZ>(G\\\YN,SY/I3UR.>SZG_PAQ_]?GL>'F&/.#]\QGUEY]6 ?H> M/.8".4-!,WA,'&LBFED^"V/J14H0!G3#EYZB?N."@0<6IY@&%8W!URG%K9=> M;('Y'B^GF,4$41*L$N,.Y;Q;#M]9J M$G[8>\MJ6; 7U#&A+G3MJ?FT+#&X#%L;Z<),W0TOTE=5Z V>N )%18*S;=*V MA34E3"[YM 86M82Y._F/:,@O*9UZ/=?U^;Y?QW'%UA%_-N;NCC^T[G!,%=5@ MJ^MJZ5"(#FR=Y'H:G!H EO&4>-5E 8(%9PKG=[4YXYR]%,>Z& MN:K0IZ/@)(?/Q,WD/GA7C#?+^V21)?]@F2.TF'"E'B-T?G#M\F^I$2O\GL&$ M&=2=88C15A9'BO8OJ$$3>MC']R28Z.)';#LKWNB>V-CUH/_PI.3$N86?))/_ M8J!'$46E4)ID3_B03.:CM_7S4N'WJO@6*@P3L5Z?J2BW-^L09OI++B^3YZ"9 M[FM_M*@W/$6>.\M.@JH#L=D0U\'K:'L]THER61S-;5&18K"ICM/25( M4#IA.;@JP"0K78U@U'']R)G9U#K'L;2 D;< M.O%J-]VM"'O\$'/KNX2"DL DIS#)$ODQKA\TB MF66^W6,!\C"SYEW*Y#$^ITTMXWH',P]"Y2C<@&")T)W]^FC1.9L540J_K([7=[5%9;IWR+ 4;UX]+ MQUH:-#$J=Y_5<"@* O45YM,X;ZW[;$Y,PY9QD=VHCFPM5S;FV[;87%#'=N;K M)$O9#>K(CC0)WXS_)&\%6Q]_WI;IS0?8XV=M3-MP7##PT:-A10_NRZHCOO#OJ&K/&1.I@V$[F3E2 M_(NVP!UFV!65(Y$1W0';">=<"J2&H2B7?L=G95F.@YP@RT-:5LEQB!-D>+)@ MN"S+NS"GR/234Y;E&$0-&?:7HN+S$0=?1PDV>(:SZ(;AMO5O/_AF;H+M\G G MR'RL4J1@V^-7CE3F=K>4H'#KX\\?>%U=M/R]S?!U;/J,1!5Y$\R6$6LEVA]O MZS)3C9SZC@/))^0I@5*N=H>FJD']QF":VNL\=JY/BIU6'CNMDV(G[A,SW];8 M"Z9IWO5[BO?U\'3;[ZQ'9(:%.WV8D3)CCL<<3YR=PA#5O=W*9WC?;=M=4D,2 MVP&%D$S!#VXHWPS;YQ]?R#M0YB^H[)?.%A*U1I/,OF:U>[D3LNB;* QSGH MH?!50='=Q'@6:R7)2)+QM@Y^:D8HMFXQA1_BYDU!;%@SU*:<9H&%GS35#=M@ MZ^UQJQA_>R$YON46I=^A_O;$5>S8[3XR*82S%B(JM$HXP%[FBN/>6$YEI;$+ MDQ(C.H62= :R5S5,* F#R:3#>$EA6*V@/8,;YA/-X6P&\2=9TU *XOBN;_.1 MV?[JV,0RUMO/( 3,5H;>8R0+% =7M+9EH_"]6>/8:7Q%L/F;=P5M@B9L(BE2V.;X%WV?XO?D8Q+ T4'Q3["QM,)\\1 M@WMAJ)DSK2B6O2126V%D&CW?;^)4!^7^_6A7> #S16[75]>7K>O) BB>+X;@ MC.%1BS][OSLP]L92/V]0@*7W:99NKDL+1HVE?H+93C(3WE'VHH[DBYL]Q+T/ MCF];/$GF1#KAJFWJ$' 9@'JR&\U\]2=CU<4NF5/.31>;@0VVKB^OWO.2!7.! MK]*\5X(^>4%<[R6(>H_?4JRT]A)$G9>X2[)RLY<@;O[_".+M7H)X>]J"^ "L M?*CL+.70)R^(\LY2#GU*@KC#4^9#FOZN2O14 Y^Z& J;@QKXE,1P;S!S M\U&4>1G(*;$N+JMX1#7PJ8NA\ !0 Y^Z& JGCFK@XR^L!0<%ARMQE(+. MQ30^.@(]QA0_&78PP=]L3)>">-%STY7TG+PP)57BJFI0/[--W?^3K.54-:@? M.P/L,WX- 6@^U?NG' UF6]Y/T\.N*K:./ZGDT*RQ6&LWN#^C/0M*A. MNC-,<1)K^,2+(=8=AZW"==CO"\?%8D=SX?!%6K?-\(3YKN>*-T'AA FHB;C' MT?8M?&41ZT,NN8R6V(6[3YO)%H?>NIV\_!H^Y7$X"9:&$ICS,LX M^=7)#Y0D=PK* -3/T<>IY[5T[3CQP1-^%%_!.#VY^ 6GY"@,EIAL;L;LL%6Q;1R;GX%N8.,&A_R#\(JOOG),D>SFM MZLB8S2>+(_B=BN,9[^K(!#\D^]UA=DHAZ1?U)#_ELL!V)$Z^6-/CYU5C#*&< MCAR;F&N1'D'D%:E+-%_O&FOQT4=]0<1MHEL&RP/6X$;$\/QZ_#.6\:O!D[;]C"CPED\N+S<S,,V$#"46WG82I-TB]2/U71^I MAQQ^YQ_ZH-Y:*IVL-C6<;(6JX'KA)5'#*2_2Y)52VK,I+O(![8@)X^8*A>1] M/WMAJ-TE0-L/!2?OCNP#5[R[S:RZ6-,3XG 2OYLEOUGADV*+-9^W^%/\MYT4 M$Z=#L/AJ0WC=XFYD4[P_?C@+B>L[=,Z/LG(B=T^[@'N9,V,Y<*@9$)]@JQQD M;6^2W"4]FJ??&82%Q\':2WX.>.A['!<_%[ CA[*0-9:#^,YB\'52/EIB'U,- M\Y0H[ YG,QR[%+L29/WV,G1,B<."S"Q29G(\*UK48$3S)9+4E_G:/#N8BZ:W MZVV3Z$ 0S[8W6@)#VL:=0V&KH:;]U#N)GM?5O&^ALPPP\)+@_UP;R%<6P/@(*D558OC MIS*3\'LR#G.C:B#X$3T-/LT(22\Q[."(57B-08\^XN!.J3Y9$B_&[&&PG+PNQ5W.7@\=-IXIZ+A%E4 /S[K"7X^*MK+L!R__CE M_P!02P,$% @ 8X2G4)A'/:T_8@( !#\@ !4 !I87)T+3(P,C P,S,Q M,3!X<2YH=&WLO6MWHSBZ-OQY/[^"-_OP=*^55"&!0%3WU+/$J=M[IY)TG)J9 MWE]F$5N)F;;!#;@JF5__2N #ML&G8 >,9LW4))$ Z3Y<]T&WI)__W\MH*'VC M4>R'P5\NP ?Y0J)!+^S[P?-?+KX^N%?XXO]]_C\__W]75W\W[Z\E.^Q-1C1( M)"NB7D+[TG<_&4A_Z]/X#^DI"D?2W\+H#_^;=W65/33^]/0(#1E350:XK^H] MS8, 0ZC)!NT]ZD]][_+E$W[2%/R('Q49(E7MRQAJ.D >-CP%Z'VY/WO9XNN] MZ=/'[]^_ M?_BN? BCYX_ ,(R/+[S/1=;I4]P;T'[H7SW1?A F=/[0DQ<_IH_T_?CC2J>/ M4 ;&E0RN%#![S5-\Y0<)C6B<%+\BUZ'@\?AI?.4_ANN/QLGHX[2QY+%XTV-Q M\6-^[RI.^O/'7AZCX8>8]CX\A]\^3AOY8V#EL60<;7ANVCK['W\!7GY!;Q)% M3/A>KQB+RU^TVJM@ D/J%5.9-11T[R6/P^+^O*7@@>>)%Q4_P%L*'H@FQ=VC M21'Y.:6\X7 #'5GK['\%=&2SC$OG'Y?(26\8T0V2DC87/.I[H5_\+=Y2]"VF M)WY0,+[T2UEC$8_"29!$VT1CN1-_C5[XFHV/%SR6:F=<(E33QH)!!Y[?BXN_ ME385#;!7@C&LH8C\P;<2Z@??R@:TF89+70H&&$?+#R_X%Y6I8RJR_(V;A7K: M8X-@S[MM1IEICPU(,P-LW_=*F)KO43"E27SE1;TH'-("2/@E7LPO9Y.A+(./?_]RW64<&7E/3S^M?)SV6'QO'-$>]SY*GS$^3MG_<=%Y60-+!SMO+M"\J 09HB)@ MX-J8O(Z+Q'/>5&2H*.M1]IEL>@40U"LP'%,0ZA49C2437DJ+U5Z;7K3=6RB& MIJ5O,&[M,!+6J^!%7E1" ]90T)V^] ;%W^(M!0^$O?%3B5%/FS;,;?.<2JW$ M%@M1;AT*P6;:4&C9^_Z3SY2$12!78R\J<)#7NA0+?.%7BQ!XKI5@@PZ7*#"C MPE69)F9MI4Y/T0#G3D_10.GHGR7FG;<4?8<-()Z,Q[WR\:7-1=_Z<^(GKR5? M2]N*=/^EC(" 6(\2#Z;<=RFRF.,2YK*& M0K-G/XD^!YHQI?37H;\R-IA;-4G.U9$_/E MD(PW/WHQS7^I%_2?_!(#M6@O=!Q+'BKJ/(\$MDAQD6/S,+E4CW,=2C,!^8$A6>TGR-OZ#_1#[V0FP?.OB4OI"1& MG;644+ P[36C8''J*VOI^U&!45@\R=N+D# .GYY*P) WE41XFP$QWZ/(3I< MQX:LZH;9S=N+$B]L5/X&=5M-NE.A.KD<)GI8K0=98),TE"%\(\$$8 M[&!>63RY8F*97L2/);":M17Z&G$X+L&YK*TPU_)$.5304M)/@]!YQ_D82P/E MTO!X:NU+W8"2%%))D#!OVN#);\W2%V<0 IILHP?KLJ;56Y2ZB/S#H"Q$29N* MPL42%B=%=)CY5QN=KV(07>3@MR0*RP,A)C.E9-2X1"T9I$WT*Z8>MP(;343) MS$I +2@$-6:VRQV/66N1M?2?OI6%W+RI."IB.O92HOBSUA*[4I0/FI&O.!_$ MQO[MS_)Y??NS-+E3$($M4CM%$5AJ9C9[U26FO,0Q*O:B!K17%I[QIB(NA;TR MGY*U%!JY @.06;?"B(2O4FQRM8I7O_V@EW@O)5-/VPH>&H]+,DFL80-&;LUT M%"NW_\+<+]I;4O#9DXNLV\*4OP==R7AI&$&)H+7&O>,L&^T:YH-Z%?E"2^2_N M5^*&]E?"W[G%RAKG9J0$. JSZ'%1.CS%@.)$.$?$S4Y[R5)BO\A52J6@7QS) M9.GXC1%RUEZBC!MS+<5YEI=AL0ZFCO[?KW,)I(@^AR7F,&TJ\>M[P[+:CJRQ M$ U+THI9S%B'/F]9*9XZM,_Y)29: MEC(JLJ*I8B2%6H,RK4DN/O^??_MY0+T^^_]_^WE$$T_BO:_XL@Z+HZV0A>EL M"@\L(KJ0>MEO?[E(Z$OR,2N%^Y@^F/C)D'Z>U>#]_#'[G;WZX_3=/S^&_=?/ M/_?];U*O)$_?/WTX(]H+-W0[])]./*"G]*VV/\7_03D^[YNC;/ M-?P&?G^P+Z3 &_$W4O\382/O\]&[0^_Y0O(99UROEUSIBFQAW;1T73$0M%2# MN"9Q9&+JKDZ0!:Z^_W&U4\<+*3->?[E@UN[38\BXZP5/WC!FDTC_[^>/2X,^ M8 Y6FF!*7#_N>/'YM\J'S$F].F"L8QM!Q3148B"5_:,9-M!TU86Z:VFF/1_P MMHX7G_D(WCYD)V!:^6IQ6^L-.T&?OOP/?*SS/YC !WM/6R ?U-_6PR;9PP_V?0Q(;W4ZXWO:8_ZW[S' M(>W2WB3R$_]?J3?X0*-1;BH0J(;!QLAT4$4N4TM'E6UL8@(40Y=MMVV=&_="F@1^-J%@,GJDT<72)#L9:USZ*"O_ MX-/[!Y^>%7ZC@1B3%S\N:P-?*'_I/Z:>4]JC$\1)E$KCXLDN#?PPLB+: M]Q,V4W_(6)\]ND;;Q>.S3WWQ7OS19'1-O]'(>Z;WG,0YZLHVTA!P;$1D YF& MS12. !FZL@.AI>.%*F[K>/$9?9#G(C*CY[O2%]: OEC5+,305L%$1M"T#8>X M2(4NT@V(&?D6R+&EX\5G]0.J%WV5&M!7EUW5(HX%,-20J6)L0!7)AJZ[P "J M1A86?4M'3M]R^=T"S?^(V33OO>"9IK/FOWWQ S[N@GG>LZD$$^I&X8B[9/Q+ M?_.3@36)DY!]Y2X*^Y->$G<'_GA,^[SI)B3#A$8!F_LW^C6F).C?\WT/MT]W MWFMJN<*(L21U28(>_>(%DR?V5H:IP7/&JAS%+&9,,9(5YL<8R- 1E!CO\@0 M:TC!8&$:MG5D> J^[(ZG5TI.'"=Q?UD6W0YW>7]39Y2:RM0G,AR&W_FDV!3M MV=&1RHT;9\JEYNJIJIA%6J&[!B:;B#" !HPO\Y1=S[5;1TO/FL:,_/[ M317EIAH/O(C&%^N>@/$;R'D"\PDS)Z;O#R=@6W3XX7!4R@8R;17?XA,N*DR7L*C(/ 4"S+-@ Q;0:G)C*(IG$/ #L*7'@* M6SHRGG.OYV ZE$DWF$.ER7SY?"HJ7 61&NMGS MC$"/?I 2B&,)(T\*G4'LLQ@J_?.U[SVFB)M7#N9&8]4P52 S'0>RY@!$=$.S M@:L#S5(7RK&E(W=G]R34LEEBE)JQA4$W"7M_W'G1;=1->$3]5V\X MH8L7S2?J$.;W8:@@PL(>UU8,U=(LAFNJ9A-DRPL4V-:1N<$?9'"<:19AP7[3 MU!R;8)/Y[(Q%R+$T[#+/WA/S.G$\69H95AR( M+88=%I,T(,O,AU!,8LN6;=JFX^0BYBT=+SYCK"OH"!/;B6UK$P.*K4/+Q193 M)61!0'1=LS"#2 L K*K*?&+;.K*)&4!6CV!FU+F96?:Y4PLS:V*($O0?7Z]I MPCS+^/8IZUJ91S\CZ,K[;R<)KS'AVX[7S+=I 45Q"?,L'=LQ9>9QFH[!Z,6L MLJO*IC6G[+:.C+)',=^[T94[,K3/*;(LW(<$^'W)8QLY:\ M/O!EP.R=L?F:;YG'4>3IB1&%_SW+>143YW:$7C._N-\)F+X\ M^\SS)W%,$T:F+]X_F>X-/>8]Y@6O$[#(D3F,+%:(J1?U!BQ*M%FH.0S'7-Y* MZ,8+'K9\,1\[,@ND&+KI0H0-RR:J";'!_ <7R99BX06J;^LX(V/UQKC(7-VE ME55,<[;98V1@2R4VP#)QD(P44\,Z4)F=55GTF\_6;.O(YH=.Z&WL/$'B*#8$ M)I)=;")-,[&."0OF%6@A5;$M8Y%YW]+QB!/NX86J%B:[IR',0GF:P[NG(\X,LQS3+/=T^#OWG-/#D(-QCL/W@CUB7VZSEA"LVM=^Z(?\/?_@8[^2U2MYC?)O_MXTC9^W,SI2'0LR M\0$*8EX*<_HLEV$%(28B3BZYMJWCQ><[HRRY]L9D9/J7![ZH>_O$H-__YO;/K;@VY+L7]?FZ\A(_G=%X M&+Y2F@KV[9A3K-@*I4+/"_W[/.'#3'=*>1)%?!+<>)FOBR[3E&?Z2<8=J%Q8.*Z6B.J2]K#Z3<^KGYD^HUQJD/YK\8S0/V%MI4(QTSX*WUI%>QH())\^*2>D\:X,HY MS7&@YI,VJN5TSJO-)2Z3U"ETTM,JN,<8!NS7Y6P(Z?4FHTF:3TIS'+Q;1 ?, MMV1>;"?HA2,Z]45/1<\Y8M)G/OKT3]G?^NS++^.AWYOE7Z6^/^(CY67[=]\\?"S^=C?3CVE ;Z32LY=:$[-1<=HYJ* \1A7X_79SWAG>> MW^\$EC?V$V]XGNS?--]!X"R8&\S@'FJO/_M!(N$G0FA_++F-9WA]]'U,EXM(3 M9BWK8;Z:"3N-T>MZ1!>"R4W3Y$/ 6ZP^OO_J8\6B<'*GM>ZR\9[^9EU]O8*] M4L+=JXF[5[,R1RQJ6IIH58Y1$KB_*(A,UUFS5UB#4Y8L5O]4W MQ')D'98CJZYQ/XRU0N$;Q>2#@5UX:^<*Z0>+A$#U5+[X(5*I9BF2_194E&*LF'A2I MLUK(Q;+VYQV2"I=>!9<;K?U5+JF^5_@U]W>\F%^QQ?^/KVQ]\X;GDPNM11PV M]W@V$+I5 9E((=4AA51E('9D#,N6S><+\(4PMMNU@347G1KAV0::+R!M)Z*W M =N.DHDX9%ES2GW:?Z"]01 .P^?7>_]YT!2#7I/DQ$%KFEM(W\!\1?7U/D*V MA6R_">+?K\RI-A#?V,J5)BO .Q2LM 76A3RW0Y[K ^6S*Q!^FUXRS(*8_J27 MW$9=&GUCA%F(_%WD?V,?NO8>Z7!%U.>AT8S]W8PJ\>+IVR@9<*/)PC2/16U^ M'$_HW(#ZM"%BSBCTJ8A"4_E>)U%%%9,X'.A5&\FE\#J6F/U#9U$8.E$5(O-6PRY$IB$BTQ1+ M*N)V$;?7&_)$W"[B]G/'ZMUD740](NIIOHRWQ;]HF,%_?P'9S6$5R4N1O*RK MRWI 8J?1 BD$Y"A^GJ@/$?4AS3+;OT]E^MX+GC-!YK]]\5[\T634'(&;#__B M,_]U:?RM@*C52UGOZ3<:3.@]'7D^/Z+ZCD9/833B>Q)O'X?^<[I[QWEAH)Y0 MI@@CUN7VJ&4:4(TVU M1+C(OOUO/Q_G]5,:?U[0^.>/Q_U21LJ/Z[2L0...=ZOQ9CQDY&DT'N;'WTH\ M[ 1]^G1 -?I9["-=[,_[=TL6=AKFT"V M,A\OK,ND9_Q&;$(HX;;]24,.YP.2F?\RD0HN*C M#-XD O,S529Q$HYH=$^'J4L5#_SQ.8O!_(B3\GDW412J,!8"$$X#".=D1(2# MT12$>#.K^?4P0YKD-]:?.]=+IWP. G!HV)E"9@.-P\$1YNJ$F\C\*OR#[F3, MYKMPF;IG[BJF$+!ATL)#$%)3)ZFI-WH(]^$4[D.-D..-0B,2%.^0H*B1^*P: MGM84J32I:.2HTGOWJK?C+74=P&RAZ^^GZT=@_[Y0+W3]7(!=^(0U M]PE/!_LBIJQE3%EC 1#)I=,GEXXM!&)=HL;K$DGK[A^ M_]BEDBI,L?FO5IO_*EXEF88]+GV4%Z)BT\=D<8!D#D6^AP^#<)*N"GYG+:\N M/X>/!CXC61A\HU'"27D3)C-%6]QG% ;/"8U&_,T/K^/E_?2Y9WE[LR1JG58S M^-F76)ND9X\!%9$ZYZ07T?I4P1J\DM7JY599"%)$^W[B>CU_R :V)&-=]K'^ MX^LU31AMXMNGK&NS1&U]>@N^;IK?"=FK'"L=LXFUM#=AK0MQWHYC3#VN0R^8 MO6[E,=?SH[]ZPPDU7^<__LI8R&&?49B!_M+WYWTZP7B2Q&D'>$:2M4K>BG"J M'#@+N5/15W?C[6+V&YC;P!27/4=-8>R%L3]V\),W]SL$/_GN52_<;# ?]_1; M./SF!\_+?81-V& 3-M),(/4)_=LL+?B=L6+H!Y2;S>9+69;U6Y]3$_W8@F-5 MA<$5!O?LLHV[GZ2Y50^F7"RP+'67VK<K[*J%6I256Q4=[D^:B!3T[!AK[SI MAI3Q&1OI8V;3FVK$3R>/(O@1P4\#9':IK=U!:8.1J;&6.D&7[ MO699MGGK[9@7+O+BHQ?:?P@[?$=]%#M_3AC)LG^77^8-A]DC9R)M9V*P]OCR M;AS/C66%Y2(2K:K(@S03N6M9DD$:'Y#4M0)"F IA*FIO*MZOH&/?+T-1&U%V+?[+8-GG*%[ MRP6%34T UE,&CUD+XM(^C;RA.PGZL?/T1'L)CV:^>V.!HU74;^Q WC9(\]Z; MX2K:,=44T:VE"WH6(=NNZZ2MB[EJ*7+O$/4QG;O(4PO1L*_J0P%3L:P S4%X"L@[W$%$#[N%4"B M:OH@O[:U5=/'+%),!2==G F_T8"]]2Y]TT*HUMO@V8MCRO-BHDP%HI0JYRV) M%0/[_#&?$EX63QG%W61'GM!["]7OV17=:T)=.1_\_@" MR((%]W[\QW*Y8!3&<5;ET7OML#E%;$0\9V*Q"49>;]V177]I_(OG!]?L/>;K MK[3_[ ?/^1._5ZH3XX$[#+]/^ZV\?/I7F\;^<[ H\%E\._L[[9-XVG4QB)57 MW84Y&N6K,)NANCP?]Q9)FI^9DA.EBG2Z1!"7+HVK&$3*Y3A7!+F;(!]Q3-O5 M(%^R6: '%8VM6(L6W]Y!C2H:25X)%]]?:&$#(S&!];7!>H'A L,%AA^$X>T! MUX=!1 6\"GC="*\Y(1$ *P!6 .P^ /L]%/!:>::B.PBC%N+P3)8$"@L4KD.J M(J>& NV%.RTRT\+M%H!_SH OY'$%F#? K _$^]>(/,YI;4%N@ET M:P+JB SR>R.9R"B(!+( X7J[F"*?(/+'(J,@$L@"\%L"^&>24Q#>_7OC?9M@ M7'CM L1;DCK!N81MA4YA-V']%BIGA:-Q&'".+[V1]'J3T63(7WF;#&C$NT5T MP-G#Q:07CAIV!&5]O(&-#%@,:&<.G$2^\5&.8EL^8ZI^EON&)@L3=?1P+6/J M7#R63JY?],GFW$05/$?;5RXAS3" >XQD@W@NAE,DG\<#J!H=F&:GX5#M$>UD MN:==P"RU:S=A$#)*LU;^-OZ0\S)FLB? [=W!K<&.?=6XMHNHG@;G6*BQ#\[Q M[A4?#+D4F=01Y(3;)I!-N&WU==OJ%U?F!9;G&<_8Z9I-]8R]K&)NU@1ZA%.U MQJ=W\*(:&BT*G!(X)7"J13CUSM%>0_+TM0(ND=6J=^PG@*V&6:WW]\=6<>[\ MZW(:46-1(R%9W44GBC)J+GGG7I1QY%VBPM,3GI[P]&H/70WP](Z-64!@EL L M@5D"LXZ%695?K6B(8+/FP>;[9UZ;4$\H2FV$01.E-O4MM:D1HJVZZB)]5G-; M>O[ILTK=NM4KTX6Y%N9:F.L:@U8-S?4"G587KZI&)V%]A?5]3^M[;/D6Y92B MG+).=E7D==^KG/*HF+/_7CB!.0)S!.:T!G.JWN'6A/VWM0(AL>!=[X2# *GZ M+7A7CUFUSXP*S!*8)3"KN9AUC-BN[L708C5' )58S6G":DXMRIY%YNF<@$AD MGIH%.8TO6S[((Q*8(S!'8$Z;,.?]_1P1A8DHK%;()**PVD1A)Z\YJI$WTV0( M:(DC4.-LZ.XK..GM7*NNXH(P+GV,)E[TJC&%U!\B+V#2!AH:%_S5BWSO<4CY M+!=SSRX;9/0;?.W:UQWS]K[Y"KBPP>G56 >QMR;FN,'XL,=(5D5SRK@RV6P[ M*MWVDI#-%\A\^7LJMO"L4.DV:"TF;6"NP*3WQZ1BR6P[(MFTETX8X)S4GI>C MU&)(VL1=@4D"DQJ$2<)-.F=,$GZ2P*1:8U)1PD% TIE T@;F"D02B%1/1)K; M424GM4A TGE TB;N"DP2F%1/3"I*@8IDTIE T@;F"D02B%1/1"JTHXJ I/. MI$W<%9@D,*F>F%1D2 4DG0DD;6"N0"2!2/5$I"]>U!M G1M1@4/G@4-K+!7H M(]"GGNA3Z,6+M-&9 -$F[@I,$IC4($Q2!2:=,2:I I,$)C4.DT01TCECDJA" M$ICTOJ<.BA7_]D*26/$7B%2(2,(L$H%(M4&D&B%&DY6_)=K59$D7IQ.*TPG%Z81UM[[O M>3IAG5%)K"^?,RB)]>5ZHU*[8@)QRH7 )''*A<"D)F*2V+]YQI D]F\*1&H< M(HG]FV>'0V+_ID"?AJ"/.*_YG(%(G-*<(4F<J]Y$;;8>R.O MESQ\#ZO%H1N:=()O["O\N:.#T5T8^VLOZ ["*#D[ -J=E34!G7)).#ODR8OA MXOLY.3P%VKS_F3I;1=1E#PNX.0^X6?!2X(W FWKB35:"WCS :1..Y'@D@*02 M(&F1@O/8KGGJ+?R)3:P4*"#K9-,"*RKL*=$*5C;<^%BLJQ>GD2(A-Z'ID) 38B@R'0IGEH$*]&N]98V:;=81VF7[H''Z:S+INFY/8#V@.]4Q,E.)6IXH,(DZ=-; M)&F*4$NB5)&.EPCB#!-SDGA$U&MZQJ8=!S"='"D=X, MK@5[' 2\MFJ7194X7/DF"X'$[49BL3R/0 M7J#]86A?=46/0'N!]@+M@4#FLTIK"W03Z-8$U!$^ID RX3H*#W, M&WI!CW8'E";786\=*.XB.O;\OO,R9A2D,0GZM\F 1ID,)22.:1(? I:K=]>W M#K[F2%'"@84H[LZ"DV)),0>%>KY1/8'QF[J[>J:2<.U[C_Z0&1EZD"J*H\#J MK/W%'!9>@SAA8 LV >,*P*9CDW 3F@04PB6H@=H=RV/?UTT0NEE[%_ZTAETH M<,OTHKT,WRW'DN:;2:\736@9-)PXM&N/;)9C=IJAW9,K K7?6XF/G2AMCV8( MAHO46QODO!$1M4B]"6S:(P=P?(]2).2:[T"*--T[!GUU2],)ET(D H6;T4@, MJT<()&J 3A6*B%*?-BM;71P&H9;"G L%?J>$H3"93";M9EQ)9X:0*)[4% MRO;N6:TW*IM(7@G]KH=3*W)4M37_=2FN$IZ!6 H3*EJ5ARXJ'=L<*8N,U6F\ M^9.&SL*;K[W6"V]>>/--0"2Q5:*.4%)[]UZX%752XKJM9 M_0ZR5"T=$8%B= M,$PD%9L.*"*EV+YU2*&6[W[\PAD3*JE7(?.V54@7*O7TS4!.5>Y,0: M?H][E2A0]<5 ;4>!/492BXO,&X V+GOX[."F.;>058DV"U8*N*D'W)SV'JX& MH$W115Q-@)LVP4CU]V"U'4=:I.!N.(D:J-\B>MG(2X$#]? G1/AR'IE0 334N3)<*YJ1G%*Z$R$N(=0Z1F*B?/R$6.LXC,R&"%Y'!J#W8M"AXF742!T[6%4-FO<3I MCB)TN7#M5+G![P_VXHR<2>P'-(Y)[\^)GS.JF1L1]D=>L(/ROC!BX1(G-/IY!CPS8?^=OG+?E'J!!/]<] M?V+0K.4-;LC245YO.#.V*;I[K%-5JS)&51\*56",ZFA:A+-YYG#?;F>S1IAO M9YC_FP $ 0@"$.H "-SD[P$(JQY"!4[@_KDHX00V+"/!,5]D),[50(B,A,A( MG(,QXK9(_TV][24RK!M4G4OUA<"*VE0PZ%> Z0^LR,PW3GF:5TH@=*U'_X75,%_IRS\@:^3UFI;M)V/LC[<%O OL:^+/[3IHBR4NSF\KO M#M-K@Q.2%X:8$JYN9E^6G-E?G=%X M&+Y2FM+V=LPUJ!DBPV;ZJ9 &%Y]YTS(1*L*8%?&<_;F4AFV3RS,5-<'^M\)2 M:J=F=&HM+J7F;)D* IA.)IGW7O!,YT;RB_?BCR:CJ2QND=R9,8F]H&_1*/'\ MP'FAO0GW@&^?GOP>C5;O#SM#J9X3,+.P2Q1\HQQO4YK=&2 4ZJAK,DN%.2(6 M.6DL*=J/YFVKL?C-M M!8SO'+#E:3?P(MIL<9@G"HMGU3;6;W.)S]06'-F1K9^I:8ST^8$(R-XFQWD* MBH#L_!4JJZ*'7[Q7-@CVKP).)K4'THN7#:/]JHS1$0/8NRADSR>O=T/F[&/ &=M65@P5DAK?+QFN0FU>,4B=D"4[FZ3Y9SXV;V^&-&T!BQ*"5.3I%Y$SMT^HB)YM<.NGXNK21U3W MA1L^]>P09<_)MJTQZHY1)7SO7$W/4$%>>[X6]31.LFC(IZS K745??YJXLQ95'R)V>G^,A?(!M MIFWJ \BU= *6X[J\3:\HKLL?^=8)>N&(/G@O9)(,PLB?QG"S9@[D_G.0NK'1 MZXJ%6W]V[O+/C=QW/XY=VJ>1-^0=^R,_\.,D2D\^<1](LQ2JF%@+E2JB5D7& MKYS6.?NW$[';$I9.#:*0="'I-9/T2CV:U5/[MFP]2^L%VM\F 1L[+F-%O=0OX_$%>O9:\6N%H' ;LUWCI!:37 MFXPF:VI"$?F$+M10%UHMRD*4*O,A]Y8CFS[Y >V;-& _)+PP/B;] M?TZR,[W/78QVF/R9^)Q[RT6Z>)X=L]L>>=@PZ5:@216"(P#EO0"E1H+T9K,D MW)OW*IU76Q]%AW'AXN M!.LX,KL-8M9OL?1Z&R6#<$S[?H^O1S[X<3RA#[0W",)A^-RP;2^5B]4A\%5$ MZND*\&ZT;D7D?'(YSVX\Z8YIS_>&?'-T].SWO*$0[^K$>R.)A50+$RZ$8%T( MK# :AXQ6]"8,IL0Z'S$HG5Q;!&$/AUX(PCD[]6^/[(2S(YR==DNU"%7;&:J^ MOYSG_;DY]7ZAX7/DC0=<[5,A[65[#?[QM=L$&2R=Q\7GZ40^?>VVQ4_;C<'I MN2&Q[]UY/<:!7G/P9@.OT]-!5N=%:'CK;'= MN[-=Z'A+F"TAT_/+!IS^IG7B591QVDKZ MZ0@.H7TK]&"U0'!?)6BE@+Z-^R<]O/9@4',]/_JK-YQ0\W7^XZ^,%U[4&[Q> MTV]TN'R&S*Q/)QA/DCCMH)2_\MKW'OTAK\8<>O'2^E*A/L^[MUCH]OCN;KS+ M'6E3SKSJ1[3.^OG"URZ\;X5;.CV"5&BQT&*AQ8=:U^QTW*KW61WN*@FE%$HI ME-(X[N9'H91"*852[J^41[E_:B>E)-$??FSZX4PR.D'O@]#-$^MF.1.$BIZE MBNZ;_Q9:*K14:&GMT_E5+FL)?18>L5#DAJ[+"2T66MQ2+3[=:3K"8ZZ[;@J/ MN7TJ^J9%FO,0^W>J9ZD@N3\)_(R3XZ$7Y)DQHEX\B6@V/]XX>\&L8?%*_HZU M]ST_C@M?%XZ'R]W_.%D[A_1Z/TWIK\B_O^-Z8O>3'C3]Q,1ARJPCPH MK@_B:]=>'\2_+0UC^46Y+]@T"$=^4/J-J:*DU^QL^\C*NV9-\ZEMH\LF0A?. M<>,+LS&7RVO9G#:^=#BS&*52.^^QYYLC&M#OWO ?X9AC6^GKE[OM^8WI]N32 MET_;]WSK. K[DU[Y6Z?MV][ZT7]ALXO#2<0P//MU0#UFJMG/3(0^_YS^XV6\ M-54%R[J!(0$:TA698"QCS4%8A@92-?V"/>3E'I3BY'5(.?\">C6@_O,@^02@ M_)\_C;U^GWD&5TDX_J2.7W[BV'SE#?WGX%./\LM0?GIB@'T5^_^BGX V3GYB M;X['7C![8=KZY(W\X2N#_P%#^V3UB?37[]DW'\-AG[WBZTWGP;&E[@-Y<+H_ M?^0OW&6PIQE.DY7(C>VY/S=^I7<_.)(UNV7+YUNMW-[4]&(Y;U' M+!>/^&^D^VOGYI>'VYM+R;8D*"/5>-KWD"FG >A VZ#C5'*4'Y3&!K5XH;'O"(QB"OWPQ8O^D&X#^N/NH\I- M"V;#R/6>#7E(GY)/\HR0?L##A_3W_.L"?O'?<&F:@/=AKTR\QR&5>G0XG+;^ MY4*^2']GP^S-?B^8^@,+-V+IAGZ7[L.1%ZPRX;O?3P;L1S:/QS!B!NFJ%PZ' MWCBFGV8_Y'G/IY$.AQFNI,^DGW^>13*0VZ2DS_^)YJW3T62?T/[SIUF?U29# M7;05/)_>[MSSAM,A/(9)$HY^6B(L9$3*4RW_>]9_Z4]12FV843;'K(U"#C>+ M&(E\;RA]#?Q>V*?2EV[)HULP2=7FF.1BRU (476;&,AV'0(I4.[.J0(X@L5H\-M7&#N@@04Z?9> NB'_H_2K2L]_.I(.2=C[F 0ZX$W T-1 M"\B7BOW'5,GG?]\'> Y%X)\?HX^?JS'D54&P&T92,J#2GS-9EK(T@T09:/:E M_:UAR7=^7G_/]X&?T"L.J)1)_??(&U]LT5>$Y_JJ U.U3$>U;*@B5T>FX>@0 M$LUB'CP AEVDKW?IS)QL>6DW;?W4YSM 6<=!WWM]I?Q(^XO/7WB&4E+ I<0? MVJ:U%1%P#V_B%'(31L)D"Y-]>I.M&W,((+)&D";KQ%8MY&C8T&7$3+CI&#)T M3(T4AA'\>H(TY5N)S5;;;K,?[LE-MY-:9F&TCY "V&*UD[DXS\SV4Q2.I"S2 M>_N_4A)*RU'CVQ,L%8SJL! 6P.,$U@5S7*2W)+=S[4@WMQ_V2948N;!$-8BI M*CIRL89T YF.#1S9T(AK6:[C&GF,<]+U)M7(.C/%26(ZXL:>7\G1NJ&_+%X=;JWOFET^5F\$$B7:E[YU@=M^/84N=&ZCPP M.OV:!K5[)+AJ(>CKGVR?RXZVNNQ0+??907G3IL>4\B85%T%FL4AECP@AYH^.H_ ;_P!/%-ATZ'WW>"W#FX.$TP1U*W$"WI>%N!1LWCT$ M>F[RMY^F/).68:#1++(BJ<+YCPLO67AZ+WTWRP:[=J=+%Z]=4LM MY2G&UKGAWM74^4F'>/\+N>G\;_K[CP(USD4$.Q_N/W0_2,Z7N^O;WYW[]Y4Y MV[EY8)ZKE0D=BUB+!*TV$!&R3ST-P^^?!GZ?(>-/4V<3RDOKU)6ZRS-9S*5T MVS/OVC"^-A9= [DLC:(2Q5& #1T7.;:"3>3H!"&BV3IP@+INT4F_'_$2Y.S_ MKEF\!#98<\!B&KR_\R5K,[IT%4%D((+%MYD^J)E8L#6$9\&I& M2$S--(DE(\TM%<"[D 4MP__UQYM#G<\R1NK6E$W+F1OR87P;-U_TRBFK_66TU4/Z\C>9!1^W^)-CM@XAK2Y4<[_=NXDZ]9V MWAY/O$>6J#(R,!-][W2[?,G@[IY%^)T[LKP^=O_*5!!9[.=WV1?<' M+>OOM:Y;U<+/8J'M_\;2 QW2,3\ 72J!"_EL+F3P+^XQ8,K6?TKF:LF M&Y6M[I5\XL?URH)M!%J4_]FFJ3%SQLR8XR#5,;"J6;*,B.4XEF*[2Q;M.F0J M<\=Y=<"Z^*890!U=R4B6CTVI PH>IJJ.5] GTA57.8-T$CB"]*7TO27J4LA M>4%_]B?7CQEKI-^IQ_3'?Y*L@1<\T[[4Y:>4.@#\\_BB%3VE%#^DEGRI=[V[0NNW(BY[] M(!N>-TG"V1\R(Y7^I:*E767KTJX"-ZS?ROLOTM;*MZM*QA\Z#]=I$81#K%\E MZYITN_OX+TV?_3WAM3!2]_X= M^Z#,4).(LU,DKJORPF]Q$" JH;*PJ1%6P@F3%D0LUPWGII1[CYL+'M=P498_-TU)> MW/?^E'X9AH_,$^VRJ*Z72'Q;*C\O9*]T][XQ;,WJ_ [DWN\#RKS9K$@]FL?-T@_@1VG@Q=*3/V3.L#<]DP0N/O,F_D6 JG/6EDTSKN.(]JC:6P. MH)1NYXJE']C[F&1(\:0WD.)!R+>_S:KHDX&7K([]N[<\2C[$[.'I''Z\3&.; M'V VQT;QCR%+?>XT_%-3P[QXI MZ[F-WQ$LF\6%1 M\\7GW_G!*!7&Q\L["+:]8\.FH]G+IEMOWSZ6_+\W8?6C5$^IUWON>CDQCG#] M8JHU\I.$*6,*VE$8<%,Y?)4H,YNO4H=#*E, _QN5;"_Q)+XQ8A5F%N_(!^;W M$]93E1%'DGOZ/!FF-7=2]^I!^H$S5/\)*O##M$,R\&,V8F_,/O?CL3$G&^\< M2FC\XS)0[ $1NCJ'",R<'%NV9$!<#1'-Q9KN.I#($&-L6HY35#$[)RZG[10Q M!$0(B*@-1#"M]*2A%S&GP.OU&$1$'M=SKC41-]2%?Y68[%T5-L0CABWL*]', M*C)9'[$)O%YROX2]CAESGJQZEIZC\'LRF#5_8&X*36F V+?+\>VY"]13792W^* !O+B^WR*H*Z;JH( 8R0BH@! %0QDEVD& 9R"FK$N,<4 M60R(GL/H=9_X.GTZQ:[>]&D>:E\7(UZ]RT'*%\*W<&U?MZ*I\RR33K+@<^;A M3)G=[-D>YH:]/]B4U(V#$]3+B[F*N39ZKG4Y<:<:7+XIBG!JPN&CP7 5^8.F MFJRR.7:SH#*;Y#RRS'Z=!I UF7IU8K&+RZPM& 6Q3UGC)OHEL1\.6:[LJ M-"R,3-G4M767.27J[(*!$QXN)9P+,5GYOK5"I!AY.OF+TM&%EYE+RBQ>4_*>BY>9TD9G%2T&8KA%/XFQ5AY$H.RFY MX"C&,$J_-7SE'__NLT^SSTH!_&=^]U/? MB_JQQ+?0^?VRRG'E!^_'XF4=:>O1S=6O*.Y0>?\>BX#Q@ Z',ZY+/S!>IDMQ MC*:%RV.,?#]^*%NT_9W&AZVW&W"QN\= 2$,(8=. )D) ,S3H0%G1-$V156+; M!6$%G\*;4;\Z4:A^E?[8*^.KB?;J=I!4MA2Y?PG,HHRN/SW?.-M>LW-1';P\ MI+ NGCS&[,TT Z-T;9N/RG^+%&R8,'2.FA?S>.2ZY3WXTRD;AL5\G M48I5TENU2UEHEV(@DY@*@0Z2D0&9FD$+RM@!AN,0%9CKVF5ZP1_19)ST7N^B ML$?3HIUX7OZVM;A%J-W)U.[-.O; A#6[?3 5T_3>MIG8+Y3KO_X=0Z#_%$O+ M=?7_(?-R^K$72=]X=?VE%$Z2U%)SD^VE[SF4)U^\UXSL:':IP&'O22O&#GUX M2=''$&3U3+J=;FNX"@"S9MI$" M,(,E&ZHN D"V -0<7HJPT^URZ^7B'&NNV%_Y)#[%DQ&S%J]O#R+27_<]";C2 M@WJK'+CM_/V$\49)]?T;JHGV*R'R]@D6I4'$->K?=Q'1O0/1A[3RB $BORZ9 M^R5SHGAK\:>HF=KK'I'2"2_G&^05\ZFN)RG4M93$:3:I%*0!-I>!86/#.5K.G8P?I'B<.CWI7^7T_\T8P-9 9S?,< \Z)#,RC:^3K+K MP _(XA_K[)JU2>YH WAO!BIA]"F5BJ>G3-69LS0]!_M3&KAQ0,B9"@>ZP+'Y M53NVQFL("8(J5&T-VJJM:K*[-Y%W'L+G.W+_D&E$9YJ=<3LWY,;JD.OIGV_X ME:3+?HBWE]Z<19*W9HO J#UKA<>>:FM 1K945]8LI&$+Z38TV']4QY*)(5O0 M-< 10::3T%%&?_!!9^?08O%&)&UN#UB /<:WKO*[24;TXW48+S:*)VS$=+:E-%M]7+Z2-'T/E($A M_? U\"9]GWWT1P%=NS-:0)> KD9!EXY-QS2P8;@&T..'\W4'E/+5QA3!"M#'ICV:+K-D?Q505 )%6QF'!!2U:JI-AR+# MY1=9V3;"IHP,E\FPQ:PJE'53,5U%1L?RHBPO'D@NXY?PDZH"I^VLU 0XM6JJ M30QX?[YZUW!*2VBBGG!85KW, B'3-W^ M;RPY?T[\Y%4@UIOYI@LD:M54FXE$^]M@$^NJ9C#15U4=69IF$E\#7V4V=M M@68<[K(M/;S//8TGP]64O8"YW9D-#8%SK9IJ6W#.1,0A!+B.;>G(@=@$ "DN M 1 KFFQB[20XIWR0?N,;!'WF@O&50PY9[ _#V>\<\89A/.$['LAC.)D=P^+4+_%@"V<)I@ *0RD(6"R!X$AA3/Z1[ M!J)PF)5#I%OR^ARU!$;MSBB!40*CSA*CL&Y:EFGK.M 5Y)B&J2@(Z\1B2B#+ MEF8=N0)=ZG0^2+^!KD+UKO>,#O19UI9E3O+BF>3OL;IJ113 M)TO@V![,5$6QI\"Q<\0Q2X.*A4U%42V(%"@;+D*6:3JNKLI -TZS>J=^D+ZP MOS'\>J(,MG*+=0*C=F>4P"B!40W J(5(LYA!URS#-&P#(5M33$AT4\&6;%J6 MKN+]SMZ:'B/*,$5"'Z3;]-303I"=B,=T2@#)[E1O!I 8[0&28T^UF4"RO^C+ MAJW*EJYK-C.>NFE@Z$!B60K035E5[=,[L4!NQ MW4YK#Q(=>ZJ'(-'J >Z50U&Y+.=DWG67#\JFF>,Q%W??BY(KOK565A3P0E]> M% ^#)+1 9'7U*>1%/ !U A-ZE42=$9R M\N)U#(R=G+"7PSGD"!)VV0DS?C M"11X:NJ!"K;NQ=:N]:OSA0BF MGA53+7)M?;U.]P)(UYV;_S%)5^CM>;'8=MS.34=P^'PY?$U,Y[HKN'N>W+V[ M=[J,F0*CWW0E= 4#*KX$^@UWI$UOVMOA;IJEF_;$Y6K57")L)W3'Z0 MYC?U%&Z:?$^AF\G.]BM'=KNE\1A43 MZMMU'4@,B[G!_PJ%771Z%K$V]U=*Z MO;&=FZYCLT'>=&^O.S9Y8+]TF6USN"WK2K>N='OG9*/OUFWXY(8/_ NSQ[^R M673^ZC!08+\[TD?IA^O;;O?'N@WXAZ\WY*O=831^WZ&QD70"*1F$D]@+^O&E M1%]Z=)Q(8QIE-QE+WBB<,%#88YAO]JY*KCS= X9RO9=(Z8%]._FJZE]GJ4/CV=&!6JD@:JQ6;1X>B$%WHA]?!)? M/7O>^--])IAN%([24_?8._[F)P-K$C,"T,AYZ0TGG"0DCBG[;__!>V&.-$\[ MO23W/,/EVASM?P._/]@7TB3PL[].XOZ%U*<]GWGH\5\NKC@<,K;1%!BS#4E_ MN?!?F!,_&?7#9-KSXK."U$L%JC]_7)[P(NEP.MEX7S4H2+7L-MU3XN>)C6M] M(+)U*%@3H$-H#G2RKD/'Q;8I.P:RB8V!:[J6JNHJM)#B6D;4J\" M@CH$?/GT,N#=*R )5WJ^-OL-:J>I[H78;M5&1Y]IH A4JBFZ:MNTB%3BFI2@:T(%I 14@B-ZB MC=5YSP#B2P/ L];&6GG'QS"4]S2FZ7H1=Y#[+#P;AF->T_)&!6VP'J*%'AJF MH^D *3+ K$TS#)U@G1 %F :V9 6NA[<9,9D2V@M2.EG8<4S#".5+#*JTB[4U M?VVR<@U6(LU8Y(A,A!W-A@!K&-G\'!4-6!C+6+8MD[AKQFQ/):K0GN%+!8)S M4*+VQGU=.ARR,5Q*SS2@D3=,S9K7'_F!'R=1>@6;<#W7M!4OM%6U5<51=>9U MNB9254!,S729HCJN;EC0DE>U=4KP7S)R,YTE2\0^@>T#&KHTT'F[H;72X[J: MRS/43%W&<\U$NFL["K9MU5"1Y2 BFXYNN$@![%?#-:O2S H-JJY>8KW2Y97: M:>;9!XB=(/&"9Y^7\GIQ3!->WLSF]Z_EPTP/U-A3EF">5G'A0G%=5X98EFT7 M\<.['&)"J+A 3-[58V=+:U9[:U5+QQ9W<_1B]86.&!I-E1EPT"ZC9%,%&( M"R$6VF(-&B982^FFU2/,>9ZZRT0@Q3!-9"BF9:JRC!1G;:=?)_C&2,L+&C+]FQ'[J+;M$IWY(DRM M5+*N]NX<-5%3%ZLL *J:+ANN;".D69BX+B:$ -@0W?!6IG1[II8G36$ERJL MTAC63Q//*_3+&<-I]O6,?ZM_"L*KG\401WYZIHAIQS+V5+-W1-UG7-0 J1 M3>9HFHH!B:P237?=O16MPN(>Y1*H5:Y3-D?16A,*9I<79W'@#U,+^..&XW/: MO8"Q3:]A+ANJZ#(S4RY$T$&6XQ+=AK;AF)J,9-LTUIS5E!$W81 N9V^JLJWESR5&# M=57+Z2K[BR-#RS:)@XCC&.Q78&.$+*A;)BX(>F<+++/CCOQ@PF8Y78$)@]A, M*9WU>^!T_N('(1OKZ\R-)T%_^2W.GQ/6_(4F@["_2& ==644@$M5K3*@KFV6 MN$UVM\$JFEY7XWR6FKPE.P9D MN%C+58'L6(A8AD((DF7'X%OF %-GV2)0)VMA\QP3M-/71QB7 QSLGN8"YHG[ZG;P4 4T"FN;0 ME#O&2[&OK-5 M(8@@@I"*%H=B\QM::W%E0'V=O#.87VMX6;71EVNJ MV1>?32_V>R>2YH9=.=7X*Z4 T!=742#;1K9K V) "P'%-&2,(- TS= -Z)"U MDYH<+PK8K.([&G4YNJ>"LF,N9/9,/O" \[A#WAAWR!] I4>UB+6:NH"J@)1S M@!1CD5;5%63:P):A8UK(D!ULZ5A79!,["&H8K-UNLR.D%.8PW@8IBM@>6*!B M]?5*;'\X26C)Y5*GJ\!Z3ZQH#B1 L( $ K!N0\+\":@Q]X)OW <0 UN%MJ)C M>>U0UE5(F#*^>7Y&;=T)X34(A:]:X>%B_<+0#%>*9.1 MT8B9MW3U(I;"21(G7L"')OW0I52Z"1,J >5'<;'UV<^O-;P\B]/A*T++#6L? M;3[^"RAP<;"[;$'LZB8B%I&1BAW3 <#66'2O:4 AZP>[SS"69!![,QD]TNCV M*?7:X]L%PNZ\G)"!\T$E3!A= GS>F;]:>WNGPNQ6ZFCNN -+48EK U-U"$ V M4TM#5179-#5%-[#M*!7KZ'ID_C8=5=1*-WK43D6O%FUJK5]VB5$(B?=G ,' M"G)*5C@:1W1 @]C_-C_=YX=A&,<_YI-(ZD%'F1UE6U"S*F:V;AII0$G-MCW: M:FX!W2"RK:J&2Z""D.$8AFP26\8.\^5EUS4*+F'*R5^V,^B&)K=/#][+2 [23<-5=(6P (GOQK8- M#1LRMA2B00NO14=[ 5Z%AT.!2P1/NU6[GHF,CXG'1CG[^][O7CFY(3>1H1_0 MJ^EZ*(#R?QYI)IN^F*-EC_*3R^OCD)O$G?YVNA ?-/ M8XG%,!)[I\\^^!QY0VGL18D4/DG)@,9\G91GAV+* \P@W9?K\4>?_, +>C[K MS@*FA*8'M'U8F^F, *LS7Y_HQ='E05V1ZO3?031[QYC%A%>/$?7^N/*>V(@^ M>3*LFGJEN%HEJ-CYL]AFS_C+5%A MOZEY^\Q+&D0&JHL D"T -><@V>'ZSF6!'^S' M63RGH;=,QPV\/H64%P1GG9L'YY=[(EUW7*=K=9P;R^E*O]Y>VYV;7[J2=7M_ M=WM/'CJW-^^JGD51Y>V-[=QT'9L-\J9[>]VQR0/[Q237A,U!ZO[J. _=N@WZ MAZ\WY*O=80/]\9WA[H=.P) KG,1>T(\O)?K2H^-DL5%5\D;,K";Q'L-B]YP7)!"C__NH [-<,E[Q#(F2^8FG*I1X?#:6M:0\E_9\/L MS7XOF.6#/V)&XX9^E^[#D;<6,WSW^\G@DV%\P+*&=$V5H0*!C/]SYO0P?V;H MC6/Z:?;#3ZM>S,4\G31/:>*+\F13]D'-^,^?+M;;#O#[<@YQ#5\POL2 Q<#YQN.!^K6J\W^PP6Y,H8C K>7%,DUB4 M8)_]_%K#RS,LP3Y4Q[UX(+$87>KQ'^B?$_^;-UQ*,1U7 ]Z<8C]PWK4].^+ M^6Q>]%%E!2"*]$5%G"K+1"/ U'6D(-,P,"^&5%$4]G_]4;3E:OZ>IDR]U5G(2)]$L=5'K!0.V6=MKL.0I8:3*L&(MJ M0%7C6485*#;0$."W' #3@$@&+K -U5@[?.) 6 '&;VH5-X 9^-(X\[.NWK?T M_00>S$/D];.E5;Z@($6T1YDITO7S7SA@S)O*#'-Y@^2?^A76H(IC[/ M?ZB7BJS4N8[WB&JKY4K>9-659:B9JNO*2$/(M&4 755%AN,@Q5R[;HQ,J7T_ M)_8-3:;AXM&< *BB2Z16>1YV;6W]&9CT\]>?_!$LA@D-[+B.3FSDFA KJN4: MT-")96FVNW:#YG[Z4Y&U@SJZA,99Z(^(WVFG,<+;15\*6,1VIYK M:-MBU=/PXOHG*)L F@!!"R#900; KF:8-F%JI^K*VCFEFU6O(H.H .U21NI9 MJUYS=SX?*)EW$1U[?E^BV86)<1KHA0GK+/66UK..?)5E8[46+[360HYLJ;JN MZIJ+' 43XABZ3F19TPWFZZYM#)C2?GI7)0GZMYSN)"7WL:-#3;]4E%->05M; M:]HJHWFF6JC+B_-_%&++LJ/;AJQJS'XRU3-L'=B:B0D+.\':?L2#M+ BD\JT MT#CB7L0:::$(09?KJK-_'\+$&U9L:,_-+]9S9WL157612A0= 1LI*@M/+5.Q M=4V!NF8;RMHR[&EL*;B497RIZ2(J%5%IE42HYF;08ZIF[D@O5X$6,2W+L32( M#$,W;<6VD04=9!O81.MK(B!%1ECPU*1A1"!3(D0 M8:&C:P,%NT@A;].?JI*QBGZIRE4F8^MOHIJ\,^CB\SW_$*^HF<0T"_6D*XE+ MCI>P<4A#ZL54!'\K>HGEA5YJ4%.!;O,4T]SZ,9-H.?/EGIL2LB$FRB)3P_583J0A4Q=!3DZ+*J0X@T M%VDR,E1#MOF-:3I\JRI69",-]1(IYZV*YQ7>=8+$"YY]?L1#E@MM>D-)WR>OX1A_[L_ M'!XS'0K42PBK7->HK:UKDTEKK"9IRF)UT#%-5=<)7PY$!G&)I0*"D0X,VW"1 MO7:I^&&:5-6&BTLV_DMDG,6UGRT)\V9"(=S'%27$.??1)C9@:F<90$4 R@39 MJJG(P%*)[.#URM*CFRP#,34[\]*V6JE=74WCVS4#,3\0B0FM.A&;3)QI%M"\EWHN(T:@!%]IE0ETE MNJ+KCDF08KN&I:K0=@G"MJ[ ]2,"9J3,3H1^\%[F#N;QM@1>*I7F0VIKR]ID MLAJK.RI<.(2&HP);-S45Z0B[)D8F=BQ'A2K15-M>RV_LHSM5Q6+P4H-GL5[= MDD L+>,]S>:%\_,:M9QN$H>G]5VDN2YR <(&($!&V+(5P'?KKN7Z%^73-V'0 M.W+MI8(O#6R.VZU1U5N"K+JEYJ:J6YE\:I\#D%B>EORV?@9ML<-IGB/?A9T1U+1_8^ MCG*14D.@!\CRHAH5 ^C(?/N51DRD$X=8BJ- 9+$^J@+=-=<^@YWC^0N7JJI? M(@V=\F*DVKH&9^ !".0X*^2 BWH_Z.I$5BS'0 9!AB5C4U89D/"3-Y$K@Y+- M7L>KN.6'GUU"]:17JM7?(VERDJ# 5;GN$+-SW7GH.%V)W-A2]^'6^A]^ 9-S MW_VO?\<0Z#])SF]?.P^_BT/=Q9'^@OOG',DLCO0?^MZC/_03GXIS_<_?I6P- M+\6A#*N*/@ZCU"T-GR3FFT7A=_;=F/F.?7X3'PW\,))Z$>W[B?3D]3@BO(H3 MNL_NA&X $LLY\<5,FQU)@1^-QH_;X:A!>W8EB**2LN49FMTQUFYDP9P&Q3L(9U=_W@Q7TUJ+I"/HA$(=]9A>^S M"R*DL?>:W663\&MNQ&:0%76%\D)=-5?1(9*)8]E\/XAL&BRB="&035X>A-?. M&)_1^"XC<7J/T+&MG:%?RMIY7SC5YBBWS9H(%A=MV%AU'=T"!K]+"B #,X,) M7 0(4""SHNJ;-+$JJPF42_G,S[5I7[#(?N>,S*]OM=63AJH%:E15SF@\#%\I MO:=#+Z']ZX47<6RCA]"E=N9'NXG L)WZ:"QJ#VS-A K3&1VSL-!R( L(+=6P MD$)T9ONG&IX$KW5-1.'UL7'<[,YX:KX:J+&\_U9BJ@@(5]Q4R# M"?M'TX",+-9"H U;#.WN"CERCEP0KNJHTM#/]X.AQI=C"&BS38HG[(P MIE E!M$MS4$F0A! HMN :+IMZ!!;,@1O4+ZJC*AVB>53GF50?UMZ]C%J^6UP M%=K6LW.2%;30:\<$V%45Q66&%4$38N8RN\ABL2L&!G+6]/J$UA2JVJ5ZYFZQ M"%/;J8&ZEKL-@)@(*AI2=!5A135U]H-!-&957=-0]$,TL+)KXS2?W\:;QRMK_CF?G>?IY2N4I?1\N^='J[:*C[=51NXA M=]*FCX=D4L0DUI0!0J$35HD"$G)BJ&)00-0Y=W8E6 '9>_;<5ZO0D428AZ^2 M54O4]YNUZOYH55J$UEE\Q#$DU#A6'!#HY*5T?SK+4*]E"^AF)3TSOH)4) P, M(.W2&[.UTN\]";G=Y1[9M.]@%#&A">4,,H$3)&*<>.Z)08(P0?8%W/-7624'ES#NGF@(N$A(#RY1: M.QJ\UABK%6O?:&S$)=I:JP >WKTNR0B5(W7?08H,=S2&@ \ZZ3"Y] MD)6?M6MO+9A[^;L'YQD9:8I4<9)(#;'!B=44""PM-!S2F"%K 0=K"O.][-A9 MQJH0K&OWZWLYQ+B5DM47B;N\',\O,U]>U5< \*3C!I!-AXZ2HA^^>'=)-)]% MA[-Y%D'VXW9WQNH$O#?*XJQA<:NUA9K'_I RQ9;%)!9._D)M%%,HENLY"D(3$B06(4$5$C)%D',9<4V9MO'9VZ4E$?IM&OQ_/9\(\+ M9U-E>5$WP,S^O1C/K_M.>'L_OW>SEUM:D.+%W/LYKX/KA>?CGZ/I++I*\^AK M.EED/T%?ZZ:1;-%O-B[G0^-\0^.>:&"..T\8PX MB25C#:65$E(D6$QE@JBRC"!L.%\[1+C)Z^,1?6K:X[FO924Q M(JT5,L$<0II@HJC[0"T1R&H Y)H"^2CNV\:<[>WCOK>MB;CRT+7R3!_#-YVX M/V;36GS^"7P"L"U!$0%WB5 A!Q"0X#,18L QC<9%X0LJIO/HMS0?7D08#B(/ M].$:DPVSR],L+SF^_ G*0>2>=94YTOF:3=YMK0LN&G8'OCD&P@+)&%&=@)A M0BR6L72_)&*MH6*Y@9N0M#>1&@23&$";$*-5(): M&7,!!0=8)&RM@_'##--1M$"(+B/PVR\$W[:8X8L)3[GW^3U*)TX CD=.SD;# M]&H\3R>]>GJ3_5##?MPJ Y2)#5(QI4H*;!@5BF!"&<-DO;O34BM#RJ^]/,+J_R["*;%DX21I-9 M\0ZK;3S$OK+E(E+6(@2$XUA,J1%6Z(0#Q[I*)08QO5;\IK7BX?2&;J]W>7#R M5[?HA]G\Z.PD_?XR$5JXI7'?/5S13;Q*%8Y=X?[>S'VG?-WR/:'$<:\PF"8& M4BRE4)!CBR03UD((3>=\_129_1B^YFQ 0*>'.W:=K?$IK*[Q7LG7RPR!C8NY^H\90%+,X,;%V_UC)"4-LC:OK1;;5&K>XW&1G MX^%X@Q4? >^XJL'6'@?IC=KWP(:L$:[4&L(2R1C!@')#E2*22D %$983N)9W M]!PV[*JVB*]'SOM36=MC]*Z^A%QUWEHN?+KM2'1Q9T)_7_7@J6C0.L9BG4S6 M"6;*:$N)Q,)(H!!B"&H50[X6YFV?J[!A^3<8UL4$#@1X33&\?2&FWA[N>7B= MAQ$ K5:2$*(X9HK'V"O66DCB"Q+I)-':W)))_!@>[BP,3" ;<-QEN&CW>'B? MC-\[!72K9DF(]3Y58#]AS[';\]%LX7LI;$0U[\9)\*=-SG/K\:E5A-$"(,_Q9IXED#^WHUFH6>Z! M])BR5YA"F[J+B<42"04!H(8J 6*DE8E1;+D%&.LU9^+3,:4K'\8 ^P35-\% MI@1-YR_SU VF_KZ+9[DO%WDUF31 22$3Q@DRAHH84)E M832@&@%G.,4)!M3?DZZLPM.FECYE7M%%[G'E/PJN&4\@I!JXD6$H%+(&D81" M"#1$S#Z+=CP'>EKPA4;\%B_7,%U=QWOV^KUPVBT6S<'AB?WEBXI^/4CLL3ZP MA]H>1W\[^M4<'/YR'.FC+Y^/OJB3@Z/#;1NX/CHT]O#8&C?(P^.C7P^,.G$? MCD_B_C[=M^#_\?JA^-P=NR#\^?F@WU)6E4[IK M2OWA8.J@=;8HG'5;+,=W5SXVN,4WWA[ZU*L,DQ7="X)2TPKB,QIFDTGU:RCS MXS^[5P[KS[<,_61\Z<3"8?8M^C*[3->TZ\LT/Q]/R^&EB_FL_J)4UL,WW\:C M^<5/4GX2@ (F$&)NB07]327I59#_5?_Q\4[GXL/1T++UWXL/=?I#R MA4S^^>+QWEF]36'6-WY\U\]N\7$Y> M9]%O[H>+(K*.J4?-"8?=\?EMD@X>K!"W 3IXPDILC#*\_^E]^E?ZK0=0/HOY MW;RVI6)B5VMQ]-EZI?CPETCIDX-_')PXV'OTH'^S&'?[T#'E&"6T5;7]40#*(160"-.*8RE MM0 B)1,@@29J[>2;V^8FD?Z&L]R4 ;C_.3%=],$<0-&EK[P/K[V1!.MY^U5Y MN]43GAL&@($: RDI8$CA6!-B(-#,_<'6\H$>X&TH_P[_W@EO8S3@M,M4H"W. MZ-EU!=\73OK7HJ@Z*,QG49XYPAB.)UDT78I\_[W_-$R+B^@JGWT=>[?(Z76K M:[S?XZ\A[MK; KTMT.]^)[; QH^T/Q,R3';E8&*)W6G M^B(^ /*=M,E^@NJ[O8*LZC]1Z[GI]^@TFV9GX_E?@IY;O%R@O"[K=&<(D@$0O1VX*W9@VSW@CU.,LM-Y MZ(>43H=9*(1='G;.2NW(?2B*F7F:,SXY;YH-H6[7=%34?^NR_5 MRF>C)%MKM-NI2"0#1#JM/005KI&M,M;!8 64QE5@+S+DQ1F&) M:!)SL $&[4[PP@&F739NVCX&W2?S4 V'>59+W=.9$[%+J3L:%T.W[/-WJNX* MT#"DD-!8S PCB:+*0*DLT#IFDG#+%$:W%,HM5[7RYFPT=CB@J.\LN&?B[2V9 M)IQN_.=A]NV?-T\W/H%Y$%TR3RR0X<@FV/U!*<)*$P-]&UZF6&(U?#KSO$!8 M;;(![Y8+I!TW$7W29.0(S8FEJUF13KS NLI] MS\NK0-_[T87_DTNEZUO,&, MI&%&PS6R$G/%$*, V9AA$3-%H4+,0+S&C+^DXZE?^:.I">L^+M5,5139_.5V MWF.B$[C;PK1;ITWVYMZ[Y$G6G!$QV,0R 1A":IQ]1R7@4%N;< .M(NO.U"?R MY 8BAICU%MZN6'CZ(IV>9]%X&IVEXZHQO9>=GDS<0)R\#(6+QJ.025[EDX8^ M22_MMK"]O/E 0%^(1F RP@"/8ZJMTUX=-\:)L_@<:PIB1$+M6N'F>%&,IUE1 MZ-GEZ7@:5E0O5UJW%UKEN=^9D/A?;M+!5%UZB_OH[(Y;ZNIJU_!51"\<@$ZS M4G]^%THZ9EN* 6H80BV% M/_V9C;_ZPG3O56ZS)NPB);0T81 YM9LRAB0@*.92F4183N.UX@D'TZ%O')R9 MK/ROD\75NGY9+NNK*,Y(###HSW/M (CL!TL]8,_*ECV+DIA F1B#!:0**64L MH%BC6%*$..^(ISI49/& @RX;!>R*$=JEZKNU)[-NAN$4#0%[EE.:NL.\^ MF9F?\^PJ';?3Z.M83S1]6CX:H$;D)D 1CPPT2ABJ= M* @2& L4NMT%KGR(*5LN M),1C)254 -.#42**42UT=((AHUAFV+*[L0N'6#19:[_7F02;JTD]2FG?H\Z ME(X[J @_Q*"M4BB)L-*QJ(VEC"EF6@HBL17&FZQ*\;6#W>L,6B_Y?X_G%WI1 MN)EF^3+%=Z.UP7!?3+,W4W>/.Q]4:EN%4 "3">%.@FIL*28P9DYZ)EP+8*TO M2=TY>V[@K!P4O>&ZIX;KNF^XMTHSB%KE<(4P%A"(D$D U396&#*AC>7<))H^ MQBH-:WPXFU8K_-JV*!H@T>5)FEUAT]X4W056?(@36_XABAA1[@=D.:.*@SBQ MG"H4.T4WIA:M%7YX&2=V6<>3@2X%Z%X8H!TQW NI,'Q:[4U\^-@F92_5>Q_H M<]WI,E8O\U>LOVD[&)VT3=I8&P.D I;1!"8JME@(1'TM"0J2-9'KMDR['?M< M;5A\_7OAR]$WH9WEGFTT;1@,!.RTT,MS*>1YN]U;PUL@J'M46$6%5IJ5 P,% MA8(<,'^43BDE.<#>WX602L!:&8N7H$*'W9SD@'2J?N\9*CRL4VQ07>_8#KE% MFS@X_(<]/CDX_"52^N3@'P[+3=I<+'V)"V3"A5E;$)(Z14DYV2Q-[B:V1Y21!!"5K'K27,V'?YN =FLN> M1+)1$9WEL\MH.IMGK9)PT?O3KA]@4 (;!A66.\Y4EEIL: *A(+%17/+$$B<\ MUTODU$N=N)76L\DD&Y9UU _=HG=9,.ZU^+)/X=Q)X;B'3(E!8_$:*;E, ($L MIE(2$4N$>6)\3Z 8Z+63P,]FR@Z#3J3+LT?;QY5O9[QN6%H6;G,WYF7>76ZD M+6Y,$J>P&FD Q)0#(V+*%8Z%%5PG2<+OX\9CM[I'9V_B3,9[4%RC1U()8)-+$"%.@K,;:KFFO=V1-'=2[UF$N MY:,.+\ !$9TJLR^EE2=Y;3O)N>HCN'T.YEO""04-G%"&#+"(:\8YY8)*I)2" M'$%E8VN!Z1).-G&2D0X$Z#0._*[A9,^3-Y.#0W6H^^3-]VH"[OM>;J$!LF'_ MF@/0?/;-#2#D[PR_*?];>1S85_TAF@%A*642 M2<.E9% GB63:KO#4%.(@2(6*XPEEI1"9M>.)W_)KJIE?#7) MAPGIF,WZI,7=$WL[S&ZM_(M$2(( IY0814FB!8 P%H0)HCEG;.W$P:/9K<,2 MDWQ WB6WO0L+LCK^YRW&V56@UHML=)YYF>A(*LS79S;Z3,=W:#P^R,JTL1Z) MUA":1,08))0G3#) !-"*06F13I::ZCC-Y\OLXV26'X5E/W!&^O>3F5=9L[SP M@>;-EJ>$P G1OI-8;VWN/Q,_Q,,M#Q" "F(%*+&64\V<(4I5HA@52FJE*>N" MA[?TV$!O:KZ:HW9-L$;CRE.QMSKQ0SPHVW*4*B$I-Y8#"CB4(A&8:Z-BH4&, MU@_RK*0D+U=VTU8HY5T?G=M:-^M[DF\[RT(/ MED)HXP0>P31&B50DD5P1'L? 6K'F7[T]GO'?U5)O4L 1,G"PL=<:9F_QO4]^ M)*VRD_;JFTW#Y>W"=KKW0,>!'IXXI+ MZ\X11[''O=L?,>GBEM&8\ M[==SPV6/$>O["_0FX79RW$,,U\JC(9HID"": ,IMU!(3B%T,@ZX_VFUGMOV M%(;;4B&WY;)LQTW"=N'0N>]!LG9Y.9L>^_7>;)P0O%;']7V1C;W5N)M, M_! /M[PX!FL3*XF$BC%E,E&0(1$S98C$,+[%B_,,'MY2H=I;CJ_F9\V^9_EP M[(^6EY[6,D%G?PW(AQBP52G%Q)(F%"8)E)#J1$D!H<;&*FBQT/']E5+\8I81 M^\+62[Q1*W* =X'O;:W"O>!C5HE4I E2F%"@:6&8D:%51KJ1"3,8@SMO8'" M1[)1AW6N!YSN1;S]/9B'_F!\-$^_._OP*AV'XBC3;![*?GR1YEGLM-.14TZOLFF1^C%L-,XXP-WFH;YJU8+>_MQ.\?P. M@4&V2ID BP2S"E,0Q]1@+"TDA,!8_,WATP='B:<@ I[X%A%]I>O' Z MX=,C.M6>C:?I=#A^S?)JSUFM+2A[]!!4M'Q94C&'"P8Y>]K26"+))2,6(VT- M(E2NZ1!W5#U*ZKUYG8:TD*$! *]:/&TK6TSV)OF[Y^56-I,VEEG'SHQ!2[D M,4MX3+7$ J%82]8E+W=XPG2 99?^L=WDY$?7&]NEHJD?_FK/SK)AR(7*O@\O MTNEY%N5.Q8S*OT/QA2#G?3'P\(=W$7QU5--!)O$[M %:SCW.*( (Q@FVB@H$ M!&%(QRQ&2N441U0_*KPL>MVPE8!S*XJ$_L('BW/(I(@X4 DQ#H% D$:0ZX@8I9" MJ9'":Z?P7@4\-E T56Q'__I=@8Y]'E'MCLO*_[O-DX1>J MC3$E[FS4TT#%0 "X#X''WEFP#UR)6O$_%0M.($4AJQM816(G9HQ) . (T[7X M_5MS98?) &( 19?1@2VV^W<]&^ 6V:OODK51.H].L_/Q=.K=_+Y;6*"Z7IE_ M*DJTO(*,0,4($(AJ3 $V,F$PB6'"E7"@(=9T^2ZU]H/ ]*0+CI=B(&&72&0##CNMGO+09F^M4K('ND?6^(9N)[*\BQ&>7&11.AS.+MV- MU]Y=L9BFB]'8[7M5UC/-W06^*^P\.\_32725YB$38GZ1%;X:S-1!ES_>Y_X* MRJA/O:V3'-WEQ=Q]$=)R/ZVN0_BG7)Z;,U^?Z(?[5Z:#=6 W=BG\>Y'7S[A* MS[./IWF6_O$Q/7,C^BF=?$NO"_>FOUSDU632P*.%8181+!'5 E(KG/&"),?, M)'%LK4&)OR==686G32U]RKRBB]SSY'\4OB%D B'5P!B*H5#(IT8F%$*@?4ST M6;3CZ=?3@O:(T XRI6M4?==>OP:5WZ*['QR>V%^^J.C7@\0>ZP-[J.UQ]+>C M7\W!X2_'D3[Z\OGHBSHY.#I<(]HW'K@^.C3V\-@:-\C#XZ-?#XPZ<1^.3]Q_ M?K.')\?141+IOZG#7]R$#@ZCX[^I+]9/S'[YO\>1_?OO!R?_LVUS^N'W0_6[ M.7#S^#'J9FSRJ4,K;_CA8.IP;;8HG%57_/BF0[E%327I59#_5?_Q\4[Y_6'HFFH:2X,/=CHORC=BM]HBC,Z]T>C6>IY.>4'I":1/*<+BX7(1C^]'1W-T4^0/Z>7:138OQ MURSZ=797V_>>9-XIR7S)YNEXZNC%IKG/L^OIHZ>/%<5DYL1,5#:P>\ V>3@K M:\_7*M1%N8.!WA/3O,O-5Y>SQ?-KF.WYXO2%D[>^K@,'ED^I00 XZ[S)[J@@6:LG C$$*2VXPH@!B3@5 1UB2#19[XD0V-C7E[RK M5WKW&/'<]$JQ'R=->W#85B%\9V66BL]@JQ(#%]9:G= 8QT;3!"%C4. S Y!" M:*VT:QUE"BQQ7$G)#AAMY;F=BF,T$*P3:7QCW[>]N$K/G[WP?E54P;!IR(DX MQD0HAR14 9 ;%1 %9N(!*"UKF0;DM[W@\J+JSU!* >2=%(LKL>6'EO>,;8\ M!"VT@19EM5(QIY3$*M8T)C@)AH$$-A:"O1:T- D5/I_B8%IE4W1F), !@GC MT%ZTJ.GAHH>+5U5%6KW!&3#:-P+',C;( *>,0![P EG(V'H%BTWA19-7$])J M5K)J#J;#V676O8+"V8!T4VNNUT]ZP'G'@/,0WLB6Z6.P-<@:2TRB-6-#M8F#9.[40#*(160"-.*8REM0 B)1,@@28J>1X+ M]]S7I9][)]S99>&1X4KAD8FCD4$TSIGJ2V M+1+?D]$>DU&/3#U)]235DU1/4ANV>Q_*,2>T.:R.#%!<20U%K)#D$!/ESZ1P MS1-C%<$W#=^[,L"]'>R,XJ.SD_3[YUGN7ZOF\WQ\N@CE_4]FG],\F][=GWP7 M(_TZ2CWU)+E_9S#MFAV4'@L*GJT?S"S>G\XLHN[R:S*ZSK/KZ M:I$/+](BBZXFZ73?\^\>%42AL"F+!F"B64*0C E6RB!I82*%59HPJKDEMYX, M**NBF47N9O+WOJ[*ES&]5V09K<)Z>G8RL,XD#%DD*3".S4]A@* MB$',U2/5]G^DDT5VI];>F>-WM-GB14R27GOO^7V'^+V71CUU]M394V=/G1O2 ME1A!C8L3$01C@2V,.=** ("YUY6X(Z0KF_'F<\5S:CG MR9W@R3WE0TD;$1G'FB%M+*'"))@HQ;4R2#&6Q(0IN$4B&?F"%B;WL"7A>U'=L^?+7>#+ MA_)?.9)+QI0,&X5A(K7383ETRJL*=B7'1A .S?8P9BDS^(!@N\Q>[9G M[NUF[OZ\1$]2/4GU)+7=)/5(%42(I0J"F>;.GTU,V 8_D.U89W+WOJ[*ES"T,X@C?GI!F7&FC.@3:<8A8# 7S-'<$81M*0M1". M&OUK4E-<^U+]N_%N!C/L^,L_SH>9J5]]R4;SLZGX2G! MU-LJO_*][F0N.FD)VX-##PZ]Z.JILZ?.GCI[ZMQ:ZGR48B5QD[<&+;.<61'3 M1'$F)# Q#(J5BA.DZ%IJ]YLI5KTR].Z.<@0ZBO)L64(JG8ZB+*C3P0L>].G0 M(. B\V03IGHZR:+I;)Y%X^H@2#C6L;I6FQSTD[%VB\-I?81VIR573U(]2>UU M?OY#@7XIFR1@C1B5TLHXT9K$S":4486!L10!*?1C _UE@OY*GNZ7;!PNVX'\ M?$S?88[ .^#?G18)C^)E!$!SZ TG-*86)Y( P;!$EM-PV$8;%!L6L^<8+3=8 M\NA,-PJER4X[*\/^@A3_QR0"\0'#G9R*ZYF\9_)7=DPXEFIX/,8)X@H)07', ML5&(QT2*1&*F$@L8V&8>WW14AZ !Q:(_T].S;6^N]235DU1/4N^;I!ZG7+3K M=X*$QU@R#(F$0FIC-/#*A6"QD)0\*^KQ;.6BB\@&&4BP%X=\WTE"OW*#G62Y M;\95EYMJXARC/G5V=T)N?0Q]WV+H/77N!W7N#T4^SD,*<7.L$6AJF)&)X1 9 M C'CB"K,*4)*:B5N[ROTI9% ZR&/'8AN###HI%+G8TEDUWVB^\S\^RF:'@D$ MM+%TI(D!X@;1)*8 Q!"11"A, 4JT X<[ZI+= 02=9KYOIM01IP,"NJR?TH- M#P*["0*\ 8$82@8E5IS11!B=<&N\NR.&@">4F-OK][X&"&PZ4 +9P,V\AX,> M#O87#GISM:?.GCI[ZNRI MI'KW^0([+0]ZDNI)JHMXS2P?97D]>GCU/2IFD_$H^@\0_F_/R.RAV?9DV"-; MCVP]2?4DU9-43U(]2?4D]3A/#F;-@6#N2#".N:#4@A@*P&WL#PQSI0@T$-[N MR;F839QB5I1!K577S4'IN?FO= K@1__W/\=I/O^G7EPN)NE\_#6S9V?9<%ZZ M?H[.:ML]Q,,>=^4R";F,CSTQUO8EFZ?C:3:R:3YUFU-T?_80@4[Z?_4G#WMD M>'UD$ TR$,XADTAK36/*8TJDPE)"P#'DD,CM1X:>J5_-3[S;QQ#B=%*62/HM MS8<7$8:#R-/GBST6^.I[-)HM?"VFVF71Z4)5;_-7/,$Y\IJGC8AC]64R;I( M9K4TB#/+H(56*E]C31)C42+7^P^&)-B#VXJ*5%"R)4VQA1Q T$E)D1=3T?,H MXJVMAGV.&+]LHY^%"ALECF>BQ9_>!$QW&SM1HXLIR2PED$IAM$5(:@M P$YF M4*QX\E1=; ,(^MSHO!"==&SJH;.'SKW6M!XRW0AN,ITYM3$!G!D,#-=46%KV M"9!"L\30-55KY13"K0>=GH<7FSOE1 9(=G+*J3-R>I(M]Y:BN,^'[C6T7D/K M!G-I4T+<@6RL*302QPQ10#"5.F"NB@71R5JEK@VI:!LNK.?&-*"=UMCHD;=' MWAYY>^1]FFW,&^#5E&'*D00J < HXS3?) "OCA'@ZLEQBF<"KQIM^!#? !$P M]WC;GXVDYO'0QG]5?E)(B?/-M/)I? M_"3%)T88P$1 YOUTXL\U73EBFZ171?93__1/L^B>V]0_:N"><7.19%OWF?K@H(NL$Q6@E?QW*!Q+Z\]FW!XZS M["%ML'=!&F6>9A04V=L7I-_\O=W\.@.DW_X;V^],L8?GO4%2>,*YIHT11Q.E MCGR8^N/!-*H"U3VA](32)I0F !>%"%RT$H*+?IT514\R/+D[/ M&3UG/*=2Q1Y2P8..SMUP6/S@C-#YQ6Q1I--1L?_EJI?51OXKG2[2_#JZVUV[ MBX6J'Q.>QU V3?HPLDHEW%J).+64Q=27".$<:DQB&O.GU06!XN]D6^J"B $@ M71Y2W=H*>5.7OAO4VH0E%3% $9H3A( MJ "06L65D@FUPAKERR,\[_A"YZ#R\G-C" P8[.1@;H\M/;:\8VQY"%IX RU( M0"0$.KU$$0RPI, I(N!9IX">@Q=O<;"=T $AG9PQ MZO63'G#>,> \@#<8-OI)HI+8QEAP S5%',=6Q]!MYL[.0V M)F* >9<'%WNUI$>)=X$2+;=KHGP[%1RC)"84BT0A$&/L4 (Z;<4 _5R4Z.9L M,J<#+KLL]OAF+/Y..ID<9O-H')3(3;0UWZ8(QPNZRMXUS:V5/^^OQ,<+!-.+ MM_<5)=9+:G#T#-8SV,O[B?>0WU/DUO91[*FSI\Z>.GOJ[*FSI\Z>.GOJW&:G M'FEE/7$#!2<8FY@J2K 6"(@X@5+HF%I@[$VGWF$V+R-__E#]#7^>\4=#_@[_ MY\1LC>,?#3CMM -,S\,]#V\%#W/8XF$&@($: RDI8$CA6!-B(-#,_<'63B4] M@H?_?F)Z]NO46;\3/OFR>LIPI7K*Q!')()IF\VAV%LW3[V\=M'MS/6YKH7X/ M$+V/_?;$WQ-_CZ$]&;V"5MR35$]2/4GU)-63U&92^BEO:@- B./$6&&!U-0? M,D1*00H4)$1I),5-&_VNA'MOLCO[_>CL)/W^>9;[UZKY/!^?+D(WA9/9YS3/ MIO.N/'-OT]L.#A#NQ&W0'P'HV;Z7)#U);2])/4Z2L%:5&A3PL&SX4_G1 -+]P M=JW3^[9>\LNKNI MFG60[W5DZ3T'=CL7XWVF_5MKP#V#[0R#[93T["GR'5!D#_D]@_4,UB?+/=-X MXH V17ICBBS%UM?MIAPKD<28 D(AX4F2T+7BH7<83_]()XOL3MNI,_?[:+,5 MNSC<[^R\]\SOO4#M!6K/8#V#]0S6,UC/8#V#O;K2S9J(!84Q YI:'C-"C; * MNC\3(B1&@B)U>VWM;I3N;DZR[+NB_*;'6#877G0[&GW-BKE[N_\M1)NB4TU3@'9/4]A" MA6!70$2 YG0Y3A $@N@82TTE $[@,VD3'L<2TA@]R=GV=ACR7*4!]>C1H\?; M\2%D30,*)\V!L8@J;'B"A>:Q5@9IJ[$T#-U>X/EMA/GFFFK!GA]W@Q_W(*'W M(=YLE546ADLD"87*2.H$I#(FB9E6-#;$R)ANCXQ\06NJ>]B2@KVHVMSSY2[P MY4.)]H*"AC$3*:A6*C&)8TQBA$*(6@2M8TK'I'A[&+.3,/%C\O3I@"'Y#M/T M>^;>;N;N#V;U)-635$]2VTU2CU-!))"-$Q[#!,0"*D0UE4D<4XHIQQ(1Q!-G MN6]*!>GX>!\=0/0>VUF_D]-]@;(^EF&U88NV^J,'NQ, [O-,^CR3KA?BV+NO>7%R>P.GWBP54YO6L%?LG\OQL5XGAUG^=?Q,"O-YB_9<'8^ M#4\)%O16N>OO:Z$^@+ 3+WT/#CTX]**KI\Z>.GOJ[*ES:ZGS,8H5 ;0Y Z]% MDAC+#(=642%9C)C0-E8)-Y)HL9;;_S:*530;1;VD^ MO(@P'$2>')ZS4[-\E.7U9/#5]V@T6YQ.LN@_0/B_;IF\>IN_ KI7%;/)>+1\ MTW8@ &\0@ $>8RHPQH)39IBDL4&$0,D ,X:!MZTTA0)\3Q&F&BSL!TM[%3DJ:4/R4Q)0XH M+=.4(BLD5TQ+R!1E@-#;\T(O9A,WQ:+$Q(TCZ'.5)2&Z/"/10VKT$"P M3DVL%Y/3DQ+#WE(4/R?9O(>97D-[AQK:@YB+FKQ91#72"4$RP0EEL92QY1R3 MF(#82"+T*ZEH+S@P]ZBN&0@,(.B1MT?>'GE[Y'TSVQB2!GBMM-Q: :GV%0>$ MC!'3&"6 QM@ZNYF\$O!N.L,"#J"$ P$Z[4#26\L]F/9@NN]@^J :VRJ;J!61 M$% 0 \8HE%B2!"*GV6*#..3\]M(0&T#3MV@"2MF \5ZW[77;'HY[.'X[W58T MNJW2$%FJH8$&^)QDB8WF# #K55Y#;B^BU3T:?\GFZ7B:C6R:3]UZ%ITIM5@X MM;:;\AZ]2MMC:(^A/88&#$6M8!@Q$#-+J##&4J?J*D(T9EH[O19@R9X=.^_$ MIL>2#P &/0#>GVKXE] ?>OE]^+G0US=(I]>."1W%I8O1V!E%T70VSXK(UQ9WSQR[%Y[GZ22Z2O-0 M6MR93$7FJ=:A=%DB81JVT]M3T=EXFDZ'8W=Y44O_XM,;SW0;5GL'Q["Q-]9? MWQS!^J0_;'R$_ 8JA'\O\OH95^EY]O$TS](_/J9G;D0_I9-OZ77AWO27B[R: M3!H$1!$+3ICTM6R)/98']A#;8^COQW]:@X.?SF.]-&7ST=?U,G! MT>&;LNHM S\\.G$C/3F*?C]4OYN#$VO<: ^-/3PN_SH^^O7 */]U7[L;AVOD/!,+!VIOJX%%^GD['_QN.ENBE M&'4?U'3T.7=B=CH/'X_.DEJN+HWJPHR+X616+/+LQ+TJGCC-\D-81/_Q.)MD M0=O[R(P12%H,2"PH2GB,@3(.CX!4"D(2?VPJA,94,")CY9;;4,N2F!DH+8-N M-X F"2AUU?%TD8W4_,GO<4IMYC37*X_T^2+[\-?GK5F<%N/BZ$PYU67A!W/^ MV:W:\+K\]]Z54$)H01!+!#8)<%-*-)426Z$=M4%+6RMA::($U5PE1")->6)$ M["Y- *,,6,'O78D'W[.V$K$Z/CB.CI+H\Q=[[!BV@J"5]?GK^N2/>R+P\[=L$/Z"/]??S!;YS:\6 MQS8ER2V,I%PXMTZ@C)6;MEZZS21_-_BR@+7IJ!>WVQ MF'@Z.W/;EI4+6@0R':;%1>0]ET7]MHIC/D4ZR\,TQ]/24>,WV]]R-IO-O9$= MC98RO*CFZ>8\G@XGBY%;.G?GK:MWE6?.&"\O\"9\/@K=PGRSK^B\!"/W&/=+ M=N5W(%V*2G>G>_CXRK%1=)%^S:+3+)NV-LZMX.QR/)_?_F@_M?&T<")K6,[> ML7KB!AU!\/'O85Y?%I.L)"SW%8!^/;YDYS[4ZJXO?SC^^/]]BDZ""^%YI%-< MS!:3D1NYVY(TC-/=\Z_%M/35+0?:0BW(?RX>\>#0(LW=>9VE>91-_09LD@N- M(UP?Z6@S8G,N].F,V*::VQ9 39U0GKC]<"#K2'ZZW+K_%_9CI^:ZLIFGY0E; M1QA9-H^^I47D.'?\U6]S/KN,:AJ[;<\'T>EB'HUF@?OF]1(&5&IS9NY!P//; MZ?4=S'0+UU7;\/LTO#VH[<6GZ*C$#G=W#2@UV2)RWT99T0\??E'J\X^7!P@_DTH_#S\Y= MGLW+.R?C]'0\<=(T*TJEI>&9:AW\R/V;5Z[TM][R\" ]\^QKYLR/\OF>-IQ0 M<%QS['9M?.8(R3VK-?HPT* 15$]8/M(14S68AA,?L2\-_\^^I4%K]63I8QSS ML\6DW@[_GF$V_AK<8'Z@13H)*#%?Y)5.T#RA[,CI1-7$V?G^AJ^^0H2?ZWCJ MYCJ?Y6%1_+=+"AH[Y6AZ/@Z/+Y>['%DUU7Q>N0PJG"A'F0XKD%J[>Q#6(FQ@ MOMSV>AE'CK)F_RIYL*7)+/S".8(I1QNVS-T1C9U,&>?E:KF!3F8^!AJPMD47 MY[/9Z-MX,AE$K;%?+EVHSU; MFYE[_/.0FIZG7I%Q+W86BU\S=]?R@9Y65K8C]%Z]I1[TC5T+4J>$NE)+JD3, MRD4!XH)*&1X5\B$J9@DA-[]KH^QT?L\C[N*KH.=Z[7=)83.'W<4>G0\8KGR#S8<^%1[L>O#N9GB\K\N@5+_(.RR3C[ M6I)3J;45LVE@A6!$E[SI5'L_H>$X'RXN'4OZ_?H4J>%\$53_4F0,@^8W&I]Y M.S,(]_GJP$M-9CK[FDV\.>E>\W6[++T6)5YV1[5BNA;YJT9MQ:+O&4C M#!SH7E=/BV-KERW BI]9F M:LZK-GJ55]K,6U)+5@*H>X4WJU>-EZ7>>)&-SOUZK!#D"N/ M$/9_N>%)VDKQ_S0WT9=Q\4?)@K^[%0F&H6?<3I66+-B;8>WCJ/=;_[S\CVE.C8NQ>SX M:NR'Z"#HO)*4;>/=79JG5^.1>W/V=3;YZM:^G%DSR*&CKMFE@XX ?FX_/:R7 M^KX#!L\*_OT.!>?M*<_'2X N> -B)T&$V\D:)PPN'N7[Q M2H7/OVPR_B-S(W//KY;V8E:$@R+%_XV6@B*H@=Y227N.CIST/YDNK\A?6">HGER*Y$ M6D=H"R<2ZV4)HO%KT.6CPFD+HT E98#"*^"!-'R.3)BZ'W.U5"6%>@4E& 1G MXR+L>;@Q2ANG2[&X"D:\O_W":9;SBZ'??F=K.=ISLJ+9C^N2.;]=S!S"!D*] M3'VELJ#EMH9YFR3PRUN]TPD8KS UW/;)/ZIP4CWWFLR+^3G(+*<%9J52D4;3 MA7<7^$>=N4?.\C9MWBXI@_VQR!L=\N;HUD1]!4:W75O/Y.: E[P]"#Z"%>9; M12)GJO@1GF8U#-6;6@/G]4WEYEAYP"J"O<%0HVR27@=, MNTJOE[KZ;#'W>M6HQ*+&?JE,I]/LVI%>[6RM;BSC!X- <.XEPPL_O89W;@@# M]V)G;8X:"Z\AB"!,?(6\ "%M\\A+07#.O;7JZ-T)N=R3 M26.T!=IMEL<-;#+)@@/7T4NY"A[/E_NULMB!Y=W8)D%M*IV.E39\'5U-TI+) MZI>6COKJ5>[5S:26%![X;5K:O=/S67!>+P?W:2U.]_28YV'VK17O='KMS"]Z MV-I'1S\)X$3!Q!)H*)4(*TPAH]98JJU*A&Q%/Q-,E7#_AYDF%"9$)@@3R)1" M(A8)0_?&"1]\SWH<>/=5N\PG2#@.*2O*1??,=)3FHZW3\PZFT7\MIIGW MQ+(2/A-U'#MYZV=0N@35\>_1X>Q3N.0CQ(/GNB+7%_/#7Y<)#=%!RT#]&&D/ ME_/H5V>E>J_6R>S*L0E&[,=G^R5_ZG#4T6^-O14@8&6TWJE^V[0^/=^GZF'+ M;T/04>>E0[C4[W(GNUN(6+J^/,4Y["N]?T&/&U]Z\SNO?!\!FLZB83GLR7+8 MDUE:H7EIR#?/;;L/+K))@-;57YTVT0B#\O99*Z^EPEX_B:53TE/;Y>I*!BVD M=@:OCL^;CBWHO^D1F^?I*&N)M&J<:=N%Z:_SCK\'O!J#QA'1-NV#BK?T6@2% MH=3 PFS$(ERSRNBEHF7CC@=^,:W8Q3I5%U M*-M=_;$RP)M$C]H?X=3J,/8ZYAM"1N7YP2BK#A N_6CUL.+1BB[A)/ *-Q.))1N5/":?,Z&':GH?I@K*L4:N$0?#O6_?R8ZVVG MX#9PE&?5:':BNXPWNKU;51J"TWTZ]'+;&:)GJ^9@>;9E:3R7@<32;&PE K5< M*Y/T6P@U>7?)>5:K!./+TX5[0IFUM?0M77FS,>0-.&)I/*7>%5/,?)2K=@64 MKJO[W%9EZ*[V5-V\OQTXN<6!YI-Y@M)13_NCYT9/.;53I?HB9U/4KR]#+[-LO_^*@KSJNVL'7-EU)(-&E:M[[P MA5;6-/O6"+A*BA4WTQKRFR/)+J\FLVL/*8'* Q7Z2%EA)LO+E,4;$K22 MKTN;TI%5)4!KD;LF/>LD1+\ZNBU!&[NN.7ZQ?2 1/8 2:TX=AQ2T4Z0X6*:> M>%?.+^UH=*BTX[[TN>'Y-)U\_-WM[?'L;!YROQN,P!0X8^+YWIY!J=54,:QT M*?R<%&EE4WEZ77J JV2.(IM_7%P-6M;ZXLI)I> ,*$J/PR*OLVX=]\P6HRKY M))"Y$RS3.M$J1*J"!*ND5!I]S:8C]](?LD_GGWS:>U$VD F>5'\P^\=/T>_+ M=(@V%@U:DR@Y+PW.>']=X;#3"=]QH.@]6D:0]# M3D\X"UF"38[,EYDZ_B+W MQ:3^W%:%=]0"N[K/[+K#S%@^=S=L#78#0-EF; V'I\O-\1MSJ]Y5@ZG\"-&@ M2U=S68DL.O$);3]%QYX+*G'M1Z%6P:Q]\4MRR!L7 M,A^)G9:H6^L2V7>?Q!H<),O-KU0[!V#Y+'76?_DL1Z15PG-(PYMXNZB$Y-)/ M[.EV-IF=7U<(-QDN*H1?&4>(O-Y@Q%9>U[)%5YD9U\I?:F71A3?X2*E/7SCU M)PVK=+.L3$B['0"KI2IS83SK+9.I;JS;F6/'H>.W>LAEX+"T95J&9QA4^BT8 MD$W&9JFOU4KIC2<'1E^F"'@,KQ)R@K!R8NC*R;8Z$]8_OYR<&V:=,U9.KJC" M5>N8EY;G!VJ >U#!NP<6!Z7]FJWJ3X+Q[FWRBOO:J0X^2:H>7P6.#0HNXP@5 M"-X2W'\&#(8R*GACH%>V*BNU]-L0S__R$9#!:GVE#C#O2U:Q6O3%^^KW[%>5"K!DW_+,6)U'4F&&W]7Q9? E!.]1R!Y9>B9.%[DS M$^KS42T6_&&6+YV.-9V4+.0W_,?R>&28G.=I_]&[@&?3VX)XE6?FQ!.7T_&F MHZ";><6ORN *X3*OQH34WU:2GD_M:L-PK1T.:LWN:Z-SNCOK[,Y2:7;4>#&^ M*MHZ\&W 4L_CUX/XZ$L4L*&\^,84V[;7::E;U6$'][G,X H>W%L6IKT":SK8 M^/(R&WE/V*1,=O+.OM.L6I_1*@($UV UXS5DZ\M/-+7!;46W2]U85U=L.@=Z>;A74C-KE M^&!F\AUAVZJB!6:0&&83HR6@!"JIF$!,*R0P(AJ91U>T>,M,F-5 )'I6T8MQ MFL]_BJN4/[6"._^_*P5/Z' ]!X/%M6'7!V47?(N+E: M#4<^&9VTY5GEU=U@GQ[BHGI(*NY-Z2%?/9M'9_W$E7]2&*%O:$C(O5,XD; M)CJ)6_6M"2 )4$F"' 11H[E-%'8@I#F'B4*/(+HORQR2@Y&WML[&?FV#ME)2 MD0,BI[[\VCB0E#\!Z7O&UXNT&P0*\2>X,0+]5,FM;R&J?^G%>:1Z/#O>BH35$,F\ MJ2F&,&\XF5EY7:HR+(NE;ZHMRZNT39\_N?31>(W /;/ZJ97>[UTU54&(-JRT M(RUI!2LA0+$\"3ALA.]Z'F=:'UIM5(H0SUX&6U8U#R=WPF^E.[NN;[/4>9JB M(4V^@(^,U,$JA^!SG]@3?$SE8;ZL=-:&L'2I#54?V['K(EO>6J:[-9&85@2B M";MT<#[L>'CAY-4D.SI;UUBRT2/TE5#2]UY?B[80Q%!AECA=BFDD-!5& $BU MH0A"W?*U($P5)LA"QQ TP5C$++%8 $DXP"+13SK_U1'QG\U\*8*PRT$]=K-V MRH:[J+A1-Z.AID?2;W7.Y";Q+4\=M2:WTC4"U")^[-..RL_MV9U6S75Z_^K4:3?D*AO_\V6T=[>!6$/NI\L]PI_N'^NJQT?UELW;&(M[E-*GM78 MXQ:5Y'->Y2SDUT&AK[:!#!Z=%A>OM+]W M+M7&)_FLQF4OZ$OVZ-9CS^^,4<[G7O\VE4UPC4B-K19$"<6@)1 9FD@9J\1( MA@AD&_5O.Q)S/_@69LYJ\OD9;^+>?FPO--EI$[0WH_F^CV,_\2W00#= V4?5 M0=7R,&OI>GE 'T4;T$>W ^09:GQIW+O2$@R4H$#&-E8*F!+D8\ 9?DP&Q?-! MOMR.\LJP0UL-\IP^&,)\ G1L+9CO.G3M^_S>C9GQ.?<9L[XWBC^]7.:-^ A0 MR")Y(7AWNC9;@NJT%2%) ((6)X2!1,0 *$/C2G4WUN'Z)E&]WC9_9GY>Z?!A MR[8:W"'MM)%[K\)O"UR^VXGOFPIOUGLIO%\-7K2::B82""4T8";AUN&\8J+2 MX%F,]6-R7Y^-]?6>G*3?RZNW&^,'%#^8)MNK\&\/7?L^OW>CPA_<;!7TTPN# M@'LKK;>*$OJ);Q,(K$P4;B^S-_GT]7$/KZPMD^)OUB9^/]H:)[#1UJ#4$%)N M8@T LDYM [K4UI16,%[O1MZAMM:JGK4Y/6UY?^+[,62_^OY0S8O+4<;7OZ7_ MFN7:5V8*SZSO,37=G"S)YHO?J:(S'1"! 01=1NMZ)7"/E,!-;%\;(.JTZQOX MP!IK3FHL=!(K!*FB2*#874.(4IPA$<-U:ZYF^'NXK0?BVSXTVB1^P)HWI5W\R1\61GM;A[O6!_?8AEM?8N!L<]2;^1R M57VO]ZBOR6W>R.T$Q4@G7$C-%!8X40967A8%*<'X?LY:Z1I BK& L#N:782$PK>2Z-H/%- M7JL7=ZL#'(@/6*?&[4.TL+4B<]\EXZ[/[_U87">S>=-4KC[LNTVV5L7CX?SO MXQG\=8$;-\"-(:/&8BLU)C0!S,$UX :C1!@3$VT?J@;X&"LLO);]41VJKB O+E%3:\VV]ZG/8-Y]W/ M=0_G^F[R9*IF&T5=77'@:R#EOEYUU6VFW>.W521FF_3(+5$56P4:)9 LAM@R M&VM $VAQJ [KL^ 5-1QUH2K>=["I_4.UP9_+_57E[MIJ<]U#PO&GU@U;K4ZB M@42L=\GOH][T;B>^;][@ID+L:AG==YN%)5$C&;@Q($F(9HI+H1,L$V25Q@E( M($9:DO=0NO?1\5?<9TSM!H3M^_S>C3E@[N@>UZO[:Z!.&U WB1&8NI^(E4)2 M26"=6AMCG"CU2@>A=D6)IP,,7L4EO+5XO[>Z[+N=^'XI\>'C:C'!,"]VRCL^J[O;8==G68.LMZ_ H&2O$4L92 M 1*;(,8 -M3"1#J+26 20PU9S&E7QU?JH.JMLM91^58+5@P&0I"-9>'<0GB[ M&73==6&S[_,+PO0OH19\_7TGM'&C2V%K=B]LR[[1+C:MH\SJEN(33YC%!EMP M9&X!+LL6KBM-L4(?V)MGL4._I)'O-70Y]EV)FK8<5=OSNHUZW>?8]PJ.OBZ+ MF88F5?IN@J]7PTO@I-5D,7 MUKI?:OF8IF=J\XQOH07&>3;-0G-?SR"AH6V>7:;CT#]\$9*>G1U]EGV*COW$ MJL==^NZZ[<:NH>5"U5,^K+/WGE8]S=L=S,+]LZ):R&9)_%T^+:CLZ]1LQM1= MU!J[[X&2^?;T/D&Y^50^[(=QG5D4;LO=:Z<+WX-Y."O"FPLG@MS'+_\GO;SZ MV82O?8?F;!+.]93=BOUJ^D_5C_[+;S,G\_Q7Z96GZ;^$EL7CT\5\EE]7KQY> MI/EY5OQ8-H<,NW^5^R[(96?EA9MY6./YS+_.M\ =^S[%(]_%V3>&3GU#U7!O M/B[^6%G!,,&SQ=Q?L%P)1]YYEEX.ENTPBJ)>WF9!_L]_" 3YST78OVAX/0S1 MT;*%W%4V+SMKN>=,1T75ZKBFXG)2H6J8?]K-UVZLH7%GF8.M#IT+SRCIC7UX M>;>[^Q4_"&!3#9ARGL0:*"$Q 58;0Q&2,K9"HM@D@JT$4U=/)DQN2_XWU51\ M(_974>>>PJNNKQ6LF=!68,C%?119XY5O.-CVY!UA(Q2WPM>]#[*Z?^ MZ<,\G+9()^T&C;Y%=NAH-+^NP;#A)8<1_RH[^!2?HL-9@- \#:UC':3Z_DKG M;GK3NOUX%I7M=*\#5K7@-A"X&XQ;@*NT0I&:VMTOS0O3:3JY+GRW/]_"W+=- M*IL>?8J2HY5/^C9Z-*] M^=@1N:-A1[G'B_SLOY.&N]UAO*6=.WTE_J7W+I MF+Z4X@X5AH[:/S)&NH_!97O5&6PKWLA=80(9RA'4?L7I!2UGJ)(M' MH7R).$U3^W;?*7=?6/!!O62^,.>TS%)RZ].T**L:8[9/&8=^F>5BC(L@HQUT MC!9#KX>ZGRI@>;Z(,O5 M(K]R"EWQG'Z:KZD5W,;L@[O[2I^Z$59Z M]M)R\/U>9Z=5'+UR;@5!N6+!N"%X^AZ5 %]S80WT1<4#K2>UU=% N8ZX:GGI MYS 9_^'4FHM9W;#P8IQ]+17NY>!;PZU:^373K'3E\/AQ:S9M8V0\O5K,BR#A M9J=%EG\-3=DJ/JG$NA_W_&)1M $GC7[UIDHIK?#*JX*]=W;#V&L-RXU^F%W- M0ZL:=:PC@4 Y])*U_*AN7>VV79:OR.WR-=Y8:UD3V=F95QF\UC.=>JD\]JUW MW&X$]>53I.:EQNXF-M_"FPIFO66W1^**X-37HYIWKUO$C M9UGJ,!7F!;)NS61I)[B7CF>CDL#]XGH[T[KS! M*DLU[BF\XG]S.MAXMMI,_BJ]OESCGQUK!PQO=G4;]?V 7W'@A[O<#QB_K!\P M>8"Z-Y&]/G*JHT/#%CZLF';S<6AHNS0>[P*W%@XVP'.SQ:T;6[!3TP9^'R,3 M2@D_G.4>G&;3X%\K_5T>IBIP=M_5)M]VJX&^J7JPZ6]I33QHBR2O751MDTOS MVLF,(')FN3/OH\*M0';AF,8W$ZZU^VAQY2]]H6OI3P_YEOY_]KZT.8UD2_NO M$+ZSN".P;NZ+^YV.R*WZ:L(M^5KJ>V,^36 H64PCT%!@M^;7OYE9*XL 28"0 MQ"QN45!5N9QS\JS/P754D0NCE<7 Z411#:S#1$JIM84&:D0W@3"NE> 9'?AY M4RQIY5YBJ_/IZ1+OTI.=2_[K@7]0K@A6*F;CS _*=M&KNNG=]O=Y]AL-@_L[IA]1A08(D3QBVPG*OJTEG=3RS)=+$)NIYZ2?) M"8@<@(KG:0?M3+8&&@D>[]Q_TZ_2$*+)M5 T'"AMCFAJ0ZKV7GWM#$(,8Z_?8(O%$'"1(#$C M&'HA(!=Q\Z+XR&8NM8+U/*GB75]'HS^"!]J331[9\B/)/U99/_[2A]QI&^@B MMR"#->#_(T1LKGX4B=&-NZJGP=1/?:Z\8'/>I%-%IQI\9U>BHUR!>5C'K[W M@_>O^Y)^#34$@<+&G=MT.NEW,R\@QK>CAP:@GF?+SX>MB_1V$D5\2P91".6L M]Z1*O%@WU=;[P(8(_%S\,'Z"/__4KEHAY Z63BL$1 ;I!Z_MMOP1%D.;_B=] M+VC_&(Y^E*344K]_.?^B\O!GUO7W>X69DY];%W>9'W#K_3LU'?MWO_NIX-(T M #M',VP8#IQ!2-7X[KDX!%FZ@<_;12QF=!O''O,]!H/I37$(MR-A?^]G4[_& M_U= MPT13"B'%*_?XM\Z?_9OI3:V>VMJ[-F_ 9Z=7IC_N3F_\>1J4SM_FBQOV30J; MNPLPW:63:383X![_Y/0V4$V,*%:!UM*E.4Z_!?] T%#J.QI^A[G$EE+X!/OI M=NQG./;CS"/BP\FXDWLA'DN"\X?7IOF7LG:.,FPTLPGUAKD1 @JBF5%8<4*% M913QE11Y%G,?SZ]FC:JEQO8N2"PJJO<1&5@$=?:$]F,T[GF-Z]TO?M>V3V3Y M(3RK6-?IPB&C(C\/.SEL3\Q6*C*$9D^DZTZ,71?65I7D6.D-17I8;Y2KA=Z2 M*KZOGAL3,BHJ[+2^%B9J;O?'K[R*4)YT@3KKK+B:3KUTS!6"=J&ZAD>':-G. MA:9L>&*I=@XI0AE2.K%:6DV\T$3*^G\2=[@'8^4?.(U^QHLR;^-36.?R:?5O M/H]'0:/ZXDV"8$:K8:\IX+=UU%)YLK8E\>/%:W_XX3:?1B"8.(](^TU!6V2Y MY)18N@-R&V\\^C/ZHP9WNR8P"!K-<;"_3 &6-#&, ,O]CP*!6>L,QUBL)+ - M'$H+E84'JX?Q'7J3JG*?4JSM?(?K*@, &:$T(?)" M=KAV..9<ED08"$_X1&Z=_]WF_2/&7CR/(NU?6@;(7,OQ@/#'^D M]0R*A(N0(MU;:-R\!X/-'TQU[QYOK%'+ 39>?9= *6M0("J@I..6O1ZBBH^: M[\F\-5HBNY4Y,YI-E;1>%O$-%Z$-\G-I"775:E&N"Y5YOYW651HTC$%\6IWS M,QAEH5IE["T%/_T?G7'O(6G@N_ *3\=5=NYH.IY:EB@90 M$6SLC[,9>\E/M[)_"LD^&?>_?8O!SYWKAQ#6^B$##H+$&BP2DA@5LGQ@X$,. M !!(K3:J5]C0ER/M_^SW[@G^',:)O5MCN4YTRR/(MWXYPI_WY'D5O9;,IZJU=+I%BTG X#H=BTFSO/\T BE#E!-5/Q M.[/!R!6PQMT<-'<^4OGH=2D'5Q1"%"-\_#*OCY'FLV\(V^!*"HS86+UG;])&!K/_L^#%[!88L"V/%3/N\?'CDC_Q!V5ZMU2G[J^6%&YMM4^O] MN],+\^[^.$[UU-E11%;P=^[\?,$->Y(K*8#"3@.70&@UDL&/3_T?Q$"V@ E8 M>N4O1X7&/U^VODS1AW[Q ?D0_UUWT-1+7*[PS (_8S_.C3-93OCNSK"R_C3] MTY\9(7K9#B6O@]Z/?B\M&]7&[+\J_=0_)>)]9->C\:05@Z/A3 E_#,(YF)6$ MG,7(Z4E+>4*',.F=+W5E]^6R#FU;(]'(GA5_VLE7K!$],V8LE^ M-PVAV?'HKC.()UTH_HMYM 4/;3R=RSEO=+AY=%NJ@H6M%,?@#]-.7G"Y'=2( MY0TM/?O5EC>T5B'C1,*,55ZQDR1)E*$.$&837N?F+M7XS^,L*D[\'$O9+J9? ML_1_IU'K-Q417/BEVRR0]J)X=4FSRRHN$@S#LL/E'*+2DZ,CU1J7=GA.V7,Y MWZ6?\&N:I\S>>$+-XVTQ+)?'.69"QR_J&7*8VDE!RWU2WK&F.I-= H%I,!*L$\EQHL#^I(X.UD^K1 XZA MT4>G&X>QG[0:KJ;RX,IMNV:&:- GXYK$7H;[S[Z!M.[_I[BPBDK$!2> @<0 M!%HB9A"Q%%NQF<>@Z+RRU%\ #\=?L(&NM6@E/7P3MF#VT(82%]BE,/ +:(X M9N*IM2PN7^.9*'+-2KRPVJ".SH)JWY98M$L]0SU[/['^5%5 MU)@,TI/%U3MP_(^EB(KQGT[&< M8J\,)'JE5V#M>[RBG'J!<1O@#,;3]-TO7]P_W-GO[J*5?#G_+92T7WY1YO*B M]<_3R[^US.\7E^>_N2\7K7M5PTV+U2FS#A*J$PZV^%&PF>3Y7G*ZJ(U)?,' ^3U()_;Q?3F)GB$0EEWG6[T>>0?5!BHK:QKY ?[RSQP;H?!O!.C0:AS1 MSBD&LCOXJ6TBM$4ML("(:8=8:KOT\6?EM$J4TO)C[>AH8O.5T*;9-*)]MJ[2 M6/D2ERW7L[>P,/N#K@L A-6V9M?]V]N V!888D/F:W48,JGG:+.L$)_TY$U[YIUZE8LF%6@09$5XYVWD[):J'SB2^AU*;EJ>J=!Q*&/S':4-W;+K$.JT(IQW%0&&SQ$>G MXZAZAP".7^2\V+*0+EF>,3#/JN.T*7,J(, <96EQ)O[9TX#+Y[78K("F+)_5 MP%2>W-V&,I!GLP2?GEE_GT-0$")3TG#'*T<8-<1)HB7ECDMG(.98(Y= "^DL MB.P:S>USL9(7.:.%K\Y&JB:'W[/4VWQ?PLZ?7Q5^?<\BG^M=_ZW:'L^6N7MQ MT2 LU,K_SH+5%V1X- +#I\)]LXFS+CBZ M[T<'*]=7?=K MXFA7<&N'C6C>I M)^%>DTA&^C1LHNC4R8O.T;22(A-^5*D@)H%EH M*@&B-KALPN7&2=I;I1<\/I-B?ZNM6A'6L@;+;2Q2J2[7-D[9V:#(88R6Q[=A M#.8'GU8L;PK8W)T(Z^D5$*^R1(3_7-7N];,2YK]H!."_&15UY=43;J_OLD(' MN4X'L<;[JA_^R.,T%;IH/%BS)M2V5U[RH.6!E-T,*.(!BWM M:^JUSP@"$Z!Y;P*TL)]U.TRI4&2#QCM>9OV=M%X40G=EPQ9:9EBRQA+.FH11 MZ4Q#9PW/.7%GTGXTGSKY>GJFJ+&5*\4]A"@"&$"_%PJ7O/&9I46GAD@"H?[C M^R@4'<^D^L<,W! 73[]W2A.E;#F1;_K<+A=/R0>94VHL/U#=,4 (UH3;:HHGO"^:DJ+JW5[=N\&7LHYQ]/[KQ,N_,3 M":I#H4#E*U2#L%0&2B[*\1;:'7GWA5,(!KP\ O%%(YH[SRFY*0AYP.IY+J2E'DEL@_L7Y@.*NA:R( M2C#^^^(X_%XV )D.W\!>Y>QJ:/6M\QHX]N#G- .4?>\IF>,*>TD>1?W@;OVI M.2-!RC+'60C.(#F"AV9&//@+$1@]9^O%[!)O<3$'+R]N"BBK_*FY M0'I!A_)*/VICOO\Y[444^I= 6+]GT2"*N(^S[KL7 MS9?NV]FBV4$E;@ORRCHWBTZ1? QWQ8AF?"K9:%#ARM2\D,6RZV]>J 6DTV$@ MI*4@:W.CR,HW5;I"_L9XV(04ENFPWRV!POUDBM4(Q]FU9['1.&)R](>Y/1^3 M'F,/H;*'0Y&Z$CL.G;1L_^HJ=#D*?/8UG?P(2DS5:R3H>6FUWFEQ:^ZB"HZE MN#8_TIE=".N1@_74ZUDL9=.E=U?&,B-JR%)O4EX^,AB,?@01443W3UI_JR8Y MN"M=KPUPH,*Q-LGUL0:SOX 38K;M0$T?>3>09Q).B/UY".LU5T% "K0?]I=0W M/<-V!J-OQ<$6V:@\I-HEP'%6:F-1P9KZ11L72#8QG-/['D_52M7*Z\OB"&K= M^Z3U>Y6[UGQ".^AB48&J$@X*);?,6,W/W?R!A=L_UM_'#*$*6#_JF(5K.:V\ M]0WVK97HG?ID&:^KLHAR1E$KN$HHTE9#SCE"2B22663IG$\VS"\&$>].PP*< M7YFX+"7"A/43#![;BV)J]SI45SM,AYYD"Y5\^_[2E\4H03J-TV\=OS*Y.(I M; 6:U%5_Z*DZ5P'+%)O^C%>AC$A&0[JR&/NQT4<_!U@J>X_EITQYBLT8;K'$ MMQ0YS2!*3?K->&K)(R%I)]8+^2\'%:C%"H6RC G.V'"-;)]*%N=E;E6L,+9R M]#,9UJ^L+;G[0\)+(\&O1&\M8R9YN]*X@Q5,YL%/K.$B:5!")3B;'K.F&Z $ M3\F)ND3C*TZ*WF*8?ZYO5/FJO!% KCQ6'H0J^A>SS(JTMF*)\T309J%;KD.G ML>9E1;%;5=*A/ ZCU-L]E0HMC)TK"D[I,[&^B/AEEQ8%Q#%GH+# M#^/TRO\@^FJ6W1:MT-M!^J&08(N/F8_<=NIH]5S&;N:'G%WURY#W/>9X04CY M7@;KY"[6EU1.W;)P;)XK6\,CW%V&_5J97D>Q08(C[:A65#BN)!+$6<(TPU "W$RO MPY@I8YRTG%(@N"8HD=9Q1C41)EE==+?V/0OI=8?)5Y M*#EFFSO-":C<^"]]CX5@R:IS_-$J53.\O21]'(%'/_GCDKCUC"YX\%%K=(Q: M'Z/6CXM:K^X$M?9VLE'4>@/AN$UQ>.]>-UY1WAY2YC^"\O[^,+BQX^?F&(;A M_!S,O!*&W_A'YA*RFPX&Q;<1;#!\]MO7+3\OH:_+?JAG.TM_M+Z,_.$\/UHO M<+_UA_GP.M/)J+P0L\SR*S_ZO[_K/7SO=/[Z-0TE,F.AH_/$OW6[J+=6?9_82S=%&\W-!/LU+^7JB?#.7 MR_'M5%5L;D;-<7ZQ?-5^X7<'M$S!<@E-.3]>]WN>=;9QFBT+L#^,4&8G"@Z4 M(!K;'C6G=H6O,*?0S-+! V:^V<1W/LU_><)$'C/NN(-;*8-J.CD7ZP:CEY.2 M.O,4.@A88J%$2E,EA# 0&H2A%$AD5SP0HM:FYV:PY1M,]#=%^2ZOT: M4<5J3 'A8$*029)0X(Q%(I065G G@,80@F1C4?4E[8:R_)CY<3GZ4A'W-;YH@*A17W%)MC)5*,#D3L%VEQYQ?/8>$X&U)R%') M63RP7HXQM-RY^Q"IGOM$BEGAVS];O=$TJ$)_ ?%_'L6I]RYS\;;H&O*OBJ&U MZDT':6*M79^U)+5JG1ZU''L5=ZR)WHV%HE0#SE3B99W5"@-(D52<2,/@0G/P MAUEN0:X=H%![/ $\+[$_65;NPQ%6>(ZCP-VE4^PAGL'7-.^CU[@^,>])N3EZ MCE^_Y[B*M!^]QR_1>\PX;'B/+50D$5[_(%0C*%BBD18D<4PH !=@ZI?I(&MZ M5&]!"8'0:R'L:%J]-O]Q Y\ISU(L2F ;Z88S?M=9G^M@PQ/H+;I=F:B[DVCB M$JN85008RI 42F&GL)"$.TWDPWB\R%ZM6]OOTJ,"VTBN;?-T]+F^'9]K0_,H M_*ZES)A-JS]Z6A=% @=U:0S%W#G&L<-04F"YI))CKI"C1FEJT5I/:R4/"F_K MG%!0PUXR&GNK;&AB/GCW+H8*!]&>V*W$8%N5&$=%X2 $0$%,175!]RX/M^3D M]-33?\8AM>A9>HW: 4>\ 3L-@2$< &(PE5@*BH#$ ">$V@0SNKDH.!UVQVDG MB[AF.^3^4%7EKZT6 V0]O/1C?9:/()'7JE:\,&?%@49W7E\0YW7$:CBM0],. M$8BUAC(!G K"M!>2S&C_'YPPA3>*U:SPDVPI6 -1&\JUO;6W&JTYW*#,7V.6 M?'E]*\]^4-^V'6&L/:%Q8)1_S:Z!3ZA?:M==;3X$.*WY&L%%+\U.VVGD#,M1 MG6N6:)*,JI8MH(B87QUB:47"7(X80[99"B\D$;\)_P$ M[VY/(C3.4]J'5M\VKZXOLGX!-=8J>Q)=;E_&E074_5F0ALKAU.KQ[CN?V<7$&Y36K]E,\P]@^ ? !-P3"*J?#NO*^ C M&0KP^Q$SI_'-3_<6US>*_R?7WA[]=AWIOUW#:-9MYTNY4,&--)#._$VP/#:\ M11^J=^88.;Y)3'6(,-6-U99^YXGU=7OJZ'%2NR_LF=#V.:_^7\&X4.2IMFB MRMLL2]^_PKM!I>\FV_649CY@#GYM4!T");S)5=&AHEK2ZW))&SC3$5GE:CJX M\DI$ 2N935I^;))#1(:8!?7MT![E!!S?TXB#D31I.&?G;&?Z^0N M%U[+9!:'@G $"-32"R+ E$Y0@BGAH=>?$:@ALY!EG#LJ$IY0JJC1B&E)M: * M:**!W+;0V:F$*1:H5:Q0?UZR'*# ?/=+V<-E ;_\)NU%(,1>^CV'YLL),)#N MSVF!=.YY(P<3*M"8@HE6@>"$ M,?1O(A,BD[DK>;(,RSTFKVY6L:4?R8[2CUL$50E?L,QU U@IXX5R@ M-;:A!.KB_']VPB139>L0L(S^8 *M1T_\.;1YBG#S5$YS?K*>KE M97V0WEQM2*#L!V-R_,4ZG MB9;_>/7\ *T0V\\ZW[X%#- P\X*!MZ"D-9[K7UGEIZP';M-$.>8/-42THP D M2C#L3RZ0&'^H(-Q>.2 M3G9&/)*Q_?4X!PK_PZJ!$#2.A]#(3 MKO(FQ%5\^&+B39!@E^L"$/\BS?M6U7>;4<]KDA?!]@[-DBX*%VS9S?CI27:" MM"593 YY@44&1PX]. [E#6AX*!U @GA./6LHXQE7 &+"($,+<*E;85#H7P% M',IEFZ(CWN3+09QX]\OI,)N,ITM:$!X+>C:0&J+&@[5:)!Q@8Q305%"HF)52 M8:NY98IC]8SG>F./#T]H$-8F\B"JAIY3'7C=1?-KN$C6V%S:$>2YQ4A_WE)L MK-1, X.%A@&LR^R&BS8[>P^:BRAM R+V4;)_^$?R2RF5NQR%*&=.&:V*-%HE M;;S9@GGH&;(!E$, D@E15/E#51)AG;7.$<8$ 18OP*QO]5@]( 9'&+;)DOSG M%ZA;[YJ*7T")(P2XAN>V$!F-M7)4HU R)?UQ)Z%(/*T#I 3>Z9EW4"1.VI1M M]1 [W"K)@[,M7P*FY7%!WN*"O+;PS3_#?K4":$^T*.ID--,9IV]8ZQ.UUH=A M*%NE@$-E*0%*(V03:3A*>")T\IQ!DB]IWE%]TO^>7OS1'ZIA+V[HPVW"\_'D M>G0;$MQ#Y/(RMG^_3+O70\_)W_IIMK6#E:,V8MMTL;Q:U?% 6,&KAS4"!H2$ M <$AL(AJ3 0U":8(54"80()0(8A!$T MN_'=;G;0%KL9-_.0Y81L0[)5.;&&\E[&.?N*V:?1!L-:Q!W6QB0RZ*F)$DI MB974! %_%#_CB M5I.*'BMDRH7:9\;>2XC*0EF+)B,N8NV/8<= G<=\ G_(C/\QLOP-8ZX]T?<^P4!B>LB)*(D3H"WCX)E M!(11.A$<6.R4#5@GN\M[W$X_($Q)&Z/]-C ^5*5@_RS^:KGX4!B5U!TJ .?( M)<)JX"2UR@J8Z,00;Y0C0W&R4Q?&5AA5MIG<9E[QVGU^7OUB-^TI9B /E[6K M*&^STN'W+;^99^^#I..W]\B"#4'SN#'YV[ MS+_JK]?C8C:KAK@)&-(#!QT_SL(_G)Y=NE^_J-:GT\1=F%-W9MQ%ZV_GG^SI MV:\7+7/^Y?/Y%W5Y>GZV.=#3?@9^=G[I1WIYWOK]3/UN3R^=]:,]L^[L(O_K MXOS3J57AC2=J"M/U8++;\8_CYQ[ZW;?K=^-Q\=8*3 M\M=T]&W1N>.!P^Z'5'M>NFDTQ_,HMU58*MYDY5N9Z8-3@G< MN$$GH5_^7R=R0B;\X:T!0B2AF#*9:"Z8T0A;@(S4G 4!V-ED/W]Z2 ]OZI6K&A"M![$$@'%(&'*&. 7 B#!M%< @=<8I5<=71.WUH+$ M:X@6^MERRB@2GKPX(A)@2P$+:S8'8KE>X.+#&KP\=6;$ "@3@:8")XMW]/K,",)$_#MZ0;!TP M\H]9A0YK@^RQ^ MV1V"X^F3D1O]?%Y\A4/2'_8SKW?F773V).V>+_SW*.?QNBT^9*>F"A=5):XD24D('J%""4BI$X@1/"(/80;UE\Z/5FCK..[[?3Z"'#^431ELLBD/Q5E6(>VHM%Q3Y!QB6!%, MM! +:=L5F_H]^*W< C7L?2Z:>/8^=\:3/1U_C+>QV%VBTTM(L'[+=NZ1Q5>P M.*[S&14TW+,V2P0TE!&F/*<;F6"14 $$@SMA\2V=S(RV!85OFL5?E<69UT_T MZRR"8X+U:T^PSN41K:$ $>="$FTM10D%FBEIB+6(F<0I!/!"'68EC[S(V9DN M@;%H [&[:JU#RII^ \;V48"\-@'"1>T31T!#I"%%!E+@0JEIPH(-XX6'__W] M-LM2 ;(E305#U@9TK_51K['L8B&7=W(U?WH#P;>V#H=3CK#;WW/ M8:%L;))MF.5-K;&<8T@LMY1 KA+--+9*62\O#5>-C&4LK98*,:"$"WTX) >) M5D)RK4SB"7MEEO?:]RQD>?]Z?F[_>?KI4TN=V=;YY=_G?Z_)F-YD5$^9%'I8JM;F<\OO/O+(J<0AK]MV)58Z%,^,VC:VTFH1WW MH^_^<..O7)>54&GLYOWHAZW( G[PL_)"L$Y6%!MD5:G!VRL;@&AMW0"5CTOE MWWYQP,MZV;%(X0VEIB^4BMZK?>YC-*L[QAV)\943XQQ0X+.2XL8@A4>J?.54 M&6,WQV*=J'7!8[7.ZTDG*JW85F?2VKA$[9AH_Y(3[BDB71+ \H'%(73D9QFX+7G9;_EO.@CF+HI8LA5,]ZXU&7>&V6 &1.X-]M1YOX8'6=W[T6! .3<&"RH9SNA$I-@K#56$!B] MD.]4\F"Q\J98^,MZW7_M](>?1ME\WO;C^E5LQ7[)_$#]M=6(^FVQU:;'FY)/ MS2R'D >XS$_SEMRO;UDHB%HH2(P5MD@"ER24)598I3F Q&(KJ1$+*-5[%@K; MM28VD0Z"RJ-L.,J&MRH;>+/#O+82.X T=UYIYU102( %5 N0>#5BH8?E4V7# M SI,;,+)J,T1._+R,1[3F;1BVECK";B1N^FX\[(\$FL;K;QXEP5O--H)<-74 M"LF%\M+/ $V-8-(ZNU4-SK1XEW9N0 M=*2.6W@" M:D]]V)Y8K18@42?II_[W=*&\NG54Y8FT4G"3<(I M33!E1 J,M/_@.=(0Q(UK+(U2'&AB &464.>M-,>-!L9!;9 2?'5KH;7O65R: M5?6!NX"W"05]HYO;T3"H2V5+'..O=(9W__87@2#_.?,KZ+_M7_5C95F_6NY6 M)Z[WO<5MQSXZ&Q7$D;4%<02MJ/_"]W^WZK:ME[:]GI>]Q?J MUHCLEFOG[=# M$6^2"/X9/Z7/6[>F_)IWOJ7/.H9/_:OTC4=DWZH@-*-L7@#E-&HNX?(ON=<@P4:V8Y3O?0+SOK4(:"U4QU##4AB6,(9I@8G0B8< M:BL8]_^#DX6>-_<[4G_/TJOI(.B]]V:*56'&%>Y8??=;YW]&8S/H9#/I%<7F M5I'&NS+.V'#0?\C2[L?>='R7=L;O?H%RWHO<"E]D3W#/O[E@VV.+35Y((&TC MGC_X(!D$O%$Q@J!2"F)HK:94:$E$HH!V&$(8O.8E0P>V^AA,E?,K6\0 (O;D MRH# K^-1EKD_NX-I6(D-Q/CMD) =N";C7%].!"MHC+(V!:];1WM5=?YFFOFWI^/6.,UKQK+K_NV#L"+W,-G]^EA@ M ]B'*2XX%]3*A%)BB$I(P@3DW!%L,%YHY+U_'TMY3[F17YK[N-[1@K;M:'D% M9_3ZPM3'TORA'&2XX464%&.M#**"^?^S$DAG)6>< 2"I/'"GPT;4OP45'K:A M?!6MAH_L^P+8=YVQ#6D-]<0M0$9(J1*OA2*%-:0:&66)$LQ()P_*V-X/NT*$ MVT)N10EM4LK+-ZR/S'T S+V.MYLM\XBU@!@<^I11#82RE@J!,>$.09ZXPS0R M]\/DDK>1W":NU(';DR\]QG\Y[O32F\[XC^RO7\>=82^2[H,-S;<1Y8>RE@'$ M 6H!LQ9"0H5$PG!+<,!S-(#30[! HU.IWEX==O8PQ'T7$*Q<1ZR0$:2@*4&*GK)0FP31)G+88,8288)*S1,C#-)YW+RIX0&)_ MW?K!ZXK0YCTN)X$F L6^VMALS7A'U^:K=&VBAFM3217P1"C"6%!OSFGL)353 M5B4XX4:A_9MQ:YYYKYLS"NLMVW ,M]E6NV4 X-PI*@C M13WZ),"PT:N("0(U4DAZ/5T!J2$S.G&4ZL2;]1CM3T\_G@#'\-9C9W\QO;T= M])^:1_DVPEL8U]R?4,"TX$(8JKPR"'62(&&@$(1[A9 >2GBKW-XREGVQ478E MXL?XUM%MM<%QV&C=1URH*1":)=I2**UR 0I?.FX9850_@V&T769Y>B-2TN;; MA98^./_540J\2BFP+KZ%&:O](\)9QJU"3D#J_U0)E=!H[(6 Y8[!PXMO[9;K MH6ACL!6\YF. ZR@C#E=&K!,1HM84,!9.*@LITX9Z"2&-9A1 2"GE1%!QP &N M'+X(UQ8FI0:#UFCBORPG]@A>F=ZNF/<*B&U^.WGWRWL8 M).KT]M&E *_"#">@[DGC$$10.T2<22B70G-F+69-C6>-C3\T7W&QSS>%)H&Q@E' I,4D L8HFSLA$:L<39!)CB87)"S"SYYEA M"ZFC;2[VV:K[8 WL([>_ &Y?9TZ31I6SQDY(;STG7"&*C)4 TNAIEY[AH(M M]%EY?G-ZZ]Q-VIQL)>WK(73S\NWHHRAX :)@G22@]<&OC6<#1!-L(::()4)Q MBQ*$-=<,0X /V&K>NDA@;4#H6SCO-\;.?LU>L^/$CQ-?+NS?5@O.C>;_"N#J MB"35J2>2!'(LL&5)0C&TP@D'6<(@9LX:JO9F[F[#3&T32-L]Q:[-DG0!L0GL1JF0A*$TD9M5 J@IV6&'%NB5&)WI5/ M8!NV//!"<#M%7-NABP?9^<_+-<=@^F'*TCO<*0S$TH_GL]+A]RV_F6?O@Z3CM_?.A< M^2%][ Q^=.XR_ZJ_7H^+V:P:X@["__'C;,.QT[-+]^L7U?ITFK@+<^K.C+MH M_>W\DST]^_6B9MWX_4[_;TTMG_6C/ MK#N[R/^Z./]T:E6XG)R>J3-SJCZU+B[]A=_5%ZWUUVT^M]U63^GD5H)SK M#-W-$684G+.=[:DUEG,,B>66$LB]SNB%I57*(@T-5Q_0NTT> R3QO\8*2<4H M0T1;01UPECDOC*5@'V N+>/0U>3!MV\VBD0G"3<)]_HPIHS(T'#(?R *&(*X M<6M&L?9VM(95-R&GQOTSJD?H<1_O[_N3:)A_;KY@&,Z+PJF M@T'Q[7^\ ^_B9T\AW?+S$A*^[-^D6>LL_='Z,KKI+&AI-YWQM_XP'UYG.AF5 M%W*E+UXI6JX#/_GBA.F&KH"W6?JQ_./G^2/C7>7&KILDDG?W>[GS=Q"\HN7[ MBB[RKZ>;_5Y?=NS4^79ZM=JT&Z-Q^2IAV&XA$+H7/CX$]>*)XDW2P3_CI^?N M'>W7W*NCSSJ&D/GYQM,LWJHL#'&CX]:_R:UO.,"?5P(VO.]'4GR3I'B6+A-" M;T?]VEPG?ZD[_-X&\WB@"&\JN@)RK^3)Q4]K>C7>']? M-WE$'ME2@N K#G)NNK6''\84L &=P*T &#HCJ?_? #2I$BVAE0! VN99:HDK8CM+N*.T.6'6CM>J60(NUPUY3 MXXAJ043"M!1>=>,T<122G6:@':[48XRUY2O'O'M=/1N*UI>/1X-])A?=;GTO MO/:]2.'9V0A%O'I#!:328JFHPHAQF4@&GM_WLE$;T_L=,.B(0/.(0O0GS/50 MCC-1$[D&1'A]W1]G %%*G6:0282ULEZ'U5@>MB=B/WU\$4)MRK=9A7ZP7HN'WYTG,!ZLZ1?_T:6D=&VGV,X?DVL@$D:<@!)C$WGNLQ-50H([2S5OC3 M'QC, 7M .?A.LP%6]0:]OQ&).*8#[. $?(T(XY(V[%=J.1'$&(8M=,/Q*/@QE'X4!"]1$*PU@WEM!A-NH!3<4)H(:OWY*"'6 M08UF4B8(R(,R@W?/^$BT*=Q*-Y)C%/HH* Y=4*R3$[+6&!QQUJD$,FLLY99+ M[/4%*Z0%%G"G#M28WKW X+2-Z58!ZPY.47A= =Q1[\;?,@DT$2CV0%R!.S&4 M:]X[D%D>JO!^N3(:@8;#4VH+G3;,(@RI U(:K#2PR@J%B'B._.@#:[P,$7L- M'L\CZQXZZ_[;7P2"Z#&9C4>B.A+5D\X#U@AQ&^,$A!HE)*&"*LV9%DK[P\ E M2!NX/YW]> X<(U^/G7W94O+)*9=O(O*%@*@%@).A%9J_#JVE+E$"&N2E@84V MH9*;0XE\K6P:>G_HBQ]#7T='UF:'HJQY G$D*>1$.04I%U I)K2QP#GIF*'@ M!82^=MMD%Y,V?^4E"4=!\%H%P9K0%X*-UKC,)L@Z9XB# =P4ZX0!RQR0W$L" M6'<*/9S0UXZ[:_.V)'OIKGV,?1TEQ7-+BG6" H-&(BEQ4C"-,.842:BD<90S M( RT@L+=PNFMROFO0*7 MG]].2O'R'@;1.KT]%+?CL]GFD*+:.:<)HI8"J"BF_H.45">< \TU5?P0ZB27 MMB:]UQPGQ[+(-^EPAJRF:9H$2,L1=@6V^]%2\$ M;<&VF2!RL%;SD6$/@V'7VL"-0F8G 0**)MQ90A43"AFAI'6<$8U$G0A^.#;P MUAF4M!D!QYK'(T,?+$.OX6<$ZA.8:(P<1RH4.E*KH58RA'LEI5A 0?88\GU^ MQF9MA%[%P7MLX\Q+Q.B85,2P:-PCRA1C!% MM 08) 31T"(:[LTBW4H'5 )IFXO#Z(#ZO%QQC.P>Y>517F[)(8 :0)TT0<20 M!!D9"L9%2!M-A%-:($(ML0]HG? PA\ V$E<$:4.YE9>D6=$]>ZYY.2ZUEXHS6@&(EI2,J05XA5489A^G.?3%;T3D!AFTJMYH/ M^,ITSNB>^6OL-UU>W\:S&Y/91XOVY?.;:R^^[,J#&FTWV9PMLGFXU!SK?"_N MUN*@E[7%1B0_/PIR?$@JQ[NM-'9'3VOLCC<:Q0:=V9_4V!V_6TV$G06T&^=Z MV0@;@4<_JQ7 ZQY]]^JNW ]^7+O5*5.D6OUA.%337NOT\Y=_Z]S<_FQ;HZO' MCS17%_YEC;Z 8=T0!G)..?=4B)'5&'NM 2I/?$IQ%Q W^+SI%:,E:Y2%1<4 M@;_#)]?EG0X_CT?=-,N^I%D:B,.K+3;]G@Y&MS?^/%H;PJ&5^L%6JQ\GBY'9 MEE_W0;,+[*/W_L=UOWO=^M$)_2;+=?@P" MQTFH]4@S-* .KN'SNY!-SAD+X MO!M!H#N9)W)/BO\[]8JG5Z=2SY#IG]UKO_5I:^S-]IL,L;;W/ M6<0/,7P_'4ZRUCB]]3_TS^L//:5ED\ RM^-1;]J=^.^^I_[HR7YJ];/XC&YL M93EJ?4U;G5O_JS_])D_2P=W.F0S53":=E"$2:I&E5"JN+;<6)3*!3D/,R4/\ M&XTUWO(3QVUC, MZ4GB\$EG1GOG%()QH\L@9) RJZG0E%+NSVV5 !O^\1H!=$^CD$ 0ES]&.Z,) M1DX6$[*W1A.>RY]" ?" *: !& N M)!PY;A T_#T4 M<#U.Y[-UMT@#X$0<+ V@ Z8!VL!.$-+0Q! H$:#(*($))@"' C%)$O2@Q+CE M-)",IKL[&CP)[$YS>BH)X$,F 5&'0B" V#$4FC-2+(#@3B$ &.0(."RV[TP[DR2*^^Z&0 #E@$F!U-$QH*(2S%&C'*? G ?+6O?)D8;D$!LX6BS]\ M_R_Z?^YR^];0B0\64Q)W!I3!H= V@D3.5EGOL;+G;C6F2;:&LP% M(-Y2,DQ*@H4 &@OK!/(64O"D=C9Q2S^331L__LC'\74TZ/E'L)/67"G6?&54 MV-'_NK3S0MRF7R?6FVZ#438=I\&SIP>C[A_OECCZA'34**N8(80JJX6Q7EN@ M5 ")O-% /]3:A*#.PQ MGJ;O?K%.7[;FZ[%F*6*]'W.3USYEU&B-&_0YB2G^_&-_XI_=749>7D9,KEOJ M)AT&AV$0@E_2;!(R'5H7Z;#O+6QNV.MW M_1O#TP;^V<%!];4S_"/+?Z']G^$K%?F@TVZ=G:B3=JN3M53OQI\1V63L>>![ MZC?+#^JD=>E?>L^(6W[A\ST/(_-2?CH.X^R%E_L56;:"-']@N8(EQV3A]]<= M_];PI,XW3R??PE-NQ_UAMW_;&10NMC#PZ6WX\9Y<9A1CE!+4:-U+M,34'Q'6 M:T/8)!P0?T(H0[U=Y)6@A4+53YZ@SZ_RW2HWZ[>.'_CT1H_&X]$/OSVF$T*# M?A-GQ')QSOI5!+AR-0>!?#KT>S0-&]"H;(]4,?>:-7[GT[.D.JCE:ASX9;KS MURT=TYWOG?X@1DW]MGJ2GER/1]-OUY$2KD:#05RBUE4^J7Z:?6R][_^4TU1G MUQO?@#V0E#E_9CF#%$7,>L7+\+#Q G!H,5IPE6YYXVS[_OY(@M1Z MC"<#S_G(,4N] HZ!A220A('&)9PM>$7V1Q)?TN^CP??PN!U)!'BRV YF:Q)A M7(Z^U0Y/TMG,7]-&W]Y]2_"X.HB\*3!2/PX1;R1?=\;?^,!]>9SH9E1?RQ/1X)4\R9)372RHUCN#WB82PB%O^X+JG4J9^"3+U*57W^R".0A[2 M[1Q7CZ:3XU1?XE2?E9)WX*M.HKI\E0OU(HNQ5?A]8_0KUZ\&HRQ&U4OY-B%7H"0-!:H?_OBX%,V45WC/1V$JW@BJJ7TCH^%LP?\L1W MPB+DA-8L\E1HH9?*#C@ZSL)Y,.CX0Z/7N0M^D[33O9X_0.KDB3<,@/@Z#@?2 M/!SV6[4YGW2QB6\JNC70[@H^2O=KUG GWA-Q_YIV0B54B/)GDW:K,UGJJAK= M!C]7_+H3*T9:J>>BP3HOTJ,K1$I9Z&-+('5=WV+ Y5^? MGO\XVC4AU*%P*X71E#+CG*58"(61 (1#)RR6)MD/(>3NK1=-"'PQ>>+)A/!3 MN^7/MG6'_O$X>MAQ](+.HVO_DC16HWX\>#*0[#G(@*-'DL%\#/F J2"/!80$ MW<+5'XRI8;C62E*O"'N-]L."]L[=79Y MJA2KFX1-<%$#[']/+WYT;L,OMWO0@!.Z"XWC*%RV*ES0RQ$NM^-@GI3IYN,B M_7QIKKE71HYTLE4ZP2^'3D;^33?^B^L%(WGW)P<#M>'*)0YX!I9:D5 IM20, M68FD1<1R1I<60AW>R1%O/!^FOX45K1=T^^?%CBS4=7)@4WXMG.$N6:&I M;1T7[@$,_Y@W7B[Z>[)69YRVOI;8-P4^<8ENG%MWZ-1[TPZJO1=!Q7*>U.8\'3; 0D*V/H?HC5!'\ZV7SGGZ=R MK5E=%; P6[>=.[_J_O^&TY@;>7/3SU?X*MVKVY#!&E0&&P4(8<0H&'-:!:2 M4VPQAAA*I3?)IC;53)(T_9R.0[S$T_9S> ZWIY7#';A_=NX'9+#188 0:(EB MDDA&*<%*0"881PF'@E.R8)'M:F>WY K$)1?RQA9(T1V;U'.9L7U^:DY+S07XYT/TY\?Y;*AT:C79++>7IVZ7[]HEJ?3A-W84[=F7$7 MK;^=?[*G9[]>M,SYE\_G7]3EZ?G9L\+H+AGXV?FE'^GE>>OW,_6[/;UTUH_V MS+JSB_ROB_-/IU:%R\GIF3HSI^I3Z^+27_C-G5U>M-Y7M_W4>E\5W,_#I)9S MG:&[+13YK\:077O[\V"=7MX?X.X'43$(30G&_K7_E^M17ET+A5>3?FDI?ZW#^LAL[X MW3]MY(W#NL(CQ$R'H4(\J&UUN4;6^7]NH M6U9SF"N/[]Q&U(6P,;NM=6.H+G34% *BL0*)\E_R1!H)>*AQ)18HS18JG6UZ ME8[]#B9Q?]+0-RAO!K3G>O;-<6=.%MMB;*V^+5@6.:&&HS*L1;[SL_50>:E1 MM],L7;N'&0)5_QB/HD=MAPB\.1G@VKENA5328.:P940#XI5VH9CV"AZ$@)H% M5>Z?_K5>E[N*/:,B0<3-+(#!818-/O08 -9AEZ MGDIZTW'X,*DJ(,M4//^(L%([,SV/L-IS=V\=5CLZ,^(AL&/V);S1NBAQ5FG* M;?!S>HN,)DI9*Z'3!!*T$JAD#4[V]H$'-N=5NE,HQYT"N.5;1&O\-L(234VB MD<4PH(L((JP0!E$(,01V 5)Q]1;-])M]QBW"G.YRBT;3280%\!-H!U?B;1XG M'=RU5QFK0?,:#=,<06C583M9C).7":"%Y_7I,/CK**3&YR:( L,3Y14O2X$_ MD!,D"9<6:0<4=,FR,,4_B_&K?/BGQ>A#4&#W?+WH)<&;^DC0$N"8ISN_ML#1 M:[:KD0[I-26=""]L0< 'LL1Q)KW*))# F".S-*KTH.W:-H\_8;OP$JWIR=LU MR]$GK:,^\;SZ!*_-@22!7I6P#D,E0IZG=$)JA+R=Z*F=N)6>W6*9HR2ATLO)1"N(E,,: M:&7U@M*SLR-M%Z3UI.-OL5/!2SC^1'W\442$HA!H)JC"ECO"G3_^)$DX4IPN MM.S9V?%W8%O[IH[*\G3J[SJ;1\@:B$\:X)1R@%! !3/^-UX)TSH!2/I_5P+Q MK1$@NC,([JN+ZS2=?!KE#KNF7ZHB-#,=CZMF3P=RM#4CE&"&1#]D:3>0Z8_1 MN)>EPW>_#$?;/]FZ^9+,0W0]X@S+&FZQ97B]_^&_N0H.+PI-=[W/S8!NH?W:WC9C6J\\*!W4*$H02 P8H M)X)3R*R#! 7Z\">)A53*U?315%,N(M+Y?7DJ+X%BGEI*L .]]3Y!&,5\[+61 MHZ''/^,W[W[*8Z?UE3S_+<*2A\3CEII^\\*\!6F[[M8Q4^'=J.#>/2GR(RF^ M#%*\]:9WR)Z\":F4,44J2V_Z'_*$RL%=B.YVO)[3&6?!4(\9L/[#H)_&[-(P MV[07E/7;J5>R\W2ML?_8"YT08CUXI]OU6EB=%1 (.RQ@E6D15SFG[H8J%=)P M0W?);IKVLCS?-GB$NJ$]:0YCZ3^E_SLMG #QJ:%(HWCHZ.HJC0''W;N1.(0- M-Q)FCG%#K&4B"3GW'"MF) 2(<236G,L-\C%^T>_\^/-C^OS*KXZ+DS6E4OGR MJ/_143% =HBZWBY 8X)TS,]KKVY_3?MYX]/0.2B'3*W$:-DA=9J5 >VT+&>K M?W233JY'O0J>J1#.=8N();=$R=P/*31=;QT42 J#?N=K;B74UL2N;4_>Z%,, M6.(3K-C[^&"76?--S# =_('H1*&DB!@YSIQ%H%.+>*60@% MX8:K!220.?HX&PT+M]$:Q]PK(6/"\4Z[NM<]J_-T_OK$[O6S;B2=/=!'(ZU0 M&)8DA!')K63<6SK:>E%GD<;8&NSPZO/R]WH"MAC_VZ 3KQ_OE$Y*7,!%WTP= MEMP+I;!&+9$_%1/CE2M_("K*%<'*4PIS& E,%CO.;N;">ZT$LEOO7=&9H],? MM[YW!M/*BFQX6PXE\WX?5$IJ_5]PQ1$UVA+@B=012&V@4L&8L5KSA5K&>2KM MC_\1%O2-$"G@)WQG*10G4"P-?KJWQD#C?.U M-KF8#G=U&_[1V'XR%EV';[-K_WU6NM1#O6\H8)Z,NG_4Q8*A%7#>*24\)0L$ MGH/^-"NU>R'T=5,$YW9K3M-:/0A9((Y3:X@5D%DN)%?!&6J(LE12L[E_J)I; M;&DPA\Q@*\OH8 VC14N:W!/,76(:48X7.RL_F<\*V@H>T7^!;0# @KJ0+3D8 MWN=-V\;IK;\YS0NUEI&@?U9W&Y[W=<*;LD9;+ZTAPBBQTBN@QE$-B6+.ZQ<) M)]X*?P2U?0ZS@"_2#O^CE6>Z$ MG^T7VNV/N].;H+EV8\M0^%.KGU-FM^B$4)';?.ET0V)>=X*G,QT&Y6:0!LCL MW0K"1BXQ4Q@Z2@W3PC)(J); >=+DR(M##))*KXC-W6=IJ:A^OTC]J3C\%@GR M_,K$>5V$:45G^1S%VEA]]#FB8[P"4?D0;)M=E.:7=+4@WAI57CD4R<^M]ZBB MS3(]7M,G&[1-KVLQR%97+MASP:UUC4.Z;<&@N6R$0CI R"7:) M3*QFW%.N A1 8IA=3[E%,F!-HE%%/K_* [UOBCJEV!UQEM36(-+[C+N";#LE M?LXBHG7>L\XKL)Z@\4\QE#Z\*R*.D1#S7C0-@)Z\(\'/X;OW)+) R&?,0Y?= MT?AV%.,]GA6&63YSKUQTO8I\TE)1S8A&8ZNT%]LMOT;ET+,XJ5X_OROUNQ62 MGZ/OO\B:+-'9F]KX,,ZK$WXR'4P6O@YJ]TQP=3 *G.S)X@&I9ELP(OXV&O2* M;JA5=#C/=:@ZJ,?^ F&*XQ 'JP"0H:ZOULB]I+[V)H/SQ:+LOG/;: M10?<"69;117S9U$!_AHHK-/MCD.Z7^"HZ?"VT^\UNBA,;POHF0:%V=ZP"++QQRS MDT*X)L*G^>NU!MM+!Y[&O*0LH,W**<6U&HXFA?8ZKHC] 5)H!ZZ-_>/BW=-F MMME >E:$ST9Z(\1-I*OH/O%T,G/41-B%SMA?FLQ\T8Y8IYVQ'UH!XG%UU1_T MR]+0G$1SV[:4L>.E5G'X',!3$/CY.NUY8K_M!)Q.SU'>1(Y?P)\+:@X 95& MN3#2/?@[&T4>SA%&&0X^Y_G963(:GT<:/?7< M^^?E**!"^&7)$W8>CYFY3ZE'L>\2*K$F MUEF9.DZ[J5_GG>='B-JD0$0RPH#"7 EL,)#"_\4A8(0S:LA"?L3G(BTN&8]N M2@22\ZM_YNR<'0GNH4'J7::7Y1 I11ICWO(FH-4O$;WW4N:B3.P/0P&TI]%" M!D>74-1P;XM'E2]:E+UU,'3I(*I'9[E_9?:YQ;F^^-3BL,B;,02PN7'_C[0P M\*.M'ET"58YH\Z'Y),M39>;.9ST4ZJ0/"Q, #,/&2DRU-(X"KZ\G0#&>$"@6 MP$96D?1%G-\R-^JA*NR[X=3#\\;.QH>&D_Z'7G\PC:111XNR.?RXK.\?VBD4 MWE&6EGK\/ ^O(N^E?+@'"I=U7 IZ[499G$AKL&50:H8\=2>8$*.0M@MQ*1,\ M!=61U$#"/$)7JQ[WH$*,T.[74^KHYO@ MA;J7B@\>Z-G6CN3)]3CUIJ3_Q75$K7Z*:K8[#$2O-HZ^#6/J6?0W56G=.X_X M"4 :$"W"&(<)I%HY1J"62GE-DAO*O24F%OBX3-!V>4Y[8 )7HEJJ/!4MANH? MCVWWPE(XP!*<@JWB;W4:JUH> %6NXNC^I/\]D%&M\ "AB!%:!.P*AQ%D!%!/ M1M+_T &R"([8))4 D/AU4J8O?AZG-_WIS9NAGV4P3ULU73L%X'4E7[Q&/?ZV MA\0" 1M9KE! IH1%Q!D(:1* [3U]&)H8#KT"L8&8>4,4L9BJLCWCLM(V0:%M M;O5@WP\L0(2*Z%="L<1%V*NWM:%OA,X9WI:=P2>%8H5WM9,7.<;\H-Q[5-11 MSDRK!)0O2GOOF?2[GPHXI#RK:-ES_8!*5WQO=..YJM^= :;.\^[\T@;J"+[T MX8>@G$S'6>RITH]6?">/1N9NW-M@N/@IQ=$53MN+SZ[TTK:+P?1#]/!K9_C' M>'H[Z=[YI]Z,0EK=#!Q_-9*[N>23DY:*E:!^F0/HTR+BMG]C''KHJ5(#]ONQ M9GZ)LJL\3'!_]F",[N4!A'YAII4KK7K;FA7>C M!EXD;)SS)+'Y29AG>/03$+_6C?P+IC['DHI8] A M+!QG%E(CO#6:]T28[?N^HQ,!->L>. > 0*BTI<8H)9$V#$FE.4=0FQF_^64P M=*_2\6B#_Z.\6A5^>>I4D4**O(G3JG_.IS#/)0!*XN]D&U 1NX5A+;'A ME^^J^C9.8ZOLUOMY&5%]Y85$/W<7UJF&^89'6^G#72C[#P==U#@#@7_U_/WG M)!I/2U]?O_5;WC>SD(7WC3*LO!= 626)9F'JP[O]%L9[TN_1X&RIX7Q(M/@N MK_:^ZH2DA%S!F;^[0HCSL[YWX&&:WT)![;B?I:6C,L\4J+*%IX':@MLRI@F4 M[TGS)U<=/XH$C ,T,N\!VL^#O,T-:"2++-F,UG6G5VY&;Z;T[Z4T.6%S SXV M.3DV.=FX2\F3FIR0W5/WUJ%=2X365@G..BM5O#38B[J Z[(BK)BU'"HHA* ( M<\TP\ M/V-"""7+P 39!:A]GX=/==, M@G:Q2DU?CU"[%09QN\P* 9$6C=P6F*-13FE!,"3 TC(/@/7.)PLZ9NBQG6XL_ MQW)/6OP=Y&O/0;T^#M<2HIUU?5DL#;[/7E^%\OGOV6+;AD!U2^!"#ZG8.&#= M[O@THG7<@6M%%))02"TI29"2RNMBDF 2&$2H54BWY4)7-K>NA_&WOF=:OR5WG[SQ-9AY:/6;T^&M'V3\ =HBA,RN@UGM79,&:U3. M8J^9 $&919"2 " $+)-2)U@P8Q8CF_LCC<U MN+U/[WJB3K5-09H_YDM\9@V9=IYE'(P-BX'2W!%##4A$8!RQJ-]7 M2[D%KCDH2I:[M!@BZ69-XLWRP[.7YOZW/#J08P9VJHA_F2UR-1C]"%T3TT$- M8U#BB]]TQG^DD_D^33,1DIDP2SZ0?ES" DW!L\S76&\6!S'ZFJ7C/*Y1/+O7 MF72B/[E,9RLS$/I%X5@$O?<_F*D1"[['_K 5MZF%2GYLL.]UN=4GU8^*8575 M\N6%''\Q(-G6@RO3G&*8*+B&J[R(=BOMAR'Y=1Q[X3&(P9_^L/Q4 TF,XJ]B M FHGAULL9MQX37,$?I+!$Q20I&*RE)_E_TY'X3\Q8R]WNO=#B4Z_&TJ#B@#6 MS()M&:=C"QKLIW0R*K$+4;ZQI9[3$,P;84.M4FK"<[[>S;U@FQWG'Y^AM6B# M;E6*A]Y36S![UNUZ[8/3(;?* 6PAPA0YH+DB_I!&4E.<>%+84>^I?>_P,[?K M*!%<>N/.C^$A";TYCT<^[S._X/[$N:^49YXD+KK7:6\Z\&3Q6UYRZ<^A\ZNF MH_8RG'4AUJ$'H^X?[Y9$3KQ&J"#D%C,+J6!6"@JM)II:"1*$X8=&E9SAT'J2 M54Y9RJU56E@'C'/>0N. \'>MU&_T;8@.CJ?IFHC)L[7S-?Y"(*^ (%$U6ZG< M.(_HXQ+4O6G05XHZU^SCKM*L[PWN-5Y1WAY2LC^"\OZ\P#A^;HYA&+AQ,.M2 M"[_QCYQ$+:F;#@;%MY%]PV<_MV[Y>9SH9E1=BS#Z_\J/?FUS[7_OU\?IK+QU_Z/J%[=QFZ?R1_/?X?N_@BN^$AO=MF1$,0O1 MB\EB4CE!_#RSFVB..IJ?"P)J7LI7%.7;N3)T7V^1>"A3B66QXO@&?P0$X\/+ MF(\Q7!+HSC_[[T6"G8LI_;-P%W.QX-E%W-\"A5R88)I]O.[W/-ML0^C,.@!F MYU<1+'[WUHCAJ)[-9[<\ MB)J_=KI_?!M[];47SK_1^.-?NMTTO;K:]=)LJYCK2T3H[I7)U(\2[WM=@Y?. MZO,Q0"A1( MO#F/%FMCFD9:;;Q5IZ WXZJSL>*C\ZND'RSI_TH[XP?G.M71?CSK:/F_=#SJ M=;+K0*P"0?3S.B-\&WN\&448NE2AQG#G'DN&(,+&9);"YA3H=!I%S^&&U/JLQWB\9M3A>+*QXO M60Y?@+QT]\VKU'%;K.BHZ!RT:"%'1>>HZ%3"2#3:M2%H M$I4@:XBD!'#)I ;"$<98PIA8:.SW<&'4_[X[/8?Q-CWJ.2]-SZ%'/68Y M <5,X.V?K8A#TOH+B/_SDD4/;/A[N%(6:*HI-%8GBN5UF@@2I05Q:@%^] &B M1X7J^-U+'R;;>*NZT+J=/WPI])J5AN/$U],L]C3;&TU#:M53Q-6]JUF\+29R M[9\]'A4&7+<^3XD3/FXY]BSS2+.KYY?]UXH2R1%I''%:: M)]XTY%@AQB#2"74@00CCD.O9V7X.\-8V:DGN$C\ICKE'9:-;_^/OG5!N5=<. M9&K8^UO:^Q9J4T(E5M1) TKL8)1-QZLSTQ$6' ++'5600I1HY@#@6#O)A*(2 M-#+3#?>+'XLH#*9.*ADV &%&H&,&6;X2_&?M>^!\8KMU7T[_H2Y/_^%:IV<7 MEU]^SQ&.%AEV+L-_#5=L,I"GS ,=9DI^_C'\? 5::(E^T0KP%ZV"I X2-**H MR(S)-/SG; [S9=S/_LB;?*41D?/WDXL3?_H-0OFE5U5'.31=K_6],^X7=8K- MVVO=5%J^N=M M9-"B;6 0L[&Y2-GYJS^_OFQFTL7?RKL'HWO^I4N7OP M_M+YS5;A->-;'3O3=F[5_G5++=-MS[$YB M42*) QP\Y^#! ^#FIE]LD7G9^RN_6-T#9_#H<+ZEZDC2?VBTP8=HL%J"+!N4 M=)$)PY3G'$ECO5*(8*J"#);ZM5U]XWL>058=._Z#_I)=Y?V+E?..GW2F^BSA MRM[/.NY\D5EO6?K[VJN 'HP;%Y@V6^GSH;SRN(F:N%)(XX\,"<)W6RZ$U<;U M0F3+14$__FK- J3M'HCY =PF*K?ZQU]5O"#K-EGTRT%VND1K?4"GX_3 M.Z;C5)]R+VC^5C5_N+R<;LX%C=^^QC]?VCB^O]ZY*<+';LR\HM^VJLA7C!5&&M0DN#A1+/[T;@&BUS#7"'NM5*:PT' M=P!W '>HLSOL9WD*N,8AN<:N([7ZN,Y;C>\^+S:S/IR%-EM7P+O_HA^NT[6K M[(\S/]67E/M^MIS@V.LBXQT:<[W46G"M9"[$XB@LJP53WE'/(N.**T4Y42P0 MAPV2_O'!(@LMT'QF[%E[;3\E(?K2&_][L:?R\K%.9W>=F_G42WXQEZ<*@K L MCLGM7N7XT4[-3TB4?NWT!I^'X[']/M/)?2GT9L7AR5>]FX>GGW?&5S%YV>QW M*P^?75V:#'IP\Z*D9CS[Z:(0*X_ZWS,Y6V'ETHDHQ2X/OQ6=,/7!L@N^9#?I M]:IUCBK>XV%OZO(6P,\^ TIU,?7=?\V[[-1641Y%(&MB,C3I5DWZOVX'^4PO MB* ]F]>>;=UUNK%9GL2++ _1Z"RB).*(.5+8!JP=E\YAC9G3^L=97CGUN9R; M0:+WNHG>X_-)^7//)\4?%7U\Y.'VF=[CGKJ+^U%VR6(4662SC42)!:"2*<2.9L4PICI%B!D=NU\@" M]DT8MRR1W8DN%IR\12);5V)C&QZYR9#7]$'\!BY7X:5#Z;WS/GC#3" RZW93"X,Y.;FK;-4+@3Q]L^*K=-8%]O3-\ Z8S?0[J(-E#O M.)=:<.6,P3[EM238B(*(QM: F"TW92.R@/%6P_<^Z=C:LJX-P)RF:.>6-D\D M$L20A]^@/N^6D+2\(2:TZ6&WZ2.&LZ7G0S%UYQ(1L,QR"5!3FZ YRCFX3K!-Y#^O4 M!IE26&<)91Q'K(5B)"CA."8^ 7U=:=IVJ_[W2=/6EHUM /XT19%6&;<*;5J; M-JV(*846K4V+5L9[0IO6.=N3BVP/(QJ8(=1^LT]5)O[A%FH0YW%FI#(,!8W0<"SBV+1#KEA.%,>D45UH($ MH8,)8=W&T_ME*VFKX1_V' 4HJYOA=2<^P0L.V O^UVW_ 4^JZUX/X "OO"*? MU;TB&NL!])%)2&B^#4H0YX46=Y:0M2V5WXF$9:?56 M>R G;== ?A.EB]72:"EK4: MS)]/T(*:](#@IYDZ-5"3-J%-JZ!(H3EKU)P5$)[0GG7.\O@BR\-:AR"LD,X3 M;JU4.F)7G/U,2""4UUE&VK)$KT;T95V'Y2 C/634VL0Y$KDXZLU9ZQU3 1.7 M!J=.&,90H,H8(K1*>%9_SK%EZ+4SYTB/M(:M2>LTY5)OSA%FGPYW]FE#(*!H ML3&U$UA$*HI%3XQSYA1U)/W(&&],2#^L*TO)6PW_SV,$!>P'L30H^\.0:?5"3MEY-2ODBG37**2:M+@=YWN=L*F?MY#:;07B[]"Z]C*@][4Z&!9BC8G0..TV_B*>5'-2D!X,^^XPG53(J MLPX[8]40;&1Y^$VZ(B8E")KSL)MS14S*H3V;E>,QMI3CI:%Z8%Q((03W5%M+ MD(HH8I5&]=2M&[N_(7L):=XNY"7]2$@E>=Z*\]=M3 Y:TD,&K4V,8P*II9V4 MI41(LFAHY)Q$XXWU03KAJ3".K3DW8P^,(X!7!80C.L)*M ##=N(504L*HVA=[>GLB@M8EP%'2QA3*5IE#!"QJ4X0F^E/!,Q> MI<0POF8+NIH0CBT# MKVKTHU42CG7%,-"/@GZT[5-/FP+!TM8EBAH5M$6*$\VI5U9$%FS0/J6O4JLZ M+'&_W[!$P?H!.-(>H*Q=VK&5O4@52$C!"V:\&@$O:+473-ERV)>X]5I2B1<) M+?+281J0B0QQC["UWDONO%"<JRI3AFOT8$3K!6V M)OT7^R"4"&[-EC#[97+;O71@KTSNAJY16T*W ?C5%+%;9?0LM&E-VW0'LA7: MM*YMNCUU"FU:XWQ0H44^2#&+2!'A->?,(8UE\%ZJ=;!6$W:S9>A6 M ;NI>*63/<_L*W7#P,-5MCYX!RY^7_ZB-T@0.OGTH;Q2216=#R>=?M:;]<=L ME#PUN=Z\>XW3WW-WSSKCK)MZ3E:@>7:57#^'*;5M^Q!-?>AB>)NP8:> \\/: MG+VMN'5[EFH'M_K/UZBAC;ZSKJ:VJI W'XUP(K2+FBCBE/9:$ M1!&U<]:\)CM=HUA:"0]\1$GEN\)N[:R5=$U0!!_D:=1@.!@.AH/A8'@=F* 6 M5 (8#F,Q&(MMQZ%J+)<4HM+K0-/8*XW1,!,F$D*Q"=0851QE_R87Z]BJ'BDBG]WB#_<)67%84)^FFU M9M1*Y:DYASDU_U^WXTGO\GL58>#\*L_<\#K=]CV[ROL7V21=N!SVD_NGEZ]P MF^.[SLVXH#*'E]G_\2EI -9;/RY[?Y%*VQEEG9*P&:5YIUVDY/4&4>][O1S@22]P6UGVF_*GTW;;K71'DLEWJUOU J:!Z]J)LI_ M7XWF#[GI?,L_?!WEG7]_Z%RF(GWJ].\ZW\?I57^[&LVL65?$=?*/+0M=?KR; MON/KL'^1'G%\7Z'>9N"GYR>IY*>GV9_G)@__/%Y\*FT)SZGY@3=VP^ M9V?GZ<)OX>3\+'M_?]O/V?N9G^47JY SM_6!WZTX9AE>SY/-9WD_+R'^ Z%* M8N1EX 9S3*(5 2%);=!"&:Y1,95__TXS>?'M]-US2A%=L0^9M\;I%(>\U9&D M_]!H@P_18/4!KRT%DIHCXE*"P 5WFEG+K8PNE88C(Q3[@#;TL9GI6(\> !:N;_XO%S.01&]^P^*A=$TQ2]C3-;-^_W9MW]_A]Z5GY.'=.>? MGW#A\]YU/LY.\KOLR_"Z\VA <-T9I<1C6KS.[60XOS -S>65N][%Y.J3P&(1 MA+L%D-Z,\T_S/WY9#;GO[F?_[@>(6+[[\>3@]"68J*FY*PG(]%N^Y7=,KOF2 M;OE0M6U)M[]1;'DC76?CMJ71ZQZZ_-WFF>!GJKX/9#G,$\&AR.[SB^QXDE^W M7"Y$-Y%$^_6!ZH2M3WB!NQV-TO.S^;QA-ITX;*='M-8+EMB S*>A$C1_JYH_ M7%X6">V?.31^^QK_/!]=]UK?]Y\_8]1@5RB7,F1S@6[V!;RAS=X0QI/>=:G^ M+.8QLG(B8RM1[=M,.;Z BJ]5:&GP1.SS1UC@&BUS#7"'NM5*:PT'=P!W '>H MLSO411W27!(99: ^..,% MX32DO,YCKP.6<;>]VB"UJS*UVV&S-OQ1459A;O>XJ^[B_[!96]V@JIJ5A3N- M33>L*B1I=+JTJM!;;ZQ16&A/B$>HP#B7_M361<*J6%4(6/:*P]27+W:L9)WC M+FA6R6K%+7O(X>['MK/ICTZB Y_.U9R/\<1O29=2>CRX<(:,XM4P)KPR!CE MGI5TI2%.$^UJ2E>V>X-..%L84*QNAM>7^(3V/^#VWY4JA<9O1N-O1:Y"XQ_6 M$9J;\E:UR%L9CXHKQRTFC @JG."L9#(D-X;)-9O5[IN.;5GJNA,9*ZK9INFY MO:()+"U@7F/&Z10M3@SFQAJ;NH,53E)+D1=NBGZ4WE1UKP5H_E?EMPFI>STTU@%J0Z,ROLA?632:12N(\M(@@@1#KJ0JO#+! M,5\/&A52V)T85?(Q51L(,@'T:@QZKTK.,HGO$4][1V*".4IQ,,$CB[TI$(]1 M%Q4QZQ#O[JQ*LA2:,[:-.?NU"DTPC4Q@K,I!NA8D:KQNP[M]TY(MR_!J M1$LVB7T$I*HKE\BYO(1BY)]],K1E*'6E7VDK49[V'X3 M8*QNAM>8R 0'.& '^%^W_3GOJ>M>!=#VK[<&GM6]#AK;^+7A5059)*Z6>6N5 ML(%:2XDF%,=B$R3/.<<\A'7;T>V;5VU9[KH3K\H(/7B]$\@]FPQZKTK1"D87 M%"V*QC+"&8LA"$V5]KY$/*>BB)S4GZ)M&?#M3-'2(UZ,=PX<_D#N"7+/=LL] MA5@<@(<$MY2CX*2)3G%/@RX(5YL&.,X1MT:TOU_"E;4:N^%P]D9"3^,49:#V M;$)S[DAY0DO6J"5W(S"A*6M,1\JER""!("K5]:1 MMQKMG\\Z$I!Y-AK&ZF-XC1E,<( #=@#8W+/5S;^Z)A[4GK47/KTVO:J6#A^6 MVEOEO30\(.E(T)*5:D\1B.4:U9E>;5D*NQ.]2C&H/0'TZ@QZK\K4*KPX>8GS M!'<869,PSZ?1.M*H.([#2^814D35GZEM&?#MS-2*(Z[YP<,?J#U![=ENM:>B MBTWIJ8G":Q4I1EP%R9G1KN1='>78QCIL[GG:G0P+Z$;%L!OV97X1[2HYB#T/ M!GGV&4*JI$IF'3;#"#:#//S67&@]"8*6/.R67&@].33EVR9TKTY&JD521XQG M1" 38E".6NQ\G [-M>&"\W5#\S_,>&4?0>=8)Q&H9 MOVI&7D+['W#[[TAW0ML?=-OO1I!"XS=*WZGE(FO%-&"IG!(TNN",=5J5^DY% MC:(NK-O;;L^4:LL2UYTHU300J9!2!7EG(S&ON?).K9;.W2 T4F*4YI$$3*A@ MKCR[7:F$=H29VK.S+<.]*MA9!GMY@KJSV?-JC5=W4H06NZE($8B1U DNL+,J M%!O/EUPKCTARAFK*M;9[&V90=S82>9JB(@-U9Y-:$]2=S6E)4'CNA-5244VB7%L+% =NKJ3(KG8 M;]@AY@VFUD?G)-=,!J0I50&Y-1NZU80_;!E85< ?*E0E?]@XFA#4G4V> M*VJONI,BO=@5Q% D&)&<&\LHUQ%%6IX>A(V6T3M1 \;Q?B\0!5I^.*X=8*Q= M&J_%/IX*!)ZM=H 95T; =KJ %/>&W;R;;O2DV*VR&"C-88;S:US4B.A@I>B M)"X4-X2ZNNWDV>(D=J>=/)6J9"L[D'HV&?0:*_6DJ286*S(C)SQ(&SQS3AM2 M'+A1(IX/R!%>TS.76@Q\.W.U[$C3-QG#-X[$;0U7VP!,?SXE.QQ=Y*.Y)?CF MKVP\[/QF]A*PA:;&ZO(@Q"8^.BPYI@KA4@)8XI9G0:V]6W@5O_Y&C6TT7?6U=16%?+F(P])%CM]H\@0888H+8U1H9AD+*AGPI0DELA7 MI)YK%$852JAWMF37\3753)VJ9K,^]NDX%?GURL9$:7V*5RV-[CM3!MHR;!^;Y!_ MN,K+:L,$_;1:3VJE*M6Y?/R9*SY-WB&8-T+1M>;GCVX*(LRRCO M%KY2EB3K7G4&Z27IA^7'RX03V9\%4,P>]_3#5KC'SFJABXNW@U&>ZO5_TD^^ M)<1(Y1ME_6%9]O2R3K=[>WW;+Y\P3.\9)2"ZOAGE5_E@7+RK^&7V_O_[#T4( M^L6J.QN6C']5+^]RUY1.S%,U@R&J3S)G-%1\;3>92I#]C75\77Z[F8T_%IT@71[*D'ZXJ[7[R_?,5EJ MV_*[^T)\+[\;Y=>IF*D46:>DC K+'Q5^.)C]=EJ?JXUQW^#IEJ(J"]ON:>7\ MKYM4Y7E10649)[WK_./#/E?+'O8$-D YMR[G]&/Q\T^]27IV=WKE;EJRK\/^ M17IH'([2YT'F;D>C?-#]GLW"QC H1^O[.$H-V4&A0]M7AJ MZI9%[WST@I1R#Z][L^ PZ@S&T]3CI<"_5,2R(W=&^0I,7TV;:SDH3-^Q% 0> M!H!'95T-3N5;5O'E^1 ]7L+8TT$W?P!CZW[^$#B7@'L\P\GQDZCW(T1?:IZE M%G@#>-\>U)>L>8C=6>JF2[Y0%&:C&QRMY@*/\X#%$^=-_FU0!O>BR&4 [PV* M2LG>SR+*+%+/$HMT>YF2EH483])_IDE)>OKP)A^5N5R*TOUA*MA=;W)5WC2\ MO!SGDTE1V$>>^%1=I50Z'_6_E]$R]97)-.?H=;[V^KU)\HU#B&M%?QS?II' MHF//'*C(@+#\9=& R?N^C3K7J7E3A5^D1DPU8@Y,WA:KMV'T'/=^5ZF":->7O31VT$G=>EN[V;JE_,&R?^:^L^C;*] W *S M_IH4F>/449/Q^12A>JEG%P](/_R:3^[R_ %8%CEK*O1MIS\O>]'%+VY'I?VI M1,.+J8'S4OPY+,:BJ;F3#S9X5[MTHM=^'^V!?J&2R0@TTKKUY[_[K=)#-]W4F MI4Y?'CV.^*7OI\;NEH;>>\4XV9AUOHWR&405OQ@.BD%^&N@,9A.X2\@]KXZ7 MIX;E??^YB0 2RYL0$A$Y11$;Q)T--AI+*#)>.(,=4=M-/!>LC_PG2Q6&R#W] M8F_'O2*[,-W_>]L;]^[IF5(CY887UYW!,V1?][JR>TJHJ.NY3RWKS-PLOJP\ M]/?ATKOG%\^NAJ,734*+]9N3(O3Q\01TEAJOG_Y888!>W,I9GBHPA=(2_(:[ M>LM&9UDZ\48P32US%@7*K5"*."YIP($ZR1E=(RQLE+-\'LZ9QR5?Z5Y=;NRDN^CGL7J5&_%V'T+.5I M_Y/RK3)&C\O,8YK(IE!][P;3D@V__FLZ7EF05$^ ;C*L1-L$S+N$IHK>:-#V+^Q^R/(F4L?YGJZGJ)1+O/=X]FQ-%5)Q7_ M:Y&?K!7>C9](^J\[_\X7C,M-Y_LTL$SK,.5YL=#13BU+F4\^Y=IFOTX_>MC2 M?]S,LMWDHBD/FM;.HS(_*D-ZZ[2I4^I4Y&[+$:RX/O>L'Q=IN1C993F@+A/[ MVZ*H1>L_SK!7R-H2KT,LQ[Y3Z@ M*?RD1^079O+BV_&[G3.4JNG@O'\Q<\U^\IHBD5WI"Z72<]HA.N.=,HS?.JE? M3^?BZ,JA""_'IO_C]*J_78UFUJPKXKHE M;[ND\0^3]N.3\_#K%Y-]/H[AS!V'$Q?.LG^9>[TR^^G7\SY\>G) M\Y/XMRGXR>EY*NGY:?;'B?G#'Y\'GTI[XL/)V?2OL]//Q]X4E^/QB3EQQ^9S M=G:>+OP63L[/LO?WM_V8 M%J]S.QG.+TRG3\36]UE_CQ5UL:O=U7]%FW;5Y$TI+5&/\R&/\]'Y<1:0JZSW[39=>D,1-3DS?NL:^+WSO9!9PXXN#PP?#>\VS(/5[;C5[1<6/5Q5M&U]@%,T MUBF>G/9J,SK4Q_!7:?QGKXB7'-P67/ M.+>"H'_B_S,>3?[/6?7X?_>]B;??\LG5\-T\Y_IUF+YR>.K>7Z2 MWKM8MU6L]2PV0W^XQJHF2[UJOC/5%DO2'A^2L;PJ;<,Q&?BC?+QWU>),B7IW M2\"CQWO*;6UY#;+3US?R>9BK]&+';H$QBBBF+Q#GMCA;(TB$C? .1VG(]CMV M ^ >*N"N60.\?M-R2HXHKV2KP$V][]7'L[#G^ X#EVULW5]3_^#X3*]G+ M@+^Z_O4JQS=MW>%VTA(<.@W\96E+A!>=I]."\ F&[]WP_?%M=4PQ@I17-@3#UQPW\O;3?>=W M0Z"?#T+6KD#6?LAX!++VZC$7+XYXHMSSF# 7>4^YE$I'D=#7>$8M#Q;AVLSW M >#67];.U!&'Z;[&QH=EBFX_@YBZ "A=)*TV&.*%ER)JQXVP-@IN.3(6,\V, M6J=1VY<('*#T=47@:Q"24URU^+NV4-D:[A.TW(8"J:" MJ6 JF JF@JF@Y886!BUW6^".I%%'(N&YOQ+>?[KL:Y;"9R&&HN36HN0\9D4#-73WJ M,G&/NDJ;:#PB+B#/F: Z(J5IM-)JYPQ=0>@)X;,W[$M80YOX:& MB.T$W1M.7&XDQHI%9JLB)I(010G%W(1@(W=8&BU#\)B8-3OD[4_P#6B[/\DW M/4KN\UJB[VW[(HC"010.0Y,6&[X_EHB@Q7B%D2@YHU0$S8MMO16F)% B),-I M &,1L$1-"*)[D(5S C31 4,2R,*K!EVR1,T7FZYH&KT4B#-M%3%&$1\9BTS9 M&($D:B7B;BT,QZ ,;VZ$ &4XF JF@JE@*I@*IH*IH R'%@9E>%LG-8WWMS6:*2 MK,HYNZU[QGZUB'^;=%(IY]7:JT\+'>X/;SK125RZ4'>X\V7F6]_.RWC\@ MJ3DB3DG/!7>:6Q#&<8LDX4%RXYC&5#+. M&$.1F6A7>7]BVR2 M+EP.^ZFGI#=EW:*3?NC.>FDV2ET@&]]U;L999YP-+[-Y-;_XO3[OEMUF&ODH M+IMJ_3DBO*7['X17 ME)JDO+\W2'G!]//R"P9%U^\_:$6,ID&F]/BLF_?[LV___JYPK_0Y%;P[__Q$ MC9SWKO-Q=I+?95^&"8A72WO=&26PFA:O6[O/33%_]V/J;?H.2G_ZY=TC[)J]?\U7Z[ZKRVWB MQU^I[-'#(>P4$CU6,N(8N->YFSFDOM&:,< M(ZF(55HX'@TV4BJ\_1Z2 +B'"KA;'S-"R1'EC^$6]H]L1GQX]L!E&UMKMWRX MNF%:#2+"^TTA@2U"0D#N_RX M>%"ZMC[31KCJPU&>V\$6^+A+EZL*3W82$QPZ#PRGI1S"^*JUAN^1Z%+T/L)* MI8.AU@K&)6?*&YK^+V).K>E*EP4$K33:VCL!T.2@%=>QV4 (=/[H.N'9QB@ZX= M SK4U/#]3?=INMA[/W*J6.1"869YY,1J&F(,SBHA)7&V3M-]YW=#H)\/0M>N M0-=^R'@$NO;J,9?C>\RE3E$KA-/6*TX"LE'[2"T)S$J$N*C-?!\ ;OUU[4P= M<9CN:VQ\6*;H]C.(J8L,7(NEK-5A0Q#W3FC,C8HVD$"09]YX3$VHHPP*QVQ8%P( MAH$6:B7>;BT#Y^@((02\4!/# \C P50P%4P%4\%4,!5,!1DXM##(P-LZGP$R M<%#\@@P1&"$T45M$AIJ2C+LA: M3?==C7+8A^0PA. :A."'C$@@!*\>=15:",&M8X@;IY"Q//VC*4;.!LNHM5@& M5I\9/X#< Y""8\:/DI/!G%]#0P1HP>]!5"]2UTB"(SY2K WA5A(M!%*!.><# M1M[1.FK! 4YKH 8G"M3@H 8'-?@AC$E::_C^Z"'"%BM6)9+4T(BP(Y1S'[6+ MDGJ.'4\1UVL#]% 3@NL>]."< #]TP) $>O"J09XHK+QC1!BN+N"K4 M&E(J2H)GR$3GJ]L1%R;X]J57Y.B%>L57[B$'(F+\VZ23S)I?KV2F,35"T3=Z M@]O.M!663.NG7O%AQF=@@G[ZY7447(]+M:X,RPVD4FLLE>E?M^-)[_)[):S# M59YUB_[[(>O.>G VONO.L-[UY\?7TV:.\6[CS1=89 MIPXWRI-I_Y,^?4LX,,Z&HZR?"C6]VYRZSQ^SF*X5SYD4RH7L.AER-<[R0?&$ M>:6^V/K?.J/NU31F4UPNND5;/ZNTN0#%&+Y8K20LQ9H+'C1!T24TTA0;R4S@VH;HR&J(.4U%'Q5%'^57^6!<0G1W M>)T7R+R,N_D>>OE5#DB[K])_[O$F6(UA%'YK0K M?-P%Q(E%^-%BDM?T\91N@8^_FH^O<6WZ\?%Y*E6Y]E$"\?%-WBWJK__]J A) MP\*'TA^%W[S/_[I)?I3_?)0-4B0<%;68\'XRG$7 XO>+X+?\?1D6DRNE^EE$ MWU'Z-DN-.!A/6Z/XX?#R7?Q^-3X6\>7;H R=LRC=*_RA.PL__6%G\#%[ M>=8Q2P/52J;X>HG(H8?W6;N\/O(M[0 1@HN$$4<#(P8987'T"?D"H@P+$=#. MR#=%NE7\,X,+"/!U C_^\?$HL]*X_NH^K9=\&A$KB4RIJHD*25?1H"^MY\^O$V)*\8T(LQYL;0G=!]?CA<_@@AMCDA5BTX6D0H MUYQPJGG"(LZ5,"K!D1::NN#=HPW^YWWP=/!D%SW))[^/\@E$SQHA#7Y%I'F3 MZ*F6,D*'4CH8/?78>!VXM(HF=S5,>X$Q>[3HT_PP^-)^D]9_05D#V_RT;3*5P? O5FC3@>^%[W+R_1Q,.EU^FOC M[0O&M*_'G*=BIT:9S&)3*FPG54J*J7\5=3@U\6O)=,]RS>FE=55Z.1I>3Y.1 MSFZAKM+ ?->;7,W:>) J,YO.D#W@>@\=2 X'QHEX8#^86_':6>>Y+LQ.2WTL(G9U:+> WH]_;# M OQJZ/)=JX1'<)'0=9GEG-$C-,2XP MI5- _&U_,@?7B]YX/B]:S.9-KXZ+J;_Q55:H8[*KHK.,TY.[G=MQ7MXT'/52 M^R:$+H;2Z9)#V[.[UR-RW9UV'_ M(CTTH4"V6&:=E1@RWBH*52897_*0A#"=HIFZ^6A2Q*(YKYS_-1O*CA*XC(NQ MW_#VVU5R@S\[HUX^^5ZT>.JEJ=]^Z^7CHUE,3Q5>MGOZ[\=L^373Z#8<3R/9 MDR^9QK#>9#P-[5.H**+Y(@68E^(1^7USFWI09UP49)I@S*N[G B>_WQ\^W7< MN^@5!HRG<\V/'I0Z0)YN*K[K]SI?>_V$R47MC/(R7,^#60$T_03MMZ-QZ?M? M9SC^,3L=9//MF,NNC-7#'EG* N8=[(D,)>M\2Z/L:=$O[J&QZ($/#9MWK_24 MFQ0L4MK3_[[,]^E4&?&F.)*[DA%&]OXBU7=GE'7*72]F M6I'A[3@5>?SSITT2GB=%/7.=S2H@/];T;/#*"EQL45$S$\I_7XWF#[E)D/WA M:\*D?W_H7*8B?>KT[SK?Q^E5?[L:S:QY8YW2$X'O^.0\_/K%9)^/8SASQ^'$ MA;/L'Z>?_?')KV>9._WR^^D7K)5,'S%@I^2GI]F?YR8/_SQ>?"I MM"<^G)Q-_SH[_7SL37$Y'I^8$W=L/F=GY^G";^'D_"Q[?W_;S]G[>_Q;%:W- M;7W@=YLQEU E,?(R<(,Y)M&*@)"D-FBA#-?H UN+N1MOY^\J07Z\MA1,:J^- M3+:]*@+'[GZP=/\#$32:AX7>X"+=6WY>?L$TN#^()!A- M98VEO#"E2OW^[-N_ORM"7/JC/-/\S\>A;QW]^L@ M[]<1X**5?[1,KAS;??6\*J[5=B_[ M7.O0=/L>RK3QS5]9R8KNM)3CD.QONGW0OLVV#]JWV?:UH'V?O]*T^771=ON? MO6O,/NIBW0!0O;0RU-,T0$FF9:L\6ETW8@3D;U9O?PL/#^4D07$D@N],3ZZ[DUGV*#IV]7TY2D-V9?6-GKKTQKS[=LH_U9,2\[WCL^FF\972W=37,U>ETJDX'1VBK M(YSE-Y-2HIU15$YQ8?"%FAJ^OY.!%5Y:),Z5.>>.44-YB5.Z<%(QYMX?+\,WD!Z[;$NOQV].-]M=<=/LZ.%*]T1VTX#;=& MZ/SLI'T;6VMW&$)U0Y0#P..E/:DY?LF[>2$7_./CV<>MSFIIQJ.'HHWU-1B1II+' .Z\4MCP*% @7S%G-@PO>*HH#<_+1 M"2+ $+T^V&T[8.'D""$$%%$3P1EDP6 JF JF@JE@*I@*IE:EC]U$5#?+[!:9 M"@KHN@P30 %=MSGTP^>U00$-CO"T IJ"+]34\+U-< G$Z.)4M^BED-Q:Y3FG MAEMA7'2.1Q8$D8S7:H+K_&[8.,X7%- !:" ?E6XXVH!=XH8$HBBABANJ3/2 M46:Q5XX9A_":!1]O/;_5&JS;5@'-\9$4,+W55'1>IJ3VD\#7!;[D(EOS&F-A MC7=4(TZ0-5(2RJ-5D6NLA*JC8/@P@:R"^7=Q1+0"P7!=,BL0#+,!B 8KAKO MZ&)$XKCSAO+@*:9<>FDHE3J$2%0@46L#A,K;@]W6 Q8$@N&F@C,(AL%4,!5, M!5/!5# 53 7!,+0P"(;;.H Q8!T5E5Y*IYQ/8PX)K,HA"H?QXP-:@%BIN>$@ M''Y%Q!.+44E 4D2BG43*CQI&^.RN'5VA? M_%' WCB'C :5S?_4("6LR207QXOC-*GSGNMBBV'D.8E$:V6*TS6Q%E&RX.LS MR=4>N/OV]6:K*2Y,U!%1+U3FP1S7P> S:(?G $87*1O5)&#&F5=.%__6EA-F MJ=?$I7_I=;JDO6F'#Q3**IB%Q^)(2@K:X;ID5Z =;E-:#8:WS? ]TBIR,)4#A@.0#E<->'HQ* E4!1$= M%Y@(SB15.# =E%(.1X0I U;E@)3#6,@C#M+A9L(S2(?!5# 53 53P50P%4P% MZ3"T,$B'VSJ-44B'W3\B#)#:JA@%Z3 X DB'#Y;4?N,Y+DD6QVI:XH2CR$O! M(G><6A(X"T0:[@S'HF9S7.GFQK&^L.DP8,%KS/[4("&LR1279(MC-0F-TE$N MJ)6<6ZQUU$*;J%5(Z&==K-$45VO KGMUN>4,5[&E)X$9KH;B8FUC)YPQ;7CV@:"@\116:6L$+54#A\FECUW%KYX4+JV_@S@(RUXU0KB MY_K\HD/OXO158=W/;>;JYI+C&JSKJAG<@^%@> TZ^AN3,0JQQ3IN)(+7F%"> M!B=4(H5=#%+'8(QPT1@@8PY.< P+N0\<#F A=_60A_4]Y&','8^4,D81IX99 M+H.P*@&>1-9A GS,'O .5G(#(0.2X]9IA,!4,!5,!5/!5# 5),?0PB Y!LGQ MCVK@?#CI]&%X!(:#X6 X& Z&@^%-,_S9&7J3*P$,?]+PX>@B'\U+3V_^RBZ& MMU_[>?8?J/QGJPK8']>_U5Y FZI@HW/4?Z).ZX5PVA#/L16<&$HX1EQY1PC& M0BCC+1+A;66'\Q]MG+4[P!F["O;^(?R(BDJ%T5M[^]XFZLJA^-\FG53*^?4J MGKUD3+\WR#_,B 5,T$^_O(Z*J/HR+-W_ *A1@I[R_MX@19CIY^47# J/ZS\ M,(RF<%76<];-^_W9MW]_A]Z5GU/!N_//3]A]WKO.Q]E)?I=]&5YW'H6UZ\XH M]9%I\3JWD^'\PC1*EE?N>A>3JT^*?M2*4UN(V_Y-O'CK_1VY=CN*_:LVVHU M)=UTXK@^^29.X6<\[/V9['W6Q;@"H7EH9Q0WEI[OI"/#KL'^1GN#S[FR7&5SN.*3KKA<%\&]6AW\+ M)P^7EWFWH HSWYGDT/"M:?CS?'3=FW*WT/3M:OIR'67VI;6-WOK,QGS[-LJ_ MI?;/YNO+LND"LP/I). O;PP8G=XH*V!4G*D0_O@" MJN 'AK=H*WTX4P$(U%,S7(!^NQ,DA2O#@U7#,E MC*0Z>AHT#Y298!/<.44-TLC1[;?P ZS;$NORV]%6ZX88.U)2V6=T5)S&5T(U%B-$Q[[0*G@W*X[TNO9*S4!F:M: MJ7G$7@JXF_VZMN#;&O9P?LK#'Q_//FZUNKS!40@,!\-KT-7?F""BFFYJ'270<,0#**#K,(=^^+PV**#!$9Y60%/PA9H: MOK\)+DX6FX6CR#C12E'A/<&!:>59XA9Q[4L9[@$P9$X5J,9KO:@W;:B M8:J.%($IKJ;B,XB&YP"F%AD;<4J9@+G@GD1D3:#:E:)ACXT@7M12-'R@4%;) M/L.($I -UR6[ MEPF])J,+QMAN^/55%D,K/@+@:HZ MCU]TYUU(BA"T)CEGTABIN=!#&(V;*XX>= M40(IR];,Z;_Y%%=KP*Y[=;GE#!<_PO*%6X'"#-?!X'-[!,>; (SJ)0!3@2H= MM.5.2>0BC;S4&PNCI:&DEGKCPX2R*B;ACPAY+#B"O8H/G'";ZX9KL*BK9I@- MAH/A->CH;\VHJ,4((P@O&%<(*Q^(H4%'-654+.)!&6!4#D\U#*NX#QP.8!5W M]9"G%V.2P"A1R$CJ&8X>6V?B5#?LN(]82B!5]H!WL(P;6!70#;=.Z .F@JE@ M*I@*IH*IH!N&%@;=,.B&?U0#Y\-)IP_#(S <# ?#P7 P' QOFN'/SM";7 E@ M^).&#T<7^6A>>GKS5W8QO/W:S[/_0.4_6U7 _KC^K3;TV50%&YVC_A-U3-+[ MB3K'"<&<4X&X,M933"4NQ8-6*4GT&XL'YS_:.&MW@#-V%6@'U9%@O,IIN*V= M?;^"PK]-.JF4\^N5/#O5:>&VO<%M9UJI2^;U>X/\PXQIP 3]],OKR(H>EVI= M&5;@1:V I??*Z$(KO*L6_3/#]U9!\W&=YV;<7:7>FG6[8Q& MO?PB2Z@S*7Z8>MNPW[LH>D;VM=/O#+IY-K[*\TG6F627"4*R/PL,R3J#E)E< M=0;?\G'6F]Z[^';V[%'>+1SV(NN,4U\:YGJ>2CHN2C_"H?C$L$[@ZO\P)X'\%J?@_)>4*Y_$O>[7?&X]YE0J82 M40<7YYV_5N*'+ZKXG_B?YQY"R)H0PN]#B-BP0N;C8^%:EKRHG_Y8B23;.?2K M.^M"6.FM5'_7J^.@L3 M"6[[972:#*<1JPQ"Q;=+T2EA\.0'8>]CI2&[@O@,4>]Y0,+1XM 9%:BSG"M' MN.(Z>FN\QC&(2$@"$\)7@63>U4X'3_;$U+]^'^43B&6O"P_DX^.5GH<4ROC2 MK@O(:!UHN8B/84.#E4RG4$:P=I9H_2COVMX#(4!5Z8'T]3RPB$&]656G/XI$ MI?A/_[9 R=X3XZOQ)/VGK.D"/HS;Z1]4 MH"L&HLF*U!*36=A(94^CREX*=W_=Y-V9Q5_+@>,L=YM>6JW5R]'P>IH,=':+ M/)7&R;O>Y&K6S(/4@;/)7=[_\SZB)RM?&Y[(8A]PKQ!W"C$DO.8!"6.Q"U$) M1KP/UCS:!_P!1'3&5[$_O'N05)\/[5)*G5_XVU%RCY-D)R:_E18^2246X1.0 MJP+D4J\8.[= B@(6Q"M15M./Q<\_]2;IV=WIE;MI,;X.^Q?IH:Y8;9*/;CJC MR??,C?*+WB0K?*E>IDQ!;YXR7W<&G9(O2X"?.DI!14X1O\"P[K)!W:E!HV10 MP=?:.C,MM*KRX< M\<^\_[T N=YD6$!"@7]I'/;PAO+WP]M)BGB#HM*SF]DJF'%A7JK2X>#;L+C^ MM3/NC3]FJ=9&Y2C^X9BCB)Z]5!'C6=!;JJ19''QH]C,XXSF-N^HNCRGC=^O= MJ0)?602?68'+?U^-Y@^Y2=[SX>LH[_S[0^E3IW_7^3Y.K_K;U6AFS1O3 MX$_TS..3\_#K%Y-]/H[AS!V'$Q?.LG^9>[TR^^G7\SY\>G)\[OJ MVQ3\Y/0\E?3\-/OCQ/SAC\^#3Z4]\>'D;/K7V>GG8V^*R_'XQ)RX8_,Y.SM/ M%WX+)^=GV?O[VW[.WL_\++]8/9QM;NL#OUMQS#*PGR>;S_)^7D+]!T*5Q,@7 M9TACCDFT(B DJ0U:*,,U*N+(_3O-Y,6WBPW>_39@.TYGA@7E1FGREP>XF-!T,)[&QH0XHSP;WW[]5ZJ! OZZPWZ14X^*G'F4 M#8MG9^,\9=T:@@D4I$G6);^<:B0HLL]68T_+,W+I]:)JP7^4V>?G-[ M,YLT62W2"O:5V6H)7\O7L]294X9SB+&WF$G._O><:%LD8-E2!E8OLQ[&X:LT M:E@:8'3ZY3AJ39"=9?:?\Q3K,C+WQ"6^\:J7/"L-);XG_^UV;L>I8KZ.\]&? M92SN#6Y2Y"L=LO-GI]4C;U-9DI=>S]_Q=('* /E@ MOFWV\XDT7SE3]\/YOXO"IC3T3.X\+KTR90>C?Q?3?3?)[3O=JR(D3^<' M;VZ_)H=()5U8,?OM]U[>3R^Y':6LH7Q?R68#!S?#X=_E ]]S+:*&Q6ZTA,3O]/$_"2USJC7?9)#_.]SOSKF.NM>Y1>W M_0=ZC*4>=#PXF_,#IY=QGJS-EP_?JSD*H+?]8???[YX(&XC'()DE5 C*A4NC MP$"0420B(U,H"!\6$XDZA!0*'/-.:.YU2$-*[)F6R&&FTWUKX\O&]^!W:>C? M[=P4F=7H-M\0;5X/ BY3&!C>E6EJZ<#CV^ODP^E'X]4N77301>\KH&$^S"M( MAZOI0.\!2BPHGHM\4/29'T^FCVM%7.Q$G?J\6XYQEPN#]=:/^_3\WOW8)99^ M_4#YAN9AI558*T5X>6W[PBO]_?'OS@ZI,5?'+FH##;R;O_NL]+@;WMS=; M$*\_*-"GEO?U32M4W\:S9V\ILX!'KWA[:%B3ZH&;U 8 W\(3UJ?:==DC"-*@ M?:1!AY'FO#\NQLC#VW$:6X1F0][U?Z3/7L=T9 NSLX%R MZE.R(A\5'%*A5NN,K[)"4YF5HLIMD*NQP0LB.+1^RUM_B_R-K(KTZY._'3\2 MH>P@?-^6H9877$LG(TJ.D8\>;04>L,^+B4OM&'YQ6P6K9Q$F\^N/5C),!MXA=FXRPPNI@NP MIX.N*?7TC-47CY9T+*_B.$MP4(NM6C:?N;O]/BU[VVT%0 U [8U!3>.%AI!C M0Z6/D1&FN>'&,"-EP-8@'E "NVI [<'V5 !J:P^":0*H5/+UT/7 O@Y4=( M5+KQ7^WV]0,<:BL.L<4F*!Q%@8A0-F+)4UYFO'1,6N]C8)(%W*1\[U!QB%:9 M ]8/A[:A3@]O_N@DGV2+;2JVGT1J$O@V?..HTH[U-' M2KVBG'OFC"Z&K"I(K".+1$JN"0MM'L(>^)96S]\='PLXI!J0KHE(1Q>#9"T" M]MK(!&R>*^4,M0@C0C3#+@V;'VW%UZ9!0GI(]&(HBC#!E!3'RAO,/;(F$L8B==AX M3E'S8+8[(&B?VXD]NQHJM_J-@QU;!#L4HO**2!YTY,AY MS9PTP1,FE,$ZZE=(W^L!_?J(4U$E]F]RGOWVAZTSWM> AL?8^(+* > $X-P7 M<(K%UK02Z4BID,ICP;'0"FM,(I<:<\J=>8UIL5H )Q8I:<8 G,\_:'2?G,%< MD5U0S:U=-/&&E7 8"RC *\ K]E8DGGU(X>=>YVNOWYOT\JU.*FP )]&: M66-HR^;86J4"H,:;.YAN=W2;KSU>L+\ L$.+_77I#$VNA-8:#JW?#BUG!3M) M''I#MRGP0ULVQ]:6R#B;L?U#8\/D:R#*_B0H6TT<;6K:^BO'N%Q,IKOH/'^4LVT4(IPIADW0ECI2-"$ !<@ MM(!0<20H"&4/9]^W:M9O-2 XM&&?);&T=H$PZM+_,#,X\]LP,*[ MEYY5> #IUT'B!T95*C!KGG0=_%SZ]* $F"Z'"5.8+H?6A^ERF"YOP10KM&5S M;(7I5TCI*Z5Z\N]O.?&#; M<(:J(T[@4%28>6TNA!XR4FIVCY0!8TTYDHY%PWDPUAI*D,6(>8^IJG#FY.TS MLL.<(SG"N,K=*FN;B %8' 18*+RT::[C1$D42$B8843Q-U'1!!&H0\C;0TZK M#A(L^!%CJ E@T?+3G:LZ7Z$5@]O63KA!Z[>Y]6' "3GDH>:0:C'@9,H(XRQA MT5HNM+'>86X3_J#8;N'GX+BN<#V%7<4T7491Q)R5B5!6S2%I2(Z1SBO(8I4+>\%=*ZFL1 M3C 21XA7.MF]M6O5<\_QU^]*<(H#(#0@]".$YDNGP^%H$<+<&F.Y8=ZZB!SQ M7$4G-0JO-757"X3F](C)*J?)F@;0Y4#B;Y-.,N'^>OGOI>*LT7YO-1WV-/"5 M9;\_ZW-_?X?>E9_3K[KSST^\Y+QWG7+^D_PN^S*\[@Q^R1X;_W"D=->[ MF%Q](FR:A,^:_24#JW?/K9[R_0^P&$U?^N;R?#R3Y[\\Y!2/WV#PDK_^ZW8\ MZ5U^K\)ESZ_RS VOTVW?LVZ_,Q[W+GOEB&^.1&G$5QR/5V[TO+16M1@(IL[^ M8;[K\]?..(T.$T9.T@.[Q9JN(HR/RXVBN\7 <3+,ON99;U#><)'=]297O>FO M+X?]]-/4>!DFTYJ[3J6\&G_&]QV[H/+>6KC ML[R?EP!:KKJ7S!(J!.7"&8L#04:1B(SD!H!H=TB,2P$]>?#LYP"Y&UG6Q ME2I]9J>KH"$VU>3K]%TSR;9>B?1;9]2]FE8BQ4=9,?#;^EDE-FQ]M\^[92*R M7!BLMW[<48DI@V'1<)U^UKE.6<(D&Q6DZA2%)@O$*RDL^N M;&_5-('\STT9Y-+$72"8(R<,MAKSY%5*4B5E"%@:S+A8,\8_F1EK2ELWC.EW MT,#_.%4\/HGWN:)>/YK_^'C+Q2P%E7[Z8R5A?&,_?&:+Z<5J*TEB4,1$HISC M45N%C96*)%C0GH>P0XL]R/$;W&)'J6..BP0A&=?_OAKPGX;S1RG P]^4MT[S M\-44>PF%NWE17YM2K@HPFN 5H\I_7XWF#[GI?,L_?!WEG7]_Z%RF(GWJ].\Z MW\=%5G$UFEGSS,@RL^DUI@2.3\[#KU],]ODXAC-W'$Y<.,O^I:Y MTR^_GWXQY\>G)P^-W7_!3T[/4TG/3[,_3LP?_O@\^%3:$Q].SJ9_G9U^/O:F MN!R/3\R).S:?L[/S=.&W<')^EKV_O^WG[/U]JO7S4TVZZG-#-B_3% M]H?=?[][*IN1T4GLO;0NP90PQE/JC @R*&&U#1\6"*=$<"QPH24Q7*2 A$)( MMW&%J6*!IOPS3QAR4_2MT6W^K%R*I*B&D9-KQ<'CCU%@VW,H-V/SZ:SZ7- MQDV=;G>:F!0O2/5X46QL56@&!B614=X^GK=\\;;A33Y5NZ8WW(Z*NXK'; G' M,R9E1I:LRFF3,Q=*VLG5*,^WC]#3D5V6)]-V"-7U25YW2E4_9<^'R\?^N_3K M1R.SLO%ZA?],/R\_;E!@1/]!G\&ST5QE ^B5TDZ'RQ@E.V8$7?*U?DJR\T_S M/WY9I>,68^Y[R0Q6[WX\QIX-R<5/2R/RA]_A-5^M^Z[RK][T9>@-7R:K?B"A MB^^>?;)N Y0#SU=C/V#*'U/>KZQ!>92YJ9=6AGHZ;YOIMZ9UU!M,_VM.W>5H>+WW3E(P[\.] MEB)T1D5$AWTGV]E=ZYEHAN)4Y0;EC=8SU?+5*MF4*4UU)[CGF\4ZI M9G4%.KUG.[=:K/&*7>/'6K*M$.&9F(WE6ZXA>S6P>W]JBCDON/;LMREE'DK*O&2^LU72&Y;RPZ(C:'UH?6A]:'UH?3"\389O M3@ZO4R'Z^4-#7_]8J#T=E-*:PR=:P(! 6S;'/FC+YM@';0GV'81]S\Z-ZK+Q MZ]95\.,SFI[3W$]EB,]L[OT=G/"B)?O/;><:;"[V?OT*'(S8_V/O39O;1K)T MX;^"\)V^XXJ@U;DO5?=61*[5FNN2W):JYYU/$S0)6>RB2#47VYI?_V8"( &2 M6B@2E"@2W1$N$02!7,YYSI)G865A%*4UL(P:J82A0B-E (=.8D^)4L:OI-U? M3(:=/Z^'_:!6C]V_ID\GV-?1,F3+NE]1\8]Z_ZY*?E6FT1G>I/-CGWOKILVF M6G1=?EX-@3B4<.W1="-"6Y#0.HH)K$OS)4QMPP5UL?5]!R!':]PWB'T8B"U* MQ&8$P@#5E'M *"-, >619@(@33"6]I MI0"P#]H<]DXBX@CUF C!K9<0:.FH<7XE2?[9>+^"]#&-NL'Z?<1ZV )DM9A M _4-U#=0_U:A'I45;+0A3C"IC=",:NA4T.>!-BR6"D!:K:CVZSACZJI=TP#V M)H M:8O3!K$;Q*YE;_>Z$'[E#"'-V:FV8),]/C=9NTW4TWU+MI#;+R7-GA1F MM"Q]X[AR&CMBL524**\!!Y9[8PF'BFGR,B<++]QB9*^D6V8)G@T'19&;^+3X MHXV$W6-&"6_: ;\-Z7,<&,3D'(.,)P8:X)3QAG)+!/3 40RM0(!9O;WOY 5\ MY0V"[1S!:$N"!L,:#-LCKX 0Y8$?8]I((03WC")LE4.,$@8HL< SLJ)([9L# MN &P>@!L+0>QJ*7/SQ(+O7V?0@-\^P%\3^$> Z7R1IAF@#FI@ME(#5/24N8= M(U(9;(& +^,-;=!KY^H7:R'&&O7K3:!0[.SXG_Q%,O-G]9O>;W3_.B3>[?\R[?YP3;TZS M#]H9P3$LG1'0:$RDHY!82K"1%@#M-*%<&>O%1J%9>W^:'13_4N_?"X_$;,[Y MO36V2&\A)!L7Q/Y#[M%@3R62!EL%E!&,0,#N@6T-0YH8AVSV!#!#O+<^7B@A[4D:4Z;WP;V M',)I\SPK)C]P?C/E^?=IJQ>[E>#;'TEW.(VM5K=I5_+@:A9ORQJ[KC1&V<], MV*?69YM4V64P ]8)3QF*]LZV=M36*PKD0 MS%\J3F=Z,^W'1SYD(]4?3(I)B^-:O**UD>FS(E%?EX^;U-<& MX!N KQ'@20GPF!).M:(>*TLE Q)3Y*01"CIOD "O[!'?7CS4">/!XA&D%A=Q M ^,-C#\'3@Y1#\ MT>(QM93QG8'2QK3WNGRVJ?NK >$&A(\4A)_6I46EZ!BR %C+E6:0"FR54EX: MZ90W5B"+MS[N. YG"4,M2FHMP]MHV0W ']?$#ZD%=?;I6>V(H6RZ)1WZ_)J] M/)SY-7MY./-K]K*9WYN87U.-H.8VO@>K3!^M%='L?K/[S>X?[<2;W3_FW3_. MB1]<(8)7:T>\ER=6VXS[9<_W(01EWK+W!!-*@$9,4Z^A)!AB;R7W $'K5JIO MKQ6&*YK>PKMI9_/8V19L:B.\ 2G0X.'^5?(._ZMD%D+N##1*8PHI5U #IR"W M0B..!54KS=9W'+8*9=/.\77;.=*6D'7&#&QT\K^7A_L-%C=87+MNBBM03"0Q MTGKNE:"(.:6)]<@3BF-A+^Q>,/:T@>'7T6IABX F$;S!T@9+-])K::7,C^(6 M,:"8,(9RJ81@2#FML390*;,"IFOFVS9]:U]/,V4MQD6CF39HNO<>XAJ:S:YY M+K"_[O+ZZ_;6>E2R/T)+T+*B+\".$.4A!X R@$6L(4$!\T(!1*!Y&>]TTU[H MY9JCL1:4M52=:WJQ'X(4/&PL? H*$2BA4'&& S8*PYBAAA =B^9@AS02B@NH MWH)?N@'2G?=IXRW"<9T9R0_QU=YZ4AHX/%@XK)0/TT0Z$##0 $4IAT9Z0[@' MCG.IK 8KFN&^^88;*'R!CN&P'O=( X4-%.Z;E8RJE;9L/"DC6&L"J?-2$R<4 MHM)*Z"7UF_:]V>]BR >+:&M5?6P)64O=F<9*/@0L?#G\>P6_:=V=@,/LWLK4 M=]'4]V#)_7#FU^SEX\,<4)Q#XH!VTJP4Y3Z( _7#ZINTUBDZ1B_A^&R\ WLO M"@X>_IY$/U&B'Q& : ,(0=ABAC@A@D3TH\@9A+EOSM /'#N?:B]>2YY7@2 !K 1!2Y3Q1 J%*98"2 E4!H)<6BO(2L;_D9^<'PT HA9&=38I;_#O M;>+?0DGSU3+CAXF/J,1';9F'#BDHI0TZHM)$T@P?#77*J<,\33\:E.,MQ&JU MC3=EEP8%]\WK^];]H34V,3[8K=YI^YW#Z[*SLUF_M ^<,#@7\!;&4CX<4V> MX!QABK1#UE$ M!9@I:79LWW@1]),IX5 +9D&SR7& V^9TV!O@[UO"7N?A%Y1 M0B]&Q&GGK)6,$L>=CF5\,N@E8]_3=@[XO>@H"5NB'ER]UT*YKT?9FVP= MVMLP ,HUYG8;ZQ M6]J'Z[S_+$3@+SM2%K)_VAF:CBD3%$EFJ8J%$ZB7F% M 6=802PY" _X:[OR MPP>'6F&S?T['D][5W?:CSSXN]N.];__V8%CB)/D_"_NZHCC']NK_=6F7Q9#M MC3O]X7@Z2L^O(L '=,_H)#N93;MF.)Z,+Z[;HU2WQVGW4_LN.\B]#$_6_2# MWF6[&#]>I/TTP^H/ $%%.&=(24:Q5T(Q[ #FL4&\A@!_J'3[L(A+#) 4%%)E MK0+2A@_6<(>8@B07B8%V@U2;//L]\%V2!NES&T%X-$W?_7IQ>6[^WP>M+IQ- MS/GOG]S9A;H\/3];X8F%[5WBH$UF#+>;"'KW.)$M09M80K_X>1=T^.Y7-4Z& M5\ELN9[Y\^)0LQ":R^T;PW;$SHU9L^N]0-7]P&.1!UED$G+;Z)&D_XHE-$ M/RS<]QKCR8_EYQ?Q08U&K4'7S,%4M^M@(.*4PR<%!3# M\ZM/_?9@O&K%S\%HKCC>AANKFN/IF9^KCF!!8_PP3CM1:_P>5+!Q.GCWZ^3[ M\"E]\=FKFL3QC'."00# )->4DZ#VABD&_3>),TO>Q^__]_\2"(%?LMOBU>PS M_.6GC R*!^#U'H"SJZWB"=D# I=D./$M[=_EXRENSY9V]JZ39'V1]&IH<5'E MMJ0W'@#3Y[\_QB9FA%S_]WO[1NYG>+!F( MV4,O[V[3!8/0W=SVAW=IFNWC>;:-,P-PF3^[T]&C4:WF2TTXTMWX(H^AK6:Q)'$SY<]3K!MLZ8*"U&'H@F?MR.7-:C!5*>,BD: MA#G3"&L-*,1 >\M-O,\):JA>K1K[8K1PV9OT@^)W&B31MUYWVN[/Z<+V1@%U MAJ-=$D9@K(PN=D,6JR31+>:4TT2)'NF/V_#-CLFAK)PIL2*4&*"@]A03+C#' M$&C-L>.*\Y6.3ME>?WF:'+XLDX.+\\INSHEA$UJ(:L!\?W=)#)F VC5,Y+20 M448DB"58R&[;I0P9]WYL/HG)\-7E&\6E&FFE#7JD5XX BA0*=IOV2 !@A8 . MO181/R;*- RF8=#1I]P;N1]J91M7KO! FNV2 23K8%?FO8%\GGU_4 MLO()SL7E27)9L9&^M?O3=+Q@)N4\-$ZFXVB\1*;ZTAL,;WKM?GA'-'F^3+/; M;H;=M'^2?%XV@QY0^V*L]W@-3>_564#,60 Q%91O&8&;4 V#N0Z9 YY!H3%5 M^GX6V+E8OY\V,PHO]R(CS>R.L1IT_XBV[%HD>CU*TQT1:3L>^:[JC;X' ,^JO/B(L8[>7&20G>V]!+9-M-N,X MN+EME:/-^'7=DV_2+13TO^_QG_;M[6@8I$:@P^C=_=L M./FO-,!(9_AU$":P+%]/#1(Y_X=]GAPQY@!U3@M;@^[D369Z12_^9(F ME>=G8JZ=Y"[\M/NA'3ZWOZ:%O(N#JI4,'Y=HO$PUXX!+0* UBG(JE99.4HP$ M=\@+KRUZ,2+,I9P?CHI+\;YGR[QM];'=";N,5F:(LUO/KR@]OUQAQ7C %@L= MA>$#<@0Y[+R'6E.RLKL;ZRN%%/HM4Q1/G]+;*Q QCH\;K^<&7BE!2T2+BB<3 MAI\/$0M MS_9=[]^6C$2[SV2 M+4YC2^_"=6#E<-N_IKUQ+W#QS&@L_!"[-FK6T-8HJ-3.LQA@3RFCWE$1.#OP MN+2WT3KZZFK=)1=NZ?J?<5 MYT( _BB;9EZ*TJ>09.[,).#S*/V6#H(T^#H,T)69':6;[219<+H5)<7'V2T5 M01)^]! %AQ>TPY51._+>A\B'\VZ6 MYSQQLL)3G?"KR*ZLCN6(\LXJ8S@.&AL+1CD0V@N)*8*, MK60H[K=)7I,;^OMPAW;YG&9FIMY.#72*<*6EHK944< THI08)*F.1CJ71'!! MX6HA@$T%>AZ+5"G,D\7W7UZW!\\SW>L#HVTL?\10BZ$=*/@/2=NH2^Z8*,I3 M)NX))=8JR0FF#@0+#@5)Y!SV1H:[ZPL>V3%1S*Y6=;]LTVNE!2A 2_ G6Q%M M9.PM6Q0Y,6SO"-H++\\+NG"R%R6S=SS;E_(85SX0I_L"'A=*2D>K%I@3P;CF M!BHL!10T5FS#4FJB$%HYRWDIEMW<%U.KUKF-*X?@$R'KY^X:$/U)^BC[XW'$ M#-56 ,95L-NE CK2!S$"4$8.B#[6Q_SMR0+O@"RBAR]#ERPUX'86AKW_[KYW MOUXN9#J,D\$P7[]^)6?V_WO[;MQ3%*['A6S63/7;K?/JODXZEW%^;4G1EWD?SM_*,]/?OM(C'GGS^=?R[RGC:($]GA MP,_.+\-(+\^3/\[4'_;T,DO3.K/N+$_8.KLX_WAJ5;SL3\_4F3E5'Y.+RW#A M=W=V>9&\G__LI^3]/-]J.5FV3$<%T-.5Y[FZ15A8* JL/DIMT;Q/"_J#,E M,X=!X?'_-$.!E?04=_'ITRS=I)5\O^X%)>YV-/S6ZZ9!LPN#[L59)(B@$M C*(@S;6Y2^%RB6R12VK?H,/UR ME]RD,:HK.F+*O/3DMGTW&O;[061TIYTR#B.)@XT18.T ?(,/N63[UG)$_WL+D\_ M9Z"2?/JHSBZVS0]=8P1O #M*V.B&;1X$_OF2;WARFU-%GC07>#[P<"=SJ,[C MC.>H$#ZH:308VJTD*&I!(VPE_]$.SV\EOZ511;S+E/&+@![_DX["\[IO0=N* MC5'GJ#5;E=RQ/%.BBE6," KY+T^MX>Q7V[D4'K.[-]>*ZXA:>L1:(I*EU?KG ME"D(O>#>*42Q,LHY)FU 7>C"_^5*F+7-%[8 HRC&PNY\*C:GN!H=W&L&'FQT M1@)/P,Z.2'(!UYG7;)D=)@X>IL%AUK(X\.4@NW-V AB_+!^TU2G@>KM:24.V MCGE(&/762*H-D,(#B!T1CADMS4I^Y.JN%B<'?1-C[#N'UH76OND&A MW+'[,&>-TN-/A4/"&JV<,-0S*C&S 0 E0MX! %=+>&P,>$4QO5JX9-7GW@ > M(66 OU?26F2Y1])1K(4.YB36P )B ;5NY1SGF8!7YU:N!M&^&. M,MZBV^VX M,3#R0(PONLEF4IZ)9%/);-KV>)S&LXX74,](&:# D"9"",8TQ=0'2Y@3JCAU M&FEGO%B)*E^EZ[E[.2\7HK)IW!_]4D?X"MQE^,IN#Q*RM:\DX0*!!10.8*D8 M51(K*J31@ E#F %D#25JS;4/Z$+J6'MP(G:X]OL3R+8='=BTDYV/+(+A%E%U M"X<7F33-9&<%- J1NJ@EY7!;1%7U!C,_W60TS5* M<(^3CVG8B 3-1%3E?/NZ%T126)=BEQ:#/Q>7OS?.O^E&C^E,':FO^;;G)W33Z1W-E^BY7IVZC4!TMWIJ/N'Q2%HXZ2;_> M+06[_OL]NODL7S<(U>OH(KY)TWQ._5[[2Z_?F_3*81>DF47'WH5Y1>?O-,_K MC;^,&?]%;%\@^\ET-,B\O//8P$)&Y@5@(OW'J+[;42\&&HQZXS^C2_NJUT_W M7R7(/\;;?^Y-PK,[&2E?I:-1F&?UH#ASY6\\';8T';8XG?J:104%\*[0^JIE MVMK=X6UV3AFNQ8Y27T?MY&/O*KWH]-)!)]#%PW->.+ZH5N8Z2?Y82!9OW>.H M7*3:0%AWD6Z+']WFA^PYU;5_%.>>5\GT=HLR'4_'AF7ROY+1IP$ C$$KL1"* M<2LH0LYH$DQ';*FP"[7<5H5_MG*S>(&L)44VD1A&<-'NMT=WP8B,IWWMKTLG M_[F]@<*& ?@A_(NKBME@FI_MWQ^^]0$]W@YOU8S\2RTQQ8'"1QDD)N-L:MG6 MO&"X@I92IH"-K1CC$'%F\X78-!]/Q[$"FR@,OOWL0K+H] M:]F^+W&.2?MF.(TB*FY=;OK-CQT[[?'U0A3"%@7Q7@CQ;!DX>-4;C2?)OZ9A MW]-,K.8NOQ*,;MNQY''OMCW)Q?4AG<2+!2:O+DG4'K*SN5*EF2_P M(/,*26%Z;*4]"6U/'9W>%MO7XRGG:N2QX(6N6\WDX9QE.9QSBF]MSS MM']_B!AR>V#)Q9*A2M+)&K].9L/+D^GB$N7J9V6?JUIGN/BOZ3".[J8]^C-: M'*->D-CWZ;9Y*L;L\9,E[_=+.&!E6:]/8T=1P&1%'/16*:JHU!(2;CQSB*V4 M\I]I( O@NWM/!MQA88R3Y/SJ*HP^PYLJ/6=A8QD7Y@3W;%*J/.Q9(1?2*P(P M1!1;21&@FD).':6$*1F^,76&7-2.]O>$8$"P:0S&QS3057J>>R\'7S\&X$T? MK\AMB0VT3*5 UE)#H? <0NP<\H!#AV$ETD)C:3A3!&')J4!,,!P8 1C)@5* MRTG+MQ%HLYL\ME]S$*[/JG/E_^5Y%]L&WBQSH"VF<^Z,5_W MJ!$["M+H9]00K*9@L?MWK]+-U%29UG)PV#@%-OTP*A.GMO/X"4"UL)&QX.Z@A3OEK=D1_8:!9#0E"!2 MR>-P5B.F.7*"LO"/B,5["="*>ZFA6[#7[D/E617TST&[^][N%T'WZT0KC/)? M_'=>7V+#PNAAB^N/B0]4>3,FCD+W+3_.1Q%FLB2X;,G9T,(JYD6 MU=;SUV8QG9D*,AA.%M20>,_G\S^JNFS^DT6U/?.!INO6#CX?<,=*/C=L'5W1OD/)$9>M_:O7Y60[Z@M#G^ MW43G8>;#RW+,PO+-_-PSH_PV"LG!9,%&*7X_ __=.1GJU ZR=/IEN5T%Z6. MR[=VET%Q9*?GN#L\0Y^M=1E>"HW@UAJCN8B)UH ;(*6"Q FF-?AU@TM?H4]+6[RU%[,,X'-M9WU6_FYA^+%6G7 ^^C$+W\2YAD%), M*5$\UMDA3"NA"?486F%T^%SQ27 =OA3<(!9^P;34-/"L4989X!5&YO'F6D^] M9\4GL7?>HW>_7DQO;_MSY:?=SQ/&S]RFCN$D9;5)&-_,^HNV\C_C=6HFK3P/@QD[,!S>V\KR% MQJQ@]OM>L!0&^>?J"P=9COK"*R'(^[)FK5&#;=SO%]]F_H_X.>Q59_;Y'F*Z M[-T$_#M+OR>?AS?ME2ZN-^W1U]X@'UY[.AG.+N1-8;,KWWO=R76X.RQ&T?@W MLTUOQ^G/LS]64#^.>)2UK0VW1&KZO^_(NVJOU^+;8L#Y*P3\RR^SFY:_>^PK MOM;/[GGM8?;2K2XZ?O?X7!?[0Z\V=#\4-4X[G32]NFIHJ++!+[I(+T$_[T^CKVTXC;V2QJU@4'32 MVTG%^3@[5^K$8(7,1W=?R_)7Q:,=:.FE5_E^>JI]CCN?T;]M,9%-QIUM5AT# M7^>HAV)8R6)A!%H-L&;!NM1<,HVE)0X@38F1*R69%AT0G^.PSZ_^&*>91?SL MB \\]QO@1_T&DK:$7 VQ6W(9/&.O=DY ]W6D?SORI5!*$:CG5+,>67,,"W)H MDL$4\7,K!XV-H'@+@J+2IPM:2(&@ED%OJ')0$CLFB\!:&&T>GBZ.6,^N+7[S[&+Q ?VEC/S M"(HZ9/>BHP#?_DBZPVET:V[C;=K,M_2:DG_M9:A]UB\*40RB"D19+[EG.* 2 M18!)P@WQG&.(N4+@B1/N.43M#I@@;B&YFE"P!3 ]M-Z/M)J*?)Z="*4 M5=T>:+'4&"I[R+*SK*$M&?;M\J4H^=)9"9B@#@ #*.=4 DH-$EH8"XQ%3^C= M+\J7_RBV[6F^+"OT;<^6^\]]1Z%7-HKVL2G:"^$1C5K=J-7'IU8_X#?CM)(* M9;V+Q8\]YI9:R802'"&II*4,P*?2VI\[$ %7^6#?3A4_DNCLQ^@SOX0T_-*(UR ,8&!SSD*&KNW"G!"E*,,,^"( M@'O$],M*>QU,CY[.^-L@S.*-\/9?LSC_V?5:K(V5%*+G9[J9]OC:!UUHW>PV MHA"&FE--B*4X)I-B*6,E"4Z$1UA7LMNLA<@P*AR4X7X@@F@3P (<;@QTSWS= MZ6DU;-Y".EI6>B_JB0^EHA4):#&%NDS[VNO$\_>]2GCSLLN[ONS )GNFR9[9 M0UOLY>W.)COFD&GDE;-C]HRX%E)GCB$K)JI.R6T[+'H4^;/ZIZF, M'5^]UHQ3"(,=Q0%PUGJB#,= /NX)*(JEKU5Q;]/ .=Q"Z,G6\\=X3/ZVCY_V M3;;LW;';6T^WJ)2 ''Z)Y19S723]T;EN#[[FA?%JUT(.UAXX.+?\^>OH&GNI M4KP9S4%6^A(:@ARV0@)F.61""$^A5(AIRS$CP"UK#DLYW.<%)IP.7($(?CA: M+RB_5O6"M@2H,UWH=;6(W3CWJW%0M574G^_N[^U8-7UR][33WS.LL24$QC0T M*)$ R!"($#1*(R]IU>DOC16:$6B0H "Y^-%@C;"RCA-M'RT,Q5UX&'<((F:I MM4X@QXPGU(/P2J7X![##DG8U5J;UT["RP?3O#7HWTYNEVKI%^YFW6L?NL05? M:S7?T!E 30Y^B)[T\%.VF8U;)-8S/;E M2DPT5+!?5'!YW1LU-'#D-! 3U_?=H_=21 #A2\;.O8'SP[?NP7O@<+XY GK[ M1T PF+9S6YEH;2T0R'@J*01, >ZX0)8(R)G&*R67'K7F9T=">2I7-W9G\KWH MB?FOF%IU?UQH[ 5@XK%U.LH*ZI^%UV5!H#$TL-I4H'=/'.BFCA^$7B3R^]7\ M07N%3B\LDQI\>O/X1.@2*6N(E4Y1A!PS %.K5VJ$OC$^9(5 W M.D'0PKC.*/4&H!J :@"J1H!B91]+(12&"@GLF:2$.0$4L<0918R%6)A= U0] M>$,I.VB\.;2XS[#W\&BSV2 4Y6$?I !X(A@&V-'81SMR8_@O=TQIB5:.HM?B M/SM-(\==?A_NE=4BZV32O97]!R#BCX()91D/0K$01AK"&+74Q6-W Q0VS%IG MK$ K.:4OP82[4I,&SJJ;^QXP'4U%99Y490,"PL8HHAB312EV@ B,9+6 MXZVX,:9G'ZYJNG_VXU[Q\[Z*T8/D:%K*5\BL]E@P*)2E$$D) :.$*^4-C9Y+6E >=B>%AJ6/E:5YF0(I).8 (PLT\91"J[%%6CM&@O#&&FUV MO/0T2]?#H40>]B'1 3IME_N9'Y.E*DM)RB&%VGKMB9)4,*V#HDP$0AHCK(3< MRE_DA]/]BC5IO+:')A7?,!=B6 J_(.L8BGE-"#C*M-!> 0$MAA) X UZ%2[< MC3H+6XPV;MN&#?>$9@HDETE1A[*(*2B'5UDKH.6,&2"P=VPT;UL-5DC9^ MVS?FMR6-2;C*CK24BIP#@K"C"$E"8UU1ZQE75EFF/)!4;\6.O6^-VW:/I&7C MXSE4AN:E?+4$"X\4]UHK2HV0B@#.H>&2 <_U=O)U4X;>E9H+FLR&AJ,/DJ-E MF12@M,<<$@$1\U1J)#E!-M:S![$F.-G*:_LP1]?#H+C6\*']8]!#<]I>ANMI M^RJ@^+9,N8,\Z#WA30)9I:@D-XA#H#7&5 NC( )&&(,!BLWB-CXD57$+]E&' MABU2;XW*)^AD;T7O44G8 V9F7 I:(ZVDG$HHH:42"*6<,O&@1@!C"!>OQ\P[ MT9]EU)]KM8@;7MY_7G[+O$K+1#2*,(!6:"R-H)AYI936#%A+#:",;9P(LP:O MUL%ZJ$4H;7S);\B7G!7 >:# X-98B0-6=H?36%-O&YGZX!IOUKCB5?-FGUJ? M;1)K-UN.%P:[:M9?T$R@A)B)L3 MT.LR2^,*;)"T0=):D70A=1-83I D5B-J(%->4VZ\1(I90M3&04#[8]5!"ENH MWOH (V2-H@:8.D 5K*H&9G%21!!?4:D&!S:VF5U#06@U%&8;*Q ;Z[TRA* M6D#"!AB/YC KDMS/R>G-[722=>0)4C@=3]Y AZ;7% (',+]F+P]G?COU:U=@ M^![TWA>ARTNO-T9430NR!_GR5T_QAT>^-.9IUTW8]. MN%5E'55W)H$):'&Y@\/CY^[?WLC1P_")K[2V:SK;;6A_'?#$F]UO=O](8SE9 M)<1$0>LE]PP;H2D"3!)NB.<<0\P5 N#Q)L0/M0FL,V03MY \[*#JPS1SS70T MBAWOZY;&!X ^ASZ_9B\/9W['$,?%9)E_""VD0%#+H#=4.:@(9-00[:US2H"5 MCBP/",0"_78G%U%+LB;Y]RT9IQ^'<4CIZ*8Q4!L3I3%0F]UO#-0'Y#&O5'U4 M4'OJI%.Q\3B@5'"C/ C6JO/0 K42:OB /#X;#CJ[%LD M# Z@O3"^CO=5R;S M8 OW2+;L=E?]VIM!-8,ZUD$5@'4VO0D_Z>2?(T;V!M-VCF#9;?D/EZ>QVA?V MW>/3K&$.*T5TLG^O1[.'W+:_IA^^C-+VGQ^RU.&?V_WO[;MQ>-5?KT?%;!X; MXF.];C<<=/9QL=OMZ=FE^^VS2CZ>>G=A3MV9<1?)W\X_VM.SWRX2<_[YT_EG M=7EZ?K8^";W,P,_.+\-(+\^3/\[4'_;TTMDPVC/KSB[ROR[./YY:%2_[TS-U M9D[5Q^3B,ESXW9U=7B3OYS_[*7E?T%G:76[W.YOK MTM$6:F-UR&.5^D_303 MMA\LL8HX*@6*F5<4"L\AQ,XA#SAT& 9IOLYCN/.2+"\Y5 M5PQ;"0)0;ORXY'L:AM\>![6J'W3K\<\;D?K#"UIYP((Z#&8[$KN\#?+/U3<, MHI;77]A$"'+].--]DD[:[Q??_M]WX%WV.8R\,_M\SR)<]F["XI^EWY//PYOV MB@'QO=>=7(<_P]2**(*@\O7;M^/TY]D?ORPK>N_FCI.R$SAZ][!?)7\'97_Y M97;3\G?PD:_09C\[F)<=96?Y)YT/.\C$?X9O;F>MZ(NDLJ3(ACARW_^Q4D&6 M$-/0P''30(PIV[=3^],:;]QRX>S,+G+[VG_6_I[ M&./U>-6[#N7?25->M\D;W?.PFP:=7AJ=.)ZC$^$2* (0]Q)02H2VAGKD,,$* M>(35JZ+3;K+B40L"T,!3 T\-/.TG/$DTAR?)E/+6,B\4H=)H":E#L5$/L\93 MN'%1U?7@J1ZTP0>N#!U:$'TPS.#11N0B *I]U0UQACL'"*!<^L!UD$!M9:R/ M \1*1.[6?=4/Q6+96\E_ +^*)@0E6'Q5#G*,59<&$ E0=(0Z+0AP&.%K-JJ M+<^F3+@KQ5S2.HNR-%S8<.%67$C*ZOY!Z!FF ;0>ZL"13 $I**,PV,R,<[\; M45@'4^%6F- A,-4Q'0R@)C1]E1M9*1.5@XX3QC *PE$$N]!ZH[AQF #BL-JJ MC?(#W*>\HM8XHJK36BC@MJ&,4 4W!QJ7J MGV#I.CB4M "IM3K9WG'H 3IM\?%:JA"5DI0ABZ30P48U@AK.-?3<&X8XD@AB MM_&)[L-=U0]%-=Y;<7E,4O$M/24:2=<,A#(@P5A$,.M_(7 M;>6T!HYX;K.&C8#Q M^ON7'XINNG\6Y%ZQ\[Z*T4-D: 1*^E=J+F!-V'##T8?(T:A,")""8@*$-0 @ZK2203@K;I'E"&FR*Q%=DQU: M;[.[O6/00W/:7H;K:58G:%NFW$$&]+[P)BFE+7(&""Z8]PY2*X-A*X-,XEKR M<-49OZ-.YZ^G0\,6J;>LWQ-TLK>B]Z@D[ $S,RL%K0#$8HZ%49A13Z&D4&E M"%38$($WCF':GIEWHC]+V$([[.K=\/)>\O);YE51IJ$!:I"$T"C/!'6 2PV% MI/O]G_<*7_>I@D"# MI V2/HZDE=1-HJ4TBC&B/:824<6L$ A8KR C?O/23_MCU4&*6D3LSJQKD+1! MT@9)CQ1)*^FWWB/ $"*4$48YT^-.9IUTW8].N%7=Q$\[D\"$MABN M-1YDL_W;&SEZ&#[QIH-K7?;7 4^\V?UF]X\TEI-40DPHUL8RKK6+1>BM@\*9 M3(!;(C%4*]E/#XCNW1G)0+8XK;,Z51.S^3)FKLD[^M8NC0\ ?0Y]?LU>'L[\ MCB&.BZ)J_J$&V"MB".1.&ZD!1))(8#D3W,,5-_(# M$\U,^\OJ+AJ-8*4?LO M_=ZZ4CFX: [4Q41H#M=G]QD!]2!Y7JCYBZJ0@3#(D +-0$&)E+H^% MU)"LE(A[0!Z?#0>='8MDR5L4D,.W5/^:==F>7:_EV4L]W]?KWE[0+5LB[=TU M=,]R$?.NZ+/Q[X;^6:5$(O/*&\^!D$Y2+X1""H9_B,+82TGQ,OW[WJ ]Z*2U MA3.[F2J^ED&M;[_C#W,.AN M.DHZ[=O>W.\_3MJ3S;?'IITL[BV'9@Q;25R?C1]WLDCG>TC5^<=X^\]Q#7N= M_,K#_;;ODH_Y,N_]U#*&327J# MY%._W1N,OPQ'PU9REGY/_B,=C=.[5G(U&MXD[>1K.@C"I9_$T,GPU_BZ=YM, MK@.]]<:[1@0HRVZA5BBE&);.,$JY%LIK I%FP"J'U%PBQI#.GS^EH]BH]_SJ M]^JD?3'G\^^#M*OOS'!T.QQET/N?U\-Q>G'='J778>_#'-4HO1R%+1EGW^BP M E>]3GATL%I.!YW^M)OZ;()YO.CX_*I8\+$/2)&.;&^4=B;#Y2I8-K:V_3O\ MKTO[WP5P5US69%Q9\23\F4RR-6\5 M7W^I+GL@U&S=D_R5R4V^\LGP*A#CG.#_]_\2"/)?QLEMV/!.[S:0[7@R[/R9 MOR1I#[K9"H0_N\46G2217S(#M7A49\&%V_XZ2M.(NY'<)]=!,?EZG9R'7R[A M)481@L/RM =!GO>3,-$T/K%]>SL:_@@K/$G#J+?DEW][BF$J]2H\HT9%YA#" M4.VP- @IYQS0EB+)\0+#J&S0G\,@SZ\RI%.S:;\\"2]KHG1.P.Q1^@4GJYZA M($+[_?#'UG0<].OD+FT7Y/(0B80!#P/I#;_UNH%BW_=^"F1?#T2>30/1]CJK M&U[IAR0II8!BCW78<,"$,P!C;DWLF\$$7-CP\]NX/I=#]V.2#KK9EL=TR^5^ M?_=L]Z?1,"S&Y.YB^N6?@8,NA^S8&'&_8>1@RYS]BJX"\=K/">/NHEM6:'K3D=Q=P,(SDBH6/"M=;D/\;E) MH);T>T"%83;[^/HJ:B6389)F&Y%=S:DJD[Z[)1X,RWI5GH;%ML@B1ZF&4$AJ M@@[.I15 !*F[3DC3(DT=!R7].GMM,I,"2S(B*<0#KYNPHKB)U'+5[HV"0B*!71J*3-=Q@O_Z?=D8C8TH9\TP+ 96BDBGI%!08 M:R<)HHJ(0%]_;6]@CHLEML.A$@/"D<'@O,L #%+E,W)>C0%0! 2ZB M$7,9?J#[X8]WV=K$CQ=I/\V()6A_WG(HE2*Q@JPP0EG%B?' <6>UE1]*#J/, M<<$(<;&2'1=82\FM<#3V%.*8@9Q?PGZD735Y]GN"GID&??TV^FA'T_3=KY>? MG;KXX_-_)1>7Y^;_/4A\V0XNT<(F\X3OMB:$W?AE5&:L_MX>=:X+5D0@$\HS M]ULR\[RU(K_LW.F*A4Q)Q6 $5EI,2# 5/'7$6Z$$4,B%I171P\(>IX9&Z*Q;>N+AM R./W&/D;8U?A9&8;<:.E[MBKE&$-59!_6$.:Z8( MLRPLMR3*<:3MXU#P^'(O^;:W6&YT\F2WG\V7.Q]7)AZ*N>7.FF0XG8PG83.B MH_)[;W*=.8_&DWCG[APHV?Y4+"(+H($2LF!$,P,!LXY'=K"88@L\7]%#[MF? M?[3[]QT]+''#IOZ.\*"3U03SVCP>-3##DZM=.? Q3$!/D21:*1#AW+G(#4HB M$;3!E92:]5?[B7/.=5<;0KE#7FAESL,DUQW2;M+^%C3.KVE.]M'WE/'*2S! MZ7'GS!#A@7<.!;W+4 1C]6IG.?94$O8X ZC.OZ:]45 @\HF8,(]/Z2@#K ?5 M\<5=*F^_SY<-'I<2_ 0^&3V]ERQ1*6KJ,$#6$JXL,E1C@0T/!G/0?\-^4$Q7 M8@ V7__((O6N/SP1]:]_*U@5X]NH!WY+^W?/.&7<0:S ^:!4VV"NMHE,;4OT ML#WJ1DZ='0*-D_9T4;)%(1+["# MSE/A@(;!(' ,$J\MM7ZEGG5&5I_GXPTF\]=1^T;-IY9G+<)%ZHKX*_Y.PE+! M1T1>];3]"9F'Z,GJ,55M,N^!PZ1.)E]RY20_ +C-9Y^T^_WA]_$CNQI/7F=Z MSNWM<#0):S#.HE[Z=[EC9=*[2>./XG_SAU=^/J.:'UG&9)['!91*V8W(]3M)!-_#4HDG56MB-"P6E==0);9QU <0Y4RO(O<1:W7RZ 8![P^Z].OZ],G,+-1^>K$9P MU<94I9I_&J80V.9>ODK:XRS"(-XWG(X"K4<^"9N>:SX/\43.,;/=GDYZ_0QF M=PRCE49:/*A"###I@FYDD- :&Z>-CRY+CSQ;45P#;G;2M#N.CD(S'&0Q<%_Z MJ4V_K''4&H.IXU%UO/OR[C9W1>J$( =8^X@G41$S=:E ,7KJ.Q> MI1G;SU%Y/K_D(AWTAJ/D;#@)E)7YK-/.=))F]ZT0S*3B4XWTTIL'$^R>4,KJ MD9P;09U$7G*A%!'(81((A07#PEIH5D+:-B*4QRN=F?",=F_PJ5B8T7C)$?TJ MY,5/5FL1U$9<&3%U\FDGM_-YST,]*B0UR&@IW!8N_G,ZR+?/2@'?(.6L !TP# M+H4*9KL*"J9D'&G(5MTEJM-)^_%8)>@[O1N M)RO*9:3[L/R KDN(XV $A&M/E(7>I3ALEQ-?A:KW[]3%YW<_14@+PO&VGQ:8 M-DIO @5' MSUCI;V/Z1 *^X%=QX@CSA&Q@? LK&I5; 65G;T,2WF'M^,G>_> MVIOWJD)J>:\6-8]1)-!O.U(.[]-T76F8,2QUTTOPPNP#KP%(QI+ 7C(2P?>&N",G=>B/SGMJW MTN_/@45862FUM111@IFQV@*(&7/0(K88E_-U=G2+B%&QDXC1?-/28DH!"N-!1?06\+ZEE\6*ZY36^SZ.2(%?%0.(ZU?&JX:\%DO6G?)5_"8]-^@/Y1_JJJ MZC<+C5B2%9U9N+AXW2W'$;GW73_C.-9U_M\?4L^R,\ M,[LS.P^/]Q0OKPPQ6L\+PRQ&%6 PZ51L@R+R.5NV?'/G8BZSJ19F5@0LMC,G M7W;?M#,?5"L:[]_3?C_^-XL$Z<55FQUBW(YZG;0\Q0A8'# [/OY+YI:)44?A M-]^&_>E-^F'E""3[=2OII^. [LFL5EIKR5?W[TO>A,I65V.[*Z;@P3O-JNI) M )8=:XX4E/XO+ZFCADC. =14"ZLHU!([3F)0@43KN98_SV"^]#&7]]SK;:[Q M[C_'0SN:AZGR-#Q=.H2>^FL$KC+A=I8W-I\]C# M9Q[LC!>[Z6T,^8N1R>W\R")C[T T_?1;VL^1+Z)0G@N4QS!'TWIX6WPLP"QG MX@P?\I/\V\)Q'>1>C/V*F2!IL&N&=VG$O^R9!>+EN6TQ,KH=SZ[&O>*Q@4MZ MW3"Z\&?$[.%-KY--O0@TBS">WYI=S5^;+= Z<68OS_&SR\L(4#FCZF0N@U^> MB&.J882(+BU1]N_U:/:0VX"_'[Z,TO:?'[)FE#^W^]_;=^,8G;I?ONLDH^GWEV84W=F MW$7RM_./]O3LMXO$G'_^=/Y979Z>GVUTTKC#@9^=7X:17IXG?YRI/^SII;-A MM&?6G5WD?UVSW_V4_)^'NKWTWVT M\ C![DV$)0J2?*/@RM-!4!G2R_8/&Y2*_G &&LBCZ4"U5<8I9H%U #BB'PVQ?/(]*R&6IV?F_'>7 M7*K_+]#%MA&6Z[Q^F]&C=\O1X&ONUT7G.NU.^]%TNKK*PP#F6QA3USY'^=#) M8J-C]'<,WGX\9)8P1+D5&$I-#0;**P^UD@ )N)1>;F?&F. -;,<*4:)HD(& M< NZ#UV?EKS=A[C&?^?/PIKU2NN1[KSNY#G^&>13UBSMA_=JW MX_3GV1\K<2/OYB6;YH5*,L'V0$&G_!4<_^67V4W+WT'TR'>;?;7>$_>T^*)X M+OF+]4O*T'WJKKNB'&PT\WNDX646'O%['A[A%L,CWDX1SEW2P6MT67[&2NR, M,J)8;8HY'NG6E]5 I8U/9%4/@U5YI@A:VGT $D-5HY)[Y?>3>Y11&6XGSN4UHGZFWU M6 *O>RP!YN=>?E"5@\%Y*';I".IE7#77EL;S8C7W1-YO? "6V:35\EFE M;;)!1-TV:5E;53K<=89V1,I*7L%A:5K;AX#4D(_WE)RJ1/H?J)SZ:>M]6,K+ M2WP!&!L_\,D"_Y;IS2 D]5T[-I8KX*;>(:88V&/&2,&ARV'T ;8I!X^&"BP?,+\ MXV_16(HA,0]MXCR\=OZ,(IJM*.@U^]KGH)'E;HWNED)W5W\[S^N:1^]^[XW' M/NW&2LWQQFZL'3Z>Y J&OU0U9@/>H\K51DKO=TT$97H+\LP8A!70A'"I8,QK MB43 35#NF)4+(=WK!1S,R.'12@O[3A7;U'T )W '*1[SR.&?JKC23J[RB64X MWJ9Y_?UY1NSJO MA:EW@H[Q(@@JRV16!*4E6C'!%<>(0J\D#,R#D$+,P]7B50\CJ,E&/RXH_<': M)'O+,9WKJPT#C'<97VS^YEM)0?R=\..@<4ZS6/N8*M!.QNFW=)#7_[S-$L!: MD0,B4P3^"?H^>4YP_"L7U-L/)]1B+D<,MX]601&"U2UM@=*[%I,U!H&.1NEM M>S+*ZGDF84-B4'B1!#\S),;3+^->MRB#GQLK=UFY_&XL.QZ?&1X?R#3+8PL_ M&7Q+Q^%I)\E%#.+.7Y4;'KGZ'2_; . =9)"42)^9DT.TYP6VH-)+W8D*#)Z!VDN MQLKM7W/WV]';,NW/[<,GK,5E3MZLZ]!N&;F.H%24U63*C57$%Q/Q1\-!^UMO M-!TGJA>@[G/:[Z57>4%L-TLIN$@[TR@1$A46\[U1G]U%_/.G3'>()M8LA;_? M_GZ2Y#)Z=M.LG,1X;I=7G.@9!HPSYU#TI%>Z8.2,%;@W9CA,@_AHQ?RJF,Z1 ME>3=K]ER9'C9S1?LY(045^=*]7W*=(_;XDC!\ OASZ_H]G+XTAS.BNY^(7H M^<$5V_E<_VT7R2>;&#$OE7,%&8+I0G-? Z 01@&#.(W%E9P#$"GI@02&J)6J MTX$Z\L//C\/Q6L&^R^$A9; I?KQV:@O>4Q5PBUR(5R.R^T+WFRRG!D/>-H80 M5!8BM0R 6'D<2$D!0PIK0XB%P+#P!UMI /($ACP=M;@NAF#4XG2U*/@A@<@! M61SO?OW/U:Y5>27&HB1EVS+!'D_"JOV7Q>+FYFS6W8*&1=UA0TR/S/'0B\X[V.:ZU'N M\3$< S[K]-\^$DB[[?G_T>I;ASSQ9OVD_O!DS02!T?.?_>^M1 M>.M0UO#WWO$W@4=X-K__!OZK:C.S'#6R1U;AL2Q(LP@-51RR ;!^W$Z2U0E& MOR29>_EHHPU$I0)2$\6S#T+\"+3T(^ K"7D3Q;-7?'4,SO)WO^95'6/II*RH M1*Q^/\[+ /72Y>(1;TL?.EK-N-&&]\\%#O<7 2XJ7C7B>JQ5DO M\3UL*;>6D!X#IQZ'0OZ$1RH6JIR5?YL72YW' MK&S+_W6NW7XP/@05PUI9S1$7 E$O*'1&"BX4IR#(:6+QJHQ^P+ NHH96[.O= MNZR$1 <=<=K852_-I7O1*?,I%L9EAILP2C '&/#:406\#(SK@9;<64RM [6S M<+W>,=9"]$6"QE^WH^6;BB@'>W2">&#S/J:Y'N4>[V<$R0X0[8%(\2;9]>!3 MTR $9="I@H);I)P2B%$$L=0:(@$M019S 5;:IBWGIA5DU.2[-K;"7LG5!E1> M&E10&>DJF?080F:IL%0' T$#*I0/QHV%5J\Z)-<&E2;E=2,#Y:^93W=VO99G M/Z/A_6YF]]@;E[B$+4%&_+R;/C:FT)[R$\BKI'U[.QK^Z,6.5OV[G?64+QBP M4@:.&(DT<@ H0HC#EBMB+0"&40N4]2M^0368]&;A$A?S: GW(^N U/6CX4WL M4S2=9 F'JWU-'FEZ2Y[T%J[;7 ^6][':^.=; M]:K,VU['ZMJ]\7B:-Y*[#ICV]3I)?Z2C3F^UU9R.]^/3V[=+]]5LG'4^\NS*D[,^XB^=OY1WMZ]MM%8LX_?SK_ MK"Y/S\_6!^Z7&?C9^648Z>5Y\L>9^L.>7CH;1GMFW=E%_M?%^<=3J^)E?WJF MSLRI^IA<7(8+O[NSRXOD_?QG/R7OYQVFEFO0S^;Z$-WMK.5F#9VST':=L_ F M/!%D20;^@TZ:7!1H'##P*BD(<+DO,TEYSS M_K7J>WO4O;R[S;O:QH?\=V6U\D>$M2J7*ENIE:ZV6\G>IP_D5T#W^>M> ^GB M5:$>!$ZGJI=EHFU)0'U9:47V??G8^IX,BK!TG6D_'VO6WS.76=W8^#.\-9.? MD9YG(FTP3*ZFHZP19)CGN!<[$N<3'2?=:5KMA)UU 9W]ON@#FA=ZN,O>7#U# MWZ[#X\[4\WG[1L2Q-IH$[1-;&O9)>V:MH=HPI20T*LJUM=HW[D(80+)I;\:H M$H_2ZS1LY*R'_-EP\GA#/X.$9D9Z XFD 1X4,UHC1I!SD&J'*@W]).&(>">A M-X*&Y=.48!I^YYU#PI#'NQL^^9Z5%HWF_/=/G]W?@A \_8>;-6M\__'\XN*G M;3LUKC&8K5LMWK,9,6WVZ1:+1'J.M/%6*D.I!U(@9XT0@E$6*)96=L0KIY#1 M =*MHX%\!1;0:FR,X09#:)[58O'EK>)Z[-MRE6>J^_M^6.B?FC:-39O&IDUC MTZ:Q:=.X58K)P?;J:]HT'NW6[U^;QOT4 F\#Y!=Z,AYXY\5J0;6FWM)^'T,+ M@EE*)6WJJ>U-Q,H!B.^&O_>*OQDD33VU?0IO/X0,-3\)\'(84KCW*]ZPE8)V58IZDF))']D'PW&<+''-,ZW$C RF1 M@5/$'2+0:F\H\D:R@!0<*"89Q^':GB'#,Q6!=9"!MP"0#3('9_Y-VDW@LE@3&Z(;??&O'0+5Q*PMYB\?Y[1\'7!GN*6S@Y9FJY@P3 MH"BEW 4CW0MI.:$!'AR3PABY+C9$G=ZTQ]<^X/O?TN[7]+=V;Q OJAA ]SGM M]-OC<>\JK.,,+P(JO)QJ@& +@SI-@K?#Z$?@)#@*II4ETRJN$?"& 148%VBA M*+/.$JT 0-KZE3JI+\&T.Y#:I(7POW>Y*YB[-"::O610N;7O4&:5>G@_#' MY%,_Z/LOZP-XS/2O-8ML6X+9?X!I_ +'"AQ/X 8N<4-1RRDC&&&H*516(XZQ M$ 8I!YE5*U6C7PXW=J!KU.H=V)1N]ORF>P!E3^E M*SR)16PA$BO$*94.BF!5A8(QS 'WLN5*E_WY184 M2/4B_@HH6P#PG6'2(_OZ]G67 U!1&C!ZS0Z,O=]G5X2!8'\F7=/(] MECS8.)W9IITL%;A:FV*;^A!;E::HLTI&ELD;UFX<0YWGJ;QYIM>7-$C+JA/O M&0EI:Q'!\>6H0?YDDAHE=:>4R1=,7WO)=XF]>]=>E;)]:U&]>S:_HT\ZB@>) M>0&1J)*D61R&+>,P&JHX2JHH/,%)X0I.9@> IY/TIJ&)XZ2)6?#W+*JP(88C M)H;+X:3=W[=DU48WV@V10]KDXQY427O=[F?ELMJ3Y#_:@VE[=)(Q55P";(GUPJT$3]B1K&9C?;69>S7%6RG!>X+!TBLXB0,_2R4)D:!Z* ML5+3LQ$9K +&S MVA?:)I4,J5= S7N3ANM'2P):@-4:3=? 90.76\/EP2'BWH">*$&/ 6M\^ 9+ M;9$%(.B+7!+#)'*0L>B#?&G0>RAXJW[>4I4-YKYDFAU%D'Q$H5MO-.3ZE7Q/((9 "P&B9D.!D!::@N^I%FPU MJWM?^/Z%/66U9H8W+-^P_ NS/"E9WA!D%&(>:8JQ-A1"C JO-_7A_WO+\B_D MYJF[_F/#[0VWOS"W,U'6,[?7JGKS M%J''*8?K#O[:D1]BX24PWE_-H?J07:EAA3ZFX_'/2=ZN>IR,YH2:=O/^C>MD MYS7NZJ::S1Q0G\)369:K%X1S[9#FC .B)+=<%Z=?3 !D5QPERS :N["K8:>7 M!ZI//H5A#;MOV&?RF-\8'762\=&O7.'\]]#BZ M<)JWERW1H,8!H$8PHDHS2V#APO\\ "I&X2AF.(#&< ND5GCM5JNOAQK'%)'3 M $8#&*\!&+B,Y1$REOT0"@&+,9?6:\0D,=QH;#F7*V=%NP*,6LT(T8+BU>/I M]X^YC['<4U95.EDN*-UXKU^IF<,A)>@_M3X'G\&/6=G)FW!-*<;> !G,5064 MAD(@+8W1!E*VXM]?)YDUBH:WX[PBO"5QK2FM6Q/8&Y=7#30WT-Q \V;0+$IH MQA908@0%B$B*K-#<(V>X@T(#A^Q&=0:V@^:7+TE5:WIM \P-,#? W #S)L!, M8-G"RF!HI1#4 \I6ER$RY?CY-TT$V[#SCSG_WD5C:P MR%3MP=UBKF\[;[,YO$HV'W@..__V%.PP6#I//32"8VVX=C2Z4)FNA@*>$ MP-=( ,U19@Y7'X?YFQ9@*L,F]^,VX%*!1Z_FK:5SM&/KH1TX6775)F%?^^&/ M)<1[-@&LGS&>3(;%=[ULO9/W:;Z"&F8T M)H#$:'VB@3/P-1('UZ'#T]@_)QU/JI)Q/RCQ40)KQS-23(&*890\+18.4+ MBACFC&@#*-!.5#I7$Z4!\DQ;92&U*-C]A@J&O50HK&P,N2CV)>VJR;/? Y<; M7U^XWWYW9Y>).K/);^[\M\_JT]].37)ZYL\__ZXN3\_/5A2*!4)9HI--Y@ZW MFQ)Z]_HT]N[7RXK.D+'6H-WOWR4W[4'[:SI>-%!KSJ=B5#*9$E2F>,-@D2"/ ME74 8,@T@L9*Q3R*_GUM5Z@Z;&V K?.KG*PC!!=T/EXG(J>XMXIS@7SF0 <6 M@.[#..U$L/L>U/%Q.@B*W/?A4T;%AOZ K_WAEW8_:'"S227C8E:9Y,ROCS-M M+P#AM#_)-+M>^,^7Z3A04=;_-8C@>*5SW4NODN%M.FI'ML^FFK4 O6G_F8Y. MDK#]+[+'O-GCA3U^:'/#IO9&27S5M]ZD%_8QMGSO!N@+2D;0N+(N[TLB[UE= MU)<1Y!Z0JN7GD2BS"TD@P6P%DDZDR?$T/*L=<*8W'D_3)-!@+D?3H(_>QF&UDNYTE,-8 M.Y#T[ VM0)FC]$O\9GS;"\(FN>I/>]U"X&3SZ:;?>ITTW!GD4>"Z4?O_9^_- MFQ/'LO3AKZ+(J9[)BL >)"$DLGY=$:Q5[C?+SDX[IV+^FI#A8E0I)%J+G?2G M?\]RKW0%> -L V9Z.AN#EKN<_9[SG @FCBYSD,4)"C'M'3@\=44*G!"$P;\7 M!D+7? SDV@11"@8$,]SJI9G&,+UL FO^LC)12U?MV5:G:3D#J]MHNX,V^,O] M+LK$1MWM==NMHBHF\)-LR90[BUB$!63JD*S\(A?[8CR&Q1ZM%I3_7)7/WI%+ MHF0LN1/XVO]C.BS(4%'ADN<@-_II$G=5XY#ZHT=%'60JB'47X08OPBR2;@ DV"H9,=5GY)F). MC9&!8752%+7I]R"B^^\PMBP%:\VX!L>?OOXK!H%IC(,?TJ.9SD(?Q5P0D>3+ M9V %,J''=_ )Y$$BIF1ER(?<)/X8)33+_.26'YN): 2/6Y#CC]+TKK@V"8A) M$&XT%1FP@C]OXF1>59RW?A+$>0K+(H8YF%^B!DL98<)US9CDJ(+!V([S!/\. M2I%KI/,4&ZCSPHH;5&AY1&(+5I+4#BB[2%=P-:61X+=T LKTY-I/Q8@":2)* M^;'#.%U:Y)V,B.,JE_Z%YI @S:E%76GNID!,(D5A.B(S-XHS6@,_H0LQB$B4 MS;MV+89^G@K<*S:AP8[(?*#M\N7EHQ/!:GPD9H(0$UBATY-@<+B\BBZ*W2+; M)T?W%Z-Q,*8; 4P@=8,_F@91 $K$1]+ K_X;KI:OCM&,@?W-QZ"O_TN]U>M^'U'HR_//J>I9 28F&D8*3P6H.@&P>9<3TW MA ^2>)F"B5[X+&AUH.GQ$--3QKC)%*WG,[0\L93GBR0RP#J+FHK$Y2>1L'AKB M\IQ>(M9^=G[5_^UKV_A\-NA?=L_ZY]W^I?'[Q>?>V?EOET;WXNN7BZ\RSOQ4 M'?TZ S^_N(*17ET8W\[;WWIG5_T>C/:\US^_Y$^7%Y_/>FW\>G!VWC[OGK4_ M&Y=7\ 7&TR^-C\5M/QL?"^&SF >@YEJANRT(/)186PC-/Q9;7UYW[>J*1U)? M0%["O_7'1:C]PHJM9=;9B7F65_>0R[8P6G;0S#K,0R:'@- ._5DJ/JD/ORRF M@I1>7E$H['VXWZGC5S3=OVDN8/4W\X&?&NO=]I(O>U-LK[)Y MSYVZMUK>75%&S1]L4_2K&36[CO*VX6H\D0[L-Z"#9ZS$BU'&FK71AR0"WN_6 MER;YKC#_KJJ!_1#S'\\PC!GG*;AJZ7HX$!CQW6\0"/X3+_^$AQ+!<-5*R2B, M@?&,2XQG;"HCWFV5Q0%/_+C[3Y,7U5DNAM5W12Y\^/7>-(%7,H!VL@QHDW&_ M$J@X)P,TW3+J;?8;=:LU:+2=MN>8K8;7Z_=Z_7ZCV?0:]9[=6$Y7OA51+C!+ MN1M3QD3V9Y!-NGD*<\1,=CSD@EFW,2\L%:,K_\>K)@2L"T=N@?_6:&RSGO+% M:73=7@+[+DJ/ F7G!(J&E-$SK6['[K3[3L=R&O"+[75:IC< R5*WVMX2YNY6 M!(K9VD&!TJ@Y6\73?3.!LE5?9W>-FB[G>M5G<)).>M; EMHV&?>9OU7=Z:## MJ^9YC6V6 M ^]<'Y.C6_M.&5^KI&FYW7JCU6MXW1[\V'9 W_><>M]NNG:SW6PU=T7GOR+C M.S5@_H-F_,.*:%S%&94/$&&NU87Z14!2#@\+95\@3QZ1?@U/JT5MV8-ZKV<- M6AVG[G7;G8'GUGMVO]WK.OT7#*%LIQ&;[31JMK55(^51S)(W)>MCW.0HP8X2 MS&V65;)UU[7Z Z_7J?=;3J_=\\Q!9]!M--R&U77LP8K&DMNSW[8BP5JU9NMU ML?!V4H(=#Z47#J6_<%K]\5#R>"1]W/W#=N".1]+[?(+D69H_9??K;M]M>XU^ MW:E;;J?K]MQNKU]O-.U^J[\$Z7NAZL_*+DKWAXE3.OJ)2&%3PO\9UE-6(=G4 M\U0 Z3XTK+<[7/+751TR@=GW:CWQZX7:=N-CP'D?OL MCM?JU >6[7H@<%IKB1H5F#X,4=,R:_96<<8/PSO:74/H%8ZQ'TGC/\#3+J]I ME>T>K9;M>$Z_B=&29KW1,EN-9JO9[7INM][K+'>5WCW[Y-4.PFRS9KDOU]#K M&;2WLQ;.P?J7[_R W/-*<.I6UQD,O([M=7JF8W6ZK:;;[]8;=K=I-SI=:SV1 M\;IVQJN)C$:]UFAMT[?9/9%P6)$7%6QE#),W:!B]&_S>JI?\WC3K@[YG>TZS MV7+:3;?3!P>CVZ]WV[VZX[67CH1?R4381F:+Z=6<>O,0_(%W$'HX_#[MC_"D M55:Z#/K]KM,;#-JNV72Z=<_KVF:[5?= (W?=9GT)A>J5=/ V>!*L;,_=JLH\ M'F^^F3IM3Q'KC'%EWZ-5?6^O*P.GVW.Z_7;'LNR!V1RX MG>:@VW/-19;6E_9B?!9E?G037(<"\Q2>AO"]+HLV:ZWMMD_=:M>G%Z?I8[N] M(P>7'*QU;6J[GM?SNEZS;[6=9@\TE&3LUR ME[O-_/S>W=*=5:,KL'A?..R]SRRIQ:JL_J!A.U:_8;NFTVMV6^VVV6^ _U!W:XO56YNVS=^%9YO-6K6"_9FW6>>?Q^> M=4&ULIO?SM1('%MA[T\K[,>DJM9\K-/H#)I.W>WW.HYCM;Q.OSMP.U:K";Y- MSVRLG\BXG9B$Y=;,NKT3O:IW,][XGB,41REXE((;2,%&LRPNZW2Z7:?1JC MZ/Z&.?BM3X%&U?IF1:>A4^,\YJLJC9L"U99(C-3-#W=+I;#5B!LGPSVRK18W MB<+^@_K#L3<,]8V1@]B73DYJJ7W9UERD!0(#+M*-B&\2?S8)AMBVQ$\-[EP5 M\U*$LHVYZOXTE-6GIT8%RP%[ZDS]OV"%%AZ',B4-4FHMST_@IB@P]4];7;_E MQ=(>6-&4Q_8/Q_8/+^2R6[+,:NV5\+J MU+S6L49N/ZR!=\&*S::6G5&R\#5_PT M??D2K.C5FH?1UNE]!!7::> ;7_QA, Z&[[%VYC%&]K3$"M"F7J-MUUVO[S@# MJV77L?V"W>EWFU[/J[^Q3L6=E!NY/3B95JW5W"K0[\Z9P._9,7_7K&W7G1(O MIN&V.^[ ;#3LGN.:=L?M6;;;]MQ.8] S>R_;1.V-6-NIN?7#9NV#\FZ_BC3# MQ)D_XR0,RF\>XVBJYNMEJ=IJVV>K;[L#I#CRO:7;L=GO0K'>\7KO>?T.% M31!/N*478]K0[;5!-&M-\S4+[796<;\K_7S #-TH&QYZ_0YH9G/0L=RVTVF[ M;;O5T00[\/AYN39;_N6N.S_3I1 M>\EZCUV1>\W6L>/9]@E@9\V50XXS[) \.Q:W[5UQF^UYQ\YIQ^JWS9X-"X[; M&D2Y+U=\Z9N'RHY>9L;TCT_TGM:;3<]I= =]#$R:;KO3]BS;;EENQ^PW&RX5 M]/C:C?<.]8TJS%8D[YK-4ZD5F-S/URGER?B"A[4">/A]P^TC/CGI0@%L=5)TW1[;;?3L\QNQ^FUVNU>WS(; M" AL#ERGV3\IT4H[W:YM]1RK;YH]9U!W.U:W.^AT6QUWT.SU&Q9+!2 6,6IG MSWZ/^<$0("!FR$M)+C[\VKWXXX^SJS_ZYU>71ON\9W0OSJ_.SG_KGW?/^I=* M/,CU6B":!;I=9]KF9K.Q/CR- N\OR'LV\YQ%7#XXHN)-68(Y!(GH8Z&F@D6? MUXRI'^5CV- \@1'4L*"32QWAGAJ5>*8BA '?&*3#N&-'& Q%!/+? )<^T@I& M9;ED3?_#F/APTTTB^+*9/S>2>.Z'&5 E5DJFH 52C-.JP)0/L81UXF=& MD-$ TE,#ZS'YSCD^A*$LL9["<\2B%4<#-.+9)@ACJL%JHKF%YQ706QG,A4HUHXH3?/X2GBBPH_KX#$\* %9W) MP>,XBWV6 \8_@++\ZR ,8(L?FU<-%/"4IG$W"883(+-;85P+ >LKLBP$:H-1 M:S,\-<[D0LR"2%;E NW[-T0<\+0<'B+GZP.=B 1^0P@IW^!W! A+AQ8%/S< M( )1ZD=#7%:&[KL+8$VQ*G:*E"5&-?S%E_0F?N#$\4NX(K@-1KD?P@/A"KDY M_@U0Z0V\IH:K PN5AUB=;?@PQ PHPP^!%T?P>G@)F"*XBK+(N-R_LO(:&'\4 M( .?&K_'=V#0)37D(Z"?69RFB$:YQ#?_ENT7B^WS32@-B4J!R9"E1K2:= 7]#K<+&/X4 M;V29YT\Q23>5[Q\1457JS,=Y&,JK%%?S(W"AZ:'7 @8M"H40$,"4HF#)4\Q@ MHY@(EB4 @H4C^)Y Y&&QAB8OJ!I)-AK44XG(,43L6IDQN=B^,J*S7EN:FU5 MI7N4A>5"K_>R%5OCHYZ(@=CH6;A^Q0. #N,\PU5!>@6=%N+5?DG#Z1Y@%?"? M>+GJ.$QO 2&.:F$83G'JA4T(C.'[E#S??8H,BRR7OONDRE\,U$$)JA&>^V'47$W MNPRV63/T(M]G/XOX?WLC*578J4"UN+DX,D@JIE <%9L/!<'1 6ICQ:U+C(YF]JC[YTW+DJ>++ MKXH[J>#0HJY:+K%^A"RW0&"6MS !^G>2J(?,P,1L'AKB0V7CVXL]G9U?]7_[VC8^GPWZE]VS_GFW?VG\?O&Y=W;^VZ71 MO?CZY>)K^^KLXOSI=L+K#/S\X@I&>G5A?#MO?^N=7?4I.-3KGU_RI\N+SV>] M-GX].#MOGW?/VI^-RROX@H-)'XO;?C8^%N)PL6B^C#YJ=+>%P-*&83+[PU-& M\01)_CJR^_W!2K4>@%SB5]BMM9"><%O6N6T]6"EOO=O<-2"GWAB 9QN (RN$ MU$/ 3,;]V#Q/QJ[95UBB^YQ1XW,1"/PJ0E^Z_NWAO_) !J' *FLGW\&N^'@) M*WL>9\*PWGNW@-U .-H=*KK75'F-0?&./86.>P+4FW$Y# 3Z&R^(\[]O^_I9 M(6B"OS HXM!%3NFJI7JZGCG@]*&M"8077J0=PT+['.,$@!F/V6A'THZN#:$^UP"!%#7Z#F_^&#BY[,C0__R-_<^"[/9=&SA:$F8 M;J?=-/N=NM?L-UNVX[F#;JO5=AOFH#>P>LY2M6QQE/!'&6G&+,RE8X.T>FZ0 M5D\9"MN3GK60IGE&:9J-HL-51Z9_:+9I6:=#GE8GB)6->A8-3[E@I[B_&'-G M7GS\/0!#'+S<.47.*PVUBFMX'G2!??\CBZET0S]-RX&5EG_%\"\NWUY54:-F MF2^0A[ICV:3OP%L^2M@#D;#->@G?Y3IUK]YK>/:@[SF6V?7JIF-Y;G=@M;IM M=[DGZ,Y)6(H!*/'ZOD2K91_EZK[+U=T,N[S !G^1N29'?)@E<:PU%NRYC6;? M<=L-#X\8VV9SX+3:=J=CU]N>W726($_7%Z;MOR;,?N-SO-3K_; MMURST3#=?FL)IVYGI=5[,B*/8NI=B*E#"PECMU!CG,13+:OYB;GK89E7;&PH MT'=9;G]\1'"[9B&X!]U&SVQ[W69GX/;:[49OX#79S.PU6FY]J7_UE@7W;WX0 MX7Z><;7,Z"SJ^PGF%!^MSHW#K;6Z8VY1HB]S^B84ORUA\-[SE?993#TBI5JE ME')LN]%P7+OI64W':K9;9G?0:@VL1J<'OG!_L*]2ZFAM[CE@^X&85%]%*BB7 ME@I8D73B&?+,>PY35C,/GI)J_(S$GB/DU!%RJJKN7*M4=Y8))GC+MAW M]?!"8)3;P]RYMPY]CTJ3IWYR$T0\/#_/8O4%$P!]LZ7JY>;CU+S3J/.Q2O98)7M(^WJLDGT)1_: )WZLYUR3SX[UG.\[ M>>>!>L[W:E4=JZD.)#+G.1INI-.QFSW7-NMVW:WW^Z[E..U>PQXX]5:]:6XM M8^&YU53>L9KJ;2)S>Q9?VW>YNIOF^:M74^W.U'X "S,\M^Q'[+KVH.[9 M@UZ_66^T!K9MMGJ@AQI6QVL/ZLM=QE^S, -[7!U3Y8Z%&>]53!V:;_>BA1D' M;:V\CXSN5KW42\VNU>LW'+?9MOO-OM5QFFZ7]-*@9?5;=G.',KJ/:NJ8T;UW MLOB8T?VT)_PA1L&$>N6I+KW5?IW^$+MEXL6J_9DV M(3T<Y@:[@5)):C"#4Q'V%Y4=F73QEUV.?5E+U5.$>.L#.K^.<06 MP/X,?O6'D^H0J>UTF A_A.VB@PT:H;'5\-,C9D/3*L,#9K-5=WOUOMON.O9@ MT/;L7L<<.$U[T!O8[27T,WD*,HB3Q[2C3.^*;MHPAEM:XAC]M--:>PQ$BLAJ_H=N^5Y/:_3\U"\@JW*!/B@" -:Z!@/#1]VSM>8Z;^_6?G@V+_ MZY7]/TG%$&G@#J1)*J(/OUY$XC$+[_G[OF)G481-_2!*9:=Q)@WJ%QF)K&Q@ MORPT#?%#MBLONMNK;LXC,:;>M44#<-FEWK@6V1WVA]:;VJ/I([OSTI7G!L\MS[!X8E /'M;Q^W1D, MO);C#5I>#\Q-D-?-1F-]7OAE]V)YZ_)UMP#L"Z/UT> MR\*1'OWCT^-3NVU9?1=S$NRZ8[6;GMEK]EVSVVQVS&ZCXV!!DK_](K;M.H0+ M;6"O^G\PDUFGQA_M\_9OU">5SDC<7RZ-WMEE]]OEY=G%N=$^[\%_VY__]_+L MTK@8:.U5L?_JV96ZYFO_\MOG*[KDXDN?F\A>+J_JHXOS\KWEN3\QJFO4HGF: M(B&AT/(C/YRG@>H%K13S?Z7&N"BX *+ACN1T1R+2/,SH!G2O.,QGI),X#\&W M$P8Z)JC\X:Z_\H@%R%V038PX3^A1(DK9T*2($4OUXEUI4=Q1^'3*8(UBLDU@ ME@+T/?A&PJ=NYR),Q1U^RR8'S"41LSC)Z 'RI8^\2OEZV)(@F9K M#:;E62C.#F?3CB)T;K_R'&%QP;N:&F;]Y/];;/;^]J3WIP!O]5: $3<2^GHO M;!1;G[A-69#E&9)K%G=MC!L<1OS99M$V54;S'[*V[I_Y 9$^6]#>,C7H12PZK_HE] 7YF__$P6 M2_K@''R@U32__@M&@*:K;T3DG> KDB#]GM9 1TFSFL9!C(KQE1DSFW\-;N>2 M'1TC:\!29YE(TB>,0A)6S;B&A^&0@,' -9@&[!W6]&L7G,922H@?,YB%% *) MN/&+@(AFPP=P]3 K9WAK))1:28FT)D!WS2+0B2.$]QG$"./C@68QAOG,! >)%@2KQ, MBTN4Z;+UDQZF^2_<)G:R8-'B:_:1AD!;&!,"/VHH1CDL^FT]?I%Y:'0"+PP<_N6(0Q3"\>9PGBBZ 1V%!1["5FY, MXI2^A'M Z20Y$>\R!:7Y;!;.,3#+;H$!9&TES,%GCTKC$7@^/'O(GB[\,8NCDK35>@*+ M46M[7G0F87SB31A?P_N8&&_@-?AR(*P8UYY6%58PR.#-R7>1E?2;(I5/A!]F MDR$) +E4#V[J;9 7 TV3:L=P(\,8 M!!:.'>:?,OC J*Z].:P=+235(T?\4%'? SI6A^7(/NLB' M\F]YOA_TF7Y84*VG!JA@NB?SOZ.$!TD$8L]7K#C+X<\A;&8^XU@U,L=M0%LZ M?V ':Z"S!?'2PE9&X@Z&P,X3">UQGJ&8$[>T\?!\8L$[>,7I2T%A;-& ^=\X M1REIH&S!9SY.VM?+RT9Q/9!SF/:3*OJ\%F$ BU)3M"F_GOKSI:]P'1:_)*9< M_/(.?-#%[U3H9/D!?%BT^'W)RHN_X-E*M/3.5(COB]_-0C]:&@<9"DMW3U;. M []4WR'5IR 0N3('[-$2JTE0K_?F35;S:[KMMQ&RQXXMMGJV.C$UEM];V"W MW;JYZ\[L?<@QZNO'T0T^/#RO+8S06DS5HG\GB7K(#+3P">G3$W\,0_KDAW>@ MS''I)XFO+L<#>[;KM+9KXUP1X/FM?][_VOZ\AA.L8 #JU<%N M*U7E#*CB)O%KI++_E?M)ICR0+V###D6&>A)!D?X!=JN8@P6$.A6TAC3C0,>2W\:+/EM3CNLGCX#(0*$Q#1#2P'#82 MDV[P9*9XM $B/$,M;N0I&UX@9C'T+LU>$0GR8[( W%)Q:ESB//!-$1[FTW3I MG%JFN&+T!KR81DX&ZDRHB$&6LO1RO,!Z\@&"K'TL?1WO#5UWD2R?Q9 M,9,C@-6"F8-9(JUX.5J8*G@M/ENMRL>Z3L#34-ZDN@SF5'/^ZDH5P)<#GT"RI&EG 5VLT'_)S>T@4&49DDNS:A(Y$E<_*2.UV!T MHUMTSD8\,0,]AEJY43"?)/A1GL;A@@'Q18%/,X#- S8;&O_I3V>_4)H"O7)( MP\27B63."X V-&X/7#P!D^6.7I--8*-NP%B!%Q9A>ERD%'8S@6$J%TC/Q%A( M:,;+B^&AY9!$Y#3H'JD0[.T &8[(X<-U'8*$B(%4^(G2[0)S)*",$AC?^F;C M2_'WGQC@BG)T8-#4)8,%W&KR-;0U,+*[6%HKI# *(DG%#5'#)Z"V$3S)N 13 M"7RL;&Y<*LK AUX4F\6+<\6D?Z7HC@[J+^"E]S^F& [L["Q!.Q^WM;BNI-$I MVG R"%L2+%,"L2>P4>R/B#,K#PGX"##608+L5S-^PW/5".X_P\ P.(7&)9@: M_Q9)R&=*(^-++A*0]5^#84PQ"-HWCKH!!Z;%ODS@XHD 0V>U>BQ%TU1D4@S. MY@E,++G&HU III@N68C .N!W) M&@?ZJ-'05 0#<:ZL.B0CO)-DMLR?H,_2W"N.@"FW%BX@??"GX"4VR!*1@>X9 MW.TGQ:F!7,WY)\/\&71'$(Y83H)F$4,R.T[4-@WS$*VVFF']#/;')!"W>"F( M-7&+4H020FJ&_3,..HGI1_^&SW78-HKB6[_4C8V?#65$X!FX8A*,?B64AD(3 MD,$_7IAKL+M 40)_$7OAH8>:'T<;@3#]4HSQ. 19^5&DY#]N2!Y)AZD&ADD6 M3(-_%U( GQI$X\1G54X3KI =&>=$+KBG^?#["1U7E09^S;@3% JEY53K IH8 M!R?(GA09;7"D;#A>3D$O#Q7$G'$3@R[8/>*^BMD-Q1 G4:8D%1@_^^#I) !O M4_A3]@53-.*#=")&U4- )LEG( M*"W9JMS*YZTCM#H7A8U3?<)+[^ ME;02SG6_1&-<)F8RN5(@CV ,DT1_2 L(!96<7)D0E8(L!^&5S*4%KM]0!$*J M>U7X+!Q0T<93\?QTULGI+! ?LQCNTN^'-<]DV4.*)YGH/M.]P%37B9*:Z!:5 MKH8V&DJQD#$+=O2JFTA3PT 8]L9H<@I^,,$45G48V)$P&:G!,+>*+XHBIMAWX.CQ04U:3# MV9(5JT-8-15X$)*+.BS6;M=GQCP$BSW.V4-(LWP4<'(%)VHL9VG@;YCX@0?P MT:)"T>6#"P?0:M !'%W YQ(^ ][$I)4P:4U#WX>>%] M)POO8Z=V:?DY+E:,G^APU\RF58P.T@XL7LK=ZH)W'XD0=D01YP;6 J=18-'Y M@EVJDV6@BP\V0CD6))*J>BI#71410UA5+0GW$DG652."<:IZB0 MLFY4QFNQ!V6NDR8YT >+..U&I0C16XGYOO-:%%NF\VJY/G%RXT?Z7*E0!_9K M<0 QW8EA4.6^1ILVK>H&L-;#S ;E9_(+L)8TTK4\F =W&'7W M4^EJPKCR5 J)&5IEP#^Z2&,#3N-S]FSRFO'5655F="ZWEY,VE\PFN7Q:&E'E3:YSZG1TC1G92Q4/GO54J>S/6EL MD440$UL#UX/OHR+@ZMAWUTS9#[_V^#1-^@YEFE%#\J6Z77ZORG_*%THVOGJDLYIF0<5[&[_3$(6G2R[V8"C0JE^5: M(?E *(=I3/O)"=&\G=UOEVVC&[+<+#*C.+='1H $[7D>@@67QA&ETT2C62#P MM+0X]\EC X[C82I#22P106?(KR!M16E HY+R69@/!B MJC?4 P4J!YIYY$=F:,D'L)&?^ST]C:'04+UO%_1;P7B_@VG.U3N7Q#X[%P%; M+4WB2A+(O2>2*\4*[M(7<-U\R91G9\;55==H)^A.C 26<)[[02@71,5TOYU> MC9"<<=$3+'\'#:&,O'*X)ID)SE4+?FNFF:C":2]M+14 M]=(769+V]$F\Q,%>M:J9(C$C9DXZ\).QUR&0"U43," *I721[41VDJ3.FG1; MJ@$;DE-A,!8GJ7^KFU4UY2=DTD8C[T"$X33#>K.1'.8$>1[S!J7V MD5N@%<<%T0B6ETY^(EFAEQ:7E_?+LZ.B])'&Q&]E'-GE]5I*Y%VY:#*0@[\O MYUH5Z1YTRL=Y?X0HJ!UDL1?*TD6N(=X-EC4*#UP@>>8$%U(BK"RWE.:V](Z+ M>K34'PN0(\L$4XEG+,A5PL8NRJF)V"BUPX6.,O5>8#V&P)*^K_AF>-\R3$&^]M+7LDK<,B MK=^#A N+A/@WN.H"G8TR>3:F,4ZQ] 9,*"WMILP>EA%D53J$Z4S8.E,=YL0+ MP>LC7;T/NKJLI&EH\D8A95#4! PW,KZD53E,*-D+Z:< TBA3"H">P'2LJ5)Z M/G-%EUBZ'!3^?XR^WMYD>SOWKW#N*/0YHIP?A;BACL&+O+\@*U+^Y'U@O1-+ MHW6"@H&#$QA@Q;Q6A4%#A55B@DF(MR7(!WB+ #D*J(@#=PC]G.1]^0LWXU M9"H^_2K<0'\H.*?.3SB)MG"!$+WC?T6&"?IXS"PD0$;Y>]4K4"N@!53)T%+. M:7%*I1R/(F]7Q^6@]/>$G+]Q'F)<=O+ !UM4L,1)=$%D MZ#6/%2B<:N$EPI&,_%FFL'1DK0OF@J/#MK! Y- O.)OLUP72*?:7D'N(O V_QBE97-9YK2Q<4H$RPMIH&W M*>-/;9HH,AK(/2M%AG+0EK(55([QOYG=S*%"-AH\681[48%Z0JPL+,$&AGF''\1>%ES27%93*EC[EY-5(2 M996H$M-R/JM'@K.\%G/XZAE!N8,4J6NX\*?89C8;)\:.JK-7D9!![VV\0>#L>W!D^,[/BQ\^^%G=,N$U"N@8PFE M__/G+LCSCQ_P#RS/A:T57(_G3Z,@QI+UJ9ABLI5"%I!(^44(?A03(%11.HYR M#O&H2%\EXB8/94)::OS>O?KO+RD>.&/)$>,F2E3CJ1%D#:D_S'0)Z"AGF,IR!))SH7^'RE)E MW$E%K:U!F7]:H"G0LE-S+#G:A66NE=T/Z+ =]1XEO50C@;=8<23(_"SA/],2 M'0(WG@*6JH9(R*Q#N+K$[]8O+W+9_31%0Q9BE5 M$U*A9'P.<.L-69 H1<0[^"R&.@O!W2^$OA3R?/*$2O\F# M$8F?$?@+) 0T(-!)CFDQ4DZS6*H5Z'LLBF/PFK/!L_81M59FREGXP_9-[!'VJW50;R[_%4Y9Y\2X7"#],U&ND$8T!S M^TW.K8+;:JRZPD"?*2._:5'\50FIH!65Y["JK.H)6N]D3:TG:;!0?BN.AW"; M?8R/,)N@&@-#2[Y0]9OA$S#R4U0 GHZ%0LS?FF)^LRQ/>.H$6#MRSC>L0+$Z M09+-@39_("A'-DGY3+]\;QD2J88NXBZK#*%(:< MR*"[$:-8L&@HRW&UN5&OH2?.;XPQ:* 1/I_$09[0(%&5WE -77NIN:557SJO MP[&@"@]NR=2:%U Y$0Y"+"Z/1.>7$$J\MR4$+YU=KJ"UE3,X!9$0(:!C2/"[ MLM1W*C$C$7N8D!_2,F""+R/_2?=)Q0],^D_YX'3U3K(9(6OB%]!@-^"1FD0S MGVOE4G)]I%C' 0\U.M3B+=(%K,(7%V@BQ,RKNT7AII%EI8"%RW)L7I2T2$<> MB8)542IR)ASZT7XVH;HB17//G_ONNT=XA$,.OP3\(A7[X$07&4R&H]9.3\_ M>A)*S#"P:Y49-^BX@5&]D%,LX%[SM/XWV52]1)V7\8Z7VZHM>H:\+FY-YJY= M]<]6E<12OF8 @C:9+U1M:R+,^)/;=U=\1:F+JS\I+5PS>,%X$$TUB$+&?8LH M%^PRHTC"((XYT-9+\ANC/4)3D"JS"EE_)]\2\@"T$(1"J5 I_6R&8(H&!M"J M61\25&>N0^ITXI2 ^RK@.?S2XF4R"89&3PF^C 1"0- @B'P9@"X>#X^]&&;Q MM0PWZ6::)P\)J ]"69*(ZXU)?+(-*]M8,DM;&JQ%KSC.*2DZ,Q'J<<.SY1@H MQT.H-GIJH,ORKGC,2$@<<)6?4V23DI&1JH9]PSA)9/:W7P82?69&,%>NL3,L MVQAIX?AB$]DP3S7Y78ZI1N,H4(VC2G:+*K,ER$)E"5!T4U^A)1D]0G2BE213 M6 DJ%+I28VE8[SH6'"9X8P%9(/WGXUA*/Q$!0NJ^DI.)66NH?W&4<"#6;1B-CDMH.0-( V!Y>N_ MX3E'I')^8:!L+1DW\!XD[!Q6,)1I7['"D2_C#7+GT1NK%KO,\!R"2P>4'JRD M;=.8J$SH[.P,\RT#"=9>1G/_*=E79I9J5K V%)]B(IB1#?YMV0=2GTJ1DO[T MN>"*DE0D"5!RK[;Q*6&8^4/ESEPC\V. ),[N4-%+4OUZ2"TY8%$D*G\L' IP0Z):D%RQT5&G<Z/FQ3T:O#H:J28F"@%9)DYTW>4ER_B!P>2"4M1_6.&W];?V1W&MH/Z,B MY.T/Z5[LC65#-\NM6[UFL^YX=FN?[T$2YW%(#90K5)!-3M,XZS+^L(UA^9;9UZ&Z_.IHMC>UM< MG-&=#V_+^U'-KO62I0P"XG1 2ENP,E) M$HA'&>32U\+J,5')85%NY1 (CS+R!FR@5U.?J'YRXH\X$"3?1JADV XBS0I? M3CY^U?%_-XXHNQ6/'R]%A&EKY['"'<>NR-+[PU .WQ<5IYLC,18)20K_!QW; M+_?AHE<696&K%Z]$Z;Z.X^^*,AA52R0G\'!XQ5_@+J0CF3:VF:7^,H3]A5+^ MY"J7!6QJNLM):PR/,M*R%1G1R\!4S5$!TJ[E26!VAWZG2E6,D3BJ^6WXPC*[ M4L_^Y/KHL&S:(-\JD8@(:@OAXL(]UEM)GAJ_ MJPA!44'0%5SG#QN *U M0$8AJJFL]^98*G+@P"FBBL[+,KX*A!_54@?4-%>&9,N\Q]J"2*1C6F9U&)#$ M%,'E3?P&GC27N;F(49-,#IA :++](*52Q&-9UK:08*6EYSJ75@4&Y,4Q5(,B;Y4 M9$.G>B&S@KG"B"BJY:&,4F@-2/4";6D8,'#&E$#GJ+\G63-*DFUH.KZ>Z-.D\I!L,JK MSH%T!I-+T1HVG>39*+Y3QW,96D\LQM%XPG>1N"0=VYT$D0\:N;**&:%8J "7 MX:_(**GQR'^RG89RYVIENP(&K%!TC?VL3YV_<TJQA'XP\&AJL&#W_"9)@8_L=1PWX0 :'B]09TJA;<EI2/"T,/T3:036#"%13!'.J8(H'BVT&R(Q"-M<*Q,C ME23ENB"P9N0A%6=>%DG( MBA*8.(\(\>%'HQ=N7=2J)X]&8%,IZ_4 MOUOP$] 2/5\%R%XS0M8ML(&L_/-LP5OH7@X6B_$7VG Q'9YI^%!%&9F4!2!B MXQP>?S("/LW2AYF;T LC7>$5'C9O/7C2Q!@$0%344_XK#V;%"'6_:;&KT&)* M _HX=(" ?D%2Y*2I83':UFI'*DOO6];2G;NGM9ER\TN41KEE"ORL5EWJ&=@+ M$V(.E*L%^)?NR041HR04Q8PC!1>HL($QJT(08KBJ7USVDRAI5*M_(O>OT#3\ M S=VNV-3YS8H='C53JDMI, 288*/+&:*+G@RE&BG46JYBC.5JIJ$<]V[+9W6 M"UJ(HB5AH1T+PKN>$\8WFE0ARI['Z0^S?1$WM"##Y<$N1("8HE8 ZL2R1W'1 M"B]=5'PF*S[3+A3?)KIM=T784SHQK11FW#@,"(=M13TXLM37K2093XO% MJPH/D]O-W0?S)3F#9$P!UBH1@2JT"M[]+!1:-.:?)A-MD5 AH:V6/1Y\A;]0 M;9EJG?F4N:N''YL#:Q""Z2\/*$D4=;LZRQJ]YG*HE/(C[I[%/V M0EQ8?=9"R$F%=WM#R%+27F*G6 Y%"WE3]ZWJFJ4K"&1B^@"0N!UPX M%T\0LAAY6R5D3>M09>P5>5TSM/>HI:?;]%WOM9+Q/U; M/PA5#B(:V[)U@@Y:6D,S*>6F*1+Z#IB]L,]J9+4P/$+9(56OJL?^:W$\E3G] M*MX"QMEXK%?;WQ3)B9583$K%%F6!L9[ER=9.3;I(8?!=4*VDGZUTZ633 1:8 MD@(QJI]0FN2JV/YJSOBSK)PI_:S3F],:^_DU)%?TO"5DNE!-HM0X"\P"AL_$ M*P@K@,.QQ4PYJU$ZD&5894E$+(G<@>K)^K"O@9OQ##6>+N/1^6G*S="P"T;1 M\#G6FC:I-G]<3!-'\N0+CQME+0V)-T6294Q9Q?]K*OP,Q"\H2\[7K@I2=KDY M(@_7QE281H5[O$!8TQ +XJQ=1:U2&C.$21AR+L\RW$ M6"I^$&, ZTR@(JL2T5SAI5SG(U2%!6:&K!!HJ\";2/" P;_13EJ+KF:KB[R6 M24<5>]WG^ZEN[$4+YJJU)#=BZO\5:P=9Z:HW:4W%"?"R$EZCBE8&R-"#)0Q= M8=BD"EO@96/-DWBR?QBRC7NL]*#\K /W65YD)GZ4QP6=?(DP7ZGTIJ19 -*-%>! M4IF"G$D^#MEUJ9ZT5]%+]$80B\@XI,$J37R*6&[">QWZ\U(;K492T7!,< ,T MPWXL9(13:4D\>:"8L08=GY$LBTNF+<\R:M([&95( <7!9C5V,^9RJ9*:%?&" MB7BCE1R03MGCVNW,1@>F.DR?#O'S!?)SO]:W;S 5@^J_PM'RB?9;4P9Y0!\YJ>)1'S MX#D[Y05TI1+6.WH1&#%UEY+G4$+6M%!8A0I;%MJ"/98]Q4;Y*L.4$-,P[Y]. M+,'NPM/.4"%K2K>P. Y+" :-M/ EVA;+/SRYBJ"JK\M.P[JC7-H88#MCW9H, M2" \:&&^D+R1;JQ";I/BYIX\J&%19IR6W0UD@>/B:9 ")) A!5G94#E86JCP M8L0_:>-Q#Z!*6R%TR$O$R3!F)&>9;R$+"0+!UTU$Y1O9Q0XC7X$:34:8+PJY M4B]42%BXPVZHVI-55*-UAU-GM7JY&M;!+56*R-A;95Y*C\L10I3]^6J_RXOZQ:P^H@(@6\"A!A E2]+?^A@A/:L+* M>A&DRH>?+3)!@!$6V#35";;'#[H>'YRJI1R$!S7[($\K_J-/_K;46'QZQ M;\N9>,^=NK>Z(N:* C=_\&%%OUJ!=A]0[5M1POU%8&NMQA/IP'X#.GC&2KP8 M9>AI_D\!<3Y $?!^M[ZLFGG?S/^8$M@/(?^13OCC/,5LU9_7VEF$:+_VA]]O MJ(L.VDQQ\ND_P.,!T_N5]WMMGF^7/#;V8<]UKU'%MMA%C-;M49S,0"^GSSV M-(VW)XKM4C8^P"/!619,Y>'IP\JLL'&LU[1QMD:+5LUKK2/N=U:J'X#PWG.2 M:M3EPJTNS-0*E"/;_G8N[_UL9P4;99WKK M$.KNJ>'W;.KN.97>;R76S/JJ\-'^4>=!&8F?N3;VT.U"NW&T"O=4SNTF09DU MJ[&..-MQJ;7O5F$O2,NZ3)6;SC6 VQ%O>Z9U;; )G8/0ND>;\/"HTZPUZNN< M)N\>=1Z43;B<,[EP#F9\-%>=%^Z_5F_4W/K14-Q3X;>;)$7U+]8ZYUH[+LSV MW53L*U10K3/>2%QC,9!,$(YNC/>ECZV:VS@,?7RT%@^/.M>7I+M'GX=E+VK@ MQB1!L7*=JB86(9(/4L-;-D?IP,;$?U.Q;_']:!=Q/QI'W(^7[CF@L^U6FM1] M^/6C^;/1E4<96F/I G:"W-8DG^DMA].L:"FB&D/?UZ"H@.*HXEN4L (24R.< M;Q=08 LK0W"XU%6[0.7TKV.$5TB*#@ E4!'")Z!;/ZJVY<9L,I]M[=T]F=_OQLW:3R(T:TUWG7/G'9=W^V['7XHP#+ OB.I[R*T# MIT&$G6T),/E])7F:9LVRCSG([T9:[AEY6E:MT3P,\CPH@_+L/20:.S6K>4PT MWE-!MYLD=4PTWE&!=DPT/J82'A.-CU;X,='X*!V.B<8O:TSP)M^["IFX(!\Q-RJGWF5"U M\%-_SLVCJVW"*-T5NR;'5";/GVK8NII[K1GY3#5!*]'T:SJ4?MDUC3")\1YL MOW8K&T_CK_<,.!%Z/:D1^=C7C!IS/72#Z@G*=?W4>+G2!W3JP_RR?(3-0+%; M5AB(6]D.[R:X%3R9.+J)<:04BA,WU-HL%>([C[Z8*+8)RQ/5L!I_',?#G/K" M\>2!$/Y-RYUC.^* .V^77=KH<7@0@C&_X#JG]0JB<>*KY1)%7S;M)8FX#<2= M:MT:Y^D"X!4L%B4WX].P)S-U:L/VTUF9Z:QF5N-FL++!Z2)-P+ M2P5;FCG;8N*[8E""Z!9Z($\RWOO$3XJ6R/1UU M?%5;E<'.C62^.EXFMW1%,SO%:\O][$Z-L^*%R.IP,V:I!VEE7'DJQCD.57;] MQ;<-,8T]T1K($W\4;=]E0SX?6YO?(RS*9^'"QM=_<7]YV918ZYN-[:5AC""3 M@W0B1BP<_!L_B##GA9H8TF@B;C=.(X%Y "$D<^)FN0?+$ZLL>!H7VSS'/L#P M&C^<_ULLS$RMH^K-B\+CSI\OC9IZ$5,SQA@7+=;OT\E#9M8BW3Y)VSB'@Q7K<2EN"%+ M^5QDQB5V*'\?K1E[: DETNLX5CO$([ UC4OVM<'_O)3-XH\9V7N7D6V!7=,X MHDSNO8X^,ME.,UFCYC37.N#9.28[J#RUBP34^0S[EJ7&?_K3V2_&59"FN3"N MQ' 2P8+?!)NWJ'A-OWA[B;^65?.\13R=YY])[M#AXGORU/8S_DVF\+:1N9;E/>XV5O MEOUZ3)D^W)1IJU[S&L>#LPQJI@0?FKXF,Z, MQ_[^#6?+/\&D>%'[5J.!%:3S\G3?M$[7P==:WLJ7F^NV:.%O1_=L#]VS9N-T M'=]L+0)]$Q)\N%>&;P2COW](S6:_;;=;?7/0:#MUTVUU';/I-&RW[O3;IF5C MHK&OW:A&M<.5!2L29Y_?5."^AU,*+G.%;=8,/15S\X>C(J%*@X2KTUYW)F5F MX19FV>M3Z8Z%RO$U&T3IUMS *2;A4 M/R>+ [4BL.?[6^O+L0^_GAJ]>"J *8O??='^]3[ M^6\;%=%[RG5B2:1K#@O!QY$ M6Z'LQJGSQ@+1K+NGSO9$T:YNI*RU9MMPD]6R3^N;K]:(\0E6R&[\:@9_),9< M^,FI@06TD<@*28H\],;Z]XY"-ES"C<.!H:$MAZ,'TVUBI%Q= M(_%[C:HR"5 M;=\6.KSY6.,;AA0"BHP\&ONW<4(UM-SL#1\.= 4F8F2('\.)'W%\Z">S5)XD MU'ZR2Q+6WBIA'1!A@8 @L$@=_I"%QNGNEWX_4*2Q4":]@6ZQS=/&%K2KOR42 MM4_-C4ET0UUOGMH;Z'HF\H*/3Y"/)8,S.Q?K!+]/_00>)IE)M4 \BQ"BA'F( MH5A*.XKCCX"8@'(IQ"L+A&J%EHAOU/9;6WV4$[-++$?^X/1PJ#(2O8N8C M7 )\['Z[;!O=$$9 X!/T) (>>3(S[@,'Z%;XR73LK9BJ?J;>W@; M&6D;2),R+OAVW+N)I?X@]WZ;P2>BHL\QD KP09:(*:$M@1X/*P[/-!B=,%,: MDEEU"V11\X=^FK'&7V*IG6K-NPA^.#JVYGWIUKPO(Q8K9W!O&4_:S#&VZJ?> MEIV7$W)>%&/ND NSSWK!W,!S4X;]AC$WR]XJK:R6WL:SSK;?<#LW\X/Q@'H3 M'2O7<.TGC(,DS=9__[]R/P'MM!%);Q:-V(R6\?AU@^774=>6*?@*,=;>4,[H M7E'H2ZQ)%6[#L2/:7)3%";E-(KF58<2*PU\%;:1F\Q)+,!X27N/(N!9#/V=O M=:GG_.X[-O1G]0CNHH#7ZTODT>?/XN71X!C-#4<9H'1,\^D4H5%+1$7XI4!. MU07H9ODZ_>Z;#\"F\2N:[@.P:\[60=Z>]L0=1?=Y26@O9Y=*V8\0 M;V]&!V\!:?",E7@/$&\O@/+X0 '!<>?717@[!#ROY[5_?9@^]JNVWSE=IX'7 MHY/<_2S5G2H:>HF=W8EJJ=<@X'4Z&1\ 1]46W;I:\/,4VFJ?KE&7M M#V6^L;7XYA)T1\G..UT':&)_R.Y]F*IG4>9'-P'&N[!O1X9MAF"2_Z8LRXVK M/9?]F3TS!ZS3M:!^-EV$W>>.H[W[/AC /-V\R>9!,L!!V[^\3]WDWN?25<9ZU:\ ,BW/WJ=WJ?J*W)7/-A'*4!(Q>FCTP+0VB5!=#)+8DI&?^QJ?I?F%VB/V5)9H29QU\Y*VS!9V3IM;)*LO&$Q M4\O>P@JH=*)=K?RJ;:OTJ^5MHUAO1?(5?(4G5Z>[7_A__RE3F;.S\Y6 6RK= MM+9!#?YR64!9_;=4((3BFC('AW&:I7I^G,IWTW8$I>TPS)$F5OU<[%,D[O2^ MRS2>4.!S"[K\[7[QSR/96IVW]V9+&E*%E+8..%F]U[9:;95(6'U)0>O5Q/$B M)857NX6 MO9$G6B,I-0JXTHY6NT;-OQ-\]! ;+8>RM_=8X.6PERG5?0,# M9=A:&JY3I6!?G&,!1^%' [>&HI[0^QS3,LQJGQYR2@ M5#^><[',=T#!976@4A0"6U OK?I"#2Y^1@Z7&D;EEQ/#EKL0!E.:^_7\OD6< M8N-Z.>+JN%1N+36#KGR##(#MN,%4D_W04R!96#G)0EAVBX-:[LU.;\%&WG/D MJH JV4&)8&MV^;5:XN*9IT:W0BIJS:@"V4]I7CG,)@GG])9R\MC"'A8L2X+A MPVM0$A+L(\A+V?F;N5^I.2[EE+S"W;5Q=2.ZJ%@YZF=-+:O%>,RMN55]\CTO M3W-F$5B$&R&ET"1.9]C,S\!=S225W0F:T1R=E-G-9Q&(7J;M]1.=7]_M>C#W.8(9EBY94,Y0T=LSNE^O M-9_WE]#\>*_K9G.]S.3&6K=9+_FR=YC^>NQT?4R#?M_MCG:XQR[5^ZY?CRRVPRSV_W@^ MP0]PS:,!!C8I)CCZ^X>1U7";;LMLBE;+.;G[?C* 'T\&IM5HNO76H-YSG&;7 M:P\&7KO=-ENFUW('IO/!B/PIO#Q/3VY\?_;IC.)Y&/_D.(P2RA\H'@@3^HH0 M/(,>VB#_-/]YU?M@Y%' W^;IZ ,&ZX*I'Z9__W""]ADLKR!+;8R1A.SO'X(? MV:?_OOZMS*KGR ,3)025V%7I:!J\VK%;/6S8[=LMKU M1KOI#@;+\IZ968;:7U+,FW;-;+2V*.?WA]/>AP-WD<$/TGO[*)7#SS7$-]ZT MH'V_\ML_-MQW4+&\CD8Y9+?I4*GY*1Z'67?-0@69IM5VK:;5:78:3L/L>^U. MR[5[#=-UVYYGM1=5$(F-\S@J#DC9\W@%C637++MY^(['O8VN=@AY=K'NW"7=02.XKO^JMBTB, M@^SG@TZ:LVI6)G__J.Y%LT,GW2UZQ_!VK.W Z_5:[;CG. "QHJ^793L>:2\;S)\B_;TX\M_U-,:I;1 M"_OP\\8;0?BW,YYK.-_]))(/OPYV7*C5%'8C@62-$EC8)%5Y>A-80)$4(IJE M$%@P\-UU'']7(CR(^,L3/!X8&7_E29". MIS3NGSC9_L4[L C[SUPYP! 'V$ MZN+,P*B ZE.Y0B,Q%M1$&M]/+4Q2!3ZG(.%&(A/)%#9[)%'@" @NBF$\T0V, M0I(;R.A8CPF'%ZR=X M0NW/<1LO[X+LWR()B9[AOS_5RSP[G5'4*[0G(IAE-J>$.A&E1/E59,-$# 6, M'AE%?XT^DB%GE\+ 3:MX;??W00$H#HL'M)IC^B Z&HA\ATB&)YRE1VE[-:.$ M&@6AT=@'(KR(9(J-Y;*DJTD!D,21?QLD>6JT YC95Q$&8LRHC7W0<3%RWZ48 M M/!TK>!1S]VVU_[E_CQ9^,.P1]AI)S=#.+"OSLU>$O413+)&3%H)0-K!NLL MB6^#E.0;6JW#.)G%4L-*/$Y8S&"4@_:L(;XZ(I12;FIY8Y4"1K%(23AA8'J8 M\1R+H< ()_XM$C$..AB#R1R.#ZL&A4/-[G %Z_+-BMG%L*4OH!/Z!P M \9Y&'*.*4P?2-N?P?1^ +-G*,T_FHW3YL]_8[:/M#14"3D*U_XEL60)N;5\ MVBP1^*XP3E,&)7X ^%:N;8G6^^WT\M3XK=W^8HR#"!17 .S) +&TH:!\!) ^ MCA&(HM ?L"F,],SSRA![%;%E@8$R1@X-(C:FR#!,<8PIYC<4R;=R!,_@V)>) MU[_P&Y%:Q%*TSIB""+Y%(4_[)7.0$9";/XV$@H+%5@$ZNR$2;IRD+#-N1'R3 M^#,0E\2C!8+R-/A!&^__H!Q:H!&$%&9&1BI!R&'B+A#*!#:,/X")D(64YY\R M?#*,+XA!&L&5=$V>3>)$01$+;O@P$HDR/'A@#"6+0TTKD+@5F@.J@FL)P91; M1!!\Z>)P\7XR75*"JD4\7_\:P9#GN%+2AM'M&S2_%.(Q\HV?!L\Q2_:2OA@3 MFJW$>)R!X!@%8Q"G"/!, .\"#32)PXU\&><922=E"B'Z,*%- X/&85[(%Y!N M,Q^C3GD((@88&6&D"UAM11L#5N@U@RI'6%DI$Y1VIB2:&F(/7Z-20T9 BQ5W M5&%L*SQP>OHT3C.4=]=:TV_/)!+PT]EKZN0:0;[_>*[,W?^A>_?6U_^?VL:WSY>M'[ MUKTROO;_IW_^#4WI\YYQ\:7_M7UU=G%^N6O5KKJE#/HC":[SC"0]=1E(4>CH M%@R6BJ'21G\ODB[OT%<*B>22A/,'B4G=J%2_ K"0I_Y?(.\6'J>:4N$3^0D% ME/HS@-&75^)8[;1<+>3:ZQ4@/?3;UG]ZVFUOFNC^5F>JQWJG8\G#^RYZ.=8[ MO=NM/]8['>N=#BY)\%M$7;LN,3)S+'':Q_*+9LU;"RIV]^HOWG/:XI')=IG) MG&;-M191XO:3R0ZJR*F?)_'L,,N9&D[-:ZU#5U6#W:JUFL>N/>]&+NX;>3HUMWX8Y'E0=A^"D.)I MW9]Q$HXV):EU3@DFGP?YB?G M27R5&1<;[Y\-^S>*]RR ]=@2[':$RW8:-7L+O/N^LICED2WV' M^%B^C1*<7E_D[QR3K[<<6Y0 K5JSM9:OL_:JO"T%K-.V1KW@P61)TWJ5;$E9 M%2'22GE4D3@9YQF67E!&(];OU S?F,6)2I7DC&W,(:?BGA'F^24G(($PK9M+ M^!(_2GU9SSJ,(TQBETTIBB3+%)X3%R,I(@)_:H"#U>+:IQ2 M+-V^R4.?2EFP%#(,N/ W@Y#-WP.*@(<-2TY9NQ17M:Y8_P&X MPNOWO+ :S=/6YETO'D @65%S_[0.&:<&G\WA6(ALMM3FP]I&FX^=AUQYXA+W MY)HB1Q=D3:7 :NT+&L?2WZ6F):JF\]_ZEQ27L(MY0B%=ZIGUL4XEC% MYO SQ>=V?[FWU+_*+<$>7GCK]:WD2N#K>3&+5"NI[.582=\&>RM-9?NFF1\D MB@"X0"Z'MX%]=I=A/ROC'SZ,F8OTRB^ISU7DR[)=R='P#"J@HUHY)B?4;2-C MEL/FR)%0/7Y"M;ZC($%5HG3'4LW@C*J&^01(=J@F1!^PCO06F ;++#.,MB%O5BO[-^A\Y;A;Z7VU M"=C33V;+VX(IP@+=SW9$+VRT)*"S_-$UFKKT 84/;3#<8D *D,:S4''VQ'UKM&7@;V5B0W+\VOP;<(?!3P MQD2 (;$MCC$=Z]3:G&-D.?@];(ZUT[@__JT?A"30T ZB,O(%IZD"B8(P!8FZ M/\A F##VDT(U8)R5#,RGE+7G2(P#3.*F>O4@ND7SBPK6H\(G!,(HX!T(2P*A M2)07&Q!0N/!DGN"59@&_)+BL>05KIQ0@?'B@ZTQ M#&88)\ +(\%&#GBS/@P3OZX.4@VP0@=^&2]01N8C8%3/08)94!_-!?6Q4 7[ M@H&H7:LO7P327:.^_%@F_O9VRGV6UR",[YYA92V/8^^*G5NM4\OT7.?%^SNZ MK]G?<(?! M8P=5$5/HM5QB+G,D^"DZ;<^+6C]:)I"D<] -Z]Z3P[6G5&@Z-:^^3D'6_E#A M#GH(6XV(RV#T/4Z"1+[?ID#=LVI8LVG5ZO5U).WN*?_W;& ?*GTZ-;MU[$2^ MZS.'9S>AU_+89,=/:9Y[7P=0%FC\E 6?A"] M43O<4P,=$]E%A?*L*%F2IL;^UV@O:9@D=::=T&X]BH*BU] ML,QK)$/\4VZM17]%64Q9TEH7UDC)E(_3S:#B1%<.AN,&2Y2C#K/*I'^78 MG"]/2&=+]@7>C8>!7U1]DWB>SV>A85W1Y+ MGDYE:]HPC;5I49,TK!WCOF H8<8@.?"G\D:4)\.A:E>&W6,I253**)CF38*R M!,O/XS"4C3!!9,5)M@>]AQ^V"K_)@YVSXF!G$XOP99LZ]9B.CJ9'M;SE#@LF M@XW*K)JGS@9K(ALH4_->?Q8@[!/V]D.P@CQ!K4Q-%0MT".)3KMID88+U.7_X M43H.1#BJP<3'+N"IMCC%@$ HDYC2YQLTJ$QCN" N>XAE>@)@& 0@/>"67 MVWP5UQC76X/W7XM!F+B(V/FC3KC5>,3FU+MQVW%5U(-DO.'@D);-#2L%7XN@ M[Z/40]$I@^)L:PM1AD>JIK899!BLA6G-JI:LBC M:BJ&1(RQ@2=L.J?VYGH)#+BA$".]07F:YHR70_57%*/DVO H )X_C[,*W '! M 2&(#3+LG9\DB(BDXQC5-M&]IGUJ;3[)ZSA)J+LD5FB*A$20G$X7&S%GQD!7 MD*H*_M_%@V)N(W#6]PD#3)KO9W:A.2L^C;V:22NLY*3L(@W7;2D MVE.61@P10GVZ1VJ2;7"JJ(Q\(^:I;R"="OE0X(I@^"FA O>YI+(-^&'IN.6^ M)@@_-;:Q':2<5!/L@/0O!L.P>!PH*2V:E+]N5_K-=.F^6+$D?38U7)ON%B0- M#X+6M= (Z48JX2D"=M.I.^X68J4\B.U+V@UU8G,;^N,%F'MW/(>56J*Z3YJR MN,]>JRWN'S^.]='O8G2S=Z>=ET+0U(SFFH3#?^+EG]"'#89(2B=&#Q3W^J0H M53O#8V8RKOZ?_^%9IOL+ WJ*2,)N4W!A;>$GVF<16F6Y%,=VF&](XSE!9I(:B[UY7/02+9 MF3J^ZKUG=A28Q+#),--!X? S?IL$ NU&A003SHTP!ATC4>"(-E+X"J>92A#5 ML4@0\@U= #HB0$-!/1:6X$]!R#@(\ +R,F//S<^*"ISP0'7VSAM;A!5))%41G-'0^@WBSF400QK4)(F#Q27S'Y+.2.'ELB'Q80]!=M@:'JB"8D$B-<9[07%;1 M*OF,&P IK5+%6Y!NJX&3=G)0.X7FM%C8?T1S>G$TIY=V$\(R+5'IR]Q KH\SR9Q G>/*D=+# FG MII3/-H3(MK1SQ(V@_K0Q:D;T%%0K1Z X;X1R$/PI(JGC (&@KTQ M0]+_\L.UV]7BL64 ([%<#MGM) MT:8E'MR'9FZHTY+JB6:YMB/#+(,34 "%2F-[.JJTB/4D'EYC*]LH.U?JBJ+65/$-_.!0A==L8+>_BQP_MRZ\? M?F8O#IP?(;>;?2)<[67"6GQ(E2(YRXIXPE[D">"P.+]!_-,GC4J!UA;M*\0B MHJM7_YLB![94R3S%0WU^HY*":C+6(]>C>:S](,-OQJ@4$BD:\R/C7T!LZ"G MPYC<\EFL6HFH!+;RJ1@4UWD?36ERPL+@5FBIO&H-XZ0F?4S%-\,@&>;3-$/? M-*T2MWQ8@A%#^:PIFN>^K$B5F3# V'BE"*73+E^N#9'M=FV8ZJCG\BL#IXL$ MY16'C>6R13FI#D45)#8J,Y,.NC_%![!_/RP&54,I2"ZD# 2@LPU_H ]Z@ZH1 M6XS,U"!KA==90!?C/;=QF$^%M'200O2[:P8!U'(L"H=06SE3;8/1HUT1PE2L9(%COBZN1+]C8J5%\)EUS3 MZ'7QM+LX!J?<= &B.)X+9'5ZIF1N+;A:37X/L/PG&L''2JR!&R=HS87H6WXM M+=!>'BKTY&R-+W$8#.>[EJFWR$B(9$TG._@%[6:Q74A-2[(H#2(91!DCO + MGXO[S[="H.\L79"RY2M4Q Z%/XC=4Z-=2[+LR7?&KD&?MNT;X?X)B!KT/TK ,/!=P]R6H_=+A]?VQ<8IK M5H/U3"S,'QH0/2/J+^=S%B<$>'20"L&P^D3]S%22$]2]%4&[(/>GI#^8UFH+ M.62R\8VD?E6CQ )?*B")P\^5%86/=E93I&&, =(UK-8@]@(?/"7P/%%X,;2H:/MCFJ/9.>4<=1 M=[R04H3H($(=5*O>*Z?&@ /#9-WI'JYJ#4@6:H0V6HG&GU9Z]DC)4*ZC.G+0 M&A>&\TK ^;[-IZC&'J2F/NW+5DJ.2+IRZJ;*80E(N6B&+'1'*RKGBE$@_ M-#LU_@#6P6./XH!F' ]S:8"+*%6F,ZL9/LP8 54@8H,J,9KCM1,Z0*'R'9S& M+,9P*HI]4!])/E,\L?KP1:9>I_EL!B(F*<@SD-_-L08IH-2 &I7\)+AGV/B$ MVQ.6)Y1H59)/E5'RRP3V'H10:<258W[4[:-!7(MYO%;!P-NKE(OQ^*3CA\3= MEQ,!IF(;,V!O1.5L>X>99MG6PK 0!=S,7Z[ES%*:F9:+ILU1W^,U716) "/1 MFVF>P%(Q<]NG*([$02: $\,3MZ,[0HZ3G\9X=(LFZ7?!'=[P NPCJW)*XD+C M"@GR\H -J!4%WV,CJLZU27$>?J_E6*C!VFI=H16$),K"*@]7RZXV+(>HO9U( M][5($+["#JYX.'UQ#:_3K"ATI8-L7P1 >[,D\.U6Z^G*.8"!\SO.OS+N?6C?T(;#)7 MI3\E/RTC3KL4$VX5^_R7,>&MQH2_P4-+;=_5*EFOR/45VL&#=69N?..'/#PW M2R/U!;<.HF_DF3*UVO..W6G4OGGN3G/#HW!J&]W6*%^VC9[3B34/]+/= M::9_E7/,,(;]SH7 >]W[2RLII#RS[)T2 6Q]_1#^TRCW_[WN?Q/W_SF-;LO] MW]_]O\;*'8*G=LT._&X^P?&;.;Q09J!M>';A]SC6X04RZB]UM7PQM^)#_;7Z MLI?'J6WQ2)5VK;J)M;I[1U;L%.?M.\14LMCV6(S2!QJ;[%S)9*^MWC:==\EC M)8^]21XK%5G)9"63E4Q6,EGID#V1Q78T[KEYPMP MU*OU-^%G[A2)[JIK1R5Q[H'\?(<87?.XI,U2<.XJ<;8V2JPIB;,D MSE?0ZF\D+OS6(AM#.OV(3BW3I\$GSH?FVPQOU*J=?7+%2W2G)*B])Z@=]3QV MDYY*"+H44B51E415$E49V=A\ 2[X+)[PQODHZ.#5=^9KMEO53;K,[IZWN5.$ MNJOR<=^HLU9BR'LA1=]A?*/1V:B"O*3-4G"^ G$V-ZI%+XFS),Y72*EIE &. MG=3BG[/8FX(39!^^^28=\OI^I1F6",^N$]1F?LJ[(J@=]3IVE9[VJN]+*:!V MG:#V$((NB:HDJC*NL7%<(YVN/#WJ#?N594[G.Y*(>T:;FWF<)6WNHTNQ9Z2Y M65Y>29JEV'P-L5G&?TO:W%7:?!N%P6\MBG$=I6ZPR<[D#A-NSN^=<91A%ZOG MG"8L'XI7+!]/_.)+L=&Q-H]=AJW/>GN<63EN-S9S!K\U^>^[G^\8*BM9]UVP M;F/#IK@EW^ZFTURR[?M@VU9[LVS(DF]+?5LR[G_JO-9S #\7A5! CUANU_RCNVU&!H/&S-05/8)O# M%4.R7I%CD)JZWP^!L_FS/88PBF=ND'MEO<8"@B;B>"((Y*^_'-0.Z#/,W%.? M5RS%7?+\[BS(<'=PT$DX0P5>[X6'P%O%>],82E=]([$=R*PQFLX-29PVI&X^JJ4NF]9M@G M%4*7#/L=&%;W(?:!L-W RP(W95)'2B7B#R)XIL62^,,:EM1\8O,(/3Z&QR; M_F#XC)@]I)BH.O^WEZP6 Y/'<+H'@QL)8CMXMHO\N"".KSAA9-X_=1.X3 ' MAUZ0C6&4/D]131H>6OU_;XW_GE2R6/+?=^"_GM0XR32Z"YT,K-[86=T6;QP! M0:>*?D&7S>8B3)@;@,2S@'IND.)S'6_JAC<":1QT7AI'0?6MD?:3@I%OA+1? M$%/9PE0N0"J+49RY\<)I59Q&K5&KV)(>5$R2@>#]"YU*X,## J1=]P9H_ ;4 M@S./@;C]N1M(.TS9?_"_6K7]'XY]$)940.<1JI5Q)O!U;><#ONZ _J1?#GZH M.FB2FF^<.W@MV*)I%@M45+WL!IC9J;J7IE*%1> _G:.*-AV?N&W\$2__R4^! MRCS82#QD;,/''?Q:<28P&QSD6*2N'R3*EC![4)!%VZ7"M4C>*\ =6TNXL9@& M#1=QKVP6=#_@:G@_:@?ES[ 2B'2-,1 3FW'@C[C(5E',_H^TRA9(X*[W9^8G M/M4D2W\)S2%4%ZZ7 B5;#P0#C>C<'46WXF>X$*S%P%=>S]0%PPO>!?3C ,?X M,WKWQ/5CY]8-,F*GI+_5FM:6$Q<9/02[>^.9/+O ITU6SSH)MXV>A/"HL MGC1,]2:/A.=FB:#MD(*0_5&V<&$?\9=YA-ZG#TLN?6IGC#(*GHU6PL2_%^!/ M.FLY[5N4WBU0>O<[4'HT)V)&(D9:!8&-WLI-3.1U-8VR *VE/B)LX&LSY9^% M7K7BW$U];XH+&2&T-X,U<],(U%(V1X7C37UQ2U854B882R"171"[B0NR&A87 MQ/XT"L8LR6!"))[L7#.R"'D<=['K$3,#"X[0WL!4[1D"L2>A8J M/DC=>UB.4$QHPYZ@&2K2.T%'Q-A/L*"P>R[X)P(,(E(3>,'F&J%6[;YAA?# M7JRGZ3L$,D*D2X)97;0 ?-H8I9"5ZUD^;QH'94:PT&I\->&\,/[O;99&N. M.'V\XW&,0/:C.W/]^_#2^=2[OAY>7KT4G[_D!/H(EX'SZ/3 G5+2_35Q>N2+.9<"<4OT0$ZC>.;4:X=_U^[)Q$_P MP60+BQ"?LC$/#X0G9B,1VR*A?KRY;)JZMZQD<)JQ3TXE(SJKF'#7=FX%*5X* MC 3#+,X8 K H\@IC+VX\W@>*/ LG&'^6+M8-C!IG$(H[FSSG<11&*%$9MO/S M9$KN>GV+SKISZ)RXB4_0P&=0N/!2'N#&Y(<1,V0]Z2RRPJ#.!)V?R?T<@RTF M.)J&F0SL[?FA&WIH+B7P?I[[LG6D&@T3IM MU^NU?KUQ--Q()I-- :36CRCZ:;C670)5UFWVTH1?20B=70\_20E==?[QI7=^ M?7;=NS[[Y]#IG0_PBX_J\^#LJO_QXNK+Y?#*Z9URU%WXCD $3+@4(7..9Z@(E6L$KE <[RW&3J8$IL0E2, P2B!OZ' MB=I#?7A$/ N*.,"KYC@6G)[--/BR$&2*FR0"8Y(BC&8PU)2-FV$61XGSX6#X MY?+@AXIS@L8[#&R.Q;GX_6\GG_'[JSO@*V<"S_7PV_[OI_AM'Z3 V(>]&B.@ MA[&3O[FP=^/C6!:OLAA0G(C$AAI\01IE,EL ]A%$[ L7?D(+X$;X4DVS/H2 -_#@SM_&%*/MAW]$F9IV"BT1O0,03KF>V3IA W#@$^;Z)2GC MV]F"T#LM)LP1K5CDL;3=:I?UMELKKW7Z$F=IM;F6>%US$R\S[&.(,#S"L>E" M.R++%+ZH.KV$L"^4DY4")RU-@&CH1TD_>H]I#&J;6)*Z<\I*29Y*W!FE,&&2%;J0,AWP$@%P7$WR&CM;#O)J=C^SF'QCKQ&W=9+% MDC&TG_QB"/EV+>@9["@&P1:08\:^0IRV+(2+%'!]'8C0A&S=+['FUEUCSCE)Q"IR%&B M]222SKFH*SW;%N)5=-P2\6=&<$SE 2%N"6\R4] L3K+1'SB;3+(X@U.\"IB# MP=$QRZ"811QG@QDKI/HQDEO.;LVETOBH:,PW"B08A0Y2*,"""%G1",JP!!8,]H0!5[GJRN743L=^S"(G8^DM M8[1C:"-^HN0^'"YB\VB+D'F*?PS_S$ T!#:>\G30^-!91@*T:X*95+8;OVQ. MHJ[4NE'6>&C+](LZT\4J:4 RJ@" MF #^-RP5@4HPW =?DT_4WY'HG12.L& Q'G:VM(3 B00QW%/$ GAT\ZAGTY25 M/GV8*MDN(DN*,]5XCY[^S*Z,6VX\FO/(28#W_ GZ4V(0J%3:#:9U;Z[6%/>963G!^.LB;8F"P\ MRM\($-II:?:LA$$07!=97!!/M,AL4"<6E $K_:5Z594.OO/Q[.3BDDH%[U'K MJ7H;]B8SFQWIH6MP/..M(&$9T]_&50PR@)MM3*Z\.*-DTZ77)G?N/,%\D;R0 M-0"355M!(U"DGI\>#(/PT$.ZT9ZL3@-]#0]AFXFA1:5$*[7[S,'6&N<[@AW& M/JB5LKQB]]&G9'3/39Z5#KE=Y>4^P^'[RW'M&:_6B7,GJF0(2=]6\8;"=T;; M5X!9"\9-8I5:%&P;UEUDK3,*(:Q8BD*,I.F5A=(-+-19C4&RHA&Q^2XUS+EE MVS$;"".A%7@H(>BTT3T][G=;S5ZMWA[4^MWFH-4]J;=;1R>]?KW=V&9"T,L& M"UO@,U^<7U]>?+RB0.'GRXO^<("QP9T75"OF-41LP%4D-@#?,F"]A@'=. I8 M[WW6@,?.S[%8<\R6%[O-/34+RR& &.V^L4![E%TF^/T6:W71) 7!3KF- M"3R&JC'H#C^7!4*)R0JAD2]ENP\%FHZC]4#T,\"'&2&,;F,5" T'O?L*6)\S M-',4VLU7PP>T-26Z0P MHX,)A1K!AC;I3ZI$4J)6^MVP.#,_P7Q;#9[&62"O MPKG(< 5.+LF\:6Z&&//RO&PF"T.YC'HVRT(PWB4TA1,U()@=:<9?3%4/F#%> M1O9$- ';7\1R0]3O)C0@?Z^@MK1"M!7*!<>@"ZT$&(1@D/H)^; F'T?OB2&! MJDWI:\B!ZD5ATHAX3^$-=R((#&7@M3(J"%M%<2A)*%%(X8H5U()^!^6:4Q1[ MRG3&^4:_!.YBY5%ONH?U]H?1#_E*N"F%H^+8I^5-*;JA!7-%EH%28" #FKLE$J?U MUN5@%)1 MK$]AQ=B0FF+L $+=U+NA390D$HL]K"&\PBB>98U+-L]RSXZ10;=SWXJ-&3;(?2M3V'9!##V9G9$5=0V(FSZ6 M4>]$;$F />-;6S>1@;-*0>V^TEEASO<-%$4Q$T0BI"7O7-S";I_J_;]4X>57 M3::ZQJ 54T^80\XBA?F%G.3$)@ .V9"LB8A_((-DHB#5)04[^<%2FK8N_D%2 MN4?H*]B$8"%+^^//#'2H4,G_1&^.(C5^.-U*#OR**%L%8X[H/6AB6CB!_U4P M3+ET0^5I,]Y]:L0H'4'@&% F_T>E9?JR2I.,%AT17[: V* ) EG2S %DE4- MHZ5+DA16>(;3?M#BX)H.*VV.UE>$MWX')\TF^UNI]>O];NU6O^HO^OPQN?>Y;5S=E9U MN,KI[/STXO)3[_KLXOR!.?>'K6>VJ=3X.?^M]9"QG.#@[_^T)8,Y6.,-CM-#K-1KO1[AQW!ZW> ML%/K' U;W5:SNX?%@18M]:I4%N"<]OK7%\^H%'S%WA*3"#$4PDHPSC8!(1W% M'$7%!+PQ)QS;"00$!WBQ/UHJMM.0DJFP8TU\AKF/]5[%P2L:M9\QBP/;=N&K MZ*OZSQ01HB+CW:W%XPH(&F62C63JE$ZBE0H;9Q (RSW_-A2'U0%)YK):*MR2 M Q- M=6/FRW&PF:T.MS4)K=W9GM& O$Q+(8@R\5X[IP0AO0G2-K,4 ]+Q7R#0YXP>#V"@Z_UNNFL8[^Q3_/!H?U8P=>-Q8S MF#*ML)7+@!B="O7(L@%P;#"]U3.)_$P2=*O.V*+@E\[Y0BR8 #\@ S^LH'^F MNR149)L*8!U/$%$04.DF!0,H255!.6Y[E,QQJHFU;QXL9S03L<0>N1B!<_0P MA7:<>8S_AMPLDP>'52T68LII\'RK;?&N*FE0QM6:.H;*RIH'YF*V B/O*SJV MS_'47HO"J!D6>Q3UNMT*ZU]1#$OUNW #$!07\8T;JH:&'Z28_-?O%U(Z_H#; MCPF1@H,"W/CI5J"'!R:M"X9MEB"P3A[-!D"U:?'EW3'AW6 MC_ICV1<%O_@2^M1K):6 )CCI@8M.E(L5#!SV%D!!-Y0@X^>]@94,4P4OE<#. MR00C(9A+(>UT COG8.B/"9J1-U9DOJWL&4NGO-&E=[B.^783/.#J5;6B8ZX! M8:$PX!DL$<$8Y@;T_ERTF)".Y;(E4Q%PPKLS#UQ/*#5%/9VMRU(0KN@9 OL4 M+TEC%W<(8[Q JI*RM5]A');\!8DWC6 1) @C.5(6E/E :* 6T\6<4YG47%@) MF/QV1H5YG8DSL2]9BNZ5ZJM9D;ASAABFG8&E952^2D^WA4@7]OK*&JCB7G#: M,GGK"#'!KB66\I&-UP+<8.I*)<5C+##\12Y<# 0&%$"?JLYO#VP\62H8J9G- M585@KGQ&ST>NSF@!*P//Q?Z(;&E@"X$LP!I)11DX*+@DP73%4*2<;Z3U.3\H ML6FSZIRRJSJ+8A#$6&Y(<0Z?G5Y*0EY\@W[U0%7]X!UP:ID12Q/J-H*74:;GB?.3[#*5+TL M5$FCF V>R!(C0Z]$!O>I=/M93VEQI'<3*^VX$Y#42; &UZ LS883U0)=BI"2 M5.358P%,'LUE_I@*(T]A>8!HLG"._6L]V1B'"I?DP"H,/TIEGZE M>R1_*%+*25?$U-*H2GESXAYHEB6@BK1Y2'.8ST:#QTQQ!7["_U/!>IUZ6YDN MV&IM#E45"]!3A6"#,5[@SCF)/(RV2. MC^12RN!E&Z%H8QD)1K,$#DJF_D2%./V8G\9=B:3]B>WM9,T%-P4S]03*X )V M2["&,"+W G=0MO8B$D%_0[;%P5%0\9.-5>& .QUL,!4*"(TP2S)Q2'N;>13"37P@N>3+8AY ML)XK>[XK04;Q"/:J/)'D=;\1:WIVX^@N! [DR?V(>V@T"/!N;YT^66&CKK), M[3=RP[< U*^5YJ#ZAGGX%D[\)<.Z(BMC;\A&UFX U[2K:AQ\ )FQSVCB\BHH MP:IL4&1NJ\T]\'F&OBT%MFO$T@9SQ:X;[H/O\0&X6&'*EF&\:R$X$=@D%*J7F++*D"M4_FZU6\HRQ;LB\ MG+*GHI1$ 0[ \9,?BA-%ZH8]4,9?E9K\T$.QT&S5[45=83"+"(4)L(\*!J 0 M<;"MLTV\T/8G'\+JJM63,>\JI=:ZX5H/0V[IG#4%D)(SB9Y,Z4A,>E'H'KO96#+ORQH>X_-',E"E]!": MM(P5R2P3BP!5 IMJ9\"XABD.S.MYI7(V 0,*G0ZD42>;*U6(T#&7AB2V3,E8 M176!#WLP)K,K-H*\P@N:X.Y7Y $$[&%9O&R,SC\1N<.Z67WE+U4O*RH8KCX$ZG M8W@J,;S65W!+0INO3$'8+21*LF4U?O#Y\U!!!^2RDS5]2XQ*QJY^'%Q()T/[;J=HLU7P9 ME*170)4=[*,7:-6/!3:>$IT)O$N@T&'1W)O!/# ^BCV@!?=7N"@G8B M@>$DI+_0ER$HM@=.8N#4CYX Q6*O5T05$(N=!Z[TT;GBA!.D]9@27)!8&HBH M;M4^TDOP&U MTW9$9/AAU MM0':=N/MV84NE$R^W<[1@XT\E>%D!L.*ND;$N6WXPP5'L4_'7$$_KR6-&0"_:M$:/1P/"5.-)CM?A:''('MA(M>Q,9=^' MF49\UA"R[JTB@1/+B";>B,D) ]F%X+II1V8EG4FK7P<3T3%0+@,Q#*F*+\ER^!D9$ BNH_F $(0\ MADTVV0OUTJG?\ 0'QL,9AGYDXSP^TV<9']V+,++%.14[[& E5JK2H95.>6%/ MR$NEW$*(9/$:XGL*5,.- 7HO!-Y^3D>"A(B3^E1T?"IA6X-XE MLE#.4(YIS\1J7J\7V#>"XB0%_[0"SQF)0/Z _5(I.!&.T@D+(E>*:4#,6,IM H&APDD#>+LYLDCB/5 5TRK9AD:% CE9!HK0A6X=T28NAX8"!RI$D? M#O$ &=C,JW89A3^VS3:DC=W#*#HS=77K;!3 T9B"U'(I(Q/N,K>2Q'TZ+^OS MIC?PM8I'5!=8>U/O[6%ID#_"K=6E]Y+==/3SQCXI-ZC,90.83@:HC'\N5W:S ME958KXQ$HX'N\Z%S$THD3%T^7<8H+"NB*!(0#,".Y>)ON/A^B#DOPF@X4B?4 MPZ.6:/X\W2N% M7/1RZ3?5"2JERT2IK/9[8]E3(4M6P%%[X*TX_,^_]&%4(Q.V9H!2YB1AE@;* M81T/?:1Y^12;\G'FXS+JP.8P"B39[DL-=LT8$<>PK*=M#&%U*+6R)I:ZSN5= M&5G=!S(Z 2L(2 8M_RC>8CAIR5"RF>HFNRK1$:[0XU,;,!-Q?[KF%0I<]>H00,; M"[SL5JENDMW<@*VGO&X%0^D<%)DF'<7FC$IUH.Y8N)@3 WPO^(@1/_PCPT!' M7%%/F[F!#@SHVF,F!-W2TA0+<]5%[E4/OXE@_EC(CI*":@%SX(C55]62E3F" M\1,;+E#A!93-MSZ>:(5U3QJ/$08LPB%/X8^;J2G]\4..ULBD9[D=AO075C)S M-,(HGE%]5%/4ZC8KJM0JP<:?GHLZ\$[V] P$MN5)*FH7V;/R(IB^C!%Y?)K, MV433 K*Q[AZ;!Z467)#.TZ;T$:V>U/&>*Y*HK#4E[(D,)2TX",+@W;=298I< M315VIHT",AAF&U-0P6I*(,,/".-7'C7.&>BR&3$J9+K;Z* MXT.44PF25=F$%=L@K/"\)YC)3JXL/,>Z7V^./!0CHBP9.1_@W@GG8^9*D:SD M6;50ML^:+I\D8/(-7RW$WT3+\[@@SR" M BU%/.QD004C0BDCBPF9EV2&VD+AJ!HWYJ*4Q6,HB_#;?&!+W279FLI8"MJ$ M.'E&I,WR7QH@K)*MPA<1_A'YVERA0*)6>+=^I!'+28'["E732X1,9@-G1WO^ MK<\V6^SC,1.!.8T6IHB]XCAR(/NCX*!4XB 1="8M0C5EPGIU7@/2=$(M6(PF M&F!0/%4I#G]#)RTYD+5F5*N6VYI5;I[UJ,!(LBIIU' MLH%$ E4<8K(1=#.'HVT MX0J>W6BQ$GU8BJG9V0!FF*2]$ZS[YXZ((=B?$?LR]$T>2\C9ZS*K/3^.W"WB\*';GL5;BP3XT9U^0F=F?F"'JS#Y3: MR0ZAW<>C46LTU",?MT-D;GT:?#GM.6=G9Q6K ,TJ6LCQA*E;4:LPQ')66)PI MF5^7M&2J%14LT$>)O0$MY,>#5BZ0A*YOUEDJ.:!FEF%W[Z5]*+IYA F",9U; MW!X76Y)V,!F4!30IR:,Z2%A8; ?TPE@4B2N*#1I+CG27/F0BXD.4"@,GXL@7 M#TK/7J>_Y9U=-18+&#L+5=4?9P16-)P;"G99P,D4\0P;=?D3>_<"F7]V*[XU MSKOI2H#MH6W-K1>SY9GT2]V'7T<)<["<@=!E,[1#H2B"[XH6Z0:37'>WLF9' M[H^"OO2CR=^U2S4]A005,YF>"3R#Q5B:%K<@XTME@ M%B1ODPCY;@_CO4SB1?RFF#M4U-4KBIA,^7TNB6\/-BOGCB%7/:]W9X/^@>?F MT](5LGL:12"P,(VI(GN3)3,\'(ITOM+U&T?13@=];2.@KIWY=!2MQ&]M<<*( M,=97&G&)_,[5R%R$E>ACKL9MAPBG)W MEX$6-IA)9;+5K#"'PDA1GBR-%0B7Y\U!9(C*NWYQ5\3]O@*U=D/+Z&Q$ZAAB+"9 M/A:WD;3M*9\^H0PG=HOLMVJ; S0@G3M#]*D T<3E4-6:Z*>U*;^!8,># BRL M][,,^.4V'6?].9>!JK=C^(5^79,$JX[0RJ6#H]4KXZ>/#)]^(.D>)<(DU5K) MLOGB/HYG]T8N)=UIBJC:S,0("5: 3*(L*QRX33D12J< MIMS6PK@&O@QJLM;D,9'G$5H&=BS4.>P$BM!Q+D3J+$3HVP*FH*-&,"&>C''/ M?5NX5HI.&?IXLIDDZ$KG0_,':(E73)O,(PGD2)?(]5)<@=%RL(M.PH6MH%QY&OX^PP$GW)M+!758; MDEYD6AHO&Q*MAS,P UP6N_(4&\34YX$*_2E+6>VAW.05W(38$B9;41]-4^&J M]EZ:E2DJ+=H8W>%O:5. N;.$JQ"X2!2X3Y;7XF.LSRV-- ^_#'J?A@-GH);G M6[>2((Y Q_.:@=T&>X MRE.?"[F;:A%6K),]S6M_!D,\![ER&8&,P@;"Q15*8_AWK)Y_YX_3J_*\? MTS'^*/_XD2[-70ZRB32?W <8U=/BB[ELUT9K.5?U47M6R#*5<38>^_J1?BL4 M^C+TI8_5R#7!);-]64ACD1+9/[DD20N4QB1]-/OAJZ]"S%?G2AJAM&J):%=_ M)"(L:?%]T>(,:YDL;5'$:BH&NF;4SPTI#ZU29XZ=JBLT-=H;2BASZDG;?-^TBJH!TIN@-+4?0L+YJ\JB-.1-C ML=LH3FP5'^6:M_\5,XGB&W\ISV"9Y';2@L%CC"@9<:W)XI%G1$>Q!V"NH,U) M945$Y*:)FEK:V(H>)\[7JQ$XT6K:8KHQ&J)/=D8VH.\ZE>BWF-N7RDQYH=6ZT\J,>PU6/" /.J M%8V5G?.C;"6UIDV&EK_%UG-Z:)3FMI X'Q^<1H4CM-"$C17J9RL:QK;SVN10 M["PVI0^JCG/%"?WTQ"=%Q%>MVJJN*V^EX$&7&M<4FE7I M-G25Y:-:U?U$]MW-M4^(<]>1.E=%]KJAS=A0>ZG#T>.5I,_N MKT"3:PZP6=I MU[F!,DE%, 3Y6$5^J6_78G!#77HNL.KX1J1)H='6PZ_-T8M\ -4T92F?+1#3 M.=52V/JQN2:$)P=<71=PE,X:&2=>+D=K=15!/DA+G;@J\D1L$&EQP')3=_53 M4S1];M4I#'@[S#/&$B/8->RXQBTA8-:QR]W"0I%A)H+5E@@1!!&E%'G+M[#9 MB-CM,]@1&I?U@C)#F*.8JTZ14IW&O@KJ3$W0OX]%+#@$TY3:Q<>Y::X#/Y$G MMHVT>MIK65WH+)6K2^%]4@=75%XGFKX'C'^]TI; @$8@4R/-J0[4F)M*FU1B MNCSKPZP*6ZM4MD>M1W#US2$]O#^+*@;B%Y8?3-O 02?!9F7L"VZ@R#PZMII? MY\XET?GQ?JY!>NRBUI#LHXHK\R=KV!0/A$S^]]B,59W74+'1"IG)7I0CC^L< MOB;A8D]/5,!^@G14"W/:*,5*7XZ^61K9*>3+\F;0,@O=QF 1ZT9[2TUI-2Z59RKCUG-LMR<:VW*\H$ M).L@H\-)7#12X&$@ 5$C,51ACC["SR)E*U@GU0644RB5V+BDVI)J3;&M[,1= M.'2'R4CH:IA)(.[]D3:%T2L)9>$6I;.K4-PTMF :?*%L]\+(2Z[!G/ALU ML.H/%"Z'*;\8A7C-X.RV5A!MYK4^2RY]DZT>/EJ:6YP1.]K&:EU0+;Z#SN*/^?H _8/5>GS1>.4+6V M4A[+*VO-5F^]#5N!NRO&7!)_ R253@M=,59(1IE)BRH\%#<1N"),*WQ.Y4J, MG79@:>7-D:7Y12#Z)366S6+JT\_7@X'SE7OX_#*N3AUAO_XM6YCJE=QL*YHB- UV]__ZC1['=/FLU6O]%N-FK'I^UV M_^1D>-IIU>J=XZ/]V?Y6U?ET=CZ$;3\=PFX/SJ[Z'R^NOES"=F\,5[W(+ Y^ M/X#[OCM*O. MQ?7OPTOG[/STXO)3[_KLXGRK._("UL9Y%#ZT+[7C0:O6[W2.!L NG9/C;F/8 MZ/7[S7KGI-9J#>J/WI?#1'B','RLK/HIR6:@9K854EZQ$T=59_C?OY^=G%UK M4V&T[!_5:S"O M$46K#[TH"-QY(GY2?RQ-V#A9< FNVB\']8/U/I7UB@>N*O@SS!<%?ZK )(UE M?]'^BKM.-WC]K"W9 A]=BHG@Z"*8>/*,]9D[UBG*P_LI^.,IF*IC<8\&)*;0 M:1)[2O:;[!50HW]X)\9@G+$Y!P03"BM!;G#:;!_WAL.C9J_3[O?[W4YW<%*O M]UO#[O&PU>P<_-KJ$@<_><+?]*P*J7*;,$_CR9LA[^"LO W8=XMQF=6#V*DL MSZ/G9WDJ/=%L#(Y[]?;1H'?'S7JOJ"?*]-#M;N8* M17AU]MMY[QK-PJ?;("\;L?RK' MS59%WLAI@[+*<9QA#CEWF);%MPB+J%.<8!9BK-J CL34#28J&9!\#WD!]23* ML-"8GF?Z<3TA&&RF?/S4-3J6>!]:^L]QU?;.XCAN5[O'(#<9'JUO&AY' MQNQ8LDFZZW]K'*__K=79$5,&X1I$^WZ:^F/8WY_EKC9JVW'H5M'EPS!T.==R MKGLRUYUBW+>VJ>O-_.Y3I]?=O=GMQ.YAQ.]UMVZ+L,WY]?"WRY[S\>QT>-4_ M&Y[WAU?.[Q7*P"UW>/;5Q3,VN1I'+RK>;^;N3XJ'6$_ M6/[@UX&;BI]V9$.MZ=$EVYC?)W?!&]GA2KL=F>K.:";IT\FAU^?W#J4C.PK) MW!,R_C'YT?F,%9'.WZI.+QYG?NCONDYZ:_*XM"5+6]*"$TMN++GQ;>_>/G%C M++"YJ>Q#W)_Z8N(,[^DLKUOA7/!Q8"6+EO-[<_/;(R;]\%GG_2[QY@^[SIPE MPE(B+"7"4B(L)<+R=A&6OAO'OG ^XOFNF)H1A;NNE=Z:1"Z]NM)@-'>4_/B] M*;;DQ[>Y>YNSI*[%_"=6B:["74YU55^)NY3S*^>W"VQK02]+[%E"+SM$R^5< MR[F6T%()+>T2[9;0TO.AI;^)R206"Z=7=3Y%B1C%4?1UU_7N6Y/)I3-;@DOF MCI(COS_-EAQ9(AI'EBJ. 9RPN+G. J"$E(JY_<&Y[='K&KA23W/ MB[*0>J)]"U!Z:I..+0QT#_IA=+;6#^/;?5?*?ABOWBUJ'0VN'<8R$2X_T;H_ M)S%VL,\"'UC)PW.S-%)?L+2B;V0KAN/J4>WXV9T8J*7BPRV@Z@^T6UC_4_=) MW1:6A7EM5X&H8CYNU(P0I4V\.^&Z>'&.RI-9OU M>W%_WZS7J]-TME$RCGW,-5K##Q18.';_LRL^/U0>VU1KZ/YG;CQR0Y$<7MP' M"(URZS,8:V.%?;VK.J1^]/)R=1=+-%Y\WF]0QC9*&?O2,O8["-3&"PC4I;2I M4J"6 K44J'F!VBB-UK5(',FO\^N?SHG(5X>+TGG$'D M97A"A7,HS\25WX_5]^-()$[(!YX)-Z8C'^'",\P;P,-VP;P>N*D+RB$0SDC0 M.15T% 6])W5O$CK[6@HN,+U?O6GK_S#A5":6&_*8%YU?^] M%)C[*C"OW7LZ*-89XN&Z=/SOE3<5,U=+T%)PE8+K;0JN?N]C*;C>D.#JNX&7 M!>S@?_3#KR,\DK@48Z48>]MB;# \+<78OHJQ@9CXH5^*K%)DO2>1];%W4HJL M?159*RROC^Y(!$DIP4H)]EXDV.?+82G!WI $P[)Y$%A/=!Y?LRYWU4G3>U3- MN-52Q<8W2Q4?.#3ZN/6\W_?*,\BR&XL0,_"@RR;8L7OU&TO.%)\)N7 M+*LZFMRF-(\*G'S8W)K.)EWFR'^NI\*9Z#P8/YR@A%"I,A@4O8E=D(L3<>7Y M(O2 TW^/ AQGHMN,X,7_R-PX%7&P<"X%?)DZ\-TI/,JIUP[_X#W?".[)SX+)(Y'!<)\QG-5-Z388"RU^"N/Q0PXC M?Y":"F7S298 &26)7&+8 ["_PYO,O1$__.1\\'_@4>!"]R.DF@0>!']1"S@7 MGWH%>DZ@7DMP=R_F@GBRF^[19CV5XT$Q5X[".>>^(&%&2_F@J1 M)G23NNNS&\/[IH)$$$?6T\AYTK-NGSJQOIM,G5,P>^%VG-D']83S* 4"AO>O M>8Q)"#,/K#A^XDRR./23*5PB N&E<13B=(#:E7"J/I[U=T+^O)#Q_XQY?X=F M$4KR[LC(7G<8.]71I;NBH\O_4A]&T7CQZ__^KQ^GZ2SX]?\#4$L#!!0 ( M &.$IU"?QOL/3B0 )R* 0 5 :6%R="TR,#(P,#,S,5]C86PN>&UL[7U; MG/KZTE9C7]YB_X*W[[Q8UNY M!_CK]\>G-:V=FU'T_?G-1>3[U[\ZV< M7KWYW?G)'V]"75V_^;VJ_RAO-0#S2F^:7T;E^(^_I1]&3_R;[Y/R;Q-[Y:_U MI\KJ:=/WU71Z\[=W[[Y]^_;7[Z8>_;6J+]]A",F[^UHOEDA_@64QD#X"" ." M_OI]XMZ^B2,<3YJ^6W2R+/[]6?EOI"F-E%+OFF_OBT[*505CL^C=_WS^=-&, M$Y3CR52/K7_[C[^\>3.'HZY&_HL/;]+_OWWY>-](.9[ZRUJ/RN#_:JOK=^G[ M=\=Z4D[.PGGM)Q'\!K-(0-/.5>W#+V]+74_CV--HYB/_CS55IGWD_+Z M9A2'_*X_FLZK46E+/]F!MJ=5>Z)Q-BG'?C(Y];=^5-TDSMU(V\M5!J/I:#+Q MTR/[_V;EI$Q@_*KK.J)RZT_]5)>CS7CNWN1@8UI^=%)=FW*L>QK6%JWF'%E: MYFXV\I&G9[6]BJ+DO"ZM/QJ-%A*NUQ%OV]M@2'S59M1BM6^JV ]]$:#K11BZJ#T_A!E_5_Z]',WW\ZC;]-2N?K9DZ/]2CM(!_' MH:JOM^&I(?L<')5M1<8.30T^AG:KI'4#O=%[4_LK'V?[-DYP_-Q_JB9MJ%Q7 M;5#:=N"%;9H9E/8?(OOD2L=YG7P<']FH2L]&28L^FU[Y>D7-X[OT836.3-%M MS'UWGPNKYP5ZPV%CTX..L;5,V%RY+SK'+O;CD^291%W<)<98R/^+*^^G+8AM MVT(NBL]U'5GWRD]+JT?=R5_9W(!CN8B6D6\VA,BN>G+U851]VVT6UK:4:P1+ MP7-Q%7&\JD91R9B\C_;)]*[[F#:WG6F49S<+U6F^B>^XQ_;823_C/O5FH^'\ ML$Q_O29%J-9V.M.CSWHZJ^.4-N*OY3ZP11/]T?Q9?R^O9]=?JZD>?8I&3ZTO M_9#L]"RN_//63\G*<9,IR*_@O[Z+T/!NOEC&MF2 S(0/B=V\7OT#Y\=U# MQ>#3=F<\P_4X("+;BX0M&AF0[@<*?QUWQ9-9'74X>W?Q3=_\*-^)Q7?J(Q_@GL?SJY]^',>^FT.2N:CH?8A;]3'@J-MN=ANK]D3CXMHOZIOOQ].H0#TX M$MQ(9(NZ_5#YSZIRW\K1*/;4'&E\'$^C75!&.)K;D(UPMJV?A]K[LY?)_+1" MC^\F'Z-A,"U#F:;X:?F6"V#@;O-@L^UVM&M[>4:SXG3N)!)T5XXOCZZKV3@J M4,LF>AKO[CWF0:2=^-NNE7XHGUO87_7WS>2M*-H[#=LNA!95>Z?Q8G9]K>N[ MLS"W!F*/\>-HQNY <]NF>A]#.X9\L4)?]-Q&.5S5+6XT5Q3MG89G6M/B\];3 MNFU+O8^@[:R^4*$?>CYY/?'I).^+;VYCSB,!=_,/-U'6HNK@-'Z836>U_UR. MTTE5\]&YODOZWF]CY^N%]3Z^7+00IKX^]@TVYLT=##[> M=CM+ZP;ZH;?97).&=1G&VDZ87B@]"R[:RVK-X7K5%UG<7M MOJZNE]>@D]_+Z=7);#*-X3FE9/0NMVXKB'9O+,Q8_O="C1AL_KZM03H_OOOB;JIXF%EC4[6F8V_>4 M!8%VBV:K1O+0G=RC%FMY(7Q^E#NJO>YGVK;MIJ>Q3RO[1[1??./HY\>3=D)B M;:TA*=M:)&S52C^4?XV3-9G5=TW?FPA<67@ .K8%KE7E%^FT>F23\W_$^E/\ M>U$\4;5S(.J\+_]]ZL?.NZ%Z6QTGVF^OFR) A^YMN]C-H:G9.N1R#P3M%A%Y M3V@BD3 -$B_OP_ M%A\7*VC^XFUU.2[_U[N'[A4+XR)-?NW=@QON!\9&+#.[;HZQEN,9:>-'O[R- MM!<#]UA YA0Q3 2! <$$P.D001 X2PE#$GR]$J@F8.J7K##2S@_EW#IDUV' MH5>1_[C(Q[$=S5*J@^605X"9FX0"BF-XB@1_3T_C;Q^H(% H+I4ZY92SD^,V MR#Y8:D>U?5/5SM>_O$5OWWSSY>75M/EUWHJN[:,5^#PSPJ+$NTFZ>$\M@G+J MKY?U4\:' ^2ZZE5,7H1VPY+8J^A9.17I9B7Y\<4BM]&$>>#-WI\$:MEQ(97Q M! L-G%<6,&XY,,0A@*"WQ$C-@C*'NEP.ES6K Y_#5[EJ&I_PQ;EAXZF6:]4\ MZ[A '"(&F01:6 @T5!1@0@U0WAA"@E92A=U7#?YSU1SD'+[&57->5S>^GMZE M:[+I0FX\,L8&7CPO]E\0A*541 '/?(2>:0HT5PX8AH-7PKO@]>YKB/RYA@YY M*E_C4CKUP40L_Z+5A4U:7 "$CA%�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�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end XML 94 R63.htm IDEA: XBRL DOCUMENT v3.20.1
INCOME TAXES - Summary of Effective Tax Rate (Details)
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Tax Disclosure [Abstract]    
Reported tax rate 19.80% (32.00%)

XML 95 R67.htm IDEA: XBRL DOCUMENT v3.20.1
COMPREHENSIVE INCOME (LOSS) - Schedule of Comprehensive Income (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Equity [Abstract]    
Net income $ 9,180 $ 32,756
Foreign currency translation adjustment (6,813) (7,009)
Change in unrealized loss on derivatives, net of tax (21,306) (4,236)
Pension liability adjustment, net of tax (68) 9
Comprehensive income (loss), net $ (19,007) $ 21,520